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Impaired wound healing in SAD mice: a model to decipher the pathophysiology of sickle cell 
leg ulcers
Dany Nassar1, Ouidad Zehou1, Tamara Galaz1, Pierre-Louis Tharaux2, Selim Aractingi1 1UPMC 
Univ Paris 6 and INSERM UMR_S938, Centre de Recherche Saint-Antoine, Paris, France, 2INSERM 
U.970, PARis Centre de recherche Cardiovasculaire – PARCC, Paris, France
Leg ulcers occur in 2.5-40% of sickle cell disease (SCD) patients, a hemoglobin disorder causing 
hemolytic anemia and vaso-occlusive events. Pathogenesis of SCD ulcers remains unknown. The 
aim of our study was to decipher the mechanisms of wound healing impairment in a SCD murine 
model. SAD mice harbor hβ-globin transgene encoding human SCD hemoglobin along with mouse 
hemoglobin. Surgical wounds were performed on the back of 6-8 week-old and 6-8 month-old SAD 
mice and respective WT littermates.Wound healing and epidermization were strikingly delayed in 
old but not in young SAD mice compared with WT. Old SAD mice had hemolytic anemia and high 
circulating leukocyte counts features of SCD. The surface of the wounds correlated with the severity 
of anemia and hemolysis. SAD wounds appeared necrotic and highly infiltrated with neutrophils. 
There was no difference in wound bed vascular morphometry. mRNA expression of inflammatory 
cytokines and chemokines in SAD and WT wounds showed a significant increase in IL1b (x6), 
IL6 (x5), MCP1 (x3), RANTES (x2) and CXCL2 (x4). Wound edges of SAD were macroscopically 
more fibrotic than WT mice. mRNA levels of TGFb1 and TGFBI were significantly increased (x2) 
in SAD wounds, although Collagen1A1 mRNA levels were lower (x0.6). Primary SAD fibroblasts 
displayed higher proliferative rates than WT controls.In conclusion, wound healing on SAD mice 
was impaired and presented an inflammatory pattern and a neutrophil infiltrate. Proliferation of 
fibroblasts and collagen synthesis were also affected in these mice. These findings shed new lights 
on the pathogenesis of SCD ulcers.
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Monocyte/Macrophage specific expression of matrix metalloproteinase-14 is dispensable for 
murine wound repair and induced contact dermatitis
Anke Klose, Paola Zigrino, Jan Gruetzner, Cornelia Mauch University Hospital of Cologne, 
University of Cologne, Department of Dermatology and Venereology, Cologne, Germany
Monocyte infiltration and differentiation into macrophages has been shown to be crucial in 
the inflammatory phase of tissue repair and contact dermatitis. Metalloproteinases have been 
described as key enzymes in these processes, however the role of matrix metalloproteinase-14 
(MMP-14) in this context remains largely unknown. To answer this question, we generated 
animals with conditional ablation of MMP-14 in the monocyte/macrophage lineage by crossing 
mice carrying the floxed exons of the MMP-14 gene with mice expressing Cre recombinase 
under the control of the lysozyme M (LysM) promotor. LysM-Cre+/MT1-MMPfl/fl (knock out) 
animals were healthy and fertile; skin architecture and differentiation were normal. To analyze 
the repair process, full thickness wounds were induced and closure was analyzed over time. No 
macroscopical differences in knock out compared to wt mice were observed. Microscopical 
examinations showed no changes in granulation tissue formation or angiogenesis in both 
animal genotypes with a comparable infiltration of lymphocytes, monocytes and differentiated 
macrophages. However, croton oil challenge of the skin resulted in a significantly reduced 
number of infiltrating monocytes/macrophages even though the resolution of the reaction to 
the irritant was comparable in both animal genotypes. Interestingly, a reduction in the number 
of a specific subpopulation of CD8+ T-cells was observed, whereas the number of B-cells was 
not altered in both animals. Even if skin repair and contact dermatitis show an overall normal 
resolution in the absence of MMP-14, our data point to a role of MMP-14 in mediating specific 
cellular functions such as transendothelial migration of monocytes and T-cell attraction.
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Release of oxygen radicals from macrophages in a β2 integrin-dependent manner is essential for 
the activation of TGF-β1 in the inflammatory phase of cutaneous wound healing
Andrea Schlecht1, Yu Qi1, Susanne Schatz1, Seppe Vander Beken1, Dongsheng Jiang1, Bruno 
DeGeest2, Karin Scharffetter-Kochanek1, Anca Sindrilaru1 1Department of Dermatology and 
Allergic Diseases, University of Ulm, Ulm, Germany, 2Department of Pharmaceutics, University 
of Ghent, Ghent, Belgium
Leukocyte Adhesion Deficiency Syndrome type 1 (LAD1) is an autosomal recessive disorder 
caused by mutations in the gene encoding the common β-chain of the β2 integrins (CD18). 
LAD1 patients present with spontaneous skin ulcerations and severe wound healing 
disturbances. Previously we showed that CD18-/- mice show similar features as LAD1 patients 
including spontaneous ulcerations and delayed wound healing. This is due to impaired 
formation of the phagocytic synapse between apoptotic neutrophils and macrophages leading 
to impaired oxidative burst and reduced release of active TGF-β1 at wound sites. Even though 
it is of major importance, the exact mechanism of TGF-β1 activation at wound sites is largely 
unresolved. Importantly, in co-cultures of apoptotic neutrophils and macrophages the release 
of active TGF-β1 was significantly reduced in the presence of radicals scavengers. In addition, 
injection of Rotenone, a complex I inhibitor, with enhanced release of O2·
- at the wound margin 
significantly improved wound healing in CD18-/- mice compared to mock-injected CD18-/- mice. 
Notably, injection of the O2·
- scavenging SOD, encapsulated in polyelectrolyte capsules, around 
wounds of CD18 wildtype mice significantly delayed wound healing compared to mock-treated 
mice, supporting our hypothesis that the release of ROS - and O2·
- in particular - by macrophages 
is required for TGF-β1 activation at wound sites. In CD18 deficiency reduced oxidative burst 
may lead to reduced release of active TGF-β1 and impaired wound healing. Modulation of the 
oxidative burst and thereby the release of active TGF-β1 at wound sites may prove promising for 
patients suffering from LAD1 or fibrotic disorders.
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Identification of Growth Factor-induced Mechanisms Regulating Epithelial Cell Proliferation in 
Cutaneous Wound Healing
Sabrina Schmitt1, Kathi Westphal1, Kai Safferling1, Manuel Hrabowski2, Günter Germann2, Stefan Holland-
Cunz1, Peter Angel3, Peter Schirmacher1, Niels Grabe1, Kai Breuhahn1 1University Hospital Heidelberg, 
Germany, 2BGU Ludwigshafen, Germany, 3German Cancer Research Center, Heidelberg, Germany
Growth factors are central regulators discriminating between keratinocyte proliferation and migration 
in cutaneous wound healing. In order to define hepatocyte growth factor (HGF)-dependent 
effects on epithelial cells, we analysed the target gene expression of isolated keratinocytes after 
stimulation with HGF in a quantitative and time-dependent manner. Target gene expression and 
functional relevance were examined in primary human keratinocytes, organotypic 3D cultures 
(OTC) of multi-layered keratinocytes after wounding, and murine full-thickness skin wounds. 
HGF-dependent targets included essential transcription factors and regulators of cell proliferation (e.g. the 
AP1 constituent c-Fos and the microtubule-destabilizing factor Stathmin). Selective Raf- and PKB-inhibition by 
chemical compounds reduced growth factor-induced expression of Stathmin and c-Fos at the transcript level. In 
vitro, the siRNA-mediated inhibition of Stathmin predominantly reduced keratinocyte proliferation (SYBRgreen-
Assay) and to a lesser extent migration (time-lapse microscopy). Stathmin expression was reduced in the migration 
tongue of human OTC and murine skin wounds. Instead, a correlation between Stathmin expression and 
proliferating keratinocytes of the basal layer was detected (Ki67/Stathmin/phospho-cMET staining). In addition, 
HGF rapidly stimulated phosphorylation of Stathmin, which is essential for microtubule turn-over and mitosis. 
Based on mathematical algorithms and biological dynamic short-term consequences after HGF-stimulation 
combined with functional long-term effects at the cell and tissue level, we identified Stathmin as a critical 
regulator of keratinocyte proliferation in wound healing. Our data revealed novel insights into the role of growth 
factor-dependent signaling in epithelial cells at multiple levels and thereby will contribute to a quantitative basis 
for the generation of mathematical models describing cutaneous regeneration.
005
TSG-6 Released by Mesechymal Stem Cells in Murine Full-thickness Excisinal Wound Margins 
Improves Wound Healing by Dampening Inflammation and Reducing Scar Formation
Yu Qi1, Anca Sindrilaru1, Stefan Wieschalka1, Dongsheng Jiang1, Markus Rojewski2, Heidi 
Hainzl1, Andrea Schlecht1, Hubert Schrezenmeier2, Karin Scharffetter-Kochanek1 1Department 
of Dermatology and Allergic Diseases, University of Ulm, Germany, 2Department of Transfusion 
Medicine and Immunogenetics, University of Ulm, Germany
Proper recruitment and activation of macrophages in inflammatory phase of acute wound healing 
is essential for physiologic tissue repair. However, there is strong indication that robust macrophage 
inflammatory responses may be causal for the fibrotic response always accompanying adult 
wound healing. Local delivery of mesenchymal stem cells (MSCs) may represent a promising 
tool to control macrophage activation and scar formation during healing. We therefore study 
the effect of MSCs on macrophage activation in vitro and during full thickness excisional murine 
wound healing in molecular detail. Macrophages activated in vitro with LPS and IFNγ produced 
high amounts of pro-inflammatory nitric oxide (NO), IL-12 and TNFα. Co-culture of activated 
macrophages with MSCs either isolated from bone marrow (BM) or adipose tissue (AT) resulted 
in significantly diminished release of pro-inflammatory TNFα and IL-12. Interestingly, in presence 
of activated macrophages MSCs highly up-regulated the anti-inflammatory TNF-stimulated gene 
6 (TSG-6) on RNA and protein level. In wildtype C57BL/6 mice both BM-MSCs and AT-MSCs 
injected around full-thickness excisional wounds significantly accelerated wound healing when 
compared with wounds injected with PBS. TSG-6 was up-regulated in the MSCs engrafted in 
the wound margins for up to 48 hours after injection and correlated with reduced leukocytes 
numbers and TNFα levels at day 2 after wounding and with decreased fibrosis via diminishing 
TGFβ release, and similar effects were also induced upon injection of recombinant TSG-6 in 
wound margins. Taken together, these data may suggest TSG-6 released by MSCs improve wound 
healing by limiting leukocytes recruitment and activation, inflammation and fibrosis.
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Thyroxine (T4) promotes reepithelialisation and angiogenesis in wounded human skin in vitro
Guoyou Zhang1,2, Natalia T Meier1, Wolfgang Funk3, Markus Geisen4, Sebastian Debus4, Ralf 
Paus1,5 1University of Luebeck, luebeck, Germany, 2the Second Affiliated Hospital of Wenzhou 
Medical College, Wenzhou, China, 3Klinik Dr. Koslowski, Munich, Germany, 4University Hospital 
Hamburg-Eppendorf, Hamburg, Germany, 5University of Manchester, Manchester, UK
Despite growing evidence that thyroid hormones may promote wound healing in animals, 
their effects in human skin wound healing are very incompletely explored. Therefore, we 
wished to evaluate whether supraphysiological doses of thyroxin (T4), which could easily be 
applied topically under clinical conditions, promote reepithelialisation and angiogenesis in 
wounded human skin. Wounded full-thickness human skin was organ-cultured in serum-free 
medium, using a ‘punch-within-a-punch’ design. The newly formed epithelial tongues at the 
inner and outer edges were analyzed by quantitative (imuno)histomorphometry, using a set of 
reepithelialisation and angiogenesis markers. Reepithelialisation was significantly promoted 
by T4 in a dose dependent tendency, compared to vehicle controls. T4 also significantly up-
regulated the proliferation of epidermal keratinocytes as well as expression of the wound healing-
associated keratin, KRT 6, and of the epithelial stem cell-associated keratin, KRT15. Furthermore, 
expression of the endothelial cell marker, CD31, as well as the number of CD31+ vessel cross 
sections were up-regulated, indicating that T4 stimulates intracutaneous angiogenesis during 
skin wound healing. Preliminary evidence suggests that this mediated, at least in part, up-
regulation of VEGF and bFGF, and upregulation of FGF receptor1. Given the importance of 
mast cells in wound healing and angiogenesis, it is interesting to note that preliminary evidence 
pointed to an increased number of dermal mast cells in T4-treated human skin fragments. These 
findings provide the first definitive preclinical evidence that T4 promotes reepithelialisation and 
angiogenesis during human skin wound healing. This strongly encourages one to further explore 
topical T4 in the management of chronic skin ulcers.
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Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for 
development of a novel treatment option
Kirstin Dienus1, Ardeshir Bayat2, Brendan Gilmore3, Oliver Seifert4 1Dept of Clin 
Microbiology,Ryhov Hospital, Jönköping, Sweden, 2Plastic & Reconstructive Surgery Research, 
Manchester Interdisciplinary Biocentre, Univ of Manchester, Manchester, UK, 3School of 
Pharmacy, Queens Univ, Belfast, UK, 4Div of Dermatology, Ryhov Hospital, Jönköping, Sweden
Keloid scars are benign fibroproliferative dermal lesions. Fibroblasts are considered to be the key cellular 
mediators of fibrogenesis in keloid scars. Fibroblast activation protein alpha (FAP-α), a serine protease 
located at the plasma membrane, promotes cell invasiveness and has been previously associated 
with keloid scars. In this study we analyzed the expression of FAP-α in keloid fibroblasts compared to 
control skin fibroblasts. Dermal fibroblasts were obtained from punch-biopsies from the active margin 
of four keloids and four control skin samples. Flow cytometry was used to analyze FAP-α expression 
and the CytoSelect® 24-Well Collagen I Cell Invasion Assay was applied to study fibroblast invasion. 
Secretion of extracellularmatrix (ECM) proteins was investigated by multiplexed particle-based flow 
cytometric assay and enzyme-linked immunosorbent assay. We found an increased expression of FAP-α 
in keloid fibroblasts compared to control skin fibroblasts (p<0.001). Inhibition of FAP-α activity using 
the irreversible FAP-α inhibitor H2N-Gly-Pro diphenylphosphonate reduced the increased invasiveness 
of keloid fibroblasts (p<0.001) indicating that keloid invasion may be partly FAP-α mediated. FAP-α 
inhibition had no effect, (i) on the synthesis of the ECM proteins procollagen type I C-terminal peptide 
and fibronectin, (ii) on the production of fibroblast growth factor (FGF) or vascular endothelial growth 
factor (VEGF), (iii) on the expression of the proinflammatory cytokines interleukin-6 (IL-6), interleukin 8 
(IL-8) or monocyte chemotactic protein-1 (MCP-1). These results suggest a potential role for FAP-α in the 
invasive behaviour of keloids. FAP-α may increase the invasive capacity of keloid fibroblasts. Inhibiting 
FAP-α activity may be a novel treatment option to prevent keloid progression.
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Human fibroblasts in skin regeneration: a preclinical study in diabetic wound healing
Lucía Martínez-Santamaría1,4, María José Escámez1,4, Almudena Holguín1,4, Blanca Duarte1,4, 
Luisa Retamosa1,4, Nuria Illera1,4, Sara Llames3,4, Alvaro Meana3,4, Fernando Larcher1,4, Marcela 
Del Río2,4 1Regenerative Medicine Unit, Epithelial Biomedicine Division, CIEMAT, Madrid, Spain, 
2Dept of Bioengineering. Universidad Carlos III (UC3M), Madrid, Spain, 3CCST, Oviedo, Spain, 
4Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain
Cutaneous chronic ulcers of different aetiology still represent a challenge for public health. Its 
prevalence is around 1-2% and it is continuously increasing. These pathologic conditions affect 
greatly the quality of life of patients and also represent a significant economic impact on the 
healthcare system due to the cost associated with the clinical management of these problems. The 
development of effective treatments for healing chronic ulcers depends largely on understanding 
the pathogenic mechanisms, which raises the need of reliable animal models that recapitulate 
situations of impaired wound healing. In order to resemble a chronic skin repair-deficient 
condition, in the present work we have established a humanized model of diabetic wound healing 
that faithfully mimics the impaired healing exhibited by those patients. Thus, delayed wound 
closure observed in the proposed model is mainly associated to alterations in the granulation tissue 
formation, involving defects in the fibrin clot degradation, vasculature, inflammatory response, 
collagen deposition and dermal innervation. Furthermore, we have used that preclinical platform to 
evaluate the effectiveness of fibroblasts-enriched fibrin-based dermal scaffolds in a diabetic context, 
achieving a dramatic overall improvement of the impaired healing process. Consequently, the use 
of bioengineered dermal equivalents emerges as a reliable alternative for the treatment of diabetic 
ulcers in a clinical context. In conclusion, we report an impaired-wound-healing model as a 
suitable preclinical tool to provide a better understanding of the biologic and molecular underlying 
mechanisms involved in wound healing impairment and also to evaluate innovative therapeutic 
approaches clinically meaningful in the dermatology field.
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Simvastatin Inhibits Transforming Growth Factor-β1-Induced Expression of Collagen Type I, 
CTGF, and α-SMA in Human Keloid Fibroblasts
Je Ho Mun1, Young Mi Kim2, Byung Soo Kim1, Jae Ho Kim2, Moon Bum Kim1, Hyun Chang Ko1 
1Department of Dermatology, School of Medicine, Pusan National University, Busan, Republic 
of Korea, 2Department of Physiology, School of Medicine, Pusan National University, Busan, 
Republic of Korea
Simvastatin, which inhibits 3-hydroxy-3-methylglutaryl coenzyme-A reductase, is used to 
lower cholesterol levels. Accumulating evidence revealed the immunomodulating and anti-
inflammatory effects that prevent cardiovascular diseases. The beneficial effects of statins on 
organ fibrosis have also been reported. However, the functional effect of statins on dermal fibrosis 
in keloids has not yet been explored. To determine whether simvastatin can affect dermal fibrosis 
associated with keloids, we examined the effect of simvastatin on transforming growth factor 
(TGF)-β1-induced expression of collagen type I, connective tissue growth factor (CTGF), and 
α-smooth muscle actin (SMA) in keloid fibroblasts. The levels of collagen type I, CTGF, and 
α-SMA, and the phosphorylation levels of Smad2 and Smad3 were assessed by western blotting. 
Simvastatin suppressed TGF-β1-induced collagen type I, CTGF, and α-SMA expression in a 
concentration-dependent manner. The phosphorylation levels of TGF-β1-induced Smad2 and 
Smad3 were abrogated by pretreating of the cells with simvastatin. The inhibition of collagen type 
I, CTGF, and α-SMA expression by simvastatin was reversed by geranylgeranyl pyrophosphate, 
not by farnesyl pyrophosphate, suggesting that the simvastatin-induced cellular responses are due 
to inhibition of geranylgeranylation. The present study suggests that simvastatin is an effective 
inhibitor of TGF-β1-induced collagen type I, CTGF, and α-SMA expression in keloid fibroblasts.
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Identification of a reddened-skin-associated marker: vascular endothelial growth factor 
(VEGF)-A in stratum corneum
Kentaro Kajiya1, Mika Sawane1, Katsujiro Sato2 1Shiseido Research Center, Yokohama, Japan, 
2Gakugeidai-Nishiguchi Clinic, Tokyo, Japan
Reddening of facial skin is considered undesirable by both Caucasians and Asians. Although 
the reddening is evoked by vascular alteration in the skin, the mechanism involved has been 
unclear. Here, we present a histological analysis of reddened facial skin and propose a possible 
mechanism of the reddening. First, the facial skin color of 10 female Japanese volunteers was 
determined using color space CIE L*a*b*, and 2 mm facial skin biopsies were obtained. Biopsy 
samples were divided into two groups (N=5, each), i.e., reddened skin and non-reddened skin, 
according to the value of a*. These studies were approved by the ethics committee of Shiseido 
Research Center. Hematoxylin-eosin staining of skin sections revealed epidermal hyperplasia. 
Immunofluorescence analysis for blood vessels revealed enlargement of blood vessels in 
reddened skin. Interestingly, double immunofluorescence analysis using antibodies against 
proliferation marker Ki67 and CD31 demonstrated that proliferating endothelial cells were 
increased in reddened skin, suggesting increased angiogenesis. Moreover, a potent angiogenic 
factor in skin, vascular endothelial growth factor (VEGF)-A, was markedly increased in reddened 
skin, especially in keratinocytes and stratum corneum. We also developed a method for 
quantification of VEGF-A in stratum corneum obtained by tape stripping. Our results indicate that 
VEGF-A could be a target for treatment of reddened skin.
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Peroxisome proliferator-activated receptor (PPAR) δ agonists induce endothelial ICAM-1 
expression
Julia Naidenow, Igor Hrgovic, Monika Doll, Gabi Reichenbach, Andreas Pinter, Jens Gille, Roland 
Kaufmann, Markus Meissner University of Frankfurt, Dept. of Dermatology, Frankfurt, Germany
It is a known fact, that endothelial cells isolated from human tumors express much lower 
levels of adhesion molecules, that are involved in leukocyte vessel wall interactions, such as 
intercellular adhesionmolecule-1 (ICAM-1). These mechanisms seem to be evolved by tumors to 
escape immunosurveillance. Therefore, the development of angiogenesis inhibitors that can make 
the tumor additionally more vulnerable for the immune system might be a new approach for the 
treatment of cancer. Peroxisome proliferator-activated receptor (PPAR) δ agonists display a variety 
of effects on pro- and antitumor processes. Recently, we could demonstrate, that PPARδ agonists 
induce pro-inflammatory cytokines in human endothelial cells and inhibit endothelial cell 
proliferation and angiogenesis. We now hypothesized that PPARδ agonists might also enhance the 
expression of ICAM-1 which would be an important prerequisite for tumor specific leukocytes to 
reach the tumor cells through the tumor vasculature. We found that treatment with PPARδ agonists 
induced endothelial ICAM-1 protein expression in a time- and concentration-dependent manner. 
The expression of soluble ICAM-1 was not significantly affected by PPARδ agonist treatment. We 
also demonstrated that PPARδ agonists significantly induced accumulation of ICAM-1 mRNA. 
The treatment considerably induced transcriptional activity of 5´-deletional ICAM-1 promoter 
gene constructs. PPARδ agonist-mediated induction was conveyed by a GCrich region, harboring 
one consensus Sp1 binding site. EMSA analysis demonstrated that constitutive Sp1-dependent 
DNA binding is increased by PPARδ activation. Hence, the induction of ICAM-1 expression might 
represent a critical molecular mechanism which might be essential for a pro-immunogenic and 
therefore anti-tumorigenic effect of PPARδ agonists.
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New mouse models to investigate the neurogenic erythema of skin in Rosacea subtype I
Christelle Nonne, Genevieve Gozzerino, Sandie Wise, Coralie Pascau, Marlene Schuppli, Andre 
Jomard, Michel Rivier Galderma R&D, Sophia-Antipolis, France
Dysfunctional cutaneous vasculature and neuronal dysregulation have been proposed as being 
able to induce the transient (flush) or permanent facial erythema and oedema found in Subtype 
I or erythematotelangiectatic Rosacea. The histopathologic findings have revealed oedema, 
vasodilation, and infiltrates of leukocytes in the facial skin of patients. These characteristics 
may be related to neurogenic inflammation, a process by which inflammation is triggered by 
the nervous system. The aim of this study was to set up an animal model relevant for Rosacea. 
Resiniferatoxin (RTX) activates the vanilloid type 1 receptor (TRPV1) leading to the release of 
neuropeptides (CGRP, SP ...) with vasodilatory properties. Neurogenic skin inflammation was 
induced by increasing doses of RTX applied topically or αCGRP injected subcutaneously into 
the back of hairless SKH1 mice or the ear of BALB/c mice. The relative area of vasodilation in 
mm² was evaluated by laser Doppler perfusion imaging. Two TRPV1 antagonists, Capsazepin and 
AMG-9810, at 5 % decreased significantly the relative area of the vasodilation induced by RTX 
0.03% with a shift of the kinetic. Treatment of mice with the NK1-receptor antagonist, CP96345 
1.5 mg/kg i.v., significantly increased the vascular response and inhibited the edema induced by 
RTX. A CGRP-receptor antagonist, BIBN4096 100µg/kg i.v., was able to block the RTX-response 
in mouse treated with CP96345 and inhibited significantly the αCGRP vasodilation. These results 
indicate that the two present mouse models represent useful tools to investigate the vascular part 
of the neurogenic inflammation underlying neurogenic skin disorders such as Rosacea subtype I.
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Establishment of a real-time in vitro three-dimensional model to detect interaction of lymphatic 
endothelial cells with inflammatory cells
Yuuko Matsumoto, Junko Yamane, Kentaro Kajiya Shiseido Research Center, Yokohama, Japan
We have previously shown that blocking of vascular endothelial growth factor receptor-3 
(VEGFR-3) prolongs UVB-induced inflammation, whereas promotion of lymphangiogenesis by 
activation of VEGFR-3 attenuates skin inflammation, indicating that lymphatic vessels play a 
crucial role in skin inflammation. However, it is unknown whether or not lymphatic endothelial 
cells (LEC) are actively involved in resolution of inflammation, especially clearance of antigen-
presenting cells from skin. Here we established a system for real-time imaging of a three-
dimensional (3D) in vitro model in which LEC can interact with macrophages. First, we captured 
time-lapse images of lymphatic cord formation in 3D Matrigel and revealed that cord formation 
was promoted until 15 hours after seeding. Based on these findings, we next carried out time-
lapse imaging of macrophages migrating towards lymphatic capillaries to visualize the process 
of inflammation resolution. CCL21 secreted from LEC is the only chemokine currently known 
to attract inflammatory cells and tumor cells. Interestingly, silencing of CCL21 with siRNA in 
LEC resulted in decreased migration of macrophages. Finally, we investigated the possible role 
of LEC in aging, and found that extensively passaged LEC showed decreased ability to attract 
macrophages as compared with LEC at low passage number. The extensively passaged LEC 
showed decreased CCL21 expression, suggesting that aging of LEC could lead to prolongation 
of inflammation resolution, and thus may be associated with skin aging. Our model allows us to 
visualize in detail the process of inflammatory resolution, and should also be suitable to examine 
how macrophages participate in lymphangiogenesis in inflammatory states.
014
Novel hierarchy of resident endothelial progenitors integral to skin wound angiogenesis
Elke Seppanen, Mathieu Rodero, Nicholas Fisk, Kiarash Khosrotehrani University of Queensland 
UQ Centre for Clinical Research, Brisbane QLD, Australia
Vessel formation in granulation tissue is essential for wound healing. However the contribution 
of endothelial cells to this process is not understood, in particular the role of resident versus 
bone marrow-derived endothelial progenitors. We sought to quantitate endothelial populations 
in wounds, blood and bone marrow over time to determine the ontogeny of cells participating in 
wound angiogenesis. Excisional wounds generated on C57BL/6 mice were collected on D1-D7 
and tissues analysed using 5-colour flow cytometry for CD45, CD11b, CD34, CD31 and VEGFR2 
to establish hierarchy in both myeloid and non-haematopoietic fractions. Absolute number 
modifications were then calculated for each compartment (wound, blood, bone marrow) to 
inform the potential exchange between these sites. We identified a CD34+CD45loCD31negVEG
FR2loCD11bneg population in skin that had characteristics of endothelial progenitor cells (EPCs). 
This is because their numbers in granulation tissue remained constant during healing, suggesting 
self-renewal, but also gave rise to 2 distinct populations that expanded from D2 to D5; a transit-
amplifying population, CD34+CD45loCD31loVEGFR2lo, and a terminally-differentiated 
population, CD34+CD45loCD31hiVEGFR2hi. This expansion of wound-associated endothelial 
cells was confirmed in collagen culture assays. The EPCs identified in wounds were not present 
in bone marrow or blood, which showed only a myeloid CD34+CD45loCD31negVEGFR2loCD1
1blo population from D3. Furthermore, any contribution of EPC-derived terminally-differentiated 
endothelial cells from bone marrow or blood was similarly negligible. In conclusion, our results 
identify a hierarchy of EPC to mature endothelial cells and suggest a prominent role for skin 
resident EPCs in wound angiogenesis.
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A cream containing lyophilized culture supernatants of peripheral blood mononuclear cells 
(LivosecTM) accelerates wound healing
Michael Mildner1, Stefan Hacker1, Gregor Werba1, Thomas Haider1, Bahar Golabi1, Erwin 
Tschachler1,2, Hendrik Jan Ankersmit1 1Medical University of Vienna, Vienna, Austria, 2CE.R.I.E.S., 
Neuilly, France
Non-healing skin ulcers are often resistant to most common treatments. Here we investigated 
whether application of a cream containing lyophilized culture supernatants of freshly isolated 
unstimulated peripheral blood mononuclear cells (PBMCs) (LivosecTM) is able to enhance wound 
healing in a mouse model. Furthermore we analyzed the effect of Livosec on human primary 
fibroblasts (FB), keratinocytes (KC) and endothelial cells (EC) in vitro. Compared to the cream 
alone, application of LivosecTM containing creams on 6mm punch biopsy wounds on the backs 
of B6/129 mice strongly enhanced wound-closure. H&E staining of the wounds after 6 days 
revealed that wound healing in both the dermal and epidermal compartments of the skin was 
more advanced in the presence of LivosecTM-cream. Furthermore there was a massive increase 
in CD31 positive cells in such wounds, indicating enhanced neo-angiogenesis. To investigate 
the mechanisms of these in vivo findings in more detail, we treated primary human FB, KC and 
EC with this bioactive protein cocktail. In FB cell-migration but not -proliferation was induced. 
By contrast, LivosecTM induced migration and proliferation in KC and EC. In addition LivosecTM 
strongly induced tube-formation of EC in a matrigel-assay. In summary we have shown that 
creams containing LivosecTM led to enhanced wound-healing in mice in vivo and that this 
bioactive drug also induced proliferation and migration of primary human cells in vitro. The 
formulation and use of such creams might therefore represent a big advantage for the treatment 
of non-healing skin ulcers.
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Skin repair using a bioresorbable dermal substitute: an emerging concept for acute skin wounds.
Hinda Dabboue1, Xavier Garric2, Hubbert Taillades2, Jean-Pierre Molès1 1Inserm U1058, 
Montpellier, France, 2CNRS UMR5247, Montpellier, France
Progresses in tissue engineering and biomaterials allow us to design a new dermal substitute 
that would temporarily replace the tissue loss in skin wounds, and that would stimulate its own 
colonization from surrounding healthy tissue as soon as its hydrolytically degrades. Our approach 
consists in using a porous bioresorbable polymer (poly(α-hydroxy-acid)s derived from lactic acid 
(PLA50-PEO-PLA50) to develop dermal substitutes. In this study, the biocompatibility and the safety 
of this matrix were determined in a series of in vitro and in vivo systems. Its therapeutic potential has 
been next evaluated in porcine model of full-thickness wounds and compared with Matriderm®. 
In vitro, the substitute replaced equally a collagen lattice or a mortified dermis during 
the reconstruction of an artificial skin. In vivo, when grafted subcutaneously in mice, the 
substitute showed a rapid colonisation by the surrounding tissues including the presence 
of a new vascular network. Finally, in a 5cm x 5cm full-thickness wound, the substitute was 
as efficient as Matriderm®. In addition to comparable clinical outcomes and histological 
results including neovascularization, reepithelialisation, and inflammation features, we 
showed a clear decrease in wound contraction (wounded surface 8cm2) compared to 
Matriderm® (1cm2), 3 weeks after grafting. The same result was observed 5 weeks after 
grafting and histological analysis revealed residual polymer in the bedside of the wound. 
These results suggest that this new artificial substitute can represent an alternative to others 
dermal substitutes and that the concept of a controlled-bioresorbable material may provide new 
benefit for the treatment of wound healing.
017
HIF pathway in epidermal keratinocytes is controlled by Egln3 and Siah1 proteins
Lynda Weir1, Douglas Robertson1, Irene Leigh1, Keith Vass2, Andrey Panteleyev1 1Dept. Cancer and 
Molecular Medicine, University of Dundee, UK, 2Translational Medicine Research Collaboration, 
University of Dundee, UK
Activation of HIF1alpha is a key component of the hypoxia response and its deregulation in the 
skin is linked to psoriasis, cancer, wound healing pathology, etc. HIF1alpha activity is regulated 
by complex and ill-characterised mechanisms in which prolyl hydroxylases (PHD/Egln-1,2,3) 
are primary players regulated by E3 ubiquitin-protein ligases Siah1 and Siah2. Previously we 
showed that in keratinocytes HIF1alpha is activated by acute hypoxia but is suppressed under 
chronic exposure. Details of hypoxia pathway regulation in the epidermis remain unknown. 
Using human N-TERT and primary mouse keratinocytes cultured at ambient or 1% oxygen we 
assessed epidermis-specific aspects of HIF1alpha regulation by hypoxia. Normoxic keratinocytes 
express Egln1 and Egln3, however only Egln3 appeared to be hypoxia-responsive (mRNA 
and protein) suggesting its primary role in HIF1alpha control. This was further supported by 
the high dependence of HIF1alpha protein level upon Egln3 and their co-localisation at the 
nuclear periphery under hypoxia. Siah1 strongly co-localises with Egln3/HIF1a implicating Siah1 
in their control while Siah2 appears to have a different role given its location in nucleoli and 
downregulation in hypoxia. In psoriatic epidermis, BCC and SCC Hif1alpha and Siah2 are elevated 
(particularly in SCC) whilst Egln3 is elevated in psoriasis but not in cancerous keratinocytes 
suggesting differential roles for the HIF pathway in these pathologies. Thus, our results identify 
Siah1-Egln3 interactions as the key factor of HIF1alpha regulation in keratinocytes. We also show 
that this system is perturbed in skin diseases highlighting the importance of pursuing hypoxia 
pathway components as therapeutic targets in the skin.
018
In vitro wound healing-promoting activities of quorum sensing peptide Plantaricin A
Giammaria Giuliani1, Daniela Pinto2, Maria De Angelis2, Fabio Minervini2, Marco Gobbetti2, 
Barbara Marzani1 1R&D, Giuliani SpA, Milan, Italy, 2Department of Biologia e Chimica Agro-
Forestale ed Ambientale, University of Bari, Bari, Italy
We investigated the influence of pheromone plantaricin A (PlnA) on the wound healing process 
via in vitro model scratch test in human keratinocyte NCTC 2544 cell line and the molecular 
mechanisms regulating peptide-induced wound healing. PlnA was chemically synthesized and 
used as pure peptide or biologically synthesized during co-cultivation of Lactobacillus plantarum 
DC400 and Lactobacillus sanfranciscensis DPPMA174 as the signaling molecule involved in 
quorum sensing mechanisms. The cell-free supernatant (CFS) was used as the crude preparation 
containing PlnA. The inductive effect of PlnA on the proliferation of NCTC 2544 cells was higher 
than that found for hyaluronic acid, a well known skin protective compound. As shown by 
wound scratch and image analyses, PlnA enhanced the cell migration of NCTC 2544. Compared 
to the control, the highest inductive effect was found using 10 µg/ml of chemically synthesized 
PlnA. Similar results were found for CFS. In agreement, the percentage of the starting scratch area 
was decreased after 24 h treatment with 10 µg/ml of chemically or biologically synthesized PlnA. 
As shown by RT-PCR and ELISA analyses, the expression of transforming growth factor-β1 (TGF 
β1), keratinocyte growth factor 7 (KGF7) and interleukin-8 (IL-8) genes was affected by PlnA. 
Compared to control, KGF7 and IL-8 genes were up-regulated after 8 - 24 h from scratching. 
KFG7 gene was markedly induced after 4 h of treatment. Since peptide-induced the proliferation 
and migration of the human keratinocyte and stimulated IL-8 cytokine, the use of PlnA for 
dermatological purposes would be considered.
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Phyllocaulis boraceiensis mucus total extracts as inducer of wound repair in model of induced 
wound healing
Ana Rita de Toledo Piza, Durvanei Augusto Maria Butantan Institute, São Paulo/SP, Brazil
Phyllocaulis boraceiensis mucus has proliferative properties when applied in cultures of human 
fibroblasts, allowing significantly increasing proliferative response of fibroblasts inducing 
synthesis of collagen type I after 24h of treatment. The aim of this study is evaluate P. boraceiensis 
mucus as inducer of wound repair in model of wound healing of the dermis of mice. Briefly, mice 
were anaesthetized intra mussel by ketamine-xilasine and a 1cm2 dorsal skin incision was made 
under sterile conditions. Groups of two mice each were treated with papain cream as control (T1), 
papain cream associated with mucus of P. boraceiensis 17.84µg (T2) and papain cream associated 
with mucus of P. boraceiensis 1.12µg (T3). During 20 days both groups received a portion of each 
topical treatment and everyday images were captured of each wound using a dermatoscopy. 
Proliferative process was accelerated to T3 being observed after three days presenting high 
deposition of fibroblasts at wound margin hypertrophic while in T1 was started five days after 
surgery. Animals submitted to T2 presented inflammation during all period of observation 
even when healing process had already begun, the new tissue showed capillary fragility. 
Remodeling process was started after four days of surgery in T3 while the others after six days. 
These aspects show that this compound in high concentration is toxic avoiding natural healing 
process meanwhile when used in low concentration present proliferative effect. Dermatological 
treatment using prescription made up with mucus of P. boraceiensis is recommended since this 
compound proved to be a potential therapeutic inducer of regeneration.
020
Cutaneous wound repair following cryosurgery: a pilotstudy using reflectance confocal 
microscopy
Dorothea Terhorst, Adrienne Maltusch, Eggert Stockfleth, Susanne Lange-Asschenfeldt, Wolfram 
Sterry, Martina Ulrich, Bernhard Lange-Asschenfeldt Department of Dermatology, Charité 
Universitätsmedizin Berlin, Berlin, Germany
The dynamic process of wound healing is routinely evaluated by clinical or histological 
evaluation. Recently, a number of non-invasive imaging techniques have been evaluated for 
their clinical applicability in dermatology. Among them, reflectance confocal microscopy (RCM) 
represents a non-invasive imaging technique that allows the in vivo characterization of the skin at 
near histological resolution.The aim of this study was to monitor epidermal wound repair using 
RCM in a model of tissue damage induced by cryosurgery. For this purpose contact cryosurgery 
was performed at -32 °C for 10 seconds on the volar forearm of five healthy volunteers. 
Clinical and RCM evaluations were performed at 9 consecutive time points.RCM allowed the 
visualization of edema formation and blood vessel dilatation immediately after cryosurgery as 
well as morphologic features of wound repair including the formation finger-like protusions 
of keratinocytes into the wound bed, the appearance of hair-pin-like vessels and inflammatory 
cells. This pilot study illustrates that RCM represents a promising technique for quasi real time 
monitoring the kinetics of wound repair non-invasively and over time, thus offering new insights 
into in vivo processes of cutaneous wound repair and angiogenesis as well as potential effects of 
topically applied drugs on the process of tissue repair.
021
Differential effects of high glucose on human keratinocytes and fibroblasts and the effect of 
KdPT as a potential modulator of high glucose-induced adverse effects
Paraskevi Gkogkolou, Thomas A. Luger, Markus Böhm Dept. of Dermatology, University of 
Münster, Münster, Germany
Foot ulcers are a major complication in diabetes leading to significant morbidity and mortality 
among patients. Here, we investigated the effects of high glucose on normal human keratinocytes 
(NHK) and human dermal fibroblasts (HDF), two effector cell types in wound healing. High 
glucose (10-30 mM) time- and dose-dependently reduced metabolic activity and viability of 
NHK. This correlated with decreased cell proliferation, but in contrast to other cell types, with 
no significant induction of apoptosis. However, hyperglycemic conditions led to increased 
vacuolisation of the cytoplasm indicating autophagic cell death. Moreover, high glucose 
significantly reduced NHK migration as shown by scratch- and transwell migration assays. 
Mechanistically, high glucose increased intracellular oxidative stress accumulation and induced 
the expression of glucose-regulated-protein-78, a marker of endoplasmic reticulum stress. 
Next, we investigated the effects of antioxidants and KdPT, a truncated tripeptide of alpha-MSH 
with cytoprotective properties, on high glucose-induced adverse effects. Vitamin C and KdPT 
significantly reduced high glucose-induced intracellular oxidative stress accumulation. However, 
this did not correlate with increased cell viability indicating that additional mechanisms except 
oxidative stress are involved in high glucose-induced cell death. In marked contrast to NHK, 
high glucose did neither affect cell viability nor increased oxidative stress in HDF. This could be 
attributed to an altered metabolic rate of HDF or differential expression of glucose transporters. 
In summary, our data create a basis for better understanding the mechanisms of impaired wound 
healing in diabetes and possibly point towards novel therapies for diabetic foot ulcers.
022
Hair Follicle Transplantation Improves Wound Healing
Azar Asgari1,2, Rodney Dilley1,3, Nicholas Rufaut1,3, Rodney Sinclair1,3 1Department of 
Dermatology, St Vincent’s Hospital, Victoria, Australia, 2O’Brien Institute, Victoria, Australia, 3The 
University of Melbourne, Victoria, Australia
Correlation between the presence of hair follicles (HF) and skin wound healing has long been 
noted. Shallow wounds, where portions of HFs remained intact, healed more quickly, the 
participation of follicular keratinocytes in wound healing has been well documented and a delay 
in wound healing has been observed in the skin without HF. Hair transplantation surgery in 
humans is a well established technique used for hair restoration. In this study hair transplantation 
has been considered as a technique to introduce a source of dermal and epidermal cells into the 
wound area to improve healing. Whisker HFs (15-20) from GFP-expressing (α actin promoter) 
mice were transplanted to skin of the right flank of a nude mouse. Six weeks later, 6mm full 
thickness wounds were applied to the transplanted area and similarly on the non-transplanted 
left side of the mice. In histology examination GFP positive hair follicle cells were found in both 
dermal and epidermal area locations in the wounds. At 7 days after wounding, wound area 
was significantly reduced (50%; P=0.01) in wounds placed adjacent to transplanted HF. This 
suggests that HF transplantation have the potential to improve wound healing. Considering the 
outer surface of the hair follicle contains epidermal and dermal stem cells, hair transplantation 
could be a technique to introduce a source of dermal and epidermal cells into the wound area 
in chronic wounds.
023
Role of heat shock protein 70 in keloids Jung U Shin1, In Hee Jung1, Jin Young Jung3, Won Jai 
Lee2, Ju Hee Lee1
1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul, Republic of Korea, 2Department of Plastic and Reconstructive Surgery, Yonsei 
University College of Medicine, Seoul, Republic of Korea, 3Department of Dermatology, Myongji 
Hospital, Kwandong University College of Medicine, Goyang, Republic of Korea
Keloids are pathologic proliferations of the skin layer resulting from excessive collagen 
production and depositions. With respect to their pathogenesis, various explanations, such as 
the ischemia, mechanical, hormonal, autoimmune, and genetic theories have been suggested. 
However, none have been shown to be the definitive cause. To identify differences in protein 
expression of keloid-derived fibroblast (KF), we comparatively analyzed the proteome of cultured 
fibroblasts. Several proteins that were differently expressed in KF compared to NF. Western 
blotting and immunohistochemical staining were used to validate the differentially expressed 
proteins. Western blotting confirmed that Hsp 70 is over expressed in KF. Immunohistochemical 
staining Hsp70 expression of keloid tissue was higher than the adjacent normal tissue. In addition 
we found that the expression of Hsp70 is more strongly in the perilesional keloids than in the 
central lesion of keloids. We also evaluated MMPs and TIMPs by immunohistochemical staining 
and both were increased in keloid tissue. These results may indicate that the activity of the keloid 
is stronger in the margin of the keloid than in the central lesion and it is consistant with the 
expanding characteristics of keloids. So we suggest that Hsp 70 may play an important role in 
keloids.
024
Selective inhibition of 11β-hydroxysteroid dehydrogenase 1 enhances epidermal proliferation 
and cutaneous wound healing
Mika Terao, Hiroyuki Murota, Akihiro Kimura, Arisa Kato, Ken Igawa, Ichiro Katayama
Osaka University Graduate School of Medicine, Suita, Osaka, Japan
11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) catalyzes the interconversion of cortisone 
and cortisol within the endoplasmic reticulum. 11β-HSD1 is expressed widely, most notably 
in the liver, adipose tissue, and central nervous system. It has been studied intensely over the 
last 10 years because its activity is reported to be increased in visceral adipose tissue of obese 
people. Targeted overexpression of 11β-HSD1 in adipose tissue in mice has been found to model 
metabolic syndrome. We previously reported that 11β-HSD1 was expressed in human and murine 
epidermis and dermal fibroblasts, and this expression increased as keratinocytes differentiate. 
However, the function of the enzymatic activity 11β-HSD1 in skin is not known. In this study, 
we investigated the function of 11β-HSD1 on epidermal proliferation and cutaneous wound 
healing using normal human epidermal keratinocytes (NHEKs) and murine model. A selective 
inhibitor of 11β-HSD1 promoted proliferation of NHEKs and normal human dermal fibroblasts. 
Topical application of selective 11β-HSD1 inhibitor to the dorsal skin of hairless mice for 
continues 5 days resulted in epidermal thickening with increased number of Ki-67 positive cells. 
Furthermore, topical application of the selective 11β-HSD1 inhibitor every other day enhanced 
cutaneous wound healing in C57BL/6 mice. Interestingly, the selective 11β-HSD1 inhibitor more 
prominently enhanced wound healing in ob/ob mice, the mice with delayed wound healing 
and increased 11β-HSD1 expression. Taken together, we conclude that 11β-HSD1 is negatively 
regulating the proliferation of keratinocytes and fibroblasts, and cutaneous wound healing. Thus 
11β-HSD1 is a novel candidate target for the design of skin disease treatments.
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New Mannose-6-phosphate derivatives with pro-angiogenic activities
Jean-Pierre Molès1, Véronique Barragan-Montero2, Jean-Louis Montero2 1Inserm U1058, 
Montpellier, France, 2CNRS UMR5247, Montpellier, France
Mannose-6-phosphate (M6P) and its derivatives have been proposed to prevent cheloid scar 
formation through a mechanism involving TGF-β signalling. We recently showed that these 
compounds in fact inhibited neo-angiogenesis. We screened a first series of M6P derivatives and 
found additional inhibitors but also few activators of angiogenesis. Since pro-angiogenic drugs are 
also required in Medicine or in Cosmetic industry, we synthesized 8 new derivatives of the M6P; 
they were bioisosteres, retroisostere, pyro or bolaform derivatives. In cell proliferation assays on 
Human dermal microvascular endothelial cells, we showed that all the tested derivatives have 
little or no effect at a concentration of 10-2M to 10-6M. In all angiogenic assays (rat aorta ring 
cultures and chick chorioallantoid membrane), the positive control was Endothelial Cell Growth 
Supplement (ECGS) and the negative one was the Sutent®, a clinical approved antiangiogenic 
drug. Herein, we described new pro-angiogenic drugs, which were all bioisoteres or their 
pyro derivatives. For example, the phosphonate-6-mannose or its pyro-derivative stimulated 
angiogenesis in both experimental models. The retroisostere or the bolaform derivatives have no 
effect or had antiangiogenic activities. Considering the absence of toxicity of these compounds, 
their high solubilities in water and their pro-angiogenic activities, it uses in regenerative medicine 
or for cosmetics purposes could be investigated.
026
Basic Fibroblast Growth Factor Stimulation of Skin Barrier Recovery
Satoshi Nakamizo, Gyohei Egawa, Hiromi Doi, Yohei Natsuaki, Yoshiki Miyachi, Kenji Kabashima 
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
It has been reported that basic fibroblast growth factor (bFGF) promotes the healing of skin 
ulceration by inducing fibroblast proliferation, while the role of bFGF on epidermal barrier 
function especially from the perspective of scratch-induced barrier disruption and fissures of 
the skin in hand eczema remains unknown. To this end, initially, we examined the effects of 
bFGF on recovery of cutaneous barrier disruption induced by mechanical scratch using diabetic 
mice. We used a wire brush for scratching the skin, and found that this procedure induced 
significant elevation of transepidermal water loss (TEWL) in a scratch-count-dependent manner. 
This elevated TEWL was significantly decreased by topical application of 100 µg/ml bFGF to 
the skin compared with sham operation. In addition, bFGF increased the expression of Ki67, a 
marker for cell proliferation, in keratinocytes after mechanical scratch. These results suggest that 
bFGF enhance keratinocyte proliferation, which leads to the repair of the skin barrier disruption 
caused by scratching. Consistently, bFGF stimulated proliferation of normal human epidermal 
keratinocyte (NHEK), but the addition of fibroblast in combination with NHEK did not show 
further proliferative effect of NHEK induced by bFGF. Intriguingly, the addition of other growth 
factors such as epidermal growth factor (EGF) and insulin diminished the effect of bFGF on NHEK 
proliferation. This finding can be explained by our observation that EGF and insulin decreased 
FGF receptor mRNA expression in NHEK. These findings suggest that bFGF stimulate keratinocyte 
proliferation by itself, especially under poor growth factor environment, to restore skin barrier 
disruption.
027
A secreted type of GnT-V suppress inflammatory phase reaction of wound healing
Arisa Kato1, Mika Terao1, Akihiro Kimura1, Hiroyuki Murota1, Eiji Miyoshi2, Ichiro Katayama1 
1Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, 
Japan, 2Department of Molecular Biochemistry&Clinical Investigation,Osaka University Graduate 
School of Medicine, Suita, Osaka, Japan
Oligosaccharides are involved in a variety of biological phenomena and human diseases. 
Approximately 1% of human genes are glycosyltransferases, which synthesize oligosaccharide 
structures. Glycosyltransferases are present in the Golgi apparatus in a membrane-bound form 
and are released from cells after cleavage by certain proteases in pathological conditions. 
Beta1,6-N-acetylglucosaminyltransferase V (GnT-V), which is cleaved and secreted from the 
cells, is involved in the biosynthesis of beta1-6GlcNAc branching on N-glycans and has been 
implicated in tumor progression and metastasis. A secreted type of GnT-V (soluble GnT-V) 
itself could promote angiogenesis, which is completely different from its original function as a 
glycosyltransferase, and this might play a role in tumor invasion. In this study, we further explored 
the novel function of soluble GnT-V by analyzing the skin phenotype of soluble GnT-V transgenic 
mice (sGnT-V Tg), in which soluble GnT-V was over-expressed under beta-actin promoter. We 
found that the healing of excisional wound created on back skin of the mice was significantly 
delayed on day 2 and 4, and the amount of exudates were markedly fewer in sGnT-V Tg 
compared with wildtype mice. Histologically, the number of inflammatory cell infiltration was 
lower in sGnT-V Tg mice. Accordingly, mRNA expressions of proinflammatory cytokines such as 
TNFα, IL-6, and IL-1β were lower in sGnT-V Tg mice skin. These data suggest that inflammatory 
phase reaction of wound healing is altered in sGnT-V Tg mice. Taken together, our data could 
suggest the possible role of sGnT-V in skin remodeling.
028
Development of a vascularized skin equivalent
Florian Groeber1, Jan Hansmann1, Michaela Kaufmann2, Heike Walles2 1Institute for Interfacial 
Engineering (IGVT); University ofStuttgart, Stuttgart, Baden Würtenberg, Germany, 2Fraunhofer-
Institute for Interfacial Engineering and Biotechnology (IGB), Stuttgart, Baden Würtenberg, 
Germany
The objective of this study was to generate a vascularized skin equivalent (SE) by integrating a 
full thickness SE into a biological vascularised scaffold (BioVaSc) based on an acellularized part 
of a porcine jejunum. In previous studies we could show that the BioVaSc supports organoid self 
assembly of various tissues such as liver and renal tissue and was successfully implanted into a 
patient as a trachea patch. To determine the capacity of the BioVaSc to support the formation 
of a SE, primary human keratinozytes and human fibroblasts were seeded on the BioVaSc 
and cultured under submersed conditions for seven days. To initiate the differentiation of the 
keratinocytes, the construct was subsequently cultured at an air-liquid interface for another 12 
days. The formation of skin tissue on the vascularized scaffold was determined using hemalaun/ 
eosin (HE) and immunohistological staining. These staining revealed a stratified epidermal layer 
of keratinozytes on one top of the BioVaSc and equally distributed fibroblasts inside of the 
scaffold. Furthermore the epidermis in our SE exhibits a papillary architecture as seen in vivo, 
due to the villi structure of the BioVaSc. Thus we could show that the BioVaSc provides a suitable 
microenvironment for the formation of a functional SE. In future experiments we will combine the 
vascularized SE with a new developed bioreactor that enables the supply of the vascularized skin 
substitute through the vascular system and the culture at an air-liquid interface.
029
MDA7(IL-24) inhibits keratinocytes migration in chronic wounds
Girish Patel, Keith Harding, Andrew Saunders, Wen Jiang Cardiff University, Cardiff, UK
MDA7, also known as IL-24, is a cytokine initially identified from cancer cells and expressed 
in a range of cell types including B cells, dendric cells, monocytes, melanocytes, melanoma 
cells. It is a regulator of cell differentiation, growth, and apoptosis. MDA7 operates in cells via 
its receptor, MDA7R (IL-24R), which include at least the IL-20alpha and IL-20beta complex and 
the IL-22R and IL20beta complex. Skin, acute and chronic wound tissues were used to analysed 
the transcript levels of MDA7 and the MDA7 receptors. The biological response of human 
keratinocytes to recombinant human MDA7 was evaluated using ECIS based methods. Inhibitors 
to candidate signalling pathways were also used in the cell models. MDA-7 had a significant 
effect on the migration of keratinocytes (p=0.01 vs non-treated control cells). However, it only 
had a marginal effect on the adhesion of the cells. The inhibitory effect of MDA-7 on migration 
was completed reversed by an Akt inhibitor (1.4 ± 0.8 with MDA7 alone vs 3.2 ± 0.04 with the 
combination of MDA7 and Akt inhibitor, p=0.004). Human chronic wound tissues had raised 
levels of both MDA-7 and MDA7 receptor compared with acute wound. In conclusion, MDA7 
has an inhibitory effect on the migratory behaviour of human keratinocytes and may be involved 
in maintaining the chronic non-healing state.
030
Dermal-Epidermal Crosstalk: Quantification of Proliferation in Wound Healing using a 3D in 
vitro Model
Kai Safferling1,2, Kathi Westphal1,2, Carito Guziolowski1,2, Niels Halama1,3, Niels Grabe1,2 
1Hamamatsu Tissue Imaging and Analysis (TIGA) Center, BIOQUANT, University of Heidelberg, 
Germany, 2Institute for Medical Biometry & Informatics, University Hospital Heidelberg, Germany, 
3NCT National Center for Tumor Diseases, University of Heidelberg, Germany
Cutaneous wound healing is a multifactorial process of precisely coordinated events in the 
epidermis and dermis. After wounding, keratinocytes migrate into the wound region where 
they start to proliferate and differentiate to achieve fast re-epithelialization. These processes are 
triggered and controlled by auto- and paracrine signaling cascades emanating from substantial 
dermal-epidermal crosstalk. The aim of our study was to quantitatively evaluate keratinocyte 
proliferation in a spatio-temporal way and to identify the underlying keratinocyte-fibroblast 
crosstalk. 3D organotypic skin cultures were excisional wounded and analyzed over a period of 
10 days. For the first quantitative description of proliferation each wound culture was spatially 
separated into ten regions and over 100.000 basal keratinocytes were evaluated. The most 
important chemokines and cytokines were quantified in the wound culture supernatants. The 
regions displayed a specific proliferative pattern characterized by an initial proliferative burst in 
the wound center 24 h after wounding extending throughout the whole culture. With progressing 
time proliferation in the unwounded regions reduced back to the basal level whereas the wound 
center remained proliferative active. Four to five days post-wounding, keratinocytes had closed 
the wound forming a neoepidermis. Most importantly we could identify a specific cytokine 
profile and based on these data hypothesize pathways involved in epidermal wound healing. 
Our comprehensive view on wound healing serves as a step towards linking quantitative 
proliferation response to the underlying cell communication network. Therefore our approach 
might be useful for identifying important key players leading to potential therapies in epidermal 
wound healing.
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Healing of Acute and Chronic Wounds: Lymphatics may Matter
Gyozo Szolnoky1, Gábor Eros2, Szentner Kinga1,2, István Balázs Németh1, Petra Hartmann2, 
Gábor Szabad1, Éva Dósa-Rácz1, Lajos Kemény1,3 1Department of Dermatology and Allergology, 
University of Szeged, Szeged, Hungary, 2Institute of Surgical Research, University of Szeged, 
Szeged, Hungary, 3Dermatological Research Group of the Hungarian Academy of Sciences, 
Szeged, Hungary
Although wound healing is assumed to be predominantly determined by blood vasculature 
development, several clinical observations and histological examinations suggest that lymph stasis 
may also be responsible for the maintenance of chronic wounds. Despite of the results derived 
from chronic wound healing studies the role of lymphatics in acute wound healing is likewise 
poorly studied. Therefore, this comparative study aimed to investigate acute wound healing 
in mice treated with and without blood and lymphangiogenesis blockers. Six SKH-1 hairless 
mice were included into each group receiving periwound injections with sterile phosphate 
buffer saline (PBS) as control or vascular endothelial growth factor receptor-2 (VEGFR-2) or -3 
(VEGFR-3) neutralizing antibodies. Wound healing was examined throughout a 20-day period. 
Investigation comprised of regular wound size measurements, repeated intravital microscopy 
and histology at the end of follow-up period. In the aspect of the examined modalities the most 
dramatic healing disturbance was found in the angiogenesis blocker anti-VEGFR-2-treated group. 
Moreover, the lymphangiogenesis blocker anti-VEGFR-3-treated group showed significantly 
protracted reepithelisation and fibrogenesis and lower vascular density compared to control 
group, too. Based on the obtained data wound healing under lymphangiogenesis blockade was 
significantly inferior to that of control animals giving a novel insight that lymphatic circulation 
poses a non-negligible role in acute wound healing.
032
IL-23 is essential, but IL-22 is dispensable for the development of psoriasis-like lesions in 
K5.Stat3C mice
Mikiro Takaishi1, Kimiko Nakajima1, Wenjun Ouyang2, Shigetoshi Sano1 1Kochi University, 
Nankoku, Kochi, Japan, 2Genentech, Inc., South San Francisco, CA, USA
Psoriasis is an inflammatory dermatosis induced by altered interactions between the immune 
system and skin. The IL-23/Th17 axis has been thought to play an important role in the 
pathogenesis of psoriasis, but detailed contributions of IL-23, IL-17 and IL-22 in vivo still remain 
unclear. We recently reported that K5.Stat3C transgenic mice, in which constitutive active form 
of Stat3 was specifically expressed in keratinocytes, developed skin lesions following wounding 
or topical treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA). Their skin lesions closely 
resembled human plaque psoriasis regarding not only histology but also cytokine profiling. In this 
study, we assessed contributions of IL-23 and IL-22 to the development of psoriasis-like lesion 
by intercrossing K5.Stat3C mice with IL-23p19 or IL-22 deficient mice. Remarkable attenuation 
of lesions was observed in K5.Stat3C:IL-23p19-/-, while K5.Stat3C:IL-23p19+/- mice developed 
psoriasis-like lesions. This result was relevant to inhibitory effect of anti-IL-23 antibodies on skin 
lesions in K5.Stat3C mice. Quantitative PCR analysis showed that IL-23p19 deficiency down-
regulated the Th17 cytokines such as IL-17 and IL-22, as well as other IL-20 subfamily members 
including IL-19, IL-20, and IL-24 in the affected skin. Therefore, IL-23 is a very upstream cytokine 
for development of skin lesion. By contrast, K5.Stat3C:IL-22-/- mice unexpectedly showed 
TPA-induced acanthosis, which was comparable to K5.Stat3C:IL-22+/- mice. These results 
suggested that an unidentified cytokine/growth factor network, being IL-23-dependent but IL-
22-independent, played a role in development of psoriasis-like lesions of this mouse model, and 
might be as well involved in human psoriasis.
033
Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in 
the control of epidermal homeostasis
Saskia Lippens1, Sylvie Lefebvre2, Barbara Gilbert1, Mozes Sze1, Michael Devos1, Kelly Verhelst1, 
Lars Vereecke1, Conor McGuire1, Chris Guerin1, Peter Vandenabeele1, Manolis Pasparakis3, 
Marja L. Mikkola2, Geert Van Loo1, Wim Declercq1 1VIB/UGhent, Ghent, Belgium, 2University of 
Helsinki, Helsinki, Finland, 3University of Cologne, Cologne, Germany
The ubiquitin-editing enzyme A20 (TNFAIP3) serves as one of the critical brakes on NF-kB 
signaling. In humans, polymorphisms in or near the A20 gene are associated with several 
inflammatory disorders, including psoriasis. Full A20 deficient mice suffer from severe multi-
organ inflammation and die perinatally. We show here that epidermis-specific A20 knockout 
mice (A20EKO) develop keratinocyte hyperproliferation, but no signs of skin inflammation, 
such as immune cell infiltration. However, A20EKO mice clearly developed ectodermal organ 
abnormalities, including disheveled hair, longer nails and sebocyte hyperplasia. This phenotype 
resembles that of mice overexpressing EDA-A1 or its receptor EDAR, suggesting that A20 
negatively controls EDAR signaling. Importantly, we found that A20 inhibited EDAR-induced 
NF-kB signaling independent from its de-ubiquitinating activity. In addition, A20 expression was 
induced by EDA-A1 in embryonic skin explants, where its expression was confined to the hair 
placodes, known to be the site of EDAR expression. We could also show that EDAR signaling 
leads to TNF production and we found that the A20EKO phenotype is TNF-R1-dependent. 
Our data suggest that A20 prevents EDA-A1-induced TNF overproduction and assures proper 
homeostasis and hair development.
034
Role of IL-9 in Th17-associated inflammation, hyperproliferation, and angiogenesis in psoriasis
Tej P. Singh1, Michael P. Schön2, Alexandra Gruber-Wackernagel1, Katrin Wallbrecht2, Xiao-
Jing Wang3, Peter Wolf1 1Medical University of Graz, Graz, Austria, 2University Medical Center 
Goettingen, Goettingen, Germany, 3University of Colorado, Denver, USA
Psoriasis is a chronic disease characterized by hyperplastic epidermis, skin infiltration by 
inflammatory cells, and increased angiogenesis. However, the exact underlying mechanisms 
remain unclear. Recent studies suggest that IL-9 induces Th17 cell differentiation and mediates 
Th17-driven inflammatory diseases (eg, atopic dermatitis and autoimmune encephalitis). We 
employed both psoriatic human subjects and the K5.hTGF-beta1 transgenic mouse model to 
investigate the potential role of IL-9 in psoriasis. Our present results indicate a link between IL-9 
and Th17 pathogenesis. IL-9R and IL-9 expression in skin lesions and CD4+ T cells from psoriatic 
patients were higher than in those from healthy normal control subjects. IL-9 enhanced IL-17A 
production by cultured human peripheral blood mononuclear cells or CD4+ T cells, especially 
after costimulation with TGF-beta1 and IL-6. In K5.hTGF-beta1 transgenic mice, IL9 injection 
induced inflammation and accelerated the psoriasis-like skin phenotype of epidermal hyperplasia 
and skin infiltration by CD3+, CD68+, and mast cells. IL-9 also promoted angiogenesis and VEGF 
and CD31 overexpression in vivo and increased proliferation of keratinocytes in vitro. Injecting 
anti-IL-9 antibody into K5.hTGFbeta1 transgenic mice not only diminished Th17 inflammation 
and angiogenesis but also delayed the psoriasis-like skin phenotype. Notably, injecting anti-
IL-17 into the transgenic mice decreased skin IL-9 mRNA levels and serum IL-9 protein levels. 
Thus, IL-9 may play an important role in the development of psoriatic lesions indirectly through 
Th17-associated inflammation and angiogenesis and directly through cell proliferation induction. 
These results also provide the first evidence that IL-9’s inflammatory and angiogenic effects in 
psoriasis can be delayed by anti-IL-9 treatment.
035
Foxp3+ regulatory T cells derived from psoriatic patients easily differentiate into IL-17A-
producing cells
Romy Keijsers1, H. Jorn Bovenschen1, Peter van de Kerkhof1, Piet van Erp1, Rob Woestenenk3, 
Roelie de Boer-van Huizen1, Irma Joosten2, Hans Koenen2 1Radboud University Nijmegen Medical 
Centre, Department of Dermatology, Nijmegen, The Netherlands, 2Radboud University Nijmegen 
Medical Centre, Laboratory of Medical Immunology, Department of Laboratory Medicine, 
Nijmegen, The Netherlands, 3Radboud University Nijmegen Medical Centre, Laboratory of 
Hematology, Department of Laboratory Medicine, Nijmegen, The Netherlands
Psoriasis is an autoimmune-related chronic inflammatory skin disease, which is strongly 
associated with IL-23 and Th17 effector cytokines. Th-17 cells are highly proinflammatory T-cells 
and are characterised by the expression of transcription factor RORγt and the production of IL-
17A and IL-22. In psoriasis, impaired functioning of CD4+CD25high regulatory T-cells (Tregs) 
is also considered to play an important role. Under normal conditions CD4+CD25highFoxp3+ 
Tregs are important in preventing autoimmune responses. However, under pro-inflammatory 
conditions Tregs can differentiate into inflammation associated Thelper 17 (Th17) cells, a 
paradigm shift, with unknown consequences for human disease initiation and progression. In this 
study we showed that human Treg derived from the peripheral blood of severe psoriatic patients, 
as compared to healthy controls, have an enhanced propensity to differentiate into inflammation 
associated IL-17-producing cells, upon ex vivo stimulation. This Treg to Th17 conversion was 
enhanced by IL-23 and linked to high expression levels of RORγt and loss of Foxp3 expression. 
Using immunohistochemistry, we demonstrated IL-17A+/Foxp3+/CD4+ triple-positive cells in 
skin lesions of severe psoriasis patients. Co-expression in one cell was verified using confocal 
microscopy. Together, these findings suggest an exciting novel explanation for the induction of 
immune pathologies such as autoimmune diseases and chronic inflammation. In the future this 
may lead to new targeted therapies.
036
Heat shock protein 90 inhibition in autoimmunity to type VII collagen
Michael Kasperkiewicz1, Ralf Müller1, Rudolf Manz2, Moritz Magens1, Christoph Hammers3, 
Csaba Somlai4, Jürgen Westermann3, Enno Schmidt1, Detlef Zillikens1, Ralf Ludwig1, Antal Orosz5 
1Department of Dermatology, University of Lübeck, Germany, 2Institute for Systemic Inflammation 
Research, University of Lübeck, Germany, 3Institute of Anatomy, University of Lübeck, Lübeck, 
Germany, 4Department of Medical Chemistry, University of Szeged, Szeged, Hungary, 5Tumor Cell 
Biology Laboratory, Anticancer Drug Research Foundation, Budapest, Hungary
Blocking heat shock protein 90 (Hsp90) induces death of malignant plasma cells by activation 
of the unfolded protein response (UPR), a signaling pathway activated by accumulation of 
misfolded proteins within the endoplasmatic reticulum. We hypothesized that non-transformed 
plasma cells are also hypersensitive to Hsp90 inhibition owing to their high amount of protein 
biosynthesis. To study this, two different Hsp90 inhibitors, the geldanamycin derivative 17-
DMAG or the nontoxic peptide derivative TCBL-145, were applied to mice with experimental 
epidermolysis bullosa acquisita, an autoimmune bullous disease characterized by autoantibodies 
against type VII collagen of the dermal-epidermal junction. Both inhibitors ameliorated clinical 
disease of type VII collagen-immunized mice, suppressed autoantibody production, and reduced 
dermal neutrophilic infiltrate. Interestingly, total plasma cells numbers, type VII collagen-
specific plasma cells and germinal center B cells were unaffected by anti-Hsp90 treatment in 
vivo. However, T cell proliferation was potently inhibited, as evidenced by reduced response of 
isolated lymph node cells from immunized mice to in vitro re-stimulation with anti-CD3/CD28 
antibody or autoantigen in presence of Hsp90 inhibitors. Our results suggest that Hsp90 blockade 
has no impact on normal or autoreactive plasma cells in vivo and indentify T cells as targets of 
anti-Hsp90 treatment in autoimmunity to type VII collagen.
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Epidermal control of psoriasis like skin inflammation by a TNF-a and IL-24 dependent 
mechanism
Snehlata Kumari, Ingo Haase University of Cologne, Dept. of Dermatology, Cologne, Germany
TNF-a is a key cytokine in the pathogenesis of psoriasis and polymorphisms within the TNF-a 
/ NFkB signaling pathway are known to be associated with this disease. Mice with epidermis 
specific deletion of I kappa B Kinase 2 (IKK2), a kinase essential for normal activation of NFkB 
signaling, develop a severe, psoriasis like inflammatory skin disease shortly after birth. Here we 
demonstrate that in these mice epidermal keratinocytes initiate the psoriasis like inflammatory 
skin disease by producing large amounts of IL- 19 and IL- 24 in a TNF-a dependent manner. This 
is followed by the sequential expression of various cytokines and chemokines in the epidermis 
and dermis thus directing inflammation specifically towards an innate immune response of the 
skin. Comparison of the pattern of epidermis derived cytokines between inflamed murine skin 
and human psoriatic skin revealed a high degree of similarity. Inhibition of IL- 19 signaling 
by targeted deletion of the IL20 receptor chain I attenuates the inflammatory skin phenotype; 
inhibition of IL- 24 signaling by deletion of the IL22 receptor chain I abrogates it. In vitro 
studies with IKK2 deficient epidermal keratinocytes revealed that the absence of IKK2 results 
in an augmented production of IL-24 and other cytokines in response to TNF-a, but not IL-1b. 
Our results unequivocally demonstrate that the psoriasis like skin disease in our model is the 
consequence of an altered response of epidermal keratinocytes to TNF-a which involves IL-24 as 
a central pathogenic cytokine.
038
Influence of single nucleotide polymorphisms and copy number variations of the FcγR gene 
locus on susceptibility to autoimmune blistering diseases of the skin
Andreas Recke1, Ralf Ludwig1, Gestur Vidarsson2, Miriam Freitag2, Julia Schellenberger2, Siegfried 
Görg3, Detlef Zillikens1, Saleh Ibrahim1 1Dept. of Dermatology, University of Lübeck, Lübeck, 
Germany, 2Dept. of Experimental Immunohematology, Sanquin Research and Landsteiner 
Laboratory, University of Amsterdam, Amsterdam, The Netherlands, 3Institute of Transfusion 
Medicine, University of Lübeck, Lübeck, Germany
In humans, FcγR receptors (FcγR) have a high frequency of functionally relevant polymorphisms which 
influence cellular responses against immune complexes. This is reflected by positive association with 
autoimmune diseases like systemic lupus erythematosus. While autoimmune blistering diseases of the 
skin (AIBD) are prototypic for autoantibody-dependent autoimmune diseases, little is known about 
their relationship with the FcγR genotype. Only one study suggests an association of the FcγRIIIA 158F 
variant with bullous pemphigoid. However, analysis of a possible susceptibility to disease is hampered 
by the genetic structure of the FcγR locus because of high sequence homology between various Fcγ 
receptors and copy-number variations (CNV) within this locus. To investigate a possible association 
of certain FcγR polymorphisms with AIBD, we combined powerful techniques to determine the exact 
make-up of the FcγR gene locus, including TaqMan CNV assays and multiple ligation-dependent 
probe amplification (MLPA). 180 healthy blood donors and 140 AIBD patients were included into this 
study. To investigate the functional impact of FcγR polymorphisms, we additionally isolated neutrophil 
granulocytes from healthy blood donors and analyzed them in vitro for release of reactive oxygen 
species (ROS) and lactoferrin upon stimulation with autoantibody immune complexes. TaqMan data 
suggests that higher copy numbers of FcγRIIIA are associated with AIBD. By MLPA, we found unusual 
haplotype structures with multiple copies of FcγRIIIB in AIBD. This correlated with FcγRIIIB CNV 
dependent responsiveness of granulocytes to autoantibody immune complexes (p=0.0129). Our 
findings indicate an association between FcγR genotype and predisposition for AIBD.
039
Conventional DC drive Imiquimod-induced psoriasis via induction if innate IL-22
Christian Wohn1, Errol Prens2, Sabina Onderwater1, Edwin Florencia2, Louis Boon3, Heike 
Weighardt4, Björn E. Clausen1 1Dept of Immunology, ErasmusMC, Rotterdam, The Netherlands, 
2Dept of Dermatology, ErasmusMC, Rotterdam, The Netherlands, 3Bioceros BV, Utrecht, The 
Netherlands, 4Institut für Umweltmedizinische Forschung, Heinrich-Heine Univ, Düsseldorf, Germany
Psoriasis is a common auto-inflammatory skin disease of unknown etiology. Topical application of 
the toll-like receptor (TLR)-7 antagonist Imiquimod (IMQ) onto mouse skin leads to inflamed scaly 
skin lesions. The phenotype is characterized by increased keratinocyte proliferation, abnormal cell 
differentiation and a leukocyte infiltrate consisting of neutrophils, T cells and dendritic cells (DC). While 
the development of IMQ-induced psoriasis depends on IL-23 and IL-17, the role of DC to mediate 
the disease remains elusive. Psoriatic skin contains different DC populations including Langerhans 
cells, conventional DC (cDC) and plasmacytoid DC (pDC). To investigate which DC subset(s) drive 
psoriasiform skin disease, we generated mice deficient for the TLR adaptor molecule MyD88, in which 
TLR signaling is conditionally switched on in all DC (CD11c-MyD88ind) or only in Langerin+ DC 
(Langerin-MyD88ind mice). Our results indicate that restricting TLR7 triggering to Langerin+ DC, lead to 
attenuated disease. In contrast, selective reconstitution of TLR signaling in DC was sufficient to mediate 
full-blown disease as documented by epidermal thickening, keratinocyte proliferation and expression 
of psoriasis-related genes like S100A7, Keratin-16, Defb3, IL-1β and IL-17A. Moreover, antibody-
mediated depletion of pDC in CD11c-MyD88ind mice did not ameliorate skin inflammation and 
systemic production of IL-6 and TNFa was unchanged. Intriguingly, IMQ painting onto pDC-depleted 
CD11c-MyD88ind mice rapidly elicited similar levels of IL-22 as in CD11c-MyD88ind and WT controls. 
In conclusion, TLR7-activated cDC, rather than pDC and Langerin+ DC, trigger IMQ-induced psoriasis 
by stimulating innate production of IL-22.
040
Inhibitory effect of a cathepsin K inhibitor on the development of psoriasis-like lesions in a 
mouse model
Toshitake Hirai1,2, Takashi Kanda1,2, Kimiko Nakajima1, Mayuko Yamamoto1, Shigetoshi Sano1
1Department of Dermatology, Kochi Medical School, Kochi, Japan, 2Nippon Chemiphar Co. Ltd., 
Tokyo, Japan
Cathepsin K is a lysosomal cysteine protease that plays a pivotal role in osteoclast-mediated 
degradation of the bone matrices and functions as a regulator of TLR9 signaling in dendritic cells. 
A Cathepsin K inhibitor, NC-2300, not only suppressed bone erosion but also ameliorated paw 
swelling at inflamed joints in rat adjuvant-induced arthritis. We suggested that the amelioration 
of joint inflammation by NC-2300 was mediated, at least in part, by down-regulation of cytokine 
expression in dendritic cells (DCs), which was essential for TH17 cell activation. In this study, 
we investigated whether NC-2300 inhibited the development of psoriasis-like skin lesions in 
K5.Stat3C transgenic mice, in which TH17 cells were involved. Cathepsin K activities in epidermis 
and dermis from K5.Stat3C mice were higher than those from wild type mice. Topical treatment 
of K5.Stat3C mice with NC-2300 significantly ameliorated TPA-induced psoriasis-like epidermal 
hyperplasia. Under this condition, transcript levels of TH17-related cytokines, cathelicidin, and 
b-defensins were inhibited, and TH17 cells in the skin-draining lymph nodes were decreased. In 
vitro experiment using bone marrow-derived DC revealed that cathelicidin-related antimicrobial 
peptide (CRAMP) together with TLR9 triggering greatly enhanced gene expressions of IL-12a, 
IL-12b, and IL-23a, all of which were down-regulated by NC-2300. These results suggested that 
cathepsin K was involved in the pathogenesis of psoriatic skin lesions, and its inhibitor NC-2300 
attenuated psoriatic change through inhibition of TH17 cell polarization. Therefore, targeting 
cathepsin K may be a novel therapeutic strategy for the treatment of psoriasis.
041
Different ways for controlling proinflammatory 6-sulfo LacNAc(slan) dendritic cells
Anja Hänsel1, Christiane Berndt2, Katja Rückert2, Thomas Döbel1, Knut Schäkel1
1Department of Dermatology, University Hospital, Heidelberg, Germany, 2Department of 
Biopsychology, Faculty of Science of the Technical University, Dresden, Germany
Chronic inflammatory skin diseases such as psoriasis and atopic dermatitis are considered 
to be the result of proinflammatory DCs stimulating inflammatory T cell responses. However 
the identity and the modulation of these dendritic cells is still incompletely understood. We 
have previously identified slanDCs as a population of Tip-DCs (TNF-α, iNOS producing DCs) 
in psoriasis and observed increased frequencies of these cells also in atopic dermatitis. After 
isolation from blood slanDCs are immature, but show a spontaneous maturation in vitro within 6 
hours. In the immature state they are capable of producing high levels of TNF-α. Mature slanDCs 
are a rich source of the proinflammatory cytokines IL-23, IL-12, IL-1β, IL-6 and drive strong Th17- 
and Th1- responses. In this study, we asked for the flexibility of the proinflammatory capacity of 
slanDCs when coming into contact with well defined micromilieu factors. Immature slanDCs 
were treated by IL-10, PGEs or were repeatedly treated with LPS to induce endotoxin-tolerance. 
IL-10 treatment of freshly isolated slanDCs induced a failure in the production of TNF-α and 
IL-12 production upon LPS stimulation. A nearly complete reduction of IL-12 and TNF-α was 
also observed after treatment with PGE2, while IL-10 production was profoundly increased. 
In addition, we observed that slanDCs are highly susceptible to the induction of endotoxin-
tolerance. The initial low level LPS challenge led to a dose-dependent reduction of TNF-α 
production while IL-10 was profoundly upregulated. Taken together the high proinflammatory 
capacity of slanDCs, previously demonstrated in psoriasis, appears to be tightly regulated by 
different micromilieu factors.
042
Homopolymerization of ASC using FKBP12 chimeric protein induced rapid cell death 
accompanied with IL-1β processing
Takashi Satoh, Naotomo Kambe, Hiroyuki Matsue Chiba University, Chiba, Japan
NLRP3 is cytoplasmic protein classified into NLR (NOD-like receptor) family, which serve 
as pattern recognition receptors and sense microbial molecules in the cytoplasm of cells. 
Cryopyrin-associated periodic syndrome (CAPS) is known as an autoinflammatory disease 
associated with missense point mutations in NLRP3 and clinically characterized with urticarial 
rash induced by spontaneous inflammasome formation resulting in excessive IL-1β secretion. 
In addition, CAPS-associated NLRP3 mutants cause a program of necrotic cell death called 
pyronecrosis, the mechanistic details of which are unknown except the findings that this 
programmed cell death was suppressed by cathepsin B inhibitor. To explore the molecular 
mechanism of pyronecrosis, we made cell lines J774A.1 monocytes and MC/9 mast cells, 
both stably expressing chimeric protein of pyrin domain of NLRP3, full length of ASC, which 
is recruited to NLRP3 through each pyrin domain, and CARD domain of ASC, fused with 
FKBP12 for the induction of chemical homopolymerization to mimic the NLRP3 activation. 
Homopolymerization of the fusion protein produced active form of IL-1β with LPS pretreatment. 
Necrotic cell death phenotypically detected under microscopic observation was also recognized. 
In contrast to pyronecrosis induced by CAPS-associated NLRP3 mutants, however, cell death 
induced by forced oligomerization of ASC was not suppressed by cathepsin B inhibitor. This 
suggests that cathepsin B plays some role in a stage between an activation of inflammasome 
and an oligomarization of ASC in the cell death mechanism caused by the activation of NLRP3.
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Regulation of IL-23 through interaction of HO-1 with NFκB promoter elements
Jürgen Brück1, Oliver Rothfuss1,2, Katja Dengler1, Julia Geisel1, Ivana Glocova1, Michael Racke1,3, 
Martin Röcken1, Kamran Ghoreschi1 1Dept of Dermatology, University of Tuebingen, Germany, 
2Interfaculty Inst for Biochemistry, University of Tuebingen, Germany, 3Dept of Neurology, Ohio 
State University, Columbus, OH, USA
Clinical trials have shown that fumarates improve multiple sclerosis and psoriasis, in mice 
fumarates protect from experimental autoimmune encephalomyelitis. IL-23 produced by dendritic 
cells (DC) is crucially involved in these diseases. We have shown that fumarates generate type 
II DC that promote Th2 cells and suppress Th1 and Th17 cells. Type II DC result from fumarate-
induced glutathione-depletion and induction of reactive oxygen species (ROS). Interestingly, 
fumarates induced transcription and protein expression of the ROS-sensitive heat shock protein 
HO-1, which is implicated in the regulation of inflammation. To analyze this association we 
studied the interaction between fumarate-induced HO-1 and IL-23 expression. Fumarate treatment 
induced HO-1 and inhibited IL-23 expression in DC in vitro and in vivo. As HO-1 is not a typical 
transcription factor we determined the direct impact of HO-1 induction on IL-23 production. 
Therefore we transfected DC with HO-1 siRNA prior to stimulation. HO-1 siRNA prevented 
HO-1 induction and more importantly, fully restored IL-23p19 expression in fumarate-treated DC. 
Since HO-1 has been reported to interact with NFκB, which is implicated in the transcriptional 
regulation of IL-23, we characterized the exact role of this possible interaction. Fumarate-treatment 
induced translocation of a truncated HO-1 protein into the nucleus. By co-immunoprecipitation 
we could show that fumarate-induced HO-1 binds to NFκB elements within the IL-23 promoter. 
This was associated with modifications of the IL-23 promoter locus as shown by decreased histone 
3 acetylation after fumarate-treatment. In conclusion, fumarate-induced HO-1 specifically inhibits 
IL-23 expression and explains its therapeutic activity in Th17-mediated autoimmune diseases.
044
Modulation of Inflammatory and Lipoprotein Pathways in Skin and Serum from Patients with 
Psoriasis
Nehal Mehta1, Katherine Li2, Philippe Szapary2, Jim Krueger3, Carrie Brodmerkel2 1University 
of Pennsylvania, Philadelphia, PA, USA, 2Centocor Research & Development, Inc, Malvern, PA, 
USA, 3Rockefeller University, New York, NY, USA
We evaluated the skin and serum to establish whether dysregulation of common pathways 
link psoriasis to cardiometabolic diseases. Microarray analyses(Affymetrix U133+2 array)were 
completed on skin biopsies from a subset of ACCEPT,a randomized trial in 903 psoriasis patients 
(n=85 pts for baseline lesional and nonlesional skin);25 healthy skin biopsies were used for 
comparison of lesional and nonlesional skin to healthy skin. Serum(n=145)was tested at baseline 
for a panel of 91 proteins including cytokines and chemokines(MCP-1; CCL22) using a Luminex-
based platform (Rules Based Medicine Human MAP). Microarray analyses at baseline showed 
several probesets differentially expressed(>2-fold change,FDR p<0.05) in lesional skin compared to 
healthy, control skin. Significant changes in gene expression in the skin for MCP-1 and CCL22(>6-
fold change lesional vs healthy, p<0.00001). LXR-alpha, a well known, protective lipoprotein 
metabolism gene, showed a 6-fold decrease in lesional vs healthy skin(p<0.00001) while PPAR-
alpha, an insulin-sensitizing gene showed a 7-fold decrease(p<0.00001). Serum testing revealed 
proteins associated with the genes MCP-1 and CCL22 were elevated in psoriasis(mean MCP-1 502 
pg/ml psoriasis vs 141 pg/ml healthy;CCL22 1240 pg/ml vs 409 pg/ml(p<0.00001). Dysregulated 
lipid metabolism was evident in the serum,as Apo-A1, the main protein in HDL and linked to 
PPAR-alpha function, was significantly decreased in psoriasis compared to controls(252 ug/ml vs 
389 ug/ml, respectively,p< 0.00001). Skin and serum analyses in psoriasis identified dysregulated 
inflammatory(MCP-1 and CCL22) and lipid metabolism(LXR-a, PPAR-a)pathways in psoriasis. 
This provides evidence of a potential shared pathophysiology linking psoriasis to cardiometabolic 
disease;larger studies will be needed to confirm these findings.
045
UV-induced uric acid activates the NALP3 inflammasome in skin leading to immune suppression
Scott Byrne, Sarah Leighton, Gary Halliday University of Sydney, NSW, Australia
Ultraviolet (UV) radiation is a powerful immunosuppressant caused in part by the release of 
inflammatory cytokines. Most of these cytokines require processing by caspases before they are 
released in the biologically active form. The NALP3 inflammasome is a molecular complex that 
activates these inflammatory caspases. Recently it was shown that the NALP3 inflammasome 
is rapidly assembled following exposure to danger signals some of which can be released by 
exposure to UV. We have discovered that UV exposure of cells in vitro or mice in vivo results 
in the release of significant amounts of uric acid in the skin. This is important because uric 
acid has recently been identified as a danger signal that can trigger NALP3 inflammasome 
activation. Indeed, exposure of mice to UV activated the NALP3 inflammasome in irradiated 
skin. To determine the significance of these results, we blocked UV-induced uric acid production 
by treating mice with allopurinol, a highly specific inhibitor of uric acid synthesis used to treat 
chronic gout. This treatment prevented not only uric acid release and NALP3 inflammasome 
activation in vivo, but it protected mice from UV-induced immune suppression. These results 
identify uric acid and the NALP3 inflammasome as important mediators of UV-induced immune 
modulation.
046
A mutation of the immunoproteasome subunit gene is responsible for Nakajo-Nishimura syndrome, 
a distinct autoinflammatory syndrome with periodic fever, skin eruptions and partial lipodystrophy
Nobuo Kanazawa1, Kazuhiko Arima2, Hiroyuki Mishima3, Fukumi Furukawa1, Hiroaki Ida4, Ko-
ichiro Yoshiura3 1Dept of Dermatology, Wakayama Medical Univ, Wakayama, Japan, 2Dept of Medical 
Gene Technology, Nagasaki Univ Grad School of Biomed Sciences, Nagasaki, Japan, 3Dept of Human 
Genetics, Nagasaki Univ Grad School of Biomed Sciences, Nagasaki, Japan, 4Div of Respirology, 
Neurology & Rheumatology, Dept of Medicine, Kurume Univ School of Medicine, Kurume, Japan
Nakajo-Nishimura syndrome (MIM256040, ORPHA2615) is a distinct autosomal-recessively 
inherited disease reported first by Nakajo in 1939 and second by Nishimura et al in 1950, both written 
in Japanese, and further by Kitano et al in 1975 as “a syndrome with nodular erythema, elongated and 
thickened fingers, and emaciation”. The disease begins with pernio-like eruptions in early-infancy, 
getting worse in winter. Some patients periodically develop high fever, nodular erythemas and 
myositis. Lipomusculoatrophy and joint contracture gradually progress mainly in upper part of the 
body to form the characteristic thin facial appearance and elongated clubbed fingers. Inflammatory 
changes, such as high serum CRP and immunoglobulins and basal calcification are obvious, but no 
remarkable autoantibodies are accompanied at the disease onset. Here we report the identification 
of a homozygous missense mutation in the gene encoding an immunoproteasome subunit, causing 
an amino acid change of its mature peptide, in 8 unrelated Nakajo-Nishimura syndrome patients, 
with significant founder effect. As predicted by conformational analysis, this mutation causes almost 
complete defect of the chymotrypsin-like activity and reduction of other protease activities due to 
insufficient formation of the complete immunoproteasome complex, revealed by western blotting. 
By immunohistochemistry, accumulation of ubiquitinated proteins was detected within dermal 
macrophages infiltrating in the patients’ skin eruptions. These results provide the first line of evidence 
that proteasome dysfunction causes a new class of autoinflammatory disorder.
047
Plasma Catecholamines in Psoriasis
Samia Elewa, Nabil Kamel, Ali El-Arini Faculty Of Medicine, Alexandria, Egypt
Psoriasis could be a disease in which an assumed pituitary adrenal mechanism shows a lack 
of adaptation to the previous stresses. The aim of this work was to determine the plasma 
catecholamines in psoriatic patients and to compare such levels to severity of psoriasis. The 
study was carried out on forty five persons; fourteen healthy controls and thirty one psoriatic 
(twenty with chronic generalized psoriasis and eleven with chronic localized psoriasis) all 
cases were clinically free except for being psoriatics,all patients avoided topical and systemic 
corticosteroids and phototherapy for at least two months. Estimation of catecholamines in 
plasma by HPLC method. In the present study ,there were significantly increased levels of 
adrenaline and noradrenaline as one fraction in chronic psoriatics either with generalized 
(5270±1782.4pmol/L) or localized skin eruption (4545.5±504.9pmol/L) compared to the control 
group(2400±848.53pmol/L),moreover this increase was more marked in generalized than in 
localized psoriatics, yet this difference did not reach statistical significant level. Considering 
dopamine plasma levels,they were significantly increased in chronic generalized psoriatics 
compared to the control group (405±156.36,173.57±115.73 P<0.05)while the increased level 
of dopamine in chronic localized psoriatics compared with control value was statistically 
insignificant (305±187.02,173.57±115.73). This may indicate that psoriatics are more responsive 
to stress at least in terms of sypathoadrenomedullary system.
048
α-enolase autoantibodies in sera of extrinsic and intrinsic atopic dermatitis patients
Byung Gi Bae, Chang Ook Park, Seongmin Noh, Kwang Hoon Lee Department of Dermatology 
& Cutaneous Biology Institute, Yonsei University College of Medicine, Seoul, Republic of Korea
In atopic dermatitis (AD), scratching leads to tissue damage and the release of structural proteins. 
Therefore serum specimen from patients with severe AD contains autoantibodies against proteins 
from keratinocytes. In turn, the autoantibodies can perpetuate allergic inflammation. These 
mechanisms of autoimmunity are considered to contribute to the pathogenesis of AD. Recently, 
it has been reported that α-enolase showed a relatively high expression in AD lesional skin 
as compared with normal controls. However, autoantibodies against α-enolase have not been 
evaluated in sera of AD patients. We enrolled 51 AD patients (extrinsic type of AD (ADe): n=38; 
intrinsic type of AD (ADi): n=13) and 24 normal healthy controls (HCs) who do not have disease 
history such as inflammatory or degenerative disorders. We evaluated IgG and IgM antibody 
levels against α-enolase using ELISA. There was no significant difference between AD patients 
and HCs in α-enolase IgG antibody levels. However, in α-enolase IgM antibody levels, there 
was statistically significant difference between ADe and HCs (p<0.001). In addition, there was 
positive correlation between α-enolase IgM antibody levels and the eczema area and severity 
index (EASI) score (p=0.033). Since IgM appear early in the course of an exposure to antigen 
and usually reappear after further exposure to antigen, high level of IgM antibody, but not IgG 
antibody, against α-enolase may imply that recent stimuli, most probably scratching, is the main 
secretion factor of α-enolase from keratinocytes or endothelial cells. Our study also could suggest 
that α-enolase IgM antibody might reflect disease severity of AD.
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In vivo efficacy of human mesenchymal stem cell transplantation in a bioengineered skin-
humanized mouse model for psoriasis
Sara Guerrero-Aspizua1,3, Alberto Oviedo5,3, Rodolfo Murillas2,3, Susana Puig6,3, Alvaro Meana4,3, 
Fernando Larcher2,3, María Luisa Lamana5,3, Marta Carretero2,3, Marcela Del Rio1,3 1Department 
of Bioengineering, Universidad Carlos III, Leganés, Spain, 2Regenerative Medicine Unit, Ciemat, 
Madrid, Spain, 3Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), 
Madrid, Spain, 4Centro Comunitario de Sangre y Tejidos del Principado de Asturias, Oviedo, 
Spain, 5División de Hematopoyesis, CIEMAT, Madrid, Spain, 6Hospital Clinic de Barcelona, 
Barcelona, Spain
Our team has developed a bioengineering-based skin-humanized mouse model for psoriasis. 
After engraftment, the regenerated human skin presents the typical architecture of normal human 
skin. However, immunological reconstitution through intradermal injection in the regenerated 
skin using in vitro-differentiated T1 subpopulations as well as recombinant IL-17 and IL-22 Th17 
cytokines, together tape stripping, leads to the rapid conversion of the skin into a bona fide 
psoriatic phenotype. Major hallmarks of psoriasis are confirmed by the evaluation of specific 
epidermal differentiation and proliferation markers as well as angiogenesis and infiltrate. This 
bioengineered skin-based system represents a robust platform to: 1) assess the molecular and 
cellular mechanisms underlying the complex interdependence between epidermal cells and the 
immune system, 2) validate/test drug-based therapies such as Ciclosporina and Etanercept and, 3) 
evaluate the therapeutic potential of cell-based therapies including human adipose tissue-derived 
mesenchymal stem cells (MSC) transplantation.
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Detection of antibodies against epidermal transglutaminase but not tissue transglutaminase in 
Japanese patients with Dermatitis herpetiformis
Teruhiko Makino1, Waka Ishida2, Megumi Furuichi1, Tadamichi Shimizu1 1University of Toyama, 
Toyama, Japan, 2Niigata Prefectural Central Hospital, Niigata, Japan
Dermatitis herpetiformis (DH) is an intensely pruritic, chronic, recurrent, papulovesicular 
disease and is commonly thought to be a cutaneous manifestation of a gluten-sensitive 
enteropathy (GSE). Though DH is a relatively common disease in Caucasian populations, it is 
rare in Asian populations including the Japanese. Epidermal transglutaminase (eTG) and tissue 
transglutaminase (tTG) are thought to be auto-antigens in Caucasian DH. This study investigated 
the levels of antibodies against eTG and tTG before and after treatment in two Japanese patients 
with DH. In addition, the level of serum interleukin-8 (IL-8), which is suggested to be associated 
with the pathogenesis of DH, was also examined. The patients were a 65-year-old and a 78-year-
old Japanese male. They were diagnosed as DH based on the histological and immunofluorescent 
findings. They had never had GSE. The levels of IgA antibodies against eTG and serum IL-8 
were markedly increased before treatment in both patients. However, the level of anti tTG 
antibodies was within the normal limits. The levels of anti-eTG antibodies and serum IL-8 were 
decreased after one patient was treated with systemic corticosteroid. However, those levels did 
not significantly decrease in another patient, who was treated with dapson, even though the skin 
lesions disappeared. These results suggest that anti-eTG antibodies might be a diagnostic maker 
of Japanese DH. Furthermore, we speculate that the anti-eTG antibodies and serum IL-8 might 
also be associated with the pathogenesis of Japanese DH.
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Expression of Notch Receptor and its Target Gene Hes-1 in Bone Marrow CD34+ Cells from 
Patients with Psoriasis
Ruixia Hou, Guohua Yin, Junqin Li, Xinhua Li, Xuping Niu, Ruifeng Liu, Kaiming Zhang Taiyuan 
City Central Hospital, Taiyuan, China
Psoriasis is an autoimmune skin disease mediated mainly by dysfunctional peripheral blood T 
cells. Both CD4+/CD8+ T cells and CD4+CD25+ regulatory T cells that were derived from psoriatic 
CD34+ bone marrow cells in vitro have been found to be functionally similar to those psoriatic 
circulating and lesional T cells. Notch signaling participates in diverse cell fate decisions during 
T cell development and has been reported to influence the proliferation of hematopoietic stem 
cells and the differentiation of T cells. The purpose of this study was to investigate the expression 
levels of Notch receptor 1, 2 and its target gene Hes-1 in CD34+ cells from patients with psoriasis. 
The total RNA and protein of CD34+ cells were extracted, and the mRNA as well as protein 
expression of Notch1, Notch2 and Hes-1 were investigated using RT-PCR and western blot 
assays. We found that the mRNA and protein expression levels of Notch1 and Hes-1 in psoriasis 
patients were higher compared to normal controls, while whereas the Notch2 mRNA and protein 
expression levels in psoriasis patients were similar to normal controls. The elevated Notch1 and 
Hes-1 expression levels in psoriatic CD34+ cells might be one reason for the immune disorders 
which are mainly mediated by T cells. These findings  demonstrated the abnormality of psoriatic 
hematopoietic cells and its role in the pathogenesis of psoriasis.
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Altered B cell homeostasis in human sarcoidosis
Anne Saussine, Jean-David Bouaziz, Valérie Dessirier, Séverine Feuillet, Michel Rybojad, 
Abdelatif Tazi, Armand Bensussan, Martine Bagot Saint Louis Hospital, Paris, France
Sarcoidosis is a granulomatosis of unknown etiology characterized by a disproportionate Th1 
immune response in involved organs. The presence of B lymphocytes in the granuloma periphery 
and the polyclonal hypergammaglobulinemia in sarcoidosis patients reflect the role of B cells in 
that disease. Ten sarcoidosis patients (with an active pulmonary and/or skin disease before any 
treatment) and 10 age and donor matched healthy donors were recruited for this prospective study. 
Flow cytometry analysis was used to analyze B cells subsets defined as memory (CD19+CD27+), 
naive (CD19+CD27-IgD+CD24intCD38int), and transitional (CD19+CD24highCD38high) blood B cells. 
In vitro stimulation was performed to analyze the number of IL-10 producing B cells (regulatory 
B cells). The phenotype of B cells in skin granuloma was analyzed. Frequencies and absolute 
number of CD19+ blood B cells were similar in both groups. Transitional and naïve blood B 
cells were increased in sarcoidosis patients compared with healthy controls in frequencies 
(transitional: 10.7 vs. 4.9% and naive: 75 vs. 58%) and absolute numbers (transitional: 10.39 vs. 
4.46/mm3 and naive: 74.9 vs. 48.5/mm3) (p<0.05). Circulating memory B cells were decreased 
in patients with sarcoidosis (12% - 10.69/mm3 versus 38% - 31.44/mm3, p<0.05). Sarcoidosis 
patients had 63% more IL-10 producing B cells than healthy controls (p< 0.05). Most of skin 
B cells from lesional skin were CD27+. Sarcoidosis patients have an altered B cell homeostasis 
including increased transitional, naïve and regulatory B cells and decreased memory B cells. The 
physiological role of these abnormalities is currently being investigated.
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Ability of Natural Avocado Sugars to Prevent Cutaneous Inflammation
Stéphanie Brédif1, Elisabetta Buommino2, Maria-Antonietta Tufano2, Caroline Baudouin1, Iole 
Paoletti2, Sébastien Garnier1, Adone Baroni3, Philippe Msika1 1Laboratoires Expanscience, 
Epernon, France, 2University of Naples, Italy, 3Faculty of Medicine and Surgery, Naples, Italy
Inflammation is a normal host defense mechanism which is, if controlled properly, essential to 
maintain homeostasis and health. However, most common cutaneous diseases are associated 
with deregulated and exacerbated inflammation. That’s why, in those types of dermatoses, 
inflammatory reaction has to be controlled in order to limit the development of lesions. 
The presence of mannoheptulose and perseitol as the predominant sugars in avocado is of 
considerable interest for its biological activity. In this study the anti-inflammatory activity of a 
patented avocado sugars blend has been evaluated on keratinocytes, cells considered to play a 
key role in the initiation of inflammatory reaction. Inflammation was induced on normal human 
epidermal keratinocytes by treatment with LPS (Lipopolysaccharide) or PMA (Phorbol Myristate 
Acetate) and the expression of cytokines or adhesion molecule was studied at the mRNA or 
protein level by real-time RT-PCR or ELISA. Moreover, IkappaB phosphorylation was followed 
by western blot.Avocado sugars were able to inhibit the gene expression and release of IL6, 
IL8, IL1-alpha, TNF-alpha and ICAM1 induced by LPS. Moreover, the sugars were able to limit 
IkappaB phosphorylation induced by LPS, and thus to limit activation of the NFkappaB pathway. 
Those effects were similar to those of a specific NFkappaB inhibitor. Avocado sugars were also 
able to inhibit the release of IL1-beta, TNF-alpha and IL-8 induced by PMA. By down-regulating 
the expression of cytokines and adhesion molecule through an inhibition of NFkappaB pathway, 
the patented avocado sugars could limit the initiation of inflammation.
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NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by 
Psoriasis
Francesca Prignano1, Victoria Barygina2, Matteo Becatti2, Leonardo Pescitelli1, Federica Ricceri1, 
Silvestro Agrippino2, Torello Lotti1, Niccolo Taddei2 1Division of Clinical, Preventive & Oncology 
Dermatology, Dept of Critical Care Medicine and Surgery, Univ of Florence, Italy, 2Dept of 
Biochemistry, University of Florence, Italy
There are many data in the literature concerning the increase of Reactive Oxygen Species (ROS) in 
psoriasis. In order to study the sources of oxidative stress in this disease we established primary fibroblasts 
cultures from involved and uninvolved (treated with biologicals) skin of psoriatic patients searching for 
signs of oxidative stress. FACS analysis, performed on primary fibroblasts stained with the oxidative-
sensitive probe DCF (2-,7-dichlorodihydrofluorescein) revealed that the level of ROS was three times 
higher in psoriatic fibroblasts in comparison with healthy individuals (p<0.001). This result strictly 
correlated with lipoperoxidation markers content (8-iso-Prostaglandin F2α and TBARS-thiobarbituric acid 
reactive substances). The level of 8-iso-Prostaglandin F2α did not differ significantly between treated and 
untreated fibroblasts, but all together was much higher in fibroblasts from psoriasis respect to control 
ones (p=0.037). TBARS assay also showed significantly higher (p<0.001) intracellular concentration 
of lipid peroxidation markers in psoriatic fibroblasts respect to control. As a cellular adaptation to 
high oxidative status in psoriatic skin, the level of antioxidant defense was significantly increased in 
psoriatic fibroblasts (treated and untreated) versus healthy ones (p=0.023), according to the results of 
Oxygen Radical Absorbance Capacity (ORAC) assay. For the first time we showed notable involvement 
of NADPH-oxidase4 (NOX4) in ROS over-production in fibroblasts from untreated skin: western blot 
analysis revealed notable increase of the NOX4 expression in untreated fibroblasts. According to the 
obtained results, we suppose that up-regulation of NOX4 in psoriastic fibroblasts can be the reason of 
the over-production and oxidative stress development in the skin of psoriasis patients.
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Establishment and PGE2 requirement of a new mouse model for pellagra
Kazunari Sugita1, Kenji Kabashima2, Jun-ichi Sakabe3, Etsushi Kuroda4, Motonobu Nakamura1, 
Yoshiki Tokura3 1Department of Dermatology, University of Occupational and Environmental 
Health, Kitakyushu, Japan, 2Department of Dermatology, Kyoto University Graduate School 
of Medicine, Kyoto, Japan, 3Department of Dermatology, Hamamatsu University School of 
Medicine, Hamamatsu, Japan, 4Department of Immunology, University of Occupational and 
Environmental Health, Kitakyushu, Japan
Pellagra is a photosensitive disorder caused by niacin deficiency. However, its pathogenesis 
remains unknown. To address this issue, we applied a niacin antagonist 6-aminonicotinamide to 
C57BL/6 mice. Since pellagra is typically seen on sun-exposed areas, we first examined ultraviolet 
(UV)-induced skin inflammation. Intriguingly, the UV-induced ear swelling response in these 
mice was significantly increased and prolonged compared to that in control mice. In addition, 
histopathology of these mice showed hyperkeratosis with inflammatory changes, consistent 
with the clinicopathologic features of pellagra. To further explore the mechanism underlying 
the UV-induced skin inflammation, we next analyzed the mRNA expression of cytokines 
during UV-induced skin inflammation. mRNA for cyclooxignase (COX)-2 and prostagrandin E 
(PGE) synthase were markedly induced in niacin-antagonist-treated mice after UV exposure. 
Consistently, the UV-induced ear swelling response in the niacin-deficient model mice was 
significantly reduced in mPGES knockout mice and indomethacin-treated mice. Accordingly, 
a laser doppler device revealed that local blood flow at the UV-irradiated area was significantly 
reduced in these mice. Moreover, we observed a significantly increased PGE2 production in 
the culture medium of UVB-exposed keratinocytes in the presence of niacin antagonist. We 
established for the first time a niacin-deficient mouse model of pellagra. It is considered that 
photosensitivity dermatitis is evoked presumably through elevated PGE2 production, providing a 
biologic basis of the pathogenesis of pellagra.
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Th1 and Th2 cells predominantly infiltrate in the skin and muscle lesions, respectively, with 
different TCR usages in dermatomyositis
Toshiharu Fujiyama, Hideo Hashizume, Maki Hata, Taisuke Ito, Yukiko Koto, Satoshi Hirakawa, 
Yoshiki Tokura Hamamatsu University School of Medicine, Hamamatsu Shizuoka, Japan
Dermatomyositis (DM) is an autoimmune disorder affecting both skin and muscle. According to 
the previous studies, while T cells infiltrate in the skin lesions, B cells as well as T cells are present 
in the muscle lesion. Moreover, deposition of the membrane attack complex is frequently seen 
in the muscle, suggesting that humoral immune responses mediate the muscle inflammation. A 
recent finding of Th2 polarization in the active phase of DM might be in accordance with this 
hypothesis. To characterize the lymphocytes infiltrating in the skin and muscle lesions of DM, we 
used our recently established method of expanding T cells from small pieces of organ tissues. 
With this method, skin and muscle-infiltrating lymphocytes were obtained from DM patients 
(n=10) and were investigated for their phenotype and T cell receptor Vb usage. CD4+ T cells were 
the predominant population of the muscle-infiltrating T cells, while the skin-infiltrating T cells 
consisted of both CD8+ and CD4+ cells, with the former being more predominant. There was a 
great difference in the TCR Vb usage between the skin and muscle, suggesting that the antigenic 
stimulants involved in each inflammation were distinct between these organs. The muscle-
infiltrating T cells produced significantly higher amounts of IL-4 than did the skin-infiltrating 
T cells, and IL-4-expressing T cells were more frequently found in the muscle than skin. These 
findings suggest that the Th1 and Th2-skewing conditions predominantly occur in the skin and 
muscle lesions of DM, respectively, and the TCR usages are different between the two organs.
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Increased Detection of Extracellular Vimentin in Peripheral Blood Mononuclear Cells of 
Psoriatic Patients
Claire Demongeot1,3, Jérôme Giustiniani1,4, Jean-David Bouaziz1,3, Martine Bagot1,3, Armand 
Bensussan1,2 1INSERM UMR-976, Paris, France, 2Université Paris Diderot, Sorbonne Paris cité, 
Paris, France, 3Dept of Dermatology Hôpital Saint-Louis, Paris, France, 4Institut Jean Godinot 
Reims, Reims, France
We previously reported that SC5 mAb specifically recognized the intermediate filament protein 
vimentin when exported to the extracellular side of T lymphocytes membrane isolated from healthy 
individuals following activation, from apoptotic T cells and from viable Sézary malignant cells. 
This is in contrast to circulating gated lymphocytes, which were poorly reactive with SC5 mAb. 
Here, we intended to determine psoriatic patients peripheral blood mononuclear lymphocytes 
reactivity toward SC5 mAb. Fresh PBMCs from five patients with typical psoriasis were isolated 
by the technique of Ficoll-Isopaque density gradient centrifugation and were stained with SC5 
mAb for flow cytometry analysis. The detection of apoptotic cells was performed by incubating 
the cells with 7AAD. We found in all patients an increase of SC5 mAb reactivity as it stained 
26,4% (± 8,4) of the gated circulating T cells when compared with healthy volunteers tested 
(9,7% ± 2,9). Interestingly, the viable circulating SC5+ lymphocytes did not exhibit an activated 
phenotype as they failed to react with mAbs recognizing CD69, CD71, CD25, HLA-DR or 
CD101. Thus, viable circulating T cells from psoriatic patients expressed an increased SC5 mAb 
reactivity, e.g an increased expression of extracellular vimentin, when compared with healthy 
individuals. Further investigations are needed to understand the role of this atypical location 
of vimentin at the outer side of the plasma membrane in the pathophysiology of psoriasis. If 
confirmed on larger studies, these data could lead to target this intermediate filament protein as 
an inflammatory antigen for diagnosis.
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MiR-203 suppresses the activity of the NF-kappa B pathway in keratinocytes
Tianling Wei, Florian Meisgen, Ning Xu, Mona Ståhle, Enikö Sonkoly, Andor Pivarcsi Unit of 
Dermatology and venereology, Department of Medicine, Karolinska Institutet, Stockholm, 
Sweden
MicroRNAs are short non-coding RNA genes, which regulate the expression of their target 
genes at the posttranscriptional level. Using signal transduction pathway finder array we 
found that that the skin-miRNA, miR-203, preferentially regulates genes belonging to the 
NF-κB pathway in keratinocytes. Q-PCR results demonstrated that miR-203-overexpressing 
keratinocytes express significantly lower levels of NF-κB-regulated genes, such as IL-8, CCL20 
and IL-1 alpha 24, 48, 72 and 96 hours after transfection both at the mRNA and at protein 
level in comparison with cells transfected with scramble miRNAs. Next, we measured nuclear 
translocation of p65, one of the major NF-κB subunits after TNF-alpha-treatment in miR-
203- or scrambled miRNA-overexpressing keratinocytes. We found that miR-203 suppressed 
the nuclear translocation of p65. To test whether miR-203 has any effect on NF-κB-driven 
promoter activity, we co-transfected miR-203 and an NF-κB-responsive promoter luciferase 
reporter plasmid (pGL4.32) into primary human keratinocytes and measured luciferase 
activity. MiR-203 significantly suppressed both the baseline and TNF-alpha-induced NF-κB 
promoter activity in comparison to scramble miRNA. Next, we investigated the regulation of 
miR-203 in keratinocytes and we found that miR-203 is suppressed by the activation of the 
MAPK pathway, which can be inhibited by chemical inhibitors of EGFR, MEK1/2 and JNK. 
In summary, the activation of the MAPK pathway suppresses miR-203 expression, and miR-203 
suppresses the NF-κB pathway via regulating a yet-unidentified upstream member of the NF-κB 
pathway. These results suggest a previously unknown, miR-203-mediated cross-talk between the 
NF-κB and the MAPK pathway.
060
Macrophages are alternatively activated in granuloma annulare
Daniel Torocsik, Helga Bardos, Eva Remenyik, Roza Adany University of Debrecen, Debrecen, 
Hungary
Macrophages are the key cells in the lesions of granuloma annulare (GA). As the pathogenesis 
of the disease remains unknown it is reasonable to speculate that the characterization of the 
macrophages might help to understand the background of the disease. The polarization of 
macrophages into the alternative and classical pathways depends on the activating stimuli eg. 
IL4 and extra cellular matrix remodelling leads to the alternative activation while presence of 
INFγ promotes classical activation. The activation results in the charateristic expression of marker 
proteins. In our previous work we found that Factor XIII-A (FXIII-A) is upregulated in macrophages 
in the presence of activating stimuli such as IL4 while its expression is absent in the classically 
activated cells providing FXIII-A to be a useful marker for alternative macrophage activation. 
Characterizing the macrophages present in GA lesions we found high levels of FXIII-A that was 
associated with other markers of alternative macrophage activation such as CD206 and CD209. 
Cells were also positive for general macrophage markers CD68 and CD163. Based on these 
results we propose that macrophages accumulating in GA lesions are alternatively activated 
indicating their active role in tissue remodelling.
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Mathematical modelling approach for systems-level understanding of skin barrier homeostasis 
in Atopic dermatitis
Reiko J. Tanaka1, Masahiro Ono2 1Imperial College London, London, UK, 2University College 
London, UK
Atopic dermatitis (AD) is an inflammatory disease with epidermal and immunological 
dysregulations. Skin barrier defect is a key trigger for allergic and inflammatory response in 
AD, as it promotes entry of allergens, pathogens, and environmental insults into the skin. This 
study shows how the combination of mathematical modelling and microarray data analysis 
help systems-level understanding of the skin barrier homeostasis and its deficiency leading to 
AD. Kallikreins (KLKs) in keratinocytes play a pivotal role in the skin barrier homeostasis and 
the innate and adaptive immune responses. We developed simplified mathematical models for 
regulation of KLK activity by including essential mechanisms revealed by experimental studies. 
The proposed models successfully reproduced the clinically well-known and essential AD 
features: inflammatory outbreak by external stimuli and persistence of inflammation even in the 
absence of the triggering stimuli. The model predictions were also validated by the microarray 
data from the skin of AD patients. To allow the complex clinical data to be compared with the 
model prediction, we developed a new quantitative index for PAR2 activity, which describes the 
inflammation level but is not directly measurable, by applying principal component analysis to 
the whole microarray dataset. Proposed mathematical models provide a framework to coherently 
understand the current experimental knowledge on AD and strongly implicate the presence and 
importance of feedback mechanisms in the regulation of KLK activities. This novel approach to 
use clinical data for systems-level understanding of underlying mechanisms of AD can be readily 
applied to other inflammatory diseases.
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The serum IgG autoantibodies specifically reacted with precursor proteins of both desmoglein-1 
and desmogleins-3 in a patient with Bowen’s carcinoma
Toshio Demitsu1, Tomoko Yamada1, Naoka Umemoto1, Koji Kamiya2, Yumi Aoyama2, Keiji 
Iwatsuki2, Jun Yamagami3, Masayuki Amagai3, Hiroshi Koga4, Takashi Hashimoto4 1Dept of 
Dermatology, Jichi Medical University Saitama Medical Center, Saitama City, Japan, 2Dept of 
Dermatology, Okayama University School of Medicine, Okayama, Japan, 3Dept of Dermatology, 
Keio University School of Medicine, Tokyo, Japan, 4Dept of Dermatology, Kurume University 
School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
Although non-pathogenic autoantibodies against desmogleins (Dsg) might be observed during the 
treatment with pemphigus vulgaris, they are hardly seen in the healthy individuals. As a first step to 
clarify the significance of the non-pathogenic antibodies in the development of pemphigus vulgaris, 
we have investigated the serum of a patient with Bowen’s carcinoma on the hand, which showed 
high titer of anti-Dsg1and anti-Dsg3 antibodies (128 and 113 index value). Direct and indirect 
immunofluorescence revealed non-specific reactions. By the comparison of the data between 
conventional ELISA and 0.5mM EDTA-treated ELISA in the serum, the patient’s antibodies are calcium 
independent which is different from the pathogenic antibodies against conformational epitopes 
usually seen in pemphigus vulgaris. In the pipetting assay, the patient’s serum was not capable of 
inducing the cell dissociation of the keratinocyes in vitro. By the Immunoprecipitation, the patient’s 
serum strongly reacted with the inactive precursor proteins of Dsg3 and weakly reacted with the 
precursor of Dsg1, whereas it did not react with the mature form of both Dsg1 and Dsg3. In the 
domain swapping approaches using Dsg1/Dsg2 and Dsg3/Dsg2, the patient’s serum did not react any 
extracellular domains of Dsg1 and Dsg3. In conclusion, the patient’s IgG autoantibodies specifically 
reacted with the precursor proteins of Dsg1 and Dsg3. The association of Bowen’s carcinoma and high 
titer of anti-Dsg antibodies seems to be coincidental. Further accumulation of similar cases is needed 
to clarify whether or not such antibodies potentially cause pemphigus in the future.
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Kyoto Rhino Rat is a new model of acne vulgaris with or without inflammation
Takashi Yoshimasu1,2, Seiko Toyozawa2, Nobuo Kanazawa2, Yuki Yamamoto2, Fukumi Furukawa2, 
Takashi Kuramoto3, Tadao Serikawa3 1Department of Dermatology, Arida Municipal Hospitals, 
Arida, Wakayama, Japan, 2Department of Dermatology, Wakayama Medical University, 
Wakayama, Japan, 3Institute of Laboratory Animals Graduate School of Medicine Kyoto University, 
Kyoto, Japan
Acne vulgaris is considered as a disorder of hair follicle with sebaceous gland, and the 
mechanisms is still obscure. There are two lesions in the development of acne vulgaris, which is 
non-inflammatory and inflammatory acne. Kyoto Rhino Rat (krh) was made in mutagenesis by 
ethylnitrosourea (ENU) which is a chemical mutagen at Institute of Laboratory Animals Graduate 
School of Medicine Kyoto University. Krh has active and developed sebaceous gland. In this 
study, we assessed whether krh is be able to become a new model of acne vulgaris by clinical 
findings and immunohistochemical analysis by hematoxylin eosin (HE) and oil red staining. Krh 
showed recessive hereditary hair loss after 2 weeks of birth however they had hair at birth. The 
alopecia of krh was remarkable as they grew, and lost almost hair at 8 weeks old. Comedo was 
seen at 16 weeks old. Follicular keratin plug and development of sebaceous gland was confirmed 
at 8 weeks of krh by HE and oil red staining respectively. Such plugging and sebaceous gland 
developed as they grew and non-inflammatory acne changed into inflammatory acne. We were 
also trying to quantify the number of acne in follicular infundibulum at each age of krh. The result 
of each age is now under consideration. Krh was considered as an excellent new model of acne 
vulgaris with abnormality of hair follicle and sebaceous glands.
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Humanized PBMC-Scid/Skin allograft model of skin inflammation is characterized by disturbed 
keratinocyte differentiation and influx of IL-17 producing T cells
VL de Oliveira1, PCM der Kerkhof2, L Svensson3, H Norsgaard3, T Labuda3, MM Seyger2, PE van Erp2, I 
Joosten1, HJPM Koenen1 1Lab of Medical Immunology, RUNMC, Nijmegen, The Netherlands, 2Dermatology 
Dept, RUNMC, Nijmegen, The Netherlands, 3Dept of Pharmacology, Leo Pharma, Ballerup, Denmark
Although human studies can provide a snapshot of T-cell immunity in human skin, definitive assessment 
of these issues in vivo requires the use of animal models. Here we report the characterization of local 
and systemic T-cell mediated cutaneous inflammatory responses in the PBMC-Scid/Skin allograft model. 
In brief, human skin-grafts were transplanted on SCID/beige mice, after healing mice were infused with 
allogeneic-PBMCs. Within 21 days clinical signs of erythema, scaling or thickness of the skin-graft occured. 
Skin-grafts and immune cells from peripheral lymphoid organs were analyzed. Histological analysis 
revealed acantosis, parakeratosis, hyperkeratosis. Immunohistochemistry (IHC) analysis of epidermal 
proliferation and differentiation markers revealed increased of Ki67, reversed K10/K16-expression, up-
regulation of hBD-2 and Elafin. mRNA gene-profiling showed increased expression of pro-inflammatory 
cytokines (IL-1β, IL-6, IL-8) and chemokines (CXCL-1, CCL-5, CCL-20). IHC also revealed abundant 
human T-cell infiltration in the dermis and epidermis. Many of these cells were producing IL-17 suggesting 
that Th17-cells are driving inflammation locally. Human CD4+ AND CD8+ T-cell responses in peripheral 
lymphoid organs revealed proliferation capacity (Ki67+), differentiation (CD45RO+) and skin homing 
capacity (CLA+). Systemic immunosuppression (Cyclosporine and Rapamycin) reverted the inflammatory 
phenotype with clinical signs, diminished T-cell infiltration and restoration of epidermal differentiation 
markers as hBD2, Elafin, K10 and K16. Upon treatment also systemic proliferation and differentiation 
responses were inhibited indicating that T-cells are driving this skin-inflammation process. This humanize 
inflammation skin model enables the study human T-cell immunity in vivo, both locally and systemically 
and is of value for preclinical intervention studies of human skin inflammatory disorders.
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Interest of Rhealba® oat plantlets in the management of atopic patients
Marie-Françoise Aries1, Clémence Vaissiere1, Anne Mandeau1, Françoise Belaubre1, Nathalie 
Castex-Rizzi1, Jean-François Nicolas2, Thomas Bieber3, Marco Ambonati1, Christine Coutanceau1 
1Dermo Cosmetic Department, Pierre FABRE R&D Center, Toulouse, France, 2Department 
of Clinical Allergology and Immunology, Lyon Sud Hospital, Lyon, France, 3Department of 
Dermatology and Allergology, Bonn University, Bonn, France
Oat extract-containing emollients are particularly adapted to the treatment of atopic dermatitis 
(AD). To improve the efficacy and safety of oat extracts, Pierre Fabre Laboratories scientists 
have developed new protein-free oat extracts from Rhealba® Oat Plantlets, the young plants 
collected at the growing stage prior to earing. This part of the oat is not consumed by humans 
and contains specific metabolites (C-glycosylated flavonoids and steroidal saponins) which 
possess potent anti-inflammatory, anti-allergic and immuno-modulating properties. The Plantlets 
extracts were analyzed by electrophoresis, ELISA and Western Blot to verify the absence of 
protein contamination. The immuno-modulating properties of the extract was tested on: i) the 
production of lymphocyte cytokines; ii) the functions of mature dendritic cells; iii) the production 
of PG6KF1α. Coomassie blue staining SDS-Page showed that the Plantlet extract does not 
contain any detectable proteins. ELISA and Western Blot tests showed no cross-reactivity to grain 
proteins, eliminating any risk of dietary pre-sensitization. Concerning biological properties, the 
extract showed potent immuno-modulating and anti-inflammatory activities including: i) direct 
inhibition of the T cell cytokine secretion (IL2 by 31%, IL4 by 19%, IL13 by 43%); ii) reduction 
of DC-induced T cell activation by 38%; iii) inhibition of the production of PG6KF1α by 57%. 
Therefore, this study shows that this new Rhealba® Oat Plantlet extract combines optimal safety 
(absence of proteins) and efficiency (immuno-inflammation modulation) providing a specially 
adapted solution for the treatment of barrier alteration in AD patients. This extract is now used in 
the new EXOMEGA range.
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Mimetic peptides of suppressor of cytokine signaling (SOCS)1 impair inflammatory responses 
of epidermal keratinocytes in vitro and in a mouse skin model of allergic contact dermatitis
Stefania Madonna1, Claudia Scarponi1, Rosanna Sestito1, Nunzianna Doti2, Teresa Carbone1, 
Francesca Nasorri1, Daniela Marasco2, Andrea Cavani1, Cristina Albanesi1 1IDI-IRCCS, Rome, 
Italy, 2University of Naples “Federico II”, Naples, Italy
Suppressor of cytokine signalling (SOCS)1 is an endogenous inhibitor of IFN-γ-mediated 
signaling and acts in a feedback loop by inactivating the Jak2/STAT1 axis and, thus, impeding 
the activation of IFN-γ-dependent genes. In human keratinocytes, SOCS1 binds Jak2 through 
its kinase inhibitory region (KIR) and suppresses the IFN-γ receptor (IFN-γR) and STAT1 
phosphorylation. Since keratinocytes over-expressing SOCS1 cannot longer express a number 
of inflammatory molecules, we tested the ability of newly developed SOCS1 mimetic peptides 
to suppress keratinocyte immune activation in vitro and in vivo. In particular, we evaluated 
the effects of two cell-permeable peptides, TAT-KIR and TAT-P5, on IFN-γ-activated cultured 
keratinocytes and in a mouse skin model of allergic contact dermatitis (ACD). We found that 
IFN-γ-activated keratinocytes treated with TAT-KIR and TAT-P5 exhibited a significant reduction 
of Jak2, IFN-γRα and STAT1 phosphorylation, compared to cells treated with irrelevant peptide. 
In turn, the expression of IRF-1, a late IFN-γ-inducible transcription factor, and STAT1-dependent 
genes, such as ICAM-1, HLA-DR, CXCL10 and CCL2 were significantly reduced. The migratory 
responses of T helper 1 lymphocytes towards supernatants from keratinocytes treated with SOCS1 
peptides were drastically reduced, due to their low release of CXCL10 and CCL2. In addition, 
the decreased expression of ICAM-1 determined by peptide treatment resulted in an impaired 
keratinocyte adhesiveness to autologous T lymphocytes. The topical administration of TAT-KIR 
and TAT-P5 mimetics on mouse skin where ACD was elicited, potently reduced local edema and 
inflammatory responses. Thus, targeting keratinocyte SOCS1 can represent a novel therapeutic 
approach for the treatment of IFN-γ-dependent skin diseases.
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Topical valrubicin application reduces TPA-induced skin inflammation in a murine model
Eva Hauge1, Helle Christiansen1, Cecilia Rosada1, Elisabeth de Darkó2, Tomas N. Dam3, Karin 
Stenderup1 1Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark, 2Valderm 
ApS, Lyngby, Denmark, 3Department of Dermatology, Roskilde Hospital, Roskilde, Denmark
Valrubicin belongs to a family of cytostatic anthracyclines, where it excels by its lack of tissue 
toxicity. Currently, it is approved solely for the treatment of bladder cancer. The availability of a 
cream formulation has provided the possibility for treatment of hyper proliferative skin diseases 
by topical application. We have demonstrated that valrubicin treats psoriasis in a xenograft 
transplantation model, where human psoriatic skin is transplanted onto immunedeficient 
mice, and inhibits tumor development in a skin carcinogenesis model in mice. Psoriasis 
and non-melanoma skin cancer are characterized by both keratinocyte hyper proliferation 
and inflammation. We have demonstrated that valrubicin explicates its effect by decreasing 
proliferation of keratinocytes, however, its effect on inflammation is still unknown. The aim of 
the present study was to investigate the effects of valrubicin on skin inflammation in vivo. For this 
purpose we employed the 12-O-tetradecanoylphorbol 13-acetate (TPA) induced irritant contact 
dermatitis model, where valrubicin treatment was applied topically 30 min post challenge. The 
inflammatory response was determined by ear thickness, myeloperoxidase activity, and histology; 
mRNA and protein expression of interleukin (IL)-1β and IL-6 was determined by qRT-PCR and 
ELISA. Valrubicin significantly reduced the inflammatory response, as seen by reduced ear 
edema and reduced number of infiltrating neutrophilic cells. This was paralleled by a significant 
decrease in expression of the inflammatory cytokines IL-1β and IL-6. Therefore, the beneficial 
effect of valrubicin in psoriasis and non-melanoma skin cancer is not solely explained by an 
effect on keratinocyte hyper proliferation, but also by an effect on inflammation.
068
Immunohistochemical analysis of CD3+ FOXP3+ regulatory T cells in healthy human skin and 
autoimmune dermatoses
Sarah Terras1,2, Thilo Gambichler2, Peter Altmeyer2, Jo Lambert1 1Ghent University, Ghent, Oost-
Vlaanderen, Belgium, 2Ruhr University Bochum, Bochum, Nordrhein-Westfalen, Germany
Regulatory T cells (Tregs) play an important role in autoimmune diseases. In skin, a diminished 
number or dysfunction of these Tregs could explain the occurrence of an autoimmune process. 
To date, the most accurate marker for Tregs in immunohistochemistry is the transcription factor 
forkhead box P3 (FOXP3). This study assessed the presence and number of CD3+ and FOXP3+ 
cells in skin biopsies of healthy subjects as compared to subjects with an autoimmune dermatosis. 
Adjacent skin sections from patients with psoriasis (n=11), vitiligo (n=10), pemphigus vulgaris 
(n=6), bullous pemphigoid (n=8), halo nevi (n=7) and healthy subjects (n=16) were stained 
immunohistochemically for CD3 and FOXP3. FOXP3+/CD3+ ratios were calculated and analyzed. 
This study demonstrates the presence of Tregs in lesional skin of patients with pemphigus vulgaris, 
psoriasis, bullous pemphigoid, halo nevi and vitiligo. In the dermis of healthy skin only few 
Tregs were seen (median 0.5%), confirming literature. In vitiligo (median 0.0%), pemphigus 
vulgaris (median 5.2%) and halo nevi (median 5.4%) no significant difference in number of 
FOXP3+ cells was found. Surprisingly, a significantly higher amount of Tregs was seen in lesional 
skin of patients with psoriasis (median 12.4%) and patients with bullous pemphigoid (median 
10.1%) as compared to healthy controls (median 0.4%). These findings support the hypothesis 
that not a decrease in number but a decrease in function of Tregs would be at the basis of these 
autoimmune skin disorders. This could result in unrestrained activation of autoreactive T cells in 
skin of patients with autoimmune skin diseases.
069
Immature slan (6-sulfo LacNAc) dendritic cells display a unique capacity of Fc gamma RIII-
mediated immune complex binding which is controlled by ADAM10 and ADAM17
Thomas Döbel, Anja Hänsel, Knut Schäkel University Hospital Heidelberg, Heidelberg, Germany
Antigen-antibody or immune complex (IC) recognition by dendritic cells (DCs) critically regulates 
immune responses. It is not known if there is a specific DC subset hardwired for IC binding. 
SlanDCs stand out by their high level expression of the low affinity Fc gamma receptor III (CD16). 
They are powerful proinflammatory DCs and serve as a major and early source of IL-12, IL-1 beta 
and TNF-alpha. We observed a far higher capacity of slanDCs to bind IgG ICs than CD1c+ DCs, 
pDCs and monocytes. Selective blocking revealed a strong CD16 dependence of IC binding 
by slanDCs. Moreover, CD16 proved critical for slanDCs to phagocytose IgG-opsonized red 
blood cells. A higher proliferative response of antigen-specific T cells was also observed when 
antigen was targeted to CD16 on slanDCs. Spontaneous maturation of slanDCs to professional 
APCs is accompanied by a rapid downregulation of CD16 and accumulation of soluble CD16 
in the supernatant. We identified the metalloproteinases ADAM10 and ADAM17 as responsible 
for the release of a soluble form of CD16 as coculture with specific inhibitors (GW280264x and 
GI254023x) led to the retention of CD16 on the surface of slanDCs. Altogether we have shown 
that expression of CD16 by immature slanDCs mediates an outstanding capacity to capture ICs 
for the subsequent presentation of antigen to T cells and this capacity is controlled by ADAM10 
and ADAM17. As slanDCs can become inflammatory dermal DCs, the high capacity to capture 
ICs adds an important function to these cells in terms of bridging innate and adaptive immunity.
070
Pentyl-Rhamnoside interest in inflammatory response associated with atopic dermatitis 
pathology
Marie-Françoise Aries1, Jérome Besse2, Hélène Hernandez-Pigeon1, Nathalie Castex-Rizzi1 
1Dermo Cosmetic Department, Pierre FABRE R&D Center, Toulouse, France, 2Medical 
Department, Pierre FABRE R&D Center, Toulouse, France
Atopic dermatitis (AD) is a multifactorial inflammatory skin disease sustained by susceptibility genes 
and environmental factors interactions and characterized by immuno-allergic inflammation and 
genetic barrier defects. Depending on the cell infiltrate present in AD skin lesions, keratinocytes 
which are immunological cells with major control over acute and chronic phases of inflammation 
by means of cytokine/chemokine production and surface molecule expression, contribute to the 
disease process and clinical phenotype development. The aim of the present study was to investigate 
gene expression of these inflammatory molecules in Normal Human Keratinocytes (NHK) and to 
evaluate the anti-inflammatory activity of Pentyl-rhamnoside on this cell response. As lymphokines 
and cytokines released by T lymphocytes and other immune cells represent the most important stimuli 
that elicit keratinocyte inflammatory activation, NHK were stimulated by polyI:C+IL4+IL13+TNFα for 
3 or 24 hours : the transcriptional profile observed in this inflammatory model correlated with the 
one of lesional atopic skin. The gene expression study was performed by GeneAtlasTM Microarray 
System from Affymetrix and analyzed by Ingenuity Pathways Analysis (IPA). The Pentyl-rhamnoside 
inhibited gene expression of various cytokines, chemokines and surface molecules including TNFα, 
IL6, MIP-1α, MIP-1β, RANTES, Skinkine, Gro-α, Gro-g, IL8, MIG, IP10, I-TAC, ICAM-1, and induced 
filaggrin, involucrin and K10 gene expression. In the same way as a parallel work showed the Pentyl-
rhamnoside interest in lipid barrier function, these findings demonstrate the inhibitory activity of 
Pentyl-rhamnoside on cytokines and chemokines genes expression in inflammatory keratinocytes 
exposed to AD environment, and reveal its powerful interest in AD inflammatory response.
071
Inflammatory effects of common skin microbial species on cultured keratinocytes
Patrick Duckney, Heng Kuan Wong, Jose Serrano, Thierry Oddos, Georgios Stamatas Johnson & 
Johnson Santé Beauté France, Issy-les-Moulineaux, France
It has long been known that skin infection occurs when external microbial pathogens penetrate 
the skin immunity barrier. At the same time the importance of a healthy microbial community 
on the skin surface is just beginning to be appreciated. In this study we investigated the effects 
of some common skin microbial species (Propionibacterium acnes, Staphylococcus epidermidis, 
and Staphylococcus aureus) on the production of pro-inflammatory cytokines by human 
keratinocytes in a reconstructed human epidermis model. Human epidermal equivalents were 
treated with different concentrations (104 to 109 CFU) of each microbial species. The bacteria 
were applied either topically to model surface colonization or in the culture medium representing 
sub-cutaneous infection. A multiplex array was used to detect the release of pro-inflammatory 
cytokines IL-1α, IL-6, IL-8, and TNF-α and viability tests were used to measure the acute toxicity 
of the microorganisms to the keratinocytes. Our data show that the tested microbial species 
induce a strong inflammatory response when applied in the medium, but not when applied 
topically, except in the case of topical S. aureus which induced a weak reaction. Viability 
assays showed that keratinocyte cytotoxicity depended on the microbial species applied and 
was markedly higher when microorganisms were applied into the medium, compared to topical 
application. Overall we were able to show differential effects of bacteria on human keratinocytes 
depending on the mode of application.
072
Inflammatory Caspases in the Imiquimod-Induced Psoriasis Mouse Model
Maria Luise Salskov-Iversen, Claus Johansen, Rasmus Boye Kjellerup, Lars Iversen Aarhus 
University Hospital, Aarhus, Denmark
Case-reports demonstrate an association between Aldara treatment (imiquimod 5%), and 
exacerbation of psoriasis. Imiquimod stimulates plasmacytoid dendritic cells (pDCs) through 
TLR7-ligation, leading to IFN-α release. These observations underline the relevance of IFN-α, as 
a psoriasis-initiating factor. In the imiquimod mouse-model, a psoriasis-like skin rash is induced 
in mice. Previously, we found upregulation in inflammasome-components in chronic plaque 
psoriasis. Here, we use the imiquimod model to characterize the inflammasome-components 
during initiation of a psoriasis-like skin-rash. Aldara was applied to the skin of C57BL/6 wild 
type mice, and biopsies were analyzed by histology, qRT-PCR, and ELISA after 8 hours to 8 days. 
Expression of inflammasome mRNA was evaluated by qRT-PCR in human PBMC cultures, after 
stimulation with imiquimod and selected cytokines. The expression of caspase-1, -11 and ASC 
mRNA was upregulated, and active IL-1β was detected. Imiquimod had no direct effect on the 
expression of inflammasome mRNA. Interestingly, IFN-α stimulation lead to 5-fold upregulation 
of caspase-1 (p<0.05) and 26-fold, borderline significant, upregulation of caspase-5 mRNA 
(p=0.054). Our results demonstrate inflammasome activation in imiquimod-treated mouse skin. 
Furthermore, we show that IFN-α induces inflammatory caspase mRNA in human PBMCs. 
This suggests that the inflammatory caspases may be important in the initiation of psoriatic 
inflammation.
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Parametres Of Disease Activity In Bullous Pemphigoid
Katarzyna Wozniak, Monika Kalowska, Cezary Kowalewski Medical University of Warsaw, 
Warsaw, Poland
We investigated whether ELISA indices for anty-NC16a IgE and IgG antibodies correlate with 
disease activity in pemphigoid. Study was performed in a group of 74 patients with BP positive in 
ELISA test for anti-NC16a IgG antibodies. Moreover, in 34 out of 74 patients ELISA test was also 
positive for anti-NC16a IgE antibodies. ELISA was performed in active stage of the disease and 
in clinical remission lasting from 3 to 24 months. We choose two control groups: 1) 35 healthy 
individuals in the age typical for BP (62-87 years old) and 22 patients with atopic dermatitis 
with significantly elevated total serum IgE. The obtained results were statistically analyzed. Our 
study disclosed that both index for anty-NC16a IgE and anti-NC16a IgG antibodies significantly 
had decreased in clinical remission if compared with active stage of BP, however it was most 
pronounced in a case of index for anty-NC16a IgE. Moreover our study showed that the 
proportion of BP patients in whom studied parameters become negative in long lasting clinical 
remission more significantly refers to index of anti-NC16a IgE than index for anty-NC16a IgG. 
Detailed analysis indicated that in majority of patients with BP ELISA index for anti-NC16a IgE 
become negative during first 3 months of treatment. On the basis of our results index for anti-
NC16a IgE antibodies seems to be the best marker of BP activity and may be useful to evaluate 
the effectiveness of treatment.
074
cis-Urocanic acid modulates human leukocyte functions stereospecifically through intracellular 
acidification
Jarmo K. Laihia1,4, Kari Neuvonen2, Paavo Pasanen2, Christer T. Jansén3,4, Lasse Leino1 1BioCis 
Pharma Ltd., Turku, Finland, 2Department of Chemistry, University of Turku, Turku, Finland, 
3Mehiläinen Medical Center, Turku, Finland, 4Department of Dermatology, University of Turku, 
Turku, Finland
Urocanic acid (UCA) has been identified as a UV photoreceptor with a well-documented ability 
to induce immunosuppression. However, the mechanism of action by which cis-UCA suppresses 
cell-mediated immunity has remained enigmatic. We investigated the binding and effects of UCA 
in human peripheral blood leukocytes. Isolated leukocytes incorporated 100 nM–30 mM trans- 
and cis-UCA without saturation. About 92% of cell-associated [14C]cis-UCA localized in the 
cytosol. No binding to soluble proteins and no immediate metabolism in the cytosol was found. 
Incubation with 0.1–10 mM cis-UCA at extracellular pH 6.5 reduced intracellular pH (pHi) 
specifically and dose-dependently up to 0.6 pH units, while the reduction was only marginal 
at pH 7.4. trans-UCA showed clearly weaker or no effects. cis-UCA inhibited the respiratory 
burst reaction of polymorphonuclear leukocytes, and this inhibition correlated significantly with 
the pHi reduction. Anti-CD3/CD28 costimulation of mononuclear leukocytes induced TNF-α 
and IL-6 secretion, which was inhibited by cis-UCA at pH 6.5 but not at pH 7.4. These results 
suggest that both UCA isomers accumulate inside the cells, whereas only cis-UCA is able to 
reduce pHi, probably by transporting protons from the mildly acidic extracellular medium to the 
neutral or mildly alkaline cytosol. Increased cytosol acidity leads to subsequent suppression of 
certain leukocyte functions. The differential acid dissociation properties of trans- and cis-UCA 
may explain why cis-UCA but not trans-UCA is able to induce immune suppression in a mildly 
acidic physiological environment, such as in the epidermis.
075
Inflammatory responses to Malassezia spp. infection depend on NLRP3 inflammasome driven 
IL-1β secretion
Magdalena Kistowska, Dragana Jankovic, Philipp Bosshard, Emmanuel Contassot, Lars E. French 
Department of Dermatology, University Hospital Zurich, Zürich, Switzerland
Seborrheic dermatitis is an inflammatory skin disorder which pathogenesis has not yet been 
fully described. It has been suggested that the combination of excessive sebum production and 
inflammatory response to Malassezia spp, which are a normal part of skin flora, play a role in the 
development of the disease. Our aim was to investigate the mechanism of Malassezia induced 
inflammation. The exposure of human antigen-presenting cells (APCs) to different clinical 
isolates of Malassezia strains resulted in secretion of significant amounts of proinflammatory 
cytokine IL-1β. Both live and heat inactivated Malassezia were able to activate APCs and induce 
IL-1β secretion suggesting that stimulatory components are not of protein origin. When APCs 
were pre-treated with Z-VAD, a pan-caspase inhibitor the release of IL-1β upon stimulation 
with Malassezia yeasts was abrogated. This suggests that Malassezia-induced IL-1β secretion is 
dependent on inflammasome activation, the latter requiring caspase-1 activation. Inflammasome 
is a multiprotein complex whose activation results in the release IL-1β. To elucidate which type of 
inflammasome is activated, we generated cells deficient for NLRP3 or NLRP1. IL-1β release was 
absent in cells lacking NLRP3, while the NLRP1-deficient cells secreted IL-1β when stimulated 
with Malassezia. Our findings indicate that non-protein ligand(s) present in Malassezia is a potent 
inducer of inflammatory response which is mediated through NLRP3 inflammasome.
076
Activated T Lymphocytes Induce an Inflammatory Phenotype in Human Reconstructed Skin
Geuranne Tjabringa1,3, Hans Koenen2, Mieke Bergers1, Roelie de Boer1, Esther van Rijssen2, 
Edward Knol3, Ellen van den Bogaard1, Mirthe Erkens1, Irma Joosten2, Joost Schalkwijk1 1Dept 
of Dermatology, Radboud Univ Nijmegen Medical Centre, N4i & the Nijmegen Centre for Molecular 
Life Sciences, Nijmegen, The Netherlands, 2Lab of Medical Immunology of Lab Medicine, Radboud 
Univ Nijmegen Medical Centre, N4i & the Nijmegen Centre for Molecular Life Sciences, Nijmegen, 
The Netherlands, 3Dept of Dermatology & Allergology, Univ Medical Center Utrecht, The Netherlands
Both the immune system and the epidermis play an important role in the pathogenesis of inflammatory 
skin diseases such as atopic dermatitis and psoriasis. In this study, we present the development of a human 
reconstructed skin model that contains T lymphocytes to trigger an inflammatory phenotype in vitro. 
This model will be useful for studying pathology and pharmacology of inflammatory skin diseases. Skin 
equivalents were generated from normal adult human keratinocytes and cultured for 3 days in the presence 
of CD4+ or CD8+ T lymphocytes in the presence or absence of anti-inflammatory drugs. Morphology of the 
epidermis was studied by histology, gene expression was analysed by qPCR while immunohistochemistry 
and ELISA were used to determine protein expression. Activated CD4+ T lymphocytes, but not CD8+ 
T lymphocytes, induced epidermal expression of psoriasis-associated proteins such as the antimicrobial 
peptides hBD-2 and elafin and the pro-inflammatory cytokines TNFα and CXCL8. In contrast, expression 
of the atopic dermatitis-related genes carbonic anhydrase-II and Nell-like-2 was not induced in the 
epidermis. Induction of hBD-2 was strongest in case of direct contact between the T lymphocytes and 
the skin equivalents. Anti-inflammatory drugs, including retinoic acid, cyclosporine A and anti-TNFα 
monoclonal antibodies suppressed the T lymphocyte-dependent induction of psoriasis-associated gene 
expression by the keratinocytes. We conclude that the presented psoriasiform skin equivalent model allows 
analysis of T lymphocyte-keratinocyte interactions and may be useful for pre-clinical screening of anti-
inflammatory drugs targeting epidermal cells and/or cells of the adaptive immune system.
077
Impact of ROS-modulating food additives on T cell-mediated autoimmune disease
Julia Geisel, Ivana Glocova, Katja Dengler, Martin Röcken, Jürgen Brück, Kamran Ghoreschi 
Department of Dermatology, University of Tuebingen, Tuebingen, Germany
Food additives have been reported to have anti-inflammatory activities. To understand their 
underlying mechanisms, we studied their effects on cell metabolism and immune responses. First, 
we studied the effects of food additives on dendritic cell (DC) differentiation and maturation, using 
concentrations that did not affect cell survival. While the expression of surface receptors was only 
minimally affected, we found significant differences in cytokine expression of TLR4-activated 
DC. The modulation of DC-cytokines was dependent on the induction of oxidative stress. Only 
treatment wit ROS-inducing additives resulted in an inhibition of IL-12 and IL-23 after TLR4-
activation. These effects could be restored by the addition of antioxidants like N-acetylcystein. 
As a consequence, ROS stress in DC resulted in type II DC that induce IL-4-producing Th2 cells 
in vitro and in vivo. Such type II DC inhibited Th1 and Th17 responses but induced GATA3 and 
Th2 cells. Next we analyzed the effects of ROS-inducing diets on the course of T cell-mediated 
autoimmune disease using a mouse model of multiple sclerosis (EAE). During immunization for 
EAE, food additives with ROS-inducing capacity protected the mice from disease. Thus, diets with 
ROS-inducing food additives can induce type II DC and Th2 responses and influence the clinical 
outcome of inflammatory autoimmune disease.
078
Proteasome subunit expression and activity are increased in psoriasis lesional skin
Pierre-Emmanuel Stoebner1,2, Laurent Henry1, Lionel Le Gallic1, Jean Martinez1, Thierry Lavabre-
Bertrand1, Laurent Meunier1,2 1UMR CNRS 5247, Montpellier, France, 2CHU, Nîmes, France
Deregulation of the proteasome pathway has been involved in the pathogenesis of many diseases 
e.g. cancer, inflammatory and neurodegenerative disorders and changes in proteasome subunit 
composition and proteasomal proteolytic activities have been associated to various diseases 
and physiological conditions. These changes have not yet been determined in psoriasis. We 
compared the protein and mRNA expression levels of proteasome and immunoproteasome 20S 
subunits and quantified their proteolytic activity in lesional and non lesional psoriasis skin (by 
using respectively immunohistochemistry, qPCR and fluorogeneic peptide substrate). Because 
a relationship between plasmatic proteasome (p-proteasome) levels and proteasomal tissue 
expression has been already reported we investigated whether the p-proteasome concentration 
(assessed by an ELISA test) was correlated to histological, biological and clinical parameters. 
Proteasome and immunoproteasome subunits expression is increased in lesional psoriasis skin. 
This overexpression is suspected to be the result from post-transcriptional regulatory mechanisms 
and was associated to a significant increase of the proteasomal chymotrypsin-like activity 
that was threefold higher in lesional skin than in non lesional skin. P-proteasome levels were 
enhanced in psoriasis patients (mean ± SEM: 3960 ± 299 ng mL-1, range: 1484-8987) when 
compared to controls (2535 ± 187 ng mL-1, range: 654-6446, p<0.001). They were significantly 
higher in arthropatic psoriasis (4937 ± 572 ng mL-1, range: 2600-8987) and correlated to the 
body surface area (BSA) involved and appeared thus as a new biomarker of psoriasis severity. 
Altogether these results support the involvement of proteasomes in psoriasis pathogenesis and 
the relevance of proteasome inhibitors in psoriasis treatment.
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Intradermal injections of platelet-activating factor (PAF) result in wheal-and-flare type skin 
reactions but do not induce mast cell degranulation
Karoline Krause1, Estela Martinez-Escala2, Magi Farré-Albadalejo2, Martin Church1, Marina 
Abajian1, Ana Giménez- Arnau2, Marcus Maurer1 1Department of Dermatology and Allergy, 
Charité-Universitätsmedizin Berlin, Berlin, Germany, 2Department of Dermatology and 
Pharmacology. Hospital del Mar. Universitat Autònoma de Barcelona, Barcelona, Spain
Platelet-activating factor (PAF) is a potent mediator of allergic reactions and has been claimed to 
contribute to the pathogenesis of urticaria, but its role and relevance for this condition remain 
to be characterized in detail. We assessed and compared skin inflammatory responses to PAF, 
histamine and codeine by planimetric morphometry and by measuring skin levels of histamine 
and prostaglandin D2 (PGD2). Intracutaneous injections of 25µl each of histamine, codeine, PAF 
or saline were performed in 14 healthy volunteers. Wheal-and-flare responses were assessed 
by planimetric morphometry 5, 10, 15, 30 min, 1, 2 and 3 h after injection. Skin microdialysis 
was performed after volar forearm local anesthesia with EMLA® cream, and mast cell mediators 
were measured (histamine and PGD2) before and 20-30 min after the induction of skin lesions. 
Intracutaneous injections of PAF, histamine and codeine but not saline resulted in typical wheal-
and-flare type reactions in all subjects. A significant increase in intradermal histamine (115 ng/
ml) and PGD2 (22.4 pg/ml) levels as compared to saline was observed after codeine injection 
(p=0.001 for histamine; p=0.006 for PGD2). Following PAF injection, histamine levels (10 ng/
ml) and also PGD2 levels (2.4 pg/ml) did not increase as compared to saline. Our findings 
demonstrate that intradermal PAF injections result in wheal-and-flare type skin reactions 
without inducing mast cell degranulation. PAF may, therefore, be a relevant mediator in the 
pathogenesis of urticaria that acts downstream of mast cell activation and independent of H1 
receptor activation.
080
Oxazolone induced atopic dermatitis mouse model for the screen of thymic stromal 
lymphopoietin(TSLP) inhibitors
Na Young Yoon1,2, Minyoung Jung1,2, Dong Hye Kim1,2, Hae Jin Lee1,2, Eung Ho Choi1,2 
1Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of 
Korea, 2Healthy Woods Skin Center, Yanggu, Republic of Korea
Thymic stromal lymphopoietin(TSLP) is overexpressed in the keratinocytes of atopic 
dermatitis(AD)-like lesions and triggers a mechanism of allergic march from AD to respiratory 
allergic diseases. In addition to early protection of skin barrier defects in AD, the selective 
inhibition of epidermal TSLP might be a key to block the allergic march. Therefore, a simple in 
vivo model is needed to screen newly developed TSLP inhibitors. We compared the expression 
of TSLP and other skin barrier related markers in oxazolone(OX)-induced AD mouse with or 
without the treatment of topical steroid, Which is a promising AD therapeutic agent. AD mice 
skin showed a Th2 dominant immunophenotype, abnormal keratinocyte differentiation and 
epidermal TSLP over-expression. Topical steroid once a day for 10 days markedly decreased 
epidermal TSLP expression, AD-like lesions, basal transepidermal water loss(TEWL) in the AD 
mice skin. Topical steroid improved stratum corneum hydration and epidermal differentiation 
markers such as filaggrin, loricrin and involucrin decreased in the AD mouse skin. Topical 
steroids also decreased CRTH2 immunostaining which representing Th2 lymphocytes and 
reversed the expression of antimicrobial peptide at both the mRNA and protein levels that were 
decreased in the AD model. Our results show that TSLP expression is proportional to skin barrier 
impairment in OX-induced AD mouse model and topical steroid, a representative TSLP inhibitor, 
decreased epidermal TSLP expression in company with an improvement of other skin barrier 
related markers. For conclusion, OX-induced AD mouse model may be a good screening tool of 
novel TSLP inhibitors in vivo.
081
The Role of Egr-1 in IL-17F-induced Psoriasin Expression in Human Keratinocytes
Sang Hoon Jeong, Eun Young Lee, Yoon-Hee Park, Hyun Cheol Bae, Sang Wook Son Laboratory 
of Cell Signaling and Nanomedicine, Department of Dermatology and Division of Brain Korea 21 
Project for Biomedical Science, Korea University College of Medicine, Seoul, Republic of Korea
Interleukin (IL)-17 has been reported to play an important role in the pathogenesis of diverse 
immune-mediated diseases, including psoriasis, rheumatoid arthritis, asthma and atopic 
dermatitis. The early growth response (Egr)-1 is a transcription factor which plays an important 
role in the regulation of cell growth, differentiation, survival, apoptosis and immune responses. 
Emerging evidences demonstrate that transcription of the Egr-1 gene is up-regulated in the 
psoriatic skin lesions, implicating that Egr-1 function as a regulator in the pathogenesis of psoriasis. 
However, the molecular mechanism underlying the induction of Egr-1 expression in psoriasis has 
not been clarified. In this study, we explored the regulatory mechanism of Egr-1 induction by 
IL-17F in HaCaT keratinocytes. The results show that IL-17F induces Egr-1 expression in a dose- 
and time-dependent manner in HaCaT keratinocytes. We also found that IL-17F induces nuclear 
translocation and promoter activity of Egr-1. Inhibition of the extracellular signal-regulated kinase 
(ERK) mitogen-activated protein kinase (MAPK) signals, but not c-Jun N-terminal kinase (JNK) or 
p38, strongly attenuated IL-17F-induced Egr-1 expression in HaCaT keratinocytes. In addition, 
S100A7 (Psoriasin) which is markedly over-expressed in the skin lesion of psoriatic patients, is 
increased by IL-17F in HaCaT keratinocyte distinctively. To determine the role of IL-17F-induced 
Egr-1, we analyzed the expression of psoriasin using siRNA to knock-down Egr-1 expression. 
Egr-1 siRNA inhibits the expression of psoriasin in IL-17F-treated cells. Thus Egr-1 might be one 
of the important genetic factors involved in the cross-talk of signals between immune cells and 
epidermal keratinocytes in inflammatory skin diseases such as psoriasis.
082
Inhibition of sebum, prostaglandin E2, and promatrix metalloproteinase-2 production by 
antimicrobial agents in hamster sebocytes
Takashi Sato1, Tatsuhiko Shirane1, Norihisa Noguchi2, Masanori Sasatsu2, Akira Ito1 1Dept of 
Biochemistry & Molecular Biology, School of Pharmacy, Tokyo Univ of Pharmacy & Life Sciences, Tokyo, 
Japan, 2Dept of Microbiology, School of Pharmacy, Tokyo Univ of Pharmacy & Life Sciences, Tokyo, Japan
Acne vulgaris is characteristic of excess sebum production and the induction of inflammatory 
reactions; e.g., the augmentation of cytokine and prostaglandin (PG) production in sebaceous 
glands and pilosebaceous units. In addition, the aggravation and duration of the inflammation have 
been associated with the formation of acne scars, which may result from matrix metalloproteinase 
(MMP)-mediated extracellular matrix (ECM) remodeling. In the present study, we examined the 
effects of two antimicrobial agents: clindamycin (CLDM) and nadifloxacin (NDFX), on sebum, 
PGE2, and proMMP-2/progelatinase A production in hamster sebocytes treated with peptidoglycan 
(PGN) from Gram-positive bacteria walls. The regulation of sebum and PGE2 production was 
analyzed by the measurement of intracellular triacylglycerols (TG) and a PGE2 enzyme immune 
assay, respectively. Western blot and PCR analyses were performed for proMMP-2 production and 
gene expression, respectively. PGN dose-dependently increased the TG production in hamster 
sebocytes. The augmented TG production was suppressed by CLDM and NDFX. The PGN-
augmented PGE2 production was also inhibited by CLDM and NDFX, whereas neither antimicrobial 
agents influenced the basal level of PGE2 in hamster sebocytes. Furthermore, PGN transcriptionally 
augmented proMMP-2 production in hamster sebocytes. NDFX, but not CLDM, inhibited the PGN-
augmented proMMP-2 expression. These results provide novel evidence that CLDM and NDFX 
exhibit anti-lipogenesis and -inflammatory activities against PGN-activated sebocytes that may 
at least partly mimic acne pathology in vitro. Moreover, NDFX is likely to be effective for the 
prevention and remission of acne scar formation by suppressing sebaceous proMMP-2 production.
083
IL-21 production by streptococcal extract stimulated CLA+ T cells and epidermal cells in 
psoriasis: results from quantitative antibody arrays
Marta Ferran1, Ana Belen Galvan1, Catalina Rincon2, Marc Sacrista1, Ana Maria Gimenez-Arnau1, 
Antonio Celada2, Ramon M Pujol1, Luis F Santamaria-Babi2,1 1Department of Dermatology. 
Hospital del Mar. Institut Municipal d’Investigació Mèdica (IMIM), Barcelona, Spain, 2Biomedical 
Research Institute (IRB), Barcelona, Spain
IL-21 is a cytokine present in psoriatic lesions that is produced by activated CLA+CD4+ T cells 
that induces epidermal hyperplasia, parakeratosis and T cell infiltration in the skin, in an IL-22-
independent manner. However, it is not known whether IL-21 can be induced by a clinically 
relevant triggering factor of psoriasis. We have generated a culture system comprising circulating 
CLA+/CLA- memory T cells and autologous epidermal cells, activated by streptococcal extract 
(SE). SE induces preferential activation of CLA+ T cells together with epidermal cells that leads 
to epidermal cell hyperplasia upon supernatant injection into mouse skin. No activity was 
detected in CLA negative T-cells from the same psoriatic patients, or in T cells and epidermal 
cells from healthy subjects. In order to further characterize our system, we analyzed 5-day culture 
supernatants by an antibody array for 30 mediators potentially relevant for psoriasis. IL-21 (2,1 
± 0,8 ng/ml) was detected in cultures of circulating memory CLA+ T cells and epidermal cells 
activated by SE, whereas it was not found when using CLA- T cells from the same patients or 
when cells from healthy controls were studied. In those samples where IL-21 was increased, other 
mediators such as IFN-g (6,3 ± 7,1), IL-17 (5,3 ± 8,3), CXCL10 (0,7 ± 0,1) CXCL9 (18 ± 2), CXCL8 
(147 ± 95,3) (values in ng/ml) were detected. Our results indicate that IL-21 and other relevant 
mediators present in the psoriatic lesions can be induced by SE through circulating CLA+ memory 
T cells and epidermal cell interaction.
084
Describing a new animal model for Bullous Pemphigoid. In vitro experiments
M.Estela Martinez-Escala1,2, Gloria Pascual3, Salvador Aznar-Benitah3, Ramon M. Pujol1,2, Josep 
Herrero-González1,2 1Parc de Salut Mar, Barcelona, Spain, 2Insitut Municipal D’Investigació 
Médica (IMIM), Barcelona, Spain, 3Grupo de Homeostasis Epitelial y Cáncer. Centro de 
Regulación Genómica, Barcelona, Spain
In vitro experiments over humanized skin (HS) from adult Swiss nude mice were performed in 
order to demonstrate that, it might be a useful animal model for bullous pemphigoid disease. HS 
with expression of human epithelial and basement membrane proteins was developed by skin 
grafting on the back of an adult Swiss nude mice, stem cells of human hair follicle buldges mixed 
with mucosal fibroblasts from C57BL6/J mice. Serums from seven patients diagnosed of bullous 
pemphigoid were obtained. An indirect immunofluorescence (IFI) was performed on biopsies 
of human skin, HS and native murine skin (NMS). An induction of dermo-epidermal separation 
with leucocytes over frozen sections of human skin, HS and NMS was also performed. IFI was 
positive in six of the seven serums from human skin and HS and in five from NMS, although 
the fluorescence was less intense in the latter. An induction of dermo-epidermal separation was 
demonstrated in human skin and HS from all seven patients, however it was only demonstrated 
in two samples from NMS. Bullous pemphigoid patients develop autoantibodies against different 
proteins of the epidermal basement membrane; collagen XVII (C17) is the main autoantigen. 
The patogenicity of these IgG antibodies against C17 has been demonstrated in different 
animal models, however, none of them have humanized skin, with the exception of genetically 
modified mice expressing the human C17. We present a new potential animal model for bullous 
pemphigoid disease.
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High epidermal expression of Thymic Stromal Lymphopoietin as potential differentiation factor 
driving the strong Th2-mediated autoimmune skin inflammation in Scurfy mice
Eva Hadaschik, Britta Heckmann, Alexander Enk Dept. of Dermatology, University of Heidelberg, 
Heidelberg, Germany
Scurfy mice spontaneously develop autoimmune inflammation in multiple organs including the 
skin due to the lack of functional regulatory T cells. The purpose of this study was to analyze the 
inflammatory infiltrate in Scurfy skin and cytokine profile of skin-infiltrating autoreactive CD4+ T 
cells particularly with regard to Thymic Stromal Lymphopoietin (TSLP) as potential differentiation 
factor. After isolation of total cells from skin and skin-draining lymph node of Scurfy and wildtype 
(WT) mice FACS-analysis revealed CD4+ T cells and granulocytes as the predominant cells in 
inflamed skin. The CD4+ T cells from inflamed Scurfy skin secreted high levels of IL-4 and IL-5 
and low levels of the interferon-γ as determined by intracellular FACS-analysis. Next we analysed 
the expression of TSLP, a soluble factor known to mediate Th2-differentiation of CD4+ T cells: 
Scurfy mice showed high TSLP-serum levels measured by ELISA whereas WT animals did not. 
Since TSLP is secreted by epithelial cells under stress-conditions we analysed TSLP expression 
in inflamed Scurfy skin by immunohistochemistry and found strong TSLP expression in Scurfy 
epidermis in contrast to WT epidermis. To determine if skin-infiltrating CD4+ T cells could 
respond to TSLP we analysed TSLP-receptor-expression by FACS. CD4+ T cells in Scurfy but not 
WT skin show high TSLP-receptor expression. In summary we show that skin-infiltrating CD4+ 
T cells in Scurfy mice spontaneously develop a Th2-phenotype with overexpression of TSLP in 
Scurfy epidermis and serum as potential driving force for this Th2-differentiation.
086
4SC-101, A Novel Small Molecule Dihydroorotate Dehydrogenase Inhibitor, Suppresses 
Systemic Lupus Erythematosus in MRL/lpr Mice
Onkar P. Kulkarni1, Sufyan G. Sayyed1, Claudia Kantner1, Mi Ryu1, Max Schnurr2, Miklós Sárdy3, 
Johann Leban4, Ruediger Jankowsky4, Aldo Ammendola4, Robert Doblhofer4, Hans-Joachim 
Anders1 1Medizinische Poliklinik-Innenstadt, University of Munich (LMU), Munich, Germany, 
2Medizinische Klinik Innenstadt, University of Munich (LMU), Munich, Germany, 3Department of 
Dermatology and Allergology, University of Munich (LMU), Munich, Germany, 44SC AG, Planegg-
Martinsried, Germany
Immunosuppressive treatments of systemic lupus (SLE) remain associated with significant 
toxicities; hence, compounds with better toxicity profiles are needed. Dihydroorotate 
dehydrogenase (DHODH) inhibition with leflunomide has proven to be effective in autoimmune 
diseases including SLE, but leflunomide can cause a variety of side effects. We hypothesized that 
4SC-101, a novel DHODH inhibitor with a more favorable toxicity profile, would be as effective 
as high-dose cyclophosphamide (CYC) in controlling experimental SLE of female MRL/lpr (Fas) 
mice. Daily oral gavage of 30, 100, and 300 mg/kg 4SC-101 from 12 to 22 weeks of age was 
compared with either vehicle or CYC treatment (30 mg/kg/week, i.p.) in terms of efficacy and 
toxicity. Three hundred milligrams per kilogram 4SC-101 was as effective as CYC in depleting 
spleen autoreactive T cells, B cells, and plasma cells as well as the respective DNA and RNA 
serum autoantibodies. This was associated with a comparable amelioration of the renal, dermal, 
and pulmonary SLE manifestations of MRL/lpr mice. However, even the highest dose of 4SC-101 
had no effect on bone marrow neutrophil counts, which were significantly reduced in CYC-
treated mice. Together, the novel DHODH inhibitor 4SC-101 is as effective as high dose CYC 
in controlling SLE without causing myelosuppression. Hence, DHODH inhibition with 4SC-101 
might be suitable to treat active SLE with fewer side effects than CYC.
087
The role of serum amyloid A in the development of psoriasis chronic skin inflammation by 
inducing IL-23 producing DCs
Hideaki Tanizaki, Satoshi Nakamizo, Yohei Natsuaki, Kaori Tomari, Yoshiki Miyachi, Kenji 
Kabashima Dept of Dermatology Kyoto University Graduate School of Medicine, Kyoto, Japan
Psoriasis is a chronic, immune-mediated skin disease characterized by epidermal 
hyperproliferation and inflammation with marked infiltration of T cells, neutrophils, and 
dendritic cells. Recently, it has been reported that serum amyloid A (SAA) acted on lamina 
propria dendritic cells (DCs) in the gut to promote Th17 cell differentiation. It has also been 
established that TIP-DC (TNF-alpha and iNOS producing dendritic cells) and IL-23 producing 
DCs are essential in the development of Th17. It remains, however, unknown how these DCs are 
induced and how Th17 cells are maintained in the psoriatic skin lesions. Initially, we investigated 
the gene profile with DNA microarray in the psoriasis skin lesion and found that SAA was the one 
of the highly expressed inflammatory molecules. In addition, SAA was elevated in the serum and 
the skin lesions of psoriasis patients. We then evaluated the effect of SAA on human monocyte-
derived DCs (MoDCs) and Mo-Langerhans cells (MoLCs). IL-23 and TNF-alpha production were 
significantly increased, especially from MoLCs, in response to SAA in vitro. Finally, we found that 
Th17 cell differentiation from human naive CD4+ T cells were enhanced with MoDCs or MoLCs 
in a SAA dose dependent manner. These results indicate that SAA expressed in the psoriatic 
skin lesion is a potent inducer of IL-23 and TNF-alpha via DCs/LCs and activates the IL-23-Th17 
pathway to establish/maintain the psoriatic skin lesions.
088
Peripheral CD14+ monocytes from early-onset sarcoidosis associated with NOD2 mutation do 
not show the molecular signature of NF-kappa B signaling
Naotomo Kambe, Takashi Satoh, Hiroyuki Matsue Dermatology, Chiba University, Chiba, Japan
Pathogenesis of idiopathic sarcoidosis veils mystery. Familiar Blau syndrome (BS, MIM 
#186580) and sporadic early-onset sarcoidosis (EOS, MIM #609464) are systemic inflammatory 
granulomatous diseases caused by the mutation of the intra-cellular pattern recognition receptor, 
NOD2. In contrast to Crohn’s disease-associated NOD2 mutation that are located C-terminal 
leucine-rich repeats and defect the ligand recognition, BS/EOS-associated mutation are 
recognized in centrally located NOD domain of NOD2 and though to mimic active conformation 
change induced by microbial ligand. However the molecular mechanism how activated NOD2 
mutation recognized in BS/EOS induces granuloma formation still remains unknown. After the 
informed consent, peripheral monocytes were purified from heparin-treated peripheral blood 
cells from EOS patients (father and his sone) with R334W mutation in NOD2 by the magnetic cell 
sorting with FITC-conjugated anti-CD14 antibody. Purified mRNA was then reverse-transcripted 
and expression gene profile was analyzed with Agilent 40K gene chip. Even though in vitro 
analysis by luciferase reporter assay using HEK293 cells that showed spontaneous NF-kappa 
B activation after the gene trasnfection of BS/EOS-associated R334W mutation of NOD2, gene 
expression profile analysis from peripheral CD14+ cells of EOS patients unexpectedly did not 
show the molecular signature of NF-kappa B signaling. Thus, granuloma formation in BS/EOS 
may be not simply induced by NF-kappa B activation by NOD2.
089
Activation of PPARγ by (R)-(3)-(4-Aminophenyl)-2-methoxypropionic acid suppresses 
inflammatory responses in keratinocytes
Arianna Mastrofrancesco1, Daniela Kovacs1, Massimiliano Sarra2, Nicaela Aspite1, Emanuela 
Camera1, Pierre Desreumaux3, Giovanni Monteleone2, Mauro Picardo1 1Laboratory of Cutaneous 
Physiopathology and Integrated Center of Metabolomics Research San Gallicano Dermatologic 
Institute, Rome, Italy, 2Department of Internal Medicine, University of Rome “Tor Vergata”, Rome, 
Italy, 3Department of Hepatogastroenterology and Nutrition, University of Lille, Lille, France
Peroxisome proliferator-activated receptors (PPARs) regulate important functions in the skin, 
including proliferation, differentiation, and inflammatory responses. These functions are in part 
due to the ability of PPARγ to antagonize inflammatory signaling by interfering with the activation 
of nuclear factor-κB (NF-κB). Consistently, PPARγ agonists have been used with success in 
various skin disorders, such as psoriasis. However, the wide use of PPARγ agonists has been 
hampered by their frequent and severe side-effects. In this study we assessed the response of 
human and mouse keratinocytes to (R)-(3)-(4-Aminophenyl)-2-methoxypropionic acid, herein 
termed GPD-L34, a novel PPARγ agonist, which has been reported to exhibit a strong affinity of 
binding to PPARγ and low cytotoxicity in preclinical studies. We show that GPD-L34 suppresses 
lipopolysaccharide (LPS) and tumor necrosis factor (TNF)-α-induced IL-6, IL-8 and TNF-α 
expression and other inflammatory mediators such as cyclooxigenase-2 (COX-2) in cultured 
keratinocytes. Mechanistically GPD-L34 decreases LPS- and TNF-α-mediated degradation of 
IκBα, thereby preventing the nuclear accumulation of p65 subunit. Moreover, GPD-L34 inhibits 
the TNF-α-induced keratin 6 mRNA expression, an inflammatory and hyperproliferative keratin 
up-regulated in psoriatic skin. Finally, in mice, GPD-L34 attenuates IL-21-induced keratinocyte 
hyperplasia and K6 expression. These findings are the first to show that GPD-L34 suppresses 
inflammatory pathways in keratinocytes and suggest its therapeutic application in psoriasis.
090
Interleukin 20 mRNA stabilization in psoriasis
Pierre-Emmanuel Stoebner1,2, Geneviève Garcin4, Laurent Meunier1,2, Thierry Lavabre-Bertrand2,3, 
Lionel Le Gallic2,3 1CHU, Nîmes, France, 2UMR CNRS 5247, Montpellier, France, 3Faculté de 
Médecine, Nîmes, France, 4UMR CNRS 5235, Montpellier, France
Several members of IL-10 family are implied in the pathophysiology of psoriasis. It has been 
recently demonstrated that interleukin-20 plays a critical role in maintenance and development 
of skin psoriasis. We checked the IL-10 family mRNA expression in skin biopsies from psoriatic 
patients (n=20). In most of the patients IL-19, 20, 22, 26 mRNAs were overexpressed in lesional 
skin as compared to healthy skin. Only IL-20 mRNA was found to be always overexpressed. By 
using qPCR and quantitative amplification of pre-RNA we found in psoriatic lesional skin that 
IL-19 mRNA was mostly increased at a transcriptional level whereas IL-20 mRNA was stabilized. 
The mechanisms of IL-20 mRNA stabilization were studied in vitro. In Hacat cells, UVB and 
anisomycin induced an increase of IL-19 and IL-20 mRNA levels that was consecutive to an IL-
19 mRNA transcriptional accumulation and IL-20 mRNA stabilization. IL-19 mRNA expression 
and stability was only moderately affected by chemical inhibition of JNK or p38 whereas p38 
inhibition dramatically decreased IL-20 mRNA expression and stability. These results were 
consistent with the fact that contrarily to IL-19, IL-20 mRNAs contain AU-rich elements in their 
3’ untranslated region. By using siRNA and overexpression strategies, we showed that both p38/
MK2/TTP and AMP-activated kinase/human antigen R pathways are involved in IL-20 mRNA 
stabilization. In conclusion the IL-20 increased levels reported in psoriatic lesions are associated 
to a stabilization of their corresponding mRNA.The implication of the p38/MK2/TTP and AMPK/
HuR pathways seems probable and need to be investigated in psoriasis skin.
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Phenotypic characterization of “signature T-cell subsets” in the peripheral blood of psoriatic 
patients
Jiang Zhou, Frieder Koszik, Patrick Brunner, Georg Stingl Medical University of Vienna, Austria
Skin-infiltrating T helper 1 (Th1) and T helper 17 (Th17) cell subsets have been implicated in the 
pathogenesis of psoriasis. However, fundamental questions where and how the activation of 
these T cells occurs and how they contribute to the major pathogenic features of psoriasis have 
not yet been resolved. To address this issue, we have established methods to analyze cytokine-
secreting profiles of different T cell subsets in psoriasis. A comparative assessment of peripheral 
blood leukocytes from healthy and psoriatic individuals revealed only slightly increased numbers 
of circulating IFN-γ + cells but significant elevations of IL-17+ and IL-22+ T cells in psoriatics with 
active and, less so, in those with mild disease. Some of these Th1 and Th17 cells may well exhibit 
skin-homing properties as suggested by increased numbers of CLA (cutaneous lymphocyte 
antigen) + T cells in the peripheral blood of patients with active psoriasis. Somewhat to our 
surprise, we found that the percentages of circulating IL-17+ and IL-22+ T cells were increased 
not only in the CLA+ but also in the CLA- memory T cell subset. Our findings underscore the 
importance of Th17 cells in the immunopathogenesis of psoriasis and point to the existence of a 
systemic inflammatory response in patients with severe disease.
092
The diagnostic value of an array of laboratory techniques for paraneoplastic pemphigus
Angelique Poot1, Gilles Diercks1, Isabelle Schepens2, Takashi Hashimoto3, Luca Borradori2, 
Marcel Jonkman1, Hendri Pas1 1Center for Blistering Diseases, Dept of Dermatology, University 
Medical Center Groningen, Groningen, The Netherlands, 2Dept of Dermatology, Inselspital, Bern, 
Switzerland, 3Dept of Dermatology, Kurume University School of Medicine, Kurume, Japan
Paraneoplastic pemphigus (PNP) is a multiorgan autoimmune syndrome with mucocutaneous 
involvement associated with an underlying neoplasm. Immunologically it is characterized by an 
autoantibody response directed against plakins, desmogleins and anti-alpha-2-macroglobulin-
like-1 (A2ML1). PNP is associated with high mortality and its accurate diagnosis is important. 
We compared the diagnostic value of various laboratory techniques in PNP. We performed 
immunoblotting, immunoprecipitation, an envoplakin-ELISA, and indirect immunofluorescence 
(IIF) on rat-bladder using sera of 19 PNP as well as 24 pemphigus vulgaris (PV) patients, 
and 3 patients with mucosal lesions and anti-desmoplakin antibodies (a-DPK) as control. 
Immunoblotting detected anti-envoplakin and anti-periplakin antibodies in 17 PNP, and in 
none of the PV or a-DPK cases. Immunoprecipitation studies detected anti-envoplakin and anti-
periplakin in 14 PNP cases, and anti-A2ML1 antibodies in 15 PNP cases, but in none of the a-DPK 
controls. Either anti-plakin or anti-A2ML1 antibodies were detected by immunoprecipitation in 
all 19 PNP patients. Anti-envoplakin ELISA was positive in 12 PNP, one PV, and none of the 
a-DPK patients. IIF studies were positive in 14 PNP sera, but none of the controls. Two PNP sera 
that tested negative by immunoblot and ELISA, were positive by rat-bladder IIF. Furthermore, 
medication-induced decrease in antibody titer resulted in negative outcomes of ELISA and IIF, 
but not of immunoblotting and immunoprecipitation. These results indicate that immunoblotting 
and immunoprecipitation are more sensitive than envoplakin-ELISA in detecting PNP associated 
auto-antibodies. In addition, IIF on rat bladder can be of complementary diagnostic value when 
used alongside immunoblotting.
093
Comparison of microRNA expression using different preservation methods of matched psoriatic 
skin samples
Marianne B. Løvendorf1,2, John R. Zibert2, Peter H. Hagedorn2, Christian Glue3, Niels Ødum4,5, 
Mads A. Røpke2, Lone Skov1 1Department of Dermato-Allergology, Gentofte Hospital, University 
of Copenhagen, Hellerup, Denmark, 2LEO Pharma A/S, Department of Molecular Biomedicine, 
Ballerup, Denmark, 3Exiqon A/S, Vedbaek, Denmark, 4Department of Biology, University of 
Copenhagen, Copenhagen, Denmark, 5Department of International Health, Immunology & 
Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
MicroRNAs (miRNAs) are small non-coding RNA molecules that modulate gene expression at the 
post-transcriptional level. The inflammatory skin disease psoriasis is characterized by a specific 
miRNA expression-profile that differs from normal skin. Extracting high quality RNA from human 
skin can be a challenge since the skin contains high levels of RNases. Furthermore, fixation of 
tissue samples using for instance formalin-fixation, paraffin-embedding (FFPE) causes extensive 
damage to the nucleic acids stored within the tissue, making subsequent RNA extraction and 
quantification challenging. Due to their small size (19-23 nucleotides) and lack of a poly A tail, 
miRNAs may be less affected by RNA degradation and damage than messenger RNAs (mRNAs). 
We investigated the effect of three different preservation methods, FFPE, frozen (FS), and Tissue-
Tek-embedding (OCT) on the global miRNA expression levels in matched lesional skin samples 
from 25 patients with psoriasis. We found that there was a strong correlation of the miRNA 
expression levels between the three different preservation methods of psoriatic skin samples with 
correlation coefficients ranging from 0.91 to 0.95 (P < 0.001). These observations were further 
confirmed with panel and individual quantitative RT-PCR. Our results demonstrate that miRNA 
detection in human skin is robust and reproducible and thus, the miRNAs offer an appropriate 
and flexible approach in clinical practices and may hold great promise for biomarker and novel 
target discovery for skin diseases in the future.
094
Label free real-time monitoring of the interaction of keratinocytes and Propionibacterium acnes 
bacterium
Gábor Tax2, Kornélia Szabó1, Edit Urbán3, Lajos Kemény1,2 1Dermatological Research Group of the 
Hungarian Academy of Sciences, Szeged, Hungary, 2Dept of Dermatology and Allergology, Univ 
of Szeged, Szeged, Hungary, 3Inst of Clinical Microbiology, Univ of Szeged, Szeged, Hungary
Acne is a common multifactorial inflammatory skin disease of the pilosebaceous follicles in 
which the Gram-positive Propionibacterium acnes (P. acnes) is an important pathogenic factor. 
It has been shown previously that selected P. acnes strains (889 and ATCC11828) belonging 
to various subgroups within the species differentially affected the proliferation and viability 
of cultured normal human keratinocytes. To investigate this phenomenon in more detail we 
performed a real time experiment to monitor the effect of three P. acnes strains (889, 6609, 
ATCC 11828) on the proliferation and viability of immortalized human keratinocytes. For that 
a novel, impedance measurement-based technology was used allowing the real-time, label-
free, kinetic monitoring of these processes. Increased cell proliferation rate was detected in 
case of the P. acnes 889 bacterium-treated keratinocytes compared to control cells at 24 hours 
post-treatment. In the cells treated with P. acnes 889 and ATCC 11828 strains the cell indexes 
rapidly and significantly decreased after 48 hours post-treatment, suggesting that the bacterial 
infection induced the death of these cells. No such changes were measured in response to P. 
acnes 6609 bacterial treatment. These results correlated with the observed pathogenicity of the 
applied bacterial strains. These results suggest that assorted P. acnes isolates exhibiting altered 
clinical pathogenicity have different effect on keratinocyte proliferation and cell death. The 
exact mechanism whether it is a result of necrosis or apoptosis requires further investigations. 
Real-time monitoring of the interaction of microbial pathogens and host cells can enhance our 
understanding on keratinocyte-pathogen interactions, subsequently acne pathogenesis.
095
Serum chemerin level and percentage of plasmacytoid dendritic cells are higher in TNF receptor 
antagonist non-responder patients
Kayo Hama, Ryosuke Hino, Haruna Fueki, Shun Ohmori, Yu Sawada, Rieko Kabashima-Kubo, 
Motonobu Nakamura Department of Dermatology, Kitakyushu, Japan
We monitored peripheral blood mononuclear cell(PBMC)s of 13 psoriatic patients treated 
with infliximab or adalimumab. Psoriasis area and severity score (PASI) were also measured. 
Peripheral blood mononuclear cells were taken before, 2, and 6 weeks after treatment. 
To evaluate dendritic cell(DC)s, cells were stained by anti-CD123(plasmacytoid DC), and 
CD11c(myeloid DC) antibodies. For intracytoplasmic cytokine staining, cells were stained for 
surface CD3 or CD8 and intracytoplasmic IL-17, IL-22, IFN-g, or IL-4. PASI was significantly 
decreased during the treatment, however 2 cases had not achieved PASI 50. We denominated 
the 2 cases as “non-responders”. Among the responders, the percentage of IL-17+ cells and 
IFN-g+ cells were significantly decreased by the treatment, while the number of pDCs did not 
change by the treatment. On the other hand, the percentage of IL-17+ cells was increased in 
non-responders. In non-responder, the percentage of pDC and the serum chemerin level tend 
to be higher than responders. These findings confirm that the function of pDC plays a TNF-
independent pathogenesis. Taken together, the percentage of pDCs and the serum chemerin level 
can determine the responsiveness to TNF receptor antagonists.
096
Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid 
in mice
Misa Hirose1, Andreas Recke1, Tina Beckmann1, Atsushi Shimizu2, Akira Ishiko3, Katja Bieber4, 
Jürgen Westermann4, Detlef Zillikens1, Enno Schmidt1,5, Ralf J. Ludiwg1 1Department of 
Dermatology, University of Lübeck, Lübeck, Germany, 2Department of Dermatology, Keio 
University School of Medicine, Tokyo, Japan, 3First department of Dermatology, School of 
Medicine, Faculty of Medicine, Toho Unviersity, Tokyo, Japan, 4Institute of Anatomy, University 
of Lübeck, Lübeck, Germany, 5Complehensive Center for Inflammation Medicine, University of 
Lübeck, Lübeck, Germany
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease of the elderly 
associated with considerable morbidity and mortality. As unspecific immunosuppressants are still 
the mainstay of BP therapy, several animal models, based on the passive transfer of autoantibodies 
or immune cells, have been developed to obtain a better understanding of the pathogenesis of 
BP and to evaluate novel therapeutic interventions. We here describe an experimental model 
inducing BP by immunization of immunocompetent mice with a recombinant form of the 
immunodominant 15th non-collagenous (NC) domain of murine BP180 (type XVII collagen). 
The homologous NC16A domain of human BP180 has previously been identified as an 
immunodominant region in human BP. Immunization of female SJL/J mice with the murine 
peptide led to clinical disease within 14 weeks in 56% of mice. In contrast, none of the other 
strains developed blisters despite the presence of autoantibodies. The clinical disease manifested 
for at least 8 weeks without further manipulation. This novel immunization-induced model 
reflects key immunopathological characteristics of human BP, including binding of complement-
fixing autoantibodies along the dermal-epidermal junction, elevated total IgE serum levels, and 
infiltration of skin lesions with eosinophilic granulocytes. The use of immunocompetent mice 
and the induction of sustained clinical disease not requiring additional interventions make this 
immunization-induced mouse model most suitable to further explore the pathogenesis of BP and 
novel therapeutic interventions for this and other autoantibodiy-mediated diseases.
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The regulation of thymic stromal lymphopoietin in skin by vitamin D3 is distinct between mouse 
and human
Janneke Landheer1, Barbara Giovannone1, Geuranne Tjabringa1, Claudia Hofstra2, Carla 
Bruijnzeel-Koomen1, Rene De Waal Malefyt3, Yu Ying3, Svetlana Sadekova3, DirkJan Hijnen1, 
Edward Knol1 1University Medical Center, Utrecht, The Netherlands, 2MSD, Oss, The Netherlands, 
3Merck, Palo Alto, USA
Topical vitamin D3 (vitD3) on mouse skin induces AD-like symptoms, for which thymic stromal 
lymphopoietin (TSLP) expression, a key cytokine in allergic diseases, is crucial. We examined the 
effect of vitD3 on TSLP expression in the human skin. Biopsies from normal mammary reduction 
skin were treated either topically with vitD3 (silkis®ointment, daivonex®cream) and cultured in 
the air-liquid interface or cultured submerged in medium containing vitD3 (calcipotriol) for 24-
72 hours. In addition, primary human keratinocytes were stimulated with vitD3 for 8-48 hours. 
As a positive control for the induction of TSLP a mixture of pro-inflammatory cytokines (IL-4 and 
IL-13 and TNF) was used. TSLP and Cyp24 mRNA levels were determined by qPCR. TSLP protein 
expression in supernatant was measured by ELISA. Treating human biopsies with topical vitD3 
or culturing biopsies in vitD3 solution did not induce TSLP mRNA or protein expression in the 
epidermis. Furthermore, stimulation of primary human keratinocytes with vitD3 did not affect 
TSLP expression. Cyp24 mRNA levels were increased in these conditions, indicating biological 
activity of vitD3. Stimulation with the cytokine mixture did increase TSLP mRNA and protein 
expression and showed peak induction after 8 and 24 hours in keratinocytes and biopsies, 
respectively. In conclusion, vitD3 does not induce TSLP expression in biopsies or keratinocytes 
from human control skin. The difference is likely due to a differential regulation of TSLP in mouse 
skin versus human skin. An effect of vitD3 on TSLP expression in the immunologically ‘primed’ 
non-lesional human AD skin can not be excluded yet.
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CD11c+ dendritic cells and CD163+ macrophages are the source of TNF-α in plaque-type 
psoriasis
Patrick Brunner, Frieder Koszik, Bärbel Reininger, Madeleine Kalb, Wolfgang Bauer, Georg Stingl 
Medical University of Vienna, Vienna, Austria
The spectrum of tumor necrosis factor (TNF)-α-producing cells in psoriasis is not clearly defined. 
The elucidation of this question should allow us to better understand the mode of action, 
efficacy and, perhaps, also the risks of an anti-psoriatic treatment with TNF-α-antagonists.
Using conventional immunofluorescence methods, we were not able to reproducibly detect 
TNF-α in sections of lesional psoriatic skin, but by the application of a tyramide amplification 
system, which allows to detect even trace amounts of antigen, we obtained reproducible and 
firm stainings. TNF-α was exclusively found on dermal leukocytes co-expressing CD11c and 
HLA-DR and, to a lesser extent, CD163. This marker profile is consistent with that of mDCs and 
macrophages. Consistently, we found corresponding populations of TNF-α-producing mDCs and 
monocytes in PBMCs of psoriatic patients but not of healthy individuals. TNF-α+ mDCs of the 
peripheral blood were of the 6sulfo LacNAc (slan)- rather than the BDCA-1-(CD1c)-subtype, and 
their number closely correlated with disease activity. In addition, the total amount of slanDCs 
was increased in psoriatic patients compared to healthy controls with a concomitant decrease of 
BDCA-1+ DCs. Isolated slanDCs produced high amounts of TNF-α upon stimulation with self-
RNA-LL37 complexes. These complexes are known to be a key inducer of skin inflammation in 
psoriatic plaques via the activation of TLR-8. BDCA-1+ DCs did not produce any TNF-α upon 
stimulation with self-RNA-LL37 complexes. Our data strongly suggest that certain myeloid 
cells (slanDCs, monocytes/macrophages) are the main source of TNF-α in chronic plaque-type 
psoriasis and serve as a key target of TNF-α-antagonists.
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The major epitope of BP230 is limited in bullous pemphigoid cases reactive only with BP230, 
but covers entire domain in bullous pemphigoid cases reactive with both BP180 and BP230
Machiko Fujihara, Naomi Tani, Norito Ishii, Hiroshi Koga, Ryosuke Sogame, Bungo Ohyama, 
Takahiro Hamada, Teruki Dainichi, Daisuke Tsuruta, Takashi Hashimoto Kurume University 
School of Medicine, Fukuoka, Japan
We have noticed that a considerable number of bullous pemphigoid (BP) patient sera reacted 
only with BP230, but not with BP180, by immunoblotting and ELISA. We tentatively named 
these cases as BP230-BP. To investigate the pathophysiology in BP230-BP, we studied epitope 
profiles of three BP groups; i.e., BP reactive only with BP180 (named BP180-BP) (35 cases), BP 
reactive with both BP180 and BP230 (named BP180-BP230-BP) (50 cases) and BP230-BP (35 
cases) by using recombinant proteins (RPs) of N-terminal domain (BP230-N), central domain 
(BP230-M) and N-terminal domain (BP230-C) of BP230 by immunoblotting among BP180-BP, 
BP180-BP230-BP and BP230-BP. As expected, BP180-BP sera showed almost no reactivity with 
any RPs (0/35 to BP230-N, 1/35 to BP230-M, and 1/35 to BP230-C), while majority of BP180-
BP230-BP sera strongly reacted with all RPs (43/50 to BP230-N, 45/50 to BP230-M, and 47/50 
to BP230-C). Strikingly, in repeated experiments, BP230-BP sera showed clear positive reactivity 
with BP230-C (34/35), but only a few patients’ sera reacted with either BP230-N (6/35) and 
BP230-M (6/35). These results suggest that production of autoantibodies to BP230 is different 
between BP230-BP and BP180-BP230-BP, that the C-terminus of BP230 is its pathogenic epitope 
in BP230-BP, and that broader epitope distribution in BP230 in BP180-BP230-BP is the result of 
intermolecular epitope-spreading mechanism between BP180 and BP230. Although the precise 
mechanism of production of anti-BP230 autoantibodies is still unclear, the results of this study 
will give us an insight to understand the new mechanism of intermolecular epitope spreading.
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Autoantibody pathogenic activity parallels disease activity during pemphigus vulgaris course in 
rituximab-treated patients
Giovanni Di Zenzo1, Anna Sinistro1, Valentina Calabresi1, Marina Ruffelli2, Francesca Lupi3, 
Ornella De Pità2, Giovanna Zambruno1, Giuseppe Cianchini3 1Molecular & Cell Biology 
Laboratory, IDI-IRCCS, Rome, Italy, 2Immunology & Allergology Laboratory, IDI-IRCCS, Rome, 
Italy, 3Dermatology Division, IDI-IRCCS, Rome, Italy
Pemphigus vulgaris (PV) is a life-threatening autoimmune blistering disease mediated by IgG 
autoantibodies targeting desmoglein 3 (Dsg3). The anti-CD20 mAb rituximab is increasingly used 
in treatment-resistant PV patients. Although in the majority of PV cases anti-Dsg3 ELISA scores 
fluctuate in parallel with disease activity, in a subset of rituximab-treated patients high ELISA index 
values have been reported during remission and their significance remains so far unclear. In the 
present study, six rituximab-treated (two 750 mg/m2 infusions at 2 week interval) PV patients were 
prospectively followed-up and both anti-Dsg3 autoantibodies levels and pathogenic in vitro activity 
were measured. All the patients (Ikeda score ≥ 6 at rituximab administration) improved following 
treatment: three were in complete remission at 3 months and one at 6 months, while the remaining 
two patients achieved remission 6 months after a single additional rituximab infusion. During 
the 18-24 month follow-up, all patients presented relapses which regressed following adjunctive 
rituximab administration. In 4 out of 6 cases the ELISA scores of anti-Dsg3 autoantibodies and their 
in vitro pathogenic activity, evaluated by a keratinocyte dissociation assay, fluctuated in parallel with 
disease activity. In contrast, in the remaining two cases anti-Dsg3 titres, assessed using serum serial 
dilutions, were elevated during remission. Of note, the pathogenic activity of sera from the latter 
patients was markedly reduced during remission. In conclusion, our study highlights the usefulness 
of a keratinocyte dissociation assay that, by specifically detecting pathogenic autoantibody levels, 
can allow a more accurate monitoring of PV activity during disease course.
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Immune alterations in peri, early and chronic hidradenitis suppurativa
Hessel H van der Zee, Lisette de Ruiter, Errol P Prens Erasmus MC, Rotterdam, The Netherlands
The pathogenesis of hidradenitis suppurativa (HS) contains many “gaps”. Our aim was to 
identify histological alterations and leucocyte subsets by a comprehensive sequential analysis 
of normal appearing perilesional skin (n=8), early (n=6) and chronic (n=10) HS lesions. A broad 
panel of antibodies and in situ immunostaining were used. Perilesional skin already showed 
mild psoriatiform hyperplasia and follicular plugging as well as a low-grade influx of tryptase+ 
mast cells, CD3+ T cells, CD138+ plasma cells and FXIIIa+ dendritic cells. These alterations 
clearly precede clinical disease. In early HS lesions, neutrophilic abscess formation and influx 
of macrophages, monocytes and dendritic cells predominated. In chronic disease, the infiltrate 
expands with massive participation of CD20+, CD79a+ B cells and CD138+ plasma cells in 
‘pseudo’ lymphoid follicles. Mast cells are increased in all HS stages including perilesional skin. 
As in early lesions, free “rod-like” keratin fibers were detected in the dermis and within giant 
cells. We argue that ingested “rod-like” keratin fibers activate the inflammasome in inflammatory 
macrophages and so fuel dermal inflammation, because lesional HS biopsies released significant 
amounts of IL-1β. Furthermore, in chronic lesions, single detached keratinocytes and strands 
of follicular epithelium were observed in the dermis, the latter frequently expressing Ki67, 
indicative of active proliferation. These proliferating strands of follicular epithelium may represent 
the primary events leading to fistula formation, which are so typical of late stage disease. Early 
therapeutic intervention, aimed at reversing the early, subclinical alterations, may prevent further 
clinical progression of the disease.
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Poly(ADP-ribosyl)ation in the skin: physiological roles and contribution to skin pathology
Laszlo Virag1,3, Peter Bai1, Petra Lakatos1, Edina Bodnar2, Eva Remenyik2, Eva Szabo2 1Department 
of Medical Chemistry, Medical and Health Science Center, University of Debrecen, Debrecen, 
Hungary, 2Department of Dermatology, Medical and Health Science Center, University of 
Debrecen, Debrecen, Hungary, 3Cell Biology and Signaling Research Group of the Hungarian 
Academy of Sciences, Debrecen, Hungary
Poly(ADP-ribosyl)ation is a protein modification carried out by members of the poly(ADP-ribose) 
polymerase (PARP) ezyme family. PARPs activated by DNA damage, certain DNA structures, 
phosphorylation or acetylation regulate various cellular functions ranging from DNA repair, 
chromatin organization, metabolism, proliferation to cell death. Information on the role of 
these enzymes in the skin is scarce although it has been implicated in inflammatory dermatoses 
and burns. In the normal skin we detected PAR in keratinocytes, sebocytes, in hair follicles, in 
endothelial cells and in subcutaneous adipocytes indicating that PAR may be a versatile regulator of 
various, diverse functions of skin cells. Previously we have also shown that PARylation contributes 
to contact hypersensitivity and regulates oxidative stress sensitivity of keratinocytes. PAR content 
was also found by us to correlate with clinical parameters of cutaneous malignant melanoma. 
Based on our previous and recent data, here we would like to give an overview on the potential 
role of PARylation in the regulation of skin functions as well as its contribution to skin diseases. 
Distinct and overlapping pathways of activation may be responsible for the different roles and 
modes of action of PARP enzymes in skin (patho)physiology.
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Inhibitory effect of benzothiophene γ-hydroxybutenolide compounds on skin inflammation
Rosa M. Andrés1,2, M. Carmen Montesinos1,2, Francisca Valcuende3, Pedro Navalón4, Miguel 
Payá1,2, M. Carmen Terencio1,2 1University of Valencia, Department of Pharmacology, Burjassot, 
Valencia, Spain, 2Center of Molecular Recognition and Technological Development (IDM), 
Valencia, Spain, 3Hospital La Plana, Dermatology, Vila-real, Castellón, Spain, 4General Universitary 
Hospital of Valencia, Department of Urology, Valencia, Spain
The aim of this study was to characterize the anti-inflammatory capability of two promising 
benzothiophene γ-hydroxybutenolide (BTH) compounds, which previously demonstrated a potent 
inhibition of NF-κB activation in macrophages. Normal human keratinocytes were isolated from 
healthy donors’ foreskin. After a 7h-stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA, 
1 µg/ml), TNF-α and IL-8 levels were determined by ELISA. Stimulated cells released 59.7 ± 9.4 pg/
ml of TNF-α and 421.2 ± 20.73 pg/ml of IL-8 compared to 4.9 ± 4.9 pg/ml and 27.53 ± 14.48 pg/ml 
by basal cells, respectively. Both compounds were able to inhibit the release of these two cytokines 
in a concentration-dependent manner within the micromolar range. Analysis of DNA binding 
performed in nuclear extracts of 1h-stimulated keratinocytes showed a clear inhibition of NF-κB 
activation by both derivatives. None of these compounds affected cell viability determined by the 
MTT assay. In addition, we tested the leader compound in the murine TPA-induced epidermal 
hyperplasia model. Topical application of the BTH derivative (400 µg/site) significantly inhibited the 
edema by 66.8%, as well as the neutrophilic infiltration (54.9%) induced by repeated application of 
TPA (2 nmol/site). Furthermore, BTH treatment also suppressed the increase in TNFα (1313±1829 
pg/ml vs 1829±91pg/ml in control group) and CXCL-1 (93±11 pg/ml vs 143±9 pg/ml in control 
group) determined by ELISA of tissue homogenates, showing the ability of the compound to impair 
skin inflammation in this context. In conclusion, our results show the ability of the BTH derivatives 
to inhibit several key biomarkers up-regulated in inflammatory skin diseases such as psoriasis.
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A crucial role for caspase-4 in inflammasome activation
Gabriel Sollberger1,2, Gerhard Strittmatter1, Magdalena Kistowska1, Lars E. French1, Hans-Dietmar 
Beer1 1University Hospital Zurich, Department of Dermatology, Zurich, Switzerland, 2ETH Zurich, 
Institute of Cell Biology, Zurich, Switzerland
Interleukin (IL)-1β and -18 regulate inflammation and immunity. Both cytokines are initially 
expressed as inactive precursors, which require processing by the protease caspase-1 for 
biological activity. Caspase-1 itself is activated in inflammasomes, recently discovered innate 
immune complexes. In addition, caspase-1 activity regulates unconventional protein secretion 
of many other proteins involved in inflammation and repair. Human caspase-4 is a poorly 
characterized member of the caspase family, which is supposed to be involved in endoplasmic 
reticulum (ER) stress-induced apoptosis. However, since its gene is located on the same locus 
as the caspase-1 gene, there is a putative role for caspase-4 in inflammation. Here we show 
that caspase-4 expression is required for maturation of proIL-1b and for unconventional protein 
secretion by UV-irradiated skin-derived keratinocytes. Caspase-4 interacts with the central 
inflammasome molecule caspase-1. As the active site of caspase-4 is required for activation of 
caspase-1, the latter most likely represents a substrate of caspase-4. We further show a role for 
caspase-4 in activation of the NLRP-3 and the Aim2 inflammasome in THP-1 macrophages. These 
results demonstrate an important role of caspase-4 in inflammation and innate immunity through 
activation of caspase-1.
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Neutrophil activation and subepidermal split formation mediated by bullous pemphigoid 
antibodies against epitopes on BP180 outside the NC16A domain
Jenny Dworschak1, Michael Mersmann2, Christian Probst2, Lars Komorowski2, Detlef Zillikens1, 
Winfried Stöcker2, Enno Schmidt1 1Department of Dermatology, University of Lübeck, Lübeck, 
Germany, 2Institute of Experimental Immunology, EUROIMMUN AG, Lübeck, Germany
Bullous Pemphigoid (BP) is an autoimmune blistering skin disease characterized by autoantibodies 
against BP180 and BP230. Previously, the pathogenic relevance of human autoantibodies against 
the 16th non-collagenous (NC16A) domain has been demonstrated ex vivo and in vivo. Here, 
NC16A-specific IgG and IgG-depleted from anti-NC16A reactivity was generated from sera of 20 
BP patients using recombinant NC16A coupled to sepharose. BP sera and both IgG fractions were 
probed by indirect immunofluorescence microscopy on salt-split skin, complement fixation test 
on the same substrate as well as BP180 NC16A-specific and BP230-specific ELISA. BP sera and 
both IgG fractions were then employed in an ex vivo model of autoantibody-mediated leukocyte-
dependent neutrophil activation and dermal-epidermal separation (DES) using cryosections of 
human skin. All sera induced DES. IgG-depleted from anti-NC16A reactivity lost DES-inducing 
ability in 7 patients (all without BP230 reactivity) and in additional 8 patients (3 reacted with 
BP230), DES-inducing potential was reduced by at least 40%. In the remaining 5 patients (4 
reacted with BP230), the IgG fraction depleted from anti-NC16A reactivity still harbored 100% 
of the DES-inducing potential of the corresponding sera. Our results indicate that in a subgroup 
of BP patients, autoantibodies against epitopes outside the immunodominant NC16A domain of 
BP180 may be of pathogenic relevance. Further experiments will explore the pathogenicity of 
these autoantibodies in vivo.
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Pathogenicity of autoantibodies in anti-p200 pemphigoid
Stephanie Groth1, Katerina Vafia1, Ute Hoppe1, Tina Beckmann1, Misa Hirose1, Jenny Dworschak1, 
Takashi Hashimoto1, Detlef Zillikens1, Enno Schmidt1 1Department of Dermatology, University 
of Luebeck, Luebeck, Germany, 2Department of Dermatology, Kurume University School of 
Medicine, Kurume, Japan
Anti-p200 pemphigoid is a subepidermal blistering autoimmune skin disease characterized by 
autoantibodies against a 200 kDa protein of the dermal-epidermal junction (DEJ). Recently, 
the C-terminus of laminin γ1 has been identified as target antigen in anti-p200 pemphigoid. 
However, the pathogenic relevance of these autoantibodies has not been demonstrated yet. 
To address this question, we employed an ex vivo model of autoantibody-mediated leukocyte-
dependent neutrophil activation and dermal-epidermal separation (DES) using cryosections of 
human skin. We showed that anti-p200 pemphigoid sera (n=7) induced DES in a time-dependent 
manner, in contrast to sera from healthy controls. Furthermore, laminin γ1-specific IgG and IgG 
depleted from anti-laminin γ1 reactivity was generated using the recombinant C-terminus of 
laminin γ1 (LAMC1-term; amino acids 1364 to 1609) coupled to sepharose. Depletion of anti-
LAMC1-cterm reactivity was demonstrated by immunoblotting with the recombinant protein. 
Interestingly, both IgG fractions labeled the DEJ by indirect immunofluorescence microscopy on 
human foreskin and recognized a 200 kDa protein by immunoblotting with extract of human 
dermis. In the cryosection model, LAMC1-cterm-specific IgG failed to attract neutrophils at the 
DEJ and to induce DES. Rabbit IgG generated against human LAMC1-cterm was also ineffective. 
In contrast, patient IgG depleted from LAMC1-cterm reactivity led to the same extent of DES as 
the corresponding sera. Here, for the first time, a potential pathogenic effect of autoantibodies 
in anti-p200 pemphigoid sera was demonstrated. This effect, however, was not mediated by 
antibodies to the C-terminal portion of laminin γ1.
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N-acetylcysteine (NAC) suppresses matrix metalloproteinase (MMP)-activity and angiogenesis 
during cutaneous delayed type hypersensitivity reactions (DTHR)
Johannes Schwenck1, Christoph Grießinger1, Kerstin Fuchs1,2, Daniel Bukala1, Nadine Bauer1, 
Jürgen Brück2, Martin Röcken2, Bernd J. Pichler1, Manfred Kneilling2 1Lab for Preclinical 
Imaging & Imaging Technology of the Werner Siemens-Foundation, Dept for Preclinical Imaging 
& Radiopharmacy, University of Tuebingen, Germany, 2Dept of Dermatology, University of 
Tuebingen, Germany
Reactive oxygen species (ROS) and NF-κB regulate the expression of pro-inflammatory mediators 
and MMPs required for angiogenesis. NAC suppresses ROS and both NF-κB-signaling pathways, 
BAY11-7085 exclusively the canonical pathway. Aims were to analyze whether inhibition of ROS and 
NF-κB suppresses DTHR, MMP-activity, and angiogenesis. Mice were sensitized at the abdomen and 
challenged at the right ear with trinitrochlorobenzene (TNCB) to induce acute cutaneous DTHR. To 
elicit chronic DTHR TNCB-Challenge was repeated every two days. NAC- /BAY11-7085-treatments 
were initiated two days prior the first TNCB-challenge. We analyzed ear swelling responses 12-24h 
after ear challenge and investigated MMP-activity in vivo using a MMP-2,-3,-9, and -13 activate-
able optical imaging (OI) probe, performed H&E-/CD31-staining and RT-PCR-analysis of mRNA 
expression patterns. ROS and NF-κB-inhibiting NAC strongly reduced acute and chronic DTHR. 
24h after the first TNCB-challenge increase in ear thickness in NAC-treated mice was suppressed by 
32%, 12h after the third TNCB-challenge by 51% and by 42% after the 5th TNCB-challenge. In vivo 
MMP activity in NAC-treated mice was reduced by 48% after the first, by 78% after the third and by 
57% after 5th TNCB-ear challenge. H&E- and CD31-staining confirmed reduced inflammation and 
blood vessel formation. RT-PCR analysis indicated decreased MMP-2, 9, and 13 mRNA levels after 
the first and third but surprisingly increased mRNA levels after the 5th ear challenge. BAY 11-7085 
displayed only faint therapeutic effects. Thus, ROS and NF-κB-Inhibition is a powerful therapeutic tool 
to minimize acute and chronic cutaneous DTHR by suppression of MMP-activity and angiogenesis.
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Expression of tryptophan hydroxylase in atopic dermatitis
A Rasul, H El-Nour, L Larsbrink, S-B Lonne-Rahm, K Nordlind Unit of Dermatology and 
Venerology, Department of Medicine, Solna , Karolinska University Hospital, Stockholm, Sweden
Atopic dermatitis (AD) is a chronic inflammatory severely itching skin disease. AD is often 
worsened by stress and anxiety. The serotonergic system has a role in AD. Tryptophan hydroxylase 
(TPH) is the rate-limiting enzyme for the synthesis of serotonin. The aim of the study was to study 
TPH expression in the skin of patients with AD. Ten AD patients were included. The extent of the 
disease was evaluated by using SCORAD. Biopsies were taken from lesional and non-lesional 
skin and fixed in 10% formalin with 0.2% picric acid for 1 h, then rinsed in PBS with 10% sucrose 
for at least 24 h. Immunohisto-chemistry was performed with a monoclonal antibody, which 
binds to TPH, followed by a biotinylated secondary antibody and a streptavidine complex with 
the fluorochrome CY2. TPH positive cells were determined using a fluorescence microscope. 
The TPH positive cells were predominantly found in the papillary dermis of lesional skin, but 
there were also some cells intruding into the epidermis. The number of TPH positive cells was 
higher in lesional compared to non-lesional skin. There was a correlation between the number 
of TPH cells and high degree of acanthosis, indicating a role for these cells for the magnitude of 
the inflammatory process. The degree of acanthosis correlated with SCORAD Antagonistic drugs 
targeting TPH might be a possible pharmacological treatment for patients with AD.
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Defective production of prostaglandin E2 (PGE2), IL-6 and IL-8 by psoriatic fibroblasts
Jorge Arasa1, M. Carmen Terencio1,2, Francisca Valcuende3, Pedro Navalón4, Miguel Payá1,2, M. 
Carmen Montesinos1,2 1University of Valencia, Department of Pharmacology, Burjassot, Valencia, 
Spain, 2Center of Molecular Recognition and Technological Development (IDM), Valencia, Spain, 
3Hospital La Plana, Dermatology Division, Vila-real, Castellón, Spain, 4General Universitary 
Hospital of VAlencia, Department of Urology, Valencia, Spain
Fibroblasts modulate immune responses in the skin via the secretion of different factors. In 
particular, fibroblast-derived PGE2 is critical for stimulation of IL-23 secretion from activated 
dendritic cells. However, a reduced capacity for prostaglandin synthesis by psoriatic skin has 
also been described. We sought to determine if there was a difference in the production of 
inflammatory mediators by dermal fibroblasts obtained from either lesional skin biopsies 
of psoriatic patients or foreskins of healthy donors. After 24h stimulation, TNF-α (10 ng/ml) 
produced increased PGE2 levels in supernatants of fibroblasts from healthy donors compared 
to fibroblasts from psoriatic lesions (5.16 ± 0.70 ng/ml, versus 0.91± 0.19 ng/ml, p<0.0001, 
n=12-15, respectively) as determined by RIA. Similar results were observed after stimulation 
with the protein kinase C (PKC) activator, 12-O-tetradecanoylphorbol-13-acetate (TPA, 1 µg/
ml) for 24h. We further observed an altered production of IL-6 and, to a lesser extent, IL-8 by 
psoriatic fibroblasts after TNF-α stimulation (16.8± 1.6 pg/ml, versus 67.8± 8.6 pg/ml in healthy 
fibroblasts, p<0.0001 and 142.9± 11.6 pg/ml, versus 195.1± 19.9 pg/ml in healthy fibroblasts, 
p<0.05, n=12-15, respectively) as determined by ELISA. No changes in cell viability determined 
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction were observed 
under the experimental conditions assayed. Our results suggest that chronic inflammation as 
occurs in psoriasis could cause a phenotypic change in dermal fibroblasts, which are essential 
for regulating tissue homeostasis.
110
Interest Of Pentyl-Rhamnoside In Lipid Barrier Function For Atopic Dermatitis Treatment
Hélène Hernandez-Pigeon1, Jérôme Besse2, Marie-Françoise Aries1, Sandrine Bessou-Touya1, 
Nathalie Castex-Rizzi1 1Dermo Cosmetic Department, Pierre FABRE R&D Center, Toulouse, 
France, 2Medical Department, Pierre FABRE R&D Center, Toulouse, France
Atopic dermatitis (AD) is a multifactorial inflammatory skin disease sustained by susceptibility 
genes and environmental factors interactions and characterized by pruritic skin lesions, 
immunodysregulation, allergic inflammation, and a defective epidermal barrier. The permeability 
barrier defect in AD is characterized by a defective keratinocyte differentiation and cohesion and 
by a global reduction in the contents of all three key lipids, i.e., cholesterol, non-essential free fatty 
acids (FFA), and ceramides. In a complementary work, we demonstrated the inhibitory activity of 
Pentyl-rhamnoside on inflammatory targets such as cytokines and chemokines genes expression 
in keratinocytes exposed to AD environment. The aim of the present study was to investigate gene 
expression of the proteins which allowed lipid synthesis in Normal Human Keratinocytes (NHK) 
treated or not with the association poly I:C + IL4 + IL13 + TNFβ (AD environment) and to evaluate 
the protection of pentyl-rhamnoside on this keratinocyte response. The gene expression study 
was performed by GeneAtlasTM Microarray System and analyzed by Ingenuity Pathways Analysis. 
We demonstrate that this association induced a transcriptional profile correlated with a lesional 
atopic skin and we observed also a deficiency of all three key class lipids. The pentyl-rhamnoside 
induced gene expression of various enzymes and proteins that participate at cholesterol, ceramide 
and FFA synthesis like EBP, DHCR7, FDT1, FDPS, FASN, ACACA, MCAT and LASS gene expression. 
Our findings demonstrate the activity of pentyl-rhamnoside on cholesterol, FFA and ceramides 
synthesis in keratinocytes exposed to AD environment, and reveal the powerful interest of pentyl-
rhamnoside in lipid barrier function restoration for AD treatment.
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Human type VII collagen harbors multiple pathogenically relevant epitopes
Artem Vorobyev1, Andreas Recke1, Jacqueline J.A. Buijsrogge2, Marcel F. Jonkman2, Takashi 
Hashimoto3, Norito Ishii3, Hiroshi Shimizu4, Reine Moriuchi4, Soo-Chan Kim5, Jong Hoon 
Kim5, Richard Groves6, Enno Schmidt1, Detlef Zillikens1, Ralf J. Ludwig1 1University of Luebeck, 
Luebeck, Germany, 2University Medical Center Groningen, Groningen, The Netherlands, 
3Kurume University School of Medicine, Fukuoka, Japan, 4Hokkaido University graduate school 
of medicine, Sapporo, Japan, 5Yonsei University College of Medicine, Seoul, Republic of Korea, 6, 
St John’s Institute of Dermatology, St Thomas’ Hospital, London, UK
Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease of skin and mucous 
membranes, characterized by autoantibodies against type VII collagen (COL7), a major 
component of anchoring fibrils of the skin. Several clinical phenotypes of EBA have been 
described, including mechano-bullous and inflammatory types. Most EBA patients’ sera react 
with the non-collagenous (NC)-1 domain of COL7. However, it remained unclear, if binding to 
only certain epitopes induces EBA, and if binding to specific epitopes within the NC-1 domain 
causes the different phenotypes of EBA. Therefore, we expressed 10 recombinant overlapping 
proteins covering the entire NC1 domain. Sera from 69 EBA patients were analyzed for IgG 
reactivity with these recombinant proteins by immunoblotting. Most sera recognized clusters 
of epitopes throughout the NC1 domain. No significant correlation was detected regarding 
antibody specificity and clinical phenotype. However, a, strong dependency of epitope 
distribution on gender and age was noticed. To study pathogenicity of antibodies specific to 
different subdomains of NC1, rabbit polyclonal antibodies to different epitopes were generated. 
Interestingly, all antibodies, regardless of their specificity, caused dermal-epidermal separation 
ex vivo when incubated with cryosections of human skin and subsequently with leukocytes of 
healthy volunteers. These observations suggest that the different clinical phenotypes of EBA do 
not depend on antibody specificity, but rather on the ability to mount an inflammatory response 
subsequent to IgG binding to the dermal-epidermal junction.
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TRAF3IP2 Couples IL-17 to the Epidermal Defense Response
Sylviane Lambert, Stefan Stoll, Andrew Johnston, James Elder University of Michigan, Ann Arbor, 
MI, USA
TRAF3IP2 encodes Act1, an adapter protein with ubiquitin ligase activity connecting IL17 
receptors to NFkB via TRAF6 and the IKK complex. Recent studies have implicated TRAF3IP2 in 
susceptibility to psoriasis and psoriatic arthritis. The gene expression profile of psoriasis lesions 
is remarkable for marked KC overexpression of genes involved in antimicrobial responses (e.g., 
DEFB4/103, S100A7/A8/A9/A12, LCN2) as well as cytokine genes involved in promoting innate 
immunity and inflammatory cell infiltration (e.g., CCL20, IL19, IL20, IL24, and IL1F9). IL-17 and 
TNF-a (TNF) synergistically induce these mRNAs in cultured KC monolayers, identifying KC as 
a promising system for molecular dissection of TRAF3IP2 function. We thus investigated the 
effects of shRNA-mediated knockdown or over-expression of TRAF3IP2 on IL-17+TNF-stimulated 
gene expression in KC. Using either normal primary KC or telomerase-immortalized tetracycline-
inducible NTERT-TR cells, by QRT-PCR we found that TRAF3IP2 knockdown induces a marked 
and significant decrease in expression of DEFB103 (89% inhibition, p=0.02), DEFB4 (91%, 
p=0.01), S100A7 (60%, p=0.09), LCN2 (76%, p=0.006), CCL20 (85%, p=0.002), IL19 (92%, 
p=0.00001), IL20 (88%, p=0.007), IL24 (80%, p=0.006), and IL1F9 (67%, p=0.02), in response to 
IL-17+TNF stimulation. Similarly, overexpression of TRAF3IP2 using a CMV promoter markedly 
increased expression of several of these genes in the absence of exogenous IL-17 or TNF. Our 
results confirm that IL-17 and TNF can synergistically induce the epidermal defense response, 
and demonstrate that this response is Act1-dependent. Additionally, they elucidate a plausible 
molecular mechanism by which TRAF3IP2 may influence psoriasis susceptibility, and provide a 
tractable experimental system for its further dissection.
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Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita
Ralf Müller1, Lars Komorowski2, Artem Vorobyev1, Christian Probst2, Andreas Recke1, Ralf Ludwig1, 
Marcel Jonkman3, Takashi Hashimoto4, Soo-Chan Kim5, Richard Groves6, Detlef Zillikens1, 
Winfried Stöcker2, Enno Schmidt1,7 1Dept of Dermatology, University of Luebeck, Germany, 
2Inst of Experimental Immunology, Euroimmun AG, Luebeck, Germany, 3Dept of Dermatology 
Genetics, UMC Groningen, The Netherlands, 4Dept of Dermatology, Kurume University School 
of Medicine, Kurume, Japan, 5Dept of Dermatology & Cutaneous Biology, Gangnam Severance 
Hospital, Seoul, Republic of Korea, 6Dept of Immunoderm, St John’s Institute of Dermatology, 
London, UK, 7Comprehensive Center for Inflammation Medicine, Univ of Luebeck, Germany
Epidermolysis bullosa acquisita (EBA) is a subepidermal blistering skin disease characterized by IgG 
autoantibodies against type VII collagen (Col VII). Differentiating EBA from pemphigoid disorders 
is of both prognostic and therapeutic relevance but no simple detection system for autoantibodies 
in EBA is available. The aim of this study was to develop simple sensitive and specific ELISA and 
immunofluorescence microscopy (IFM) systems for routine serological diagnosis of this disease. The 
recombinant non-collagenous (NC) domain 1 of Col VII, previously identified as immunodominant 
region, was expressed in human HEK293 cells. The recombinant NC1 domain was applied by ELISA 
and as chimeric membrane-bound protein by indirect IFM on the surface of transfected HEK293 
cells. The novel assays were probed by a large cohort of EBA (n=73), bullous pemphigoid (BP; n=72), 
anti-p200 pemphigoid (n=20), anti-laminin 332 mucous membrane pemphigoid (MMP; n=15), 
pemphigus vulgaris (PV; n=30), and healthy control sera (n=254). Optimizing test accuracy resulted in 
sensitivities and specificities of 94.5% and 99.2% (ELISA) and of 91.8% and 100% (IFM), respectively. 
Both test systems did not significantly differ in their ability to detect or exclude EBA and a high 
reproducibility of the ELISA was demonstrated by an intra-class correlation coefficient of 0.97. The 
two novel highly sensitive and specific assays will be helpful for routine serological diagnosis of EBA. 
In addition, the ELISA may be helpful in monitoring disease activity in the follow-up of EBA patients.
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Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis
Abhishek Aphale1, William Swindell2, Philip Stuart1, Cynthia Chen1, Xianying Xing1, Rajan Nair1, 
John Voorhees1, James Elder1, Andrew Johnston1, Johann Gudjonsson1 1University of Michigan, 
Ann Arbor, Michigan, USA, 2Harvard Medical School, Boston, Massachusetts, USA
Psoriasis is a chronic inflammatory disease of the skin characterized by erythematous plaques 
with silvery scale. These features are so consistent that diagnosis can be made on clinical 
grounds alone. However, even among patients with stable chronic plaque psoriasis there is great 
variability in regards to treatment responses suggestive of heterogeneity in the inflammatory 
network between different patients. In addition, it is unclear how risk alleles influence the 
cytokine network in psoriasis. In this study, whole-genome transcriptional profiling along 
with immunohistochemistry and risk allele typing was used to characterize inflammatory and 
cytokine networks in lesional skin of 62 patients with stable chronic plaque psoriasis. Significant 
differences were found in the inflammatory gene expression signatures between patients, with 
58% having strong and 42% having moderate to weak signatures, with no change in the degree 
of keratinocyte signatures between the two groups. The strong inflammatory infiltrate group 
was mainly defined by increased dendritic cell and macrophage signatures. We found that 
gene expression signatures for IL-1β, IL-17A, IL-19, IL-20, IL-22, IL-24 and IFN-γ were most 
consistently associated with psoriatic skin. Inflammatory infiltrate signatures correlated with 
cytokine signatures with patients divided into two main groups defined by IL-1α/IL-13/IFN-α 
response pattern in addition to IL-17, IFN-γ and TNF-α signatures. Heightened inflammatory 
and cytokine signatures were found to be associated with risk alleles in the REL, NOS2 and 
TRAF3IP2 genes. This study confirms the presence of heterogeneity in inflammatory signatures 
among psoriatic patients and may be applied toward developing individualized treatment plans 
for obtaining optimal response.
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IL-13 expression is up-regulated by TGF-β via GATA-3 in Systemic Sclerosis and down-regulated 
in healthy controls
Julie Baraut1, Dominique Farge1,2, Francette Jean-Louis1, Ingrid Masse3, Elena Ivan Grigore1, 
Jérôme Lamartine3, Armand Bensussan1, Franck Verrecchia4, Laurence Michel1 1INSERM U976, 
Paris, France, 2Unité Clinique de Médecine Interne et Pathologie Vasculaire, Hôpital Saint-Louis, 
Paris, France, 3CNRS, UMR5534, Villeurbanne, France, 4INSERM U957, Nantes, France
Systemic sclerosis (SSc) is an auto-immune disease characterized by cutaneous fibrosis. Produced 
by T helper type 2 (Th2) lymphocytes, TGF-β and IL-13 are two pro-fibrotic cytokines involved in SSc 
fibrosis. TGF-β activates collagen synthesis whereas IL-13 promotes fibrosis by stimulating TGF-β 
production. IL-13 serum levels are increased in SSc.The aim of the present study was to determine 
the effect of TGF-β on IL-13 expression by lymphocytes from SSc patients (n=8) compared to healthy 
donors (n=10). Jurkat cell line was used as a Th2 model. Cells were treated with TGF-β during 0.5 
to 24 hours with or without specific Smad and MAPkinase inhibitors and 5h-PMA+Ionomycin 
stimulation. IL-13 promoter activity was studied by transfection, IL-13mRNA expression by QPCR, 
IL-13 protein expression by FACS analysis, GATA-3 protein levels by western blot, and GATA-3 
enrichment in IL-13 promoter by ChIP assays. Our results showed that TGF-β inhibits IL-13 mRNA 
levels in Jurkat cells (mean inhibition 49.5±2.7% at 0.5h, p<0.01) through Smad and p38 pathways. 
TGF-β inhibits IL-13 gene expression via repression of GATA-3 transcription factor and inhibition of 
its binding capacity to IL-13 promoter. TGF-β also down-regulates IL-13 mRNA by 1.4±0.2 (p<0.01) 
and protein expression by 1.3±0.4 (p<0.01) in lymphocytes from healthy donors. In contrast, TGF-β 
increases IL-13 mRNA levels by 2.1±0.7 (p<0.5) and IL-13 expression by 1.6±0.4 (p<0.5) in 
lymphocytes from SSc patients. This work clearly demonstrates that TGF-β acts through Smad and 
MAPkinase pathways to alter IL-13 expression via GATA-3, with a dichotomy between lymphocytes 
from SSc patients and normal individuals.
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MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis
Florian Meisgen, Ning Xu, Tianling Wei, Mona Ståhle, Enikö Sonkoly, Andor Pivarcsi Karolinska 
Institute, Stockholm, Sweden
Previously, our group performed a genome-wide screen for microRNAs in psoriasis skin, and 
showed a distinct pattern of deregulated microRNA expression.  However, the interaction 
of the microRNAs in the cellular context is not yet known. MicroRNA-21 (miR-21) is one of 
the microRNAs we found to be significantly up-regulated in psoriasis implicating a role in its 
pathogenesis. In order to identify the cell type responsible for the increased miR-21 level, we 
measured miR-21 expression in epidermal keratinocytes and dermal T cells in both psoriasis and 
healthy skin samples and found that both cell types contributed to the increased miR-21 level. In 
cultured T cells, we saw a highly increased expression of miR-21 upon T cell activation, suggesting 
its general involvement in this process. In order to determine the role of miR-21 in T cells, we 
overexpressed or suppressed miR-21 in primary human T helper cells. Measurement of apoptosis 
rate revealed that inhibition of miR-21 increases the apoptosis rate while overexpression of miR-
21 has an anti-apoptotic effect. This suggests that miR-21 regulates apoptosis in activated T cells 
and thus contributes to increased survival.
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Pharmacological activity of JAK-kinase inhibitors on gene expression of psoriatic skin explants
Carolina Salcedo3, Pedro Michelena3, Marta Ferran1, Ramon M Pujol1, Manuel Merlos3, Luis 
F Santamaria-Babi1,2 1Department of Dermatology. Hospital del Mar. Institut Municipal 
d’Investigacio Medica (IMIM), Barcelona, Spain, 2Biomedical Research Institute (IRB), Barcelona, 
Spain, 3Palau Pharma S.A., Barcelona, Spain
Janus kinases (JAK) constitute relevant targets for psoriasis and other chronic inflammatory 
diseases. Activation of JAK/STAT system has been described in key cells involved in psoriasis, 
such as keratinocytes, T cells, and dendritic cells. We have studied JAK inhibitors in the in vitro 
psoriatic (Ps) human skin biopsies. The culture maintains the Ps histological, cellular and genetic 
features along the whole experimental period and allows studying the pharmacological effect 
of drugs. Biopsies from 12 patients with active and stable plaque-type psoriasis with no treatment 
before biopsy, either systemic (4wk) or topical (2 wk) were used. The procedure was approved 
by the centre’s Ethics Committee. After 8 days of culture, gene expression was evaluated by 
quantitative RT-PCR. Several well-known inflammatory genes in psoriasis were up-regulated 
in the biopsies, including IL- 8, IL-17, IL-20, IL-22, IL-23, ICAM-1, IP-10, INFgamma, STAT-
1, beta-defensin, and keratin-16. The pharmacological activity of two JAK inhibitors in clinical 
development for psoriasis, i.e. CP-690,550, and INCB018424, was evaluated. Both compounds 
(1 µM) down-regulated the expression of several key genes, such as beta-defensin, IL-20, and 
IL17, showing a slightly differential profile. In conclusion, psoriatic human skin biopsies have 
proven useful to validate JAK inhibitors as a promising alternative to current topical treatments 
for psoriasis.
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The chronic inflammatory mediator angiopoietin-like protein 2 contributes to carcinogenesis 
and cancer cell metastasis
Jun Aoi1,2, Motoyoshi Endo2, Tsuyoshi Kadomatsu2, Keishi Miyata2, Satoshi Fukushima1, Masatoshi 
Jinnin1, Yuji Inoue1, Satoshi Hirakawa3, Yuichi Oike2, Hironobu Ihn1 1Dept of Dermatology & 
Plastic Surgery, Kumamoto University, Japan, 2Dept of Molecular Genetics, Kumamoto University, 
Japan, 3Dept of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Chronic inflammation plays important roles at different stages of cancer development, including 
carcinogenesis, invasion, and metastasis, but molecular mechanisms underlying this association 
have not been fully clarified. Recently, we reported that Angiopoietin-like protein2 (Angptl2) acts 
as an important chronic inflammatory mediator in a variety of pathological settings, including 
obesity-related metabolic diseases and rheumatoid arthritis (RA). Angptl2 is expressed in a variety of 
tissues. Moreover, both hypoxia and ER stress increase Angptl2 expression, and both conditions are 
commonly observed in cancer development and progression. To study whether and how Angptl2 and/
or its-related inflammation contribute to cancer risk and development, we focused our investigation 
on the roles of Angptl2 in squamous cell carcinoma (SCC), a common skin cancer. First, we found 
that Angptl2 was abundantly expressed in human skin SCC and chemical (DMBA and PMA)-induced 
SCC in dorsal skin of FVB/N genetic background wildtype mice, suggesting a possible role of Angptl2 
in skin SCC. Second, we found the significantly decreased susceptibility to chemical-induced skin 
carcinogenesis in Angptl2 knock out (KO) mice relative to wildtype control mice. Conversely, both the 
numbers and incidence of tumors were markedly increased in transgenic mice-expressing Angptl2 in 
skin tissues (K14 Angptl2 Tg mice) compared with wildtype control mice, suggesting that the presence 
of Angptl2-related inflammation in skin tissues might increase susceptibility for chemical-induced 
skin carcinogenesis. Taken together with these findings, we proposed here that induction of Angptl2 
and/or Angptl2-related inflammation might play important roles in the skin carcinogenesis.
119
In vivo functional analysis of the EMT-inducing transcription factor Snail in skin cancer 
progression
Geertrui Denecker1,2, Bram De Craene1,2, Petra Vermassen1,2, Marianthi Tatari1,2, Alexander 
Gheldof1,2, Jos Jonkers3, Elaine Fuchs4, Geert Berx1,2 1Department for Molecular Biomedical 
Research, VIB, Ghent, Belgium, 2Department of Biomedical Molecular Biology, Ghent University, 
Ghent, Belgium, 3Division of Molecular Biology, Netherlands Cancer Institute, Amsterdam, The 
Netherlands, 4Howard Hughes Medical Institute, Rockefeller University, New York, USA
It is well established now that the Snail family of transcription factors plays an important role 
during epithelial to mesenchymal transition (EMT), migration and cell survival. EMT is a process 
in which epithelial cell layers loose their polarity and cell-cell contacts, express mesenchymal 
features and manifest a migratory phenotype. EMT has been attracting increasing attention 
as a determinant for the progression of epithelial malignancies, which fits very well with the 
action spectrum of the Snail family members. The identification of Snail as a transcriptional 
repressor of E-cadherin and additional in vitro cellular analysis, indicate its potential role in 
tumor progression. To address the in vivo role of this EMT-inducing transcription factor during 
skin cancer progression, we used a transgenic mouse model in which Snail is under the 
control of the skin specific K14 promotor. In these mice Snail is overexpressed in the basal 
layer of the epidermis. When we subjected Snail expressing mice to different chemical induced 
carcinogenesis protocols (DMBA/TPA and DMBA(/DMBA)) we could observe that these mice are 
more susceptible to the formation of tumors. In addition, Snail overexpressing tumors displayed 
an invasive growth pattern, which was not observed in WT mice. Surprisingly, the K14-driven 
Snail overexpressing mice also developed spontaneously tumors, pointing towards the role of 
Snail as an oncogen. In addition when crossing these mice in a skin specific p53 null background 
we observed accelerated tumor formation and increased cancer metastasis.
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MiR-203 functions as a tumor suppressor microRNA in basal cell carcinoma
Eniko Sonkoly1, Jakob Loven1, Tianling Wei1, Ning Xu1, Florian Meisgen1, Petter 
Brodin1, Viljar Jaks1, Maria Kasper1, Takashi Shimokawa1, Masako Harada1, Johan 
Heilborn1, Mari-Anne Hedblad1, Andreas Hippe2, Dan Grander1, Bernhard Homey2, 
Peter Zaphiropoulos1, Marie Arsenian-Henriksson1, Mona Stahle1, Andor Pivarcsi1 
1Karolinska Institutet, Stockholm, Sweden, 2Heinrich Heine University, Dusseldorf, Germany
MicroRNAs (miRNAs) are a recently discovered class of posttranscriptional regulators of gene 
expression with critical functions in health and disease. Basal cell carcinoma (BCC) of the skin 
represents the most common malignancy in the Caucasian population. Deregulated Hedgehog 
signaling is of vital importance in the formation of BCC. Here we show that BCC has an aberrant 
miRNA expression profile when compared with healthy human skin. Among the miRNAs 
deregulated in BCC, we identified miR-203, a miRNA abundantly and preferentially expressed 
in the suprabasal layers of the epidermis. Compared to healthy human skin, miR-203 expression 
was reduced more than 4-fold in BCCs and in situ hybridization confirmed that miR-203 was 
virtually lost in these tumors. Further, miR-203 expression in BCCs was inversely correlated 
with PTCH1 and GLI1, two key genes in Hedgehog signaling. Using luciferase assays as well as 
real-time PCR and Western-blot analyses in keratinocytes overexpressing miR-203, we showed 
that miR-203 negatively regulates the PTCH1 and the c-Jun oncogene in primary keratinocytes. 
Overexpression of miR-203 in primary keratinocytes resulted in a significant reduction of cell 
proliferation. Our results suggest that miRNA deregulation is involved in the pathogenesis of 
BCC. Down-regulation of miR-203 in BCC may represent a critical step in skin tumorigenesis and 
contribute to the increased proliferation of transformed keratinocytes via the deregulation of the 
Hedgehog pathway and c-Jun.
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Role for microRNA-21 in skin carcinogenesis
Mohammed I. Ahmed, Andrei N. Mardaryev, Majid Alam, Krzysztof Poterlowicz, Natalia V. 
Botchkareva University of Bradford, Bradford, UK
Increasing evidence suggests that microRNAs (miRNA) are key regulators of the oncogenic 
processes, and the expression of many miRNAs is deregulated in cancers. miR-21 is 
overexpressed in many forms of cancer, and exerts its pro-oncogenic activity in a number of 
cell types. However, miR-21 functions and targets in normal skin and during skin carcinogenesis 
remain largely unknown. Here, we show that levels of miR-21 transcript are gradually increased 
in mouse skin at different stages of chemically-induced (DMBA/TPA) carcinogenesis. By in situ 
hybridization, strong miR-21 expression was detected throughout the entire epithelial tumour 
compartments. Similarly to mouse skin, up-regulation in miR-21 expression was observed in 
human primary keratinocytes treated with TPA. Inhibition of miR-21 activity in human epithelial 
carcinoma cell line A431 with anti-miR-21 “sponge” caused significant inhibition of cell survival 
as determined by MTT assay, decrease of cell proliferation and activation of apoptosis, assayed 
by the BrdU incorporation and caspase 3/7 activity, respectively. Furthermore, inhibition of miR-
21 resulted in changes of expression of the genes implicated in skin carcinogenesis: expressions 
of the transcripts of selected tumour-suppressor genes Pten, Pdcd4 and Timp3 increased, while 
expressions of p53 or Bcl2 were not changed. Bioinformatic analysis revealed the novel putative 
miR-21 targets in keratinocytes, including the chromatin organizer special AT-rich binding 
protein 1 (SATB1), which was confirmed by the luciferase reporter assay. Collectively, these 
data suggest that miR-21 operates as a pro-oncogen in the epidermis and promotes neoplastic 
cell transformation and cancer progression via targeting distinct tumour-suppressor genes and 
signalling pathways.
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The developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
Giulia Spallone1, Elisabetta Botti1, Valentina Pinetti1, Francesca Moretti1, Giovanni Blandino2, 
Sergio Chimenti1, Luisa Guerrini3, Maurizio Fanciulli2, Antonio Costanzo1 1Department of 
Dermatology, University of Rome Tor Vergata, Rome, Italy, 2Regina Elena Cancer Center, Rome, 
Italy, 3University of Milan, Milan, Italy
The transcription factor IRF6 regulates craniofacial development and epidermal proliferation. We 
have recently demonstrated that IRF6 is a component of a regulatory feedback loop that controls 
the proliferative potential of epidermal cells, being transcriptionally activated by DNp63 and 
inducing its proteasome-mediated downregulation, thereby limiting keratinocyte proliferative 
potential. We have hypothesized that IRF6 could be also involved in skin carcinogenesis. 
Therefore, we analyzed IRF6 expression in a large series of Squamo Cellular Carcinomas finding 
strong downregulation of IRF6 that correlated with their invasive and differentiation status. IRF6 
downregulation in SCC cell lines and primary tumors correlates with methylation on a CpG 
island located in its promoter region. To identify the molecular mechanisms regulating IRF6 
potential tumor suppressive activity, we performed genome wide analysis by combining ChIP-seq 
for IRF6 binding sites and gene expression profiling in primary human keratinocytes after siRNA-
mediated IRF6 depletion. We observed dysregulation of cell cycle related genes and of genes 
involved in differentiation, cell adhesion and cell-cell contact. Many of these genes were direct 
IRF6 targets. We also performed in vitro invasion assays demonstrating that IRF6 downregulation 
promotes invasive behaviour and increases SCC side population. Reintroduction of IRF6 into SCC 
cells strongly inhibits cell growth. These results highlight a novel function for the developmental 
regulator IRF6 suppressing tumorigenesis of stratified epithelia.
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Immunodeficient mice as recipients for Sézary cells allow functional studies into the 
pathogenesis of Sézary Syndrome
Leslie van der Fits1, Heggert Rebel1, Stephan Pouw2, Jacoba Out-Luiting1, Lisanne van Zijl1, Rein 
Willemze1, Cornelis Tensen1, Kees Weijer2, Maarten Verneer1 1Leiden University Medical Center, 
Leiden, The Netherlands, 2Academic Medical Center of the University of Amsterdam, Amsterdam, 
The Netherlands
Sézary syndrome (SS) is an aggressive cutaneous T-cell lymphoma with CD4+ tumor cells (SS 
cells) present in skin, lymph nodes and peripheral blood. Identification of molecular pathways 
involved in the pathogenesis of SS and subsequent validation of novel therapeutic targets has 
been hampered by the paucity of available functional models. We therefore aimed to develop a 
mouse model for SS by using immunodeficient RAG2 common-γ knock-out mice that completely 
lack T-, B-, and NK-cell activity. These mice were successfully used previously to reconstitute a 
human hematopoietic system upon intrahepatic injection of hematopoietic progenitor cells in 
newborn mice. Using this approach, injection of SS cell line SeAx led to long-term (>4 weeks) 
and reproducible repopulation of the mice, with SeAx cells in liver and lymph nodes. Injection 
of mice with SS cell line HuT78 led to the death of the mice due to massive growth of internal 
tumors. Four weeks after injection of primary SS cells isolated from the peripheral blood from SS 
patients, SS cells could be tracked back in the mice in the liver, peripheral blood, lymph nodes, 
spleen and skin, although the engraftment rate varied when using cells from different patients. 
Thus, injection of primary SS cells or SS cell lines into RAG2-/- common-γ-/- knock-out mice 
results in successful long-term repopulation of various mouse organs. We therefore conclude that 
this model is suitable as a tool to uncover pathogenic mechanisms in SS and screening of the 
validity of novel therapeutic targets.
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Function of the polarity protein Par3 in Ras-induced skin tumorigenesis
Sandra Iden1,3, Helma van Riel1, Ji-Ying Song1, Tomonori Hirose2, Shigeo Ohno2, John G. Collard1 
1The Netherlands Cancer Institute, Amsterdam, The Netherlands, 2Yokohama City University 
Graduate School of Medicine, Yokohama, Japan, 3CECAD/CRC829/CRC832, University of 
Cologne, Cologne, Germany
Cell polarization is crucial for the development of multicellular organisms, and aberrant cell 
polarization contributes to various diseases, including cancer. Conserved proteins of the partitioning 
defective (Par), Scribble and Crumbs complexes, so-called polarity proteins, guide the establishment 
of cellular asymmetry in various organisms. The Par complex is composed of Par3, Par6 and the serine/
threonine kinase atypical PKC (aPKC), and cross-talks to Rho GTPases to induce polarization processes. 
In mice, Par3 deficiency is embryonic lethal, and the function of Par3 during later development and 
in pathological situations remains to be identified. To investigate the function of Par3 in the skin, we 
have generated mice with conditional gene deletion in the epidermis. Cultured Par3-KO keratinocytes 
show impaired tight junction formation, reduced wound-induced cell migration and mislocalization 
of aPKCzeta. Moreover, apoptotic resistance and oncogene-induced colony-formation of keratinocytes 
depends on Par3 expression. Mice with epidermal-specific deletion of Par3 are viable but show impaired 
tumor formation in a two-stage chemical skin carcinogenesis model. Upon treatment with tumor-
promoting agents, increased apoptosis and decreased cell proliferation was observed in Par3-deficient 
compared to wild-type epidermis. Interestingly, despite the overall reduced tumor burden, Par3-deficient 
mice develop a normally rare skin tumor type also found in humans. We are currently investigating the 
origin of this tumor. Together, these data highlight that the polarity protein Par3 promotes Ras-induced 
tumorigenesis in a context-dependent manner. This contrasts the tumor-suppressive function of Scribble 
complex proteins described for D.melanogaster and vertebrates, and thereby suggests that polarity 
proteins highly differ in their contribution to pathological processes.
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Onset of pro-invasive squamous cell carcinoma microenvironment is associated with ROCK 
and JAK1 signaling which controls acto-myosin contractility in stroma fibroblasts
Cedric Gaggioli1, Victoria Sanz-Moreno2, Jean Albrengues1, Christopher Marshall2, Guerrino 
Meneguzzi1 1INSERM U634, Universite de Nice Sophia-Antipolis, F-06107 Nice, France, 2Institute 
of Cancer Research, CR-UK, London, UK
Carcinoma associated fibroblasts (CAF) lead collective squamous carcinoma cell (SCC) invasion 
by remodeling extracellular matrix and forming tracks through generation of actomyosin-
dependent forces. Using a chemical compound screening based on 3D matrix-remodeling by 
CAF, we identified JAK inhibitor I (inhibitor of the Janus Kinase family) as a potent inhibitor 
of matrix remodeling by stroma cells. Original 3D-organotypic invasion assays revealed that 
Janus kinase and Rho/ROCK CAF-dependent signaling cooperate to promote collective SCC 
cell invasion. Consistent with the fact that proinflammatory cytokines are frequently observed 
in tumor microenvironment and that chronic inflammation is involved in cancer initiation 
and progression, we found that interleukin6 family cytokine signaling generates actomyosin 
contractility through Rho-kinase dependent signaling, which involves the receptor subunit 
GP130-IL6ST and kinase JAK1. We further demonstrate that actomyosin contractility enhances 
activity of STAT3 transcription factor downstream JAK1, which implies positive feedback within 
the signaling network. These results: -i) unveil a mechanism by which chronic inflammation 
enhances SCC invasion by modulating the tumor microenvironment, -ii) validate a 3D-screening 
procedure allowing identification of molecules active on stroma cells and inhibiting both 
formation of permissive tumor microenvironments and SCC invasion; -iii) suggest that SCC 
invasion can be impinged by pharmacological compounds that interfere with inflammatory 
response signaling pathways underlying the permissive matrix remodeling operated by CAFs.
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Interferon-alpha inhibits lymph node metastasis in human malignant melanoma xenografts in 
nude mice through inhibition of tumor-associated lymphangiogenesis
Mi Ryung Roh, Hyun Jeong Kim, Jae Yong Sung, Kee Yang Chung Yonsei University College of 
Medicine, Seoul, Republic of Korea
Interferon (IFN)-alpha (α) is the most commonly used biologically active cytokine in the treatment 
for high-risk patients with melanoma. Although IFN-α has shown to be clinically effective in the 
adjuvant setting of high risk for relapse melanoma, the reasons are unknown yet. The purpose 
of this study was to evaluate and compare the efficacy of IFN-α2b and IFN-β1a on primary 
tumor growth and lymph node metastasis and investigate the mechanism regarding lymph node 
metastasis by using human melanoma xenograft mouse model. IFN-α2b and IFN-β1a both showed 
inhibitory effects on tumor cell proliferation and induction of apoptosis. Both IFN-α2b and IFN-
β1a treatment were effective in inhibiting lymph node metastasis compared to control. Among 
6 mice, control group showed lymph node metastasis in 5 mice compared to 3 mice in IFN-β1a 
treatment group and 1 mouse in IFN-α2b treatment group. In the xenograft tumors, the number 
of microvessel density (MVD) decreased in IFN-α2b and IFN-β1a treated tumors compared to 
control, however, it was not statistically significant. As for lymphatic vessel density (LVD), the 
number significantly decreased only in tumors treated with IFN-α2b (p<0.05). IFN-α2b and IFN-
β1a treatment both decreased in vitro and in vivo VEGF-C and VEGFR-3 protein expression and 
secretory VEGF-C level in vitro. In conclusion, IFN-α2b and IFN-β1a both showed anti-tumor 
and anti-metastatic effect on human melanoma xenograft mouse model through different action 
mechanisms. IFN-β1a showed stronger anti-proliferative and anti-apoptotic effect while IFN-α2b 
showed stronger effect in inhibition of lymphangiogenesis.
2011ESDR_8.25x10.875.indd   21 06/07/2011   18.24 
S22 Journal of Investigative Dermatology (2011), Volume 131 
ABSTRACTS
127
CYFIP1 is under the direct control of NOTCH1 and is downregulated in the cutaneous 
squamous cell carcinoma
Piotr Dziunycz1, Karine Lefort2, Nadia Djerbi1, Seraina von Moos1, Sandra Freiberger1, Guergana 
Iotzova-Weiss1, Lars French1, Gian-Paolo Dotto2, Günther Hofbauer1 1Dept of Dermatology, Univ 
Hospital Zurich, Zurich, Switzerland, 2Dept of Biochmistry, Univ of Lausanne, Epalinges, Switzerland
SCC belongs to the most common skin cancers in the general population with UV radiation 
being one of the most important risk factors. This cancer is associated with a substantial risk of 
recurrence and metastasis. Recent work uncovered the role of CYFIP1 in epithelial tumors as 
an invasion inhibitor. Its downregulation was observed in many cancers, and correlated with 
metastatic properties of the malignant cells. We evaluated the CYFIP1 expression levels in SCC 
of the skin and observed the downreagulation on mRNA and protein levels. CYFIP1 expression 
was negatively correlated with the histological differentiation of the tumors. As keratinocyte 
differentiation is highly dependent on the Notch1 signaling, we investigated the Notch1 
influence on CYFIP1 expression. The immunohistochemical analysis showed significant positive 
correlation of the two proteins expressions. Conditional manipulation of the Notch1 signaling 
pathway has proven its role in the induction of CYFIP1 expression. Furthermore existence of the 
Notch1 binding sites has been confirmed by the chromatin immunoprecipitation assay. We have 
also investigated the UV influence on the Notch1 and CYFIP1 expression, and found that low 
doses of UVB radiation significantly downregulated mRNA levels of both genes. Taken together 
we show that CYFIP1 is under the direct positive control of the Notch1. CYFIP1 may be a link 
between the loss of differentiation and invasion properties of the SCC. Disturbed differentiation 
of the malignant SCC cells may lead to the CYFIP1 downregulation, which is further attenuated 
by the UV radiation and thus may contribute to the SCC progression, invasion and metastasis.
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Immunosuppressive treatment sustains increased S100A8/A9 and RAGE levels in cutaneous 
squamous cell carcinoma
Nadia Djerbi, Piotr Dziunycz, Dominic Reinhardt, Guergana Iotzova-Weiss, Lars French, 
Günther Hofbauer Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Squamous cell carcinoma (SCC) of the skin is the second most common skin tumor in the general 
population and the most common malignancy following organ transplantation. Several reports 
have underlined the role of the immune system in tumorigenesis. It has been postulated that 
acute inflammation supports the eradication of the cancer cells, while chronic inflammation 
creates a tumor-promoting environment. Recently, roles of the receptor for advanced glycation 
end-products (RAGE) and its heterodimer ligand S100A8/A9 in the SCC development have 
been shown in the mouse model. As this pathway acts through the critical transcription factor 
NFκB and regulates the inflammatory response, its involvement is particularly interesting in 
the development of the skin cancer in the immunosuppressed population. We analyzed the 
expression of S100A8/A9, RAGE, NFκB and its downstream targets in SCC of both OTR and 
immunocompatent patients. We also investigated the influence of the most commonly used 
immunosuppressants on these gene expression. The RT-PCR measurements showed increased 
expression levels of the S100A8/A9-RAGE pathway members in human SCC. The downstream 
targets of this signaling pathway were induced independently on the patients’ immune status. 
To assess the influence of the commonly used immunosuppressive medications on the S100A8/
A9, RAGE, NFkB mRNA levels, treatment of normal human keratinocytes was performed and 
followed by RT-PCR analysis. Interestingly, immunosuppressive treatment even increased mRNA 
levels of S100A8/A9, RAGE and NFkB in cultured keratinocytes. Thus our findings may suggest 
increased expression of S100A8A9 and RAGE as one of the mechanisms for the increased SCC 
incidence in immunosuppressed patients.
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S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell 
carcinoma of the skin via RAGE
Guergana Iotzova-Weiss1, Piotr Dziunycz1, Severin Läuchli1, Jürg Hafner1, Thomas Vogl2, Lars E. 
French1, Günther F.L. Hofbauer1 1Dermatology Clinic Zurich, Zurich, Switzerland, 2Institute for 
Immunology, University of Münster, Münster, Germany
Squamous cell carcinoma (SCC) is a common skin neoplasm characterized by infiltrative, 
destructive growth and metastasis. SCC is the most common neoplasm in organ transplant 
recipients on long-term immunosuppression and occurs 60-100 fold more frequently than in the 
general population. In this study, we present the receptor for advanced glycation end products 
(RAGE) and its ligand S100A8/A9 as a link between inflammation and the development of human 
SCC. We investigated the role of RAGE and S100A8/A9 in the development of human SCC. 
Our previous studies demonstrated that RAGE, S100A8 and S100A9 are upregulated in the 
epidermis of solid organ transplant recipients (OTR) and immunocompetent patients (IC) with 
SCC compared to healthy skin. We were able also to induce the proliferation and migration of 
human SCC-derived keratinocytes in response to exogenous S100A8/A9 stimulation which in 
turn was abolished by a direct blockade of RAGE. Recently, we detected that normal and SCC-
derived keratinocytes secrete spontaneously S100A8/A9. In relation to that, we were able to 
inhibit partially the binding of the secreted S100A8/A9 to RAGE by blocking anti RAGE antibody 
and by siRNA specific for RAGE. Moreover, our new studies show that exogenous S100A8/
A9 exerts its effect on keratinocytes by inducing p38, SAPK/JNK and ERK1/2 phosphorylation 
subsequently. We hypothesize that RAGE and its ligand S100A8/A9 are drivers of the progression 
to human SCC, thus linking inflammation and cancer development, and do not seem impaired 
by profound drug-mediated immunosuppression in OTR.
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Genital Squamous Cell Carcinoma Mimicking a Venereal Disease Accompanying With a 
Chronic Well-healed Scar Tissue
Pelin Ustuner1, Nursel Dilek2, Hasan Gucer3 1Rize 82. YIL Government hospital, Rize/Turkey, 
Turkey, 2Rize University Medical Faculty Dermatology Department, Rize/Turkey, Turkey, 3Rize 
University Medical Faculty Pathology Department, Rize/Turkey, Turkey
Genital squamous cell carcinoma (SCC) may develop on the basis of bad hygien, chronic radiation, 
endustriel exposure and chronic fibrosis or scar formation like Marjolin’s ulcer, Fournier gangren, 
hidradenitis suppurativa. A 61 year-old white, married man had presented with complaints of 
painful, exudative, firm ulcers on his pubic area for one year. He informed that a wide non-
healing ulcer also developed on his right inguinal region 5 months ago. He emphasized that 
an asympthomatic wide scar like pearling has been developed on his pubic area for at least 10 
years after the improvement of an abscess. On the dermatological examination; multiple painful, 
deep, punched-out ulcers with a centrally yellowish exudation were noted. Another wide and 
perforating ulcer in 5x6 cm was also noticed on his right inguinal region. Anti-HBc, anti-HCV, 
anti-HIV and VDRL were negative. The gram and acid resistant staining, the bacterial, fungal and 
tuberculosis cultures were also negative. The histopathological examination of the excisional 
biopsy of the noduloulcerative lesions showed an infiltration consisting of atypical squamous 
cells in the dermis and the diagnosis of SCC was confirmed. The development of genital cancer 
in this case could probably be explained by the added effect of chronic irritation secondary to 
fungal infection or poor hygiene. We wish to draw attention to the possibility of the malignancy 
in the differential diagnosis of long standing, unresponsive, recurrent ulcerated lesions on the 
genital region, as they may easily be mistaken for an inflammatory lesion or a venereal disease.
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2-Year Carcinogenicity Studies Demonstrates that AN2690, a Novel Boron-containing Small 
Molecule for Topical Treatment of Onychomycosis, is Considered Noncarcinogenic
Irwin Heyman, Liang Liu, Sanjay Chanda Anacor Pharmaceuticals, Palo Alto, CA, USA
Anacor Pharmaceuticals is developing AN2690 (5fluoro-1,3-dihydro-1-hydroxy-2,1-
benzoxaborole) for topical treatment of onychomycosis. This novel, low molecular weight 
compound demonstrate superior penetration through nail plate compared to ciclopirox (the only 
topical treatment currently approved in the United States for distal subungual onychomycosis) 
and has broad-spectrum antifungal activity against dermatophytes, yeasts and molds responsible 
for the disease. AN2690 was tested in two 2-year carcinogenicity studies in mice and rats as part 
of the extensive nonclinical safety program. Both the studies were conducted as per the published 
International Conference on Harmonization (ICH) Guidelines and protocols were approved by 
the Carcinogenicity Assessment Committee (CAC) of the US Food and Drug Administration (US-
FDA). In the study performed in mice [Crl:CD1®(Icr)], AN2690 was administered once daily 
by topical application to the dorsal skin for at least 104 weeks. Four study treatment groups 
consisted of the vehicle (80% ethanol/20% propylene glycol) or AN2690 (5, 10 and 15%). In the 
study performed in rats (Sprague-Dawley), AN2690 was administered once daily by oral gavage 
for at least 104 weeks at doses of either 0, 12.5, 25 or 50 mg/kg/day. Separate toxicokinetic 
groups maintained in both the studies demonstrate very high systemic exposure to AN2690. 
Detailed histopathological examination was performed on approximately fifty tissues in both 
the studies to investigate signs for any AN2690-related neoplasms. There was no evidence of 
AN2690-related neoplasms observed in any of the two studies. Based on the data gathered from 
these two carcinogenicity studies AN2690 is considered non-carcinogenic.
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Five putative components of the TIP60 histone acetyltransferase complex, including C20orf20 
but excluding the catalytic subunit, are necessary for cutaneous squamous cell carcinoma 
survival
Stephen Watt, Celine Pourreyron, Irene Leigh, Andrew South University of Dundee, Dundee, UK
Cutaneous squamous cell carcinoma (cSCC), the most frequent skin neoplasm with malignant 
potential, burdens high risk groups such as immunosuppressed patients and those with recessive 
dystrophic epidermolysis bullosa with increased incidence, metastasis and mortality. As yet, a 
specific therapy for cSCC remains an unmet clinical need. We recently identified C20orf20, a 
putative member of the TIP60 histone-acetyltransferase (HAT) complex, as being upregulated 
at the mRNA and protein level in cSCC versus normal keratinocytes and siRNA-mediated 
knockdown of this gene resulted in a potent decrease in cSCC cell viability (35% ± 2.2% of 
scrambled control siRNA, n=22) through induction of apoptosis (2.5-fold increase in cytoplasmic 
nucleosomes detected by ELISA), without effect in normal keratinocytes (n=8). In vivo, targeting 
C20orf20 in cSCC xenografts resulted in marked reduction in tumour volume after 11 treatments 
(Control: 409mm3 ±107.5 vs C20orf20 siRNA: 198mm3 ±51.9). An RNAi cytotoxicity screen of 
known C20orf20 interacting proteins revealed TRRAP, DMAP1, EPC1 and VPS72 to invoke similar 
cell death responses upon depletion, while little response was seen by knockdown of TIP60, 
the HAT catalytic subunit. In addition, immunostaining with novel antibodies raised against the 
N and C terminal domains of C20orf20 show abundant nuclear localisation in cSCC tumour, 
in stark contrast to extensive cytoplasmic distribution within the suprabasal layers of normal 
epidermis. In conclusion we have identified C20orf20 and four other putative components of the 
TIP60 HAT complex to be required for cSCC cell survival, indicating a role for a novel tumour-
specific, TIP60 independent, nuclear complex in cSCC tumourigenesis.
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Peritumoral regulatory T cells in human cutaneous squamous cell carcinomas suppress immune 
responses
Suzannah August1, Chester Lai1, Chris Pickard1, Carolann McGuire1, Michael Ardern-Jones1, 
Jeffery Theaker2, Stephan Gadola3, Eugene Healy1 1Dermatopharmacology, University of 
Southampton, Southampton, UK, 2Department of Histopathology, Southampton General 
Hospital, Southampton, UK, 3Immunology, University of Southampton, Southampton, UK
The suppression of the body’s antitumour immune responses leads to the development of 
skin cancers, in particular squamous cell carcinomas (SCCs). We and others have noted the 
presence of regulatory T cells (Tregs) in the peritumoral immune cell infiltrate surrounding 
human cutaneous SCCs and that Tregs are present in precursor lesions (actinic keratoses and 
Bowen’s disease) at a similar frequency to that in SCC. Tregs can suppress immune responses 
and there is evidence that their presence in the peritumoral infiltrate is associated with reduced 
overall survival in with cancers of the breast, ovary and pancreas. To determine whether Tregs 
are similarly immunosuppressive in patients with cutaneous SCC, fluorescence-activated cell 
sorting was used to extract Tregs and effector T cells from samples of tumour and peripheral blood 
obtained from patients attending the dermatology clinic for excision of their primary cutaneous 
SCC. Flow cytometry analysis demonstrated there were significantly more FoxP3+ Tregs in the 
peritumoral infiltrate (16.8% of T cell infiltrate ± 9.4%) than in the peripheral blood (3.8% ± 
2.3%). Functional assays showed that CD4+CD25hi Tregs cultured with autologous CD4+CD25lo 
effector T cells from the same tissue compartment suppressed cell proliferation with a mean 
suppression of 59.9% ± 20.5% in blood and 54.5% ± 26.5% in the corresponding tumours). The 
results indicate that peritumoral Tregs, which accumulate in human cutaneous SCC, suppress 
immune responses and thus may lead to the development and persistence of these tumours.
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Association between serum level of folic acid and methylenetetrahydrofolate reductase 
(MTHFR) gene polymorphisms in BCC patients
Aleksandra Lesiak1, Michal Sobjanek2, Adam Wlodarkiewicz2, Karolina Wodz-Naskiewicz3, 
Rafal Pawliczak3, Michal Rogowski-Tylman1, Anna Sysa-Jedrzejowska1, Joanna Narbutt1 
1Department of Dermatology and Venerology, University of Lodz,  Poland, 2Department of 
Dermatology, Venerology and Alergology, Univeristy of Gdansk, Gdansk, Poland, 3Department of 
Immunopathology, Medical University of Lodz, Lodz, Poland
Basal cell carcinoma (BCC) is the most common cancer in Caucasian population. Their 
pathogenesis is not fully known, however genetic and environmental factors are relevant. 
Among genetic disturbances, genes encoding intracellular signalling pathways and regulatory 
proteins are considered as the most important. Ultraviolet radiation (UVR) is one of the major 
factors involved in skin photocancerogenesis.. Some data indicate that folates, especially their 
metabolite 5-metyltetrahydrofolate, can protect DNA from UV-induced strand breaks. In folate 
metabolic pathway a key role plays an enzyme -methylenetetrahydrofolate reductase (MTHFR). 
Aim: Thus the aim of present study was to assess the folic acid serum level in basal cell carcinoma 
(BCC) patients as well as to analyse its correlation with the occurrence of 677 C/T and 1286 A/C 
polymorphisms in MTHFR gene . Material and method: The study group consisted of 79 BCC 
patients and 46 healthy subjects. In all subject folic acid serum level and MTHFR polymorphisms 
were assessed. Results: Serum level of folic acid in control group was significantly higher than 
in BCC patients (median 16,5 mg/l vs. 9,6mg/l). It was found, that among BCC patients with 
1286A/C MTHFR polymorphism and the presence CC genotype, the serum level of folic acid was 
lower when compared to patients with AA or AC genotype (p<0.001). No correlation between 
the serum level of folic acid and 677 C/T polymorphisms in MTHFR gene was found.(p>0.05).
Conclusion: The obtained results indicate that alteration in folates pathway at genetic and 
molecular level play a role in the development of BCC.
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Ultraviolet A radiation plays a role in the pathogenesis of malignant melanoma through 
involvement of the Warburg effect in skin reconstructs
York Kamenisch, Evi Maczey, Anna Katharina von Thaler, Martin Röcken, Friedegund Meier, Mark 
Berneburg University Tübingen, Tübingen, Germany
Malignant melanoma is a highly aggressive skin tumor. While recent studies elegantly demonstrated a 
causative role for a single high dose of ultraviolet (UV)B (280-320nm) radiation in the development of 
melanoma, the role of UVA (320-400nm) in the pathogenesis of human melanoma remains unclear. 
We could previously show, that UVA irradiated melanoma cell lines increase lactate levels 
and increase levels of the transketolase-like-1 enzyme, which is an important enzyme of the 
pentose phosphate pathway. These findings reason for an increase of aerobic glycolysis after 
repetitive UVA exposure. This phenomenon is characteristic for many carcinomas and is 
known as the Warburg effect. To gain more insight in the role of UVA in the pathogenesis of 
melanoma it is important to focus investigations on model systems resembling the human 
skin better than single cell cultures. To address this issue, we constructed in vitro models of 
human skin, either employing melanocytes or melanoma cells of different malignancies and 
exposed them to sublethal, repetitive UVA irradiation. During repetitive UVA irradiation, levels 
of lactate and glucose were measured and upon completion of UVA treatment transketolase 
activity and the levels of ß Galactosidase associated senescence (ß-Gal) was measured. 
We found, that UVA influences glucose consumption and lactate production in skin models 
with melanocytes and melanoma cell lines. Furthermore, UVA elevates transketolase activity in 
melanocytic skin models compared to melanoma skin models. In addition to this, UVA alters 
ß-Gal. These findings support the hypothesis that repetitive UVA irradiation may also play a role 
in the pathogenesis of melanoma.
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Multiple basal cell carcinoma: monoclonal or polyclonal origin?
Cristina Ramos1, Chaxiraxi Medina1, Jonay García-Luis1, Ricardo Fernández1,2, José Suárez1,2, 
Félix Machín1 1Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 
S/C de Tenerife, Spain, 2Servicio de Dermatología, Hospital Universitario Nuestra Señora de 
Candelaria, S/C de Tenerife, Spain
Basal cell carcinoma (BCC) is the most common type of skin cancer. In some patients, 
this tumour appears multiple times in their lives (mBCC). The aim of this study is to 
analyze patients with mBCC in search of evidences of whether the origin of their mBCCs is 
monoclonal or polyclonal. Most mBCCs are expected to have a loss of hererozigosity (LOH) 
for the tumour suppressor gene PTCH1. We have laser-microdissected mBCCs from formalin-
fixed samples and analysed heterozygosity of both tumour and surrounded healthy tissue 
for a set of highly prevalent single nucleotide polymorphism (SNP) within the PTCH1 gene. 
We have studied distinct separated in time and space tumours. We have found that a set 
of patients present a common LOH profile for all their tumours. Importantly, it appears 
that the allele lost is always the same for almost all tumours within a patient. For example, 
a patient with heterozygosity for three SNPs within the PTCH1 gene (A/G, C/T, C/G) gave a 
unique LOH pattern (A, C, C) for his seven tumours obtained between 2002 and 2008. 
Our preliminary data suggest that, al least in some patients, the same pattern of LOH for PTCH1 
in all tumours is followed in the carcinogenesis of their mBCC, thus indirectly confirming their 
monoclonality and implying that they could have developed the very same clonal changes in 
different locations and dates. Whether an improbable organ-specific way of metastasizing or a 
different biological mechanism could explain these findings remain to be elucidated.
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Altered microRNA expression in mycosis fungoides
Joanna Maj1, Alina Jankowska-Konsur1, Anna Sadakierska-Chudy2, Adam Reich1 1Department 
of Dermatology, Venereology and Allergology; Wroclaw Medical University, Wroclaw, Poland, 
2Department of Forensic Medicine, Molecular Techniques Unit; Wroclaw Medical University, 
Wroclaw, Poland
MicroRNAs are small non-coding RNA molecules involved in the regulation of various 
physiological and pathological processes. The altered expression of different microRNAs was 
observed in both, solid tumors and hematological malignancies. The aim of our study was to 
investigate expression of several microRNAs in early and advanced mycosis fungoides (MF). The 
biopsies were obtained from 43 patients with MF (18 early MF and 25 advanced MF) and 23 
healthy volunteers. After microRNA isolation, reverse transcriptase reactions was performed, 
followed by cDNA amplification. Following microRNA were analyzed: miR-15a, miR-16, miR-
155, let-7a, let-7d, let-7f. The relative amount of each microRNA was normalized according 
to the reference RNU48 level. Among studied microRNA, MiR-155 was only found to be 
overexpressed in MF compared to healthy controls. Early MF showed higher levels of all analyzed 
miRNAs after normalization against RNU48 level. Furthermore, metastatic MF demonstrated 
significantly lower concentrations of let-7a, let-7d and let-7f when compared to MF limited to 
the skin. The univariative survival analysis revealed that better prognosis was connected with 
higher expression of miR-15a and let-7a. Based on the multivariative Cox’s regression model the 
level of let-7a expression was found as an independent prognostic indicator. Altered expression 
of studied microRNAs and the differences between early and advanced MF may suggest that 
microRNAs play a significant role in MF pathogenesis. It seems that microRNA could serve as 
potential therapeutic targets in the future.
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TLR-mediated inflammation promotes tumor progression of B16-melanoma
Ellen Brenner, Regina Heidenreich, Susanne Weidemann, Cornelia Grimmel, Tilo Biedermann, 
Martin Röcken Dermatology, University of Tuebingen, Germany
Toll-like receptor (TLR) stimulation was primarily developed as anti-tumor therapy. More recent 
data implicated TLR stimulation in the transition of pre-malignant lesions into cancer and 
outgrowth of metastases. Thus, TLR signaling can either promote or inhibit tumor growth and 
metastasis. Yet, the role of TLR on tumor progression and seeding of metastatic tumor cells is 
still unclear. Subcutaneous injection of 1.5 106 B16 melanoma cells significantly induced TLR2, 
-4, -7 and -9 expression, with different expression patterns on day 5, 12 and 14. On day 5 TLR2 
was dominant, while TLR7 dominated on day 14. To determine whether this signaling was of 
biological relevance we transplanted the tumor into MyD88.ko-mice, deficient in TLR-signaling. 
MyD88.ko-mice had a 60 % reduced tumor growth, and 4/18 tumors did not grow. As a second 
model we analyzed seeding of B16 melanoma cells after intravenous injection and found after 
24 and 48 hours a significant up-regulation of TLR4 and TLR7 in the lung tissue. As negative 
control we injected equal numbers of mononuclear cells. We used this model to identify the 
compartment responsible for the increased TLR expression. We separated tumor cells from lung 
tissue cells via FACS, 24 and 48 hours after intravenous injection of DiD-labeled B16 melanoma 
cells. The data revealed host derived cells as the main source of TLR expression in metastatic 
lungs. Thus, by initiating TLR-signaling tumor cells may create a milieu that promotes their own 
seeding.
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IL-1 signaling and inflammasomes in chemically induced skin cancer
Amir S. Yazdi2,1, Stefan K. Drexler1, Jürg Tschopp1 1Department of Biochemistry, University of 
Lausanne, Lausanne, Switzerland, 2Department of Dermatology, Tübingen, Germany
The central role of chronic inflammation in the promotion of tumor growth is supported by both 
experimental and epidemiological evidence. However, the molecular mechanisms converting 
an inflammatory reaction into a tumor-promoting environment are still largely elusive. In this 
study, we report the dependency of chemically induced epithelial skin cancer on IL-1R signaling 
and on caspase-1, the protease activating IL-1β. The incidence and number of DMBA-induced 
papillomas were significantly lower in IL-1R-deficient mice or caspase-1-deficient mice 
compared to wild type littermates. In order to further investigate the role of the inflammasome 
in chemically induced skin cancer we induced tumor growth in ASC deficient mice. Unlike 
IL-1R-/- or caspase-1-/- mice, ASC deficient animals show no significant difference to wild-
type littermates. This discrepancy might be due to the dual function of ASC as a known tumor 
suppressor in the tumor cells versus ASC being a crucial adaptor protein for IL-1β-activation, 
as ASC deficient keratinocytes proliferate more. Taken together, our results implicate a role of 
IL-1 signaling for tumor-growth and investigate the mechanistic implication of inflammasome 
proteins, with particular focus on their function in tumor cells compared to the inflammatory 
tumor-microenvironment.
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Transcriptome Sequencing Demonstrates that Human Papillomavirus Is Not Active in Cutaneous 
Squamous Cell Carcinoma
Sarah Arron, J. Graham Ruby, Eric Dybbro, Don Ganem, Joseph DeRisi University of California, 
San Francisco, San Francisco, CA, USA
β-Human papillomavirus (β-HPV) DNA is present in some cutaneous squamous cell carcinomas 
(cuSCCs), but no mechanism of carcinogenesis has been determined. We used ultra-high-
throughput sequencing of the cancer transcriptome to assess whether papillomavirus transcripts 
are present in these cancers. In all, 67 cuSCC samples were assayed for β-HPV DNA by PCR, 
and viral loads were measured with type-specific quantitative PCR. A total of 31 SCCs were 
selected for whole transcriptome sequencing. Transcriptome libraries were prepared in parallel 
from the HPV18-positive HeLa cervical cancer cell line and HPV16-positive primary cervical and 
periungual SCCs. Of the tumors, 30% (20/67) were positive for β-HPV DNA, but there was no 
difference in β-HPV viral load between tumor and normal tissue (P=0.310). Immunosuppression 
and age were significantly associated with higher viral load (P=0.016 for immunosuppression; 
P=0.0004 for age). Transcriptome sequencing failed to identify papillomavirus expression in any 
of the skin tumors. In contrast, HPV16 and HPV18 mRNA transcripts were readily identified 
in primary cervical and periungual cancers and HeLa cells. These data demonstrate that 
papillomavirus mRNA expression is not a factor in the maintenance of cuSCCs.
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The tumor suppressor role for Gasc1 in skin tumor after two-stage chemical induction protocol.
Yumi Hata1, Kyoko Fujiwara1, Maki Ikeda1, Makoto Kimura1, Motoaki Kataba1, Jun Igarashi1, 
Tadashi Terui1, Johji Inazawa2, Hiroki Nagase3 1Nihon University school of medicine, Tokyo, 
Japan, 2Tokyo Medical and Dental University, Tokyo, Japan, 3Chiba cancer center, Chiba, Japan
It has become increasingly apparent that epigenetic changes including histone modifications are 
critical mechanism for cancer development. Several groups demonstrated that GASC1 (KDM4C: 
lysine (K)-specific demethylase 4C) encodes a histone demethylase catalyzing lysine (K) of histone, 
specifically K9 and K36 of histone H3. In addition, GASC1 has been reported to be within an 
amplicon at 9p23-24 frequently in esophageal cancer and overexpressed in undifferentiated ES 
cells and breast cancer. Since these reports suggest the involvement of GASC1 in carcinogenesis, 
we generated Gasc1 knockout mice to analyze the role of GASC1. It was shown that heterozygous 
(Het) mice developed without any remarkable phenotype, while homozygous mice are lethal. 
Back skins of the progenies, including 28 Het and 24 wild-type mice, were treated with the 
two-stage chemical induction protocol. Het mice showed significantly lower incidence and 
multiplicity of both benign and malignant skin tumors than those in wild-type. To identify genes 
involved in skin tumor resistance in the Het, expression profiling of the skin samples obtained 
from Het and wild-type mice were analyzed using Agilent whole genome microarrays. We found 
that in general cell adhesion related genes were up-regulated and hormonal and immune system 
related genes were down-regulated in Het mice compared to those in wild-type. Those may be 
candidates for the genes mediating the function of GASC1.We are now analyzing methylation 
status of histone H3K9 and GASC1 binding at the promoter region of those candidate genes to 
find direct involvement of Gasc1 during skin tumor carcinogenesis.
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Identification of Differentially Methylated Genes in Cutaneous Squamous Cell Carcinoma from 
Epidermolysis Bullosa Patients and Normal Population
Nikol Mladkova1, Angela McHugh2, Thomas Down3, Vardhman Rakyan1, Charlotte Proby2, 
Catherine Harwood1 1Blizard Institute of Cell and Molecular Science, Queen Mary University 
London, UK, 2Surgery and Molecular Oncology, Ninewells Hospital, University of Dundee, UK, 
3The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, UK
Cutaneous Squamous cell carcinoma represents the second most common malignancy, yet its molecular 
background remains largely elusive. Modern genome-wide profiling approaches may contribute to better 
understanding of molecular events corroborating oncogenic changes. We applied genome-wide methylation 
by microarray hybridisation to detect differentially methylated genes in squamous cell carcinoma cell lines. 
Materials and Methods: We compared genome-wide DNA methylation patterns of three primary normal 
skin cell lines, three primary tumour cell lines derived from epidermolysis bullosa (EB) patients), six 
primary tumour cell lines derived from non-EB patients, using Illumina HumanMethylation27 platform. 
Results: Comparison of skin and tumour methylation values revealed 371 differentially methylated 
genes (pvalue<0.01). Differentially methylated genes included several cancer-related genes (WT1, 
CDKN2A, TP53I3, STAT5B, ADORA3, H2AFY) and homeobox genes. Positional signature of this 
geneset discovered cytogenetic regions 17q11 and 4p16 as significant for epigenetic silencing 
(pvalue <0.05). Detection of methylation differences between EB and non-EB derived tumours 
showed 37 genes (pvalue<0.01), including cancer, cardiac and neurological diseases-related genes. 
Methylation profile was substantially different for EB patients-derived tumour cell lines as detected with 
clustering analysis. This is the first study that systematically detects methylation differences between 
normal skin and squamous cell carcinoma. Our results underscore the potential of dysregulated 
methylation in the onset and progression of skin cancer and warrant further in-depth studies to elucidate 
this role. In addition, our results suggest EB-derived skin tumours may represent a distinct tumour type.
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Study Of MYC Chromosomal Aberrations And Their Correlation With Human Papilloma Virus 
In Penile Squamous Cell Carcinomas
Emili Masferrer1, Carla Ferrándiz-Pulido2, Belén Lloveras1, Magalí Masferrer3, Blanca Espinet3, 
Marta Salido1, Maria Rodríguez-Rivera3, Vicente García-Patos2, Ramon Maria Pujol3, Agustí 
Toll3 1Hospital de Sant Joan Despí-Moisès Broggi, Sant Joan Despí, Spain, 2Hospital de la Vall 
d’Hebron, Barcelona, Spain, 3Hospital del Mar, Barcelona, Spain, 4Universitat Politècnica de 
Catalunya, Barcelona, Spain
The aim of this study was to determine the presence of MYC gains and amplifications by 
fluorescence in situ hybridization (FISH) and its correlation with the presence of HPV infection 
in different stages of the penile squamous cell carcinoma (PSCC) carcinogenesis. We included 
77 patients with PSCC treated between 1987 and 2010 and 10 samples from healthy controls 
(children circumcision samples). We assessed HPV serotypes for each sample by PCR technique. 
FISH was performed on tissue microarrays (TMAs) and evaluated in normal mucosa of every case 
(the 77 cases), in situ carcinoma (8 cases), invasive tumors (69 cases) and in metastases (5 cases). 
The percentage of cases with MYC gains and amplifications in PSCC increases in correlation with 
tumoral progression: Gains were observed in 1% of normal samples, 32% of in situ carcinomas, 
74% of invasive tumors and 100% of the metastases. Amplifications were detected in none of the 
normal samples, 2% of in situ lesions, 10% of invasive tumors and 100% of the metastases. We 
detected HPV in 45% of PSCC (genotype 16; 86%). We did not find a correlation between MYC 
gains/amplifications and HPV infection. A good correlation between the presence of numerical 
aberrations in MYC and the progression of PSCC was observed. However, MYC gains seem to be 
independent of HPV infection status.
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Antagonising the CXCR4-CXCL12 chemokine pathway inhibits sunlight-induced skin cancer 
formation by altering the number and distribution of mast cell in skin and lymph node
Seri N.E Sarchio1,3, Gary M. Halliday1, Scott N. Byrne1,2 1Discipline of Infectious Diseases and 
Immunology, Sydney Medical School, University of Sydney, NSW, Australia, 2Discipline of 
Dermatology, Faculty of Medicine, Sydney Medical School, NSW, Australia, 3Department of 
Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 
Selangor, Malaysia
The UV radiation in sunlight is a potent immunosuppressant and widely acknowledged as the 
primary cause of skin cancer. However, the mechanism by which UV suppress the immune 
system is not fully understood. We recently discovered that UV-induced mast cell migration 
from the skin to the draining lymph nodes is one of the first steps in the induction of immune 
suppression. Upon exposure to UV radiation, dermal mast cells migrated to the B cell areas of 
the draining nodes. Mast cells express CXCR4 and UV exposure up-regulated the expression of 
CXCL12 ligand by lymph node B cells. Blocking the CXCR4-CXCL12 chemokine pathway using 
AMD3100 abrogated immune suppression in UV exposed mice. To determine the significance of 
this event to the formation of skin tumours, C57BL/6 mice were supplied with AMD3100 in their 
drinking water and then exposed to 250mJ/m2 solar simulated UV 4d/wk for 30wks. Control mice 
received UV only. Tumour incidence, size, number and multiplicity were then observed for the 
next 10wks. A 100% tumour incidence was observed in UV control groups, while administration 
of AMD3100 supressed the total tumours incidence by 55% (p<0.05). Although the tumour 
diameter in AMD3100 treated mice were larger (p<0.05), tumour burden in control mice 
showed a significant correlation with time (p<0.0001) compared to AMD3100 treated group 
(p=0.2344). Our results indicate that intefering with UV-induced CXCL12 by antagonizing the 
specific receptor CXCR4 significantly inhibits skin tumour developemnt. These observation direct 
attention to the CXCR4-CXCL12 chemokine pathway as a novel target in skin cancer prevention.
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Chromosomal aberrations in gray zone lymphomas
Franziska C Eberle1,2, Itziar Salaverria3, Christian Steidl4, Thomas A Summers Jr1, Stefania 
Pittaluga1, Susana Ben Neriah4, Jaime Rodriguez-Canales1, Liqiang Xi1, Kris Ylaya1, David 
Liewehr5, Kieron Dunleavy6, Wyndham H Wilson6, Stephen M Hewitt1, Mark Raffeld1, Randy 
D Gascoyne4, Reiner Siebert3, Elaine S Jaffe1 1Lab of Pathology, Center for Cancer Research, NCI, 
National Institutes of Health, Bethesda, MD, USA, 2Dept of Dermatology, Eberhard Karls University 
Tuebingen, Germany, 3Institute of Human Genetics, Christian-Albrechts-University Kiel & University 
Hospital Schleswig-Holstein, Campus Kiel, Germany, 4Dept of Pathology & Laboratory Medicine, Centre 
for Lymphoid Cancers & Centre for Translational & Applied Genomics (CTAG), Vancouver, BC, Canada, 
5Biostatistics & Data Management Section, Center for Cancer Research, National Institutes of Health, 
Bethesda, MD, USA, 6Metabolism Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA
Gray zone lymphomas (GZLs) demonstrate transitional morphologic and immunophenotypic features 
between classical Hodgkin’s lymphoma (CHL) and diffuse large B-cell lymphoma, especially primary 
mediastinal large B-cell lymphoma (PMBL). A number of common genetic aberrations have been 
reported in PMBL and CHL further underscoring their close relationship. Since GZL is a rare and only 
recently described entity, genetic data are limited for these unusual cases. In this study, we analyzed 
cases of GZL, mediastinal composite lymphoma and mediastinal synchronous/metachronous lymphoma 
by fluorescence in situ hybridization to investigate the presence of chromosomal aberrations previously 
identified in the parent entities of PMBL and CHL. Gains including amplifications in 2p16.1 (REL/BCL11A 
locus) were observed in 33% of all patients, whereas alterations affecting the JAK2/PDL2 locus in 9p24.1 
were present in 55%. Further studies revealed rearrangement of the CIITA locus at 16p13.13 in 27% 
of cases. Gains of 8q24 (MYC) were observed in 27% of cases. In line with recent reports describing 
overlapping morphologic, immunophenotypic and epigenetic characteristics among these lymhomas, 
our data on genetic alterations further support a close relationship between GZL, CHL and PMBL.
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In vivo model to study migration of circulating human Sezary cells Hut-78 (CLA+CD4+CCR10+) 
T cells into mouse skin
Catalina Rincón1, Marta Ferran2, Ana Belen Galvan2, Erika Barboza1, Antonio Celada1, Ramon 
M Pujol2, Luis F Santamaria-Babi1,2 1Biomedical Research Institute (IRB), Barcelona, Spain, 
2Department of Dermatology. Hospital del Mar- Institut Municipal d’Investigació Mèdica (IMIM), 
Barcelona, Spain
CTCL originates from a clonal proliferation of CD4+CLA+ memory T-cells. Little is known about 
the factors that drive a mature T-cell clone to accumulate in the skin. At the moment there is 
a need of in vivo models to study the migration of those cells into cutaneous sites. We have 
established a model to study Hut-78 T cell migration into mouse skin. In Balb/c mice DNFB was 
applied topically on the right ear to and acetone was applied on the left, finally Hut-78 T cells 
are injected i.v. Net ear swelling depended on the number of cells injected and the percentage of 
DNFB applied. DNFB-treated and Hut-78 CLA+ cells injected mice presented a superior net ear 
weight than Hut-78 CLA- cells injected mice, and DNFB-treated mice without human T cells. IVIS 
studies with Hut-78 CLA+ cells demonstrated the presence of fluorescence only in the inflamed 
right ear, even 3 days after i.v. injection. Histology clearly indicated the presence of abnormal 
cells in the right ears. The cutaneous inflammation induced by CLA+ Hut-78 T cells depended 
on GPCR due to sensitivity to PTX. Furthermore injection of Hut-78 CLA+ transfected T cells with 
human CCR10 induced cutaneous inflammation, which directly correlated with their in vivo 
chemotaxis capacity to mouse/human CTACK. Our data indicate that this novel animal model 
may be useful to study the molecular mechanisms of migration to skin, and survival of the human 
HUT-78 cells in vivo.
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Complement Factor B and Complement Component C3 in Cutaneous Squamous Cell Carcinoma
Pilvi Riihilä1, Risto Ala-aho1, Markku Kallajoki2, Reidar Grénman3, Seppo Meri4, Sirkku Peltonen1, 
Juha Peltonen5, Veli-Matti Kähäri1 1Department of Dermatology and Venereology, University of 
Turku and Turku University Hospital, Turku, Finland, 2Department of Pathology, Turku University 
Hospital, Turku, Finland, 3Department of Otorhinolaryngology, Head and Neck Surgery, Turku 
University Hospital, Turku, Finland, 4Haartman Institute, University of Helsinki, Helsinki, Finland, 
5Department of Anatomy and Cell Biology, University of Turku, Turku, Finland
The incidence of cutaneous squamous cell carcinoma (SCC) is increasing globally. Inflammation 
is a typical feature of cutaneous SCC. We have investigated the expression of complement system 
components in cutaneous SCC cell lines (n=7-8) and in normal human epidermal keratinocytes 
(n=5-6) by Affymetrix based expression profiling and quantitative real time RT-PCR (TaqMan). 
In addition, expression of complement components was examined by immunohistochemistry 
(IHC) in tissue arrays generated from cutaneous SCCs (n=49) Bowen‘s disease (n=68) and actinic 
keratoses (n=52). The mean expression level of complement components Complement factor 
B (CFB) and Complement component C3 (C3) mRNAs was increased up to 4-fold and 6-fold, 
respectively, in SCC cells compared to normal keratinocytes. The expression of CFB and C3 
mRNAs was also 10-fold and 4-fold higher, respectively, in SCC tumors (n=6) than in normal 
skin (n=5). IHC of SCC tissue arrays revealed that CFB was specifically expressed by tumor cells 
and the staining intensity increased during tumor progression from premalignant lesions (actinic 
keratoses and Bowen’s disease) to invasive SCCs. Staining for C3 was localized in SCC tumor cell 
surface. The expression of C3 and CFB was also increased in ras-transformed tumorigenic and 
metastatic HaCaT cell line RT-3. The production of CFB and C3 by SCC cells was up-regulated by 
inflammatory cytokines TNF-α and IFN-γ at mRNA level. These results show that cutaneous SCC 
cells express components of the alternative complement pathway, which may play a role in SCC 
progression. These results suggest complement components as potential diagnostic markers and 
therapeutic targets in skin SCCs.
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Identification and genotyping of Human Papillomavirus in a cohort of 73 penile squamous cell 
carcinomas: correlation with pathologic subtypes and p16INK4a
Carla Ferrándiz-Pulido1, Emili Masferrer2, Belen Lloveras3, Ines de Torres1, Javier Hernández-
Losa1, Claudia Valverde1, Santiago Ramon y Cajal1, Ramon M Pujol4, Agustin Toll4, Vicente 
García-Patos1 1Hospital Universitari Vall d´Hebron, Barcelona, Spain, 2Hospital Sant Joan Despí 
Moisès Broggi, Hospitalet de Llobregat, Barcelona, Spain, 3Hospital del Mar-IMIM y Institut Catala 
d’Oncologia, Barcelona, Spain, 4Hospital del Mar-IMIM, Parc de Salut Mar, Barcelona, Spain
We aimed to provide novel data about prevalence of human papillomavirus (HPV) in penile 
squamous cell carcinoma (PSCC) in a Mediterranean population, correlating results with 
p16ink4a immunostaining and histological subtypes.Paraffin-embedded samples of histologically 
confirmed 63 cases of invasive and 10 in situ PSCC were used. HPV detection was done by 
use of PCR with SPF-10 broad-spectrum primers followed by DNA enzyme immunoassay and 
genotyping with a reverse hybridization line probe assay. We also analyzed the expression of 
p16ink4a by immunostaining. We found HPV DNA in 32% of invasive PSCC and 90% of in situ 
PSCC. The most common HPV type was 16 (76%). Prevalence of HPV was significantly associated 
with some histologic subtypes: 100% of basaloid and warty tumors were HPV+, whether only 
22% of common subtypes and none of the verrucous or sarcomatoid subtypes. HPV+ tumors 
were less differentiated than HPV- tumors. Strong immunostaining for p16ink4acorrelated with 
HPV16 infection. Our study shows a considerable prevalence of HPV16 and p16ink4a expression 
in PSCC, consistent with an active role for HPV in interfering in the retinoblastoma pathway. 
However, implication of HPV in determined histological subtypes suggests the involvement of 
different etiological agents and, possibly, alterations in different molecular pathways.
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Vascular endothelial growth factor (VEGF) genotype and serum concentration in Polish patients 
with basal cell carcinoma
Michal Sobjanek1, Monika Zablotna1, Dorota Kozicka1, Igor Michajlowski1, Boguslaw 
Nedoszytko1, Adam Wlodarkiewicz2, Jadwiga Roszkiewicz1 1Department of Dermatology, 
Allergology and Venerology Medical University of Gdansk, Poland, Gdansk, Poland, 2Department 
of Maxillofacial Surgery Medical University of Gdansk, Poland, Gdansk, Poland
The vascular endothelial growth factor (VEGF) plays an important role in physiologic and 
pathologic angiogenesis. VEGF is also overexpressed in various malignancies. Several functional 
single nucleotide polymorphism in the VEGF gene were described. Association between VEGF 
gene polymorphisms with susceptibility to basal cell carcinoma (BCC) has not been studied. 
We evaluated the connection between VEGF gene polymorphisms and BCC susceptibility. To 
study and VEGF serum concentration in patients with BCC. We analyzed VEGF -1154G/A, 
-406T/C,+405C/G polymorphisms using PCR-RFLP and ARMS-PCR in 177 patients with BCC 
and 215 healthy volunteers. The serum concentration of VEGF were measured by an enzyme 
linked immunoassay. We found that -1154 AA genotype frequency was significantly decreased 
(2,3% vs. 17,2%; p=0.002) and -1154 AG increased among patients with BCC in comparison 
with control subjects (63.8% vs 47.9%; p< 0.001). We also observed that VEGF-1154 A allele 
frequency was significantly decreased among patients with BCC in comparison with control 
subjects (34.2 vs. 41.2%, p = 0.05). A significantly reduced risk for BCC was associated with 
-1154 A/A genotype (OR=0,11;CI=0,04-0,32). The -1154 G allele was linked with increased 
risk of BCC (OR=8,83;CI=3,07-25,4). No relationship between -406T/C,+405C/G genotypes and 
occurrence of BCC have been found. Serum level of VEGF were significantly higher in BCC 
patients compared with controls (596.7 vs. 255.9 pg/ml; p<0,0001). Serum level were also 
correlated with tumor size (p<0.001). The present study suggests that -1154G/A polymorphism 
may play a role in the development of BCC.
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Skin cancer development in solid organ transplant recipients: a 2 year interim analysis of the 
Swiss Transplant Cohort Study (STCS)
Mirjam Staubli1, Mark Anliker2, Andreas Arnold3, Robert Hunger4, Werner Kempf1, Emmanuel 
Laffitte5, Anne-Karine Lapointe2, Carlo Mainetti8, Francesco Pelloni9, Markus Streit7, Thomas 
Fehr1, Andreas Serra1, Günther F. Hofbauer1 1University Hospital of Zurich, Zurich, Switzerland, 
2Kantonsspital St. Gallen, St. Gallen, Switzerland, 3University Hospital of Basel, Basel, 
Switzerland, 4University Hospital of Bern, Bern, Switzerland, 5University Hospital of Geneva, 
Geneva, Switzerland, 6University Hospital of Lausanne, Lausanne, Switzerland, 7Kantonsspital 
Aarau, Aarau, Switzerland, 8Ospedale San Giovanni, Bellinzona, Switzerland, 9Lugano, Lugano, 
Switzerland
Organ transplant recipients on long-term drug induced immunosuppression suffer a greatly 
increased life-time incidence of skin cancer, in particular squamous cell carcinoma. Switzerland 
has the highest skin cancer rate in Europe overall. No data on Swiss organ transplant recipients is 
available yet. Since May 2008 all patients who underwent organ transplantation in one of the Swiss 
transplant centers were included in the STCS and followed up amongst others for development 
of skin cancer. All recipients of a solid organ from the start of the STCS till December 2010 were 
included. Data on skin cancer occurrence was validated by independent chart review at the 
Zürich University Hospital. 437 OTR at the Zürich Center were identified for chart review. Data 
on skin cancer was validated for all cases. 31 instances of skin cancer had occurred overall. Out 
of these, 22 were squamous cell carcinoma of the skin, 9 were basal cell carcinoma. In addition 
17 precancerous conditions were found. Median age for OTR with skin cancer was significantly 
higher than for OTR unaffected by skin cancer. Male gender was significantly associated with skin 
cancer risk. The analysis of the STCS data base showed a considerable proportion of OTR already 
affected by skin cancer in the first two years following transplantation. As reported in larger series, 
SCC was most frequent. Risk factors seem age, gender, duration of transplantation, in particular 
a previous transplantation before the index transplantation for inclusion into the STCS database.
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Cationic antimicrobial peptides as novel therapeutic agents for non-melanoma skin cancer and 
infectious skin diseases
Nhung Do-Sydow1, Günther Weindl1, Hans-Christian Korting2, Monika Schäfer-Korting1 1Dept 
of Pharmacology and Toxicology, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany, 
2Dept of Dermatology, Ludwig Maximilians University of Munich, Germany
Cationic antimicrobial peptides (AMP) are known to be toxic to pathogens and exhibit anticancer 
activity although their effect on cutaneous squamous cell carcinoma (SCC) has not been investigated 
before. Here we studied the cytotoxic effects of four cationic AMP (melittin, cecropin A, protegrin-1, 
histatin 5) on SCC cell lines and normal human keratinocytes (NHK). Additionally, antifungal 
activity was tested on two clinical isolates and two laboratory strains of Candida albicans. Using 
MTT assay, melittin, in particular, was highly cytotoxic (IC50) against SCC12 (0.41µM) and SCC25 
(0.59µM) cell lines with weak selectivity over NHK (1.35µM). Similar results were obtained by 
BrdU incorporation. Importantly, melittin showed strongly improved antitumour efficacy compared 
to 5-fluorouracil (5-FU) and maximal inhibition of tumour growth. No obvious synergistic effects 
were evident between melittin and 5-FU. Determination of minimum inhibitory concentrations 
for C. albicans by microplate dilution tests revealed that melittin was superior to amphotericin 
B and showed the most effective antifungal activity in vitro. Next we aimed to investigate skin 
penetration of peptides following topical application to human skin ex vivo using a nontoxic 
cationic peptide with similar physicochemical properties. Lissamine Rhodamine B labelled low 
molecular weight protamine (LMWP) was rapidly taken up by NHK and appeared to be toxic only 
at high concentrations. Yet, a functional stratum corneum prevented LMWP penetration into viable 
epidermis. In conclusion, cationic AMP may represent innovative agents for SCC and infectious 
skin diseases but are challenging regarding skin absorption. Consequently, incorporation into 
nanocarrier delivery systems might facilitate skin penetration.
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Defining and targeting differentiation pathways in basal cell carcinoma
Antisar Benketah, Girish Patel, Paul Bowden Cardiff University, Cardiff, UK
Basal cell carcinoma (BCC) is a common tumour mostly localised in hair bearing skin. While 
the hair follicle elegantly demonstrates both inward and upward differentiation patterns, BCC 
differentiation and its regulation remain unclear. We hypothesize that BCC, like the hair follicle, 
demonstrates differentiation influenced by mesenchymal cells? To test this hypothesis, 20 human 
BCC samples were taken to study differentiation pattern and regulatory signals within the 
tumour. Normal hair bearing skin was used as positive and negative control. All BCC samples 
expressed the outer root sheath (ORS) keratins, K6 and K17, consistent with over expression 
the sonic hedgehog signalling pathway and nuclear translocation of the transcriptional regulator 
Gli1. Similarly, all BCC samples demonstrated K19 expression, which maintained its’ relative 
incongruent relationship with cell proliferation. In seven samples tested, there was also 
expression of the ORS and ORS companion layer keratins K16 and K75 respectively, in a sub-
population of cells within the tumour mass; coinciding with nuclear translocation of NFIL-6 
(CEBP-β). Those BCC samples expressing K16 and K75, also expressed the inner root sheath 
keratin K26 but not K28 in a small sub-population of tumour cells. In contrast, none of the 
BCC samples demonstrated expression of the early hair shaft keratins K31, K32 and K81 nor the 
transcriptional regulator GAD-153. Thus BCC reveal multiple hair follicle differentiation patterns, 
demonstrating a hierarchical organisation. These findings are consistent with the cancer stem cell 
model of tumour growth and support the potential existence of tumour initiating cells (cancer 
stem cells) within BCC.
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Protein tyrosine phosphatase receptor type delta (PTPRD) stable knockdown leads to increased 
proliferation in cSCC-derived keratinocytes
Malgorzata Romanowska1, Sally R. Lambert2, John P. Foerster1, Karin J. Purdie2, Catherine 
A. Harwood2, Charlotte M. Proby1 1Cancer Research UK Skin Tumour Laboratory, Centre for 
Oncology and Molecular Medicine, Ninewells Hospital & Medical School University of Dundee, 
Dundee, UK, 2Centre for Cutaneous Research, Barts and the London Queen Mary’s School of 
Medicine, London, UK
Cutaneous squamous cell carcinomas (cSCC) are amongst the most common human malignancies 
and acquire a mutational spectrum reflecting gross UV-radiation damage. Defining ‘driver’ genetic 
events is challenging because primary cSCCs are the most highly mutated of all human cancers (R. 
Cho, in press). Our initial genetic screen identified deletions in the protein tyrosine phosphatase 
receptor type D (PTPRD) gene in 15% of all, and 40% of poorly-differentiated, cSCC. Deletion 
at the PTPRD locus strongly associates with metastasis (p=0.007). Sequencing of PTPRD in cSCC 
revealed a high frequency (37%) of coding region mutations. PTPRD is proposed as a tumour 
suppressor gene, however the functional significance of these genetic alterations is unclear. 
Using our in-house antibody, endogenous PTPRD protein was detected in primary 
keratinocytes and fibroblasts, and in cSCC-derived keratinocytes. IHC in normal skin 
showed a membrane-associated, polarised pattern in the basal layers. Well-differentiated 
cSCC showed a similar pattern with immunoreactivity associated with tumour leading edge. 
Poorly-differentiated cSCC showed strong but dysregulated immunoreactivity of a diffuse 
pattern. Cell lines harbouring shRNA specific to PTPRD sequence (sh1 and sh2) show stable 
knockdown of PTPRD with Q-PCR and Western Blot. PTPRD-shRNA cells show morphological 
changes and exhibit increased proliferation, while cell viability remains similar to control. 
We show PTPRD protein to be abundant in poorly differentiated cSCC but with loss of its 
membrane-associated location. Knockdown of PTPRD leads to increased proliferation of 
keratinocytes. Further studies are underway to elucidate the function of the protein and its role 
in cSCC pathogenesis.
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The Expression Of Collagen XVII Is Upregulated In Invasive Colon Adenocarcinomas
Jyri Moilanen1, Erkki Syväniemi2, Tiina Hurskainen1, Raija Sormunen3,4, Stefanie Löffek5, Claus-
Werner Franzke5, Leena Bruckner-Tuderman5, Kaisa Tasanen1, Helena Autio-Harmainen2 1Dept 
of Dermatology, and Oulu Center for Cell-Matrix Research, University of Oulu, Finland, & Clinical 
Research Center, Oulu University Hospital, Finland, 2Department of Pathology, University of Oulu, 
Finland, and Oulu University Hospital, Finland, 3Biocenter Oulu, Finland, 4Dept of Pathology, 
University of Oulu, Finland, 5Dept of Dermatology, Univ Medical Center Freiburg, Germany
Collagen XVII is a hemidesmosomal protein that connects the stratified epithelia of the skin to the 
underlying basement membrane. Similarly to its binding partners, a6b4-integrin and laminin-332, 
collagen XVII has been linked to the pathogenesis of squamous cell carcinoma (SCC). Laminin-332 
and a6b4-integrin are involved in the pathogenesis of colorectal cancer (CRC) which prompted us to 
investigate if collagen XVII also takes part in colon carcinogenesis. Immunohistochemical stainings 
of 36 cases of invasive human colon adenocarcinomas and tubular adenomas showed that collagen 
XVII was expressed in malignant as well as in normal colon epithelial cells. In situ hybridization 
demonstrated strong collagen XVII mRNA signal in invasive front and immunoelectron microscopy 
showed gold immunolabeling concentrating to the invasive tip of the malignant cells. Quantitative 
analysis by laser capture microdissection method and qPCR of two normal mucosal samples and 
five CRC samples of different grades showed that collagen XVII mRNA expression levels were 
highly elevated in CRC samples. Western blot analyses confirmed the result in protein level. qPCR 
analysis of four different colon carcinoma cell lines revealed that collagen XVII was produced 
100-times more efficiently in CaCO-2 and HCT-116 cell lines than in COLO-741 and RKO. Our 
findings show that collagen XVII expression is up-regulated in CRC and may thus participate in CRC 
invasion. However, further studies are required to clarify if collagen XVII plays a similar role both 
in CRC and SCC pathogenesis.
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Common alterations of Claudin-1, Claudin-4 and ZO-1 in squamous cell carcinoma, its 
precursors and sun-exposed skin but specific alterations of Occludin in SCC: Relevance for 
resistance to apoptosis
Susanne Rachow1, Ulrich Ohnemus1, Michaela Zorn-Kruppa1, Nina Kirschner1, Claudia Bohner1, 
Sabine Vidal-y-Sy1, Ewa Wladykowski1, Peter von den Driesch3, Jürgen Eberle2, Ingrid Moll1, 
Johanna Brandner1 1University Hospital Hamburg-Eppendorf, Hamburg, Germany, 2Charité 
Berlin, Berlin, Germany, 3Clinical Center Stuttgart, Bad Cannstatt, Germany
Tight junction proteins play a role in several cellular functions, including barrier function, cell 
polarization, differentiation and proliferation and are known to be altered in various epithelial 
tumors. We analysed the presence and distribution of the TJ proteins Claudin-1 (Cldn-1), Cldn-4, 
Occludin, ZO-1 and JAM-A in epidermal squamous cell carcinoma (SCC), keratoakanthomas, 
actinic keratosis and Bowens disease, as well as in sun-exposed and non-sunexposed skin. We 
show that a broader localization of ZO-1 and Cldn-4 as well as a down-regulation of Claudin-1 
in the lowermost layers is frequently found in all tumor entities investigated as well as in sun-
exposed skin, hinting for a common alteration due to chronic UV irradiation. In contrast, a 
complete loss of Occludin is found much more frequently in SCCs than in its precursors or in 
sun-exposed skin. Proliferation assays did not show a clear influence of the level of Occludin on 
cell proliferation but apoptosis assays revealed a reduced susceptibility for induction of apoptosis 
by TRAIL in Occludin-deficient keratinocytes which argues for a role of Occludin in the extrinsic 
pathway of apoptosis in keratinocytes. Because a downregulation of Occludin is also observed 
in SCCs from other origins, we suggest that this may be a common principle in SCC pathogenesis 
and could be a target for therapeutical intervention.
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Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia
Elisa Zavattaro1, Alberto Peretti1, Marco De Andrea2,1, Cinzia Borgogna1,3, Davide Rossi1, Antonio 
Ramponi1, Gianluca Gaidano1, John Doorbar3, Enrico Colombo1, Marisa Gariglio1 1Department 
of Clinical and Experimental Medicine, Medical School of Novara, Novara, Italy, 2Department of 
Public Health and Microbiology, Medical School of Turin, Turin, Italy, 3Division of Virology, MRC 
National Institute for Medical Research, London, UK
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western 
nations. These patients can be considered as immunosuppressed individuals because their 
immune system is often compromised by the transformation process affecting B cells and the 
pharmacological treatment of the disease. b-HPV types are widespread in the general population 
but, in immunosuppressed and Epidermodysplasia Verruciformis patients, these viruses can 
spread unchecked and have been implicated in the development of NMSC. In this study, we have 
investigated for the first time the incidence of skin cancer and its relationship with b-HPV infection 
in a consecutive series of 320 CLL patients presenting for initial evaluation at our institution 
between June 1996 and June 2010. Thirtytwo patients developed NMSC with many recurrences 
in some cases (50 skin biopsies were available in total). Correlations between development 
of skin cancer and clinicopathological features have been evaluated. b-HPV infection in skin 
biopsies has been investigated by PCR and immunohistochemistry to detect expression of viral 
proteins such as E4 and L1, with in house polyclonal antibodies, and viral genome amplification 
by FISH. MCM staining was performed as a marker of cell proliferation. Epithelial cells displaying 
the classical β-HPV-induced cytopathic effects, already demonstrated in skin cancer from OTR 
patients, were visualized in some tumors from CLL patients. Accordingly, L1 expression was 
observed in the area where some morphological differentiation of the squamous epithelium was 
still evident. Overall, our data show enhancement of b-HPV activity in CLL skin cancer similar 
to what is known for OTR.
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Tumor Cell Associated Expression of Receptor Tyrosine Kinase EphB2 in Cutaneous Squamous 
Cell Carcinoma
Mehdi Farshchian1, Risto Ala-Aho1, Elina Siljamäki1, Liisa Nissinen1, Reidar Grénman2, Juha 
Peltonen3, Veli-Matti Kähäri1 1Department of Dermatology, and Medicity Research Laboratory, 
University of Turku, Turku, Finland, 2Department of Otorhinolaryngology, Head and Neck 
Surgery, Turku University Hospital, Turku, Finland, 3Department of Anatomy and Cell Biology, 
University of Turku, Turku, Finland
Cutaneous squamous cell carcinoma is the second most common form of skin cancers with 
high potential ability to metastasis which may be curable with early recognition.The Eph/ephrin 
family as the largest member of receptor tyrosine kinases has recently emerged in tumorigenesis 
and tumor invasion. We have studied the role of Ephrins and Eph receptors in cutaneous SCC. 
Affymetrix based expression profiling of primary (n=5) and metastatic (n=3) SCC cell lines for 
entire Eph and Ephrin gene families revealed high expression of EphB2 mRNA in SCC cells, 
whereas expession was low in primary epidermal keratinocytes from skin of healthy individuals 
(n=5). Quantitative RT-PCR confirmed significant up-regulation of EphB2 mRNA levels in 
cutaneous SCC cell lines, as compared to normal epidermal keratinocytes. Western blot analysis 
of biotinylated cell surface proteins, as well as indirect immunofluorescence showed presence 
of EphB2 on all SCC cell lines, but not on surface of normal keratinocytes. Moreover, tumor cell-
specific expression of EphB2 was observed by immunohistochemistry of cutaneous SCC tissue 
sections. Stimulation of the EphB2 receptor with the EphrinB2 ligand induced early activation of 
the ERK1/2 and p38 MAPK in cutaneous SCC cells in culture. These findings identify EphB2 as a 
novel biomarker for cutaneous SCC and suggest a role for EphB2 in progression of these tumors.
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Tumor-specific T helper 1 (Th1) cells prevent epithelial-mesenchymal transformation of cancers 
in vivo
Thomas Wieder, Heidi Braumüller, Mohamed Alkhaled, Karin Schilbach, Martin Röcken 
University Medical Center, Tübingen, Germany
The immune system is capable of inducing tumor dormancy which depends on two cytokines, 
interferon-gamma (IFN-γ) and tumor necrosis factor (TNF). RIP1-Tag2 mice develop islet cancer 
due to expression of the viral oncoprotein Tag2. We analyzed the effects of IFN-γ- and TNF-
producing T helper 1 (Th1) cells on the differentiation and proliferation of developing cancers. 
Analysis of the proliferation marker Ki67 in vivo and of isolated tumor cells showed that Tag-
specific Th1 cells suppressed proliferation by > 70%. As differentiated cells proliferate only poorly, 
we investigated the effect of Th1 cells on the differentiation markers of the islets synaptophysin, 
insulin and glucose transporter 2 (Glut2). Within 12 weeks, cancers of sham-treated mice lost > 
90% of the late differentiation marker Glut2, about 50% failed to produce insulin. In contrast, 
tumor cells from Th1 cell-treated mice fully preserved their functional phenotype (Syn+, Ins+, 
Glut2+). To determine whether differentiation of the cells affected the metastatic potential of 
the tumor cells, we injected isolated tumor cell lines from sham- or Th1 cell-treated mice into 
immunosuppressed SCID mice. Cancer cells isolated from sham-treated mice growed rapidly in 
vitro and in vivo when transferred into SCID mice. In sharp contrast, well differentiated cancer 
cells from Th1 cell-treated mice remained growth-arrested and failed to expand in vitro and in 
SCID mice. Thus, Th1 immunity may inhibit cancer progression by preserving the functional 
phenotype and differentiation of oncogen-driven epithelia.
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Induction of tumor dormancy by tumor-specific Th1 cells
Heidi Braumüller, Thomas Wieder, Matthias Hahn, Sonja Fischer, Martin Röcken Eberhard Karls 
University Tübingen, Tübingen, Germany
Genome wide analysis of cancers revealed multiple alterations in cell cycle genes in all cancers. 
These mutations remain susceptible to therapy, as targeted therapies, such as BRAF-inhibitors, 
improve the outcome. Yet, surprising data suggest, that these therapies critically depend on 
adaptive immunity. To unravel the underlying mechanisms, we investigated the mode of action 
of Interferon-γ (IFN- γ) producing, cancer-specific T helper 1 (Tag-Th1) cells to treat mice with 
endogenous solid cancers of Langerhans islets. Treatment of mice with Tag-Th1 cells significantly 
reduced cancer cell proliferation and cancer size, and doubled life time of mice. To analyze 
the mechanisms underlying the therapy, we isolated cancer cells and treated these cancer cells 
with IFN- γ. IFN- γ inhibited cancer cell proliferation by 70% without inducing apoptosis, as 
determined by TUNEL or caspase 3/7 assay. Cell cycle analysis showed that IFN-γ significantly 
suppressed the S-phase of cancer cells, and increased the G1/G0 phase, shifting the G1/G0 
to S ratio from 1:1.7 to a ratio of 1 : 3.5 within only 3 days. We next studied whether Th1 
cells really induce stable growth arrest that results in senescence, and ultimately leads to tumor 
dormancy. We characterized the growth arrested cancer cells studying lysosomal senescence by 
senescence-associated β-galactosidase (SA-β-Gal), senescence associated cell cycle molecules 
and DNA modifications. Both, Th1 cells and IFN- γ induced a 3-4fold, significant increase in 
SA-β-Gal, p16INK4a or senescence-associated histone modification, such as nuclear translocation 
of pHP1γ, in vivo. Thus, Th1 immunity prevents cancer outgrowth and controls tumor dormancy 
through IFN-γ-induced cancer cell senescence.
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Induction of cancer cell senescence by Interferon-γ and TNF signaling in breast cancers and 
human sarcomas
Matthias Hahn, Heidi Braumüller, Thomas Wieder, Ellen Brenner, Michelle Dierstein, Martin 
Röcken Eberhard Karls University Tübingen, Tübingen, Germany
Recently cancer immunotherapy showed first efficacy in human cancer, including melanoma. 
Surprisingly, all studies showed that, instead of cancer killing by CD8+ T cells, Interferon-
gamma (IFN γ) producing, cancer-specific T helper 1 (Th1) cells arrested cancer progression. We 
analyzed the underlying mechanisms in endogenously developing islet cancers, resulting from 
aberrant p53 and Rb cell cycle control (RIP1-Tag2 mice). Cancer-specific Th1 (Tag-Th1) cells 
reduced tumor cell proliferation and induced cancer cell senescence in RIP1-Tag2 mice. In vitro, 
IFN γ had similar effects on isolated RIP1-Tag2 cancer cells. To determine whether Th1 cells/
IFN γ -induced senescence in cancer cells is a general phenomenon, we studied IFN γ -induced 
cancer cell senescence in breast cancers from mice transgenic for polyomavirus middle-T antigen 
(PyVmT) and a human rhabdomyosarcoma. We analyzed the effects of IFN γ - and TNF-treatment 
on proliferation and senescence. Proliferation was measured by XTT, β-Galactosidase-assay was 
performed to quantify the amount of senescent cells. Additionally we used immunostaining 
for senescence-associated histone protein HP1 γ. When treated either with IFN γ, TNF or both 
cytokines simultaneously, PyVmT cancer cells showed a significant decrease in proliferation, 
approximately 70% with IFNγ and 50% with TNF or both cytokines. All conditions induced 
a 3-fold increase in senescent cells. Moreover, IFN γ -treatment significantly elevated HP1 γ. 
Interestingly, IFNγ induced p19ARF immunofluorescence in PyVmT but p16INK4a-expression in 
rhabdomyosarcoma. Proliferation and senescence were equally influenced compared to PyVmT 
cells. Therefore, induction of cell cycle arrest and senescence by IFN γ and TNF is a general 
phenomenon, valid for an extended spectrum of cancers.
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RNAi depletion of PRSS21 induces apoptosis in cutaneous squamous cell carcinoma 
keratinocytes
Kim Robinson, Steven Watt, Andrew South, Irene Leigh Dundee University, Dundee, UK
In the UK, over 1 in 4 skin cancer deaths can be attributed to non-melanoma skin cancer, 
principally cutaneous squamous cell carcinoma (cSCC). High risk groups exist, including 
immunosuppressed and recessive dystrophic epidermolysis bullosa patients, where cSCC is a 
major complication resulting in increased morbidity and mortality. Targeted therapies capable of 
halting growth and metastatic potential of cSCC remain an unmet clinical need. Protease, Serine, 
21 (Testisin encoded by the gene PRSS21) is a GPI-linked membrane anchored protein frequently 
overexpressed in malignant tissues and shown to promote tumour progression and metastasis. 
We show that PRSS21 is overexpressed in cSCC in vitro (7.4 fold, p<0.0005) and in vivo (average 
fold change of 1.5 over multiple data sets) compared with normal skin. RNAi knockdown of 
PRSS21 significantly (P<0.005) increases cytotoxicity (20%±5.1% PRSS21 vs non-targeting 
control siRNA n=4) as measured by LDH release and decreases cell viability (40%±5% of non-
targeting control siRNA, n=3) in cSCC cells without affecting normal primary keratinocytes as 
determined by MTS assay. Depletion of PRSS21 induced apoptosis in cSCC as detected by a 2.3 
(SD±0.4) fold increase in cytoplasmic nucleosomes and a 25% (SD±5.2) increase in annexin 
V/7AAD positive cells. Additionally, PRSS21 depletion resulted in a 60% increase in expression 
of maspin, a serine protease inhibitor and known tumour suppressor. In conclusion, we have 
identified a potential therapeutic cancer target - PRSS21 which is overexpressed in cSCC and 
whose siRNA-mediated knockdown results in apoptosis in vitro. Further studies will continue to 
evaluate PRSS21 as a viable therapeutic target.
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Multiple malignant melanoma (MPM) co-occurrence with several multiple primary tumors: 
Genetics and environment
Zsofia Hatvani1, Bernadett Hidvegi1, Mercedesz Mazan1, Dora Pinter1, Katalin Dobos2, 
Beata Somlai1, Sarolta Karpati1 1Semmelweis University Faculty of Medicine, Department of 
Dermatology, Venerology and Dermatooncology, Budapest, Hungary, 2Semmelweis University 
Faculty of Medicine, 1st Department of Pathology and Experimental Cancer Research, Budapest, 
Hungary
A sibling with the same constellation of four different primary malignant tumors with subsequent 
aggregation of other primary cancers in their family raised our interest to obtain genetic analysis. 
In their medical history MPM, basal cell-, lung-, and prostate cancer were identified, while neural 
crest tumors, gastric-, renal-cell cancer and pancreatic cancers (PC) were reported throughout 
their family. The set of malignancies don’t fit into any known cancer-syndromes, although co-
occurrence of some has already been reported. Mutational analysis of genes sharing etiology of 
some of the appeared malignancies has been performed in one of the patients: CDKN2A, MC1R 
whole, while PTEN and BRCA1/2 hot spot containing exons. We identified the CDKN2A mutation 
R99P that has been published in two other melanoma-prone families with PC in individual or 
familial setting. Three MC1R polymorphisms V60L, V92M, T314T were also confirmed, that are 
common low-risk variants with debated role in melanoma formation independently of red-hair 
phenotype. We identified a point mutation in BRCA1 exon 11 (Q356R), a rare variant reported 
only in a few cases, without consequent significance in tumor formation, although in-silico 
studies suggest the position as critical for protein function. We hypothesized that CDKN2A 
mutation together with MC1R polymorphisms could be responsible for MPM and partly for 
PC formation. Prostate cancer is reported more frequently as second tumor among melanoma 
survivals and BRCA1 mutation carriers. Additional suspected genetic and environmental factors 
in development of these unique tumor aggregations will be presented in details.
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Specific upregulation of non-canonical wnt signalling in non-melanoma skin cancer: Wnt 5a is 
strongly expressed and controls directional migration
Celine Pourreyron1, Kate McLean1, Louise Reilly1, Charlotte Proby1,2, Andrey Panteleyev1, Alan 
Evans2, Irene Leigh1, Andrew South1, John Foerster1,2 1University of Dundee, Dundee, UK, 2NHS 
Tayside, Ninewells Hospital, Dundee, UK
Wnt5a signal transduction cascades have been extensively characterised in cancer progression. 
However, available information on spatial distribution controlling Wnt5a gradients is limited. We 
show by immunohistochemistry that Wnt5a is strongly expressed in non-melanoma skin cancer 
cells (squamous cell carcinoma, SCC, and basal carcinoma, BCC) and in the stroma. Within 
tumors, Wnt5a is preferentially localised at the leading edge, suggesting a role in invasion. The 
accumulation of wnt5a receptor Fzd3 in polarised intracellular structures indicates the presence of 
intra-tumor wnt5a gradients. In vitro studies using Transwell assays showed that Wnt5a induces a 
1.4-fold increase (n=3, p=1.5E-3) in Hacat keratinocyte migration along a gradient while it inhibits 
cellular movement (2.5-fold, n=3, p=6.3E-11) when present without gradient. Expression profiling 
of primary SCC confirmed upregulation of Wnt5a (4.2-fold vs. sun-exposed control skin, p=8E-6). 
A comparison of wnt-related gene expression between SCC and the non-invasive hyperproliferative 
skin disease psoriasis revealed that upregulation of Wnt5a is accompanied only in invasive SCC by 
significant downregulation of canonical wnt3a (0.3-fold of control, p=6E-6). Moreover, the secreted 
frizzled related proteins (SFRP), inhibitors of wnt-receptor binding, are highly expressed in normal 
skin, suggesting a role as active diffusion barriers for wnt gradients. The most highly expressed 
member, SFRP2, was down-regulated only in SCC, but not in psoriasis. The concurrent upregulation 
of Wnt5a and down-regulation of Wnt3 and SFRP2 suggest that non-canonical signalling is 
hypersensitive in SCC. Our data suggest that Wnt5a contributes to invasion in non-melanoma skin 
cancer by enhancing migration of tumor cells toward tumor-associated stroma and vessels.
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Trex2 gene and protein expression alterations in cutaneous squamous cell carcinoma
Joan Manils1, Elena Marzo1, Rocio Salgado2, Agustí Toll3, Diana Gómez1, Ramón M Pujol3, 
Blanca Espinet2, Concepció Soler1 1Dept Of Pathology and Experimental Therapeutics, Universitat 
de Barcelona, Barcelona, Spain, 2Department of Pathology, IMIM-Hospital del Mar, Barcelona, 
Spain, 3Department of Dermatology, IMIM-Hospital del Mar, Barcelona, Spain
TREX2 is a proofreading 3’-5’ exonuclease that is predominantly expressed in keratinocytes. 
Loss of Trex2 gene in mice increases susceptibility to carcinogen-induced skin tumorigenesis, 
highlighting the importance of this protein to the maintenance of keratinocyte genome 
integrity under conditions of genotoxic stress. In fact, keratinocytes are exposed to multiple 
DNA-damaging agents, including chemicals and ultraviolet radiation, which are the most 
common risk factors for skin carcinogenesis. To determine whether Trex2 gene and expression 
abnormalities occur in skin tumorigenesis, we evaluate the presence of Trex2 gene numerical 
aberrations and analyze TREX2 expression in precancerous actinic keratosis (AK) skin lesions 
and cutaneous squamous cell carcinoma (SCC) by means of fluorescence in situ hybridization 
(FISH) and immunohistochemistry. Nineteen controls, eight AKs and twenty-seven SCCs were 
evaluated. Trex2 numerical aberrations, including amplifications, gains and polysomies, were 
detected in twenty of twenty-seven (74 %) SCCs (p < 0.001), and in two of eight (25 %) AKs. In 
the other hand, we have observed that TREX2 protein expression is heterogeneous and differs 
across tumour, being more prevalent in differentiated areas, and almost undetectable in poorly 
differentiated regions. This preliminary study suggests that Trex2 gene and/or expression can be 
deregulated in cutaneous SCCs.
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sRAGE levels relate to melanoma clinical stages and progression
Christoffer Gebhardt1, Jana Eubel1, Kresimir Mikic1, Helmut Naeher1, Wolfgang Hartschuh1, 
Peter P. Nawroth2, Bernd Arnold3, Angelika Bierhaus2, Alexander Enk1 1University Hospital, 
Department of Dermatology, Heidelberg, Germany, 2University Hospital, Department of Internal 
Medicine I and Clinical Chemistry, Heidelberg, Germany, 3German Cancer Research Center 
(DKFZ), Molecular Immunology, Heidelberg, Germany
Melanoma initiation, growth and progression have been related to microenvironmental factors 
orchestrating tumor-stroma interaction. However, the mechanisms that sustain a melanoma-
promoting micro-environment remain largely elusive. We have recently demonstrated that the 
receptor for advanced glycation end-products (RAGE) is mediating experimental non-melanoma 
skin tumor formation as well as for experimental chronic inflammation by sustaining positive 
signaling feed-forward loops regulating specific sets of pro-inflammatory genes. Here, we 
describe that RAGE activity relates to human melanoma clinical stages and progression and 
therefore might be central in regulating melanoma growth and development. Markers of RAGE 
activity include RAGE protein expression, serum levels of a soluble form of RAGE (sRAGE) 
as well as protein expression of RAGE targets/activating ligands such as S100A8/A9, S100B, 
HMGB1 in human melanoma specimens. By using sRAGE specific ELISA levels of sRAGE are 
significantly down-regulated in the serum of melanoma patients at stage III / IV compared to 
patients at stage I / II. Moreover, sRAGE serum levels are significantly down regulated in patients 
at stage IV compared to any other stage. Protein expression of S100A8/A9, S100B, and HMGB1 
as determined by a combination of immunofluorescence and ELISA on human melanoma 
tissue/serum specimens correlated conversely in a stage-dependent manner. In conclusion, 
we provide multiple evidence for a novel role of RAGE signaling in driving melanoma growth 
and development by highlighting the importance of melanoma-stroma interaction in a RAGE-
dependent manner. Moreover, we shed light on RAGE signaling as a novel clinical marker as well 
as a promising target for anti-melanoma therapy.
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Evaluation of the anti-neoplastic potential of orally applied metronomic temozolomide alone 
and in combination with Rapamycin
Christiane Thallinger, Daniela Laimer, Christine Bangert, Michaela Schlederer, Susanne Heider, 
Georg Stingl, Tamara Kopp Medical University of Vienna, Vienna, Austria
Melanoma is the most deadly skin disease in caucasian populations and causes 1-2 % of cancer 
deaths in the western hemisphere. For late-stage melanoma there is currently no cure. Metronomic 
chemotherapy is a possible alternative to standard and high dose chemotherapy, which means 
daily administering low doses of the chemotherapeutic drug. We have examined the antineoplastic 
potential of orally applied metronomic temozolomide alone versus standard temozolomide 
chemotherapy in a xenograft-model using two different melanoma cell-lines, 607B and 518A2. 
To potentiate the anti-Tumor effects, we combined metronomic temozolomide with rapamycin, 
an inhibitor of PI3K/AKT, which acts through inhibition of mTOR, reducing proliferation and 
angiogenesis and enhancing apoptosis. We show that treatment with metronomic temozolomide 
plus rapamycin led to significantly reduced tumor growth compared to saline-control in both cell-
lines. In cell line 607B the tumor-reduction effect of treatment with rapamycin alone was less 
pronounced than with the combinatorial therapy. In line 518A2 it was equal. Treatment with 
metronomic temozolomide alone result in reduced tumor-growth in both cell-lines, although to a 
lesser extent than treatment with the combination of metronomic temozolomide plus rapamycin or 
rapamycin alone. We performed immunohistochemical analysis and immunofluorescence-staining 
of tumors derived of cell-line 607B. In tumors of mice treated with metronomic temozolomide 
plus rapamycin or rapamycin alone, and to a lesser degree also in tumors of mice treated with 
metronomic temozolomide alone, proliferation, microvessel and lymphaticvessel-density 
was significantly lower than in the tumors of control mice. Thus, treatment with metronomic 
temozolomide plus rapamycin might be an interesting alternative for melanoma-treatment.
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Receptor for advanced glycation end products (RAGE) expression in non melanoma skin cancer
Rodrigo Valdés-Rodríguez1,2, Francisco Javier Gonzalez1,3, Claudio Castillo-Martinez1,2, Ana-
Arely Rentería-Palomo1,2, Bertha Torres Álvarez1,2, Cornelia Fuentes-Ahumada1,2 1Universidad 
Autónoma de San Luis Potosí, San Luis Potosi, Mexico, 2Departamento de Dermatología. Hospital 
Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico, 3Instituto de Investigacion en 
Comunicacion Optica, San Luis Potosi, Mexico
RAGEs on the skin are related to aging, inflammation and carcinogenesis; non melanoma skin 
cancer (NMSC), basal and squamous cell carcinoma are among the most common cancers 
around the world. Many reports point out the significance of RAGE expression in carcinogenesis, 
tumor progression and metastasis of several epithelial tumors. To our knowledge there are no 
reports regarding the expression of RAGEs in NMSC. In this study we analyze the expression 
of RAGEs in NMSC. Patients with a mean age of 72 years old, with clinical and histopathology 
diagnosis of NMSC were included. Each sample was stained immunohistochemically with anti-
RAGE monoclonal antibody. RAGE staining in the tumor samples was noted to occur in both a 
membranous and nuclear pattern. Imaging software (Image J; US National Institutes of Health, 
Bethesda, MD, USA) was used to quantify the expression of RAGEs. We quantify the expression 
of RAGEs in the tumor and in the epidermis (lower and upper) above the tumor; the mean 
expression for all tumors were 26.3% SD 9.14, in the lower epidermis were 64% SD 23.9 and 
in the upper epidermis were 61.7% SD 32.3. These results indicate that RAGE are expressed in 
NMSC and could play a role in carcinogenesis of these types of cancers.
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Regulation of Circadian Clock Genes in Human Skin Cancer
Martina Schmid1, Nazanin Mostafaie2, Barbara Bittermann2, Walter Krugluger2, Beatrix Volc-
Platzer1 1Department of Dermatology, Donauspital, Vienna, Austria, 2Department of Clinical 
Chemistry, Donauspital, Vienna, Austria
In mammals, the most important pacemaker of the circadian rhythm is the suprachiasmatic 
nucleus in the hypothalamic region. In peripheral tissues local pacemakers are found in the form 
of a cellular machinery named the circadian clock. The circadian clock consists of different genes 
which influence the circadian rhythm via regulated expression and control many physiologic 
processes like metabolism or cell growth and differentiation. Several “clock genes” encode key 
molecules of the cellular circadian clock, like Period1 (Per1), Period2 (Per2), CLOCK, BMAL1, 
cryptochrome 1 and 2 and timeless, which show diurnal expression fluctuation. Because 
of their involvement in the regulation of cell proliferation, Clock genes might play a role in 
carcinogenesis. Per1 functions as a tumor suppressor gene by sensitizing cells for apoptosis. Skin 
cells constitutionally express proteins of the circadian clock. We compared the amount of clock 
gene mRNA Per1, Per2 and Clock in different skin tumors and adjacent non-tumorous tissue of 
patients of our dermatological clinic. Analysis was performed by RT-PCR of paraffin embedded 
tissue. In melanoma and squamous cell carcinoma, a clear reduction of Per1 was found. In 
contrast, in basal cell carcinoma the picture was more heterogenous. Taken together, apart from 
influencing adaptation to circadian changes, oscillating factors of the cellular clock machinery in 
human skin might play a role in the carcinogenesis of skin tumors.
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High Resolution Genomic Profiling of Vulval Neoplasia Reveals Genetic Differences between 
Human Papillomavirus-Associated and Human Papillomavirus-Independent Tumours
Karin Purdie1, Karen Gibbon2, Tracy Chaplin1, Bryan Young1, Irene Leigh3, Charlotte Proby3, 
Catherine Harwood1 1Queen Mary University of London, London, UK, 2Barts and the London 
NHS Trust, London, UK, 3University of Dundee, Dundee, UK
Vulval squamous neoplasia, comprising vulval squamous cell carcinoma (VSCC) and 
precancerous vulval intraepithelial neoplasia (VIN), causes significant morbidity and mortality 
and its incidence is increasing worldwide. Two basic pathogenetic mechanisms are thought to 
be responsible, only one of which is driven by high risk alpha genus HPV (hrHPV), leading 
to HPV-associated and HPV-independent disease. However, the associated genetic alterations 
are poorly understood. We have used high resolution single nucleotide polymorphism (SNP) 
microarray analysis to investigate genome-wide allelic imbalance in a series of 30 VIN and VSCC 
samples of known HPV status. In HPV-associated disease the most common recurrent alterations 
were gains at 1p and 20, with the most frequent losses observed at 2q, 3p and 10. HPV-negative 
cancers were characterised by recurrent loss at 9p, an aberration not observed in HPV-associated 
disease, together with frequent loss at 3p. The other recurrent changes associated with hrHPV-
positive tumours occurred infrequently in this group. Our data indicate that HPV-associated 
and HPV-independent SCC are genetically distinct. The most frequent chromosomal aberrations 
observed in HPV-negative VSCC were consistent with those that we previously identified in a 
series of cutaneous SCC, a cancer not associated with hrHPV. Moreover, the pattern of genetic 
alterations observed in hrHPV-positive vulval neoplasia, in particular gain at 20, was consistent 
with previously reported HPV-specific changes in SCC of the head and neck (HNSCC) suggesting 
that these events may be crucial for HPV-mediated carcinogenesis.
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Indian Hedgehog regulates cell proliferation and differentiation in mammalian skin
Parisa Kakanj, Gilles Sequaris, Claudia Wodtke, Catherin Niemann Center for Molecular 
Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Out of three mammalian hedgehog (Hh) homologs, Sonic hedgehog (Shh) is the best 
characterised Hh ligand in the skin. Mutations in Shh and other components of the Hh pathway 
result in skin abnormalities and tumour formation, e.g. BCC. Indian hedgehog (Ihh) also activates 
the Hh pathway in the skin epithelium. Ihh is expressed in the sebaceous gland (SG) a hair 
follicle associated epidermal appendage, which secretes sebum to lubricate and protect the 
skin. In addition, overexpression of Ihh was also observed in mature sebocytes of sebaceous 
tumours. We have identified that components of the Hh pathway are up-regulated in mature 
sebocytes. However, an in vivo function of Ihh during development and homeostasis of the skin 
and under patho-physiological conditions has not been identified yet. To address these issues, 
an epidermis-specific Ihh knockout (Ihh EKO) mouse model was generated. Our results clearly 
demonstrate that in the absence of epidermal Ihh proliferation is significantly inhibited during 
early skin development. However, morphogenesis of the SGs, hair follicles and the interfollicular 
epidermis was not altered. Applying different epidermal tumour models, we examined the role 
of Ihh signalling for skin tumour formation. In sebaceous tumours, Ihh promotes tumour growth 
and SG and sebaceous duct fate differentiation. Importantly, this was accompanied by a decrease 
in the number of follicular progenitor cells. In addition, Ihh signalling promotes proliferation 
and regulates p53 in squameous epidermal tumours. Taken together, our results reveal a novel 
function of Ihh for keratinocyte proliferation and differentiation in patho-physiological conditions 
of the skin.
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Cadherin mediated regulation of the tight junctional skin barrier function
Christian Michels1,2, Ann-Kathrin Richarz1,4, Matthias Rübsam1,4, Carien Niessen1,3 1Institute of 
Dermatology, University Hospital of Cologne, Cologne, Germany, 2Center for Molecular Medicine 
Cologne(CMMC), Cologne, Germany, 3Cologne Excellence Cluster on Cellular Stress Responses 
in Aging-associated Diseases (CECAD), Cologne, Germany, 4University of Cologne, Cologne, 
Germany
Intercellular junctions, such as adherens and tight junctions, are crucial contributors to the skin 
barrier. We recently identified the adherens junction component E-cadherin as an important 
regulator of tight junctional skin water barrier since loss of E-cadherin in the epidermis of mice 
results in perinatal death. Using E-cadherin-/- keratinocytes we asked how E-cadherin regulates 
tight junctions. Surprisingly, loss of E-cadherin did not interfere with membrane recruitment 
of key tight junctional proteins or with strand formation, as judged by freeze fracture electron 
microscopy even though these keratinocytes are unable to form a functional ion- and size barrier. 
This indicates that E-cadherin regulates a late step in junction formation. Since differential 
incorporation of claudins determines the strength of the ionic and size barrier we examined 
the expression of all claudin family members. This identified claudin-14 as a candidate since 
expression was reduced in primary keratinocytes and in epidermis deficient for E-cadherin. 
Unfortunately, constitutive overepression of claudin-14 interfered with tight junction assembly 
suggesting that skin barrier function is either claudin-14 independent or only requires low 
expression levels. We are using inducible systems to test this. Actinomyosin contractions can also 
regulate tight junctional barrier function. We found increased phosphorylation of myosin light 
chain (MLC) associated with increased association of phospho-MLC and altered actin assembly 
at intercellular junctions. At the moment we are directly testing of increased actinomyosin 
contractions contribute to the barrier dysfunction in E-cadherin-/- keratinocytes and if cadherins 
directly regulate upstream kinases, eg. MLCK or Rock, that affect actinomyosin contractility.
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Essential role of alpha-helical coiled-coils in the regulation of collagen XVII ectodomain 
shedding
Wataru Nishie1,3, Claus-Werner Franzke1, Joanna Jacków1, Silke C. Hofmann1, Leena Bruckner-
Tuderman1,2
1Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany, 2FRIAS, 
School of Life Sciences, LIFENET, University of Freiburg, Freiburg, Germany, 3Department of 
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Alpha-helical coiled-coils are potential oligomerization motives, which are commonly observed in 
vital proteins including those of collagen superfamily. However, little is known about their involvement 
in ectodomain shedding of transmembrane proteins. Here, we show a novel and essential role of 
the coiled-coils in the regulation of collagen XVII ectodomain shedding. Collagen XVII is a type II 
transmembrane protein which mediates stable dermal-epidermal adhesion in basal keratinocytes of 
the skin, and its dysfunction is linked to inherited or acquired blistering diseases. Shedding of collagen 
XVII has been suggested to be involved in attachment, migration and differentiation of keratinocytes. 
To better our understanding of the role of the coiled-coils in collagen XVII we targeted prominent 
coiled-coil regions within the extracellular NC16th domain close to the cell surface. Ectodomain 
shedding of mutant collagen XVII of which Leu502 and/or Leu495 have been mutated into Proline was 
significantly increased in host HEK293 cells. The substitutions have not led to a changed lipid raft 
plasma membrane micro localization of the molecule since the cholesterol depleting agent methyl-
ß-cyclodextrin causes increased ectodomain release. The increased shedding of the mutants was 
not mainly associated with physiological sheddases for normal collagen XVII, but other proteinases 
including serine proteinase were involved, suggesting an increased susceptibility of the mutants to 
proteolysis. This study, for the first time, has disclosed a novel and essential role of juxtamembranous 
coiled-coils in the regulation of collagen XVII ectodomain shedding.
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Oxidative Stress Reduces Collagen Production Through mTOR-dependent Down-regulation of 
Transforming Growth Factor Signaling Pathway in Human Skin Fibroblasts
Gary Fisher, Tianyuan He, Taihao Quan, John Voorhees University of Michigan, Ann Arbor, MI, 
USA
Impairment of cellular function during aging involves adaptive responses to oxidative stress. Type 
I collagen (COL) comprises the bulk of the dermal extracellular matrix. Reduced COL leads to 
skin thinning and fragility in the aged. We have investigated molecular mechanisms by which 
oxidative stress down-regulates COL production in primary adult human dermal fibroblasts. 
Exposure to the oxidant hydrogen peroxide reduces COL expression (89%, n=4, p<0.05), within 
24 hours. This reduction is accompanied by impairment of transforming growth factor-β (TGF-β) 
pathway, which strongly regulates COL expression. Impairment results from down-regulation 
of protein, but not mRNA levels, of type II TGF-β receptor (TβRII, 72%, n=5, p<0.05) and its 
downstream effector, transcription factor Smad3 (55%, n=5, p<0.05). Raising levels of both TβRII 
and Smad3 together, but not individually, by transient transfection, restores COL expression (n=5, 
p<0.05). Metabolic labeling studies revealed that oxidant-induced down-regulation of Smad3 
involves specific reduction of Smad3 protein synthesis (84%, n=3, p<0.05). siRNA-mediated 
knockdown of DROSHA did not alter Smad3 or TβRII levels, indicating that oxidant-induced 
reduction is not miRNA-independent. In silico analyses of microRNA array data further supported 
this conclusion. In contrast, mTOR activity, which regulates protein synthesis was rapidly reduced 
by oxidative exposure (76.6%, n=3, p<0.05). Furthermore, mTOR inhibition by rapamycin 
significantly reduced Smad3, TβRII and COL protein levels (67%, 53% and 81.7%, respectively, 
n=3, p<0.05). These data support the concept that adaptive responses of dermal fibroblasts to 
age-related oxidative stress involve reduced COL production via inhibition of mTOR-dependent 
TβRII and Smad3 protein synthesis.
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Decreased cathepsin V levels in the sera and skin of patients with systemic sclerosis
Shinji Noda, Yoshihide Asano, Yayoi Tada, Makoto Sugaya, Takafumi Kadono, Shinichi Sato 
University of Tokyo, Tokyo, Japan
Cathepsin V (CTSV) is a proteolytic enzyme, which may modulate angiogenic processes, collagen 
degradation, and keratinocyte differentiation. Although aberrant angiogenesis and tissue fibrosis 
are closely linked to the development of systemic sclerosis (SSc), the role of CTSV in this process 
has never been examined. We investigated serum CTSV levels and their association with clinical 
features in SSc and to examine CTSV expression in SSc skin. Serum CTSV levels were determined 
by a specific enzyme-linked immunosorbent assay in 58 SSc patients and 18 normal controls. 
CTSV protein expression was evaluated by immunostaining in SSc and normal skin sections. 
Serum CTSV levels were significantly lower in SSc patients than in healthy controls (120.7 ± 
30.0 vs. 171.0 ± 33.8 pg/ml, P < 10-7). Although there was no significant correlation between 
serum CTSV levels and any clinical features, further analyses revealed that serum CTSV levels 
were significantly lower in early-stage (disease duration of P 1 year) SSc patients than in mid/
late-stage (disease duration > 1 year) SSc patients (104.5 ± 9.1 vs. 124.9 ± 32.1 pg/ml, P < 
0.05). In immunohistochemistry, CTSV protein expression was decreased in dermal fibroblasts, 
microvascular endothelial cells, pericytes/vascular smooth muscle cells, and keratinocytes in SSc 
skin sections compared with control skin sections. Serum CTSV levels as well as CTSV expression 
in skin vasculature, dermal fibroblasts, and keratinocytes were significantly reduced compared 
with healthy controls, suggesting possible involvement of CTSV in the development of SSc skin 
phenotype.
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Shedding of collagen XVII: Are the cleavage events context dependent?
Joanna Jacków1, Andreas Schlosser2, Ulrike Lanner2, Cassian Sitaru1, Kaisa Tasanen3, Leena 
Bruckner-Tuderman1, Claus Werner Franzke1 1Department of Dermatology, University Medical 
Center Freiburg, Freiburg, Germany, 2Core Facility Proteomics, Center for System Biology (ZBSA), 
Freiburg, Germany, 3Department of Dermatology, University of Oulu, Oulu, Finland
The ectodomain of the epidermal adhesion molecule collagen XVII is constitutively released 
through cleavage by disintegrin metalloproteinases within the extracellular linker domain NC16A. 
Based on the striking amino acid sequence differences between extracellular linker domains of 
human and murine collagen XVII and the poor interspecies cross reactivity of antibodies directed 
to this region, we have compared their cleavage sites and shedding behavior. To detect the cleavage 
sites in murine collagen XVII we have used a C-terminal truncated collagen XVII construct which 
was transiently transfected in COS-7 cells. The purified ectodomain was subjected to mass 
spectroscopy analysis which resulted in the detection of a cluster of three different cleavage sites 
with comparable distribution found in human collagen XVII. To assess shedding we compared 
the ectodomain release in the supernatants of COS-7 cells transfected with six murine and ten 
human collagen XVII linker domain mutants by immunoblot analysis. Surprisingly, the cleavage 
behavior of human and mouse collagen XVII mutants with corresponding deletions was similar. 
We conclude that cleavage is most likely triggered through structural specificity since we identified 
cleavage resistant mutants with deletions outside the cleavage site cluster and shed mutants with 
deletion of all known cleavage sites. Furthermore the shedding of some non-shed deletion mutants 
was partially restored by stimulation with IL-1ß. Our results show that shedding of collagen XVII 
represents a conserved process in humans and mice and therefore mouse models will be helpful to 
investigate collagen XVII shedding in context dependent manner.
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Sarcoid-like skin granulomatosis induced by Propionibacterium acnes in mice; role of cell 
adhesion molecules in the formation of granuloma
Masahiro Kamata, Yayoi Tada, Yoshihide Asano, Makoto Sugaya, Takafumi Kadono, Shinichi Sato 
University of Tokyo, Tokyo, Japan
Sarcoidosis, a systemic granulomatous disease, is characterized by a variable clinical presentation 
and course. However, its etiology has remained unknown. Propionibacterium acnes (P. acnes), 
an anaerobic nonspore-forming gram-positive rod bacterium, has been implicated as one of the 
suggested causative antigens of sarcoidosis since this bacterium could be isolated from sarcoid 
lesions. In order to clarify the role of cell adhesion molecules in cutaneous sarcoidosis, we first 
established an in vivo model of sarcoid-like skin granulomatosis by injecting heat-killed P. acnes 
into the back of C57BL/6J mice. These mice demonstrated granuloma formation not only in the 
skin, but also in the lung and liver. In particular, mice injected with P. acnes on days 1, 3, 
5, and 14 showed prominent sarcoid-like granulomatosis in these organs at day 28. Next, we 
investigated the role of inter-cellular adhesion molecule 1, L-selectin, P-selectin and E-selectin in 
the formation of granuloma, using mice lacking each of these molecules. We injected heat-killed 
P.acnes into the back of these deficient mice as described above. Histopathological findings 
revealed that granuloma formation in the lung and the skin of these deficient mice was inhibited 
except that in the skin of L-selectin-deficient mice. Our results indicate that cell adhesion 
molecules play an important role in the formation of sarcoid-like granuloma.
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Emilin-1 expression in normal, aged, and photo-aged human skin.
Richard Fitoussi1, Laurent Peno-Mazzarino2, Philippe Gasser2, Katell Vié1, Elian Lati2, Eric Gooris1 
1Laboratoires Clarins, Pontoise, France, 2Laboratoire BIO-EC, Longjumeau, France
In previous studies in mice, invalidation of genes enabled characterization and structural study 
of different proteins and glycoproteins composing elastic fibres, such as fibrillins, MAGP and 
Emilin. In articles on elastogenesis of vascular system, Emilin-1 appears to be located in elastic 
fibres network and binds to cells or to elastic components as elastin and fibulin-5. These data 
suggest that Emilin-1 may regulate elastogenesis by stabilizing molecular interactions between 
elastic components and by allowing elastics fibres to carry out adhesion properties to cells or 
other matrix fibres. Recently, Emilin-1 has been shown to regulate formation of fibrillin-1 in 
periodontal ligaments. Its suppression (siRNA) reduced fibrillin-1 level deposition in vitro. There 
is no study citing its expression level during human skin ageing and its location in the elastic 
fibres of the dermis. We study the expression of Emilin-1, by immunofluorescence, on women 
skin samples. Abdominal skin sections without stretch marks from 16 Caucasian women aged 
from 20 to 70 were analyzed. In dermis of young skin, Emilin-1 co-localized with the other 
elastic fibre components. With ageing, Emilin-1 expression decreases in the papillary and the 
reticular dermis. In an additional study on skin samples, we observed that UVA/UVB induced a 
reduction in the expression of Emilin-1 in the 2 areas of the dermis. Taking together, these data 
identify Emilin-1 in the elastic network of the dermis and show that, intrinsic and actinic ageing 
modulate its expression. Emilin-1 appears to be a new biomarker to study skin ageing in relation 
with the elastic fibres network.
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Thymus citriodorus stimulates Emilin-1 expression in normal human skin fibroblasts
Richard Fitoussi, Christelle Guéré, Katell Vié, Eric Gooris Laboratoires Clarins, Pontoise, France
Skin ageing is characterized by impairment of fibrillar constituents of the dermis: collagen 
and elastic fibres. The vertical papillary elastic system of the dermis is degraded. The profound 
reticular dermis is also fragmented, its density increased. We focused on Emilin-1, a glycoprotein 
of the elastic fibres network which participates in the adhesion of the elastin to the cells. Emilin-1 
is also involved in the elastogenesis and in the maintenance of the cells morphology of many 
tissues. The invalidation of Emilin-1 in mice revealed alterations in elastic fibres of aorta and skin. 
In previous works, we identify its location in the elastic fibres of human dermis. We have shown 
that Emilin-1 expression is reduced with age in papillary and reticular dermis. Furthermore, UV 
exposure affects Emilin-1 expression. All these data suggest that Emilin-1 could be targeted to 
generate or maintain elastic fibres network of the dermis. So, we screened active ingredients 
to find activators capable to stimulate Emilin-1 expression in adult dermal fibroblasts. Using 
immunofluorescence and image analysis (NIS-elements software), kinetic investigations of 
Emilin-1 expression in culture medium-treated cells revealed a significant signal first detectable 
at 10 days of culture continued to increase to 14 days. We found an interesting plant extract, 
Thymus citriodorus (1%) which increased Emilin-1 expression (34% at 10th day of culture and 
54% at 14th day of culture, p<0,001). Thymus citriodorus extract exerted a stimulating effect 
against the morphological changes of elastic fibres induced by ageing and may become an 
interesting natural active ingredient for cosmetic purpose.
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Effect of C-xyloside on dermal epidermal junction morphogenesis in female aged skin: A 
glycobiological pathway to recover younger skin structures
Claire Deloche1, Anne Marie Minondo3, Bruno A. Bernard2, Françoise Bernerd2, Fabien Salas3, 
Julien Garnier4, Emmanuelle Tancrède2 1L’Oreal Research and Innovation, Chevilly-Larue, France, 
2L’Oreal Research and Innovation, Clichy, France, 3L’Oreal Research an Innovation, Aulnay Sous 
Bois, France, 4BioAlternative, Gencay, France
Recent works demonstrated that C-β-D-xylopyranoside-2-hydroxy-propane (C-xyloside) 
increased deposits of basement membrane components as well as sub-epidermal components 
in a reconstructed skin model. The aim of the present study was to confirm these results in 
vivo following C-xyloside application to the skin of aged volunteers. A placebo-controlled 
randomized pilot study was performed on five postmenopausal women aged from 60 to 75 years. 
The volunteers applied 320 mg (2mg/cm2) of either placebo or 10 % C-xyloside cream to each 
outer forearm twice daily for 3 months. At the end of the treatment, skin biopsies were collected 
from application area on both forearms. Transmission electron microscope examinations revealed 
skin ultra structural changes at the dermal epidermal junction (DEJ), after 10% C-xyloside 
application for 3 months. The morphological appearance of DEJ showed strong improvements, 
with more homogeneous and regular lamina densa in the C-xyloside-treated compared to the 
placebo treated skin areas. The number of zones showing basement membrane reduplication was 
indeed strikingly reduced on C-xyloside-treated skin. These ultra structural findings were further 
confirmed by a statistically significant increase in the expression level of α6-integrin subunit and 
laminin-332, as estimated by immunohistochemistry. Altogether, these data suggest that topical 
C-xyloside application in vivo may be efficient in inducing a better dermal-epidermal cohesion 
when such junction is deficient as it is the case in photo-aged or chronologically aged skin. 
Moreover, a statistically significant increase in CD44 expression was noted in the epidermis of 
C-xyloside-treated compared to the placebo treated skin areas.
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Development of an in vitro model of human hormonal ageing using primary human dermal 
fibroblasts
Noëlle Remoué1, Jennifer Molinari1, Eric Andres1, Juliana Lago2, Carla Barrichello1 1Natura 
Innovation, Paris, France, 2Natura Inovação, Cajamar, Brazil
An in vitro model was developed to test anti-ageing potential of actives against menopausal 
effects on the dermis, for 45-years-old-and-more women skin care. The developed model consists 
in culture of primary dermal fibroblasts from non-sun-exposed skin (breast and abdomen) of 23- 
to 27-years-old Caucasian women, in order to overcome photo-induced ageing or senescence. 
Cells were cultivated for 4 days in environment with hormones (β-FGF, IGF-1, 17β-estradiol, 
progesterone, DHEA) in same concentrations than circulating in non-menopausal women 
(Non-ME). Then, cells were maintained under this condition or cultivated under menopausal 
hormonal environment (ME) during 48h. Gene expression of hormonal receptors (ER1, ER2, PR, 
AR) and procollagens types I and III were analyzed by qRT-PCR at t0, t2h, t6h, t24h and t48h. 
Quantification of deposition of both collagen types was done by ELISA at t0, t24h and t48h. 
Hormonal receptors gene expression was higher in fibroblasts from breast than from abdomen. 
Gene expression of collagens of ME was lower at t2h than Non-ME; but higher after; whereas 
collagen proteins amount was stable in Non-ME and decreased in ME. Since skin was reported 
to have huge amount of hormonal receptors, breast skin seems to be the best non-sun-exposed 
skin to simulate in vivo conditions. To control hormonal environment allows reproducing better 
in vivo environment of dermal fibroblasts and showed decrease of collagen deposition with 
hormonal concentration reduction, as reported by ex vivo studies, meaning this in vitro model is 
relevant to test actives against hormonal ageing.
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Tropisetron, a serotonin antagonist, attenuates collagen synthesis in human dermal fibroblasts 
and reduces tissue fibrosis in a mouse model of scleroderma in a 5-HT3/4-receptor-independent 
manner
Agatha Kokot1, Anca Sindrilaru1,2, Karin Scharffetter-Kochanek2, Bernd Fiebich3, Thomas A. 
Luger1, Markus Böhm1 1Dept of Dermatology, Univ of Münster, Germany, 2Dept of Dermatology 
& Allergic Diseases, Univ of Ulm, Germany, 3Dept of Psychiatry, Univ of Freiburg, Germany
Serotonin (5-HT) or 5-HT-mediated pathways are considered to play a pathogenetic role in fibrotic 
diseases. 5-HT exerts its biologic effects via 17 different receptors. Tropisetron, an approved antiemetic 
drug acting on 5-HT3- and 5-HT4-receptors, has been reported to improve symptoms of progressive 
systemic sclerosis in humans and also to be beneficial in rheumatoid arthritis and fibromyalgia. 
Here, we investigated the effect of tropisetron on transforming growth factor-beta1 (TGF-beta1)- and 
bleomycin (BLM)-induced collagen synthesis in human dermal fibroblasts (HDF) and in vivo on tissue 
fibrosis using the BLM mouse model of scleroderma. Our data disclose a suppressive effect of tropisetron 
on both TGF-beta1- and BLM-induced collagen synthesis in HDF. In accordance with this we found 
a reduction of BLM-induced fibrosis in mouse skin after tropisetron treatment. However, the SMAD 
signaling pathway is not involved in the antifibrotic effect of tropisetron. Moreover, neither tropisetron 
alone nor its combination with TGF-beta1 or BLM increased cAMP, a suppressor of TGF-beta1-mediated 
effects. Surprisingly, expression of 5-HT3- and 5-HT4-receptors was undetectable in HDF suggesting 
alternative signaling pathways e.g. via α7nicotinic acetylcholine receptors which were detected in HDF. 
These receptors possess high 5-HT3-receptor homology and mediate various anti-inflammatory effects. 
In summary, our results highlight an antifibrogenic activity of tropisetron in vitro and in vivo and shed 
light into mechanism of tropisetron-mediated effects. These data are also encouraging for a detailed 
investigation of the serotoninergic/nicotinergic system in fibrotic as well as inflammatory skin diseases 
and may point to novel therapies in the treatment of patients with such disorders.
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Role Of Sirtuin 3 In Skin Aging
Siming Chen1, Joseph DiMaria1, Russell Wyborski1, Uma Santhanam1, Patrizia d’Aquila2, 
Giuseppina Rose2, Dina Bellizzi2, Giuseppe Passarino2 1Global R & D, Avon Products, Inc., 
Suffern, New York, USA, 2Department of Cell Biology, Ponte Pietro Bucci, University of Calabria, 
Rende, Italy
Sirtuin 3 (Sirt3), a homolog of the yeast Sir2 gene, belongs to a family of evolutionary conserved 
mammalian sirtuin genes. Located in the mitochondria, Sirt3 plays a critical role in energy 
homeostasis and thermogenesis. In yeast, Sir2 acts as a regulator of lifespan. Genetic analyses in 
humans have indicated a link between Sirt3 and longevity. To understand the role of Sirt3 in skin 
aging, we examined Sirt3 mRNA expression in primary human fibroblasts from different aged 
donors, ranging from 30 to 102 years of age. Our results demonstrated a significant reduction in 
Sirt3 mRNA expression in cells of donors in their 60s compared to younger donors. However, 
cells from the very old donors (102 years) showed a higher expression of Sirt 3. Furthermore, 
decreases in collagen 1A1 mRNA, collagen-1 protein and hyaluronic acid production, which are 
the hallmarks of skin aging, were observed in fibroblasts from donors in their 60s relative to 
30s. Interestingly, we found that fibroblasts from donors of 95s and 102s, which had higher 
levels of Sirt3 gene expression, also had higher collagen and hyaluronic acid production. To 
investigate whether SIRT3 plays a role in regulating collagen and hyaluronic acid production, 
we overexpressed the Sirt 3 gene in two different aged donor cells (56 and 70). Our results 
demonstrated that overexpression of Sirt3 is associated with increased collagen-1 and hyaluronic 
acid production in fibroblasts. These findings suggest that Sirt3 may play an important role in skin 
aging via its influence on matrix protein production in the dermis.
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Therapeutic trial with exogenous IL-1 beta utilizing ex vivo model of keloids
Yosuke Yagi1, Eri Muroga2, Shin-ichi Aota3, Motoko Naitoh4, Shigehiko Suzuki4, Yoshiki Miyachi2, 
Atsushi Utani1
1Department of Dermatology, Graduate School of Biological Sciences, Nagasaki University, 
Nagasaki, Japan, 2Department of Dermatology, Graduate School of Medicine, Kyoto University, 
Kyoto, Japan, 3Center for developmental biology, RIKEN Kobe, Kobe, Japan, 4Department of 
Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Keloids are characterized by excessive extracellular matrix (ECM) deposition including a large 
chondroitin sulfate proteoglycan versican. In this study, we investigated the regulation of versican 
expression in the ex vivo model of keloids which we established. We established cells from 
keloids lesion (KL cells). Real time PCR revealed that the level of mRNA of versican in KL cells 
was higher than that of normal fibroblast (Fb) (1.43 +/-0.30 fold, p=0.01, n=6). To establish 
keloids model, we seeded KL cells in collagen sponges (KL-SPos) and compared KL-SPos 
implanted into subcutaneous space of nude mice (ex vivo SPos) with KL-SPos cultured on dish 
(in vitro SPos). Real time PCR revealed that the level of versican mRNA in ex vivo SPos is higher 
than that of in vitro SPos (1.22 +/-0.12 fold, p=0.04, n=3). In order to reduce overexpression of 
versican in KL cells, we tested IL-1 beta effect on versican expression in the both cells. Promoter 
assays and real time PCR showed that exogenous IL-1 beta reduced versican transcription in the 
both cells (0.36 +/-0.17 fold, p=1.5x10^-12, n=6). Exogenous IL-1 beta has potential as a reagent 
to reduce keloids volume by decreasing versican. Next, we tested directly injection of IL-1 beta 
to ex vivo SPos. Direct injection of IL-1 beta to ex vivo SPos was successfully reduced the weight 
and versican deposition. Since there has been no appropriate keloid model, this sponge model 
is useful model for examining ECM change of keloids and developing therapeutic approach.
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Phosphorylation in the COOH-tail of plectin inhibits its binding to intermediate filaments
Jamal-Eddine Bouameur1, Yann Schneider2, Prakash Lingasamy1, Ryan Hobbs3, Lionel Fontao2, 
Kathleen Green3, Bertrand Favre1, Luca Borradori1
1Dept of Dermatology & Department of Clinical Research, Inselspital, Bern University Hospital & 
University of Bern, Switzerland, 2Dept of Dermatology, Geneva University Hospital, Switzerland, 
3Dept of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Plectin is a versatile cytolinker of the spectraplakin family and plays an essential role in maintenance 
of cytoarchitecure and cell resilience by tethering intermediate filaments (IFs) to various cell sites 
at the cell membrane. Plectin gene mutations have devastating effects resulting in epidermolysis 
bullosa simplex, muscular dystrophy and other disorders. We have here identified a posttranslational 
modification regulating the binding of plectin to IFs by various approaches: yeast three-hybrid assays, 
biochemical, cell transfection and immunofluorescence studies. Our results show that: 1) in several 
cell lines endogenous plectin was phosphorylated on S4642; 2) pS4642 plectin was less associated 
with IFs than total plectin in keratinocytes; 3) hemidesmosomal plectin in keratinocytes in culture 
or at the basal membrane in skin sections was less phosphorylated on S4642 than in other cellular 
regions; 4) in transfected HeLa cells pS4642-plectin-IFBD proteins were not associated with insoluble 
IFs fractions in contrast to total recombinant proteins or 4642-unphosphorylatable mutants; 5) in yeast 
the interaction of plectin-IFBD with keratins was promoted by replacing S4642 by a glycine residue; 
6) treatment of HeLa cells with PMA and okadaic acid enhanced the phosphorylation level of S4642 
on endogenous plectin. Among the tested different classes of kinase inhibitors, only PKC412 inhibited 
the okadaic acid-dependent S4642 phosphorylation. Our findings indicate that in processes requiring 
cytoskeletal reorganization, such as cell migration, the association of plectin with IFs can be tuned by 
PKC-dependent phosphorylation of S4642 within its tail. This provides new insights into mechanisms 
critically implicated in regulation of cell architecture and plasticity.
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In vitro anti-glycation properties of a plant extract of Davilla rugosa
Nabil Abdul-Malak, Cécile Altobelli, Lysiane Cittadini, Aurélie Boher, Boris Vogelgesang, Valérie 
André-Frei BASF Beauty Care Solutions France S.A.S, Lyon, France
Gycation is the spontaneous reaction between amino residues and reducing sugars. Advanced 
glycation end products (AGEs) accumulate with age in human skin and alter the optical and 
physical properties of structural proteins. We first developed a screening model based on human 
skin collagen to assess potential ingredients in their ability to inhibit AGE formation. Human skin 
collagen was purified and incubated for 3 weeks with ribose in the presence of the ingredients to 
test. Fluorescent AGEs were then measured. Aminoguanidine was used as positive control. Using 
this model, a plant extract of Davilla rugosa was identified as the best candidate. The extract 
showed a dose-related inhibition of AGE formation from 1% (v/v) with 80% and 90% inhibition 
when used at 2 and 3%, respectively. To further evaluate its capacity to protect collagen structure, 
the products obtained after 3 weeks of incubation were freeze-dried and used as culture matrices. 
Skin equivalents were then grown on these matrices. Results show that, whereas cells cultured 
on a fully glycated matrix (collagen + ribose) could not properly proliferate and did not give rise 
to any skin equivalent, cells seeded on a matrix protected from glycation (collagen + ribose + 
Davilla rugosa or aminoguanidine) could attach and proliferate and could eventually form a skin 
equivalent comprised of a dermis, an epidermis and a stratum corneum. Taken together, these 
results demonstrate that the extract of Davilla rugosa can protect collagen form glycation and 
thus protects the ECM to offer fibroblasts a favored environment for their development.
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Analysis of perlecan expression in the epidermal basement membrane during skin ageing
Morgan Dos Santos1,2, Valérie André-Frei2, Odile Damour1,3, Patricia Rousselle1
1IFR128 BioSciences Gerland-Lyon Sud; Institut de Biologie et Chimie des Protéines; FRE3310; 
CNRS; Univ. Lyon1, Lyon, France, 2BASF Beauty Care Solutions France S.A.S, Lyon, France, 
3Banque de tissues et cellules, Hôpital Edouard Herriot, Lyon, France
Basement membranes (BM) are important regulators of cell behaviour and not just structural 
features of tissues. Indeed, skin BM mediates tissue compartmentalization but also sends signals 
to epithelial cells from the external microenvironment. All BMs consist of a characteristic sheet-
like structure of specialized extracellular matrix molecules including collagen IV, laminin, 
nidogen and heparan sulfate proteoglycans (HSPG), which are in close contact with the 
surrounding cells. BMs are crucial for tissue homeostasis and are involved in important biological 
processes such as development, epithelial renewal, regeneration and repair. Perlecan is a crucial 
HSPG for skin homeostasis. It is involved in epidermal formation and renewal by regulating 
keratinocyte survival and differentiation. HSPGs not only have important roles as structural 
constituents but also regulate growth-factor storage and exposure to their cognate receptors. 
We have investigated the expression of perlecan during skin ageing. The immunohistochemical 
analysis of perlecan in a cohort of human skin samples from donors ages 22 to 73 revealed a 
strong decrease of its expression with age in good correlation with a reduction in epidermal 
thickness. In keratinocytes isolated from these biopsies perlecan gene expression also markedly 
decrease with age supporting the idea of a decreased synthesis rather than increased protein 
degradation or a deficient supramolecular exposure. Human skin models engineered with cells 
from donors of various ages confirmed these observations and revealed that aged keratinocytes 
failed to produce and deposit BM perlecan. Our results suggest that the age-related decrease of 
perlecan in skin BM may contribute to epidermal disorders.
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Replicative senescent fibroblasts alter the collagen metabolism in fibroblast-derived-matrix skin 
equivalents
David Janson, Marion Rietveld, Rein Willemze, Abdoelwaheb El Ghalbzouri Department of 
Dermatology, Leiden University Medical Centre, Leiden, The Netherlands
Senescent fibroblasts in vitro are often used as a model for aging. However, the exact role of 
senescent fibroblasts on skin aging in vivo is not known. The aim of this study was to mimic an 
aged skin phenotype by generating human skin equivalents (HSE) with senescent fibroblasts. This 
was done to study the effect of senescent fibroblasts on dermal and epidermal morphogenesis. 
Fibroblasts were made senescent by prolonged culture. By combining low- and high passage 
fibroblasts, populations were generated that had 0, 5, 10 and 15 % fibroblasts that were positive 
for Senescence Associated β-Galactosidase (SA β-gal) staining. HSEs generated with a high 
percentage of SA β-gal positive fibroblasts showed less dermal volume. In addition, they showed 
an increased MMP1 production. Staining for another senescence marker, p16, demonstrated 
that the number of positive cells was still representative of the number of SA β-gal positive cells 
during seeding. Keratinocyte stress levels were slightly increased, as shown by an increase in the 
expression of the stress-associated keratin 6 in equivalents generated with more SA β-gal positive 
fibroblasts. This study implicates that senescent fibroblasts actively contribute to certain aspects 
of skin aging. In addition, it shows that skin equivalents are a suitable model to investigate the 
role of fibroblast senescence in skin aging.
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Phospholipase C signalling in cutaneous squamous cell carcinoma
Emily Ruban1, Vera Martins1, Marco Falasca2, Edel O’Toole1 1Centre for Cutaneous Research, 
Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK, 2Centre for 
Diabetes, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK
Phospholipase C (PLC) is an enzyme that triggers cell growth, differentiation and migration 
through activation of PKC and intracellular calcium release. We have shown that the PLC isoform, 
PLC-β4, previously known to be found in neural tissue, is expressed in cutaneous squamous cell 
carcinoma (SCC). In this study we examined the function of PLC-β4 in SCC using siRNA. Successful 
transient knock-down of PLC-β4 (siPLC-β4) was achieved in 2 cutaneous SCC cell lines. A time-
course analysis by immunoblotting demonstrated potent inhibition of PLC-β4 expression up to 
6 days post-transfection. High proliferative activity, characteristic of SCC, is associated with ERK 
activation and siPLC-β4 cells had decreased phosphor-ERK1/2. PLC-β4 knock-down 3D cultures 
also show decreased expression of keratin 6 and absence of the proliferation-specific nuclear 
protein Ki67 compared to the controls, indicating a loss of proliferation. Altered differentiation 
was also observed in the siPLC-β4 3D cultures. In scratch assays of confluent cells (n-3), siPLC-β4 
cells displayed markedly decreased migration compared to control cells. siPLC-β4 cells were 
also 28% less invasive in 3D collagen:matrigel experiment as well as less adherent than the 
controls. Moreover, siPLC-β4 cells showed absent intracellular calcium-release following specific 
activation of the mGluR1α-PLC-β4 pathway using a fluorescent probe and confocal microscopy 
compared with non-targeting control or cells with knockdown of PLC-g1. These data suggest that 
PLC-β4 regulates migration/invasion of SCC cells as well as their proliferation and differentiation 
by modulating intracellular calcium. The recent finding of mutations in PLCB4 in melanoma 
suggest that this will be an attractive therapeutic target.
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24-hour wound-healing in vitro model using a Hydrolyzed eggshell membrane immobilized on 
phosphorylcholine polymer
Yoriko Atomi1, Eri Ohto-Fujita1, Tomohiro Konno1, Miho Shimizu1, Kazuhiko Ishihara1, Toshihiro 
Sugitate1, Jun Miyake1,2, Kotaro Yoshimura1, Kaori Taniwaki3, Takashi Sakurai1, Yukio Hasebe3 1The 
University of Tokyo, Tokyo, Japan, 2Univ. of Osaka, Osaka, Japan, 3Almado Inc., Tokyo, Japan
In spite of the importance of ECM, there are not so many studies regarding tissue origin-dependent 
cell-ECM interaction or cell-cell interaction in vivo. Avian eggshell membrane (ESM) has fibrous-
meshwork structure and has long been utilized as a Chinese medicine for recoveries from burns 
injuries and wound in Asian countries. Therefore ESM is expected to be providing an excellent 
natural material for biomedical use but those applications were hampered by the insolubility 
of ESM proteins. We have used a recently developed artificial cell membrane biointerface, 
PMBN to immobilize ASESM proteins. The surface shows fibrous structure under atomic force 
microscope (AFM) and adhesion of human dermal fibroblast (HDF) to ASESM was ASESM-dose 
dependent. mRNA expression study by the quantitative real time-PCR analysis of HDF on ASESM 
was performed. ECM related genes which may contribute to maintain extracellular environment 
for healthy dermis, such as type III collagen, MMP2, and decorin were high at lower dose ASESM 
surface by more than two-fold compare to the level of control dish surface. Cutaneous wound 
healing is a dynamic process, which involves the coordinated and sequential deposition of ECM, 
leading to the formation of a scar. In this study culturing HDF on ASESM just for 24 hours, 
an interesting pattern of gene expressions of ECM components were seen which seems to be 
related with the temporal expression pattern of ECM molecules during sequential wound healing 
process.
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Extracellular matrix composition in dermal microenvironment is implicated in development of 
life threatening cutaneous squamous cell carcinoma
Y.Z Ng1,2, C Pourreyron1, J.C. Salas-Alanis3, D.F Murrell4, J.A. McGrath5, E.B. Lane2, A.P. South1 
1University of Dundee, Dundee, UK, 2A*STAR Institute of Medical Biology, Singapore, Singapore, 
3Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4University of New South Wales, 
Sydney, Australia, 5King’s College School of Medicine, London, UK
Patients with recessive dystrophic epidermolysis bullosa (RDEB) suffer from skin blistering caused 
by mutations in the gene encoding type VII collagen and are predisposed to develop life-threatening 
squamous cell carcinoma (SCC) at an early age. We have previously demonstrated very few differences 
between primary SCC tumour keratinocyte cultures derived from RDEB and non-RDEB patients. Here, 
we examined the contribution of the stromal fibroblasts in the development of RDEBSCC. Global gene 
expression analysis was performed using isolated primary normal human fibroblasts, SCC fibroblasts 
isolated from UV induced tumours, RDEB fibroblasts (derived from SCC-free RDEB patients) and 
RDEBSCC fibroblasts. Hierarchical clustering analysis identified RDEBSCC fibroblasts as the most 
dysregulated group, while RDEB fibroblasts was identified as sharing a similar gene expression profile 
with that of SCC fibroblasts. Functional analysis highlighted the involvement of extracellular matrix (ECM) 
genes such as ITGA6, ITGA3, COL5A1, COL12A1, THBS1 which are influenced directly or indirectly by 
TGF-beta signaling. We also confirmed the dysregulation of these ECM components at a protein level via 
immunoblotting. The involvement of ECM proteins in RDEBSCC tumourigenesis was further confirmed 
in cell adhesion assays where normal and tumour keratinocytes were 1.34 to 4.16 times significantly 
more adhesive on RDEBSCC fibroblast-derived matrices compared to normal, SCC and RDEB fibroblast-
derived matrices. Together, our in vitro results suggest that the RDEB dermal microenvironment may be 
conducive to tumourigenesis and that it is the transformation from RDEB to RDEBSCC fibroblasts that may 
be crucial in accounting for the aggressive nature of SCC observed in RDEB patients.
191
Anogeissus leiocarpus extract acts as a (photo)ageing repair ingredient in an ex vivo human 
skin model
Hugo Corstjens1, Dominique Clio1, Ann Neven1, Lieve Declercq1, Daniel B Yarosh2 1Estée Lauder 
Companies, Oevel, Belgium, 2Estée Lauder Companies, Melville, NY, USA
In chronically photoaged skin, the fibrillin-rich microfibrils, key structural components of the 
dermal extracellular matrix, are extensively remodelled and the microfibrils that are found in 
close proximity to the dermal epidermal junction are markedly reduced. Additionally there is 
a loss of mature dermal collagen, with an involvement of the MMP family of matrix degrading 
enzymes. An ex vivo skin model was designed to mimic these features of the photoageing 
process, based on treatment of ex vivo skin for 9 days with 500 µM of methylglyoxal as a stress 
inducing agent. An extract of the bark of Anogeissus leiocarpus was evaluated in this model 
and compared to all-trans retinoic acid. Topical treatment of ex vivo skin with the Anogeissus 
leiocarpus extract caused a marked increase in the fibrillin-1 containing microfibrils in the 
‘aged’ conditions to a level exceeding the non-aged untreated control (p< 0.001). This effect 
was equally strong as that of the all-trans retinoic acid control. Both Anogeissus leiocarpus 
extract and all-trans retinoic acid restored collagen-1 staining in the papillary dermis (p<0.05) 
in the “aged” conditions. The photoageing repair activity of Anogeissus leiocarpus extract in this 
model was further demonstrated by a markedly reduced expression of MMP-2 in the epidermis 
of human skin explants exposed to ‘ageing’ conditions (p=0.01), an activity not observed for all-
trans retinoic acid. In vitro experiments additionally revealed that Anogeissus leiocarpus extract 
possessed strong antioxidant activity and potently inhibited MMP-2. These data support the use 
of this Anogeissus leiocarpus bark extract as anti-ageing ingredient.
192
Anti-aging evaluation of two hyaluronic acid dermal fillers in an ex vivo photodamaged human 
skin model
Daniel Bacqueville1, Sylvie Boisnic2, MC Branchet2, Sandrine Bessou-Touya1, Hélène Duplan1
1Laboratoire de Pharmacologie tissulaire et Pharmacocinétique cutanée Département de 
Pharmacologie in vitro Centre de Recherche et Développement Pierre Fabre, Toulouse, France, 
2Groupe de Recherche et d’Evaluation en Dermatologie et Cosmétologie, Paris, France
Injection of hyaluronic acid-based filler (HA filler) is becoming widely used for the treatment of 
facial aging in aesthetic medicine. Although clinical trials have shown the HA filler efficacy in 
skin rejuvenation, little information is currently available concerning the evaluation of the anti-
aging benefits of HA fillers in alternative skin models. In this study, two different HA fillers (A 
and B) were injected into the dermis of human skin explants (8 donors). The tissues were UVA+B 
irradiated before filler injection and maintained in ex vivo organotypic culture for several days to 
mimic skin photoaging. Thereafter, the HA filler effects were evaluated by histological stainings 
(red sirius and blue alcian for collagen fibers and glycosaminoglycans (GAG), respectively) 
and quantitative analysis by using biochemical assays (collagen, GAG and elastin). Histology 
revealed that the filler injection significantly increases the collagen content in the dermis in 
contrast to both non-treated and phosphate-buffered saline (PBS)-injected skin. The GAG 
content rose up in response to filler injection although the PBS injection also stimulated GAG in 
comparison with control skin. Biochemistry confirmed that fillers induce collagen neosynthesis 
and slighty increase elastin synthesis. In contrast to filler A, the filler B was unable to stimulate 
GAG neosynthesis. Thus, the photodamaged human skin model allowed the evaluation of the 
anti-aging effects of HA dermal fillers and showed distinct filler behaviours on extracellular 
matrix, suggesting both remodelling and stretching mechanisms in face rejuvenation.
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The role of the basement membrane in normal epidermal homeostasis
Supatra Marsh, Vera Martins, Edel O’Toole Centre for Cutaneous Research, Blizard Institute of 
Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK
The basement membrane of skin has an essential structural role in aiding the tight attachment 
of the epidermis to the underlying dermis. In addition to its structural properties the basement 
membrane is also an important mediator of keratinocyte homeostasis, adhesion, proliferation, 
migration and gene expression. In this study we investigate the role of the basement membrane 
proteins, collagen IV, collagen VII and laminin 332 in epidermal homeostasis. Stable knock down 
of each basement membrane protein was successfully performed using lentiviral shRNA particles 
in an epidermal cell line (NTERT). Immunostaining of cells on monolayer suggests there is a 
difference in the pattern of localisation of β1 integrin in cells with loss of collagen VII and Laminin 
332 (alpha 3 chain) when compared to control cells. β1 integrin plays a fundamental role in the 
attachment of keratinocytes to the underlying basement membrane and is important for basement 
membrane maintenance. Preliminary results suggest that loss of basement membrane proteins is 
influencing β1 integrin expression. The consequence of the loss of these basement membrane 
proteins on keratinocyte homeostasis will be further investigated and discussed. Experiments in 
progress include 3D organotypic cultures on de-epidermalised dermis of knock down cells to 
examine the role of collagen IV, collagen VII and laminin 332 in differentiation, proliferation and 
stem cell homeostasis in the epidermis.
194
Genetic and pharmacologic ablation of EGFR reveals its role as endogenous anti-inflammatory 
agent in mouse and human skin
Francesca Mascia, Gary Lam, Stuart Yuspa NCI/NIH, Bethesda, USA
The clinical use of several anti EGFR agents in patients suffering from colorectal, pancreatic 
and head and neck cancers revealed common adverse effects targeting skin and skin adnexa. 
To gain insight into the etiology of these common adverse effects, we developed an epidermally 
targeted mouse model of EGFR ablation. EGFR was ablated in the epidermis in the litters derived 
from Keratin 5 driven Cre recombinase transgenics crossed with EGFR floxed mice. The skin 
of double transgenic mice reproduces the hallmarks of the skin lesions of patients undergoing 
chemotherapy with anti EGFR agents: inflamed, pruritic, dry skin with neutrophilic pustules and 
infiltration of mast cells, macrophages and lymphocytes. Tissue samples isolated from skin of 
double transgenics contained high mRNA levels of a subset of inflammatory mediators namely 
TNF-alpha, IL-18, IL-1beta, IL-1ra, G-CSF, iNOS and CCL2. Higher levels of these mediators were 
also measured in plasma of double transgenics. We crossed EGFR ablated mice with knockout 
mice that were missing critical regulators of the highlighted inflammatory pathways such as 
TNFR1/2 and iNOS. We also used neutralizing G-CSF antibodies in the attempt to rescue or 
ameliorate the phenotype. None of these pathways alone proved critical for the development of 
the full phenotype of the double transgenic mice. This demonstrates that TNF-alpha, iNOS and 
G-CSF are not the primary drivers that produce the lesions developed in absence of a functional 
EGFR pathway in epidermis. Currently we are crossing double transgenic mice with CCR2 and 
Myd88 knockout mice.
195
Integrated Positron Emission Tomography and Computed Tomography Manifestations of 
Cutaneous T-Cell Lymphoma
Maria Kamstrup, Robert Gniadecki, Lars Friberg Bispebjerg Hospital, Copenhagen, Denmark
The purpose of this retrospective study was to evaluate the application of integrated 
18F-fluorodeoxyglucose positron emission tomography (PET) and computed tomography (CT) 
in mycosis fungoides (MF) and Sézary Syndrome (SS). All patients referred to our cutaneous 
lymphoma clinic with a pathological diagnosis of MF (n=36) and SS (n=6) and who underwent 
FDG-PET/CT scanning over a 4-year period were enrolled. Results of PET/CT scans were 
correlated to clinical data. Overall, PET findings were considered positive for lymphoma 
involvement in 12 of 45 scans (26%), of which there was 4% in stage I (1/25) and 55% in 
stage II-IV (11/20). Cutaneous lesions of patches, plaques (except one case with ulceration) 
and erythroderma showed no abnormalities at PET/CT, whereas tumors were detected. PET/CT 
demonstrated FDG-uptake in lymph nodes of patients with transformed MF, which correlated 
with clinical lymphadenopathy. 2 MF patients had clinically enlarged nodes, which were not 
found by PET/CT. 7 MF patients had no clinical lymphadenopathy but discretely increased FDG-
uptake considered of equivocal clinical significance and all had stable disease at last follow-up. 
FDG-avid lymphadenopathy was observed in 4 SS patients of which 2 had biopsy proven nodal 
involvement. PET/CT did not detect any unsuspected visceral lymphomatous involvement. In 
conclusion, we found no evidence that PET/CT provides additional information to a thorough 
physical examination in assessing cutaneous disease in MF and SS and whereas FDG/PET verified 
the clinical suspicion of nodal disease, it did not detect any unsuspected nodal or visceral 
lymphoma involvement.
196
Histopathology of positive skin tests in different drug eruptions
Margarida Gonçalo1,2, David Serra1, Ana Rita Cabral1, José Pedro Reis1, Oscar Tellechea1,2 1Clinic 
of Dermatology, University Hospital, Coimbra, Portugal, 2Department of Dermatology, Faculty of 
Medicine, University of Coimbra, Coimbra, Portugal
Skin testing, particularly patch testing, is increasingly used in the study of delayed adverse 
drug eruptions. Positive reactions often display distinct and variable morphology. Our aim 
was to understand the reaction pattern of skin tests used in the evaluation of drug eruptions. 
An histopathological study of positive patch tests and 1 intradermal test, biopsied at Day 3, 
was performed in 7 patients (5 males/2 females) aged 49-69 years, with different types of drug 
eruptions: 3 acute generalized exanthematous pustulosis (AGEP) from ciprofloxacine, acyclovir 
and diltiazem, one drug reaction with eosinophilia and systemic symptoms (DRESS) from 
abacavir, one toxic epidermal necrolysis (TEN) from carbamazepine, one eczematous plaques 
from heparin and one fixed drug eruption (FDE) from piroxicam. Tests clinically resembled the 
drug eruption pattern with pustular and bullous reactions in AGEP and TEN, respectively. They 
also reproduced the original histological pattern: spongiform intraepidermal pustules in all cases 
of AGEP; extensive epidermal necrosis with apoptotic keratinocytes in TEN; exuberant vesicular 
dermatitis with exocytosis of atypical lymphocytes in small microabcesses in DRESS; scattered 
apoptotic keratinocytes and a dermal lymphocytic infiltrate intermingled with the melanophages 
in FDE. Eosinophils were present in most cases. The intradermal test to heparin induced a 
classical acute eczematous reaction. Skin tests, particularly patch tests, commonly reproduce the 
original lesional pattern of the drug eruption, both clinically and on histology. Therefore, apart 
from helping in the identification of the culprit drug, they also contribute to the understanding of 
pathomechanisms involved in drug eruptions.
197
Development of a disease-specific quality of life instrument for autoimmune bullous 
dermatoses: the ABQOL
Anna Hanna1,4, Deshan Sebaratnam1, Shienning Chee1, John Frew1, Supriya Venugopal1,4, Linda 
Martin1, Lesley Rhodes1, Belinda Walsh2, Tamar Nijsten3, Dedee Murrell1,4 1Department of 
Dermatology, St George Hospital, Sydney, Australia, 2St Vincents Hospital, Melbourne, Australia, 
3Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands, 4University of New 
South Wales, Sydney, Australia
Evaluation of quality of life (QOL) provides a suitable means to monitor disease trajectory and 
capture outcomes of intervention for many dermatoses. Disease-specific instruments are the 
most sensitive tools in this domain. The aim of this study was to develop a QOL instrument 
specific to autoimmune bullous disease (AIBD). Non-structured interviews were conducted with 
26 AIBD patients and a focus group held for item generation until saturation was achieved. 
The 88 items generated were reduced to form a pilot quality of life in autoimmune bullous 
disease (ABQOL) questionnaire of 45 questions, which was distributed to 73 AIBD patients across 
Australia along with the Dermatology Life Quality Index (DLQI). Experts in bullous disease were 
consulted to refine the pilot ABQOL before factor analysis was performed stratifying each item 
under the subscales “symptom”, “function” or “emotion” to yield the final ABQOL questionnaire 
of 17 questions. Face and content validity were established through the comprehensive patient 
interview process and expert review. The ABQOL demonstrated satisfactory discriminative 
validity (R<0.52) and convergent validity (R=0.628). It was also found to be a reliable instrument 
evaluated by internal consistency (Cronbach alpha coefficient = 0.827) and a test re-test reliability 
of 0.88-0.98. No items were considered difficult, and response distribution was optimal for most 
questions. It was qualitatively found to have fewer insensitive items than the DLQI (p<0.01). The 
ABQOL has been shown to be a valid and reliable instrument which may to be used to monitor 
disease activity and serve as an end-point in clinical trials.
198
Filaggrin loss-of-function mutations and clinical eczema are associated with food sensitization 
at three months of age
Carsten Flohr1,2, Kirsty Logan1, Tom Marrs1, Linda Campbell3, Suzana Radulovic1, Irwin McLean3, 
Jonathan Barker2, Gideon Lack1, Michael Perkin1 1Department of Children’s Allergies, MRC/
Asthma UK Centre for Allergic Mechanisms of Asthma, King’s College London, London, UK, 2St 
John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, 
UK, 3Division of Molecular Medicine, University of Dundee, Dundee, UK
Eczema commonly precedes food allergies, suggesting that the inflamed skin barrier in 
eczematous skin facilitates allergic sensitisation. We therefore studied the association between 
FLG mutation carriage, skin barrier impairment, eczema and allergic sensitisation to foods 
at three months of age.179 exclusively breastfed infants were examined for eczema. Disease 
severity was determined by SCORAD. Transepidermal water loss (TEWL) was measured on 
unaffected forearm skin. Venous blood samples were screened for the four commonest FLG 
mutations (R501X, 2282del4, R2447X, and S3247X). All children were also skin prick tested to 
six foods (cow’s milk, egg, cod, wheat, sesame, and peanut). Children carrying a FLG mutation 
were significantly more likely to be sensitized to at least one of the six foods (OR=4.23, 95% 
CI 1.14-15.74, p=0.03). The association with sensitization was even stronger for children with 
eczema (OR=10.35, 2.61-41.13, p<0.001). However, skin barrier impairment (TEWL >=15) in 
the absence of eczema was not significantly associated with food sensitization (OR=2.53, 0.74-
8.67, p=0.14), and the association between eczema and food sensitization remained significant 
and strong, even after adjustment for FLG mutation carriage (adjusted OR=8.56, 2.03-36.03, 
p=0.003). Although FLG mutation carriage is associated with food sensitisation risk at three 
months of age, this is due to its association with clinical eczema. Eczematous skin inflammation 
is the main skin-related risk factor for food sensitisation already by three months of age, and in 
exclusively breastfed infants this suggests that allergic sensitisation to foods occurs across the 
inflamed skin barrier rather than the gut mucosa.
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miR-122 regulates the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma via p53/
Akt signalling
Valentina Manfé1, Edyta Biskup1, Anne Rosbjerg1, Maria Kamstrup1, Britt Thyssing Lauenborg1,2, 
Robert Gniadecki1,2 1Bispebjerg Hospital, Copenhagen, Denmark, 2University of Copenhagen, 
Copenhagen, Denmark
Advanced cutaneous T-cell lymphomas (CTCL) are resistant to chemotherapy and present a 
major area of medical need. In view of the known role of microRNAs (miRNAs) in the regulation 
of cellular signalling we aimed to identify the functionally important miRNA species, which 
regulate apoptosis in CTCL. We showed for the first time that miR-122, previously thought to 
be specific for liver, is expressed in vivo in lymphoma cells in CTCL and is further induced 
during chemotherapy-induced apoptosis. The miR-122 induction occurs via p53 and protects 
against chemotherapy-induced cytotoxicity. The likely mechanism by which miR-122 exerts its 
cytoprotective effect in lymphoma cells involves activation of Akt and inhibition of p53. miR-122 
inhibition using miR-122 hairpin inhibitor has an opposite effect and potentiates chemotherapy-
induced apoptosis. Therefore, our finding identifies a critical role of miR-122 as amplifier of the 
antiapoptotic Akt/p53 circuit in malignant T-lymphocytes and provides new insight into the p53-
mediated regulation of miRNAs.
200
MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma 
cells
Valentina Manfé1, Edyta Biskup1, Peter Johansen2, Maria Kamstrup1, Niels Morling2, Hans 
Christian Wulf1, Robert Gniadecki1 1Bispebjerg Hospital, Copenhagen, Denmark, 2University of 
Copenhagen, Department of Forensic Medicine, Copenhagen, Denmark
P53 is rarely mutated in cutaneous T-cell lymphomas (CTCL) and is therefore a promising target 
for novel therapeutic approaches. Nutlin-3a is a recently developed inhibitor of MDM2, a critical 
negative regulator of p53. Nutlin-3a disrupts the p53-MDM2 interaction leading to stabilization 
and activation of p53. We show here that nutlin-3a activates p53 in CTCL cells carrying 
a wild type (wt) p53 resulting in cell cycle arrest and/or apoptosis. This effect was abolished 
in cells in which p53 was silenced by specific siRNA and in cells which have mutated p53. 
Moreover, nutlin-3a strongly improved the efficacy and enabled dose reduction of conventional 
chemotherapeutic (e.g. doxorubicin and bortezomib). We have also demonstrated that nutlin-3a 
induced premature senescence in p53wt cells as demonstrated by the permanent G0/G1 cell 
cycle block and expression of the senescence-associated-β-galactosidase. Thus, targeting p53 by 
nutlin-3a or other drugs may constitute a novel therapeutic approach in CTCL due to increased 
apoptosis and senescence of tumor cells.
201
Hyalurosome located in keratinocyte filopodia is the target of corticosteroid-induced epidermal 
atrophy
Laurent Barnes1, Frédérique Ino1, Fabienne Jaunin1, Pierre Carraux1, Denise Grand1, Jean-Hilaire 
Saurat2, Gürkan Kaya1 1University Hospital of Geneva, Geneva, Switzerland, 2Swiss Center for 
Applied Human Toxicology, Geneva, Switzerland
Topical corticosteroids are largely used in dermatology as anti-inflammatory drugs. A main 
limitation for their use is their atrophic effects on the skin. The mechanism leading to skin atrophy 
is still not well understood. We have previously proposed a membrane organelle, hyalurosome, 
composed of molecules involved in hyaluronate (HA) metabolism and cell signaling in the 
keratinocytes which is functionally defective in dermatoporosis, a chronic cutaneous insufficiency/
fragility syndrome. In this study we explored the molecular mechanisms of skin atrophy induced 
by corticosteroids in vivo and in vitro. We observed an important skin atrophy and a complete 
disappearance of HA and its main cell surface receptor CD44 in mouse skin treated with topical 
clobetasol propionate (CP), one of the most potent pro-atrophic corticosteroids. Hyaluronate 
fragments of defined size (HAF) significantly reduced the epidermal atrophy and restored the 
CD44 and HA expression. Human keratinocytes exposed to CP showed an impaired HA secretion 
and diminished expression of CD44 and hyaluronate synthase 3 (HAS3) as shown by quantitative 
PCR. We also showed that in keratinocytes treated by CP, filopodial structures, which are known 
to be dependent on HAS activity and where CD44 is expressed, were abolished together with a 
redistribution of CD44 and F-actin rearrangement. Our results suggest that hyalurosome located 
in keratinocyte filopodia is the target of corticosteroids for their epidermal atrophogenic actions 
and that the protection of filopodial structures by HAF might explain their anti-atrophic effects. 
These observations may lead to the development of novel treatment and prevention strategies in 
corticosteroid-induced skin atrophy.
202
PGD2 acts on sebocytes to induce eotaxin-3/CCL26 through PPARγ: a possible involvement of 
the pathogenesis of eosinophilic pustular folliculitis
Kyoko Nakahigashi, Atsushi Otsuka, Hiromi Doi, Yoshiki Miyachi, Kenji Kabashima Department 
of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Eosinophilc pustular folliculitis (EPF) is a chronic intractable pruritic dermatosis, which is 
histologically characterized by a massive eosinophil inflammatory infiltrate involving the 
pilosebaceous units. However, its pathogenesis, especially how eosinophils infiltrate the 
pilosebaceous area, remains unknown. One clue to this end is an evidence of successful 
treatment of EPF by indomethacin, a cyclooxygenase (COX) inhibitor. This finding suggests 
that COX metabolites prosganlandins (PGs) are involved in the etiology. We firstly found that 
the infiltrating inflammatory cells in EPF lesions were strongly stained for hematopoietic-
PGD synthase (h-PGDS), implying that abundant PGD2 is produced in the lesions. PGD2 is 
known to act on DP and CRTH2 and immediate metabolite of PGD2, PGJ2, act on peroxisome 
proliferator-activated receptor gamma (PPARγ) to elicit its physiological functions. We observed 
that PGD2 strongly attracts eosinophils using chemotaxis assay via PGD2-CRTH2 signaling. In 
addition, we found that PGD2 increased mRNA expression levels of eotaxin-3/CCL26 which is 
a chemoattractant for eosinophils in sebocytes. Further examinations revealed that induction of 
eotaxin in sebocytes is mediated via PPARγ using specific agonists and antagonists. Lastly, we 
confirmed that eotaxin-3 expression was immunohistochemically intensified in sebaceous glands 
of EPF lesions. These results provided the evidence that massive eosinophils infiltrates around 
pilosebaceous in EPF is mediated by PGD2 through CRTH2 and PPARγ pathway, which sheds a 
light to reveal the pathogenesis of EPF.
203
Interleukin-31 - a new link between T cells and pruritus in atopic skin inflammation
Bettina Alexandra Buhren1, Gabriela Kukova1, Attila Antal1, Ulrich Pippirs1, Ferda Cevikbas2, 
Holger Schrumpf1, Peter Arne Gerber1, Martin Steinhoff2, Bernhard Homey1 1Department 
of Dermatology, University Hospital Duesseldorf, Duesseldorf, Germany, 2Department of 
Dermatology, University of California San Francisco, San Francisco, California, USA
Recently, it has been shown that Interleukin 31 (IL-31), a novel, mainly T cell-derived cytokine, 
induces severe pruritus and dermatitis in transgenic mice, and signals through a heterodimeric 
receptor composed of interleukin-31 receptor A (IL-31RA) and oncostatin M receptor (OSMR). 
The expression of IL-31 and its receptor heterodimer was analyzed by quantitative real-time PCR 
in skin samples of healthy individuals and patients with chronic inflammatory skin diseases. 
Moreover, IL-31 expression was analyzed in human leukocytes subsets and in serum of atopic 
dermatitis patients after superantigen exposure. The tissue distribution of the IL-31 receptor 
heterodimer was investigated by DNA microarray and immunofluorescence analysis. STAT3 
activation was determined using Western-blot and immunofluorescence analysis. Ca2+ imaging 
of murine DRG neurons was performed. IL-31 was significantly overexpressed in ‘pruritic’ atopic 
compared to ‘non-pruritic’ psoriatic skin inflammation. In atopic dermatitis patients, activated 
leukocytes expressed significantly higher IL-31 levels as compared to control subjects. IL-31 
receptor heterodimer showed abundant expression in small dorsal root ganglia (DRG) neurons 
representing pruritoceptive DRG. IL-31 induced the STAT3 phosphorylation in murine DRG with 
a maximum within 20 min. IL-31 induces Ca2+ intracellular release in murine DRG neurons. 
Our findings provide a new link between staphylococcal colonization, subsequent T cell 
activation and pruritus induction in atopic dermatitis patients. Moreover, our data show possible 
IL-31 induced pruritus ascending from the skin and signaling over DRG neurons, where the cell 
bodies of cutaneous sensory neurons reside. Taken together, IL-31 may represent a novel target 
for antipruritic drug development.
204
Tumour-infiltrating lymphocytes are an important prognostic factor of angiosarcoma
Hiroko Fujii1, Akiko Arakawa2, Akihiko Kitoh1, Keisuke Konishi3, Shigetoshi Sano4, Yoshiki 
Miyachi1, Miki Tanioka1 1Department of Dermatology, Kyoto University Graduate School of 
Medicine, Kyoto, Japan, 2Department of Dermatology, University of Lübeck, Lübeck, Germany, 
3Kyoto City Hospital, Kyoto, Japan, 4Department of Dermatology, Kochi Medical School, Kochi, 
Japan
Previous reports indicated tumor-infiltrating lymphocytes (TILs) as one of the prognostic factors 
of cutaneous angiosarcoma. Immunotherapy with TILs had a strong impact on the clinical course 
of angiosarcoma in a case report. However the T cell subsets of TILs had not been fully analyzed. 
To investigate whether TILs and the subsets have a relation with the clinical course or the 
prognosis of patients with angiosarcoma, immunohistochemical analysis of TILs of angiosarcoma 
was performed. Non-treated primary tumor specimens from 21 patients with stage 1 cutaneous 
anigosarcoma were evaluated retrospectively by immunohistochemistory stained CD4, CD8, 
FOXP3, and Ki67. The Kaplan-Meier method was used to estimate overall survival. Survival 
differences were analyzed by the log-rank test based on the number of TILs and its subsets or 
Ki67-index of the primary tumors. Patients with higher numbers of TIL, CD8+ T cells and higher 
ratio of CD8 / CD4 in their primary tumors demonstrated longer survival compared with patients 
with lower ones. To compare immunological parameters with healthy controls, the percentage 
and cytokine productions of CD8+ and CD4+ T cells in peripheral blood mononuclear cells 
(PBMC) were assessed by flow cytometoric analysis. The percentages of CD8+ and CD4+ T cells 
producing IFN-γ in PBMC were significantly higher in patients with angiosarcoma compared 
with that of healthy controls. This study provides the importance of T cell subsets of TILs for the 
prognosis of patients with angiosarcoma.
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Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma 
with percutaneous peptide immunization
Taisuke Ito1, Toshiharu Fujiyama1, Isao Oze1, Keitaro Matsuo1, Ryosuke Hino3, Shuhei Imayama2, 
Satoshi Hirakawa1, Yoshiki Tokura1 1Hamamatsu University School of Medicine, Hamamatsu, 
Japan, 2IMAYAMA Clinic and Lab, Fu Kuo Ka, Fukuoka, Japan, 3University of Occupational and 
Environmental Health, Kitakyushu, Japan
Malignant melanoma (MM) often shows multiple chemo-resistance, leading to poor prognosis. 
Line of evidence in tumor-specific antigen for MM suggests clinical potential of therapeutic anti-
cancer vaccination. Therefore, we carried out percutaneous peptide immunization (PPI) based 
on HLA typing towards advanced MM patients. We examined 33 patients about an induction of 
antigen-specific cytotoxic T cells (CTL). Eighteen patients (54.5%, 95% confidence interval: 36.4-
71.9) achieved successful induction of peptide-specific CTL and were classified as responders. 
Remaining 15 patients were classified as non-responders. Overall survival among CTL-responded 
group was significantly longer than that among CTL non-responded group (MST; not reached vs 
20.3 months, logrank p=0.034). A multivariate Cox regression model revealed a hazard ratio for 
responders relative to non-responders was 0.20 (0.05-0.74, p=0.017). These results indicate that 
the induction of peptide-specific CTL by PPI contributes to the prolonged survival, and represents 
a clinical impact on therapeutic approaches in malignant melanoma.
206
Synthesis and characterization of high-quality skin-cooling sheets containing thermosensitive 
poly(N-isopropylacrylamid)
Yoshiaki Takegami1, Yoshiyuki Yokoyama2, Osamu Norisugi1, Kenji Matsunaga1, Teruhiko Makino1, 
Tadamichi Shimizu1 1University of Toyama, Toyama, Japan, 2Toyama Industrial Technology Center, 
Toyama, Japan
Poly(N-isopropylacrylamide) (PNIPAAm) is the most popular thermosensitive polymer, and 
exhibits a low critical solution temperature of approximately 32°C. This study aimed to examine 
the usefulness of new cooling sheets, which are manufactured using a thermosensitive poly(N-
isopropylacrylamide) (PNIPAAm) material. We prepared cooling-hydrogel sheets containing 
PNIPAAm (PNIPAAm sheet). We measured the skin temperature on the arms of the subjects 
using a thermograph and compared the usefulness of the PNIPAAm sheet and a control cooling-
hydrogel sheet that did not contain the PNIPAAm mixture. Thermographic measurements 
obtained 40 min after the treatment with the cooling sheets showed the skin temperature of the 
subjects treated with the 3.0 % (w/w) PNIPAAm sheets to be significantly lower than that of the 
subjects treated with the control cooling-hydrogel sheet (p < 0.005). Compared to the control 
sheet, the cooling effect of the new PNIPAAm sheet also persisted for a longer duration (up to 
100 min). The PNIPAAm sheets exhibited excellent cooling effects. This sheet may therefore be 
useful for lowering the body temperature of patients with high-grade fever, such as fever due to 
influenza infection.
207
Screening of plants for inhibitory activity against hyaluronate-lyase from Propionibacterium 
acnes
Pavel Klein1, Dagmar Cozikova2, Jiri Betak2, Martina Novotna1, Ilona Matejkova1, Vladimir 
Velebny1,2 1Contipro C, a.s., Dolni Dobrouc 401, Czech Republic, 2CPN, spol.s.r.o., Dolni 
Dobrouc 401, Czech Republic
Propionibacterium acnes belongs to the bacteria producing hyaluronate-lyase, one of the 
factors involved in the pathogenesis of acne. As hyaluronan is an important component of the 
extracellular skin matrix, the enzyme contributes to the damage of skin and impairment of the 
complexion. The aim of this study was to determine inhibitory activity of crude MeOH extracts 
of some medical plants against this therapeutical target. Based on the results obtained using gel 
zymography, rheological measurements and determination of products of beta-ellimination, it 
has been shown that from the total 31 plants included in the screening, 11 samples showed 
significant inhibitory activity, among them extracts from Epilobium angustifolium, Calluna 
vulgaris and Geum urbanum were the most potent. These plants represent accessible sources of 
compounds which could be usable in protection of the acneous skin as the active components of 
gels, lotions, creams, emmulsions, sticks, etc.
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Monthly Pulse Azithromycin Versus Daily Doxycycline In The Treatment Of Inflammatory Acne 
Vulgaris
Nabil Kamel, Ossama Hussein, Walaa Safwat Faculty Of Medicine, Alexandria University, 
Alexandria, Egypt
Antibiotic therapy remains one of the main lines of acne therapy.  In the present study 20 
patients complaining of facial inflammatory acne (10 or more lesions) have been treated with 
oral antibiotic, 10 patients were given daily doxycycline 100 mg ,another 10 patients were 
given azithromycin 500 mg monthly pulse dose for three consecutive days for three successive 
months, in addition topical anti-acne treatment was used by all patients namely azelaic acid 20% 
cream every afternoon for 15 minutes for acne lesions and adapalene 0.1% for the whole face 
every night. From the results of this study, the use of monthly pulse azithromycin in treatment of 
inflammatory acne has a better effect than doxycycline ,by less frequent doses, more compliance 
and less side effects.
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A novel chromosomal translocation causing COL1A2 to PDGFB gene fusion in 
dermatofibrosarcoma protuberans: a new insight into the oncogenic mechanism of DFSP
Ikumi Nakamura, Kiyohito Taira, Hiroshi Uezato, Kenzo Takahashi Department of Dermatology, 
University of the Ryukyus, Graduate School of Medicine, Nishihara-cho, Okinawa, Japan
Dermatofibrosarcoma protuberans (DFSP) is an intermediate grade malignancy of subcutaneous 
fibroblasts with frequent local recurrences but rare metastasis. Cytologically, DFSP cells 
often harbor the characteristic supernumerary ring chromosomes. In most DFSP cases, the 
chromosomal translocation are noticed between collagen1α1 (COL1A1) and platelet derived 
growth factor B (PDGFB) genes. However, in some DFSP cases, the COL1A1-PDGFB fusion is 
not found even with thorough RT-PCR analysis. A 25 years Japanese female patient suffered from 
subcutaneous nodule at her left arm for one year, and she was diagnosed as DFSP. We found that 
tumor cells showed the expression of PDGF immunohistochemically but lacked the gene fusion 
of COL1A1-PDGFB. We then tried to find out the oncogenic context of PDGF expression in this 
DFSP cells by several rounds of RT-PCR. We eventually identified that the exon 26 of collagen1α2 
(COL1A2) gene was fused in frame with the exon 2 of PDGFB gene and the expression of PDGF 
was consequently induced. Type I collagen is a heterotrimer composed of two α1 chains and a 
single α2 chain, and thus both α1 and α2 genes have strong promoter activities in fibroblasts. 
The activator domain of PDGFB is located at the exons 4 and 5, and thus the COL1A2 driven 
PDGFB is considered to promote the oncogenic proliferation of DFSP cells through the autocrine 
or paracrine stimulation. We further expect that other gene than COL1A1 and COL1A2, which 
might have high activity in fibroblasts, would contribute to the tumorigenesis of DFSP.
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Laboratory parameters and new diagnoses of selected metabolic-related diseases after initiation 
of systemic treatment for psoriasis. Evidence from the Italian Psocare registry
Paolo Gisondi1, Simone Cazzaniga2, Sergio Chimenti3, Alberto Giannetti4, Mara Maccarone5, 
Carlo Tomino6, Antonio Addis6, Giampiero Girolomoni1, Luigi Naldi2 1Department of Medicine, 
Section of Dermatology and Venereology, University of Verona, Verona, Italy, 2GISED Study 
Centre, Ospedali Riuniti, Bergamo, Bergamo, Italy, 3Department of Dermatology, University of 
Rome “Tor Vergata”, Rome, Italy, 4Department of Dermatology, University of Modena and Reggio 
Emilia, Modena, Italy, 5Italian Psoriatic Patient Association (ADIPSO), Rome, Italy, 6Italian Drug 
Agency (AIFA), Rome, Italy
We evaluated variations in laboratory parameters and incident diagnoses of selected clinical 
conditions up to 16 weeks after the starting of a new systemic treatment for psoriasis in patients 
(n= 10.539) enrolled in the Psocare registry. Overall means and proportion of patients reaching 
a clinically meaningful increase of serum levels of total and high density lipoprotein (HDL) 
cholesterol, triglycerides, aspartate amino transferase (AST), alanine amino transferase (ALT), 
creatinine). Any new diagnosis of diabetes mellitus and hypertension, were also evaluated, and 
their cumulative incidence estimated at week 16. Means values of total and HDL cholesterol as 
well as triglycerides significantly increased after 8 and 16 weeks in patients treated with acitretin 
(n=1293) and cyclosporine (n=1833). A limited increase of the means of both AST and ALT values 
was observed in patients treated with methotrexate (n=967), and of AST only in those treated with 
infliximab (n=781). The average value of serum creatinine as well as systolic and diastolic blood 
pressure significantly increased in patients receiving cyclosporine (n=3463). The relative risk of 
developing hypertension and diabetes at week 16 was higher for patients receiving cyclosporine 
(n=1840). Acitretin was associated with the risk of developing hypercholesterolemia (OR 1.51) 
and hypertriglyceridemia (OR 1.43). Methotrexate and infliximab were associated with the risk 
of developing an increase ≥ 2 times of AST (OR 2.06 and 1.87) and ALT (OR 2.38 and 1.74). 
Systemic treatments for psoriasis had heterogeneous effects on the laboratory parameters.
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A New Modality in Treatment of Ichthyosis:ByDr. Agharid Al-GammalConsultant of 
DermatologyAin Shams University, Egypt.Chairman of Arab Society for Treatment of Psoriasis
Agharid El Gammal Arab Society for Treatment of Psoriasis, Cairo, Egypt
This is a new modality of treatment of different types of Ichthyosis. Seven hundred eighty two 
patients of different types of Ichthyosis were treated in the period between May 2009 to August 
2010. All types of Ichthyosis irrespective to sex or age were included in this study. The well-known 
traditional treatment is in the form of: emollients, preparations containing urea and keratolytics as 
(salicylic acid). Other forms of organic hydroxyacids as (lactic and glycollic acids), retinoid group 
(acitretin) and 10% of cholesterol cream in X-linked Ichthyosis are also used. This new modality is 
a combination of propolis and aloevera and a mixture of seven natural oils. The seven natural oils 
included sag oil, Lipedium Satuvum and other oils. The role of this combination is to counteract 
the pathogenesis of Ichthyosis as improvement of protein biosynthesis and cell maturation and 
improved wound healing in addition to its antioxidant and anti inflammatory effects. The average 
period of treatment was 6-12 weeks. The results were evaluated clinically, statistically and 
through patient satisfaction as follows: Five hundred fifty nine patients with Ichthyosis Vulgaris 
(most common type) showed complete resolution, Epidermolytic hyperkeratosis (80.2%), 
X-linked recessive Ichthyosis (87.5%), Ichthyosis Hystrix (63.3%). This combination of a natural 
origin is a successful and effective tool for treatment of this chronic perplexing skin condition.
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A handmade, low-cost intraoperative fluorescence navigation system with indocyanicne green 
for sentinel lymph node biopsy in skin cancer
Yasuhiro Fujisawa, Yasuhiro Nakamura, Yasuhiro Kawachi, Fujio Otsuka University of Tsukuba, 
Tsukuba, Japan
Sentinel lymph node (SLN) biopsy has become the most widely used procedure to determine 
regional lymph node status. Injection of radiotracer and blue dye is the standard method of 
detecting SLNs. Recently, indocyanine green (ICG) fluorescence imaging has been reported as 
an easy and reliable method. However, an ICG fluorescence detection system costs as high 
as conventional gamma probe system. The purpose of this study was to construct this system 
by using parts commonly available on the market, thereby reducing its cost. We constructed a 
fluorescence detection system using a charge-coupled device camera as the detector and light-
emitting diodes as the excitation light source. SLN biopsy using this system accompanied with 
the conventional method was performed in 14 patients with skin cancer. We could construct our 
system at a cost of less than $1,600. This system could observe lymphatic channels through the 
skin and detected the SLNs in all cases. Although the SLNs in the groin were easily identified 
through the skin, SLNs in the deeper locations, i.e., those in the parotid gland or under the 
muscle, were difficult to detect. Our system could be assembled at a reasonable cost and allowed 
us to detect SLNs efficiently. However, head/neck tumors still require radiotracer because the 
location of SLNs varies and they sometimes drain into the deeper nodes. Despite such limitations, 
it may be used as an alternative to radiotracer for detecting SLNs other than those of head/neck 
tumors.
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Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type 
psoriasis: results of a prospective longitudinal pilot study
Sandra Boehncke1, Rebekka Salgo2, Jurate Garbaraviciene2, Heike Beschmann2, Hanns 
Ackermann3, Falk Rüdiger Ochsendorf2, Wolf-Henning Boehncke2 1Department of Internal 
Medicine 1, Goethe-University, Frankfurt am Main, Germany, 2Department of Dermatology, 
Frankfurt am Main, Germany, 3Department of Biostatistics, Frankfurt am Main, Germany
Patients with moderate-to-severe plaque-type psoriasis exhibit increased cardiovascular 
mortality. Recent publications point towards psoriasis-induced insulin resistance as an important 
pathomechanism driving cardiovascular comorbidity in these patients. As the hormonal 
status in general and Sex Hormone Binding Globulin (SHBG) in particular serve as sensitive 
indicators for insulin resistance, we analysed these parameters in the context of a set of 
multiple additional clinical and laboratory measurements in a cohort of male patients. Of 33 
consecutively enrolled male patients receiving continuous systemic therapy for their moderate-
to-severe plaque-type psoriasis, 23 male patients for whom all parameters could be collected 
over a 24-weeks treatment period were included in this analysis. At baseline, testosterone levels 
varied between 212 and 660 ng/ml (median: 377.0), and SHBG between 11.9 and 46.0 nmol/l 
(median:29.2), thus documenting lack of hypogonadism among these patients. Clinically, 19/23 
patients experienced at least a 50% reduction in their PASI under therapy. Using a multivariate 
regression model to further analyse the sub-group of patients responding to treatment, hs-CRP, 
PASI, leptin, and resistin all improved under effective systemic anti-inflammatory therapy, thus 
loosing their significant influence on SHBG. SHBG performed well as a sensitive biomarker for 
insulin resistance and systemic inflammation in these patients. Its improvement, as well as the 
reduction of resistin serum levels, most likely reflect a state of reduced cardiovascular risk in 
patients undergoing effective continuous systemic therapy. Long-term safety data, generated 
e.g. from psoriasis registries, are needed to assess whether this effect translates into reduced 
cardiovascular mortality.
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The Use of Proteomic Techniques to Identify Novel Alterations in Protein Abundance in 
Psoriatic Skin
James Williamson1, Peter Scheipers2, John Zibert2, Hans-Christian Beck3, Ole Jensen1 1University 
of Southern Denmark, Odense, Denmark, 2LEO Pharma A/S, Ballerup, Denmark, 3Danish 
Technological Institute, Kolding, Denmark
The initial aim of this project was to assess the potential of proteomic techniques for the analysis 
of skin biopsy interstitial fluid, focussing on psoriasis as a disease model. We obtained keratome 
biopsies from psoriasis patients and incubated involved and uninvolved skin in culture media 
for 24 hours. The proteins present in the culture supernatant were cleaned, digested with trypsin 
and derivatised using a stable isotope labelled dimethylation procedure. Derivatised peptides 
from involved and uninvolved psoriatic skin were then pooled, fractionated by capillary HILIC 
chromatography and analysed by reverse phase LC-MS/MS on an LTQ-OrbitrapXL instrument. 
Data were exhaustively searched using a combination of different search algorithms to maximise 
proteome coverage. In order to scrutinize data for functionally interesting proteins, network 
analysis combined with literature searching was performed. These analytical and informatic 
techniques allowed us to indentify several proteins with altered abundance in psoriasis in 
agreement with previously published literature. For example, S100A7 (Psoriasin), Fatty Acid 
Binding protein 5 and the Serpin family of peptidase inhibitors were all found in increased 
levels in psoriatic skin. These findings corroborate our methodology. Additionally, a number of 
proteins with altered abundance which have not previously been associated with psoriasis were 
identified. These data suggest that proteomic techniques, properly applied, may be used for an 
in-depth characterisation of alterations in protein abundance in dermatological disease, likely 
leading to new interesting targets for treatment.
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MAL photodynamic therapy in the treatment of Erythroplasia of Queyrat
Laurence Feldmeyer, Valérie Krausz-Enderlin, Bettina Töndury, Jürg Hafner, Lars E French, 
Günther F.L. Hofbauer Dermatology Department, University Hospital Zurich, Zurich, Switzerland
Erythroplasia of Queyrat (EQ) is an intraepithelial carcinoma of the glans mucosa. Progression to 
invasive carcinoma may occur after a variable period of time. Its cause is unknown, but strong 
evidence suggests infection with human papilloma virus in the pathogenesis of EQ. Therapy is 
difficult and associated with important recurrence rates. Photodynamic therapy (PDT) employs a 
photosensitizer excited by visible light. The resulting photodynamic reaction selectively destroys 
atypical cells. Only few reports exist on the use of topical PDT in the treatment of EQ. We 
report 11 cases of erythroplasia of Queyrat treated by topical methyl aminolevulinic acid (MAL) 
photodynamic therapy. Out of 11 male patients with EQ treated by topical MAL photodynamic 
therapy, two achieved complete remission sustained for 24 and 51 months and four a partial 
remission sustained for 2 to 45 months with a follow-up period of 4 to 45 months (one patient 
lost to follow-up). Five patients showed progression of the disease. Retrospective cases series 
from one centre. No histological validation of remission. Topical MAL-PDT offers the advantages 
of tumour specificity, preservation of function and a good cosmetic result. It is generally well 
accepted by patients and constitutes a reasonable first-line therapeutic option for EQ.
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Resolution of psoriasis by a leukocyte-targeting bacterial protein (LtxA) in a humanized mouse 
model
Karin Stenderup1, Cecilia Rosada1, Tomas N. Dam2, Erica Salerno3, Benjamin A. Belinka4, Scott 
C. Kachlany3,4 1Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark, 
2Department of Dermatology, Roskilde Hospital, Roskilde, Denmark, 3Department of Oral 
Biology, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark, 
New Jersey, USA, 4Actinobac Biomed Inc., North Brunswick, New Jersey, USA
Psoriasis is a chronic inflammatory skin disorder which affects 2-5% of the population 
worldwide. The psoriatic lesions are characterized by epidermal hyperplasia and increased 
influx of inflammatory cells both in the dermis and in the epidermis. Enhanced migration into 
the tissue by inflammatory white blood cells (WBCs) is due to the upregulation and activation 
of adhesion molecules such as leukocyte function antigen-1 (LFA-1). LFA-1 is a b2 integrin, 
composed of CD11a and CD18, which binds to intercellular adhesion molecule-1 (ICAM-1) on 
endothelial cells leading to extravasation. Targeting LFA-1 and preventing interaction with ICAM-
1 has previously proven an effective strategy for treating psoriasis; Efalizumab, a monoclonal 
antibody targeting CD11a, was previously approved for use in treatment of psoriasis patients. 
The aim of the current study was to investigate the effect of a natural leukocyte-targeting bacterial 
protein (LtxA) that binds to LFA-1. LtxA effectively inhibited proliferation of activated white blood 
cells (WBCs) isolated from psoriasis patients and demonstrated therapeutic efficacy as evaluated 
by decreased clinical psoriasis score and epidermal thickness in a xenograft transplantation 
model where psoriasis skin was transplanted onto immune-deficient mice. Furthermore, ex vivo 
studies demonstrated that LtxA preferentially targeted proinflammatory WBC subtypes including 
activated CD25+ T-cells and CD14+CD16+ monocytes. In this study, LtxA is suggested to have 
significant therapeutic potential for the treatment of psoriasis. Additionally, LFA-1 has been 
shown to play a significant role in the pathogenesis of numerous autoimmune and inflammatory 
diseases, and we propose that LtxA may be a highly effective agent for treating these diseases.
2011ESDR_8.25x10.875.indd   36 06/07/2011   18.24 
 www.jidonline.org S37
ABSTRACTS
217
Coping with the disease as a relation mediator between skin lesion severity and psychological 
health in psoriatic patients
Joanna Miniszewska1, Jan Chodkiewicz1, Alicja Ograczyk2, Anna Zalewska2 1Health Psychology 
Department, University of Lodz, Lodz, Poland, 2Psychodermatology Department, Medical 
University of Lodz, Poland
The aim of the study was to investigate the role of stress coping strategies in psoriasis patients in 
relation to disease activity and psychological health.168 patients were involved in the study (56 
females, 112 males; age range: 17-70 years ; mean±SD 39.76 ± 13.0). Duration of the disease 
-from the first diagnosis - ranged from 1 year to 52 days; mean± SD 15.17±11.85. Disease 
severity was evaluated by PASI Score (Psoriasis Area and Severity Index) and ranged from 1.8 
to 43.0 (mean±SD 11.0±9.5). General Health Questionaire GHQ - 28 (Goldberg) and Scale 
of Stress Coping Strategies with Dermatological Disease SRS-DER (Miniszewska) were used 
in the study. Regression analysis revealed a mediating role of two stress coping strategies i.e. 
fight spirit and hopelessness/helplessness. In other words, disease severity exert its influence 
on psychological health of the patients not directly but by means of the employed stress coping 
strategies. This observation seems to explain why some patients with really severe disease (based 
only on PASI) function better than others presenting relatively modest or mild disease (once again 
based only on PASI). The latter patients would require additional i.e. psychological help in order 
to improve clinically.
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New Microtechnology-Enabled Biomedical Devices to Overcome the Skin Barrier
Marzia Bedoni1,2, Elena Forvi1,3, Carlo Morasso1, Domenico Giorgio Cassará1, Furio Gramatica1 
1Don Gnocchi Foundation, Biomedical Technology Department, Milan, Italy, 2University of Milan, 
Dep. of Human Morphology and Biomedical Science Città Studi, Milan, Italy, 3Politecnico of 
Milan, Bioengineering Department, Milan, Italy
Finding a more effective and personalized drug administration method and providing a 
more reliable electrical interface for monitoring biopotentials (electroencephalogram, 
electrocardiogram) are two very important issues in a clinical context. The aim of our research 
is to design, develop and test innovative transdermal devices, deriving from nano- and micro- 
technologies, for diagnosis and therapeutic treatments. In order to overcome, in a minimally 
invasive way, the complex skin barrier, including stratum corneum, we elaborated a technology 
platform based on microneedles. In particular we are working on two projects: a “dry 
electrodes” device for the measurements of biosignals and a “transdermal cartridge” for drug 
delivery. We created non-miniaturised prototypes with a solid or hollow microneedles matrix 
(max 1 mm tall). For testing purpose the former was connected to a biomechanical test station 
and the latter to a syringe pump infusing a green fluorochrome labelled insulin (10µl/h). We 
performed morphological and biomechanical tests on human skin biopsies. The samples were 
immediately frozen in liquid nitrogen and cryostate sections were obtained. Dry electrodes 
results demonstrated a successful piercing of the epidermis with suitable insertion force and good 
quality signals. Some preliminary results of skin piercing in healthy volunteers highlighted a pain 
intensity score of 0.5cm (visual analogue scale, ranging from 0-10cm). Transdermal cartridge 
results demonstrated the piercing of the epidermis and the infusion of insulin into the epidermis 
and dermis reaching the dermal capillaries. These data already indicate that our devices could 
improve compliance and the quality of life of patients with chronic diseases.
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Bone Alkaline Phosphatase, Lumbar Total Score In Psoriatic Arthritis Patients
Caius Solovan1, Camelia Ciacli2, Smaranda Rodica Gotia3, Smaranda Laura Gotia3 1University 
of Medicine and Pharmacy, Department of Dermatology, Timisoara, Romania, 2West University, 
Department of Immunology, Arad, Romania, 3University of Medicine and Pharmacy, Department 
of Physiology, Timisoara, Romania
Aim: the comparison of bone mineral density (BMD) in lumbar area L2-L4 correlated 
with the disease development and seric bone alkaline phosphatase (BAP) in 
psoriatic arthritis patients (PsA), in orders to monitory the bones lesions treatment. 
There were investigated 27 patients with PsA and the disease’ development for less than 5 
years (11 patients), respectively over 5 years (16 patients), and 20 healthy persons. BMD was 
measured in the lumbar vertebral column L2-L4 by dual-energy X ray absorptiometry method 
(DEXA) and total (T) score was established. Seric BAP was determinate by ELISA method. 
In PsA patients with disease less than 5 years T lumbar score was between -1.32 and - 1.68DS. 
In 81.8% patients was revealed osteopenia and 18.2% had osteoporosis. In PsA patients with 
disease over 5 years T lumbar score was between -1.58 and - 1.77DS, 68.75% patient’s presented 
osteopenia, and 31.25% had osteoporosis. The results was statistically significant (p < 0.01) 
compared with control group. There was a negative correlation between T lumbar score and 
the PsA duration (r = - 0.728). Seric BAP was increased in PsA patients (13.53 ± 0.55 µg/ml) 
compared with control group (8.68 ± 0.44 µg/ml). There was a positive correlation between BAP 
and T lumbar score (r = 0.74). In PsA patients was found the decrease of BMD, estimated by T 
lumbar score, intense osteopenia, and high levels of seric BAP. As a marker of osteosynthesis and 
bone remodeling BAP can have a prognostic value in bones lesions treatment follow-up.
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HSPA1A inhibits the cytotoxic effect of HDAC inhibitor
Kazuyasu Fujii1, Kazuko Ikeda1, Norihiro Suzuki1, Toshihisa Hamada1, Tadashi Kondo2, Keiji 
Iwatsuki1 1Okayama university hospital, Okayama, Okayama, Japan, 2National cancer center 
research institute, Tokyo, Japan
Histone deacetylase inhibitors (HDACi) are emerging as effective therapies in the treatment 
of multiple malignancies including cutaneous T cell lymphoma. However, the sensitivities 
to HDACi are variable among the patients, and the molecular backgrounds of the different 
sensitivities are largely unknown. To reveal the molecular mechanisms of response to anticancer 
effects of HDACi, we compared the sensitivities to valproic acid (VPA) and proteomic profiles 
of 33 lymphoid neoplasm cell lines. Using XTT assay and two-dimensional difference gel 
electrophoresis database, we identified 20 protein spots were associated with chemosensitivity 
(rs > 0.4), and heat shock 70kDa protein 1A (HSPA1A) was the most positively correlated protein 
associated with resistance to VPA. To confirm the functional link between HDACi resistance 
and HSPA1A elevation, we investigated a functional role of KNK437, an inhibitor of HSP70, in 
HDACi treatment. We observed a synergistic antiproliferative effect between treatment with VPA 
and KNK437 in Hut78 cells. KNK437 also synergistically enhanced sensitivity to vorinostat. Co-
treatment with KNK437 enhanced apoptotic effects of HDACi. In conclusion, HSPA1A should 
play an important role against HDACi treatment.
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The profiles of tumor infiltrating lymphocytes in squamous cell carcinoma on the lips after 
treated with intra-arterial peplomycin administration
Taku Fujimura, Yumi Kanbayashi, Akira Hashimoto, Takahiro Haga, Yumiko Ito, Setsuya Aiba 
Tohoku University, Graduate School of Medicine, Sendai, Japan
We demonstrated five cases of squamous cell carcinoma (SCC) on the lips that dramatically 
decreased the tumor size after intra-arterial peplomycin administration. This reagent is known 
to suppress SCC directly, however, its effect on immune cells in tumor microenvironment is still 
unclear. To investigate the suppressive mechanisms of peplomycin in tumor microenvironment 
more detail, we immunohistologically examined the infiltration of regulatory T cells (Tregs), 
tumor reside macrophages, and CD8+, TIA-1+ cytotoxic T cells in 5 cases of SCC before and after 
the administration of peplomycin. Using formalin-fixed paraffin embedded sections, the single or 
double staining was performed with anti-CD4 Ab, anti-CD8 Ab, anti-CD68 Ab or anti-TIA-1 Ab 
revealed with peroxidase-conjugated Igs and that of anti-Foxp3 Ab with alkaline phosphatese-
conjugated Igs. The number of immunoreactive cells in peritumoral infiltrate was counted using 
an ocular grid at a magnification of 400x and the ratio of CD4+, CD8+, CD68+, TIA-1+ or Foxp3+ 
cells among total numbers of leukocytes (CD4+CD8+CD68) was calculated. The administration 
of peplomycin significantly increased the ratio of CD8+ cells (19.2% vs 48.7%) and TIA-1+ cells 
(13.0% vs 54.0%). In contrast, the ratio of CD68+ cells (22.9% vs 3.7%) and Foxp3+ cells (40.5% 
vs 10.2%) was decreased by this chemotherapy. These findings suggest that the administration of 
peplomycin may suppress the tumor by not only directly killing the tumor cells but also modified 
the immunological profiles of tumor infiltrating lymphocytes and macrophages.
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Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by specific inhibition 
of IKKβ, but not IKKα
Nadin Pletz1, Michael P. Schön1, Karl Ziegelbauer2, Steffen Emmert1, Ningshu Liu2, 
Matthias Dobbelstein1, Margarete Schön1 1Georg August University, Göttingen, Germany, 
2BayerHealthCare, Wuppertal, Germany
One of the major challenges in cancer therapy is to overcome drug resistance. The NF-κB pathway 
was identified to play a crucial role in development of drug resistance and melanoma cells show 
enhanced NF-κB-activity and are almost universally resistant to all chemotherapeutics currently 
available. We showed recently that doxorubicin leads to profound activation of NF-κB in two 
different melanoma cell lines while other chemotherapeutics with different modes of action 
did not activate this pathway. NF-κB-regulated mediators, which are thought to be involved 
in tumor progression, were also increased after treatment with doxorubicin. Notably, strongest 
NF-κB activation was detected at a concentration of 1 µM doxorubicin corresponding to the 
concentrations reached when malignant tumors are treated in vivo. In search of improved strategies 
in cancer therapy, doxorubicin induced NFκB activity was analyzed following inhibition of either 
of the two major kinases of the NF-κB pathway, IKKα and IKKβ, by small molecules compounds. 
Inhibition by the novel IKKα inhibitor (BAY 32-5915; 8hydroxyquinoline-2-carboxylic acid), 
which was identified from a large library, did not affect doxorubicin induced NF-κB. However, 
doxorubicin induced NF-κB activation was completely diminished by using the IKKβ-inhibitor 
KINK-1. Moreover, inhibition of IKKβ, but not IKKα, in combination with doxorubicin increased 
the rate of apoptosis in melanoma cells significantly (p=0.02). Complementary, silencing of IKKα 
using siRNA had only moderate effects on doxorubicin induced NF-κB activity. Our results show 
that inhibition of IKKβ, but not IKKα, by small molecules can diminish the doxorubicin induced 
NF-κB activation and thereby improve chemosensitivity of melanoma cells.
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Preclinical Safety Studies with AN2690, a Novel Boron-containing Small Molecule for Topical 
Treatment of Onychomycosis, Demonstrate Very Promising Safety Profile
Sanjay Chanda, Liang Liu, Irwin Heyman Anacor Pharmaceuticals, Palo Alto, CA, USA
Anacor Pharmaceuticals is developing AN2690 (5fluoro-1,3-dihydro-1-hydroxy-2,1-
benzoxaborole) for topical treatment of onychomycosis. This novel, low molecular weight 
compound demonstrates broad-spectrum antifungal activity against dermatophytes, yeasts 
and molds, and other filamentous fungi and penetrates through the nail plate to achieve 
concentrations greater than its required minimum fungicidal concentrations. The degree of 
penetration through the nail plate was superior to ciclopirox (the only topical treatment currently 
approved in the United States for distal subungual onychomycosis), making this compound an 
excellent candidate for topical treatment. An extensive nonclinical safety program of AN2690 
administered via oral (PO) and topical routes has been completed in rats (1, 3, and 6 months of 
duration), rabbits (teratogenicity study), and minipigs (1, 3, and 9 months of duration). AN2690 
is not genotoxic, is nonsensitizing, and has a low potential for producing systemic toxicity upon 
single or repeat administration. The primary toxicological findings consisted of local irritation of 
nonglandular stomach after PO administration at high doses (nonglandular stomach is absent in 
humans) and local skin irritation after topical administration to minipigs. There was no evidence 
of teratogenicity in pregnant rats and rabbits. Based on the data gathered so far AN2690 has 
potential to be a safe topically administered treatment for onychomycosis.
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Comparative In Vivo Biotransformation of 14C-AN2690 in Mouse, Rat and Human Following 
Topical or Oral Administration
Liang Liu, Irwin Heyman, Sanjay Chanda Anacor Pharmaceuticals, Palo Alto, CA, USA
AN2690 is a novel boron-based broad-spectrum antifungal drug candidate currently in Phase 
III clinical development for the treatment of onychomycosis. The objective of this series of 
experiments was to compare the in vivo biotransformation of AN2690 in different species 
(mouse, rat and human). Mice were dosed topically once with 5% 14C-AN2690 solution at 50 
mg/200 mCi/kg and rats were dosed orally once with an aqueous suspension (1% CMC) of 14C-
AN2690 at 100 mg/100 mCi/kg. In the clinical study, six healthy adult males received a single 
topical application of 5% 14C-AN2690 solution (200 mL, 100 mCi) to all 10 toenails and 5 mm 
of the surrounding skin. In mice, 14C-AN2690 was absorbed rapidly following topical application 
with renal excretion as the major route of elimination. In rats, over 80% of the radioactivity 
dosed was absorbed following oral administration with renal excretion as the major route of 
elimination. In healthy male subjects ~18% of the nominally applied radioactivity dose was 
recovered in urine. Metabolite profiling studies showed that an oxidative deboronated product 
was the primary metabolite which undergoes further sulfation and/or glucuronidation in all three 
species. Based upon the similarity of metabolite and major route of elimination via the kidney, 
these comparative biotransformation studies support the use of mouse and rat in preclinical safety 
studies.
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Systematic review and mixed treatment comparison of biologic therapies in psoriasis
Jacek Szepietowski1, Marcin Kaczor2,3, Dariusz Pawlik2, Rafal Wojcik2, Adam Reich1 1Department 
of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland, 
2Aestimo s.c., Krakow, Poland, 3Department of Internal Medicine, Collegium Medicum, 
Jagiellonian University, Krakow, Poland
In the absence of head-to-head randomized controlled trials (RCT) comparing directly all available 
biological treatments, relative effectiveness of competing interventions can only be estimated by 
means of indirect comparison methods. We evaluated the clinical effectiveness of biologic agents 
for plaque psoriasis through a mixed treatment comparison (MTC) analysis. A systematic review 
was conducted to identify all relevant RCTs evaluating the efficacy of biologic treatments in 
terms of PASI 50/75/90 response at 10-16 week. A network meta-analysis was conducted based 
on the ordered probit model . Base-case analysis was supplemented with an additional analysis 
using standard MTC model for binary data (PASI 75) on a logit scale. Sensitivity analyses were 
also performed. 17 RCTs were included in the MTC analysis. All biologic therapies were more 
efficacious than placebo in terms of PASI 75 response, with a relative benefit (RB) of 19.58 
(95% CI: 16.45, 23.07) for infliximab, 17.53 (95% CI: 14.78, 20.67) for ustekinumab, 14.41 
(95% CI: 11.65, 17.29) for adalimumab, 12.71 (95% CI: 10.42, 15.23) for etanercept 50 mg and 
9.55 (95% CI: 7.36, 11.97) for etanercept 25 mg. The highest probability of PASI 75 response is 
achieved with infliximab (82%) followed by ustekinumab (73%), adalimumab (60%), etanercept 
50 mg (53%), etanercept 25 mg (40%) and placebo (4%). Biological agents are highly effective in 
terms of PASI response at 10-16 weeks. MTC, representing a synthesis of all available evidence 
from RCTs, provides valuable information on the relative effectiveness of biological drugs in the 
absence of head-to-head trials.
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Prospective evaluation of the systemic side effects during treatment of congenital venous 
malformations by ethanol 96%
Patrick Dupuy1, Denis Herbreteau2, Marc Laffon3, Sally Mitchell4, Deborah Schwengel5, Fabienne 
Lekaim1, Caroline Miklaszewski1 1Div of Research & Development, Orfagen, Toulouse, France, 
2Neuroradiology Dept, Hospital Bretonneau, University François Rabelais, Tours, France, 3Anesthesia 
Dept, Hospital Bretonneau, University François Rabelais, Tours, France, 4Radiology & Radiological 
Science, Vascular & Interventional Radiology Dept, Johns Hopkins Medical Institutions, Baltimore, MD, 
USA, 5Anesthesiology & Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Intralesional injections of ethanol 96% solution is the most efficient embolosclerosing therapy 
of congenital venous malformations (CVM) despite its “off-label” status. We investigated the 
pharmacokinetic profile of a single treatment of ethanol 96% solution in CVM and its consequences 
on the cardiac (ECG) and haematologic functions (hemolysis, coagulation) Lesion size, as measured 
by MRI, in 13 CVM patients ranged from 16.5 to 4105.7 cm3 (median: 89.2 cm3) before treatment. 
A mean ± SEM of 21.02 ± 2.94 mL ethanol 96% solution (range: 5-31 mL) was infused (0.31 ± 0.04 
mL/Kg bw). The mean ± SEM Cmax during infusion was 0.293 ± 0.083 g/L (range: 0-0.940 g/L), 
that occurred in about 40 min after starting injection (Tmax). Cmax was correlated to the amount of 
product infused, with an exponential increase when the injected dose was greater than 15 mL (R2 
= 0.55, p < 0.0001), and percentage of ethanol uptake by the blood circulation was about 40% of 
the injected dose. High ethanol blood levels were associated with a significant QTcF prolongation 
from baseline (mean ± SEM: + 9.3 ± 5.33 ms, p < 0.001) as well as a significant decrease of the 
hemolytic marker haptoglobin by an average of 45% (p = 0.001). Platelets and fibrinogen, which 
were already abnormal at baseline in some patients, further declined after ethanol treatment by 
about 27% and 14% in average compared to baseline, respectively (p < 0.005). In conclusion, safer 
embolosclerosing therapies than ethanol 96% solution need to be developed for CVM patients.
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Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single 
community-based hospital
Shinji Noda1,2, Kyoko Mizuno1, Makoto Adachi1 1Kanto Rosai Hospital, Kawasaki, Japan, 
2University of Tokyo, Tokyo, Japan
Since adalimumab and infliximab were approved in Japan for psoriasis treatment recently, 
therapeutic efficacy of these agents is not well studied in a Japanese psoriasis population. In this 
study, 21 patients with moderate to severe plaque psoriasis were assigned to receive adalimumab 
40mg every other week with the initial loading dose of 80 mg (N = 11), or infliximab 5 mg/kg at 
weeks 0, 2, 6, 14, 22 (N = 10). The treatment efficacy was evaluated by the proportion of patients 
who achieved at least 75% improvement in psoriasis area and severity index score (PASI 75) and 
psoriasis scalp severity index score (PSSI 75) from baseline at weeks 4, 8, 16, and 24. A patient 
selection bias existed between the two groups in BSA and PASI (44.0 ± 24.7 vs. 30.2 ± 13.5, P = 
0.12 and 22.2 ± 9.3 vs. 15.6 ± 7.75, P = 0.09, respectively). At week 16, 81.8% of adalimumab-
treated patients and 60.0% of infliximab-treated patients achieved PASI 75 response, but no 
statistically significant difference was found between these response rates. There was a tendency 
toward a reduced PSSI 75 response rate in the adalimumab-treated group compared to the 
infliximab-treated group (54.5% vs. 90% at week 16, P = 0.15). In conclusion, both of the TNF-α 
inhibitors demonstrated good therapeutic response similar to that in the previously reported 
randomized controlled trials, without any severe adverse reactions. Treatment response in scalp 
lesions tended to be lower in adalimumab-treated patients possibly because of delayed treatment 
onset of adalimumab.
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Improved Imaging of Basal Cell Carcinoma using Dynamic Focus Optical Coherence 
Tomography
Mohammad Reza Nasiri-Avanaki1, Mano Sira2, Ahmed Aber3, S. Ali Hojjatoleslami1, John B. 
Schofield4, Carole Jones2, A. Gh. Podoleanu5 1Research and Development Centre, School of 
Biosciences, University of Kent, Canterbury, Kent, UK, 2Eye, Ear and Mouth Unit, Hermitage Lane 
Maidstone hospital, Maidstone, Kent, UK, 3Royal Free Hospital, London, UK, 4Department of 
Cellular Pathology, Preston Hall Hospital, Maidstone, Kent, UK, 5Applied Optics Group (AOG), 
School of Physical Sciences, University of Kent, Canterbury, Kent, UK
Basal cell carcinoma (BCC) is the most common form of skin cancer. To improve the diagnostic 
accuracy, additional non-invasive methods of making a preliminary diagnosis have been sought. 
With the emergence of optical coherence tomography (OCT), capturing three-dimensional 
tomograms from microstructures within the skin with both high resolution and sufficient 
penetration depth has become possible. We have implemented an En-Face OCT for this study 
in which the dynamic focus (DF) was integrated into it. With the DF scheme, the coherence 
gate moves synchronously with the peak of confocal gate determined by the confocal interface 
optics. The transversal resolution is then conserved throughout the depth range and an enhanced 
signal is returned from all depths. The BCC specimens were obtained from the eyelids of three 
patients. The specimens underwent analysis by DF-OCT and histologically. Histology sections 
were photographed and compared with the OCT images. We searched for remarkable features 
that were visualized by OCT and compared these findings with features presented in the 
histology slices. OCT shows promise in allowing the preoperative or intraoperative assessment 
of the tumour to obviate the delays inherent in conventional histopathological assessment. DF-
OCT images correlate to histological images of BCC. Compared to the conventional OCT where 
the border of the tumor adjacent to healthy skin is barely detectable, in DF-OCT images, these 
borders are well detectable. DF-OCT imaging has the potential to identify tumour tissue from 
healthy tissue helping clinicians decide with a higher level of confidence whether the skin is 
involved by BCC or not.
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Expression of Aryl Hydrocarbon Receptor in Atopic Dermatitis
Hye One Kim, Bo Young Chung, Jin Hye Kim, Soo Ick Cho, In Su Ahn, Chun Wook Park, Cheol 
Heon Lee Department of Dermatology,College of Medicine,Hallym University, Seoul, Republic 
of Korea
Although it is reported that the prevalence rate or severity of AD is actually high in the district 
with severe pollution or a new house where environmental hormone is expected to be high, the 
experimental evidence does not exist at all. Dioxin is often cited as one of the major environmental 
hormones. The receptor of dioxin, aryl hydrocarbon receptor (AhR), is the ligand-activated 
transcription factors that exist in the cytoplasm and exhibits higher expression in the lesional skin 
of AD mouse model. The purpose of our study was to determine the significance of AhR in AD. 
Serum levels of Tetra-Chlor-Dibenzo-Dioxine (TCDD) and Polychlorinated BinPhenyls (PCBs) 
were determined by high resolution gas chromatography and mass spectrometry in AD patients 
and controls. The expression of AhR and ARNT were determined by immunohistochemistry in 
lesional skins of AD and controls. Real-time PCR were performed to detect AhR, ARNT and AIP 
(AhR interacting protein) expression in lesional skins of AD and controls. The serum levels of 
TCDDs and PCBs by toxicity equivalency (TEQ) in AD group were higher than those of control 
group. In the immunohistochemistry, no difference in AhR and ARNT protein levels was found 
between AD patients and controls. ARNT, AIP and CYP1A1 mRNA expression were significantly 
increased in AD patient’s lesional skin. In the AD patients, serum levels of TCDD and PCBs were 
increased and AhR-related mRNA expression was upregulated.
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A novel, topical, liposome-encapsulated bleomycin formulation for use against Basal Cell 
Carcinoma and treatment resistant warts and verrucae
Elizabeth Blakeway4, Shilpa Kantaria2, Manuchehr Porssa2, Graham Moir3,4, Lina Christopoulou4, 
Fatima Malik2, David McCarthy2, Sunil Chopra1,4 1University College London, Department of 
Medicine, London, UK, 2The School of Pharmacy, University of London, London, UK, 3Barts and 
The London Medical School, Department of Plastic Surgery, London, UK, 4London Dermatology 
Centre, London, UK
Bleomycin is a well-established anti-neoplastic agent used systemically and locally in the 
treatment of tumours. Bleomycin is a water soluble, polar molecule and therefore topical 
application is limited. We present a novel liposome-encapsulated bleomycin that we have 
used topically in the treatment of Basal Cell Carcinomas and treatment-resistant warts and 
verrucae. In vitro experiments were carried out using isolated skin preparations from redundant 
abdominoplasty tissue. A thin layer of liposome-encapsulated bleomycin was applied to the 
surface of 2cm square skin samples and 5 µ-sections were obtained at 2 hours, 4 hours, and 
6 hours post-application. Bleomycin fluoresces green under a fluorescent microscope. We 
present the first ever evidence of bleomycin being delivered to the skin using a novel liposome-
encapsulated bleomycin. Three patients with Basal Cell Carcinomas and two patients with 
verrucae were treated with liposome-encapsulated bleomycin 1mg per ml once a day, applied 
at night, until the lesions had cleared. We present evidence showing full response of all lesions 
to topical liposome-encapsulated bleomycin. The Basal Cell Carcinomas healed with no side 
effects and no scarring in all three patients. The time of clearance varied from three months to six 
months and the timing of the clearance of the treatment-resistant verrucae and warts was between 
3 months and 18 months. We believe that topical liposome-encapsulated bleomycin deserves 
further investigation in larger studies to determine its efficacy.
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Cutaneous type pemphigus vulgaris: a transitional and indetermined form of mucocutaneous 
type pemphigus vulgaris
Yung-Tsu Cho, Li-Fang Wang Department of Dermatology, National Taiwan University Hospital, 
Taipei, Taiwan
Traditionally, pemphigus vulgaris is classified into mucosa-predominant and mucocutaneous 
types. Cutaneous type pemphigus vulgaris is a rare type of pemphigus vulgaris with only few 
cases reported in the literature. We collected five cases of cutaneous type pemphigus vulgaris 
from a referral medical center in Taiwan and aimed to analyse whether there are any characteristic 
features. The clinical presentations, histopathological findings, immunofluorescence studies, 
laboratory examinations, and serum anti-desmoglein antibody levels were measured and 
followed. All patients had cutaneous eruptions with no oral lesions. The presentations of 
cutaneous eruptions were diverse ranging from localized seborrheic dermatitis-like lesions to 
extensively distributed blisters and erosions. All patients had positive anti-desmoglein-1 and anti-
desmoglein-3 antibodies during the periods of active disease. The titers of anti-desmoglein-1 
antibodies are uniformly higher than those of anti-desmoglein-3 antibodies. One of the 
patients had a previous episode of mucocutaneous type pemphigus vulgaris. Another patient 
experienced an episode of acute disease flare-up during the follow-up period, presenting as 
mucocutaneous type pemphigus vulgaris along with higher serum level of anti-desmoglein-3 
antibodies. In conclusion, cutaneous type pemphigus vulgaris presents with variable severity of 
the cutaneous presentations with no mucosal involvement. Positive serum anti-desmoglein-1 and 
anti-desmoglein-3 antibodies with higher anti-desmoglein-1 antibody levels are characteristic. 
Cutaneous type pemphigus vulgaris can evolve from or to mucocutaneous type at different 
episodes of disease flare-up. Therefore, cutaneous type pemphigus vulgaris could be thought as a 
transitional and indetermined form of mucocutaneous type pemphigus vulgaris.
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Histidine increases the expression of filaggrin protein and improves barrier function
Siao Pei Tan1,2, Richard Weller1,2, Simon Brown1 1The Queen’s Medical Research Institute,The 
University of Edinburgh, Edinburgh, Scotland, UK, 2Department of Dermatology, The University 
of Edinburgh, Edinburgh, Scotland, UK
Filaggrin deficiency is associated with reduced level of natural moisturizing factor and skin 
barrier dysfunction. The unusually high level of histidine in filaggrin may indicate a prominent 
role for this amino acid in maintaining stratum corneum hydration. Our early human data found 
that following abrogation of skin barrier by tape-stripping, topically applied L-histidine improved 
the skin recovery at a faster rate than control PBS (p<0.01). Here we describe improved barrier 
function in skin-equivalent models grown in histidine-enriched media and the effects of histidine 
on filaggrin protein expression of keratinocyte line HaCaT. Cell culture media was supplemented 
with 1, 2 and 5mM of L-histidine, D-histidine and L-lysine. Media pH was adjusted using Pipes 
(pKa 6.76) and Tris (pKa 8.08). Barrier function of skin-equivalents was assessed with penetration 
of Lucifer-Yellow dye. Skin-equivalents grown in L-histidine-enriched media showed reduced 
penetration by Lucifer-Yellow than controls (p<0.05), implying improved barrier function. 
Western-blot analysis showed that L-histidine reduced the amount of a large 120kDa filaggrin 
intermediate and increased the 37kDa filaggrin monomers, causing a dose-dependent increase 
in the 37kDa:120kDa ratio (p<0.01). Histidine metabolites urocanic acid reduced (p<0.01) while 
histamine (with or without H1+H2-receptor antagonists) increased (p<0.01) the 37kDa:120kDa 
filaggrin ratio. No effect was noted in the controls (D-histidine and L-lysine) or under different 
pH conditions. The expression of loricrin, another late differentiation marker, was unchanged. 
This study suggests that histidine and its metabolite histamine may improve skin barrier function 
by increasing the expression of filaggrin monomers via a H1+H2-receptors-independent pathway, 
implying a possible positive feedback mechanism.
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Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than 
etanercept mono-therapy at 6-weeks
Thilo Gambichler, Sarah Terras, Christian Tigges, Nina Scola, Julia Weber, Marina Skrygan, Falk 
Bechara, Peter Altmeyer Ruhr University Bochum, Bochum, Nordrhein-Westfalen, Germany
A substantial portion of patients with psoriasis do not achieve a satisfactory response under anti-
tumour necrosis factor-α (TNF-α) biological therapies. We aimed to evaluate whether etanercept 
and narrowband ultraviolet B (NB-UVB) phototherapy is superior to etanercept monotherapy 
in the management of psoriasis. In this prospective study, psoriasis patients were treated with 
etanercept 25mg twice weekly. Two marker lesions were selected for the determination of the 
modified psoriasis area and severity index (M-PASI). NB-UVB was administered thrice weekly 
whereby one marker lesion was covered as non-irradiated control. Skin biopsies for histology and 
immunohistochemistry were performed in both marker lesions after a 6-week treatment course. 
After 6-week therapy, the relative M-PASI reduction of etanercept-treated sites (53.7±36.9%) was 
significantly lower than the reduction in etanercept plus NB-UVB treated lesions (64.7±27.8%; 
P = 0.011). At the end of treatment, histology scores of etanercept-treated psoriatic plaques 
were significantly higher than scores of etanercept plus NB-UVB treated sites (4.6±2.7 vs. 
3.7±2.4; P = 0.045). Epidermal immunoreactivity for CD1a, CD4, and CD8 was significantly 
lower in etanercept plus NB-UVB treated lesions when compared to etanercept mono-therapy. 
Etanercept combined with NB-UVB is more effective than etanercept mono-therapy at 6-weeks 
as demonstrated at a clinical, histological and immunohistological level. However, as there is an 
increased risk for malignancy by treatment with TNF-α blockers alone or in combination with 
phototherapy, we recommend to restrict this highly effective combination to short periods of 
time, for instance to obtain a quicker response, and to avoid long-term treatment.
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Diseases profoundly affect the Quality of Life of family members of patients
Catherine Golics1,2, Mohammed Basra1, Sam Salek2, Andrew Finlay1 1Department of 
Dermatology and Wound Healing, School of Medicine, Cardiff University, Cardiff, UK, 2Centre for 
Socioeconomic Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
Diseases affect Quality of Life (QoL) of patients, but there is very little information on the 
secondary impact of disease, therefore the aim of this study was to investigate how disease 
affects family members across a wide range of specialties. Following ethical approval, in-depth 
semi-structured interviews were carried out with family members of patients from 26 different 
specialties, including dermatology. Thematic analysis was carried out on interview transcripts 
using NVivo9. 131 family members of patients were interviewed (mean age= 57, median age= 
56, range 21-85 years, female= 79). Many of the ways family members reported their lives being 
affected were similar across the specialties. Family members suffered great emotional impact 
(91% of interviewees), which they often suppressed and commonly reporting feeling anger, 
distress and guilt. Other common themes mentioned included holiday disruption (64%), financial 
impact(44%) often due to having to give up work, family relationships, including that between 
partners (47%), effect on sleep and the health of the family member (66%), and great impact 
on social life, hobbies and daily activities of the family (87%). Family members of dermatology 
patients described how their holidays were affected by the patient’s condition, and commonly 
mentioned the effects that different types of treatment had on their lives. The findings of this study 
show the diverse ways that family members are affected by disease. Consideration of this aspect 
and involving family members in discussions and decision making with the patient’s consent, will 
potentially allow for more appropriate care of patients and their families.
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Retrospective analysis of cutaneous polyarteritis nodosa: A study of 25 Korean patients
Jooyeon Ko, Myenggil Jeong, Hunsoo Roh, Youngsuck Ro College of Medicine, Hanyang 
University, Seoul, Republic of Korea
This study is to evaluate cutaneous polyarteritis nodosa (CPN) in Korean patients. Twenty-five 
cases of CPN from January 2004 to October 2010 were retrieved and analyzed clinically and 
histopathologically. Laboratory data also evaluated retrospectively. Clinically, out of the 25 cases, 
erythematous nodules or typical starburst pattern were observed in nineteen cases. Nine cases 
also had livedo reticularis-like pattern and two cases ulcerations. Twelve cases complained 
of pain and the lower legs were affected in all patients except one. The other affected areas 
include thighs (16 cases), foot (8 cases), forearms (4 cases), and abdomen. Histopathologically, 
all patients have necrotizing vasculitis of the small to medium sized arteries. The infiltrate was 
composed predominantly of neutrophils in 13 cases and lymphocytes in 12 cases. Gradual 
narrowing of the lumen or neovascularization was seen in 22 cases. Increased ESR (17 cases, 
mean 42 mm/h) and CRP (15 cases, mean 1.1 mg/dl) are the most common significant laboratory 
abnormalities. The median time to diagnosis was 14.4 months (range, 1-48 months) and the 
average follow-up period was 15.2 months (range, 1-65 months). All patients had good prognosis 
except for cosmetic concern. A review of the published literature shows that there is a lack of 
studies with great number of patients, especially in Korea. Our study showed acceleration of the 
ESR was higher compared to previous reports about CPN. The meaning of the above data should 
be explored in further research in order to clarify the nature of CPN.
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Topical treatment habits in psoriasis patients receiving adalimumab
Antonios Kolios1, Francisca Rusca2, Karin Reisenbauer3, Lars French1, Alexander Navarini1 
1Department of Dermatology, Zurich, Switzerland, 2Humira Direct Pharmacy, Meilen, 
Switzerland, 3Swiss Union of Health Insurances, Solothurn, Switzerland
Biologics are used increasingly to treat moderate-to-severe psoriasis. The effects of combining 
topicals and moisturizers with biologics are still unclear. Here we evaluated the topical treatment 
habits (corticosteroids and vitamin D derivates) and moisturizer use of 97 Swiss patients (♂ 65, ♀ 32) 
receiving adalimumab. During telephone contact with patients having opted for home delivery of 
adalimumab, the pharmacist asked patients about their topical treatment habits and psoriasis activity. 
Design: a short cross-sectional survey. 47 patients (48,5%) were free of psoriatic lesions at 
an average of 13 months after starting a monotherapy with adalimumab, and 8 (17%) thereof 
still used topical treatment. In contrast, 38 (76%) of the 50 patients with remaining psoriatic 
lesions used topicals. More than three quarters of patients indicated that the perceived efficacy 
of additional topical therapy was ³ 5 on a VAS scale (0-10). The use of moisturizers however did 
not correlate with disease activity. Topical treatment use by patients treated with adalimumab is 
associated with remaining disease activity. 83% of patients without residual plaques, or 40% of 
all adalimumab patients, are able to stop topical treatment completely.
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Evidence for CD4 expression by mast cells in cutaneous and systemic mastocytosis: 
immunohistochemical analysis of 58 skin biopsies
Magdalena Lange1, Anton Zawrocki2, Boguslaw Nedoszytko1, Michal Zmijewski3, Wojciech 
Biernat2 1Department of Dermatology Medical University of Gdansk, Gdansk, Poland, 
2Department of Pathomorphology, Gdansk, Poland, 3Department of Histology, Gdansk, Poland
Mastocytosis is a heterogenous group of myeloproliferative disorders characterized by abnormal 
accumulation of mast cells in various tissues, particularly in the skin (cutaneous mastocytosis) 
and hematopoietic organs (systemic mastocytosis). CD4 expression in normal mast cells has 
occasionally been reported. CD4 expression by mast cells in mastocytosis remains controversial.
We investigated expression of CD4 in mast cells in 58 adult patients: 35 with cutaneous and 
23 with systemic mastocytosis. The diagnosis of mastocytosis and quantitation of mast cell 
infiltrates was performed on formalin-fixed paraffin-embedded skin samples routinely stained 
with additional CD117 immunostaining. In all cases CD4-positive mast cells were disclosed and 
their number ranged from 3-375 cells / high power microscopic field (HPF). The mean index of 
CD117-positive mast cells was 108,77/HPF in all mastocytosis patients. We found mainly 50,61 
CD4-positive mast cells/HPF and 8,09 CD4-positive T-cells/HPF in all cases. The mean index of 
CD117-positive mast cells correlated with the mean number of CD4-positive mast cells in all 
mastocytosis cases (p=0.000003) and in both subgroups cutaneous and systemic mastocytosis 
(p=0,00017 and p=0,0029 respectively). We did not observed significant differences between 
cutaneous and systemic mastocytosis as far as the CD4-positive mast cell index is concerned. 
CD4 is a receptor for interleukin 16, which has chemotactic activity for mast cells and CD4-
positive T-cells. Therefore, the results of our study suggest that the expression of CD4 by a fraction 
of mast cells may account for the increased mast cell accumulation in cutaneous mastocytosis.
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Efficacy of glycerol-paraffin in uremic xerosis: a randomized, double-blind, comparative study
Jacek Szepietowski1, Elias Balaskas2, Didier Bessis3, Dimitrios Ioannides2, Claudio Ponticelli4, 
Corinne Ghienne5, Patrick Dupuy1 1Department of Dermatology, Venereology and Allergology, 
University of Medicine, Wroclaw, Poland, 2Department of Nephrology, Ahepa University 
Hospital, Thessaloniki, Greece, 3Department of Dermatology, Hospital St Eloi, Montpellier, 
France, 4Department of Nephrology, Scientific Institute Humanitas, Rozzano, Italy, 5Division of 
Research and Development, Orfagen, Toulouse, France
Uremic xerosis is a bothersome condition that is poorly responsive to moisturizing and emollient 
therapy. It is associated with cutaneous deficiency in glycerol and exacerbated pruritus (uremic 
pruritus). A randomized, double-blind, intra-individual (left vs right comparison), multicentric 
clinical study was performed on 100 patients with moderate to severe uremic xerosis for 7 days, 
during which the patients applied twice daily an emulsion combining glycerol and paraffin (test 
product) on one allocated lower leg, and the emulsion alone (comparator) on the other lower leg. 
This was followed by an open-labeled use of the test product on all the xerotic areas for 49 days. 
The main efficacy parameter was treatment response on each lower leg, as defined by a reduction 
from baseline of at least 2 grades in a pre-defined 5-point clinical score, on day 7. Among the 
ninety-nine (99) patients analyzed, the test product was highly effective with a treatment response 
in 72 patients (73%), whereas 44 patients (44%) responded to the comparator (p<0.0001, inter-
group analysis). This was associated with an objective reduction in the density and thickness of 
the scales using D-squames on day 7 (p<0.0001 compared to the comparator), and a substantial 
improvement of the uremic pruritus (75%) and quality of life at study end (p<0.001, intra-group 
analysis). The test product was very well tolerated, product-related local intolerance (exacerbated 
pruritus, local burning, erythema) occurring in only 5 patients (5%). In conclusion, uremic 
xerosis and pruritus can be managed successfully when an appropriate skin protectant is used.
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Low level light therapy: useful therapeutic approach for sensitive skin, in vivo and in vitro 
analysis
Mira Choi1, Kkot Bora Yeom1, Hyun Sun Park2, Eun Jung Kim3, Min Ji Kim1, Kyu Han Kim1, Jong 
Hee Lee2 1Seoul National University Hospital, Seoul, Republic of Korea, 2SMG-SNU Boramae 
medical center, Seoul, Republic of Korea, 3Seoul Veterans Hospital, Seoul, Republic of Korea
Sensitive skin is generally defined as a reduced tolerance to frequent and prolonged use of 
cosmetics and toiletries. The pathogenesis of sensitive skin is poorly understood yet and no 
optimal treatments have been established so far. Low level laser/light therapy (LLLT) has been 
used for the purpose of biostimulative effect without a thermal effect in various clinical settings, 
but has not widely used in the dermatological field until now. The purpose of this study is to see 
if the low level light of visible and infrared polarized light can improve the various symptoms 
and signs of sensitive skin in vivo and to explore possible mechanisms how low level light works 
on skin inflammation in vitro. Low level light worked beautifully on patients who have suffered 
from sensitive skin. Clinical analysis by physicians and the patients’ evaluation revealed the 
significantly beneficial effects of LLLT on sensitive skin. This study showed significantly decreased 
expression of IL-1α and VEGF after LLLT in compromised keratinocytes in vitro and this result 
gives intimation that LLLT can improve many inflammatory conditions and subside persisting 
erythema. This study suggests that LLLT could be used as a useful modality for the treatment of 
sensitive skin without serious side effects.
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Patients with multiple melanocytic nevi are more likely to develop melanoma, but their average 
Breslow score is lower
Lidia Rudnicka1, Monika Slowinska1, Malgorzata Maj1, Justyna Sicinska1, Joanna Czuwara1, 
Agnieszka Kardynal1, Ewa Piekarczyk1, Elzbieta Szymanska1, Olga Warszawik1, Marta Kurzeja1, 
Anna Wiergowska1, Magdalena Kubak1, Lukasz Lebkowski3, Piotr Rutkowski3, Malgorzata 
Olszewska2 1Department of Dermatology CSK MSWiA, Warsaw, Poland, 2Department of 
Dermatology Warsaw Medical University, Warsaw, Poland, 3Department of Soft Tissue/Bone 
Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of 
Oncology, Warsaw, Poland
The Breslow score in a major prognostic factor in patients with cutaneous melanoma. The aim 
of the study was to investigate differences between patients who developed melanoma of less 
than 1 mm Breslow score at the time of diagnosis and those who had melanoma equal of thicker 
than 1 mm. We investigated 64 patients with melanoma and 45 healthy controls. The percentage 
of patients with less than 10 melanocytic nevi was 15/45 (33.3%) in healthy individuals, 17/64 
(26,5%) of melanoma patients, 2/28 (7,1%) patients with Breslow score lower than 1 mm and in 
12/36 (33,3%) with Breslow score equal 1 mm or more. The corresponding number of patients 
with more than 100 nevi was 4/45 (11%) in healthy controls, 18/64 (28,1%) patients with 
melanoma, 11/28 (39,2%) patients with thin melanoma and 6/36 (16,6%) with Breslow equal 
1 mm or more. There was no significant difference between patents with lower versus higher 
Breslow score regarding: age, melanoma preventive behavior, time between fist perception of a 
lesion and excision, coexisting diseases or use of tanning beds. Patients with low Breslow score 
were: significantly more commonly females (71% versus 30% in the “high Breslow” group), 
less frequenty out-door workers (18% versus 36%), and more commonly smokers (64% versus 
36%). In conclusion, patients with multiple melanocytic nevi are at higher risk of developing 
melanoma, but their Breslow score is lower and prognosis seems better that in individuals with 
a low number of nevi. This difference is not related to more restrictive melanoma preventive 
behavior.
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Use of a panel of species-specific major allergens improves diagnosis of hymenoptera venom 
allergy
Silke Hofmann1, Nikolai Pfender1, Steffi Weckesser1, Simon Blank2, Huss-Marp Johannes3, Edzard 
Spillner2, Thilo Jakob1 1Allergy Research Group, Dept. of Dermatology, University Medical Center, 
Freiburg, Germany, 2Department of Chemistry, Institute of Biochemistry and Molecular Biology, 
Hamburg, Germany, 3Phadia GmbH, Freiburg, Germany
Diagnosis of hymenoptera venom allergy is based on history, skin tests and detection of IgE to 
bee and wasp venom. ImmunoCAP with venom extracts results in double positivity in about 
50% of patients due to polysensitization or more often due to IgE crossreactive with homologous 
venom allergens or with crossreactive carbohydrate determinants (CCD) on venom allergens. 
We analyzed sera from 82 and 109 patients with anaphylactic reactions and positive skin tests 
to honey bee or wasp venom, respectively, for presence of specific IgE against recombinant (r) 
or native (n) bee and wasp venom allergens devoid of CCD reactivity. The panel of allergens 
included rApi m 1, rVes v 1, rVes v 5 (commercially available ImmunoCAP), rApi m 2 and nApi 
m 4 (research prototype ImmunoCAP, Phadia). In bee venom (BV) allergic patients specific IgE 
was detected in 76% of patients to rApi m 1, in 46% to rApi m 2 and in 27% to nApi m 4. 
Combination of the three allergens confirmed BV allergy in 89% of patients. Among wasp venom 
(WV) allergic patients, 58% displayed specific IgE to rVes v 1, 90% to rVes v 5, and combination 
of both allergens led to a positive test result in 96% of WV allergic patients. The specificity 
ranged between 95 and 100% for each allergen. In conclusion, component-resolved serological 
diagnosis of hymenoptera venom allergy based on a panel of CCD free species-specific major 
allergens allows for a precise discrimination between bee and wasp venom allergy in the majority 
of cases.
242
Safety, Tolerability and Pharmacokinetics of AN2728 Ointment, a Potential Boron-based 
Treatment for Psoriasis
Lee Zane1, Sepehr Shakib2, Frederic Heerinckx1, Matilda Hughes1 1Anacor Pharmaceuticals, Palo 
Alto, CA, USA, 2cmax, Adelaide, SA, Australia
AN2728 is a boron-based small molecule in development for the topical treatment of psoriasis. 
The safety, tolerability and pharmacokinetics (PK) of AN2728 Ointment, 2%, were evaluated in 
a randomized, double-blind, vehicle-controlled, multiple cohort study in 16 healthy men. Two 
cohorts, each consisting of 8 healthy men (age 18-55 years), were randomly assigned in a 6:2 
ratio to AN2728 Ointment, 2%, or Ointment vehicle. The first cohort applied 9.5g of AN2728 or 
vehicle to approximately 10% of their total body surface area (BSA). The second cohort applied 
33.1 g of AN2728 or vehicle to approximately 35% of BSA. Drug applications were once daily on 
Days 1 and 7 and twice daily on Days 2-6. Blood samples for PK analysis were drawn pre-dose 
on Days 1, 3, 4, 5, 6 and 7 and at multiple post-dose times on Days 1 and 7. Safety assessments 
included clinical adverse events (AE), physical exam, vital signs, laboratory evaluations, and 
electrocardiograms. Overall, exposure levels were low (Day 1 mean Cmax: 38.4 ng/mL for 10% 
BSA cohort, 157.6 ng/mL for 35% BSA cohort), dose proportional, and did not show evidence of 
accumulation. AN2728 was quickly absorbed (Tmax range from 1-6 hours) and achieved steady 
state plasma levels in 3-4 days. No serious or severe AEs were observed. The most common 
AEs reported were headache, sore throat and application site erythema. In conclusion, AN2728 
Ointment, 2%, demonstrated low systemic exposure levels and was well tolerated when applied 
to 10% and 35% BSA for 7 days in healthy volunteers.
243
Safety and Efficacy of AN2728 Ointment in a 12-week, Randomized, Double-Blind, Vehicle-
Controlled, Bilateral Trial for the Treatment of Psoriasis
Mirna Toledo-Bahena2, Lee Zane1 1Anacor Pharmaceuticals, Palo Alto, CA, USA, 2Instituto 
Mexicano de Investigacion (IMIC), Mexico City, DF, Mexico
AN2728 is a novel boron-containing small molecule in development for the treatment of 
psoriasis. This 12-week, randomized, double-blind, vehicle-controlled, bilateral study enrolled 
30 adult males (mean age 48.4 years) with plaque-type psoriasis and sought to examine treatment 
effects over a 12-week period. Patients had two similar but distinct target plaques with Overall 
Target Plaque Severity Scores (OTPSS) of 2-4 (mild to moderate) and ≤1 point difference in 
severity at baseline. On each patient, one plaque was randomized to treatment with AN2728 
ointment, 5%, and the other with ointment vehicle; treatment was applied twice daily for 84 
days. By day 14, 13 (43.3%) patients had greater improvement in OTPSS scores of the AN2728-
treated plaque than the vehicle-treated plaque while 3 (10%) had greater improvement with 
vehicle (P = 0.021). The proportion of patients showing greater improvement in AN2728-treated 
plaques increased to 60% at Days 28, 42 and 56 (all P ≤0.011) and remained >50% out to Day 
84. Similar improvements were observed in the component signs of psoriasis severity (erythema, 
scaling and plaque elevation) which reached statistical significance at most evaluations during 
the 12-week treatment period. Adverse events were reported in 8 patients and included mild-
moderate application site reactions in 7 patients. One patient developed a morbilliform drug 
eruption 3 days following an intramuscular penicillin injection and approximately 35 days 
following his last AN2728 treatment. In conclusion, treatment with AN2728 ointment, 5%, was 
well tolerated and demonstrated consistent reductions in plaque severity score throughout the 
12-week treatment period.
244
Dermal Tolerability and Preliminary Efficacy of AN2728 and AN2898, Novel Boron-Based Small 
Molecules, in the Treatment of Psoriasis
Walter Wigger-Alberti2, Lee Zane1 1Anacor Pharmaceuticals, Palo Alto, CA, USA, 2bioskin GmbH, 
Hamburg, Germany
AN2728 and AN2898 are boron-containing compounds that inhibit phosphodiesterase-4 and 
reduce production of TNF-alpha and other pro-inflammatory cytokines. The tolerability and 
efficacy of these two compounds were evaluated in two randomized, controlled phase 1 trials: 
a dermal irritation test (Trial 1) and a psoriasis plaque test (Trial 2). In Trial 1, 20 healthy male 
subjects each had 5 test fields on the back treated once daily for 4 days. Treatment included 
occlusive application of AN2728, AN2898, vehicle (all as above), a negative control (aqua 
ad injectabilia), and a positive control (0.2% sodium dodecyl sulfate). AN2728, AN2898, and 
vehicle were well tolerated with no irritation reaction for AN2898 and only isolated slight 
erythematous reactions observed for AN2728 in 1 subject and for vehicle in 3 subjects. In Trial 2, 
12 adult male subjects with chronic stable psoriasis each had 6 test fields on ≥1 plaque treated 
once daily for 12 days. Treatment included occlusive application of AN2728 Ointment, 5%, 
in 2 fields; AN2898 Ointment, 5%, in 2; vehicle ointment in 1; and betamethasone valerate, 
0.1%, in 1. AN2728, AN2898 and betamethasone demonstrated clinical improvement in the 
psoriatic plaque and significant reduction in mean inflammatory infiltrate thickness as measured 
by sonogram. Both AN2728 and AN2898 demonstrated statistically greater reduction (44% and 
39%, respectively) in infiltrate thickness than vehicle (8%) and were well tolerated. In these two 
studies, AN2728 and AN2898 were well tolerated and demonstrated clinical improvement in the 
treatment of psoriatic plaques.
245
Adsorptive Depletion of CD14+CD16+ Proinflammatory Monocyte Phenotype Appears to Have 
Efficacy in Patients with Generalized Pustular Psoriasis
Tomomi Fujisawa1, Kana Murase1, Hiroyuki Kanoh1, Masao Tamemura2, Hidenori Ohnishi3, 
Noriyuki Shiobara4, Abbi Saniabadi4, Mariko Seishima1 1Department of Dermatology, Gifu 
University School of Medicine, Gifu, Japan, 2Clinical laboratory, Gifu University School of 
Medicine, Gifu, Japan, 3Department of Pediatrics, Gifu University School of Medicine, Gifu, 
Japan, 4JIMRO Institute, Tokyo, Japan
In human blood, two main monocyte phenotypes exist, CD14++CD16- classical monocytes and 
CD14+CD16+ proinflammatory monocytes, which account for about 10% of total monocytes, but 
can expand to promote inflammatory conditions. The CD14+CD16+ monocytes produce large 
amounts of inflammatory cytokines including tumour necrosis factor (TNF)-α. Further, generalized 
pustular psoriasis (GPP) is a neutrophilic dermatitis, an inflammatory skin disorder, which appears 
as an erythema and pustule on the whole body accompanied by fever. We determined the ratio 
of CD14+CD16+ cells/total CD14+ cells in the peripheral blood in healthy controls (HC) and in 
patients with GPP, which were divided into an active and an inactive subgroups. The ratio of CD16+ 
monocytes in active GPP was significantly higher than in both HC and inactive GPP. Then, we 
investigated the chemokine producing capacity of monocytes. The levels of MCP-1 were elevated 
in GPP patients. Adsorptive granulocyte and monocyte apheresis (GMA) selectively depletes 
neutrophils and monocytes and is being used to treat patients with inflammatory bowel disease. 
Additionally, there is evidence of efficacy for GMA in patients with GPP. We treated 4 active GPP 
patients with GMA, and determined the monocyte phenotypes before and after GMA. Three of 4 
patients had their CD16+ monocyte ratio reduced together with a marked improvement of their 
clinical symptoms after GMA. In conclusion, we believe that the severity of GPP is related to 
the level of the proinflammatory CD14+CD16+ monocytes. Accordingly, selective depletion of 
CD14+CD16+ monocytes potentially should benefit patients with GPP.
246
Values of anti-Desmoglein 1 and 3 antibodies in association with pemphigus activity
Maria A. Barnadas, Carmen Gelpí, Ignasi Gich, Mª José González, Lluís Puig, Agustí Alomar 
Hospital Sta. Creu i St. Pau, Barcelona, Spain
The objective was to assess the relationship between anti-desmoglein (Dsg) 1 and anti-Dsg3 
antibody (Ab) values and disease activity in the skin or mucosa of pemphigus patients. A 
retrospective study was carried out. We analysed 353 laboratory samples that were taken during 
the course of the disease from 35 PV and 9 PF patients. In each sample, anti-Dsg1 and anti-Dsgl3 
Abs were measured by an ELISA asay. Cutaneous or mucosal activity of disease was evaluated 
for each sample. Activity was considered present if any lesion appeared in the month before 
or in the month after blood extraction. A receiver operating characteristics (ROC) curve was 
calculated to determine a cutoff value for anti-Dsg1 and anti-Dsg3 Abs with optimal sensitivy 
and specificity. In PV patients we found a relationship between the cutoff anti-Dsg1 value of 
19.5 U/mL and skin activity, with a sensitivity of 69% and a specificity of 83%. In PV patients a 
relationship between the cutoff anti-Dsg3 value of 134 U/mL and mucosal activity, provided a 
sensitivity of 71% and a specificity of 67.8%. In PF patients a relationship between the cutoff of 
anti-Dsg1 value of 112 U/mL and skin activity, provided a sensitivity of 64% and a specificity of 
81.8%. Activity of pemphigus is associated with a wide range of anti-Dsg1 and anti-Dsg3 Abs 
values. Abnormal values of anti-Dsg Abs are not always associated with activity of the disease. 
Therapeutic strategies should not be based exclusively on anti-Dsg Abs values.
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Methotrexate polyglutamates as a novel marker of patient compliance to methotrexate in 
psoriasis: A single-centre prospective study
Richard Woolf1, Sarah Spain2, Monica Arenas-Hernandez3, Naomi Hare1, Annemieke Peters von 
Ton1, Cathryn Lewis2, Anthony Marinaki3, Jonathan Barker1, Catherine Smith1 1St John’s Institute of 
Dermatology, King’s College London, UK, 2Division of Genetics & Molecular Medicine, King’s College London, 
UK, 3Purine Research Laboratory, GSTS Pathology, Guy’s & St Thomas’ NHS Foundation Trust, London, UK
Methotrexate is activated by the sequential intracellular addition of glutamic acid residues to form active 
methotrexate polyglutamates (MTXPG1–5) which inhibit enzymes of the folate-purine-pyrimidine pathways. 
The aim of this single-centre prospective study was to determine if erythrocyte MTXPG1-5 concentrations 
reflect oral methotrexate therapy and predict clinical response in psoriasis. Fifty five patients with psoriasis 
(mean PASI 11 ± 6.4) were initiated on weekly oral methotrexate (mean dose 13.9–15.1mg/week) 
and followed-up for a median of 24 weeks (range 24–52). Erythrocyte MTXPG1–5 concentrations were 
measured using high-performance liquid chromatography. Methotrexate responders achieved ≥50% 
improvement in PASI or PGA of ‘clear’/‘nearly clear’ at 24 weeks. All MTXPG1-5 species were detected 
by week 4 of therapy. Steady states for total MTXPG1-5 (mean concentration 99.5nmol/L ± 46.3) and long-
chain MTXPG3-5 were reached by week 24. MTXPG3 emerged as the predominant MTXPG species and 
reflected overall polyglutamate status (correlating strongly with MTXPG2-5, MTXPG3-5 and MTXPG4-5; R
2 
0.76 – 0.95, p < 1.55x10-5). Age, renal function and gender were not significant determinants of MTXPG3 
concentrations. We demonstrated good disease response in 46% of patients but found no significant 
association between responder status and MTXPG1-2, MTXPG3 or MTXPG4-5 concentrations. Minor 
adverse events were seen in 55% but we found no significant association with MTXPG3 concentrations.
This is the first study to demonstrate the prospective accumulation of MTXPG1-5 in patients with psoriasis. 
Measuring MTXPGs offers a test to monitor patient compliance with methotrexate therapy however further 
work is require to investigate the association with clinical response.
248
Analysis of Ilioinguinal Lymph Node Dissection in Patients with Melanoma
Shigeto Matsushita, Kentaro Yonekura, Miho Takao, Kazuhiro Kawai, Takuro Kanekura Kagoshima 
University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
Palpable regional lymph node metastasis is generally recognized as a poor prognostic factor 
in patients with melanoma. However, M1a melanoma, considered to metastasize beyond the 
regional lymph node on 6th edition of UICC/AJCC staging classification (2002), showed more 
favorable prognosis than cases with metastases to other sites. The aim of this study was to analyze 
the incidence of pelvic lymph node metastasis at ilioinguinal lymph node dissection. We also 
examined the correlation between prognosis and pelvic lymph node metastases, and assessed 
whether there might be a useful predictor for pelvic lymph node metastasis. We treated 100 
patients with melanoma at our hospital in a period from January 2005 to December 2009. Eleven 
patients underwent ilioinguinal lymph node dissection. Metastasis to pelvic lymph node was 
seen in 8 patients, whose medical records were reviewed retrospectively. Their age ranged from 
17 to 76 years with a mean 59.8 years. The follow-up period ranged from 4 to 55 months. 
Breslow’s thickness was 4.0 mm or more, up to 17.0 mm. Tumor burden of positive sentinel node 
ranged from 3.0 mm to 33.0 mm. Micro-anatomic locations of the sentinel node metastases 
were multifocal or extensive. These findings suggest that frequency of further pelvic lymph node 
metastases might correlate with Breslow’s thickness and pathological status of positive sentinel 
node. We further revealed that patients with single metastatic node of iliac or obturator area had 
no recurrence after the dissection. Taken together, these findings might provide new parameters 
to select patients for ilioinguinal lymph node dissection.
249
Squamous cell carcinoma of the skin in lung transplant recipients: retrospective study
Simon Gerber1, Annette Boehler2, Lars E. French3, Günther F. Hofbauer3, Macé M. Schuurmans2 
1Faculty of Medicine, University of Zurich, Zurich, Switzerland, 2Division of Pulmonology, 
University Hospital Zurich, Zurich, Switzerland, 3Division of Dermatology, University Hospital 
Zurich, Zurich, Switzerland
Among solid organ recipients a number of factors have been found to significantly increase the 
risk for skin cancer including immunosuppression and ultraviolet radiation. In addition, lung 
transplant recipients are subject to recurring and prolonged high dose antibiotic, antifungal and 
antiviral treatment in order to prevent or treat infections. No data are available on the use of 
photosensitizing drugs and immunosuppressants in relation to the incidence of skin cancer. The 
objective of this study is the analysis of incidence and tumor-load of skin cancer, in particular 
squamous cell carcinoma (SCC), in lung transplant recipients. Retrospective study among all lung 
transplant recipients at the University Hospital in Zurich between 1992 and June 2010. Data 
were retrieved from patient medical records and the lung-transplant patients’ database. Patients 
with a transplantation period of less than one year and those diagnosed with skin cancer prior to 
transplantation were excluded from the study. A total of 213 Patients were eligible for the study 
with a mean age at transplantation of 42 years. In total, 119 invasive SCC were diagnosed in 1356 
patient-years. One or more invasive SCC lesions were diagnosed in 16.9% (36 of 213) of patients. 
Median time to diagnosis of an invasive SCC post-transplant was 1646 days. In this cohort, a 
high number of patients developed an invasive SCC. Further analysis of our retrospective data 
including calculation of cumulated exposure to possibly photosensitizing drugs is needed to 
identify additional risk factors for SCC formation in lung transplant recipients.
250
Comparing treatment outcome of infliximab and adalimumab in patients with severe 
hidradenitis suppurativa
Dominique van Rappard, Marjolein Leenarts, Leonie Meijerink-van ‘t Oost, Jan Mekkes 
Academic Medical Center, Amsterdam, The Netherlands
Hidradenitis suppurativa (HS) is a chronic relapsing skin disease. Recent studies have shown 
promising results of anti-tumor necrosis factor alpha treatment. We compared the efficacy and 
safety of infliximab and adalimumab in the treatment of HS. A retrospective study was performed 
to compare 2 cohorts of 10 adult patients suffering from severe, recalcitrant HS. In 2005, 10 
patients were treated with infliximab intravenous (3 infusions of 5 mg/kg at weeks 0, 2, and 6). 
In 2009, 10 other patients were treated in the same hospital with adalimumab subcutaneously 
40 mg every other week. Both cohorts were followed up for 1 year, using identical evaluation 
methods (Sartorius score, quality of life index, reduction of ESR and CRP, patient and doctor 
global assessment, and duration of efficacy). 19 patients completed the study. In both groups the 
severity of the HS diminished. Infliximab performed better in all aspects. The average Sartorius 
score was reduced to 54% of baseline for the infliximab group and reduced to 66% of baseline 
for the adalimumab group. We concluded that Adalimumab s.c. 40 mg every other week is less 
effective than infliximab i.v. 5 mg/kg at weeks 0, 2, and 6.
251
Expression and modulation of the actin regulatory protein hMena in psoriasis
Giorgia Cardinali, Daniela Kovacs, Arianna Mastrofrancesco, Sara Izzi, Carlo Cota, Pietro Donati, 
Claudio Bonifati, Mauro Picardo San Gallicano Dermatologic Institute, Rome, Italy
The human ortholog of mammalian enabled (hMena) is a member of the enabled (Ena) /
vasodilator-stimulated phosphoprotein (VASP) family involved in cell motility and adhesion 
by regulating the actin cytoskeleton assembly. In several human cancers the overexpression 
of hMena has been related to the proliferative index and to the high risk of progression and 
invasiveness. Since psoriasis is characterized by an altered proliferative/differentiative process 
and an aberrant expression of adhesion molecules our aim was to evaluate hMena expression 
on biopsies collected from involved and uninvolved skin of patients with active plaque psoriasis. 
Our results demonstrate an higher expression of hMena in lesional compared to healthy skin 
areas as assessed by quantitative analysis of the level of positive immunohistochemical reactivity. 
hMena expression was correlated with the proliferative rate of the psoriatic keratinocytes: the 
data show that specimens characterized by highest expression of hMena displayed the highest 
percentage of proliferating cells. In addition, hMena up-modulation resulted to be associated 
with the reduction of the differentiative keratin K10 and the increase of keratinocyte activation 
marker keratin K16. In conclusion, our study suggests that in psoriatic lesions, hMena may be 
involved in the complex mechanism which induces and sustains the hyperproliferative state and 
the altered differentiation of keratinocytes.
252
Intranuclear Changes Of Lymphoid Cells In Patients With Lupus Erythematosus
Irina Khamaganova, Marina Savina, Seraphima Khromova Russian State Medical University, 
Moscow, Russia
The objective of this study was to examine lysine- rich, lysine- moderately rich, arginine- 
rich histone fractions & DNA in lymphocytes of peripheral blood in patients with lupus 
erythematosus.48 patients(10 males and 38 females) aged 16 to 54 years with lupus 
erythematosus were examined.Histone fractions were obtained by stepped extraction.Three types 
of intranuclear changes of lymphoid cells were found in patients with lupus erythematosus.The 
level of lysine- rich histone fraction,content of DNA per cell was lower than in controls and the 
level of arginine- rich, lysine- moderately rich histone fraction was higher in patients of the first 
group than in controls.The duration of the disease was about 5 to 8 years, previous therapy was 
not effective in the first group. The level of lysine-rich,lysine- moderately rich histone fraction was 
higher in the patients of the second group than in controls and the level of arginine- rich histone 
fraction and content of DNA per cell was lower than in controls.The duration of the disease in the 
second group was not longer than 2 weeks, the patients did not receive any treatment.The level 
of lysine- rich,lysine- moderately rich, arginine-rich histone fraction and content of DNA per cell 
did not differ in the patients of the third group from those in controls. The duration of the disease 
was 2 to 6 years, previous therapy in the patients of the third group was effective.The findings 
showed intranuclear changes of lymphoid cells in patients with lupus erythematosus.
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Effect of anti-tumor necrosis factor-α therapy on plasma leptin concentration and body 
composition in psoriasis vulgaris
Kristian Kofoed1,2, Anders Clemmensen1, Ove Andersen2, Robert Gniadecki1
1Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark, 2Copenhagen University 
Hospital Hvidovre, Copenhagen, Denmark
Leptin is a fat tissue hormone that plays a key role in the regulation of appetite and body weight. 
Reduction in plasma leptin is associated with suppression of metabolic rate and stimulation 
of appetite in lean subjects. Plasma leptin is increased in psoriasis patients. TNF-α is capable 
of inducing leptin production and anti-TNF-α therapy (ATT) increases the body weight in 
psoriasis patients. Thus, it is a key question how ATT influences body composition and leptin 
concentration. We studied nine male anti-TNF-α naïve psoriasis patients. Body composition 
and insulin sensitivity were measured using a dual energy x-ray absorptiometry scanner and 
a hyper insulinemic euglycemic clamp before and after 12 weeks of ATT. Plasma leptin was 
measured using a Luminex assay. The median age was 31 years (range; 23-47). Five were given 
infliximab and four adalimumab. The median reduction in PASI was 95% (74-100%). At inclusion 
the amount of truncal fat correlated with leptin concentrations (r=0.91, p<0.001). There were 
no statistical difference in insulin sensitivity after treatment, but we observed an increase in the 
amount of truncal fat (mean±SEM; 13.3±2.8 to 14.8±2.9 kg, p=0.018), while the amount of 
peripheral fat remained unchanged. Intriguingly, leptin levels decreased (589±182 to 402±140 
pmol/l, p=0.016). Our findings suggest that ATT decreases leptin concentration in psoriasis 
patients. Leptin may be a key mediator of the increase in body weight during ATT. Leptin is an 
independent risk factor for coronary heart disease (CHD) and thus the decrease indicate that ATT 
reduces the risk of CHD in psoriasis patients.
254
Safety profile of selected antimicrobial peptides on HaCaT keratinocytes
Wioletta Baranska-Rybak, Malgorzata Dawgul, Michal Pikula, Wojciech Kamysz Medical 
University, Gdansk, Poland
Antimicrobial peptides (AMPs) are an essential part of innate immunity on skin and mucosal 
surfaces. They have broad spectrum of antimicrobial activity. AMPs kill bacteria by permeating 
their membranes, and thus the lack of a specific molecular microbial target minimizes resistance 
development . Investigation of safety of selected AMPs: protegrin, temporin A , Citropin 1.1 
and Camel on HaCaT keratinocytes. AMPs included in the study were synthesized manually 
in a microwave reactor by the solid-phase method using the 9-fluorenylmethoxycarbonyl 
chemistry (Fmoc). Human HaCaT keratinocytes (DKFZ Heidelberg, Germany) were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) (Sigma-Aldrich), with 4500 mg/L glucose, 584 
mg/L, L-glutamine, sodium pyruvate, and sodium bicarbonate. Cell proliferation assay was used 
for cytotoxicity estimation. The susceptibility to AMPs was determined by the broth microdilution 
assay. Protegrin and Temporin A, Citropin 1.1 as well as Camel at the concentration 0.1µg/
mL - 25 µg/mL were totally safe for HaCaT cells. MIC and MBC against clinical strains of 
Staphylococcus aureus for protegrin was 4µg/mL, temporin A - 16µg/mL, citropin 1.1 and for 
Camel 8-16 µg/mL respectively. Our work presents an effective and safe strategy for the treatment 
of bacterial skin infections. Obtained date suggest that investigated peptides may be applied 
not only on the non-injured skin but also directly on living layers of epidermis and skin. It is 
especially important before and after grafting of skin substitute and cultured keratinocytes since 
there is a high possibility of bacterial infections.
255
E-selectin: a biomarker of cardiovascular disease risk with potential utility in patients with 
psoriasis
Philip Laws1, Philip Pemberton2, Christopher Griffiths1, Helen Young1 1The University of 
Manchester, Manchester Academic Health Science Centre, Department of Dermatology, Salford 
Royal Hospital, Manchester, UK, 2The University of Manchester, Manchester Academic Health 
Science Centre, Department of Clinical Biochemistry, Central Manchester Foundation Trust, 
Manchester, UK
Patients with psoriasis have an increased risk of cardiovascular disease (CVD). E-selectin, a cell 
adhesion molecule which is strongly expressed on the luminal surface of endothelial cells in 
inflamed skin including plaques of psoriasis, has been identified as a circulating biomarker of 
subclinical CVD. The aim of this study was to explore the relationship between psoriasis, traditional 
CVD risk factors and plasma levels of soluble (s)E-selectin. 204 patients with Type 1 (onset ≤ 40 
years) chronic plaque psoriasis were recruited to the study. CVD risk factors, anthropometric 
measurements and psoriasis severity assessment were documented for each participant. Plasma 
levels of sE-selectin were assayed using validated enzyme linked immunosorbent assay (ELISA) 
kits.Mean plasma levels of sE-selectin were significantly elevated in patients with severe disease 
(defined as PASI ≥ 12) compared to those with mild-moderate psoriasis (defined as PASI < 12; 
p<0.001). Comparison between groups, using χ2 and Fisher’s exact tests, demonstrated that this 
difference was independent of traditional CVD risk factors including smoking, body mass index, 
age, diabetes mellitus and hypertension. Further analysis demonstrated a significant positive 
correlation between sE-selectin and psoriasis severity (rs=0.332, p<0.001). Multiple linear 
regression analysis demonstrated that this correlation was also independent of the traditional 
CVD risk factors. To the best of our knowledge this is the only study investigating the association 
between psoriasis, CVD risk factors and plasma levels of sE-selectin. Further investigation of 
the utility of sE-selectin as a circulating biomarker for CVD in patients with psoriasis is needed.
256
In vivo effects of IPL in the resolution of inflammatory acne vulgaris
Musheera Mohammad Ali, Maria Gonzalez, Fiona Ruge, Rebecca Porter Dept of Dermatology, 
Cardiff University, Cardiff, UK
The mechanism of action of intense pulsed light (IPL) in acne treatment is not clearly understood. 
A potential immunomodulatory role has been suggested. Further, inflammatory cytokines 
and matrix degrading enzymes play a key role in acne pathogenesis. Therefore, limiting the 
production of these mediators may assist acne resolution. In photorejuvenation, IPL has been 
shown to induce transforming growth factor beta (TGF-β) expression. Interestingly, TGF-β has 
been demonstrated to inhibit MMP-1 gene expression and inflammatory cytokine production 
through a Smad3-mediated signalling pathway. Therefore, we sought to investigate the in vivo 
effects of IPL used for acne treatment. Biopsies obtained from 20 patients with inflammatory acne 
vulgaris at baseline (B1) and post-IPL treatment (B2=48 hrs after first treatment and B3=1 wk after 
final treatment) were immunohistochemically analysed to determine the expression of TGF-β1, 
TGF-β2, TGF-β3, Smad3, MMP-1 and IL-8. Digital images were semi-qualitatively assessed using 
image analysis software. IPL elicited a consistent increase in TGF-β1 expression (B2:17/20 cases; 
p=0.004 and B3:17/20 cases; p=0.007) and a concurrent nuclear immunolocalisation of Smad3 
(B2:18/20 cases; p=0.000055 & B3:19/20 cases; p=0.00024). No specific pattern of expression 
was noted for TGF β2/β3. Although not statistically significant, both IL-8 and MMP-1 expression 
showed a downward trend in the majority of the cases. Thus, TGF-β1 via Smad3 mediated 
signalling may play a role in IPL-induced resolution of acne vulgaris. The therapeutic effect of 
TGF-β1 in inflammatory acne vulgaris could be attributed to its immunosuppressive effect and its 
ability to inhibit matrix degradation and keratinocyte proliferation.
257
Proof-of-Concept-Study to Evaluate the Efficacy and Tolerability of Repeated Versus Single 
Treatment with Botulinum-Toxin (Vistabel®) Treatment in Combination with a Hyaluronic Acid 
(Juvederm-Ultra® 2) in Patients with Glabellar Frown Lines
Welf Prager1, Ina Zschocke2, Isabel Havermann1 1dermatologikum Hamburg, Hamburg, Germany, 
2SCIderm GmbH, Hamburg, Germany
Despite the convincing effectiveness in general treatment of glabellar frown lines with Botulinum 
toxin A, a treatment option in individuals with deep glabellar rhytides at rest due to additional 
loss of connective tissue components is the injection of Hyaluronic acid, a naturally occurring, 
biodegradable complex sugar and component of the connective tissue. Nevertheless, since the 
remaining muscle activity leads to a faster decomposition and a continuous dislocation of the 
filling agent out of the fold valley hyaluronic acid alone does not seem to be sufficiently effective 
in most subjects with glabellar folds.The primary objective is to demonstrate the superiority of 
a single Botulinum toxin injection in combination with hyaluronic acid compared to treatment 
with hyaluronic acid alone with respect to prolonging the filler persistence within 4 months. 
This is a prospective, 2-arm, controlled, randomized, double-blind proof-of-concept-study to 
evaluate the efficacy and tolerability of repeated and single treatment with Botulinum toxin 
(Vistabel®) treatment in combination with a hyaluronic acid (Juvéderm® Ultra 2) in subjects with 
glabellar frown lines compared to subjects with sole hyaluronic acid treatment in 40 patients. 
Efficacy will be assessed by Facial Wrinkle Scale (FWS) at rest and at maximum frown, Physician’s 
Global Assessment (PGA) at rest and at maximum frown, Subject’s Assessment of Satisfaction 
and Subject’s Evaluation of Cosmetic Outcome. Since the study is still in progress, we can not 
demonstrate any data by now. Since there is not much evidence about combination treatment, 
we would like to share our results with the participants at ESDR 2011.
258
Belotero® Basic has a better tolerability vs Restylane®: A prospective, rater-blind, randomized, 
comparative trial
Welf Prager, Volker Steinkraus Deramtologikum Hamburg, Hamburg, Germany
Belotero® Basic is the only monophasic HA with Cohesive Polydensified Matrix (CPM®) 
technology, whereas Restylane® is a biphasic, non-animal stabilized HA (NASHA) filler. The aim 
of this prospective, rater-blind, randomized, intra-individual study was to compare after a single 
injection the effectiveness and tolerability of these two HA for correction of moderate to severe 
nasolabial folds (NLF) and to demonstrate the advantage of monophasic versus biphasic HA. 
After a screening phase subjects were injected randomly with either Boletero® or Restylane® 
in one NLF in a split-face design. Rating was conducted at week 4. The rater and the subject 
were not aware of the randomization. Besides other endpoints pain experienced directly after 
injection using a 10-cm visual analog scale, feeling of implant, and recommendation of the 
study treatments were evaluated (descriptively). 20 Patients were treated with a mean of 1.4 
mL of Belotero® Basic or Restylane®. Mean pain assessment scores on the VAS were lower for 
Belotero® Basic than for Restylane® with an intra-individual difference of -4.5 mm [95% CI: -14.0; 
5.1]) in favour of Belotero. Moreover, less sujects reported the feeling of Belotero® compared to 
Restylane® (65% vs 75%). The majority of patients would recommend the use of both products, 
however, 25% would only recommend Belotero® Basic only (vs. 10% Restylane® only). 85% of 
subjects in the Belotero® Basic group and 80% of subjects in the group rated the tolerability as 
‘good’ to ‘very good’. Belotero® Basic demonstrated a numerical superiority regarding tolerability 
vs. Restylane® in this study.
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Clinicopathological analysis of primary cutaneous CD4+ small/medium-sized pleomorphic 
T-cell lymphoma
Nora Eros1, Orsolya Kontár1, Márta Marschalkó1, Judit Demeter2, Anikó Fodor2, Judit Hársing1, 
Judit Csomor3, Ágota Szepesi3, András Matolcsy3, Sarolta Kárpáti1 1Department of Dermatology, 
Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary, 21st Department 
of Internal Medicine, Semmelweis University, Budapest, Hungary, 31st Department of Pathology, 
Semmelweis University, Budapest, Hungary
Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma is an uncommon 
cutaneous lymphoma with indolent behaviour in most cases. All the 13 presented cases had skin 
lesions on the upper half of the body, the head was found to be the most common predilection 
site followed by the neck, the upper trunk and the arm. With two exceptions all patients presented 
with solitary erythematous papules or nodules. Staging examinations excluded systemic 
involvement in all patients. Histopathology revealed nodular or diffuse lymphoid infiltration 
in the dermis composed of small and medium sized lymphoid cells admixed with some large 
CD30+ cells and histiocytes in all cases. Tumor cells proved to be CD3 and CD4 positive, the 
infiltrate included some CD8+ and CD20+ cells, 10-20% PD-1+ medium sized cells, and Ki-67 
proliferation rate was 10-20% in the majority of cases. Spontaneous regression was observed 
in 2 cases, all the other patients was treated with surgical excision. One patient with therapy-
resistant multiple lesions was treated with excision, radiotherapy and intralesional interferon-
alfa. During the follow-up lymph node or visceral manifestation did not develop in any of our 
patients. Based on our observation CD4+ small/medium-sized pleomorphic T-cell lymphoma 
could be considered as an indolent entity, however cases with multiple skin manifestations may 
be resistant to the usual therapies. Unlike previously published data we could not demonstrate 
PD-1 (programmed cell death-1) expression in the dominant part of the infiltrate in this rare entity.
260
Treatment with atraumatic cannulas
Welf Prager, Isabel Havermann, Nora Szabo Dermatologikum Hamburg, Hamburg, Germany
In recent years, volumizing the face to restore lost fat tissue, restructure sagging skin and thereby 
reverse the effects of aging has become more and more popular. Patients prefer methods and 
techniques which reduce their downtime and optimize the aesthetic outcome. New and safe 
products (Hyaluronic acid, Calcium Hydroxyl Apatit) as well as new devices such as atraumatic 
canulas lead to higher patient satisfaction.There are different cannulas on the market, e.g. MN 
magic needles: Needleconcept; Softfil: Soft Medical Aethetics; DermaSculpt: Cosmofrance; Pix´l: 
Q-Med; CSH Cannulae: TSK laboratory. The treatment is performed with a single point injection 
using a so called sliding injection technique. This means that a large area can be treated from 
one injection point with a fanning technique, allowing facial resculpturing. This is done from 
different angles in order to achieve an even more homogeneous result. The depth of injection 
varies from subdermal to supraperiostal depending on the injection site. The injection can be 
given in an antero- and retrograde manner. We conclude that the patient’s satisfaction with 
aesthetic treatments will be improved by providing a more natural result and less downtime due 
to less swelling and fewer haematomas.Therefore patients will be convinced much more easily 
and quickly by these treatments.
261
A novel certified dermal sampling system for efficient clinical research
Manfred Bodenlenz1, Christian Hoefferer1, Joachim Priedl1, Christian Dragatin1, Stefan 
Korsatko2, Lisa Liebenberger2, Samra Zahiragic2, Reingard Raml1, Christoph Magnes1, Thomas 
Pieber1,2, Frank Sinner1,2 1Joanneum Research Forschungsgesellschaft m.b.H, HEALTH - Institute 
for Biomedicine and Health Sciences, Graz, Austria, 2Medical University Graz, Department of 
Internal Medicine, Division of Endocrinology and Metabolism, Graz, Austria
Dermatologicals require pharmacokinetic (PK) and pharmacodynamic (PD) data from the site of 
action in the dermis of the skin. We aimed at an improved continuous dermal sampling method 
to enable efficient drug trials in dermatology and we now report first data of this new method 
in a clinical setting. A minimally-invasive probe for intradermal sampling based on the principle 
of Open-Flow Microperfusion (OFM) was designed and CE-certified. This OFM probe provides 
direct access to the dermal micro milieu to sample drugs and markers regardless of molecular 
size or lipophilicity. For efficient probe operation in clinical trials we also developed and CE-
certified a novel pump designed especially for the needs of OFM and Microdialysis. The pump is 
wearable, flexible with regard to flow rates (0.1 -10 µL/min) and operation modes (Push/Push-Pull) 
and is capable of running up to 6 OFM or Microdialysis probes simultaneously. The CE-certified 
OFM-system is currently used in first PK-PD trials in volunteers and psoriatic patients applying 
up to 12 OFM probes per subject for up to 26 hrs. Sampling success, system performance and 
patient acceptance are evaluated based on the relative sampling recovery, sampling volumes, 26 
hrs sampling stability, error rates, patient feedback and ultrasound verification of probe depths. 
First available data demonstrate a high sampling recovery and excellent performance of the entire 
wearable OFM system. Thus, the data confirm the device design for informative and efficient 
sampling studies. The presentation will outline the characteristics of this new sampling system 
and its opportunities in dermatological research.
262
Acute instrumental study for the evaluation of the elasticizing activity of a new composition
Federico Mailland1, Adele Sparavigna2 1Scientific Dept., Polichem SA, Lugano, Switzerland, 
2DermIng Institute, Monza, Italy
A clinical study on healthy volunteers was performed with the aim to investigate the skin 
elasticizing activity of a formulation containing a thiolated compound and a mixture of esters of 
fatty acids and glycerol, with that of white soft paraffin as a reference standard. The volunteers 
were 21 women, aged between 24 and 55 years (mean 45 yrs), informed consent signed. The 
test and reference product were randomly applied once, by a mild massage, on the volar surface 
of forearm. Plastoelasticity measurement were performed at baseline and 30 minutes after the 
application of each product by means of torsiometry measured by the Dermal Torque Meter (Dia-
Stron LTD). The parameters measured by the a.m. technique were the elastic recovery measured 
as a ratio between immediate elastic recovery and immediate extensibility (Ur/Ue), and the skin 
elasticity measured as the ratio between immediate elastic recovery and maximum extensibility 
((Ur/Uf). The percent changes vs. baseline of torsiometric parameters 30 min after application on 
the forearm skin resulted in + 24% for Ur/Uf (p<0.01) and + 23% for Ur/Ue (p<0.001) for the test 
product (Student’s t test). Conversely, the changes vs. baseline for reference were +13% for both 
parameters (p<0.05). Fats are known to increase elasticity in terms of extensibility and elastic 
recovery. Our data show that a mixture of glycerides and a thiolated compound is capable to 
further increase skin extensibility and elastic recovery.
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Tonic inhibitory effect of cannabinoid receptor 1 (CB1)-mediated signaling on human 
connective tissue- and mucosal- type mast cell functions in situ via endocannabinoids
Koji Sugawara1,4, Tamás Bíró2, Arno Kromminga3, Daisuke Tsuruta4, Balázs István Tóth2, Nóra 
Zákány1,2, Torsten Hundt1, Vladimir Emelianov1, Bernhard Gibbs5, Ralf Paus1,6 1Dept of Dermatology, 
Univ of Luebeck, Germany, 2Dept of Physiology, Univ of Debrecen, Hungary, 3Inst for Immunology, Molecular 
Medicine, Hamburg, Germany, 4Dept of Dermatology, Osaka City Univ Grad School of Medicine, Japan, 
5Medway School of Pharmacy, Univ of Kent, UK, 6School of Translational Medicine, Univ of Manchester, UK
Recently, cannabinoids have surfaced as one important neuroendocrine regulators of mast cell 
(MC) biology. We have previously shown that locally produced prototypic endocannabinoids (e.g. 
anandamide, AEA) markedly inhibit human hair follicle (HF) growth via cannabinoid receptor (CB) 
1. Now, we were interested to dissect how CB1-signaling affects human MCs in situ, focusing on 
connective tissue-type MCs (CTS-MCs) in the connective tissue sheath (CTS) of organ-cultured human 
scalp HFs and on mucosal-type MCs (M-MCs), using organ-cultured nasal polyps (NP) as a surrogate 
tissue for human bronchial mucosa. We show that Kit+ CTS- and NP-MCs express functional CB1 
receptors in situ. Blockade of CB1-signaling (using the specific CB1 antagonist AM251 or CB1 gene 
knockdown by siRNA) significantly enhanced CTS- and M-MCs degranulation and increased their 
total number in situ, as shown by quantitative MC (immuno-)histochemistry and ultrastructurally. 
Strikingly, inhibiting CB1-mediated signaling did not promote Kit+ CTS-MCs proliferation, but their 
maturation in situ from resident progenitor cells in the CTS, probably via up-regulating stem cell factor 
(SCF) production. Both, the endocannabinoid, AEA, and the CB1-selective agonist, ACEA, effectively 
counteracted the degranulation of MCs by potent endogenous and exogenous MC secretagogues 
(substance P, compound 48/80) in situ. Thus, in both human skin and airway mucosa, MC activation 
and maturation from resident progenitors is subject to an important inhibitory endocannabinoid tone. 
This invites one to target the intracutaneous and intrabronchial endocannabinoid system as a novel 
strategy in the future management of allergic diseases.
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New data on the value of the autologous serum skin test and the basophil CD63 expression 
assay in the diagnosis of chronic urticaria
Beatrix Irinyi1, Edit Gyimesi2, Gábor Mócsai1, Edina Garaczi3, Zsuzsanna Bata3, Katalin Hodosi2, 
Margit Zeher2, Éva Remenyik1, Andrea Szegedi1 1Department of Dermatology, University of 
Debrecen, Medical and Health Science Center, Debrecen, Hungary, 23rd Department of Internal 
Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary, 
3Albert Szent-Györgyi Clinical Center Department of Dermatology and Allergology University of 
Szeged, Szeged, Hungary
Currently the clinical diagnosis of Autoimmune Chronic Urticaria (ACU) depends on the clinical 
signs and on the autologous serum skin testing (ASST), but confirmation is needed by other 
functional or binding assays, since the specificity and sensitivity of the test is not sufficient. Earlier 
positive correlation was found between the basophil CD63 expression test and the undiluted 
autologous serum skin test (ASST), and between the CD63 test and the histamine release assay. 
In our recent work we studied whether the undiluted or the diluted sera (1:10, 1:100) of chronic 
urticaria patients show better correlation with the CD63 assay. We also analized the correlation 
between the CD63 assay and the severity of the clinical urticaria score index. We examined 52 
patients with chronic ordinary urticaria and with the help of a validated questionnaire urticaria 
score index was calculated. ASST with the patient’s own diluted (1:10, 1:100) and undiluted 
sera, and CD63 basophil activation test on atopic donor basophils were performed.  ASST with 
diluted sera did not show correlation with the CD63 assay, but was more often positive in the 
severe patients. A significant correlation was found between the CD63 assay and the score index 
representing severity of disease. ASST with diluted sera of chronic urticaria patients does not have 
any additional information on the diagnosis of autoimmun urticaria, although it can indicate the 
severity of the disease. In the CD63 basophil activation assay the degree of the CD63 cell surface 
expression can also show information on the severity of the clinical signs.
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Efficacy of methotrexate versus fumaric acid esters administered under daily life conditions in 
moderate to severe chronic plaque psoriasis
Martin Inzinger1, Bettina Heschl1, Wolfgang Weger1, Alexandra Gruber-Wackernagel1, Franz Josef 
Legat1, Angelika Hofer1, Rok Kokol1, Hemma Tilz1, Wolfgang Salmhofer1, Franz Quehenberger2, 
Peter Wolf1 1Department of Dermatology, Medical University, Graz, Austria, 2Institute for Medical 
Informatics, Statistics, and Documentation, Medical University, Graz, Austria
We analyzed available data to compare the clinical efficacy of methotrexate and fumaric acid 
esters (FAE) in patients with chronic plaque psoriasis treated under daily life conditions at the 
Department of Dermatology, Medical University of Graz, Austria. Data from a psoriasis registry 
(http://www.psoriasis-therapieregister.at) of 146 adult patients (62 women and 84 men) with a 
total of 192 treatment courses administered between 2004 and 2011 were extracted for analysis. 
Seventy-five patients had received 78 standard treatment courses with subcutaneous or oral 
methotrexate and 97 patients had received 114 standard treatment courses with oral FAE (49 
patients methotrexate only; 71 patients FAE only; 26 patients first FAE and later methotrexate 
or vice versa). Treatment responses were analyzed in terms of psoriasis area and severity index 
(PASI) improvement, including reduction of PASI by at least 90% (PASI90), 75% (PASI75) or 
50% (PASI50) from start of treatment. Efficacy was assessed at week 12 for both therapies. There 
was no statistically significant difference in PASI reduction rates between methotrexate and 
FAE (p>0.05; exact Wilcoxon test). Four percent of patients treated with methotrexate achieved 
PASI90, compared with 8% for FAE (ns). Twenty percent of patients treated with methotrexate 
achieved PASI75, compared with 25% for FAE (ns). Thirty-seven percent of patients treated with 
methotrexate achieved PASI50, compared with 38% for FAE (ns). Our retrospective analysis of 
registry data revealed that under daily life conditions at least at week 12 the primary efficacy of 
methotrexate was similar to that of FAE.
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The IL-23/Th17 Pathway In Cutaneous Non Melanoma Skin Cancers
Cristina Pellegrini, Maria Concetta Fargnoli, Antonella Di Cesare, Antonella Piccioni, Ketty Peris 
Department of Dermatology, University of L’Aquila, L’Aquila, Italy
Few recent studies investigated the role of the IL-23/Th17 axis in human carcinogenesis but 
no studies are available for cutaneous non melanoma skin cancers (NMSCs).Imiquimod (IMQ) 
and methyl aminolevulinate photodynamic therapy (MAL-PDT) are well-established non surgical 
treatments for NMSCs.We investigated the expression of the IL-23, IL-17 and INF-γ genes in skin 
biopsy specimens of 24 cutaneous NMSCs (19 basal cell carcinomas [BCCs], 5 in situ squamous 
cell carcinomas [SCCs] including 4 actinic keratoses and 1 Bowen’s disease) either excised (12) 
or treated with IMQ (7) or MAL-PDT (5).Normal skin of 9 volunteers was used as control.Analysis 
of the mRNA expression levels of IL-23, IL-17 and IFN-γ was performed in the tumor samples 
and in normal skin at the basal level and during/after treatment using real-time quantitative PCR.
Our results demonstrated that basal IL-23 mRNA expression levels were 18-fold increased in 
BCCs as compared to normal skin (p< 0.0001) and 2-fold increased as compared to in situ SCC 
(p<0.0001).Basal INF-γ expression levels were slightly elevated in BCCs (p=0.0005) and very 
elevated in in situ SCCs (p<0.0001) with respect to normal skin.Finally, inconsistent data were 
obtained for IL-17 expression, being increased only in a few samples of BCC and in one sample of 
in situ SCC.Interesting, a decrease of IL-23 and an increase of INF-γ mRNA expression levels were 
detected in BCC treated with IMQ during the inflammatory reaction as compared to baseline.
These results suggest a possible involvement of the IL23/Th17 pathway in the pathogenesis of 
NMSC and in their response to treatment.
267
Expression of alpha-synuclein in skin patients with Parkinson’s Disease
Ana-Arely Rentería Palomo1,3, Ildefonso Rodríguez Leyva1,3, Rodrigo Valdes Rodríguez1,2, 
Cornelia Fuentes Ahumada1,2, Ana-Laura Calderon Garcidueñas1,3, Benjamín Moncada1,2, Juan-
Pablo Castanedo Cazares1,2 1Universidad Autónoma de San Luis Potosí, San Luis Potosí, San Luis 
Potosí, Mexico, 2Departamento de Dermatología. Hospital Central Dr. Ignacio Morones Prieto, 
San Luis Potosí, San Luis Potosí, Mexico, 3Departamento de Neurología. Hospital Central Dr. 
Ignacio Morones Prieto, San Luis Potosí, San Luis Potosí, Mexico
Parkinson’s disease (PD) is a degenerative disease difficult to diagnose, due to similar symptoms 
with other diseases like Parkinsonism Plus Syndromes (PPS), and the lack of diagnostic tests. 
Current evidence suggest that alpha-synuclein (AS) can be expressed in the skin of patients 
with PD, furthermore the sebaceous gland has the capacity of express some neuropeptides. The 
histological hallmark for the definitive diagnosis in PD is the fibrillar aggregates of phosphorylated 
AS (i.e. Lewy bodies) in the substantia nigra. So, a useful tool for diagnosing PD can be the 
demonstration of AS aggregates in the skin of patients with PD compared with PPS and healthy 
controls. We include 15 patients, with diagnosis of PD and PPS according to clinical criteria, and 
5 healthy controls. Punch skin biopsies were taken from neck and lower back. Each sample was 
stained immunohistochemically with alpha-synuclein antibody. A mesencephalon affected by 
Parkinson disease was used as positive control to determine the cut-off dilution. Immunolabeled 
sections at dilution of 1:1500 were double-blindly examined by dermatopathologist and 
neuropathologist. All the patients with PD were positive for AS accumulation in the spinous layer 
of epidermis and in the sebaceous and eccrine glands compare with PPS patients and healthy 
controls. Skin biopsy is a useful and safe tool for in vivo diagnostic of PD. AS in skin can be used 
to support the accurate diagnosis of PD, and may distinguish PPS from PD in the early stage of 
the disease.
268
The role of alternative splicing in the response to vorinostat/bexarotene combination therapy in 
advanced cutaneous T-cell lymphoma
Maria Karpova1, Martina Storz-Schweizer2, Michal Okoniewski3, Daniela Gunz4, Antonio Cozzio1, Karin 
Schad1, Katrin Baumann-Conzett1, Lars French1, Bengt Fadeel5, Reinhard Dummer1 1Derm Clinic, Zurich, 
Switzerland, 2Inst of Clin Path, Zurich, Switzerland, 3Funct Genomics Ctr, Zurich, Switzerland, 4Merck, Sharp 
& Dohme Corp, Opfikon-Glattbrugg, Switzerland, 5Inst of Environ Med Karolinska Inst, Stockholm, Sweden
Cutaneous T-cell lymphomas (CTCL) represent the most common subtype of primary cutaneous lymphomas. 
Since there is no curative treatment, combination strategies are being developed to increase therapeutic 
efficiency. In this study we evaluated the role of alternative splicing in the response to vorinostat/bexarotene 
combination therapy in patients with advanced CTCL. Patient material was collected during a Phase I 
multicenter, open-label, non-randomized, dose-escalation study (NCT00127101). At first, we detected 
transcriptional changes by microarray analysis in skin biopsies from 15 patients: Pre- and On-treatment. 
Human Exon 1.0 ST microarrays were used, enrichment analysis (EA) was performed using Genego 
Metacore. Data mining resulted in the conclusion that response to vorinostat/bexarotene treatment is 
associated with induction of apoptosis, whereas progressive patients escape through the upregulation of 
NOTCH signaling. Exon microarrays allow to assess alternative splicing events through the evaluation of 
Splicing Index, which indicates independent expression of each exon. EA of differentially expressed exons 
revealed several additionally affected pathways, including response to DNA damage stimulus (Brca1, STAT1, 
IL-6); response to hormone stimulus (JAK2, CBP, STAT5B, TR4, PKC-zeta); regulation of cell proliferation and 
cell cycle (p21, p53, CDK2, Bcl-2). We have chosen to further validate expression of alternatively spliced 
variants of STAT3, STAT5, TP53, BCL2, and HAX-1 genes by quantitative RT-PCR and immunohistochemistry 
in bioptic material from all 23 patients enrolled in the study. We performed correlation and multivariate 
analyses using expression, immunohistochemistry and clinical data. Results of this study may help to initiate 
the development of personalized therapeutic strategies targeting responsive CTCL patients.
269
A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Tolerability of Narrow 
Band UVB Phototherapy in Enhancing Etanercept’s Maintenance Dose in Obese Patients with 
Moderate to Severe Plaque-Type Psoriasis
Kelly Park, Faranak Kamangar, Misha Heller, Tina Bhutani, Eric Lee University of California, San 
Francisco, San Francisco, California, USA
Psoriasis is a pruritic, inflammatory condition with a chronic, remitting and relapsing course. 
Combination therapy is often needed for the control of moderate-to-severe psoriasis because 
using two agents that work through different mechanisms of action can have additive results and 
therefore maximize therapeutic results. Etanercept is a biologic drug used for the treatment of 
psoriasis that is particularly efficacious at its induction dose. After three months, it is reduced to 
the maintenance dose, and there is some loss of efficacy. In general, obese patients (Body Mass 
Index (BMI) > 30) can be poor responders to etanercept. In particular, etanercept’s maintenance 
dose would likely be insufficient for these patients. Though obesity may affect etanercept’s 
efficacy, it does not affect the efficacy of narrowband ultraviolet B (NB-UVB) phototherapy. 
We conducted a single-center, open-label, 24 week pilot study, which started with all subjects 
receiving Etanercept 50 mg twice weekly for 3 months (12 weeks), and from week 12-24 all 
subjects stepped down to Etanercept 50 mg once weekly. At week 12, the subjects were divided 
into two arms, and one arm received nb-UVB three times a week in addition to the Etanercept, 
and the other only received Etanercept. The study measured PASI/ BSA/ PGA at weeks 0, 4, 8, 12, 
24. This study suggests that in the overweight population the addition of nb-UVB at the time of 
step down of Etanercept from 50 mg twice weekly to once weekly, helps to maintain clearance 
and prevent worsening of Psoriasis.
270
Inner surface of the stratum corneum and the barrier ultrastructure in atopic dermatitis 
investigated by electron microscopy using the non invasive sampling technique Lipbarvis®
Stephan Dähnhardt-Pfeiffer1, Regina Fölster-Holst2, Erhardt Proksch2, Jens-Michael Jensen2, Sigo 
Weissmantel2, Dorothee Dähnhardt1 1Microscopy Services Dähnhardt Gmb, Flintbek, Germany, 
2Clinic for Dermatology, Kiel, Germany
Scanning electron microscopy (SEM ) allows to get an overview of large areas of the SC, as well 
as an closer look to the singular cellular surface. A non invasive sampling technique (Lipbarvis) 
combined with SEM, was developed to generate a “profile of depth” of the corneocytes structure. 
Multiple sampling on the same area allows visualizing of the (i) general SC morphology including 
the typical furrows, (ii) distinct morphology of the corneozytes depending on the depth (iii) 
singular cell surface morphology. SC samples were obtained from healthy human skin and from 
patients with atopic dermatitis (AD), before and after treatment with a topical applied steroid 
ointment. We show that in samples of healthy patients the occurrence of the typically furrows 
differs with the sampling depth. Clear furrows with sharp edges are found in the first sample, 
whereas in the third sample more smooth structures were visible. In samples from AD patients, 
the furrows appear higher and more expanded as in samples from healthy patients. Corticosteroid 
treatment caused distinctive alterations in the SC morphology. After this treatment the furrows 
in the SC become clearer, more comparable to that of healthy skin samples. The same effects 
are visible in the barrier ultrastructure, after ultrathin sectioning and TEM investigation, the lipid 
bilayers show partially more reconstructed but not complete in comparison with healthy skin. 
In summary, the non-invasive skin sampling in combination with different microscopy methods 
is very suitable to determine the morphology of the skin as well as for the ultrastructure of the 
barrier.
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Dermatitis toxica faciei after boric acid
Anna Jiráková, Jana Hercogová Dermatovenerology Department 2nd Medical School Charles 
University, Prague, Czech Republic
The adverse toxic reaction after topical application of a 2% boric acid in a 2-years-old girl is 
described. This case report shows a danger of still very popular and widely used topical agent 
in children. A 2-years-old girl with a history of atopic dermatitis was referred to our department. 
She had a sharply demarcated, dark red erythema, erosions and crusts on both cheeks and the 
chin. There was a visible edema and exudation of the lesions. The mother of the child has been 
applying wet dressings containing boric acid on the child’s face for the last two weeks, four 
times a day. The child was admitted to our in-patient department. Screening laboratory tests and 
smears from the lesions on the face were without pathological results. The child was treated with 
systemic antihistamines, topically with 0,1% dexamethasone for 2 days and emmolients. After 
one week of treatment, a significant improvement of the clinical status was noticed, only a slight 
erythema on the cheeks was present. The diagnosis could be dermatitis contacta irritativa or 
dermatitis toxica faciei post acidi borici. According to Czech pharmacology rules, topical boric 
acid can be used in children older 10 years of age. As to its easy and fast absorption and slow 
elimination, there is a high risk of systemic side effects and toxicity after a topical application 
in younger children. On the other hand, topical side effects are not reported in the literature.
272
Histone deacetylases as new therapeutical targets for the treatment of Non-Melanoma Skin 
Cancer: results of phase I/IIa trial with topical DAC060
Elisabetta Botti1, Ciro Mercurio3, Giulia Spallone1, Alessandro Di Stefani1,2, Massimo Gabellini1, 
Augusto Orlandi2, Sergio Chimenti1, Saverio Minucci3, Antonio Costanzo1 1Department of 
Dermatology, University of Rome Tor Vergata, Rome, Italy, 2Department of Pathology, University 
of Rome Tor Vergata, Rome, Italy, 3Genextra/DAC, Milan, Italy
Non Melanoma Skin Cancers (NMSC) are the commonest human skin cancers, while not 
life threatening these can cause cosmetic disfigurement. DAC060 is a novel class I/II histone 
deacetylase inhibitor (HDACi), acting on chromatin remodeling by enhancing core histone 
acetylation, able to induce cell death in basal cell carcinoma cells and to reduce incidence 
of papilloma appearance in two stage mouse skin carcinogenesis model. The objective of 
our phase I/IIa trial was to determine the optimal dose of topical DAC060 in NMSC patients, 
evaluating clinical efficacy, safety and tolerability. A dose finding phase I trial was performed on 
15 patients with superficial, nodular BCC or actinic keratosis ranging 0,8 to 2 cm diameter. A 
diagnostic punch biopsy was performed at screening. At week 4 surgical excision of the lesion 
for histological evaluation was performed. Phase I revealed 1600 µg/day for 4 weeks as the 
most efficacious regimen with good tolerability. In phase II study, 22 patients were recruited 
and treated at 1600µg/day dose. Subsequently the lesions were excised after a follow-up period. 
Efficacy assessments included clinical, dermoscopic and histological evaluation. Four weeks 
treatment was able to induce complete or almost complete clearance of tumors in 16/22 patients 
and partial response in the remaining patients. The most frequent safety findings were mild 
inflammatory reactions. Immunohistochemistry revealed increased levels of histone acetylation 
and apoptosis, and reduced proliferation rate. In addition, an increase of intratumoral and 
peritumoral T-cell infiltrate was observed. Our data highlight HDAC enzymes as a novel targets 
for BCCs treatment.
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Oral Apremilast Is Active in the Treatment of Moderate to Severe Plaque Psoriasis: Results from 
a Phase 2b, Randomized, Controlled Study (PSOR-005)
Kim Papp1, Angela Hu2, Robert Day2 1Probity Medical Research, Waterloo, ON, Canada, 2Celgene 
Corporation, Warren, NJ, USA
Apremilast (APR) is a novel, orally available small molecule that specifically inhibits 
phosphodiesterase-4 and thus modulates multiple pro- and anti-inflammatory mediators 
implicated in psoriasis. We evaluated APR for the treatment of moderate to severe plaque 
psoriasis. This phase 2b study randomized 352 subjects with moderate to severe plaque psoriasis 
(psoriasis area/severity index [PASI] ≥12; body surface area ≥10%) equally to APR (10mg, 20mg, 
or 30mg BID) or placebo. At week 16, placebo subjects were re-randomized to APR 20mg or 
30mg BID until week 24. At week 16, significantly (P<.001) more subjects achieved PASI-75 
with APR 30mg BID (36/88; 40.9%) and 20mg BID (25/87; 28.7%) vs APR 10mg BID (10/89; 
11.2%) or placebo (5/88; 5.7%). A consistent dose response was seen across efficacy parameters. 
Most (>96%) adverse events were mild or moderate in severity. Nausea, upper respiratory tract 
infection (URTI), diarrhea, nasopharyngitis, headache (1 severe), tension headache, viral URTI, 
arthralgia (placebo group), gastroenteritis, and dyspepsia occurred in ≥5% of subjects through 
week 16. Eight serious adverse events were reported through week 24, none related to APR. 
There were no apparent effects on liver function tests, white blood cell counts, hemoglobin, 
or electrolytes. APR 20mg and 30mg BID reduced the severity of moderate to severe plaque 
psoriasis. APR 30mg BID had the best overall risk-benefit profile and is now being studied in 
the global phase 3 clinical program, ESTEEM (Efficacy and Safety Trial Evaluating the Effects of 
ApreMilast in Psoriasis), which comprises two 52-week, randomized, placebo-controlled trials 
with long-term, open-label extensions.
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Vitamin D serum levels are differentially influenced by UVB311 and UVA1 phototherapy
Laurence Feldmeyer1, Golnar Shojaati1, Katharina-Susanne Spanaus-Schlapbach2, Alexander 
Navarini1, Barbara Theler1, Davide Donghi1, Mirjana Maiwald1, Martin Glatz1, Laurence Imhof1, 
Annette Bischoff-Ferrari3, Malgorzata Roos4, Lars E. French1, Christian Surber5, Günther FL 
Hofbauer1 1Dept of Dermatology, Univ Hospital Zurich, Switzerland, 2Inst for Clinical Chemistry, 
Univ Hospital Zurich, Switzerland, 3Centre on Aging and Mobility, Dept of Rheumatology, Inst of 
Physical Medicine, University Hospital Zurich, Switzerland, 4Div of Biostatistics, ISPM, University 
Zurich, Switzerland, 5Research & Development, Spirig Pharmaceuticals, Egerkingen, Switzerland
UV phototherapy has been shown to increase 25(OH)D. Almost all studies were performed with UVB 
broadband. Four recent studies investigated the influence of UVB narrowband (nb) on vitamin D. Only 
2 studies investigated 25(OH)D under PUVA-therapy, with contradictory results. No studies on the effect 
of UVA1 on vitamin D could be identified in the literature. We investigated the serum levels of 25(OH)
D under UVBnb, combined UVA/UVBnb and UVA1 therapy in patients undergoing phototherapy, to 
determine the effect of these frequently used wavelengths for phototherapy on vitamin D levels, and to 
test the dogma that UVA has no effect on vitamin D. In contrary to broad-band UVA, UVA1 has almost 
no overlap with the UVB spectrum. 25(OH)D was determined before the start of phototherapy, as well 
as 2 weeks after the start of therapy and after 12 weeks. The first results show that, as expected, serum 
vitamin D increases under UVBnb and UVA/UVB therapy. Under UVA therapy, no increase in vitamin D 
was measured. In the contrary, a significant decrease in serum vitamin D was measured. As UVA exposure 
does not increase vitamin D synthesis, and even carries the risk to worsen vitamin D insufficiency, UVA-
treated patients should be supplemented in vitamin D orally. As the UVBnb-induced increase in vitamin 
D synthesis is linked to a higher risk of skin cancer, and as the optimum wavelength for production of 
previtamin D3 corresponds to DNA damage, intentional UV exposition is not an appropriate way to 
correct vitamin D deficiency.
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Assessment of the preventive effect of a topical treatment on Striae Gravidarum during 
pregnancy: a multicenter open study on primipare
Nadège Lachmann1, Marjorie Biassette1, Evelyne Boy2, Bernard Chadoutaud2, Philippe Msika1 
1Laboratoires Expanscience, Epernon, France, 2CLINREAL ONLINE, Toulouse, France
Striae gravidarum (SD) are an appreciable cosmetic problem for many pregnant women: more 
than 50% of them are affected and various factors have been reported to be associated with 
their development. To observe the preventive effect of a topical treatment in primipare with high 
risk of developing SG. The cream contains patented ingredients : lupeol, natural biopeptides 
and arabinogalactane which counteract tissue inflammation and stimulate extracellular matrix 
(ECM) remodelling. An open study, involving obstetricians, was conducted on 26 primipare. 
Women were included between 16-19weeks of amenorrhea and were followed up during 
their pregnancy (D0, D30, D60 and D120) and 1 month after delivery. Primipare were selected 
according factors which have been associated with the SG occurrence. The cream was applied 
twice daily during 5 months. Data were collected at all kinetic points in the form of questionnaire 
and clinical examination. Occurrence and description of stretch marks (breast, thighs, abdomen 
and buttocks) and skin quality were especially analyzed.Primipare presented a mean age of 31 
years and a mean BMI of 23.9 at the baseline. Obstetricians observed a significant absolute 
prevention in 96 % of the case (25/26). An arbitrary score, designed to assess the intensity of 
dryness showed a significantly reduction (p<0.01) compared to the baseline. 96 % of women 
also validated the preventive effect and 100% were satisfied with the cream.These results 
demonstrated the preventive effect of a topical cream on the occurrence of SG in primipare with 
high risk of developing SG.
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Principles of Translational Medicine Employed for the Efficient Clinical Development of 
Topically Applied AN2690 for the Treatment of Onychomycosis
Karl Beutner1, Mirna Toledo-Bahena2, Jose Barba-Gomez3, Terry Jones4, Micheal Jarratt5, Raza 
Aly1 1University of California, San Francisco, CA, USA, 2IMIC, Mexico DF, Mexico, 3Instituto 
Dermatologico de Jalisco, Zapopan, Jalisco, Mexico, 4J&S Studies, College Station, TX, USA, 
5DermResearch, Austin, TX, USA
AN2690 is an antifungal drug which inhibits protein synthesis and has the physicochemical 
properties required to penetrate the nail plate. Translational medicine is a new approach to 
drug development intended to increase the efficiency of the process. Applying the principles of 
translational medicine in a series of three clinical trails enrolling a total of 336 patients proof of 
concept efficacy, a dose response, local tolerability, and initial safety, were defined. The primary 
end points were based on results at the end of treatment. Safety was evaluated by recording 
adverse events, routine laboratory studies, and evaluation of the treatment sites at each visit. 
The variables studied included drug concentration, frequency of application and treatment 
duration. The initial open label trial treated two cohorts treated with AN2690 5% or 7.5%. This 
trial demonstrated that both concentrations were well tolerated and effective. The next trial was 
a randomized double blind trial comparing vehicle with AN2690 2.5%, 5.0%, and 7.5%. All 
concentrations were tolerated and efficacy was dose dependent. In parallel a second open label 
trial was done to explore the efficacy of AN2690 1% applied daily and AN2690 5% applied 
three times weekly. A final cohort was enrolled to evaluate the safety of treatment for 48 weeks. 
Detailed results will be presented that support these conclusions. Based on these trails AN2690 
5% applied once daily for 48 weeks has entered Phase III clinical trails. This development 
process illustrates that the principles of translational medicine are applicable to efficient clinical 
development of topical products.
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The Pharmacokinetics of AN2690 after Topical Application in Patients with Onychomycosis
Jonathan Dosik1, Phillip Lastella1, Regina Yavel1, Micheal Casser1, Sanjay Chanda2, Liang Liu2, 
Karl Beutner3 1TKL Research, Paramus, NJ, USA, 2Anacor Pharmaceuticals, Palo Alto, CA, USA, 
3University of California, San Frnacisco, CA, USA
AN2690 is an antifungal drug which inhibits protein synthesis and has the physicochemical 
properties required to penetrate the nail plate. The objective of this study was to determine 
the pharmacokinetics of AN2690 in patients with onychomycosis following once daily topical 
administration of AN2690 5%. This was a Phase 1b, non-randomized, open label, single center 
study in 24 subjects with toenail distal subungual onychomycosis. Multiple plasma samples were 
collected on Days 1 and 14. Prior to sample collection, all 10 toenails were dosed with a total 
of 200 µl of AN2690 5%. On other days the subjects applied the medication. PK samples were 
analyzed by a LC/MS-MS method with a lower limit of quantification (LLOQ) of 0.500 ng/ml. 
After a single application, 3 subjects had levels below the LLOQ and the remaining 21 subjects 
had mean Cmax 3.54 ng/ml. After 14 days of dosing the results showed mean Cmax 5.17 ng/
ml, Tmax 8.03, and a t ½ of 28.5 hr. Qualitative metabolite profiling analysis demonstrated trace 
levels of a sulfated-conjugate and a benzoic acid metabolite as the only circulating drug-derived 
components. AN2690 undergoes biotransformation via oxidative oxaborole ring cleavage 
followed by sulfation. The treatment was well tolerated with two subjects reporting mild transient 
tingling and warmth at the site of application. The presence of only small amounts of AN2690, 
and its metabolites indicates that AN2690 does not accumulate after repeated application and 
only a very small fraction of the applied dose enters the systemic circulation providing a large 
margin of safety.
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Novel treatment protocol for severe pemphigus using intravenous dexamethasone pulses 
combined with immunoadsorption and rituximab: a pilot study of 23 patients
Enno Schmidt1,2, Michael Kasperkiewicz1, Markus Meier3, Nina Schumacher1, Nina van Beek1, 
Jan Kramer3, Iakov Shimanovich1, Detlef Zillikens1 1Department of Dermatology, University of 
Lübeck, Lübeck, Germany, 2Excellence Centre of Inflammation Medicine, University of Lübeck, 
Lübeck, Germany, 3Department of Medicine, University of Lübeck, Lübeck, Germany
Pemphigus is a life-threatening autoimmune blistering disease. It has been previously shown in a 
relatively small group of patients that a combination of immunoadsorption (IA) and rituximab with 
daily use of high-dose oral corticosteroids and azathioprine/mycophenolate mofetil may induce 
a rapid and durable remission in severe, treatment-resistant pemphigus. The aim of the present 
study was to achieve an even faster remission by a more frequent use of IA in the initial phase of 
treatment and to reduce the number of severe adverse events of continuous oral corticosteroid 
therapy. Twenty-three consecutive patients with severe pemphigus (17 with pemphigus vulgaris, 
6 with pemphigus foliaceus) were included. IA was performed at 3- and later 4-week intervals 
until lesions healed by 90%, 1000 mg rituximab was given at weeks 1 and 3, and intravenous 
dexamethasone pulses were administered every 3 weeks and then at increasing intervals in 
addition to daily azathioprine/mycophenolate mofetil. Along with a fast and durable decline of 
circulating autoantibody levels, all patients showed improvement of pemphigus lesions within 
the first weeks of therapy and long-term complete remission was induced in 19 (83%) patients. In 
the remaining 4 patients, 2 (9%) partial remissions and 2 (9%) minimal diseases were observed. 
Over the long-term follow-up of 7 to 39 (mean 25) months, 5 (22%) patients had a recurrence and 
in 2 (9%) patients, severe adverse events occurred. This novel protocol treatment induces a fast 
and long-term remission in patients with severe pemphigus and offered an improved side-effect 
profile compared to daily use of corticosteroids.
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Morphology and structural comparison of Skin by in vivo reflectance microscopy after different 
stresses
Yolene Guerif-Ferreira1, Gilles Oberto1, Arlette Berghi1, Karine Cucumel1, Claude Dal farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, sophia Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ, USA
The aim of this study was to compare morphological changes after different stresses (Chemical 
and UV stress) compared to untreated or cosmetic treated healthy skin by in vivo confocal 
microscopy. We showed in this study the relevance to use this technique to follow various insults. 
UV and chemical stresses were performed on 2 double blind study. In both cases, we used in 
vivo confocal microscopy to assess the condition of the skin at basal condition (D0), just prior 
and 24h after stress. We observed that each insult (UV or SLS) damaged the skin specifically. SLS 
stress caused moderate damage to the horny layer, generating a decrease in the stratum corneum 
thickness; moreover we observed the appearance of parakeratosis and loss of cohesion between 
corneocytes. Cosmetic treatment counteracted these harmful effects, and thus skin appeared 
well organized. In the other hand, after UV stress significant signs of stress were observed, 
such as increased thickness on both the horny layer and the epidermis. Most interestingly, 
we are able to observe and count, at cellular level, the sunburn cells. We showed that, after a 
cosmetic treatment, the skin appeared healthy, with less signs of UV damage. These observations 
confirmed that in vivo confocal microscopy allows seeing the significant and relevant features of 
morphological changes of the skin. We came to the conclusion that [this technique] constitutes a 
new innovative way to study in vivo changes.
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Evaluation of an anti-aging product by studying the change in skin viscoelastic properties
Yolene Guerif-Ferreira1, Gilles Oberto1, Arlette Berghi1, Karine cucumel1, Claude dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, Sophia-Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ, USA
 Dermatopontin is a 22 kDa protein that plays a role in matrix assembly. It accelerates collagen 
fibrillogenesis, affects the diameters of newly formed collagen fibrils and as a consequence may 
play a critical role in the skin elasticity. In this regard we developed a compound IV09.021 
that can modulate the dermatopontin expression in vitro. The aim of this study was to show the 
role of IV09.021 in modulating viscoelasticity properties of the skin by measuring in vivo, in a 
clinical study, the anisotropy (calculated as the ratio between the maximum and minimum RRT 
(RRTmax/RRT min as well as the Langer’s line width, which gives an idea of the dependence of 
the mechanical properties to the direction of the collagen fibers. A 28-day in vivo double blind 
study was conducted with IV09.021 compound versus placebo on the neckline of 12 volunteers. 
The volunteers applied the inducer-containing cream and the placebo cream twice a day on the 
neckline during the test. The mechanical properties of the skin were assayed with Reviscometer 
RVM 600®. After 28 of IV09.021 treatment, we observed, a decrease of RRT max. We noticed a 
decline of the anisotropy and observed an increase of the Langer’s line width. We demonstrated 
that IV09.021 restores a young viscoelasticity property of the skin. Visioscan pictures as well 
as the clinical exam demonstrated that the skin was plumper, tonic, and the furrows were less 
marked. All the results confirmed that IV09.021 compound leads to an improvement of the 
“quality” of ECM matrix.
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Prospective validation study of two scoring systems for autoimmune blistering diseases.
Stefan Mühlenbein, Andrea Kneisel, Melika Behzad, Michael Hertl, Rüdiger Eming Philipps-
Universität, Marburg, Germany
The group of autoimmune blistering diseases consists of clinically heterogeneous and rare 
disorders affecting the skin and mucous membranes. Pemphigus represents the most severe 
form in adults. There is a high need for scoring systems to better monitor disease activity and to 
assess the effectiveness of different therapeutic options. Moreover, scoring systems are essential 
in performing well-designed and adequately powered multicenter clinical trials. This prospective 
clinical study compared two recently introduced scoring systems, pemphigus disease area 
index (PDAI) and autoimmune bullous skin disorder intensity score (ABSIS), in a total of 53 
patients with autoimmune blistering skin disorders, including 22 pemphigus vulgaris (PV) and 3 
pemphigus foliaceus (PF) patients, during a 12 month period. Scoring systems were correlated 
with autoantibody titers and dosage of systemic immunosuppression. Both scores showed 
a good correlation in quantifying cutaneous and mucosal blisters and erosions in PV and PF, 
respectively. For ABSIS skin score and PDAI activity score (skin and scalp) the median correlation 
coefficient was 0.83 [range 0.78-1.0]. Moreover, ABSIS mucosal score I and PDAI mucosal score 
demonstrated a median correlation coefficient of 0.87 [0.63-1.0]. In general, both ABSIS and 
PDAI values correlated well with autoantibody titers with individual exceptions. ABSIS showed a 
more direct assessment of disease activity in severe pemphigus patients, whereas PDAI allowed a 
more accurate quantification of disease activity in mild to moderate disease. Finally, both scoring 
systems have shown to be useful scoring tools in pemphigus patients and current prospective 
multicenter studies will further assess their accuracy and validity.
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Modulating protein expression on stem cell microenvironment helps skin’s preservation and 
renewal during aging or following a stress. In vivo study.
Yolene Guerif-Ferreira1, Gilles Oberto1, Arlette Berghi1, Karine Cucumel1, Claude Dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, Sophia-Antipolis,, France, 2ISP 
Corporate Research Center, Wayne, NJ, USA
Keratinocyte stem cells constituting 2-10% of the proliferative population are located in the basal 
layer immersed in a particular environment called the “niche”, which allows the maintenance 
of their stemness features. During aging or following a stress, the proteins expressed in the 
“niche” decreased, the epidermis renewal is slowed down conducing to diminished protective 
barrier function. For this purpose we designed a compound, IV08.009, that allows maintaining 
the expression of these proteins (study in vitro) and restoring a correct stemness potential. 
In this work, we compared the regenerating and protective effects of IV08.009 in 2 different 
double blind studies, in vivo, by monitoring morphological skin changes with in vivo confocal 
microscopy (VivaScope® 1500). In the first study, carried out on mature skin, we showed that, 
after 28 days of application, number of functional dermal papillae on the side treated with the 
formula containing the compound, increased by 5, demonstrating an undoubtedly rejunevative 
effect. The protective effect of IV08.009 was evaluated in a second clinical study, after solar 
spectrum irradiation. Interestingly, after UV exposure, the placebo showed significant signs of 
stress, such as increase of epidermal thickness, in contrast to IV08.009 cream where granular 
cell remained unstressed and exhibited a good morphology and we observed a highly significant 
reduction in the number of sunburn cells. All these results confirmed that the maintenance and 
the protection of the stemness potential is a key interest in skin protection and skin aging.
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Instant Barrier Repair for Atopic Skin
Faranak Kamangar, Kelly Park, Misha Heller, Tina Bhutani, Eric Lee, John Koo University of 
California, San Francisco, San Francisco, California, United States
Barrier disruption is a main component in the pathophysiology of atopic dermatitis (AD). 
Much of our therapies target this barrier defect, i.e. pseudoceramide moisturizers and skin 
barrier emulsion. However, an ideal repair mechanism would completely eliminate microbe 
and allergen penetration and transepidermal water loss in AD, both of which lead to xerosis, 
hypersensitivity, pruritus, and inflammation. We propose the hydrogel patch as an innovative 
approach to complete barrier repair. The patch is composed of an adhesive, thin, flexible, 
hydrogel layer on an impermeable urethane surface. We conducted a pilot study to evaluate 
the efficacy and safety of this hydrogel patch for AD treatment as compared to triamcinolone 
(TAC) 0.1% cream for 6 weeks. Participants applied the hydrogel patch over one lesion for 6-8 
hours daily and triamcinolone (TAC) 0.1% cream BID to the 2nd lesion. Erythema, induration, 
lichenification, excoriation, and total EASI scores significantly improved compared to baseline 
in both the patch and TAC groups. Pruritis improved in both groups but was only statistically 
significant in the TAC group (p=0.004). At Week 4, there was no significant difference in all sub-
scores between the patch and TAC groups (except pruritus as stated above). Improvement was 
maintained after discontinuing treatment for 2 weeks. No adverse events occurred. This hydrogel 
study with active comparator shows that instant correction of the dysfunctional skin barrier with 
hydrogel patch can improve signs and symptoms of AD comparable to TAC 0.1% cream.
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Improved Quality of Life With Apremilast in the Treatment of Psoriasis: Results From a Phase 2b 
Randomized Controlled Study (PSOR-005)
Vibeke Strand1, Angela Hu2, Robert Day2 1Stanford University, Palo Alto, CA, USA, 2Celgene 
Corporation, Warren, NJ, USA
Apremilast (APR) is a novel, orally available small molecule that specifically inhibits 
phosphodiesterase-4 and thus modulates multiple pro- and anti-inflammatory mediators 
implicated in psoriasis. We evaluated the effect of APR on health-related quality of life (HRQOL) 
in subjects with psoriasis. A phase 2b, 16-week study was conducted in subjects with moderate/
severe plaque psoriasis (n=352) randomized equally to oral APR (10mg, 20mg, or 30mg BID) or 
placebo. At week 16, placebo subjects were re-randomised to APR 20mg or 30mg BID until study 
end (week 24). HRQOL instruments included: Dermatology Life Quality Index (DLQI), pruritus 
visual analog scale (VAS), physical/mental component summaries (PCS/MCS), domains of the 36-
Item Short-Form Health Survey (SF-36), and SF-6D health utilities. Last observation carried forward 
was used for imputation of missing values; ANCOVA was applied for treatment comparisons 
to placebo. Baseline HRQOL scores were similar across treatment groups. At 16 weeks, all 
treatment groups had statistically significant (P<.01) treatment-associated improvements in MCS 
scores ≥MCID (minimum clinically important difference) vs placebo. Changes in SF-36 domains 
(Bodily Pain, Social Functioning, and Role-Emotional) were statistically significant (P≤.05) and 
clinically meaningful for subjects receiving APR 30mg BID. These improvements with APR 
30mg BID resulted in increased mean SF-6D scores, exceeding minimally important differences. 
Subjects receiving APR 20mg and 30mg BID had significantly (P≤.005) improved DLQI and 
VAS scores ≥MCID vs placebo. Improvements in SF-36 domains correlated with DLQI scores. 
APR treatment, especially at 30mg BID, demonstrated statistically significant and clinically 
meaningful improvements in HRQOL of subjects with moderate to severe psoriasis.
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Improving of periorbital signs of ageing by a new type of eye care product
Oliver Brandt1, Dietmar Endner1, Alfred Markowetz2, Maurizio Podda1 1Department of 
Dermatolgy, Darmstadt Municipal Hospital, Darmstadt, Germany, 2Procter & Gamble Germany 
GmbH & Co Operations oHG, Schwalbach am Taunus, Germany
The demand for skin-rejuvenation treatments has been increasing during the last decades. 
However, even minimally invasive procedures are often seen as potentially to risky by patients. 
We therefore tested a newly developed eye care product for its impact on periorbital wrinkles. 
33 female volunteers aged 35 to 65 were enrolled in a 3-week randomized, split-face study. The 
test formulation was applied with a sponge attached to the cream-containing sachet (pod) every 
other day to the periorbital region and on a test area on the forearm. Primary end points were 
defined as (1) reduction of skin-roughness parameters, (2) improvement of elasticity, and, (3) as 
second endpoint, satisfaction of the volunteers with the test product and its skin-care properties 
determined with a self-assessment questionnaire. Treatment with this new preparation resulted 
in rapid and significant improvement of the skin roughness and, to a lower extent, elasticity 
parameters. Furthermore, the preparation was rated very good up to excellent by the participants 
both for wrinkle reduction and handling properties. Our study impressively demonstrates that 
this new preparation is an easy to handle, highly effective skin-care product suited for rapid 
improvement of the visual appearance of the periorbital region.
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Risk of serious adverse events associated with biologic and non-biologic psoriasis systemic therapy: real 
life compared with patients eligible for randomized clinical trials. Results of the BIOBADADERM registry.
Ignacio Garcia-Doval1, Gregorio Carretero2, Francisco Vanaclocha3, Carlos Ferrandiz4, Esteban 
Dauden5, Jose-Luis Sanchez-Carazo6, Merce Alsina7, Enrique Herrera-Ceballos8, Francisco-Jose 
Gomez-Garcia9, Study Group BIOBADADERM10 1Complexo Hosp de Pontevedra, Pontevedra, Spain, 
2Hosp Univ de Gran Canaria Dr. Negrín, Las Palmas, Spain, 3Hosp Univ 12 de Octubre, Madrid, Spain, 
4Hosp Univ Germans Trias i Pujol, Badalona, Spain, 5Hosp Univ de la Princesa, Madrid, Spain, 6Hosp 
General Univ de Valencia, Valencia, Spain, 7Hospital Clinic, Barcelona, Spain, 8Hosp Univ Virgen de la 
Victoria, Malaga, Spain, 9Hosp Univ Reina Sofía, Cordoba, Spain, 10Academia Española de Dermatologia, 
Madrid, Spain
We describe the use of systemic therapy for psoriasis (biologic and non-biologic) in patients not adequately represented in 
randomized clinical trials and the risk of serious adverse events in these patients.Design: Registry, inception cohort. Setting: 
13 dermatology departments in Spain. Patients: Consecutive sample of patients treated with biologics, and systematic sample 
of patients treated with classic systemic therapy. 1042 patients, 2180 person-years. Interventions: Inadequate representation 
in trials defined as presence of any of the following: older than 70-years, psoriasis different form chronic-plaque, previous 
infection (hepatitis B, C and HIV), previous cancer (excluding non-melanoma skin cancer), and chronic renal or hepatic 
disease. Main outcome measures: serious adverse events as defined by the International Conference on Harmonisation. 
Results: 30% of patients receiving systemic therapy for psoriasis would not have been eligible for randomized trials. These had 
an increased risk of serious events: incidence rate ratio 2.7 (95%CI: 1.5-4.7), number needed to treat to harm within a mean 
follow-up of 2.1 years: 40 (95%CI: 23-130). Patients exposed to biologics had an adjusted increased risk of serious events 
(incidence rate ratio 2.3 (95%CI: 1.1-4.8)) that was similar in patients eligible and ineligible for trials. Conclusions: 30% of 
the patients receiving systemic therapy were not adequately represented in trials and had higher risk of serious adverse events. 
Biologics were associated with the same increase in risk of serious events in both groups, but added upon a higher baseline 
risk in patients not-eligible for trials. The risk-benefit ratio in these patients might be different.
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Antidepressant drug use in patients with psoriasis: a population based cohort study
Emmilia Dowlatshahi, Marlies Wakkee, Loes Hollestein, Tamar Nijsten Department of 
Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
Psoriasis is known for its major impact on health related quality of life. In this study we 
investigated the use of antidepressant drugs and the frequency of treatment episodes between 
psoriasis patients and a randomly selected reference cohort. Prescription data of anti-psoriatic 
drugs and antidepressants between 1998 and 2007 were derived from a hospital and pharmacy 
database covering more than 2,5 million Dutch residents. Multivariate Cox regression was used 
to compare the incidence of antidepressant drugs between psoriasis and reference subjects. 
Analyses included 25,728 psoriasis cases and 128,701 reference subjects with a mean follow 
up of 6 years for both groups. The most commonly prescribed antidepressants were serotonine 
reuptake inhibitors (50%) followed by tricyclic antidepressants (27%). Psoriasis patients received 
more than twice as many prescriptions for an antidepressant than the reference population 
with an incidence of 21 and 8.9 per 1,000 person years (PYS) respectively. When adjusted for 
age, sex and health care consumption, the hazard ratio (HR) for antidepressant use in psoriasis 
patient versus the reference cohort was 1.28; 95% CI 1.23-1.34. The number of episodes of 
antidepressant drug use in observation time was more than two times higher in the psoriasis 
group than in the reference cohort, 31 compared to 13 per 1,000 PYS respectively. The adjusted 
HR of having an episode of antidepressant use was 1.04; 95 % CI 1.01-1.09. Our results show 
that patients with psoriasis have an increased risk of antidepressant use as well as an increased 
treatment frequency with antidepressant drugs.
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Identification of 3 phenotypes of hidradenitis suppurativa: a latent class analysis of a series of 
618 patients
Florence Canouï-Poitrine1,3, Aurelie Le Thuaut1,3, Jean Revuz2, Cédric Viallette4, Pierre 
Wolkenstein2,3, Sylvie Bastuji-Garin1,3 1AP-HP, Hopital Henri-Mondor, Service de Santé Publique, 
Creteil, France, 2AP-HP, Hopital Henri-Mondor, Service de Dermatologie, Créteil, France, 
3Universite Paris Est Creteil, LIC EA4393, Creteil, France, 4AP-HP, Hôpital Henri-Mondor, Unite de 
Recherhce Clinique, Creteil, France
The objective was to empirically identify underlying subtypes of hidradenitis suppurativa (HS) 
that best explain the observed clinical symptoms. Between 2002 and 2010, clinical data of 
618 consecutive HS patients were prospectively collected at the dermatology clinic of Henri-
Mondor hospital, France. HS diagnosis was systematically validated. Latent class (LC) analysis 
was used to identify homogeneous groups of patients with similar clinical patterns. Demographic 
characteristics, HS severity (Hurley classification) and duration of the disease were compared 
across LC. Mean age was 32.7 years (± 9.7), 72.5% (n=448) were women and median duration 
of disease, 9 years (Interquartile range = 4-15). The 3-class model (LC1-LC3) showed the best fit 
(minimization of Bayesian Information Criteria). LC1 (46% of the series) was characterized by 
breast and axillary locations (probability=0.74) and fibrous scars (0.41); LC2 (27% of the series), 
by buttock location (0.54) and papules and folliculitis (0.71); LC3 (27% of the series), by ears, 
thorax, back or legs locations (0.55), pilonidal sinus (0.48) and acne (0.47). Proportions of men 
and Hurley class II or III were higher in LC3 (respectively 50.3%; 47.7%) than in LC1 (18.1%; 
38.0%) or 2 (22.2%; 13.4%) (p<0.001); age at the beginning of the disease was lower in LC3 (19.3 
years±6.7) than others (22.7 years±8.4; 21.6 years±8.0) (p<0.001). LC analysis allows identifying 
3 distinct subtypes of HS in term of locations and type of lesions. This classification was in 
agreement with the clinical semiology and may reflect different physiopathological pathways.
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Image Size and Context Influence Lay Perception of Concern about Pigmented Lesions
Karen Robertson, Robert McIntosh, Jonathan Rees The University of Edinburgh, Edinburgh, UK
Images of skin lesions are often used to promote the awareness of the early features of melanoma, 
the untested assumption being that these approaches are valid. Lesions are usually presented in 
isolation, magnified, and without contextualising body-site information. The extent to which size 
and context may affect a person’s perception of a lesion is unknown. We asked 42 members of 
the public to evaluate 36 lesions (7 melanomas, 29 benign pigmented lesions) in terms of how 
concerned they felt about each one: 0=not worried, 1=moderately worried, 2=very worried. 14 
subjects were presented with lesions shown in situ on a recognisable body-site, 14 subjects with 
a close-up view without visible body site and 14 subjects received both views. We found that 
‘worry’ was higher for melanomas than for benign lesions (F1,39 = 284.95, p<0.0005), and the 
effect of view was significant (F1,39 = 23.26, p<0.0005), with higher worry in the close-up view 
than in either the body-site or both-views groups (p < 0.0005). There was a significant lesion by 
view interaction (F2,39 = 3.51, p<0.05) because the increase in worry for melanoma over benign 
lesions was greater for the body-site than for the close-up view (t26 = 3.19, p<0.005), with the 
both-views group intermediate. Participants were thus less able to discriminate melanomas from 
benign lesions when they were presented as ‘close-up’ images. With increasing exposure to web-
based material, future work needs to consider to what degree exposure to images improves or 
diminishes appropriate health behaviour.
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Different stress copying strategies and stigmatization in atopic dermatitis and contact dermatitis 
patients
Alicja Ograczyk1, Justyna Malec2, Anna Zalewska-Janowska1 1Psychodermatology Department, 
Łódz, Poland, 2Medical University of Lodz, Łódz, Poland
Atopic Dermatitis and contact dermatitis are one of the most common dermatological diseases. 
Skin lesions characteristic for that diseases frequently bring out interest of environment. As a 
result patients feel socially rejected (stigmatizated). Stress copying strategies can influence this 
process. We compared stress copying strategies and level of stigmatization between patients 
suffering from atopic dermatitis and contact dermatitis. 35 atopic dermatitis patients (27 females, 
8 males) and 30 contact dermatitis patients (22 females and 8 males) were involved in the study. 
Stigmatization Scale in Dermatological Patients – short version (Evers, Polish adaptation by 
Szepietowski and al), Scale of Copying with Dermatological Disease (SRS-DER) (Miniszewska) 
and Copying Orientatios of Experienced Problems (Carver, Scheier, Weintraub) were used. Atopic 
Dermatitis patients do not differ from Contact Dermatitis patients in case of analyzing feeling of 
stigmatization. Atopic dermatitis patients employing both instrumental and emotional support 
strategy and acceptance of disease present lower levels of stigmatization (p<0,05). Contact 
dermatitis patients who feel hopeless and helpless because of their diseases declare higher level 
of stigmatization (p<0.05). There are differences between stress copying strategies used in group 
of atopic dermatitis and contact dermatitis patients and they influence feeling of stigmatization.
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Feasibility and effectiveness of a melanoma targeted screening strategy
Gaëlle Quéreux1, Yves Lequeux2, Myriam Cary2, Olivier Jumbou2, Jean-Michel Nguyen1, Brigitte 
Dréno1 1Nantes University Hospital, Nantes, France, 2West Melanoma Network, Nantes, France
Melanoma is nowadays an important public health problem because it is one of the fastest growing 
cancers worldwide. Targeted screening for patients at high risk for melanoma is a priority. The 
aim of our study was to assess the feasibility and effectiveness of a melanoma targeted screening 
strategy based on the selection of patients at high risk with the Self-Assessment-Melanoma-Risk-
Score: SAMScore. This tool previously published, is a risk score calculated from a questionnaire 
filled by the patient himself. Our main objective was to prove that the SAMScore allows selecting 
a small group of patients at higher risk for whom more melanomas would be detected. A 
prospective study was carried out in Pays de Loire Region (France). Selection of patients at high 
risk was performed with the SAMScore. Individuals identified at high risk with the score, were 
proposed a skin examination successively by their general practitioner and then a dermatologist. 
Of the 2404 subjects rated at high risk, a melanoma histologically proven was screened in 10 
cases. There were 2 melanomas-in-situ and 8 invasive superficial spreading melanomas and the 
median thickness was low (0.31 mm). The capacity of selection of the SAMScore was estimated 
equal to 20.8. The current study is the first to confirm the benefit of a targeted screening based 
on self-selection of high-risk individuals through self-assessment of melanoma risk factors. 
The results obtained provide evidence that the SAMScore enables to select more patients with 
melanoma risk. This tool could be used easily in routine primary care practice.
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Skin from the factory - Automated Tissue Engineering on Demand
Heike Walles1, Michaela Kaufmann1, Andreas Traube1, Frank Pretsch1, Frank Bernhardt1, 
Alexandra Stolzing1 1Fraunhofer-Institut für Grenzflächen und Bioverfahrenstechnik, Stuttgart, Baden 
Würtemberg, Germany, 2Fraunhofer-Institut für Produktionstechnik und Automatisierung, Stuttgart, 
Baden Würtemberg, Germany, 3Fraunhofer-Institut für Produktionstechnologie, Aachen, Nordrhein 
Westfalen, Germany, 4Fraunhofer-Institut für Zelltherapie und Immunologie, Leipzig, Sachsen, Germany
The rising demand for the substitution of animal experiments has lead to a growing market 
for in vitro test systems. In order to produce skin models at a reasonable price and constant 
quality, the Fraunhofer-Gesellschaft is working on the automation of the production process. A 
dedicated team of cell biology and engineering professionals, possessing the know-how required 
for realizing the first production system worldwide, has developed a prototype which fully 
automates the production process of human skin equivalents. The prototype of the production 
system is running since the beginning of 2011 and is able to produce 5,000 fully functional skin 
equivalents per month. The manufacturing of 3D skin equivalents starts with the extraction of 
primary human fibroblasts for building the dermal layer and primary human keratinocytes for 
building the epidermal layer. The two primary cell types are then proliferated separately before 
they are finally used to grow the 3D layered tissue structure. These three main process steps 
reflect the architecture of the production system which is hence subdivided into three main 
modules: the cell extraction module, the cell expansion module and the tissue cultivation 
module. The overall production system is integrated in a clean room casing with an easy-to-
handle user interface. Integrating completely new devices and well-established tissue cultivation 
procedures, the application potential of the production system is not merely limited to the 
automated manufacturing of skin equivalents. In fact the tissue factory provides a platform of 
novel product, process and material technologies for the automated manufacturing of tissues.
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Retrospective analysis of melanoma and non melanoma skin cancer (NMSC) incidence in a 
large vitiligo patient cohort
Hansje-Eva Teulings1,2, Maaike Overkamp1, Erhan Ceylan1, Ludmila Nieuweboer-Krobotova1,2, 
Tamar Nijsten3, Jan D. Bos1, Albert Wolkerstorfer1, Rosalie Luiten1, Wietze van der Veen1,2 1Dept of 
Dermatology & the Netherlands Inst for Pigment Disorders, AMC, Amsterdam, The Netherlands, 
2The Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The 
Netherlands, 3Dept of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
Vitiligo development in melanoma patients is associated with effective anti-melanoma immunity 
and consequent favourable clinical outcome. Anti-melanoma immunity can mediate vitiligo by 
targeting both melanoma cells and melanocytes. This suggests that vitiligo patients, having active 
anti-melanocyte immunity, have a decreased risk of developing melanoma. Little is known about 
the incidence of melanoma in vitiligo patients. We evaluated the lifelong incidence of melanoma 
in a large vitiligo patient cohort and in a matched control group. Vitiligo patients lack pigmentation 
and are therefore expected to have a higher risk of developing NMSC, we therefore also evaluated 
this lifelong incidence.We performed a retrospective survey in patients of the SNIP aged 50 years 
or older and diagnosed with vitiligo vulgaris. The questions in this survey concerned patient 
demographics, skin type, onset of vitiligo and treatment history, sun exposure/behaviour and history 
of skin cancer. All patients were asked to have a control questionnaire filled in by their (non-
vitiligo) partner or non-blood line related family member or friend. All skin cancers reported by 
patients or controls were validated by the official pathology report. Statistical significant differences 
in outcome between both groups as well as external factors contributing to melanoma or NMSC 
incidence were analysed.Until now we have collected 1200 vitiligo- and 800 matched controls’ 
questionnaires. Preliminary results indicate that melanoma occurs less frequently in vitiligo patients 
compared to healthy controls. NMSC incidence is also lower, despite a history of NB-UVB/PUVA 
therapy in most vitiligo patients. Results of other analyses will be discussed.
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Application of Rasch Analysis to Psoriasis Family Index (PFI) - a Novel Psoriasis-Specific Quality 
of Life Instrument for Family Members and Partners of Psoriasis Patients
Mohammad Basra1, Anne-Marie Zammit2, Sam Salek2, Andrew Finlay1 1Department of 
Dermatology and Wound Healing, Cardiff University School of Medicine, Cardiff, UK, 2Centre for 
Socioeconomic Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
The aim of this study was to assess the psychometric properties of a new disease-specific 
instrument that measures the secondary impact of psoriasis on the quality of life (QoL) of family 
members of psoriasis patients. Pooled data from previous studies conducted in our department 
from 134 family members of psoriasis patients were collected. Rasch analysis was used to examine 
the dimensionality, response category functioning, fit statistics, scale reliability and validity, item 
targeting and differential item functioning (DIF). The 15-item PFI with 4 response categories was 
found to be multidimensional using Rasch analysis and principal component analysis identified 
three factors. Rasch analysis further demonstrated that the response category almost entirely 
follows the Linacre criteria showing that it functions well. All of the items demonstrated good 
fit statistics with averages of the infit and outfit mean squares = 1.01 and 0.96 respectively. 
PFI had good validity, reliability and internal consistency with person separation=2.29; item 
reliability=0.94 and person reliability=0.84; Cronbach’s α=0.91; root mean square measurement 
error=0.12. The items were well targeted to the subjects as the difference between the person 
mean and the item mean was only of -0.90 logits. One item displayed slight DIF across gender, 
whilst two items exhibit significant DIF across the relationship type.The PFI is the first disease-
specific measure to quantify the QoL of family members of psoriasis patients. The results obtained 
by the application of Rasch analysis suggest promising psychometric performance of the measure 
with a potential to be a useful outcome measure in future clinical research.
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Refinement and Validation of Teenager’s Quality of Life Questionnaire (T-QoL)
Mohammad Basra1, Sam Salek2, Zahra Tanweer2, Daniela Fenech2, Adale Howe1, Tina 
Mahbouba2, Catherine Golics2, Vincent Piguet1, Andrew Finlay1 1Department of Dermatology and 
Wound Healing, Cardiff University School of Medicine, Cardiff, UK, 2Centre for Socioeconomic 
Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
The aim of this study was to refine and validate a dermatology-specific quality of life instrument 
for adolescents with skin diseases. The 30-item T-QoL was administered to adolescents attending 
the dermatology outpatient department of a secondary referral centre. Application of both item 
response theory (IRT) and classical test theory (CTT) models was used to reduce the number of 
items while Rasch analysis (IRT) was used to assess the overall fit of the model, the item responses, 
individual item fit and differential item functioning (DIF). The final validation of the refined 
version of the T-QoL was carried out on a new cohort of adolescents.153 adolescents completed 
the 30-item T-QoL in the first stage. 12 items with less than optimal psychometric properties 
were removed. Rasch analysis did not support the validity of the T-QoL as a unidimensional 
measure. A factor analysis confirmed the presence of three domains. Separately all domains 
showed adequate fit to the unidimensional Rasch model with good person separation and no 
significant differential item bias for gender or age. Response categories had to be collapsed from 
5 to 3. In the final validation stage, 96 adolescents completed the 18-item T-QoL. The convergent 
validity of T-QoL was demonstrated by its high correlation with Skindex-Teen (r=0.75, p<0.0001), 
high internal consistency (Cronbach’s α=0.89) and excellent test-retest reliability (ICC=0.91). The 
preliminary results of this study have demonstrated that T-QoL could provide a simple, relevant 
and valid tool to quantify the impact of skin disease on adolescents’ QoL in clinical practice 
and research.
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Wrinkling around the eyes is increased by sagging of eyelids
Tomonobu Ezure, Haruhi Iwaki, Taeko Hiroi, Eriko Kawai, Satoshi Amano Shiseido Co., Ltd., 
Yokohama, Japan
Although both sagging and wrinkles appear with aging, their relationship is not clear. This study 
aimed to investigate whether and how sagging influences wrinkle formation, focusing on the 
area surrounding the eye, where both morphological changes occur prominently. Photograph-
based grading criteria of sagging severity, fixed wrinkles and transiently formed wrinkles were 
established and evaluated. Activity of the frontalis muscle was measured in terms of skin surface 
movement above the muscle. Wrinkle severity at the upper and lower eyelids was significantly 
positively correlated with sagging severity, which was associated with decreased mimetic muscle 
function. The severity of both types of wrinkles was drastically reduced when sagging severity 
was decreased by changing the facial position to reduce the effect of gravity. Thus, sagging does 
influence wrinkle formation. Sagging at the upper eyelid due to decreased mimetic muscle 
function obstructs opening of the eyes. Therefore, the frontalis muscle needs to be more active 
to open the eyes, and the muscle contraction enhances wrinkles at the forehead. This may be 
the reason why sagging severity at the upper eye lid was significantly positively correlated with 
severity of transiently formed wrinkles at the forehead during upward gazing, and with fixed 
wrinkles at the forehead. These results suggest that sagging induces increased wrinkle severity 
at both the eyelid and adjacent forehead. Sagging is associated with decreased mimetic muscle 
function and dermal elasticity. Thus, improvement of mimetic muscle function and dermal 
function should improve sagging-induced wrinkles.
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Cutaneous squamous cell carcinoma in the Netherlands: trends in incidence, survival and 
mortality 1989-2008
Loes Hollestein, Esther de Vries, Tamar Nijsten Erasmus MC, Rotterdam, The Netherlands
The aim of this study was to describe detailed trends in incidence rates, relative survival and 
mortality rates of cutaneous squamous cell carcinoma (SCC) in the Netherlands. Information on 
patients with a first primary invasive cutaneous SCC between 1989 and 2008 was obtained from 
the nationwide Netherlands Cancer Registry (NCR). Mortality data was obtained from Statistics 
Netherlands. European standardised rates (ESR) of SCC incidence increased during the study 
period to 35.4 per 100,000 inhabitants for males and to 20.5 per 100,000 inhabitants for females, 
with annual rate accelerations of 9.2% (95% CI: 7.5-11.0) for females since 2002 and 6.9% (95% 
CI: 5.8-8.7) for males since 2003. Incidence rates increased for almost all body sites, except 
for the lips, where a decreasing trend was observed in males. No major changes in relative 
survival were observed. The 5-year relative survival was 92.0% (95% CI: 91.3-92.8) for males 
and 94.9% (95% CI: 94.0-95.7) for females, but females with a stage III or IV SCC were at a 
30.4 times increased relative excess risk of dying compared to those in stage I, for males this risk 
was 9.9 times increased. The overall mortality rate decreased with -1.9% (95% CI: -3.1- -0.7%) 
annually. Although relative survival was relatively high, diagnosis of SCC could result in many 
excess deaths, due to the high incidence rates. The elderly should be encouraged to seek early 
diagnosis. In order to reduce the incidence rates the young population should be educated about 
the possible dangers of extensive exposure to sunlight.
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Sunbeds: A Fashion To Die For? An Evaluation of the UK Public Health Campaign on Sunbeds
Oliver Mitchell, Anastasia Theodosiou, Mrinal Singh University of Cambridge, Cambridge, UK
SunSmart, run by Cancer Research UK (CRUK), is the UK’s national skin cancer prevention 
campaign, providing information about skin cancer and sun protection. Last year, the Sunbeds 
(Regulation) Act 2010 was passed by Parliament, banning the use of sunbeds by under-18s and 
increasing the regulation of sunbed businesses. These measures were supported by CRUK in 
their policy statement on sunbeds, which forms the basis of their public health campaign on 
sunbeds. The SunSmart public health campaign was evaluated by assessing the evidence cited in 
the CRUK policy statement, as well as opposing evidence presented by The Sunbed Association 
(TSA), the trade association for the sunbed industry. The evidence was critically appraised using 
the Australian National Health and Medical Research Council (NHMRC) grading system for 
research investigating aetiology, ranging from Level I to IV in descending order of strength. The 
SunSmart public health campaign is founded on strong evidence, including three Level I studies. 
The policy is moderate: although it does not recommend the use of sunbeds, it does not advocate 
their out-right ban (except for under-18s). The evidence challenging the CRUK policy statement 
is not as strong (Level III and IV), and obvious conflicts of interest were noted. However, the 
opposing evidence raises important questions that should form the basis for further, better quality 
research.
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A Qualitative Investigation into the Factors Influencing Discharge Decisions in Dermatology
Mohammad Basra1, Seetal Siyani2, Sam Salek2, Vincent Piguet1, Andrew Finlay1 1Department of 
Dermatology and Wound Healing, Cardiff University School of Medicine, Cardiff, UK, 2Centre for 
Socioeconomic Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
The aim of this study was to identify the clinical and non-clinical factors influencing the decisions 
to discharge patients from dermatology outpatients. In depth face-to-face semi-structured 
interviews were conducted with a variety of clinicians from four dermatology departments. 
Interviews were timed, audio-recorded and transcribed verbatim. The data were analysed 
according to grounded theory methodology and using NVivo computer software a list of themes 
and sub-themes was identified. Twenty-two clinicians (M=12, F=10; median age=41.5 years; 
range=30-64 years) participated in the study; two declined. The majority were consultants (n=9); 
the median weekly clinical sessions carried out were 5 and the median duration of clinicians’ 
experience in dermatology was 5 years (mean=15.1 years; range=2-40 years). Five main themes 
identified related to: patient, clinical setting, condition, policy and clinician; each theme having 
4 to 13 sub-themes (total=36). Overall, some of the most common factors influencing discharge 
decisions mentioned included: patient’s age (n=22); patients’ wish to be discharged (n=17); 
condition manageable at the primary care level (n=14); the diagnosis (n=12); nature of treatment 
required (n=17); waiting list pressure (n=18); local and national guidelines (n=14); clinician’s 
level of experience (n=17) and fear of litigation (n=9). The most important clinical and non-
clinical factors influencing discharge decision were improvement in patient’s condition and 
patient’s wish to be discharged respectively. This exploratory pilot study has identified a number 
of factors that influence discharge decisions in dermatology that are largely shared by clinicians 
with some variability dependent on factors such as clinician’s level of experience, clinical post 
and personal approach.
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Variation of skin color in Indian women
Emmanuelle Mauger1, Julie Latreille1, Sophie Gardinier1, Christiane Guinot1,2, Erwin Tschachler3,1, 
Frédérique Morizot1 1CE.R.I.E.S., Neuilly sur Seine, France, 2Computer Science Laboratory, 
University François Rabelais, Tours, France, 3Department of Dermatology, University of Vienna 
Medical School, Vienna, Austria
The India is currently the 2nd most populated country in the world after China and demonstrates 
a wide geographical and cultural diversity. The aims of this study were to investigate skin colour 
variations in a large sample of Indian women. The study was conducted on 804 Indian women 
living in Mumbai (20-70 years old) with phototype II to V. Skin colour was measured on four skin 
sites (Forehead, Cheek, Forearm, and Inner upper arm), using a spectrocolorimeter CM 2600d 
(Minolta, Japan) which provides chromametric parameters: Lightness (L*), Red intensity (a*) and 
Yellow intensity (b*), as well as, the spectral reflectance of the skin at each wavelength across the 
visible waveband (400-700 nm, 10 nm interval). The Individual Typological Angle (ITA) was also 
calculated. The range of ITA on each skin site was very large: minimum and maximum values 
on the cheek were equal to -54.3° and +51.1°, which highlights the diversity of skin lightness of 
the Indian women faces. Moreover, in all phototypes, the forehead was found to be the darkest 
area, which may be attributed to various factors such as chronic sun-exposure, hyperpigmentary 
disorders (melasma, mechanical-induced hyperpigmentation...). Finally, as expected, skin 
pigmentation increased with age on sun-exposed areas, whereas, it decreased with age on 
unexposed area. The age-related increase in facultative pigmentation seems to occur earlier in 
phototypes II to IV than in phototype V (20-30 vs 50-59), whereas the decrease in constitutive 
pigmentation (i.e. melanogenesis) seems to occur at the same age in all phototypes (i.e. 40-49).
2011ESDR_8.25x10.875.indd   50 06/07/2011   18.24 
 www.jidonline.org S51
ABSTRACTS
301
Improving the learning curves for undergraduate identification of skin cancer: medical students’ 
diagnostic accuracy is raised significantly through even limited virtual exposure
Roger Aldridge, Jonathan Rees Department of Dermatology, University of Edinburgh, UK
Developing dermatological diagnostic expertise relies on cultivating non-analytical-pattern-
recognition (NAPR) through exposure to training examples, but undergraduate exposure is 
often inadequate to allow this. We investigate whether students’ diagnostic accuracy can be 
improved through formal simulated clinical exposure. Study 1: 75 students attending their 10-
day dermatology attachment were enrolled. Additional “exposure” in the form of two 12-minute 
digital slideshows, each of 72 randomly selected diagnostically labelled images, was undertaken 
on Day-1 and Day-6. Testing on Day-10 showed that the students exposed to the images on two 
occasions had an accuracy of 55% (202/368) compared to 43% (240/560) for the single exposure 
groups and 30% (443/1472) for the controls (p<0.001 Kruskal-Wallis). Study 2: 70 students were 
enrolled. On Day-1, they undertook a randomly selected 64-image digital slideshow, in which 
they were required to identify non-melanoma skin cancers from 4 multiple-choice options. In 
the initial 12 test-images (sequential images 5-16) their median score was 5, whereas for the 
final 12 test-images their median score was 8 (p<0.001 Wilcoxon-paired). Furthermore there 
was significant correlation between their accuracy and the number of virtual lesions they had 
been exposed to (Rho=0.47, p<0.001). When students are exposed to simulation (even briefly 
and without additional tuition) they automatically develop NAPR which leads to significant 
improvements in their diagnostic accuracy. The role of simulation in improving novices 
identification of skin cancers needs further investigation, as in comparison to traditional methods 
it may deliver more consistent experiences, in greater quantities and at lower costs than face-to-
face patient teaching.
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Current dermatological textbooks and photographic atlases do not adequately supplement 
students’ learning as the image content may not be representative of real-life lesions
Benjamin Aldridge, Kate Stephenson, Lisa Naysmith, Jonathan Rees Department of Dermatology, 
University of Edinburgh, Edinburgh, UK
Developing dermatological diagnostic expertise relies on cultivating non-analytical-pattern-
recognition (NAPR) through exposure to multiple relevant training examples. Most students 
use textbooks to supplement their limited clinical exposure, but are these educational adjuncts 
relevant in aiding NAPR? We investigate whether the images in these “textbook” resources are 
representative of current “real-life” images. A library of 317 “textbook” images was obtained 
by scanning, at high-resolution, all the images from 15 dermatological textbooks. A library of 
369 “real-life” images was obtained by sequentially photographing the referral lesion(s) on all 
patients who attended a fortnightly skin lesion clinic for 9-months. 85% of lesions referred to 
the clinic during this period were photographed. 46 students were enrolled on completion of 
their dermatology attachment. The students’ diagnostic accuracy was assessed on 60 randomly 
selected pigmented lesions. 30 test images were from the “textbook” library and 30 from the 
“real-life” library (10 each of 3 diagnoses; moles, melanomas and seborrheic keratoses). The 
median score for textbook melanomas was 7 with an accuracy of 65% (300/460) in comparison 
to a score of 3 with an accuracy of 33% (153/460) for real-life melanomas (p<0.001 Wilcoxon-
paired). Students find “textbook” melanoma images significantly easier to diagnose. It is likely 
that this is due to textbooks containing more classical examples of melanoma given that the 
proportion of textbook melanomas under-diagnosed as moles was 5% in comparison to the 35% 
of real-life melanomas that were under-diagnosed. These findings have significant implications 
for education and demonstrate the limitations of currently available resources as training tools.
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Relationship between photoaging and fat intakes in Adult French women and men
Julie Latreille1,2, Khaled Ezzedine2, Emmanuelle Kesse-Guyot2, Denis Malvy3, Pilar Galan2, Erwin 
Tschachler4,1, Christiane Guinot1,5, Serge Hercberg2 1CE.R.I.E.S., Neuilly sur Seine, France, 2UMR 
U557, Paris 13 University, CRHN, Paris/Bobigny, France, 3Departments of Internal Medicine and 
Tropical Diseases, CHU St-André, Bordeaux, France, 4Department of Dermatology, University 
of Vienna Medical School, Vienna, Austria, 5Computer Science Laboratory, Ecole Polytechnique, 
University of Tours, Tours, France
Reducing dietary fat intake has shown to decrease UV damages in skin. However, use of dietary 
fish oil supplementation rich in w-3 PUFAs has also been reported to reduce UVB-erythemal 
sensitivity in human. We have investigated the association between dietary fat intake and the 
risk of severe photo-aging. The analysis included 1,075 women and 1,513 men aged between 
45 and 60 years old, volunteers from the French SU.VI.MAX study. Dietary fats intakes were 
estimated through at least ten 24-h record questionnaires completed during the first 2.5 years of 
the follow-up period. Total lipid, saturated fatty acids, monounsaturated fatty acids (MUFA), and 
polyunsaturated fatty acids: linoleic (LA), a-linolenic (ALA), arachidonic (AA), eicosapentaenoic 
(EPA), n-3 docosapentaenoic (DPA), and docosahexaenoic (DHA) acids were estimated. The 
severity of facial skin photoaging was graded by trained dermatologists at the first clinical 
examination using a global scale illustrated by photographs. In both gender, a higher intake 
of MUFA from vegetable oils (olive oil) was found to decrease the risk of severe photoaging. 
A higher intake of AA from eggs was also associated with a lower risk of severe photoaging in 
women and tended to be associated with a lower risk in men. Besides, an inverse association 
was found between ALA intake and the risk of severe photoaging in men. These findings support 
the possible benefit role of olive oil consumption or behaviour link to olive oil diet on severe 
photoaging as well as surprisingly a diet rich in eggs.
304
British Association of Dermatologists’ Biologic Interventions Register (BADBIR): methodology 
and baseline demographics
David Burden1, Richard Warren2, Elise Kleyn2, Kathy McElhone3, Nick Reynolds4, Catherine Smith5, 
Anthony Ormerod6, Christopher Griffiths2, BADBIR Study Group UK7 1Dept of Dermatology, 
Western Infirmary, Glasgow, UK, 2Dermatological Sciences, The Univ of Manchester, Manchester 
Academic Health Science Centre, UK, 3Arthritis Research UK Epidemiology Unit, University of 
Manchester, UK, 4Dermatological Sciences, Institute of Cellular Medicine, Newcastle University, 
Newcastle-upon-Tyne, UK, 5St John’s Institute of Dermatology, Guy’s & St Thomas’ Hospital, 
London, UK, 6Division of Applied Medicine, Univ of Aberdeen, UK, 7BADBIR Study Group, UK
The British Association of Dermatologists (BAD) established a web-based pharmacovigilance register to assess long-
term safety of biologics prescribed for patients with severe psoriasis in August 2008. BADBIR also participates in the 
European PSONET initiative. This prospective observational cohort study compares adult psoriasis patients treated with 
biologics to a control group exposed to standard systemic therapies. Following baseline data acquisition, clinicians 
record changes in therapy, disease activity and adverse events for 5 years (6-monthly for 3 years then annually 
thereafter). Patient details are flagged lifelong on the National Health Service Information Centre system to capture 
occurrence of malignancy or death. Primary study endpoints include malignancy, infection requiring hospitalisation, 
serious adverse events and death. Long-term efficacy data are a subsidiary aim. To date we have enrolled 2202 patients 
- 1638 and 564 into biologic and standard systemic cohorts respectively – from 83 centres in the UK and Ireland. 
Baseline demographic characteristics are comparable across the cohorts. Males account for 63% (n=1045/1638) of 
the biologics cohort and 60.5% (n=341/564) of the standard systemics cohort. Mean age±SD (biologics: 47.6±12.5yrs; 
standard: 46±14.3yrs) and mean disease duration±SD (biologics: 22.8±11.9yrs; standard: 19.2±13.1yrs) as well as 
disease characteristics including PASI (mean±SD; biologics: 16.4±9.6; standard: 15.5±8.1) and DLQI (mean±SD; 
biologics: 13.9±9.3; standard: 11.5±8.1) are similar. This is the largest project undertaken by the BAD. The data it will 
provide over the coming years will be invaluable to the safe use of biologics in clinical practice.
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The risk of metastases in thin (T1) cutaneous malignant melanoma: Data from melanoma 
registry in Denmark, 1985-2010
Martin Glyd1, Krzysztof Tadeusz Drzewiecki2, Robert Gniadecki1 1Dept of Dermatology, 
Bispebjerg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark, 2Dept. of Plastic 
Surgery & Burn Unit, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
Worldwide, the incidence of cutaneous malignant melanoma (MM) is increasing faster than any 
other cancer. The increase is mostly seen for thin MM and is expected to continue for at least 
the next 2 decades. In contrast, melanoma-related mortality seems to have stabilized during the 
last decade which has led to discussion, whether this epidemic of melanoma is true or mainly 
caused by overdiagnosis. The aim of this study was to examine the risk of metastasizing disease 
in patients with thin melanoma in Denmark during the last 25 years. Metastasizing disease was 
defined as the presence of micro- or macrometastases in a SNB or development of distant organ 
metastasis. By looking at variables as age, gender, location at primary tumor, tumor subtypes 
and tumor depth (Breslow), mitosis and ulceration, we tried to identify a subgroup of patients 
who seems to be in higher risk at having invasive disease, despite being diagnosed with a thin 
melanoma. In the period of 1985-2010, 6066 patients were diagnosed with thin melanoma, of 
them 124 (2%) had a positive SNB at the time of diagnosis or in the follow-ups. In 25 (0.5%) of 
these patients spreading to distant organs occurred. By performing Cox regressions analysis, age 
at diagnosis and absolute tumor thickness were independently associated with higher risk of a 
positive sentinel node biopsy. In conclusion, thin malignant melanoma in patients younger that 
50 years of age has excellent prognosis.
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Co-morbidities in Patients with Psoriasis: A Consequential Study on 250 Czech Patiens
Jana Stranska, Katerina Juzlova, Jana Hercogova, Zdenek Smerhovsky, Dana Goepfertova Charles 
University of Prague, 2nd Medical faculty, Prague, Czech Republic
Psoriasis is chronic autoimmune inflammatory skin disease with the prevalence rates ranging 
between 2-5% in general population. Psoriasis is associated not only with psoriatic arthritis 
or depressions but also with other diseases and disorders - Crohn disease, Ulcerative colitis, 
Coeliac disease or metabolic syndrome. The aim of the study is to determine the occurrence of 
the metabolic syndrome and autoimmune inflammatory gastrointestinal diseases in patients with 
chronically stationary form of Psoriasis who do not exhibit any apparent signs of these diseases. 
We present results based on comparison of 80 patients with psoriasis - PASI 0-20 (av. 5,0) and 
BSA 0%-80% , and 170 control subjects. Questionnaires, physical investigation, inc. blood 
pressure, waist perimeter, BMI index and laboratory testing (serological tests of markers of IBD 
and Coeliac disease, blood count, total serum protein, iron and glucose level, lipid spectra, CRP) 
were performed. Due to asymmetrical distribution most of the studied variables, the differences 
between cases and controls were tested by means of Mann-Whitney U test at bivariate level. The 
strength of association between the variables of interest was tested by Spearman’s correlation 
coefficient. The point estimates of odds ratios and 95 % CI describing the strength of association 
between independent predictors and occurrence of Psoriasis are reported. We have found that 
there are differences between cases of Psoriasis and control group in several studied parameters. 
In case of BMI, diastolic blood pressure, total serum protein level and leucocyte counts 
differences reached the level of statistical significance (p<0.05).
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A genome-wide association study on 520 adult Caucasian women identifies a gene associated 
with facial photoaging
Sigrid Leclerc1, Lieng Tiang1, Anne Bernard2, Julie Latreille2, Khaled Ezzedine3, Denis Malvy4, 
Randa Jdid1, Pilar Galan3, Serge Hercberg3, Jean-François Zagury1, Erwin Tschachler5,2, Christiane 
Guinot2,6 1Department of Bioinformatics, Conservatoire National des Arts et Métiers, Paris, France, 
2CE.R.I.E.S., Neuilly sur Seine, France, 3UMR, Centre of Research on Human Nutrition Ile de 
France, Paris/Bobigny, France, 4Departments of Internal Medicine and Tropical Diseases, CHU 
St-André, Bordeaux, France, 5Dept of Dermatology, University of Vienna Medical School, Vienna, 
Austria, 6Computer Science Laboratory, University François Rabelais, Tours, France
A genome-wide association study was performed on a large sample of 520 French middle-aged Caucasian women 
to identify genetic factors that may impact skin features, in particular skin aging severity. A high-throughput Illumina 
Human Omni1-Quad beadchip containing 1,140,000 genetic markers was used. Among the 1,140,000 genetic 
markers analysed, 91,000 were copy number variants (CNV) and will be analysed afterward. Of the remaining 
1,049,000 SNPs, 118,000 exhibited no variation in the population, 55,000 exhibited genotyping errors (no 
assignment possible or too many missing data), and 2,000 that are located on chromosome Y were not relevant. After 
SNP quality controls, there were 874,000 remaining SNPs. Possible stratification was examined using the Eigenstrat 
method: 18 outliers were revealed who were excluded from further analysis. The relationships between genotypes 
and four skin aging indicators (global photoaging score, lentigines score, wrinkles score and sagging score) were 
investigated separately by linear regressions adjusted on age, smoking habits, lifetime sun exposure, hormonal 
status, and the two main Eigen vectors. One signal passed the Bonferroni threshold (p=6 10-9) and was significantly 
associated with the global photoageing score. It was also correlated with the wrinkling score and the sagging score. 
This SNP was intronic and located within a gene expressed in the skin. This gene, which was not described before in 
the context of aging, may constitute a good candidate for investigation of the molecular mechanisms of skin aging.
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Dermatology Research In Saudi Arabia: Challenges and hopes
Omar Alakloby University Of Dammam, Dammam, Saudi Arabia
Medical research in Saudi Arabia in general is still in the developing phase. Major hospitals, 
Medical Schools and Universities conduct clinical and basic medical researches. Dermatology 
Research is hampered by several factors including insufficient funding, deviation of interest of 
young Dermatologists towards private practice, low quality research with unclear goals, poor 
integration across the Universities Research Centers. There were only 140 research papers in 
Dermatology from 1966-2004 in the whole GCC countries; Saudi Arabia was the most prolific 
contributor. There are scattered few research in genetic diseases of the skin despite high 
percentage of consanguent marriages in Saudi Arabia. To improve the quality of research, several 
measures should be taken including: Increasing funding, encouraging graduate dermatology 
students to participate in Dermatology Research, establishing collaborations with international 
scientific institutions and re-examining research policy and planning in order to improve its 
quality to meet the country’s needs.
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Factors influencing the severity of facial skin ageing in Indian women
Randa Jdid1, Emmanuelle Mauger1, Aurelie Porcheron1, Julie Latreille1, Christiane Guinot1,2, 
Frederique Morizot1, Erwin Tschachler3,1 1CE.R.I.E.S., Neuilly-sur-Seine, France, 2Computer 
Science Laboratory, Ecole Polytechnique, University François Rabelais of Tours, Tours, France, 
3Department of Dermatology, Medical University of Vienna, Vienna, Austria
The aim of this study was to investigate the potential effect of lifestyle factors on skin ageing 
severity in Indian women. The study was conducted on 804 Indian women with skin phototype 
II to V (20-70 years old), living in Mumbai but originated from the North, East, West and South 
regions. Twelve age-related features were investigated by a dermatologist using validated 
photographic reference scales. A series of scores was built summarising wrinkles, tissue slackening 
and pigmented irregularities. Forehead lines are already visible in 25% of young women (20-29 
years), whereas wrinkles between eyebrows appear later. Both signs are more visible in phototype 
III. Wrinkles on the upper lip are present in more than 50% of women older than 50, and they 
are more frequent in women originated from the West region. Tissue slackening is visible from 40 
years old and is more frequent in fair phototype and women with high corpulence. Lentigines are 
visible in less than 30% of women over 60, whereas mechanical induced and post-inflammatory 
hyperpigmentation are frequently found, especially in dark phototype. Moreover, the corpulence 
was found to be associated with wrinkles and sagging scores: the wrinkles score decreases when 
the corpulence increases, and on the contrary, the sagging score increases with the corpulence. 
Our results show that Indian women frequently show wrinkles and sagging, whereas lentigines 
are less frequent. The age of appearance of wrinkles differs according to the phototype and the 
region of origin suggesting a potential link between skin aging and cultural factors.
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RIP4 is required for epidermal barrier formation and keratinocyte differentiation
Philippe De Groote1, Mathias Fransen1, Corinne Rösselet1, Mathieu Bertrand1, Giel Tanghe1, 
Barbara Gilbert1, Riet De Rycke1, Chris Guerin1, Pamela Holland2, Kris Vleminckx1, Peter 
Vandenabeele1, Saskia Lippens1, Wim Declercq1 1Department for Molecular Biomedical Research, 
VIB-Ghent University, Ghent (Zwijnaarde), Belgium, 2Amgen, Seattle, Washington 1201, USA
The Receptor Interacting Protein (RIP) kinases constitute a family of S/T kinases, generally 
involved in activation of the transcription factors NF-kappaB and AP-1. In contrast to other 
RIP kinases the RIP4 kinase activity is required for activation of NF-kappaB and AP-1. Inactive 
RIP can homodimerize and becomes autophosphorylated and ubiquitinated upon activation. 
Our data suggest that RIP4 phosphorylation is a prerequisite for its poly-ubiquitination. By 
mutation analysis we could correlate RIP4 modifications to its capacity to activate NF-kappaB 
and AP-1. In addition, RIP4 was shown to be required for epidermal differentiation; however 
the molecular pathways are still elusive. RIP4-deficient mice are perinatally lethal and show 
fusion of all external orifices. We found that RIP4-deficient mice display a severe skin barrier 
defect. Both, the outside-in and the inside-out barrier are affected, suggesting a defect in tight 
junction function. Limb defects or other skeletal defects were not observed in RIP4-deficient 
mice. However, RIP4-/- mice have a cleft palate phenotype. We found that RIP4-/- mice display 
a severe defect in periderm development, with aberrant apical expression of E-cadherin, leading 
to abnormal adherence and fusion of epithelia. Surprisingly, patches of normal cornification 
can be detected in RIP4-/- mice, while isolated RIP4-/- keratinocytes show a clear defect in 
Ca2+-induced terminal differentiation. The defects observed in mice were largely phenocopied 
by morpholino-mediated knockdown in the frog (Xenopus). Rescue experiments indicated that 
the phenotype is dependent on the RIP4 kinase activity.
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Langerin-positive Langerhans cells but not Langerin-negative inflammatory dendritic epidermal 
cells penetrate epidermal tight junction barriers in atopic dermatitis
Kazue Yoshida1, Akiharu Kubo1,2, Mariko Yokouchi1, Ken Ishii1,3, Hiroshi Kawasaki1, Tamotsu 
Ebihara1, Keisuke Nagao1, Masayuki Amagai1 1Department of Dermatology, Keio University, 
Tokyo, Japan, 2Kanrinmaru progect, Keio university, Tokyo, Japan, 3Teikyo University Chiba 
Medical Center, Chiba, Japan
The epidermal barrier function has three elements: the stratum corneum (SC) and tight junctions 
(TJs) form physical barriers, and the epidermal dendritic cells (DCs) form immunological barriers. 
SC barrier dysfunction is regarded as a predisposing factor for atopic dermatitis (AD), however, it 
is not well documented what happens to TJs and DCs under the impaired SC barrier. In this study, 
we clarified the behavior of epidermal DCs especially in their dynamic relationship with TJs in 
AD patients. We observed TJs and DCs concomitantly via 3D-visualization of whole mounted 
epidermis. We found that the dendrites of activated Langerhans cells (LCs) penetrated epidermal 
TJs in human as well as mice. The number of LCs in lesional and nonlesional AD skin was 
significantly reduced than that of healthy skin. Nonetheless, the number of LCs that penetrated 
TJs was dramatically increased in lesional AD skin. In the AD epidermis, there appear langerin-
negative DCs called inflammatory dendritic epidermal cells (IDECs). Surprisingly, IDECs never 
penetrated TJs even when surrounding LCs vigorously penetrated TJs. To our knowledge, this is 
the first report to demonstrate behavioral difference between LCs and IDECs. In AD, both of LCs 
and IDECs expressed high-affinity receptors for IgE (FceRI). Interestingly, langerin but not FceRI 
accumulated to the TJ-penetrated dendrite tips of LCs, suggesting that IgE-dependent antigen 
uptake by LCs and IDECs occurs mostly under TJ barriers after antigens penetrate both SC and 
TJ barriers. These findings will provide new insights of immunological significance of epidermal 
DCs in the pathophysiology of AD.
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14-3-3σ controls keratinocyte proliferation/differentiation switch and responsiveness to IGF-1
Francesca Cianfarani1, Naomi De Luca1, Elena Dellambra2, Laura Tatangelo3,5, Cecilia Tiveron3,6, 
Carien M Niessen4, Giovanna Zambruno1, Daniele Castiglia1, Teresa Odorisio1 1Istituto 
Dermopatico dell’Immacolata, IDI-IRCCS, Roma, Italy, 2Istituto Dermopatico dell’Immacolata, 
IDI-IRCCS, Pomezia, Italy, 3Regina Elena Cancer Institute, Roma, Italy, 4University of Cologne, 
Cologne, Germany, 5EMBL Transgenic Facility, Monterotondo, Italy, 6EBRI Foundation, Roma, Italy
The 14-3-3 protein family controls diverse biochemical processes through interaction with 
phosphorylated consensus sequences in protein targets. Its epithelial specific member, 14-3-3σ, 
also known as stratifin, is highly expressed in differentiated keratinocytes and in vitro evidence 
indicates that 14-3-3σ downregulation leads to keratinocyte immortalization. To define the role 
of 14-3-3σ in skin homeostasis in vivo, we generated transgenic mice overexpressing 14-3-3σ 
in proliferating keratinocytes of the epidermis and hair follicle. Transgenic animals showed 
decreased epidermal thickness and hair follicle density associated with reduced number of 
BrdU-positive proliferating keratinocytes and decreased immunostaining for keratins 14, 5 and 
15. BrdU labelling and colony forming efficiency assay indicated that primary keratinocytes 
isolated from transgenic mice manifest reduced proliferation and migration. Moreover, in vivo 
label-retaining analysis revealed a reduction in keratinocyte progenitor cell number in both 
interfollicular and follicular epidermis of transgenic mice compared to wild-type controls. Since 
IGF-1 signalling was shown to play an important function in regulating epidermal proliferation, 
motility and progenitor cell behaviour, we decided to investigate this pathway in our transgenic 
mouse model. BrdU incorporation following IGF-1 treatment was strongly impaired in cultured 
transgenic keratinocytes compared to wild-type cells. Consistently, activation of the IGF-1 
downstream mediators PI3K, AKT and Rac1 was reduced. Our results demonstrate that 14-3-
3σ controls the in vivo epidermal proliferation/differentiation switch by reducing proliferative 
potential and forcing keratinocytes to exit the cell cycle, and that inhibition of the IGF-1 pathway 
is involved in mediating these effects.
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The p75 neurotrophin receptor acts as a “switch on-off” protein in early transit amplifying 
differentiation
Francesca Truzzi, Alessandra Marconi, Roberta Lotti, Katiuscia Dallaglio, Elisabetta Palazzo, 
Tiziana Petrachi, Annalisa Saltari, Carlo Pincelli University of Modena and Reggio Emilia, 
Modena, Italy
p75 neurotrophin receptor (p75NTR), expressed in transit amplifying (TA) cells, mediates 
neurotrophin (NT) signals alone or in combination with the high affinity receptor Trk. In the 
present work, we studied the role of p75NTR during keratinocyte differentiation. p75NTR 
was up-regulated during keratinocyte differentiation in cell culture system both with serum 
and with calcium treatment. When p75NTR was silenced, calcium treatment failed to induce 
differentiation in subconfluent keratinocytes. In human skin, p75NTR is only expressed in the 
basal keratinocyte layer and is confined to a MIB-1 negative cell population. p75NTR+ cells, 
isolated by magnetic cell sorting, were less differentiated and proliferated less than p75NTR– 
cells in vitro, which in turn include keratinocyte stem cells (KSC), as shown by western blotting 
and confocal analysis. p75NTR+ keratinocytes, isolated from TA cells, expressed more survivin 
and CK15, while displayed less CK10 than p75NTR- TA. Colony forming efficiency and long term 
proliferation analysis revealed that p75NTR+ TA yielded a higher number of cells than p75NTR- 
TA, suggesting that p75NTR+ cells are early TA cells. p75NTR retroviral infection of KSC induced 
a more differentiated phenotype, with the same features of TA cells. Finally, skin reconstructs 
originated from TA p75NTR- cells generated a hyperproliferative phenotype. These results suggest 
that p75NTR+ keratinocytes represent a subpopulation of TA cells, directly derived from stem 
cells that just started the differentiation process. p75NTR may act as a “switch on-off” protein in 
stem-TA transition, initiating keratinocyte differentiation.
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Rho kinase inhibitor Y-27632 increases the life span of human primary adult keratinocytes: 
Applications in human skin equivalent development
Ellen van den Bogaard, Diana Rodijk-Olthuis, Patrick Jansen, Ivonne van Vlijmen-Willems, Piet 
van Erp, Joost Schalkwijk Radboud Univ Nijmegen Medical Centre, Nijmegen, The Netherlands
Large quantities of primary human keratinocytes are required to meet the growing demand 
for in vitro generated human skin equivalents. The Rho kinase inhibitor, Y-27632 is known to 
immortalize human foreskin keratinocytes, however, foreskin-derived skin equivalents are 
considered less biologically relevant to study epidermal biology and pathophysiology. Therefore, 
we investigated Y-27632-treatment of primary adult abdominal keratinocytes and evaluated the 
application of Y-27632 in skin equivalent development. Y-27632 considerably increased the life 
span of primary adult keratinocytes but could not immortalize these keratinocytes. We were 
able to generate normal skin equivalents from high passage, Y-27632-treated keratinocytes. The 
presence of 10 µM Y-27632 during the skin equivalent culture did not affect cell differentiation 
and epidermal morphology, although higher concentrations of Y-27632 negatively affected 
epidermal structure. Furthermore, skin equivalents generated from Y-27632-treated keratinocytes 
could still be used to induce morphologic and molecular characteristics of the inflammatory skin 
diseases, psoriasis and atopic dermatitis upon stimulation with relevant cytokines. To study the 
potential of Y-27632 for large scale in vitro gene delivery assays, Y-27632-treated keratinocytes 
were transduced with enhanced Green Fluorescent Protein (eGFP) lentiviral constructs. Y-27632 
significantly increased transduction efficiency, and skin equivalents generated from eGFP-
transduced-Y-27632-treated keratinocytes showed high quality epidermal morphology with 
endogenous eGFP present in the majority of the keratinocytes. Our findings emphasize Y-27632 
as a powerful tool for large scale human adult keratinocyte culture and development of skin 
equivalents. As it also facilitates functional gene-delivery studies in keratinocytes, Y-27632 may 
contribute to reduction of experimental animals used in knockout or transgenic models.
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Epidermal expression of maintenance and repair genes upon skin barrier disruption: an 
elaborate analysis
Heleen de Koning1,2, Ellen van den Bogaard1,3, Judith Bergboer1,2, Marijke Kamsteeg1,3, 
Ivonne van Vlijmen-Willems1, Julie Henry4, Jean-Yves Thuret5, Akemi Ishida-Yamamoto6, Joost 
Schalkwijk1,3, Patrick Zeeuwen1,2 1Radboud University Nijmegen Medical Centre, Nijmegen, 
The Netherlands, 2Nijmegen Centre for Molecular Life Sciences (NCMLS), Nijmegen, The 
Netherlands, 3Nijmegen Institute for Infection, Inflammation and Immunity (N4i), Nijmegen, The 
Netherlands, 4University of Toulouse III-CNRS UMR5165, Institut Fédératif de Recherche Claude 
de Préval, IFR30 (INSERM–CNRS–Université Paul Sabatier–Centre Hospitalier Universitaire de 
Toulouse), Toulouse, France, 5Cancer Research UK, Cambridge Research Institute, Li Ka Shing 
Centre, Cambridge, UK, 6Asahikawa Medical University, Asahikawa, Japan
Recent studies have identified genetic risk factors for atopic dermatitis (mutations in the filaggrin gene) and psoriasis 
(deletion of LCE3B/C, two genes coding for Late Cornified Envelope proteins) that are presumed to affect epidermal 
barrier function. To date, no comprehensive studies on the effect of experimental barrier disruption on cornified 
envelope protein expression have been performed. In this study, we examined mRNA and protein expression levels of 
structural, cornification- and desquamation-related molecules upon tape stripping of uninvolved epidermis of psoriasis 
and atopic dermatitis patients and healthy controls. Furthermore, we studied sodium dodecyl sulphate (SDS)-induced 
irritant contact dermatitis in normal skin. Quantitative PCR was performed on RNA extracted from epidermal sheets. 
Immunohistochemistry and electron microscopy were performed on full-thickness skin biopsies. Upon experimental 
barrier disruption, several cornified envelope genes were significantly downregulated (at the mRNA level as well 
as the protein level), including LCE5A, LCE2B, filaggrin 2, loricrin and filaggrin, whereas others were upregulated: 
involucrin, SPRR1, SPRR2 and most notably LCE3A. The crosslinking enzymes transglutaminase (TGM)1, TGM3 and 
TGM5 were all upregulated, as was TGM1 activity, whereas the desquamation enzyme cathepsin V and the cysteine-
protease inhibitor cystatin M/E were downregulated. Interestingly, there was no significant difference in response 
between normal epidermis and non-lesional skin of psoriasis and atopic dermatitis patients. In conclusion, skin barrier 
disruption induces a provisional and uniform repair response comprising increased expression of several structural and 
cornification-related proteins/genes, and decreased expression of some structural and desquamation-related proteins.
316
ARNT2 and CERT: Two potential partners in epidermal barrier maintenance
Alexandra D’Arcangelis, Elena Fedorova, Jin Namkoong, Pinaki Bhatt, Christelle Lasserre Chanel, 
Inc., Piscataway, NJ, USA
Proper epidermal barrier formation and maintenance is essential for prevention of water loss 
and protection of the underlying tissue from the external environment. Multiple gene families 
function to form and maintain a barrier composed of highly differentiated corneocytes and 
a heterogeneous ceramide-rich extracellular lipid component. Complimentary pathways, 
including those involving CERT and ARNT2, collaborate to make available the required lipids 
and small molecules to the epidermis. CERT is the major non-vesicular transporter of ceramides 
for transformation to sphingomyelin, and finally into stratum corneum ceramides. In concert, 
ARNT2 modulates the activity of gene expression networks in homeostasis and stress response 
pathways. Little is known regarding the function of these genes in human skin. Therefore, the 
aim of our study was to analyze CERT and ARNT2 expression and distribution in skin cells, their 
modulation with age and UV irradiation, and to identify active agents capable of stimulating 
their expression. We analyzed CERT and ARNT2 expression in cultured human keratinocytes, 
skin samples, and skin equivalents by PCR, Western blot, and immunostaining. Our results 
show that both genes are expressed in skin cells. CERT expression decreases with chronological 
age in human skin. ARNT2 expression is stimulated in keratinocytes by non-cytotoxic levels of 
UVB irradiation. Inhibition of ARNT2 expression by siRNA induced an increase in apoptosis 
rate compared to untreated control. Further, we have identified stimulators of CERT and ARNT2 
expression in keratinocytes. Modulation of CERT and ARNT2 expression may provide a novel 
route to fortify, defend, and restore the epidermal barrier from within.
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Essential Role of Kindlin-2 in Cell-Cell Junctions in the Epidermis
Yinghong He1, Tanja Sonnenwald2, Gudula Schmidt2, Leena Bruckner-Tuderman1,3, Cristina 
Has1 1Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany, 
2Department of Experimental and Clinical Pharmacology and Toxicology, Freiburg, Germany, 
33Freiburg Institute for Advanced Studies – School of life Sciences Lifenet, Freiburg, Germany
Kindlins belong to a novel protein family that regulates integrin mediated cell-matrix interactions. 
Kindlin-2 is essential for activation of integrins in early developmental processes, but its 
contribution to the homeostasis of adult skin remained elusive. In the epidermis, kindlin-2 is 
distributed at the periphery of the keratinocytes, partially colocalized with beta-catenin and 
desmoplakin. Therefore we focused in this study on its role in cell-cell adhesions. We established 
a keratinocyte cell line, K2-, in which kindlin-2 expression was knocked down by about 80%, 
and compared it with a control cell line. After calcium treatment, immunofluorescence staining 
of beta-catenin and desmoplakin demonstrated a predominantly cytoplasmic distribution of these 
proteins in K2- cells, in contrast to the plasma membrane localization in control cells. Dispase-
based dissociation assays demonstrated that kindlin-2 deficient keratinocytes had significantly 
weaker cell-cell adhesions than control keratinocytes. The impairment of cell-cell adhesions in 
K2- keratinocytes was confirmed in organotypic cocultures (OTC). Pulldown assays demonstrated 
reduced RhoA activation in K2- keratinocytes. Rescue of the RhoA activation with the cytotoxic 
necrotizing factor Y was followed by normalization of the distribution of beta-catenin and 
desmoplakin. This suggests that kindlin-2 deficiency may affect cell-cell contacts through RhoA 
dependent mechanisms. RNA microarray analysis showed impaired WNT/Ctnn-Beta signaling 
in K2- kerationcytes. Downregulation of WNT5A and WNT5B, as well as upregulation of AXIN2 
in K2- keratinocytes were confirmed by qPCR. Taken together, these studies reveal an essential 
role for kindlin-2 in cell-cell junctions in the epidermis, involving multiple signaling pathways.
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A key role for the protease inhibitor Cystatin A in keratinocyte adhesion
Daniela Nitoiu1, Diana Blaydon1, Rita Cabral1, Phil Bland1, Alex Zvulunov2, Hans Christian 
Hennies3, David Kelsell1 1Centre for Cutaneous Research, The Blizard Institute, Barts and The 
London School of Medicine and Dentistry, Queen Mary University of London, London, UK, 
2Pediatric Dermatology Unit, Schneider Children’s Medical Center, Petah-Tiqva, Israel, 3Division 
of Dermatogenetics, Cologne Center for Genomics, University of Cologne, Cologne, Germany
We have identified loss-of-function mutations in the protease inhibitor cystatin A (CSTA) as the 
underlying genetic cause of autosomal recessive exfoliative ichthyosis. Electron microscopy of the 
patients display widened intercellular spaces and thickening of keratin filaments in the basal layers 
of the epidermis. At the clinical level this condition presents as a fine peeling of non-erythematous 
skin on the palms and soles, believed to be induced by mechanical stress. By utilising an in-vitro cell 
stretch assay combined with robust siRNA knockdown, we demonstrate that loss of CSTA leads to 
destabilised intercellular connections suggesting a possible role in maintaining cell-cell adhesion 
via desmosomes in the basal keratinocytes. As CSTA is known to inhibit proteases including 
cathepsins B, H and L, we have investigated the expression of these proteases in the epidermis 
and cultured keratinocytes. IHC of the three cathepsins in normal skin shows that cathepsin L 
is expressed throughout all layers of the epidermis whilst cathepsin B and H are more strongly 
expressed in the suprabasal layers with cathepsin B expressed at lower levels in the basal layer. 
Ongoing work is looking at how the activity of these target protease(s) is affected by the presence 
or absence of CSTA in keratinocytes with or without mechanical stress. In summary, this data 
describes the first report of CSTA with an inherited skin disease and reveals a previously unknown 
key role for CSTA in basal-suprabasal keratinocyte adhesion.
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Evaluation of sebum lipidomics in juvenile acne with different clinical grading
Emanuela Camera, Stefania Tilgher, Monica Ottaviani, Jo-Linda Sinagra, Bruno Capitanio, Matteo 
Ludovici, Mauro Picardo San Gallicano Dermatological Institute (IRCCS), Rome, Italy
Acne is common among adolescents and manifests with different severity. Multiple factors 
centering on sebum secretion are implicated in the acne pathogenesis. Sebum excretion rates 
positively correlate with acne severity. Fingerprints of sebum lipids in clinically distinguished 
acne manifestations await characterization. Extensive and simultaneous analysis of intact sebum 
components is achievable by rapid-resolution-high-performance-liquid-chromatography and 
time-of-flight mass-spectrometry (RR/HPLC-ToF/MS). To investigate distribution of sebaceous 
lipids in healthy and diseased sebum 61 adolescents of both sexes (29 males, 32 females) 
were enrolled into the study. Seventeen subjects presented no clinical signs of acne. The 44 
affected individuals were classified clinically into mild (13), moderate (19), and severe (12) 
acne. Sebum was sampled from the foreheads with SebutapeTM adhesive patches. Profiles of 
neutral lipids were acquired with RR/HPLC-ToF/MS in positive ion mode. Detected species 
were extracted individually with the molecular features extraction (MFE) algorithm. Statistical 
evaluation of the aligned/normalized RR/HPLC-ToF/MS data was performed using univariate 
analysis, including Student t-test and one-way ANOVA. Multivariate statistical analysis included 
principal component (PCA) and partial least square (PLS) analyses. More than hundred species 
were identified as significantly discriminating between healthy and acne sebum. The majority 
of discriminating species belonged to the diacylglycerides (DG) functional class, followed by 
waxes (WE) and cholesterol esters (CE), and squalene (SQ). Triacylglycerides (TG) were minimally 
affected in mild and moderate acne. In contrast, the abundance of several members of TG was 
significantly diminished in severe acne. The data indicated an association between the clinical 
grading of acne and the sebaceous lipid fingerprints.
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Cytokines modulate epidermal barrier: TH2 versus TH17
Anna De Benedetto1, Takeshi Yoshida1, I-Hsin Kuo1, Mary Behrendt1, Brian Jones2, Merle Elloso2, 
Lisa Beck1 1University of Rochester Medical Center, Rochester, NY, USA, 2Centocor Research & 
Development, a division of Johnson & Johnson Pharmaceutical Research & Development, L.L.C, 
Radnor, PA, USA
Skin barrier impairment is a critical feature in the pathogenesis of the two most common 
inflammatory skin diseases, Atopic Dermatitis (AD) and Psoriasis (PS). Tight junctions (TJ), 
together with the stratum corneum (SC), make up the epidermal barrier. Inflammatory cytokines 
orchestrate skin inflammation in AD (IL4 and IL13) and in PS (IL17). In this study we evaluated 
the effect of these cytokines on the function and expression of epidermal barrier components. 
Primary human foreskin keratinocytes (PHK) were differentiated in high-Ca2 (1.8 mM), serum-
free (DMEM) media in the presence of IL17 (10-1000 ng/ml) and IL4 and IL13 (1-100 ng/ml) or 
media alone. TJ function was evaluated by measuring trans electric epithelial resistance (TEER). 
RNA and protein expression of TJ components (CLDN1, OCL, ZO1), desmosomal proteins 
(DSG1/3) as well as markers of terminal differentiation (FLG, LOR, KRT10) were investigated. 
IL4, IL13 and IL17 enhanced TEER in a dose-dependent fashion, while reducing PHK terminal 
differentiation. Importantly, critical differences were observed between TH2 and TH17 cytokines. 
IL17 induced a rapid TJ response (peak 24-48h; up to 4-fold increase). While TH2 mediated effect 
was delayed (peak 96-120h; up to 2-fold increase). This study suggests that prototypic TH2 and 
TH17 cytokines enhance TJ barrier function, possible through a different pathway. Understanding 
the mechanisms by which these cytokine affect epidermal barrier function may lead to new 
therapies that can target barrier function more specifically.
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A Multifactorial Gene Expression Approach to Addressing Body Appearance Aging
Helen Knaggs1, Dale Kern1, Remona Gopaul1, Anna Langerveld2 1Nu Skin Enterprises, Inc., Provo, 
Utah, USA, 2Genemarkers LLC, Portage, Michigan, USA
The advent of genomic research has opened up new ways of investigating skin and body aging. 
From the present and continuing into the foreseeable future, vast amounts of gene expression 
data will need to be evaluated to produce meaningful interpretations and conclusions. Among 
the most promising routes are methodologies that seek to understand the interactions of multiple 
genes during aging. Aging is the result of complex multifactorial influences occurring over time 
between lifestyle choices, environment and genome, necessitating the study of multiple genes 
and expression patterns in multiple tissues. Here we describe the ability of several skin care 
ingredients to favorably modify the genetic expression of a diverse group of genes important in 
body skin structure and appearance. Three skin-active ingredients were tested on human full-
thickness 3D epidermal skin equivalents and primary human adipocytes, Gene expression was 
measured by quantitative PCR using custom TaqMan Low Density Arrays (TLDA). Compared 
to each other, each ingredient exhibited some common and many unique genetic expression 
changes suggesting that a comprehensive anti-aging product be composed of more than one 
ingredient to affect the necessary changes in the expression of groups of genes involved in aging.
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Filaggrin mutations are associated with altered epidermal barrier and antigen presenting cell 
immunophenotypes in atopic eczema patients
Sharizan Abdul-Ghaffar*2, Nayani Madarasinga*1,2, Zoe Venables*1, Roland Chu1, Siao Pei Tan1, 
Andrew Muinonen-Martin3, W.H. Irwin Mclean4, Jurgen Schwarze*5,1, Sarah Howie*5,1, Richard 
Weller*2,5 1Univ of Edinburgh, UK, 2Dermatology Dept, Lauriston Building, Edinburgh, UK, 
3Dermatology Dept, Southern General Hospital, Glasgow, UK, 4College of Life Sciences, Univ of 
Dundee, UK, 5Centre for Inflammation Research, Queen’s Medical Research Inst, Edinburgh, UK
Filaggrin null mutations (FLG) are associated with atopic dermatitis (AD) and skin barrier defects. We 
assessed the role of FLG on the skin barrier phenotype and dendritic cell (DC) subtypes. 94 subjects were 
genotyped for common European FLG variations (R501X and 2282del4) and phenotyped; 62 subjects with 
AD (13 FLG heterozygotes, 2 homozygote), 32 without AD (8 FLG heterozygotes). We measured trans-
epidermal-water-loss (TEWL), hydration, number of tape-strips to raise TEWL>20g/h/m2, SLS irritation 
and epidermal DC immunophenotypes by flow-cytometry. TEWL was highest in FLG AD 8.4±0.6; WT 
AD 8.1±0.8; FLG non-AD 7.9±0.7; WT non-AD 7.2±0.4 (p<0.05 for FLG vs. WT and FLG AD vs. WT 
AD). No. tape-strips to reach TEWL>20g/h/m2 was lowest in FLG AD 11.3±1.9; WT AD 14.2±5.7; FLG 
non-AD 15.3±6.2; WT non-AD 18.9±5.9 (p<0.05 for FLG vs. WT, AD vs. non-AD and FLG AD vs. WT 
AD). The amount of protein removed per strip was greatest in FLG AD 31.2±8.27; WT AD 18.58±6.38; 
FLG non-AD 3.78±1.01 and WT non-AD 4.04±1.9mg.cm-2. TEWL rose dose-dependently following 24hr 
application of SLS (0.06-4%); and significantly higher in FLG AD vs. WT AD patients at 1% and 2%. FLG 
AD subjects had a significantly higher proportion of IDEC and mature DC in their epidermal samples 
than WT AD subjects. This data infers a complex aetiology of AD where non-AD FLG carriers appear 
not to develop significant defects. In AD, our study supports the role of filaggrin mutations in defective 
corneocyte adhesion and epidermal barrier integrity, and a resultant alteration in antigen presenting cells.
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A patented natural extract for preservation of skin hydration
Stephanie Bredif, Caroline Baudouin, Sebastien Garnier, Philippe Msika Laboratoires 
Expanscience, Epernon, France
Adequate skin hydration is critical for maintaining healthy skin. The ability of the skin to hold 
water is primarily linked to the stratum corneum thanks to natural moisturizing factor (hygroscopic 
compounds derived from filaggrin) and intercellular lipids which form a barrier against water 
loss. In the dermis and epidermis, hyaluronic acid, a glycosaminoglycan with highly hydrophilic 
properties, is also greatly involved in water binding.The moisturizing activity of a patented natural 
extract has been evaluated using in vitro and ex vivo models. First, on normal human epidermal 
keratinocytes, the natural extract was able to significantly stimulate the production of hyaluronic 
acid and glycosaminoglycans measured by ELISA and incorporation of 35S-sulfate, respectively. 
Second, epidermal lipids neo-synthesis in reconstructed human epidermis was followed by lipids 
radiolabelling and thin layer chromatography. Epidermal ceramides and free fatty acid synthesis 
were enhanced by the natural extract. Third, immunostainig of hyaluronic acid and CD44 was 
performed on human skin explants. Topical application of a cream containing the patented 
natural extract clearly enhanced the level of hyaluronic acid and its receptor CD44 compared 
to the placebo cream. Finally, the cream containing the patented natural extract was topically 
applied on human skin explants after barrier alteration by a mix of organic solvents. Expression 
of filaggrin and transglutaminase, evaluated by immunostaining, were strongly restored by the 
natural extract These results show the potential of a patented natural extract to preserve skin 
hydration even in damaged or stressed skin.
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Reinforce and strenghten the skin: a way to prevent stretch marks
Caroline Baudouin1, Marisa Meloni2, Franck Menu1, Philippe Msika1 1Laboratoires Expanscience, 
Epernon, France, 2Vitroscreen, Milan, Italy
Common during pregnancy, stretch marks could appear resulting from many factors: hormonal 
impact, mechanical and physiological stress. We have specifically formulated a cream to 
prevent their apparition and to reduce newly formed-stretch marks. This cream contains 
patented ingredients (lupeol, natural peptides and arabinogalactane) for which the efficiency 
to counteract inflammation and to stimulate extracellular matrix (ECM) remodelling has been 
already demonstrated. An in vitro study was conduced on reconstructed full-thickness skin (RFT 
skin) to evaluate the effect of the cream treatment. Gene expression was analyzed by QRT-PCR. 
First, the cream was topically applied at the RFT skin surface during 24 and 48h. In this condition, 
cream topical treatment significantly increased (X15-16 and X2-3 respectively) gene expression 
of hyaluronan synthase, that allows hyaluronic acid synthesis conferring strength and suppleness 
to the skin, and KGF, a key growth factor involved in the precocious step of wound healing. Then, 
a dermal injury model that mimics ECM changes occuring during stretch marks formation was 
conduced on RFT skin. The cream has been topically applied 48h before the injury. The cream 
topical treatment significantly upregulated collagen VII (X4.7 and 5.6 at 24 and 48h post-injury) 
and integrin b1 (X1.6 and 2.2 at 48h and 8d), two main markers of dermal-epidermal junction 
promoting precocious tissue regeneration and fast remodelling .These results demonstrate that 
the cream topical treatment could reinforce the skin in order to prepare it against deleterious 
effects occurring during pregnancy, supporting the cosmetic relevance of this cream for the 
prevention of stretch marks.
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Effect of cytokines on filaggrin and transglutaminase 1 expression in human keratinocytes
Ruediger Panzer, Juergen Harder, Erhardt Proksch University Clinics Schleswig-Holstein, Clinic for 
dermatology, allergology and immunology, Kiel, Schleswig-Holstein, Germany
The disturbed skin barrier plays an important role in the pathogenesis of atopic dermatitis 
(AD). The reason for the disturbed skin barrier function in AD is only partly known. Besides 
loss of function mutations in the filaggrin gene in about 30% of the patients there are data 
suggesting a secondary impairment of the skin barrier by mediators of inflammation. In line 
with this we found decreased filaggrin expression in skin from patients with or without filaggrin 
mutations. Transglutaminase 1 plays an important role in the cross-linking of cornified envelope 
proteins and the covalent attachment of lipids to involucrin during skin barrier formation. We 
investigated the influence of the proinflammatory cytokines IL1 beta, IL4, IL5, IL6, IL13, IL15, 
IL17, IL18, IL28, IL31, IFN gamma, TNF alpha und TGF alpha on the expression of filaggrin and 
transglutaminase 1 in human keratinocyte cultures. Analysis was semiquantitatively performed 
by real-time PCR. IFN gamma and other proinflammatory cytokines caused a significant decrease 
in filaggrin expression. This way inflammation could aggravate barrier disruption in psoriasis and 
atopic dermatitis. IFN gamma caused an increase of transglutaminase 1 expression; it has been 
described that this stimulation also occurs in psoriasis in vivo. Stimulation of transglutaminase 1 
by IFN gamma may prevent a significant disturbation of the skin barrier in psoriasis. In AD the 
lack of the TH1 cytokine IFN gamma could aggravate barrier dysfunction.
326
Functions of hyaluronan synthases in human keratinocytes: HAS1 is involved during normal 
differentiation whereas HAS2/3 play roles in abnormally differentiated atopic dermatitis
Jeremy Malaisse1, Arjen Nikkels2, Bruno Flamion3, Yves Poumay1 1Cell and Tissue Laboratory, 
URPHYM, Faculty of Medicine, University of Namur (FUNDP), Namur, Belgium, 2Department 
of Dermatology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium, 
3Physiology and Pharmacology laboratory, URPHYM, Faculty of Medicine, University of Namur 
(FUNDP), Namur, Belgium
Hyaluronan (HA) is synthesized by three HA synthases (HAS1, 2, and 3) and secreted in 
extracellular matrix. HA is considered as major extracellular component in epidermis, but its 
functions are not clearly identified yet in this tissue. In order to investigate HA functions, we 
have measured HAS expression and HA production in monolayers and organotypic cultures 
of human keratinocytes. During keratinocyte differentiation, an increased HA concentration in 
extracellular medium was observed in both models, concomitant with increased HAS1 mRNA 
expression in monolayers and stabilised HAS1 mRNA expression in organotypic cultures. 
HAS2 and HAS3 mRNA expression were decreased in both models. To inhibit HA synthesis, 
4-methylumbelliferone (4MU) was added to keratinocyte cultures. In monolayers, 4MU produced 
an increase in filaggrin and keratin 10 mRNA expression, whilst decreasing involucrin mRNA 
expression. 4MU inhibited cell proliferation in organotypic cultures. Several studies report an 
increase in HA during inflammatory skin diseases. Thus, we studied potential role of HAS during 
atopic dermatitis (AD) by analysis of patients biopsies, as well as in AD model obtained by 
treatment with methyl-beta-cyclodextrin of cultured keratinocytes. Increased HAS2-HAS3 and 
decreased HAS1 mRNA expression were observed in these models. Altogether, data suggest 
that HAS1 is involved in HA extracellular production by normal keratinocytes, being an actor 
during keratinocyte differentiation. In contrast, HAS2-3 are implicated in response to stress or 
pathological conditions, indicating particular function of HAS2-3 in regard of HAS1.
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IL-31 regulates differentiation and filaggrin expression in human organotypic skin models
Christian Cornelissen2,1, Yvonne Marquardt1, Katharina Czaja1, Jörg Wenzel3, Juliane Lüscher-
Firzlaff2, Bernhard Lüscher2, Jens Baron1 1Department of Dermatology and Allergology, RWTH 
Aachen University, Germany, 2Institute of Biochemistry and Molecular BiologyRWTH Aachen 
University, Germany, 3Department of Dermatology, University of Bonn, Germany
Atopic dermatitis (AD) is an inflammatory skin disease affecting 10-20% of children and 1-3% 
of adults in industrialized countries. Enhanced expression of IL-31 is detected in skin samples 
of AD patients, but its physiological relevance is not known. We thought to determine the 
role of IL-31 in skin differentiation. We used 3D organotypic skin models either with primary 
keratinocytes or with HaCaT keratinocytes with inducible IL-31RA to evaluate the effect of 
IL-31. The consequences were studied using histology, the expression of markers analyzed by 
immunofluoresence and RT-qPCR, and gene expression arrays. We observed that IL-31 interferes 
with keratinocyte differentiation. Gene expression analysis revealed a limited set of genes 
deregulated in response to IL-31, including IL20 and IL24. In HaCaT keratinocytes with inducible 
IL-31RA, IL-31 inhibited proliferation upon induction of IL-31RA by inducing cell cycle arrest. 
As in primary cells, IL-31 treated HaCaT cells elicited a differentiation defect in organotypic 
skin models, associated with reduced epidermal thickness, disturbed epidermal constitution and 
stratum basale, and poor development of the stratum granulosum. The differentiation defect was 
associated with a profound repression of terminal differentiation markers, including filaggrin, 
an essential factor for skin barrier formation. The highly induced pro-inflammatory cytokines 
IL-20 and IL-24 were responsible for part of the effect on FLG expression and thus for terminal 
differentiation. Our study defines IL-31 as an important regulator of keratinocyte differentiation 
and demonstrates a link between the presence of IL-31 in skin, as found in patients with AD, and 
filaggrin expression.
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The C-terminus of filaggrin-2 shows sequence similarities to bacterial lasso peptides
Britta Hansmann, Ulrich Gerstel, Jens-Michael Schröder University Hospital Schleswig-Holstein, 
Department of Dermatology, Kiel, Germany
Filaggrin 2, a 250 kDa member of the “S100 fused-type protein” family, has been shown to be 
involved in the skin’s barrier formation and also shows some sequence- and structure similarities 
to filaggrin. Interestingly an antimicrobially active filaggrin-2 C-terminal fragment contains an 
among mammals highly conserved amino acid region. This 15-20 amino acid-stretch shows 
sequence similarities to bacterial antibiotic peptides, so-called lasso peptides, such as MccJ25 of 
E. coli or capistruin of Burkholderia thailandensis. Lasso peptides are synthesized from precursors 
by posttranscriptional modifications, where the ring of the lasso is formed by an intramolecular 
transamidation. The remaining C-terminal tail is then trapped within the ring by two bulky amino 
acid residues. The sequence similarities led to the hypothesis that filaggrin-2 antimicrobial 
properties could originate from conversion of a filaggrin-2 fragment into a lasso-like peptide 
inside the targeted bacteria, eventually causing bacterial death. Therefore filaggrin-2 mutants 
were generated, where amino acids required for lasso formation in MccJ25 have been mutated 
to alanine. These filaggrin-2 mutants did not show a reduced antimicrobial activity suggesting 
that antibiotic properties do not depend on lasso formation. Besides the amino acids involved 
in lasso formation, however, additionally a tyrosine residue in MccJ25 is also responsible for 
antimicrobial activity. This tyrosine residue is also found in the conserved filaggrin-2 C-terminal 
sequence and might account for its antimicrobial activity. Mutation of this tyrosine, currently 
under study, will reveal the contribution of this residue to filaggrin-2 antimicrobial properties.
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Information processing between co-cultured keratinocytes and trigeminal neurons
Anna Christina Sondersorg1, Daniela Busse1, Gitta Neufang2, Hanns Hatt1, Heike Benecke1 
1Department of Cellphysiology, Ruhr-University, Bochum, Germany, 2Dermatological Skin Care, 
Beiersdorf AG, Hamburg, Germany
The trigeminal nerve constitutes the fifth cranial nerve and provides tactile, proprioceptive 
and nociceptive afferents that innervate the facial skin, eyes, mouth and the nasal mucosa. 
Previous work including studies on anosmic patients indicates a functional contribution of the 
trigeminal nerve to odor detection in vivo. High concentrations of most odors typically provoke 
trigeminal sensations in vivo, but only certain odors elicit responses in mouse trigeminal 
monocultures. This leads to the suggestion that trigeminal perception may require a transfer 
of sensory information via crosstalk with additional cell types of the peripheral innervation 
area. The expression of various chemoreceptors as well as their ability to respond to various 
chemicals (e.g. odorants) favors the idea that keratinocytes may participate in chemodetection 
and subsequently transmit signals to neighboring trigeminal fibers in the epidermis. 
This study is designed to a) identify chemical substances that activate keratinocytes but fail to stimulate 
trigeminal neurons directly, b) to detect potential communications between skin keratinocytes and 
trigeminal neurons induced by these substances and c) to identify possible transmitter molecules. 
We screened substances that reproducibly elicit calcium responses in keratinocytes, but not in 
trigeminal neurons. Two derivates of sandalwood oil were identified as appropriate candidates 
to investigate a potential cross-talk. In contrast to monocultures increased numbers of calcium 
signals of trigeminal neurons could be detected in a co-culture approach induced by the 
mentioned substances. These results support our hypothesis of an information transfer from 
keratinocytes to trigeminal neurons.
330
Chemoperception in the human skin
Daniela Busse, Anna Christina Sondersorg, Hanns Hatt, Heike Benecke Department of Cell 
Physiology, Ruhr-University, Bochum, Germany
In its essential role as a protective barrier the skin is exposed to multiple environmental factors. 
Keratinocytes, the major cell type of the epidermal layer of the skin, express a variety of different 
sensory receptors that enable them to react to various thermal, mechanical and chemical stimuli 
and thus contribute to information processing in the skin. This study is dedicated to unravel the 
molecular and cellular mechanisms underlying chemoperception in the human skin. For this 
purpose, physiological effects of chemical odorant exposure were analyzed in cultured primary 
human keratinocytes using the calcium imaging technique. Several “allergenic” fragrances and 
synthetic sandalwood odorants have been identified that induce transient calcium signals when 
applied to human skin cells. Additionally, pharmacological characterization of the odorant-
induced calcium elevations revealed a stimulus-dependent involvement of a cAMP or IP3 signaling 
pathway. Moreover, the effects of long term stimulation were analyzed concerning cell viability 
and keratinocyte proliferation. Furthermore, PCR expression analysis identified several G-protein-
coupled chemoreceptors which might contribute to chemical perception of keratinocytes. 
Detailed investigation on the ability of keratinocytes to detect and convey chemical stimuli is 
important to understand how environmental influences are communicated within the skin.
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Monosodium urate crystals induce functional expression of P2Y14 receptor coupling to IL-8/
CXCL8 production in human keratinocytes
Hideya Uratsuji, Yayoi Tada, Masahiro Kamata, Tomohiko Kawashima, Carren Hau, Yoshihide 
Asano, Makoto Sugaya, Takafumi Kadono, Shinichi Sato, Kunihiko Tamaki University of Tokyo, 
Tokyo, Japan
Human skin provides essential protection from injury and infection. Recent studies reinforce the 
importance of keratinocytes as sensors of danger signals. Uric acid is released from injured or 
infected cells, and can nucleate and form monosodium urate (MSU) crystals. These MSU crystals 
can act as danger signals, which activate the immune system. We previously reported that MSU 
crystals could induce various inflammatory mediators from human keratinocytes through the 
activation of P2Y6 receptor (P2Y6R). Uridine diphosphate (UDP) is reported to be the endogenous 
agonist for P2Y6R. Recently, P2Y14 receptor (P2Y14R), which is coupled with Gi/o protein, is 
also shown to be activated by UDP as well as UDP-glucose. Therefore, we examined whether 
P2Y14R is involved in MSU-induced inflammatory reaction in keratinocytes as well as P2Y6R. 
We found that MSU crystals markedly induced P2Y14R expression in normal human epidermal 
keratinocytes (NHK). Furthermore, IL-8/CXCL8 production from MSU-stimulated NHK was 
significantly up-regulated by UDP-glucose, a selective P2Y14R agonist, whereas UDP-glucose 
had no effect on non-stimulated NHK. In addition, MSU-induced IL-8/CXCL8 production was 
significantly reduced by pertussis toxin (PTX), Gi/o protein blocker. Our results indicated that 
MSU crystals induced functional P2Y14R expression, through which UDP-glucose stimulated 
NHK to produce IL-8/CXCL8. Our results might provide new insight into the molecular processes 
underlying skin inflammation by injury and infection.
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Development of an in vitro dry skin model and its characterization
Mariko Yokota1, Daiki Kyotani1, Jinhua Li1, Hitoshi Masaki2 1NIKKOL group, COSMOS Technical 
Center Co., Ltd., Tokyo, Japan, 2Tokyo University of Technology, School of Bioscience and Biology, 
Tokyo, Japan
Epidermal barrier function plays an important role in preventing water loss from the skin. It is 
considered that the dysfunction on skin barrier caused by UV irradiation, dryness, and stress, 
leads to formation of dry skin. Evaluation techniques such as removal of the stratum corneum (SC) 
by tape stripping and extracting epidermal lipids with organic solvents have been accepted in a 
human volunteer test or an animal test to assess the barrier function. However, these are facing a 
difficulty from the aspects of ethics and animal protection. In this study, we evaluated responses 
of a reconstructed epidermal equivalent (REE) cultivated under a dry condition to establish an 
in vitro model for assessing skin barrier function. A dry condition was prepared by loading 
a calcium chloride-filled chamber on a REE. In characterization of the model, we measured 
following parameters; IL-1α, mitochondrial activity and ceramides. Because it has been reported 
that IL-1ra/IL-1α ratio was increased in the SC from dry skin. After 7 days cultivation under the 
dry condition, IL-1α secretion increased significantly within 24 hours. This is well accorded with 
previous reports. Furthermore, dry condition was reduced amounts of ceramides, but enhanced 
mitochondrial activity. In conclusion, the results indicated that dry condition achieved the 
situation like a dry skin by induction of IL-1α secretion, and affected epidermal lipid metabolism. 
The in vitro dry model is expected as a useful tool to evaluate substance/system on effecting 
epidermal barrier function.
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Filaggrin-2 B-type repeats exhibit different antimicrobial activity
Anne-Kathrin Junge, Ties Latendorf, Britta Hansmann, Jens-Michael Schröder Department of 
Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany
Filaggrin-2 (FLG2) has been shown to be expressed in the upper layers of skin, mainly the stratum 
granulosum and the stratum corneum. This Protein shows the typical S100 fused type protein 
structure with the N-terminal S100- and EF hand domains followed by a spacer region, two 
types of repeats, and the C-terminal region. The two types of repeats resemble on one hand 
the hornerin-like so-called A-repeats and on the other hand the filaggrin-like B-repeats, both 
about 75 amino acids long, but of different composition. The B-repeats share 58-80% sequence 
similarity among themselves. Previous studies revealed antimicrobial activities in repeats of 
hornerin. We therefore hypothesized that also filaggrin-2 repeats could be antimicrobially active. 
Defined filaggrin-2-B-repeats (such as B1, B13, and B14) were recombinantly expressed as 
fusion proteins. After cleavage of the fusion-tag and HPLC-purification the purified repeats were 
investigated for putative antimicrobial activities. The investigated repeats were chosen because 
of their amino acid sequence und composition in comparison to the other B-repeats. Neither 
the repeat B13 nor B14 exhibited antimicrobial activity against S. aureus, E. coli, P. aeruginosa, 
and C. albicans, whereas repeat B1 showed killing activity against E. coli, P. aeruginosa, and C. 
albicans in a radial diffusion antimicrobial assay system. Our findings indicate that filaggrin-2-
repeat domain B1 may contribute to innate defense of human skin.
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Notch-1 and Notch-2 modulate keratinocyte stem cell viability and differentiation during skin 
ageing and UVB exposure
Elisabetta Palazzo1, Alessandra Marconi1, Marc Dumas2, Sylvianne Schnebert2, Katiuscia 
Dallaglio1, Francesca Truzzi1, Roberta Lotti1, Tiziana Petrachi1, Carlo Pincelli1 1University of 
Modena and Reggio Emilia, Modena, Italy, 2LVMH Recherche, Saint Jean de Braye, France
Notch are a family of surface receptors implicated in maintaining epidermal homeostasis. In 
the epidermis, CK15 and CK10 expression does not change with age, while there is a reduction 
in Ki67-positive cells and an increased involucrin expression. In culture, keratinocytes display 
reduced proliferation and a lower colony forming efficiency, as a function of age. Transit 
amplifying cells appear more affected than stem keratinocytes by ageing. In epidermal sections, 
Notch-1 expression shows a reduction with age, while Notch-2 is located in the upper layers in 
Y (under 20-years), in all layers in A (between 20 and 60-years), and predominantly in the basal 
layer in O (over 60-years). In cultures, Notch-1 activation decreases with age, while Notch-2 
seems to be more activated in Y cells than in A and O cells. Notch-1 and Notch-2 are mainly 
expressed in the cytoplasm of TA cells, Notch-1 being present also in the nucleus. Notch protein 
inhibition reduces keratinocyte stem cell viability, possibly through survivin downregulation. 
Inhibiting Notch-1 also induces G1 arrest in keratinocytes at all ages. Notch proteins are activated 
by calcium, while Notch-1 activation decreases in more differentiated keratinocytes. On the 
other hand, Notch-2 is activated at cell confluence, in all age groups. Furthermore, Notch-1 
is up-regulated upon UVB irradiation (75 mJ/cm2) in Y keratinocytes and is re-activated in O 
keratinocytes after UVB (5 mJ/cm2). Taken together, these data confirm the role of Notch proteins 
within epidermal niche and their possible involvement in the mechanisms of photoaging.
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Influence of rhamnose on epidermal regeneration: Interest of glycobiology in skin aging.
Julien Laboureau1, Jean-François Michelet2, Gabrielle Sore1, Agnes Thomas-Collignon2, Carine 
Ballihaut1, Dominique Bernard2, Jean-Thierry Simonnet1, Bruno A. Bernard2 1L’Oreal Research 
and Innovation, Chevilly, France, 2L’Oreal Research and Innovation, Clichy, France
Recent works conducted by L’Oreal research demonstrated that rhamnose may modulate skin 
physiology specifically by stimulating papillary fibroblasts. In response to rhamnose treatment, a 
reorganization of superficial dermis, dermal epidermal junction as well as epidermis thickening 
was observed. Although the primary target of rhamnose appeared to be fibroblasts, one could not 
exclude that keratinocytes could also be a cell target of this compound. By using two different 
approaches (rhamnose conjugated FITC albumin and rhamnose conjugated streptavidine), we 
have shown that rhamnose can bind to suprabasal epidermal keratinocytes. We also demonstrate 
that the expression of this putative receptor is not modified during skin aging, suggesting 
that rhamnose is able to regulate skin whatever the age population. In parallel, our results 
demonstrated that rhamnose modulates the proliferation and metabolism of keratinocytes in 
2D-culture without affecting their differentiation. Besides, in a 3D-reconstructed skin model 
RealskinTM, we demonstrated that rhamnose treatment induces epidermal thickening.
336
Insights into skin glycobiology and its age-related modifications: a pilot study
Bruno A. Bernard1, Agnès Thomas-Collignon1, Dominique Bernard1, Man Pham2, Lan NGuyen2, 
Julien Laboureau2 1L’Oreal Research and Innovation, Clichy, France, 2L’Oreal Research and 
Innovation, Chevilly Larue, France
The aim of the present study was to study skin glycobiology since glycans and glycoconjugates 
cover a very important area of science Free mannose, galactose, glucose, N-acetyl-glucosamine, 
and N-acetyl-galactosamine were assayed in stratum corneum, as a function of age (30, 50, 
60 year old volunteers). A strong decrease was noticed from the age of 50 for all of them, and 
glucose remained at a higher level than the others. Glycans being involved in many biological 
mechanisms they could be biomarkers to study typologies. With respect to complex type 
carbohydrates, the binding patterns of a set of fluorescent-conjugated lectins (specific for 
different carbohydrate structures) demonstrated that skin compartmentalization and epidermal 
differentiation were accompanied by modifications of cell surface carbohydrate moieties. By 
studying lectin binding to skin samples from 18, 21, 23, 56, 63 and 68 year old volunteers, 
either no modification or a decrease was observed, starting from the 56 year old sample. 
This decrease was restricted to the epidermal compartment. By using a set of carbohydrate-
conjugated fluorescent-albumins, cellular lectin expression was also evidenced throughout 
epidermis, specific for fucose, mannose, N-acetyl-galactosamine and rhamnose. Only rhamnose 
binding did not decrease with age. Altogether, these results underline that glycobiology plays a 
major role in skin physiology. Although the results must be confirmed in a larger cohort, they 
suggest that i) overall age-related skin modifications could be related to modifications of cell 
surface carbohydrates, carbohydrate-binding activities and carbohydrate metabolism and ii) 
glycobiology could pave the way to new treatments of skin aging.
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Effect of different glycoconjugates on the maturation of cornified envelope; a glycobiological 
pathway to recover good facial barrier function, transparent look and skin surface elastic 
properties
Anne Potter1, Carine Baltenneck1, Sophie Vicic1, Gustavo S. Luengo1, Sophie Pavan2, Jean-Luc 
Loubet2 1L’Oreal Research and Innovaton, Aulnay-Sous-Bois, France, 2Ecole Centrale de Lyon, 
Ecully, France
The cornified envelope (CE) is an essential component of corneocytes. It is well known that genetic 
inheritance interfere with the process of CE formation and lead to impairment of the barrier function 
of the stratum corneum (SC). In healthy individuals, especially on the facial regions, immature 
and fragile CE are more frequently found at the SC outermost layer. Reconstructed epidermal 
skin (Episkin Ô) has been used to evaluate the impact of different types of glycoconjugates on CE 
maturation, such as C-xyloside, carraghenan and other sulfated polysaccharides extracted from 
algae. It has been demonstrated that these molecules induce an increase of mature CE. Besides, 
we have demonstrated that the mix «C-xyloside + rhamnose + carraghenane» treatment induces 
epidermal thickening. The morphological and mechanical properties of the corneocytes having 
a rigid CE have been studied and compared with corneocytes with fragile CE. Corneocytes 
with rigid and fragile envelope have been characterized using Atomic force Microscopy (AFM). 
Morphological images were obtained. Nanoindentation tests were also performed with an 
Nanoindentor XP to assess the corneocyte viscoelastoplastic properties at 70%HR rate. The results 
show that CE maturation induces a modification of the biophysical properties of corneocytes: better 
elastic properties and lower roughness. Altogether, our results demonstrate that mix of carefully 
chosen glycocongugates promotes SC differentiation and maturation of the CE, as well as an 
epidermal thickening. More generally, topical use of sulfated polysaccharides should be beneficial 
to the barrier function of facial skin, but also to the visual and sensorial appearance of the skin.
338
Heterogeneity of the psoriatic lesion evaluated by in vivo reflectance confocal microscopy
E.A. Wolberink, M.L. van der Werf, P.E.J. van Erp, P.C.M. van de Kerkhof, M.J.P. Gerritsen 
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
In vivo Reflectance Confocal Microscopy (RCM) is a novel non-invasive imaging technique 
to evaluate skin and other superficial tissues in vivo. RCM offers new opportunities to record 
dynamic events or evaluate tissue an unlimited number of times, without the inherent tissue 
distortion due to biopsies. Psoriasis is a chronic, inflammatory disease of the skin, which affects 
2% of the Western population. Psoriasis is known to be a heterogeneous disease in expression of 
clinical and histological characteristic features, like Munro microabscesses and a high capillary 
flow. Previous histological investigations are not uniform in describing the distribution of 
histological features across psoriatic lesions, particularly between margin and centre of the lesion. 
Therefore we performed a study to evaluate non-invasively the distribution of eleven well 
known histological features , using in vivo reflectance confocal microscopy (RCM). We 
included five patients, and selected two psoriatic lesions in each patient. We evaluated four 
locations in each lesion (2 margin, 2 centre), so in total 40 locations were imaged. Presence 
of histological features in margin and centre in one plaque, between two plaques in one 
patient (intraindividually) and between patients (interindividually) were statistically analyzed. 
Classic features could be evaluated, such as presence of Munro microabscesses, number of 
dermal papillae, parakeratosis, epidermal inflammatory cells, absence of stratum granulosum 
and number of capillaries. All evaluated histological features showed a high heterogeneity, but 
were distributed equally in the psoriatic lesion. There was no difference between the margin and 
centre of the plaque, or in their distribution intraindividually and interindivually.
339
In vivo maturation of filaggrin-2 by calpain 1 in mice
Valérie Pendaries1,3, Chiung-Yueh Hsu1,3, Julie Henry1,3, Dany Nassar4, Britta Hansmann5, Guy 
Serre1,3, Michel Simon1,2 1CNRS UMR5165, Toulouse, France, 2INSERM U1056, Toulouse, France, 
3University of Toulouse, Toulouse, France, 4INSERM U938, Paris, France, 5University-Hospital 
Schleswig-Holstein, Kiel, Germany
Filaggrin-2 and filaggrin share a related structural organization, an identical pattern of expression 
and localization in the epidermis, and a similar proteolytic processing from a large precursor. 
Calpain 1, a protease directly involved in the catabolism of (pro)filaggrin, processed human 
filaggrin-2 in vitro. Here, we tested for its involvement in vivo. First, calpain 1 and filaggrin-2 were 
shown to co-localize in the granular keratinocytes and lower corneocytes of human skin. Then, 
the expression of filaggrin-2 was analyzed by indirect immunofluorescence and immunoblotting 
in the skin of wild type and transgenic mice overexpressing calpastatin, an inhibitor of calpain 
1. We used an antibody specific for the amino-terminus of the protein. It produced the same 
pattern of labeling on the wild type and transgenic mouse skin. Only the granular keratinocytes 
and lower corneocytes were stained. However, the intensity of labeling was significantly higher 
on the epidermis of the transgenic animals. The full size filaggrin-2 (>250 kDa), a processed 
form of 200 kDa and a fragment of ~55 kDa were detected in epidermal protein extracts of both 
wild type and transgenic mice. However, in the extracts of transgenic animals the intensity of 
detection of the two larger bands was higher, whereas that of the 55 kDa band was lower. These 
data demonstrate a reduced processing of filaggrin-2 and an accumulation of its precursor form 
in the epidermis of the calpastatin overexpressing mice. Altogether, they showed that calpain 1 is 
essential for the proteolytic processing of mouse and probably human filaggrin-2 in vivo.
340
The consequences of keratin gene mutations in epidermolysis bullosa simplex (EBS) 
keratinocytes grown in culture are influenced by growth conditions
Tina Zupancic1, Hans Törma2, E. Birgitte Lane3, Mirjana Liovic1,4 1National Institute of Chemistry, 
Ljubljana, Slovenia, 2Department of Medical Sciences, Dermatology and Venereology, Uppsala 
University, Uppsala, Sweden, 3Institute of Medical Biology, Immunos, Singapore, 4Medical Center 
for Molecular Biology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Our goal was to investigate how cell culture conditions may affect the results obtained in some 
of the most often used cell assays. As our research interests regard the molecular consequences 
of keratin gene mutations, we performed these tests on 2 normal and 4 severe KRT5 and KRT14 
mutant keratinocytes. The assays were: 1) cell proliferation, using automated cell counting; 2) 
cell metabolic activity (viability), done using WST-1 reagent as substrate; 3) migration (invasion) 
assays done on transwell inserts. Cells’ density at seeding, number of days in culture and type 
of culture medium used (with or without serum) were varied, as well as pore size in case of 
migration assays. The type of culture medium significantly affected metabolic activity, however 
this was not entirely proportionate to the proliferation rate. Cells grown in serum free medium 
proliferated equally well after 7 days in culture, but a “lag time” was observed in the achievement 
of the exponential growth phase. The viability of cells depended also from the number of cells 
seeded and consequently the number of days in culture. As the viability assay tests the activity of 
mitochondrial dehydrogenases, not only the abundance of nutrients but also Ca2+ concentration 
in medium may play a role. Calcium is known to regulate the activity of respiratory chain 
enzymes, thus directly affecting ATP production. Therefore, the conditions used for culturing 
cell line model systems alone may influence the end result, so these must be given very careful 
consideration in any experimental design.
341
Transglutamination of SPINK6: cross-linked regulation of protease activity in the epidermis
Jan Fischer, Ties Latendorf, Ulf Meyer-Hoffert University Hospital Schleswig-Holstein, Campus 
Kiel, Kiel, Germany
Kallikrein-related peptidases (KLKs) are a group of serine proteases, expressed in several tissues. In 
the human epidermis some KLKs are localized in the stratum granulosum and stratum corneum, 
where they control the desquamation process. Their activity is controlled by Kazal-type inhibitors 
of the SPINK-family. Recently, we identified SPINK6 as a potent epidermal inhibitor of distinct 
KLKs members. Trangslutaminases (TGases)1,3 and 5 are mostly expressed in the upper layers 
of the epidermis and are responsible for the cross-linking formation of the cornified envelope 
in calcium depend manner during keratinocyte differentiation. In this study we investigated if 
SPINK6 is a substrate for transglutaminases. As demonstrated by western blot analyses SPINK6 
is a substrate of crosslinking by TGase 1 and 3 with itself. Incubation of recombinant SPINK6 
and TGase 1 and 3 together with epidermis extracts resulted in diverse higher molecular bands 
in western blot experiments indicating different substrate specificities of TGases with SPINK6. A 
similar pattern of immunobands was observed in extracts of differentiated primary keratinocytes 
without TGase treatment. These signals were enhanced by preincubating recombinant SPINK6 
with primary keratinocytes. Trypsin-like proteolytic activity was significantly decreased in 
differentiated cells, which were first treated with SPINK6 suggesting proteolytic inhibition of 
transglutaminated SPINK6. In summary, we identified SPINK6 as a substrate for TGase 1 and 3. 
Ongoing experiments are on their way to test the inhibitory activity of transglutaminated SPINK6 
and to find interaction partners for transglutamination.
342
The aryl hydrocarbon receptor is active in normal epidermal keratinocytes and is involved in the 
regulation of AREG and epidermal differentiation genes
Douglas Robertson, Lynda Weir, Andrey Panteleyev University of Dundee, Dundee, UK
Previously we demonstrated that the aryl hydrocarbon receptor nuclear translocator (ARNT - 
a key factor in hypoxia and toxic responses) regulates expression of differentiation-associated 
genes in part through stimulation of amphiregulin (AREG) - a key EGFR ligand. Here we examine 
the possible implication of the aryl hydrocarbon receptor (AhR - an ARNT dimerization partner) 
in this pathway. 3D epidermal equivalents developed using N-TERT keratinocytes show nuclear 
AhR staining in the basal and immediate suprabasal layers suggesting activity, as AhR is inactive 
when cytoplasmic. qPCR analysis of keratinocytes treated with 10µM geldanamycin (GA - a 
potent AhR inhibitor) reveals decreased expression of CYP1A1, a direct target of AhR/ARNT 
suggesting that AhR (and presumably AhR/ARNT heterodimer) is active in normal keratinocytes 
in the absence of an external ligand like dioxin. N-TERTs treated with GA upregulate filaggrin and 
loricrin - similarly to that observed in ARNT-depleted cells suggesting the role of the AhR/ARNT 
heterodimer in their control. Additionally, we find that AREG mRNA expression is inhibited by 
GA and that increased AREG expression observed in ARNT over-expressing cells can be reversed 
by GA treatment. However, we find no evidence for direct interaction of ARNT with the AREG 
promoter through both analysis of predicted binding sites and functional ChIP assay suggesting 
an indirect link (perhaps through HDAC activity) between AhR/ARNT and AREG transcription. 
These results support a role for the AhR/ARNT transcription factor in normal epidermis that goes 
beyond responding to environmental challenges and suggests its important role in normal skin 
functions.
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Enhanced expression of involucrin and suppressed expression of keratin-10 in keratinocytes 
indicate response to challenging conditions
Frédéric Minner, Daniel Van Vlaender, Michel Hérin, Yves Poumay University of Namur 
(FUNDP), Namur, Belgium
Monitoring normal or abnormal epidermal differentiation in keratinocytes is performed by gene 
expression analysis of typical markers. Markers correspond to epidermal components involved 
during alterations of keratinocyte phenotype that happen when basal cells stop proliferating 
and move upward in the tissue while preparing to become cornified dead cells. Depending on 
histological localization of their expression in normal skin, epidermal markers such as keratin-14, 
keratin-10, involucrin, transglutaminase-1, or miR-203 are considered early or late indicators 
of differentiation. Several skin disorders, like psoriasis or atopic dermatitis, illustrate abnormal 
expression of markers, certain genes being expressed earlier than usual and others exhibiting 
suppressed expression. To investigate keratinocyte phenotype in vitro, we compared the expression 
of a set of genes in two models: serum-free autocrine cultures where differentiation is induced at 
confluence of the monolayer, and during the reconstruction of the epidermis on porous support 
at air-liquid interface. Data reveal an opposite regulation of involucrin and keratin-10 expression 
following challenging conditions such as oxidative stress, cholesterol depletion, miltefosine 
treatment and tissue reconstruction. Comparison of gene expression suggests that involucrin and 
transglutaminase-1 can be expressed in circumstances which do not correspond to the expression 
of other differentiation markers like keratin-10, filaggrin or loricrin. Rather, their expression 
correlates with markers of pathological response, mostly inflammation. In consequence, monitoring 
epidermal phenotype, especially when keratinocytes have been exposed to challenging situations, 
requires that the expression of several differentiation markers with different characteristics be 
analyzed simultaneously in order to get a more complete understanding of keratinocyte behaviour.
344
Thyroid hormones regulate key parameters of mitochondrial biology and heat production in 
human skin epithelium in situ and may exert anti-aging effects
Silvia Vidali1, Jana Knuever1, Johannes Lerchner2, Balázs István Toth3, Tamas Biró3, Ralf Paus1,4 
1Department of Dermatology, University of Luebeck, Luebeck, Germany, 2Institute of Physical 
Chemistry TU Bergakademie, Freiberg, Germany, 3University of Debrecen, Debrecen, Hungary, 
4School of Translational Medicine, University of Manchester, Manchester, UK
Thyroid hormones, as triiodothyronine (T3) and thyroxine (T4), are potent regulators of 
mitochondrial biology in a wide variety of organs. Here we have investigated whether thyroid 
hormones have an effect on mitochondrial biology in human skin and/or its appendages. We 
found that treatment of organ-cultured human skin and hair follicles (HFs) with T3 (100pM) or T4 
(100nM) up-regulates cytochrome C oxidase I (COX1) and mitochondrial transcription factor A 
(TFAM) on both the gene and protein level. Moreover, T3 enhanced HSP60, PGC1alpha and BMAL 
transcription. Increased heat production (calorimetry)and mitochondrial chain complex I activity 
(NBT assay) confirmed that T3 significantly increased mitochondrial energy metabolism in HFs 
and epidermis. Given that mitochondrial stimulation can result in both, beneficial (e.g. increased 
energy supply, anti-aging or growth promotion) and undesirable effects (e.g. increased DNA 
damage by enhanced ROS production, leading to premature tissue ageing), we also investigated 
standard ageing markers that are up-regulated in senescent cells and skin. Interestingly, this 
showed that treating organ-cultured human skin with T3 and T4 significantly decreased the 
intraepidermal immunoreactivity for both beta-galactosidase and MMP1 compared to controls. 
These findings show that T3 and T4 not only are novel endocrine stimulators of mitochondrial 
activity and biogenesis in human skin epithelium in situ, but also demonstrate that intracutaneous 
heat production and epidermal aging are regulated by thyroid hormones.
345
Protective effects of a Kampo prescription, hochuekkito, against ultraviolet B-induced oxidative 
stress in hairless mice skin
Hiromi Kobayashi, Shigeto Yanagihara, Hisashi Tamiya, Daisuke Tsuruta, Takeshi Nakanishi, 
Nobuyuki Mizuno, Keiichi Hiramoto, Yuri Okano, Masamitsu Ishii Osaka City University 
Graduate School of Medicine, Osaka, Japan
We have tried to utilize Kampo, Japanese traditional medicine in order to treat intractable 
atopic dermatitis (AD). Hochuekkito is one of Kampo prescriptions composed of 10 herbs: 
Astragalus Root, Ginseng Root, Glycyrrhiza Root, Astractylodes Rhizome, Japanese Angelica 
Root, Bupleurum Root, Jujube Fruit, Citrus Unshiu Peel, Cimicifuga Rhizome, and Ginger 
Rhizome. Its effect on AD was demonstrated in a double-blind randomized placebo-controlled 
study. To clarify the mechanism of actions of hochuekkito, we examined its protective ability 
against oxidative stress using a murine model. We irradiated 70 mJ/cm2 of ultraviolet B (UVB) 
single time to the back of the 8-week-old male HR-1 hairless mice which had been raised on 
hochuekkito (0, 2, and 10 %)-mixed diet. After 4 days, we measured transepidermal water loss 
(TEWL), water content of stratum corneum (WCSC), and catalase activity in the tape stripped SC. 
After exposure to UVB, TEWL was increased significantly, and both WCSC and catalase activity 
were significantly decreased. Hochuekkito improved deterioration of skin function and catalase 
activity caused by irradiation of UVB dose-dependently. These results indicate that hochuekkito 
acts as an antioxidant, which may be related to its protective effect against UVB-induced 
skin damage. We hypothesize that hochuekkito affects epidermal stem cells to enhance their 
antioxidant defense capacity.
346
Potential role of thrombospondin-1 in epidermal atrophy in Kindler syndrome skin
Rumena Begum, Joey Lai-Cheong, Maddy Parsons, John McGrath King’s College London, 
London, UK
Kindler syndrome (KS) (OMIM 173650) is an autosomal recessive genodermatosis resulting from 
pathogenic mutations in the FERMT1 gene. This gene encodes kindlin-1, a focal adhesion protein 
involved in integrin activation and most cases of KS show a marked reduction or complete absence 
of the kindlin-1 protein. Kindlin-1 contains a PH (pleckstrin homology) domain sandwiched 
between a bipartite FERM (Four point one protein, Ezrin, Radixin and Moesin) domain. Currently, 
little is known about the functional consequences of FERMT1 mutations on focal adhesion 
biology although clinically there is transient skin blistering and persistent poikiloderma with 
prominent skin atrophy. To investigate the skin biology further, protein lysates were prepared 
from KS (n=1; FERMT1 mutations p.Leu302X/p.Glu304X) and normal human keratinocytes 
(n=1). The protein bands were assessed by silver staining and differentially expressed proteins 
were then subjected to mass spectrometry analysis. The following targets were downregulated in 
KS keratinocytes: β1 integrin subunit, filamin A and B, plectin, diaphanous 1, thrombospondin-1 
(TSP-1), Rho-associated protein kinase 2 and zona occludens-2. Verification of the differential 
expression of these proteins was pursued by immunoblotting and confocal microscopy in 
other KS cell lines. Immunblotting showed a significant reduction in TSP-1 in two KS cell lines. 
TSP-1 is an adhesive glycoprotein that binds to several basement membrane and extracellular 
matrix proteins, including avb1 integrin; it is also a natural inhibitor of neovascularisation and 
contributes to photo-ageing. Thus, reduced expression of TSP-1 may offer some insight into the 
pathophysiology of KS, notably the clinical features of telangiectasia and skin atrophy.
347
Do Changes in Nuclear Architecture Elements Correlate with Skin Aging?
Elena Fedorova, Jin Namkoong, Christelle Lasserre Chanel, Inc., Piscataway, NJ, USA
Tensegrity plays a key role in control of cell function at the molecular and cellular levels. Nuclear 
lamina is a meshwork of filaments under the nuclear membrane that provides structural support 
to the nucleus. Lamin A defines lamina structure and is involved in maintaining nuclei physical 
integrity, chromatin organization, replication, transcription, and gene expression regulation. 
Precursors of lamin A are encoded by LMNA gene and undergo a posttranslational modifications 
including farnesylation by farnesyltransferase and cleavage by endoprotease FACE1 to generate 
mature lamin A. FNTA gene encodes alpha subunit of farnesyltransferase. Mutations in LMNA, 
FACE1, and FNTA genes may lead to laminopathies and premature-aging syndromes. Normal 
aging has been associated with reduced expression and altered distribution of lamin A in 
cardiomyocytes as well as accumulation of defects similar to those of premature-aging syndrome 
cells in fibroblasts. The aim of our study was to analyze expression of lamin A and proteins involved 
in its maturation in human keratinocytes, their modulation with age and active ingredients. We 
analyzed LMNA, FNTA, and FACE1 expression in cultured epidermal keratinocytes, skin samples, 
and skin equivalents by PCR, immunohistochemistry and/or immunofluorescence. Our results 
show that LMNA, FNTA, and FACE1 mRNA are expressed in epidermal keratinocytes. The results 
are confirmed at the protein level. Expressions of LMNA and FNTA proteins were shown to 
diminish with age. We also found stimulators of LMNA expression in cultured keratinocytes. The 
modulation of expression and modification of nuclear lamina protein LMNA may represent a 
promising approach for evaluating and preventing skin aging.
348
Human Epidermal “Glycogenes”: Additional Markers of Photoaging
Elena Fedorova, Jin Namkoong, Alexandra D’Arcangelis, Christelle Lasserre Chanel, Inc., 
Piscataway, NJ, USA
Glycosylation produces abundant, diverse, and highly regulated repertoire of cellular 
glycoproteins that are involved in cellular communication and interaction with the surrounding 
ECM and the environment. “Glycogenes” encode enzymes responsible for glycosylation: 
glycosyltransferases, sulfotransferases, and sugar-nucleotide transporters. Environmental stress, 
including UV radiation, contribute to changes in physiological and mechanical properties of 
skin, giving skin a photoaged appearance. Evaluating expression of glycogenes which are key 
players in the formation of UV-induced changes is essential for understanding skin photoaging. 
The aim of our study was to evaluate the gene expression profile of glycogenes following 
exposure of human epidermal keratinocytes to UVB irradiation and to identify those genes most 
sensitive to the environmental stress. We used whole human genome microarrays to examine 
how keratinocyte-specific glycogenes are regulated by exposure to non-cytotoxic doses of UVB. 
We found that UVB irradiation modified expression of 12% glycogenes, of which 34% were 
upregulated and 66% were downregulated. UVB elicited changes in glycogenes involved in 
biosynthesis of glycosphingolipids, dystroglycan, heparan sulfate, chondroitin sulfate and 
other cellular processes. Glycogenes LARGE, HS6ST2, and ST8SIA1 were among genes mostly 
differentially regulated by UVB irradiation. The microarray results were confirmed by qPCR. 
These data allow important insights into the different mechanisms of skin photoaging, provide 
rich database resource of UVB-responsive glycogenes, and identify potential new molecular 
targets for antiaging application.
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Anti-aging skin benefits by modulating stemness potential
Audrey Amoyel1, Sandrine Pinacolo1, Magali Bonnans1, Gregory Bressier1, Florian Labarrade1, 
Katell Vie3, Anne Sophie Delassus3, Richard Fitoussi3, Rachel Chabert1, Noelle Garcia1, Isabelle 
Imbert1, Jean Marie Botto1, Claude Dal Farra2, Eric Gooris3, Nouha Domloge1 1Vincience, ISP 
Global Skin Research Center, Sophia-Antipolis, France, 2ISP Corporate Research Center, Wayne, 
NJ, USA, 3Laboratoires CLARINS, Pontoise, France
The epidermis needs to continuously generate new cells through proliferation of progenitor cells and 
subsequent differentiation. This renewal is permitted by somatic stem cells mainly found in the basal 
layer of the epidermis (SSCEs). Under certain stimuli, SSCEs are able to migrate towards interfollicular 
epidermal regions to replenish the tissue and compensate for the loss of terminally differentiated cells. 
Maintenance, proliferation or differentiation of SSCEs is tightly modulated by intrinsic versus extrinsic 
(microenvironmental) regulators. Among these intrinsic regulators, Survivin is a major player in the 
correct development of cellular mitosis and p63 modulates skin development and skin functions. 
Among the extrinsic regulators, K15, α6 integrin and β1 integrin have a main role in maintaining 
a special microenvironment allowing adhesion to the extra-cellular matrix. It is established that 
homeostasis of the SSCEs request both a correct mitosis supervision, as well as a correct cellular 
and extracellular environment. The objective of this study was to evaluate the skin benefits of an 
innovative cream formula (IVC011) containing a newly developed compound targeting SSCEs. The 
study was performed on normal human skin biopsies obtained from plastic surgery (mature donors 
were selected for this study). The anti-aging skin benefits of IVC011 were evaluated in two different 
models, a model of in vitro-aged human skin to mimic the effects of intrinsic aging and a model 
of extrinsic aging by UVB irradiation at 200mJ/cm². Results demonstrated the ability of IVC011 to 
positively modulate intrinsic and extrinsic regulators, essential for SSCEs maintenance and protection.
350
siRNA-induced senescence as a tool to study aging in fibroblast and skin
Alexia Lebleu1, Gopinathan Menon2, Aurelie Fuet1, Jean Marie Botto1, Claude Dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, Sophia-Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ, USA
FOXO3a (Forkhead Box O3a) is a member of the “O” subclass of the Forkhead family of 
transcription factors, characterized by an evolutionarily conserved DNA-binding domain: the 
Forkhead box or FOX. FOXO3a transcription factor is mainly regulated by the insulin/insulin-like 
growth factor-1/phosphatidylinositol-3 kinase/Akt signaling pathway, which has been conserved 
throughout evolution and which is involved in the aging and lifespan control of many organisms 
and mammals. FOXO3a regulates genes implicated in cell cycle arrest, apoptosis and response to 
cellular stress. In normal human skin, FOXO3a plays an important role in the control of cell aging.
In the present work, we developed a new approach to evaluate anti-aging activity of compounds 
by using a FOXO3a-specific siRNA in dermal fibroblasts. To help us in our investigations, we 
studied the ability of a specific compound (IV10.005) to modulate FOXO3a-induced senescent 
phenotype by the subsequent detection of senescence-associated β-galactosidase (SA-β-Gal) 
activity (or the GLB1 corresponding protein) and by immunocytological approaches targeting 
vimentin aggregation / accumulation. IV10.005 was developed for its anti-aging activity and its 
ability to modulate the expression level of some Extra Cellular Matrix (ECM) components which 
are altered with increasing age (collagen I, hyaluronic acid...). In conclusion, we confirmed the 
effectiveness of using a FOXO3a-specific siRNA approach as a method to screen compounds 
capable of reducing senescence in human fibroblasts.
351
Protection of telomere integrity by telomere-binding proteins contributes to modulate 
senescence and protect skin from double-strands DNA breaks
Laurine Bergeron1, Catherine Serre1, Catherine Gondran1, Jean Marie Botto1, Claude Dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, Sophia-Antipolis, France, 2ISP 
Corporate Research Center,, Wayne, NJ, USA
Telomeres are functional complexes at chromosomal termini consisting of repetitive DNA and 
associated proteins such as TRF2 and POT1 that form the Shelterin complex. Excessive telomere 
shortening and telomere uncapping trigger a DNA-damage response at chromosome ends, which 
are recognized as double-strand DNA breaks (DSBs)In order to study the role of telomere-binding 
proteins in the maintenance of telomere integrity during skin aging, we investigated the effect 
of IV10.008, a compound able to modulate TRF2 expression. Immunofluorescent detection of 
Vimentin in fibroblasts submitted to replicative senescence with a daily treatment of IV10.008 
and/or with methylglyoxal (MGO) was performedWe compared senescence markers in treated 
and untreated cells to evidence the anti-aging properties of the compound. Moreover, p53 protein 
level was studied after the downregulation of TRF2 expression to confirm the role of telomere 
maintenance in aging. Moreover, Ku70/Ku80 complex may also play a role in the preservation 
and the maintenance of chromosome ends. Indeed, as this complex is required for DSB repair by 
non homologous end-joining pathway, we investigated the recruitment of this heterodimer after 
DNA damage. In the same way, the study of histone H2AX, which is rapidly phosphorylated in 
the chromatin micro-environment surrounding DSBs, was performed on pretreated irradiated 
cells.In conclusion, mechanisms underlying telomere protection and DNA repair systems are 
interrelated. There is strong evidence that preventing the loss of Shelterin components and 
protecting chromosome integrity contribute to slow down aging by preventing AGE formation 
and double-stranded DNA breaks.
352
Expression of Cathelicidin and β-defensins antimicrobial peptides in keratinocytes and in 
human skin
Ludivine Mur1, Christelle Plaza1, Gopinathan Menon2, Jean Marie Botto1, Claude Dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center,, Sophia-Antipolis, France, 2ISP 
Corporate Research Center,, Wayne, NJ, USA
To protect the organism against bacteria, fungi and viral pathogens, keratinocytes are capable of 
constitutively synthesizing a wide variety of gene-encoded Antimicrobial Peptides (AMPs) such 
as human epithelial β-Defensins (DEFBs) and Cathelicidin (LL-37) which are broad-spectrum 
cationic mediators of the nonspecific innate immune system, with distinct and overlapping anti-
microbial activity. Only DEFB1, DEFB2 and DEFB3 are expressed in the skin; the latter two 
being possibly upregulated in response to inflammation. Besides DEFBs, the human Cathelicidin 
Antimicrobial Protein hCAP18 has the capacity to kill a wide variety of microbes through its 
carboxy-terminal peptidic fragment LL-37 and moreover modulates the immune response. 
In the present work, we investigated the expression of DEFBs and LL-37 in cultured human 
keratinocytes and skin biopsies and investigated the effect of IV10.004, a compound targeting 
AMPs production. Immunofluorescence detection showed a modulation in DEFBs and LL-37 
expression in NHK either with vitamin D3, known to induce AMPs expression, or with IV10.004. 
In the skin, LL-37 was found expressed only in the stratum corneum whereas DEFBs were 
localized into supra-basal layers with a concentration gradient. IV10.004 treatment increased 
both DEFBs and LL-37 expression in ex vivo skin, which may enhance antimicrobial properties of 
the human epidermis. In conclusion, the modulation of the expression of Antimicrobial Peptides 
could strengthen the natural ability of the skin to regulate the microbial flora. Moreover, such 
specific modulation could be of interest in atopic dermatitis, in which cathelicidin is suppressed; 
or in rosacea where cathelicidin peptides are abnormally processed.
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Augmentation of hyaluronan synthesis by β-cryptoxanthin in human epidermal keratinocytes
Akira Ito, Kimiko Kitamura, Taro Uyama, Takashi Sato Department of Biochemistry and Molecular 
Biology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
Hyaluronan (HA) is a component of extracellular matrices (ECM) in the skin and has important 
roles in providing the skin with water holding properties and resilience. As HA levels in the skin 
have been reported to decrease due to aging and environmental conditions, the re-activation 
of HA production may contribute to the improvement of skin conditions and functions. On the 
other hand, β-cryptoxanthin, which is a carotenoid pigment most abundant in Citrus unshiu 
Marcovich (mandarin orange), has been reported to exhibit anti-oxidative actions in various cell 
species. Although some carotenoids have been reported to regulate ECM metabolism, whether 
or not β-cryptoxanthin augments HA production in the skin is not understood. In the present 
study, we demonstrated that β-cryptoxanthin augmented HA production due to an increase of 
HA synthase (HAS)-2 mRNA expression in human epidermal keratinocytes (HEK). However, there 
was no change in the HAS-3 gene expression in the β-cryptoxanthin-treated HEK. In addition, 
the β-cryptoxanthin-augmented HA production was suppressed by RXR and RAR inhibitors 
(UVI3003 and CD2665, respectively). Furthermore, hyaluronidase (HYAL)-1 mRNA expression 
was augmented by β-cryptoxanthin, whereas HYAL-3 gene expression was suppressed in HEK. 
Moreover, there was no change in the expression of HYAL-2 mRNA in HEK. Thus, these results 
provide novel evidence that β-cryptoxanthin augments HA synthesis due to an increase of 
HAS-2 expression through RXR/RAR activation in HEK, which may contribute to the activation 
and improvement of skin barrier functions. Furthermore, β-cryptoxanthin is likely to differently 
regulate HYAL gene expression in a subtype-specific manner in HEK.
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Effects of 11β-hydroxysteroid dehydrogenase type 1 on lipogenesis in SZ95 sebocytes
Ji Min Kim1,2, Sang Eun Lee2,3, Se Kyoo Jeong4, Zouboulis CC5, Seung Hun Lee2,3 1Brain Korea 21 
Project for Medical Science, Yonsei University, Seoul, Republic of Korea, 2Human Barrier Research 
Institute, and Department of Dermatology, Yonsei University College of Medicine, Seoul, Republic 
of Korea, 3Department of Dermatology, Yonsei University College of Medicine, Seoul, Republic 
of Korea, 4Neopharm, Daejeon, Republic of Korea, 5Departments of Dermatology, Venereology, 
Allergology and Immunology, Dessau Medical Center, Dessau, Germany
Emotional stress is suggested to be one of the aggravating factors for acne vulgaris. It has been 
known that alpha-melanocyte stimulating hormone increases sebaceous lipogenesis. However, 
the relationship between stress and acne pathogenesis is still incompletely understood. Cortisol 
is released under stress. 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1), which reduces 
cortisone to the active hormone cortisol in peripheral tissues such as liver, adipose tissue, and the 
central nervous system has been demonstrated to be expressed in the skin. However, a role of 
11βHSD-1 in acne pathogenesis has not been reported yet. In this study, we detected 11βHSD-
1 mRNA and protein levels in SZ95 sebocytes using real time quantitative PCR and western 
blotting. Treatment of SZ95 sebocytes with 1 µM dexamethasone for 24 hours led to increased 
lipid content, as detected by nile red lipid staining, with a high polar/neutral ratio with a parallel 
increase of 11βHSD-1 expression. Pre-treatment with a glucocorticoid receptor antagonist 
inhibited the dexamethasone-induced up-regulation of lipid contents in SZ95 sebocytes. 
These findings suggest that 11βHSD-1 plays an important role in sebaceous lipogenesis by up-
regulation of cortisol synthesis in SZ95 sebocytes.
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Three-dimensional skin equivalents are suitable to monitor aromatase activity
Nadja Zoeller1, Manuel Butting1, Hanieh Sadegh Pour Saleh1, Matthias Hofmann1, Juergen 
Bereiter-Hahn2, Roland Kaufmann1, Stefan Kippenberger1, August Bernd1 1University hospital, 
Department of Dermaotology, Venerology and Allergology, Frankfurt, Germany, 2Kinematic Cell 
Research Group, Frankfurt, Germany
Skin equivalents are histologically and physiologically comparable to the in vivo state. In earlier 
studies we have shown, that skin equivalents are suitable to monitor the anti-inflammatory and 
atrophic potential of glucocorticoids as well as collagen synthesis. The enzyme aromatase is 
expressed in a variety of tissues and cell species e.g. in skin. It catalyzes the transformation of 
androgens to estrogens. The development of a non radioactive assay to monitor aromatase activity 
is a potential new application of skin equivalents to obtain more detailed information about 
aromatase.In our experimental set up primary fibroblasts and epidermal cells were enzymatically 
isolated from either foreskin or donor skin of women between 40 years and 60 years to create skin 
equivalents. After ex vivo expansion the cells were seeded into scaffolds and cultivated according 
to common protocols. Characteristically fibroblasts inhabited the matrix and keratinocytes 
formed a stratified epidermis containing stratum basale, -spinosum, -granulosum and -corneum 
at the air-liquid-interface. Testosterone was added to the culture medium as aromatase substrate. 
Estradiol concentration was measured in the cell free culture medium as analytical parameter of 
aromatase activity. Systemic treatment with the known aromatase inhibitors chrysin, apigenin 
and 7-hydroxyflavone reduced the aromatase activity depending on the incubation length, the 
used inhibitor concentration and the applied inhibitors in skin equivalents. Skin equivalents offer 
a nearly inexhaustible array of utilizations.
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Expression of protease-activated receptor-2 in SZ95 sebocytes and its role in sebaceous lipid 
synthesis and inflammation
Sang Eun Lee1, Se Kyoo Jeong2, Jung Eun Jun2, Ji Min Kim1, Christos C Zouboulis3, Seung Hun Lee1 
1Department of Dermatology and Human Barrier Research Institute, Yonsei University College of 
Medicine, Seoul, Republic of Korea, 2Research Division Neopharm Co., Ltd., Deajeon, Republic 
of Korea, 3Departments of Dermatology, Venereology, Allergology and Immunology, Dessau 
Medical Center, Dessau, Germany
We previously demonstrated that protease-activated receptor-2 (PAR-2) and protease activity 
were increased in the epithelium of patients with acne, suggesting the role of PAR-2 in acne 
pathogenesis. PAR-2 is a sensor for endogenous as well as exogenous proteases and mediates 
numerous physiological and pathophysiological responses in the skin. PAR-2 is expressed by 
keratinocytes and hair follicles, however, the presence of PAR-2 in sebocytes remains controversial. 
In this study, we examined the presence of functional PAR-2 in the immortalized human sebaceous 
gland cell line SZ95 by analyzing PAR-2 gene expression and PAR-2-mediated intracellular Ca2+ 
([Ca2+]i) signaling using real-time PCR and a fluorometric imaging plate reader (FLIPR) calcium 
assay kit. We also wanted to investigate the effects of PAR-2 activation on lipid synthesis in SZ95 
sebocytes. Real-time PCR studies showed that SZ95 sebocytes exhibit detectable PAR-2 mRNA 
levels. Stimulation with a PAR-2 agonist peptide led to increased [Ca2+]i in SZ95 sebocytes in 
a dose-dependent manner and this increase was significantly inhibited by a PAR-2 antagonist, 
indicating that PAR-2 expression in SZ95 sebocytes was functional. PAR-2 agonist peptide (5 µM, 
10 µM) increased the intracellular lipid droplets in SZ95 sebocytes in a dose-dependent manner. 
Stimulation with the PAR-2 agonist peptide upregulated mRNA expression of interleukin -1, -8, 
tumor necrosis factor-α, matrix metalloproteinases 1, 3, and 9 in SZ95 sebocytes. Taken together, 
these data indicate that functional PAR-2 is expressed in SZ95 sebocytes and mediates lipogenesis 
and inflammation in response to various proteases via PAR-2-mediated signaling.
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Implication of Transient Receptor Potential Vanilloid (TRPV) - 3 in Psoriasis
JeongEun Kim, GyeongHun Park, HyoungMin Lee, ChongHyun Won, SungEun Chang, MiWoo 
Lee, JiHo Choi, KeeChan Moon, Sik Haw Department of Dermatology, Asan Medical Center, 
University of Ulsan College of Medicine, seoul, Republic of Korea
TRPV (transient receptor potential vanilloid) is one of the seven TRP channel superfamily. TRPV1 
and TRPV3 have been identified on epidermal keratinocytes in human skin. Recent evidences 
have suggested that activation of TRPV1 might be involved in cell proliferation, apoptosis and 
inflammatory cytokine release. In addition, these receptors may have a role in the pathogenesis 
of pruritus. A total of 23 patients with psoriasis were included in this study. In this study, we 
investigated the expression of TRPV1 and TRPV3 in psoriatic skin and non-lesional skin by 
immunohistochemistry, real time RT-PCR, and western blot. We investigated the correlation 
between the expression level of these receptors and the clinical features of psoriasis and the 
severity of pruritus. We found that TRPV3 increased in psoriatic lesional skin compared with 
non-lesional skin. Expression of TRPV3 was related with the clinical phenotypes in the aspects 
of PASI score and the intensity of pruritus. These findings suggest the activation of TRPV3 may 
have a potential role in the pathogenesis of psoriasis. We also found that agonist and antagonist 
of TRPV3 had influence on proliferation and differentiation of keratinocytes. In addition, RNAi-
mediated silencing of TRPV3 could affect proliferation and differentiation of keratinocytes. These 
results suggest that targeted manipulation of the TRPV could become a useful adjunct treatment 
strategy for hyperproliferative human dermatoses such as psoriasis or KC-derived skin tumors.
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Impact of cold environment on sensory perception
Aurelie Porcheron1, Mirela D Gianeti2, Patricia M.B.G Maia Campos2, Frederique Morizot1, 
André Dufour3, Erwin Tschachler1,4 1CE.R.I.E.S, Neuilly sur Seine, France, 2University of São Paulo, 
Faculdade de Ciências Farmacêuticas de Ribeirão Preto-USP, Ribeirão Preto, Brazil, 3Laboratoire 
d’Imagerie & Neurosciences Cognitives, UMR 7237, Université de Strasbourg - CNRS, Strasbourg, 
France, 4Department of Dermatology, University of Vienna Medical School, Vienna, Austria
The subjective reactions related to sensitive skin are mainly caused by environmental conditions 
such as cold, windy, dry weather. Here, we have tested the effect of a variation of environmental 
temperature on skin nerve fibre function. Thirty Caucasian women were exposed to ambient air 
in two climatically controlled (temperature and absolute humidity) environmental chambers. 
After acclimatization in the 21° chamber (30 min), the subjects changed to the 5° chamber for 
60 min, and then returned to the 21° chamber (85 min). Facial current perception thresholds 
(CPT) of C-, Aδ-, and Aβ-fibres were measured with the Neurometer (Neurotron Inc) in the 21° 
chamber, in the 5° chamber, and after return in the 21° chamber. In parallel, thermal comfort 
and skin sensations were recorded using Visual Analogue Scales. The CPT of C-fibres significantly 
increased only 10 min after the exposure to 5° and did not fully recover after 70 min of re-
acclimatization. The CPT of Aδ- and Aβ-fibres significantly increased during the exposure, and 
was recovered for Aβ 10 min after cessation of exposure to cold temperature. The thermal comfort 
strongly decreased in the cold chamber and only partially recovered after 1 hour whereas 
skin sensations had nearly recovered 10 minutes after the exposure. This work demonstrates 
the implication of the different types of nerve fibres in cold perception and highlights different 
patterns of response. The rapid increase of CPT of C-fibres during, and the slow recovery after 
cold exposure might contribute to the beneficial effects of cold exposure for itch.
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Inhibitors of fatty acid amide hydrolase (FAAH) enzyme show unexpected sebostatic effect on 
human SZ95 sebocytes
Attila G. Szöllösi1, Lídia Ambrus1, Attila Oláh1, Angéla Fodor1, Balázs I. Tóth1, Gabriella Czifra1, 
Christos C. Zouboulis2, Tamás Bíró1 1Dessau Medical Center, Departments of Dermatology, 
Venereology, Allergology, and Immunology, Debrecen, Hungary, 2Dessau Medical Center, 
Departments of Dermatology, Venereology, Allergology, and Immunology, Dessau, Germany
We have previously shown that endocannabinoids play an important role in the regulation of 
sebocytes’ sebum synthesis; however we lack data about the effects of the pharmacological 
modulation of the endocannabinoid tone. Therefore, in the current study we aimed to investigate 
the effects of two fatty acid amide hydrolase (FAAH) inhibitors (JP104, URB597). First using 
human, immortalized SZ95 cells we have demonstrated that FAAH is expressed by the sebocytes 
(Q-PCR, Western blot). We have also shown that non-cytotoxic concentrations (determined by 
MTT-assay and combined DilC1(5)-SYTOX Green staining) of both agents did not increase either 
the basal or anandamide (AEA) induced sebum synthesis (Oil Red O and Nile Red staining). Of 
further importance, at 1-10 µM, both inhibitors significantly decreased the lipogenic effect of 
AEA. Since substances showing similar sebostatic properties are known to increase the [Ca2+]
IC of the sebocytes, we investigated how URB597 and JP104 influenced the Ca
2+-homeostasis 
of the cells (fluo4-AM, FlexStation). We have shown that both of them increased [Ca2+]IC of the 
sebocytes, which was prevented by the non-specific transient receptor potential (TRP) channel 
blocker ruthenium red, indicating the possible role of certain TRP channel(s) in the mediation 
of the sebostatic signaling. Our findings suggest that URB597 and JP104 are effective sebostatic 
agents; therefore they could be successfully used in the treatment of skin disorders characterized 
by seborrhea (e.g. acne vulgaris). Moreover, it seems that these agents are not only selective 
inhibitors of FAAH, but they may also be able to activate certain TRP channels.
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Heat sensitive transient receptor potential vanilloid (TRPV) channels in the control of human 
SZ95 sebocytes - Potential role of TRPV3
Tamás Bíró1, Balázs I. Tóth1, Attila Oláh1, Judit Papp1, Nóra Zákány2,1, Tamás Szabó2, Angéla 
Fodor1, Christos C. Zouboulis3, Tamás Bíró1 1University of Debrecen, Department of Physiology, 
Debrecen, Hungary, 2University of Debrecen, Department of Pediatrics, Debrecen, Hungary, 
3Dessau Medical Center, Departments of Dermatology, Venereology, Allergology, and 
Immunology, Dessau, Germany
We have previously shown that activation of the heat sensitive ion channel TRPV1 expressed by 
human sebaceous gland derived SZ95 sebocytes inhibited the lipid synthesis of the cells. Now 
we investigated the presence and role of other thermosensitive members of TRP family on human 
SZ95 sebocytes. Beyond TRPV1, we demonstrated the expression of TRPV2, TRPV3 and TRPV4 on 
SZ95 sebocytes (Q-PCR, Western blot). Among the above heat sensitive ion channels, we started 
to investigate the role of TRPV3 in the regulation of SZ95 sebocytes’ biological functions. First we 
treated the cells with synthetic TRPV3 agonist 2-aminoethoxydiphenyl borate (2-APB). We found 
that 2-APB administered up to 100 microM concentration did not affect the cellular viability, but 
at high concentration (1 mM) it induced cytotoxicity. The non-cytotoxic concentrations of 2-APB, 
similar to TRPV1 agonist capsaicin, decreased the arachidonic acid induced lipid synthesis of 
SZ95 cells, which was inhibited by the decrease of the extracellular calcium concentration. 
Using fluo4-AM based intracellular calcium imaging, we demonstrated, that 2-APB also elevated 
the intracellular calcium concentration. These results suggested the activation of functional 
TRPV channels expressed by SZ95 sebocytes. Since 2-APB may reportedly act on multiple TRPV 
channels, we are studying the possible molecular targets of 2-APB in our currently running 
experiments. Our results introduce the heat sensitive TRPV channels as potential therapeutic 
targets in skin diseases characterized by increased sebum secretion, such as acne vulgaris.
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α5-integrin and its ligand the oncofetal fibronectin (EDA+FN) are differentially expressed in 
psoriatic uninvolved and healthy skin with and without tape stripping
Krisztina Vas1, Bernadett Kormos2, Nora Belso1, Robert Kui1, Marta Szell2, Lajos Kemeny1,2, 
Zsuzsanna Bata-Csorgo1,2 1University of Szeged, Department of Dermatology and Allergology, 
Szeged, Hungary, 2University of Szeged, Dermatological Research Group of the Hungarian 
Academy of Sciences, Szeged, Hungary
To better understand psoriasis pathomechanisms we started to compare gene and protein 
expressions in psoriatic uninvolved and healthy skin in response to mechanical stress. Previously 
we found striking differences between psoriatic uninvolved and healthy skin in KGF, KGFR mRNA 
and protein expressions, indicating that abnormal skin homeostasis may be important in the 
disease. We applied tape stripping on uninvolved skin of psoriatic patients and on normal skin 
of healthy subjects and took shave (n=3 each group) and punch biopsies (n=6 psoriatic and n=3 
healthy) from treated and non-treated skin 6, 24 and 48 hours after tape stripping. Real-Time RT-
PCR and immunofluorescent staining were done to examine differences in mRNA and protein 
expressions. In this work we studied the expression of α5-integrin and its ligand the EDA+FN. We 
found that α5-integrin gene and protein expressions were higher in the psoriatic uninvolved skin 
compared to normal skin even without tape stripping. Tape stripping had a slight induction of the 
gene and a more pronounced induction of the protein in both skin types. We found no differences 
in the EDA+FN gene expressions in the various samples, however at the protein level a significantly 
enhanced EDA+FN expression was seen in the psoriatic uninvolved epidermis and dermis samples 
compared to the healthy samples without tape stripping. Tape stripping enhanced the expression 
of EDA+FN protein in both type of skin samples with the same extent. These data confirm that the 
psoriatic uninvolved skin show abnormalities that can contribute to disease pathomechanisms.
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PLIN 2 is the major perilipin member regulated during the differentiation of human sebocytes 
in vitro but is dispensable for sebaceous gland function in vivo
Maik Dahlhoff1, Christos C Zouboulis2, Lawrence Chan3, Benny Hung-Junn Chang4, Marlon 
R Schneider1 1Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU 
Munich, Munich, Germany, 2Departments of Dermatology, Venereology, Allergology and 
Immunology, Dessau Medical Center, Dessau, Germany, 3Department of Medicine, Baylor 
College of Medicine, Houston, USA, 4Department of Molecular and Cellular Biology, Baylor 
College of Medicine, Houston, USA
The perilipin family includes five proteins (PLIN 1-5) that localize to the surface of lipid droplets 
in adipocytes and other cell types. However, the expression of this family has not been studied 
systematically in sebocytes. We employed qRT-PCR and Western blot analysis to evaluate the 
expression of the perilipins in the human sebaceous gland cell line SZ95 in undifferentiated 
cells and at different time points of differentiation (sebaceous lipogenesis). Differentiation was 
induced by the addition of linoleic acid and ciglitazone to the culture medium and increased 
lipid synthesis was confirmed by oil red staining. qRT-PCR revealed that PLIN 2 and PLIN 3 
(TIP47) showed the strongest expression under basal conditions, and the expression of PLIN 2 
and PLIN 4 (S3-12) tended to increase during differentiation. Expression of PLIN 1, PLIN 4, and 
PLIN 5 (OXPAT, MLDP) was not detected at any differentiation stage by Western blot analysis, 
while PLIN 3 was expressed at every stage analyzed with a slight increase after day 2. PLIN 2 
was also expressed but the increase was more dramatic and clearly observable already after 12 
hours of differentiation. Surprisingly, histological investigation of the skin of PLIN 2 knockout 
mice did not reveal any alterations in the sebaceous glands as compared to control littermates. 
The sebaceous lipogenesis in SZ95 sebocytes after downregulation of PLIN 2 in vitro is being 
currently evaluated. In conclusion, sebocytes display a specific pattern of perilipin expression 
that may reflect unique properties of sebocyte differentiation as compared to other cells types.
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Development of an aromatase assay with human skin cells
Hanieh Sadegh Pour Saleh1, Nadja Zöller1, Manuel Butting1, Matthias Hofmann1, Jürgen 
Bereiter-Hahn1, Roland Kaufmann1, Stefan Kippenberger1, August Bernd1 1University Hospital, 
Department of Dermatology, Venerology and Allergology, Frankfurt, Germany, 2Kinematic Cell 
Research Group, Frankfurt, Germany
Aromatase is a member of the P450 enzyme family. It is expressed in a variety of tissues 
and cell species e.g. in liver, skin and adipose tissue. The aromatase is located in the 
membrane of the smooth endoplasmatic reticulum and catalyzes two reactions in the 
process of estrogen biosynthesis. Principally the aromatase catalyzes the transformation 
of androgens to estrogens, specifically androstendione is transformed to estrone and 
testosterone is conformed to estradiol. The development of a non radioactive assay to 
monitor aromatase activity is an option to obtain more detailed information about aromatase. 
In our experimental set up dermal and epidermal cells were incubated with testosterone as 
substrate for the aromatase. Estradiol concentration was measured in the cell free culture medium 
as analytical parameter of aromatase activity. It could be shown that the estradiol concentration 
increased depending on the substrate concentration. Systemic treatment with the known 
aromatase inhibitors chrysin, apigenin and 7-hydroxyflavone reduced the aromatase activity 
depending on the incubation length, the used inhibitor concentration and the applied inhibitors. 
It could be shown that the described non radioactive assay is suitable to monitor aromatase 
activity in epidermal and dermal cells.
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A comparative study of the stratum corneum permeation and tight junction modulation by 
excipients used to enhance intestinal absorption
Rawad Abdayem1, Sylvie Callejon1, Pascal Portes2, Valerie Bertholle1, Karine Padois1, Fabrice 
Pirot1, Frederic Demarne2, Vincent Jannin2, Marek Haftek1 1Université Claude Bernard Lyon 1, 
Lyon, France, 2Gattefossé SAS, lyon- St. Priest, France
Several low molecular weight excipients are commonly used to enhance drug absorption 
through simple epithelia of the digestive tract. Their mode of action is related to the permeation 
of the paracellular barrier constituted by tight junctions (TJ). We compared the effects of sodium 
caprate (C10) with a self-emulsifying excipient Labrasol applied in non-toxic doses to human 
reconstructed epidermis either systemically or topically. Both excipients at 1 mM induced a 
pronounced decrease in transepithelial electrical resistance (TEER) during the first 24h of systemic 
application. Effects of Labrasol were less drastic, even though the final result was comparable to 
C10. TEER decrease with topical Labrasol was obtained with 5 times the systemic concentrations. 
In identical conditions, the loss of TEER with C10 was very abrupt and more pronounced. 
Structural investigations with light and electron microscopy and use of a biotin tracer confirmed 
the loss of barrier function observed with TEER. Stratum corneum penetration with topical C10 
had a dramatic effect on tissue morphology, unlike that of Labrasol. Although both excipients 
were able to modulate TJ, the topical action required higher concentrations leading to the stratum 
corneum permeation in the first place. Taken together, our results suggest that Labrasol may be 
used to facilitate transcutaneous penetration of topically applied drugs, as it is less aggressive 
than C10 and capable of moderate modulation of the epidermal barrier elements.
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Effects of partial sleep deprivation on face appearance and on skin properties
Frederique Morizot1, Julie Latreille1, Sophie Gardinier1, Luc Staner2, Christiane Guinot1,3, 
Anne Bernard1, Aurelie Porcheron1, Erwin Tschachler4,1 1CE.R.I.E.S., Neuilly sur Seine, France, 
2FORENAP Pharma, Rouffach, France, 3Computer Science Laboratory, University François 
Rabelais of Tours, Tours, France, 4Department of Dermatology, Medical University of Vienna, 
Vienna, Austria
Sleep loss is a hallmark of life in modern society. Our objective was to investigate the effect 
of partial sleep deprivation (PSD) on facial appearance and on skin properties. Fifteen healthy 
women, aged from 30 to 40 years, have been included in the study. The twelve-day experimental 
period was divided into 3 sections: a baseline (BL) section of 2 days with women sleeping for 
8 hours; a partial sleep deprivation (PSD) section of 6 days where they were allowed to sleep 4 
hours and a sleep recovery (SR) section of 4 days and 3 nights of 10 hours. At different times of 
the experimental period, skin color, skin barrier function, skin hydration and sebaceous secretion 
were assessed on facial and forearm skin. Skin barrier recovery capacity was assessed at one time 
of each period. On the forearm and on the cheek, a significant decrease in skin hydration was 
found at the end of the PSD period followed by a return to values comparable to BL ones during 
the SR period. Trans Epidermal Water Loss measurements decreased during PSD without a return 
to baseline values during SR, but no change appeared in barrier recovery capacity during the 
experimental protocol. Besides, a decrease in a* values paralleled by an increase in L* values 
was found on the forearm during PSD. Moreover, visual fatigue-related features were identified 
and were documented by standardized facial images. Our results suggest that the autonomic 
dysfunction resulting from partial sleep deprivation has also consequences at the skin level.
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Water and skin: consequences of a bathing on skin surface properties and Stratum Corneum 
composition
Gabriel Cazorla1, Julie Latreille1, Christiane Guinot1,2, Erwin Tschachler3,1, Frederique Morizot1 
1C.E.R.I.E.S., Neuilly sur Seine, France, 2Computer Science Laboratory, University François 
Rabelais, Tours, France, 3Department of Dermatology, University of Vienna Medical School, 
Vienna, Austria
In a previous study, an increase of skin pH and a decrease of skin capacitance and SCL were 
observed 1H30 after a recreational swimming in a swimming pool. In the present study, one 
forearm was immersed in chlorinated water for 1 hour to simulate bathing, the second forearm 
used as a control. The measurements of skin hydration, surface pH and skin barrier recovery were 
performed each hour after the immersion. We also used tape stripping to quantify the cutaneous 
amounts of amino acids, lactates, UCA and PCA. Before immersion, no significant difference was 
observed between the 2 arms for all parameters. After immersion, a significant increase of pH 
(0.4 ± 0.1) appeared and a significant decrease of capacitance (4.8 ± 1.0) was revealed. These 
two parameters did not return to their baseline values after the last point of measurement: 5H30 
after bathing. Trans Epidermal Water Loss increased and returned to its initial value 2H30 after 
bathing. Moreover, a significant delay in skin barrier recovery was revealed: 50% on the test 
forearm versus 70% on the control one. The quantity of amino acids, lactates, UCA and PCA 
was found to be lower on the immersed forearm (-28% ± 5%, -63% ±7%, -34% ± 6% and -42% 
±7%, respectively). Considering, the photoprotective effect of endogenous UCA, our data suggest 
that the reduction of UCA observed in the stratum corneum after bathing might lead to higher 
sunburn susceptibility.
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Anti-Aging Effects of a Moringa Extract on Human Keratinocytes
Hélène Hernandez-Pigeon, Hélène Duplan, Muriel Segur-Derai, Marie-José Haure, Antony 
Caruana, Sandrine Bessou-Touya, Nathalie Castex-Rizzi Dermo Cosmetic Department, Pierre 
FABRE R&D Center, Toulouse, France
The ability of human skin to rejuvenate itself diminishes with the passage of time, resulting in 
increased fragility. This increased fragility, mediated in part by high level of reactive oxygen 
species, reflects reduced growth of skin cells, loss of connective tissue, and less functional skin 
barrier. We have first studied the effect of Moringa Oleifera in normal human keratinocytes 
(NHK) differentiation, and we analysed the mRNA expression of proteic (involucrin and 
filaggrin) and lipid (sphingolipid C4-hydroxylase/delta-4 desaturase -Des2-, ABCG1 and 
ABCA12) markers, by using quantitative RT-PCR. Then, in order to evaluate the Moringa 
extract on skin aging, we have evaluated its antioxidant activity by chemiluminescence. 
Moreover we have developed an in vitro model of oxidative stress-induced premature 
senescence in keratinocytes HaCaT cell line, which is closely related to chronological-
aging. The effects of a Moringa extract were assessed on matrix metalloproteinase 9 
(MMP9), keratin 1 (K1), involucrin, and Des2 which are deregulated during skin aging. 
On the first hand, we have demonstrated that, in NHK, the Moringa extract stimulated involucrin, 
filaggrin, Des2, ABCG1 and ABCA12 mRNA expression, proteic and lipid markers of keratinocyte 
differentiation. Secondly, the Moringa extract displayed a potent scavenging superoxide anions activity, 
strongly inhibited MMP9 over-expression and slightly induced K1, involucrin and Des2 mRNA level. 
Our findings illustrated the anti-aging properties of Moringa extract on antioxidant activity, anti-
collagenase protection, lipid synthesis and transport, and keratinocyte differentiation.
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Defensive genes expression profile across the human epidermal layers: a laser capture 
microdissection study
Giuseppe Percoco1, Yasmina Ramdani1, Magalie Bénard2, Sophie Bernard1,2, Elian Lati3, Luc 
Lefeuvre4, Azeddine Driouich1,2, Marie-Laure Follet-Gueye1 1Laboratoire de Glycobiologie et 
Matrice Extracellulaire Végétale, UPRES EA 4358, IFRMP 23, Université de Rouen, Rouen, France, 
2Plate-forme de Recherche en Imagerie Cellulaire de Haute Normandie, Rouen, France, 3Bio-Ec 
laboratory, Longjumeau, France, 4Laboratoires Dermatologiques d’Uriage, Courbevoie, France
The human skin is a natural barrier between the environment and the organism, providing a first line 
of defense against physical (mechanical injury, UV-irradiation) and chemical (irritants, allergens) 
stress and microbial pathogens. The major objective of our study is to characterize the expression 
profile of several structural and defensive-related genes of healthy skin explants. We have used laser-
capture microdissection (LCM) coupled to real-time quantitative PCR (qPCR) to isolate different 
skin layers and analyze gene expression. In addition, we have investigated the ultrastructure 
and protein distribution across the epidermal layers using transmission electron microscopy and 
immuno-gold labeling with specific antibodies. Two human epidermal compartments were isolated 
in vivo from skin explants by LCM, namely the basal and the granulosum layers. The expression 
of structural-related genes was validated followed by the analysis of a large panel of defense-
related genes in both isolated layers. The data show that healthy human epidermis expresses only 
two toll-like receptors (TLRs), TLR2 and TLR5. Three human β-defensin genes, hβD1, 2 and 3 are 
also expressed and only hBD3 shows a spatial modulation within epidermal layers. Among other 
defensive genes investigated, only RNase7 and NOD-1 are up-regulated in the stratum granulosum. 
Immuno-gold electron microscopy of both structural and defensive epitopes on high pressure 
frozen and freeze substituted epidermal tissue confirmed gene expression profiles observed by 
LCM/qPCR. As a conclusion, our findings indicate that human skin is able to constitutively express 
two TLRs (TLR2 and 5) and several antimicrobial peptides, some of which are spatially regulated.
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Rhelba® Nutrialba creams strengthen lipid barrier of skin by inducing de novo lipid synthesis
Marie-Florence Galliano, Hélène Hernandez-Pigeon, Nathalie Castex-Rizzi, Sandrine Bessou-
Touya, Hélène Duplan Pierre Fabre Dermo-Cosmetique, Toulouse, France
The aim of this study was to evaluate the benefit of two Rhelba® Nutrialba creams on skin 
lipid barrier. We first evaluated the effect of linoleic acid (one of the main component of 
Carthame oil, ingredient of Rhelba® Nutrialba creams) on lipid transport (ABCA12) and synthesis 
(b-glucocerebrosidase) by quantitative RT-PCR on normal human keratinocytes. Linoleic acid 
induced in a dose dependant manner ABCA12 and b-glucocerebrosidase mRNA expression. 
We then evaluated the effect of Rhelba® Nutrialba creams for dry skin (RV4350) and very 
dry skin (RV4351) on the de novo lipid synthesis of full-differentiated human reconstructed 
epidermis by using [14C-acetate] precursor. Lipids were quantified by separation by thin-layer 
chromatography followed with autoradiography. Both Rhelba® Nutrialba creams induced de 
novo synthesis of phospholipids and sphingomyelin, with a higher induction observed with 
compound RV4350. Phospholipids and sphingomyelin are the precursors of free fatty acids and 
ceramides, respectively, which are incorporated into the lamellar membrane. Moreover, Rhelba® 
Nutrialba for dry skin induced the synthesis of polar ceramides and cerebrosides, which are 
crucial components of the lamellar lipid membranes that provide with the permeability barrier. 
In contrast, Rhelba® Nutrialba for very dry skin did not induce the synthesis of ceramides but 
stimulated the production of esterified fatty acids, indicating that lipid storage was increased 
within epidermis. In conclusion, we demonstrated that Rhelba® Nutrialba creams can induce de 
novo lipidogenesis which is in favour of a reinforcement of the barrier. This study allowed a better 
characterization of the distinct properties of the two creams tested.
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Combination therapy accelerates repigmentation in the treatment of vitiligo
Jung Ran Choi*1, Ounjae Park*2, Gyeong-hun Park2, Hyejung Jung1, Heesung Chung2,Eok-Soo 
Oh1, Jeong Eun Kim2, Sungeun Chang2, Mi Woo Lee2 1Department of Life Sciences, Division of 
Life and Pharmaceutical Sciences, Center for Cell Signaling and Drug Discovery Research, Ewha 
Womans University, Seoul, Republic of Korea 2Department of Dermatology, Asan Medical Center, 
University of Ulsan College of Medicine, Republic of Korea
Vitiligo is an acquired depigmentaion disorder resulting from destruction of cutaneous 
melanocytes. Phototherapy and topical corticosteroids or tacrolimus are mainstay of treatment 
strategy and sometimes combination of these treatment options can be chosen for treatment. We 
compared the effect of combining topical tacrolimus and 308-nm excimer laser therapy vs. 0.1% 
tacrolimus ointment monotherapy or excimer laser monotherapy in the treatment of vitiligo. This 
retrospective study was performed on 276 patients with 372 non-generalized, non-segmental 
vitiligo lesions distributed on the face/neck, trunk or extremities. The patients were divided into 
three groups: group A: 308-nm excimer laser twice per week; group B: tacrolimus ointment twice 
daily; group C: the combined excimer laser and tacrolimus of above regimen. Also, for in vitro 
study, we measured the melanin contents and tyrosinase acitivity using human melanocyte cells. 
Our results showed the combination treatment of tacrolimus ointment and 308-nm excimer laser 
are more effective than each monotherapy for the treatment of vitiligo (P = 0.012). Also, there 
was statistical significance between repigmentation and the duration of combination treatment 
whereas lesion’s location was not associated. Early initiation of treatment for the lesions of less 
than 6 months’ duration responded better to combination treatment. In vitro study demonstrated 
combined excimer laser and tacrolimus treatment led to higher level of melanogeneis than 
that of the single treated cells. The combination treatment of tacrolimus and excimer laser is 
an effective therapy for vitiligo and accelerates repigmentation compared to monotherapy. 
*These authors contributed equally
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A homozygous deletion mutation in ADAM17 underlies an autosomal recessive inflammatory 
skin and bowel disease
Diana Blaydon1, Paolo Biancheri1, Wei-Li Di2, Vincent Plagnol3, Rita Cabral1, Matthew Brooke1, 
Joanne Martin1, Tom MacDonald1, John Harper2, David Kelsell1 1The Blizard Institute of Cell 
and Molecular Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary 
University of London, London, UK, 2UCL Institute of Child Health and Great Ormond Street 
Hospital, London, UK, 3Cambridge Institute for Medical Research, University of Cambridge, 
Addenbrooke’s Hospital, Cambridge, UK
We studied two siblings with an autosomal recessive syndrome including neo-natal onset 
inflammatory skin and bowel disease. In addition, the scalp hair, eyebrows and eyelashes of 
both affected individuals was short, sparse and disorganised. The affected female died aged 12 
of parvovirus myocarditis and her brother has a mild cardiomyopathy. Using a combination of 
homozygosity genome-wide SNP mapping and targeted sequence capture, followed by next-
generation sequencing, we have identified a novel 4bp deletion in ADAM17, a gene encoding 
a member of the disintegrin and metalloprotease (ADAM) family, as the underlying cause of 
this syndrome. Western blots and immunohistochemistry showed a dramatic reduction/absence 
of ADAM17 expression in skin and small intestine biopsies from the patients. Immunological 
investigations revealed a highly abnormal immune system. Peripheral blood mononuclear 
cells from the surviving male patient showed high lipopolysaccharide-induced production 
of interleukin (IL)-1β and IL-6, but impaired tumor necrosis factor (TNF)-α release, while 
immunostaining of skin sections showed an infiltrate of T cells (CD3+, CD4+ and CD8), but 
very few B cells, natural killer cells and neutrophils. Furthermore, there was a clear reduction 
in transglutaminase 1 (TGM1) expression in the patient skin, while other proteins of the skin 
barrier, including; involucrin, keratin 2e, filaggrin and loricrin, had comparable expression to 
control skin. The cases reported here show that, unlike mouse models, loss of ADAM17 is not 
incompatible with survival in man and suggest that it may be worth re-examining the use of 
ADAM17 inhibitors as a way of controlling excess TNF-α production in chronic diseases.
2011ESDR_8.25x10.875.indd   62 06/07/2011   18.24 
 www.jidonline.org S63
ABSTRACTS
373
Natural gene therapy occurs in all COL17A1 patients with generalised non-Herlitz junctional 
epidermolysis bullosa in the Netherlands
Marjon Pasmooij, Miranda Nijenhuis, Renske Brander, Marcel Jonkman Department of 
Dermatology, University Medical Center Groningen, Groningen, The Netherlands
Revertant mosaicism, also known as natural gene therapy, refers to the co-existence of cells 
carrying inherited genetic mutations with cells in which the inherited disease-causing mutation is 
corrected by a spontaneous genetic event, thereby giving rise to a clinically healthy phenotype. 
Natural gene therapy due to in vivo reversion of an inherited mutation in the genetic blistering 
disease non-Herlitz junctional epidermolysis bullosa (JEB-nH) was initially thought to be rare. 
Here, we demonstrate the presence of five different in vivo reversions, all correcting the germ-
line COL17A1 mutation c.2237delG in exon 30, in four mosaic JEB-nH patients. The correcting 
DNA changes involved a wide variety of different somatic mutations, i.e. a transition in the same 
codon (c.2238C>T), a substitution in the 5’-donor splice site of intron 30 (c.2263+2T>C) and a 
deletion in exon 30 and intron 30 (c.2259_2263+9del). Moreover, an indel mutation (c.2228-
101_2263+70delins15) and a large deletion of 2165 basepairs that included exons 30 and 31 
(c.2227+153_2336-318del) were identified. Our results show that there is no preference for 
a single repair mechanism. Further, photo-material of all 10 generalised JEB-nH patients with 
COL17A1 mutations in the Netherlands indicates that each patient has one or more revertant 
skin areas. In contrast, in the 4 localised JEB-nH patients with COL17A1 mutations revertant 
mosaicism was not obvious. The fact that all generalised JEB-nH COL17A1 patients have revertant 
patches makes it worthwhile to study revertant cell therapy in which the patient’s own naturally 
corrected cells are used.
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RHBDF2 mutations in Tylosis with Oesophageal Cancer cause dysregulation of downstream 
EGF and EphrinB3 signalling
Sarah Etheridge1, Diana Blaydon1, Janet Risk2, Hans-Christian Hennies3, Howard Stevens4, 
John Field2, Anthony Ellis2, Irene Leigh5, Andrew South5, David Kelsell1 1Blizard Institute of Cell 
and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary 
University of London, UK, 2School of Dentistry, University of Liverpool, UK, 3Cologne Center for 
Genomics, Division of Dermatogenetics, University of Cologne, Cologne, Germany, 4Barnet NHS 
trust, Hertfordshire, UK, 5School of Medicine, Dentistry and Nursing, University of Dundee, UK
We have identified mutations in the inactive rhomboid protein RHBDF2 as the underlying cause of Tylosis 
with Oesophageal Cancer (TOC), an autosomal dominant syndrome with palmoplantar keratoderma, oral 
precursor lesions and a high lifetime risk of oesophageal cancer. The mutations, found in a highly conserved 
region of exon 6, are c.557T>C (p. Ile186Thr) and c.566C>T (p. Pro189Leu), identified in 3 families from 
the UK, US and Germany. Rhomboid proteins are typically intramembrane serine proteases that cleave 
type-1 membrane proteins in the transmembrane region. RHBDF2 lacks protease activity, but is predicted 
to inhibit the active rhomboid protease RHBDL2. Substrates of RHBDL2 include EGF and EphrinB3, 
proteins important in cell proliferation, adhesion and migration. Dysregulation of EGFR and Ephrin 
signalling has been implicated in many cancers. Immunohistochemical staining of normal skin showed 
RHBDF2 predominantly at the plasma membrane. In tylotic skin, however, the distribution appeared more 
cytoplasmic, suggesting altered trafficking or processing of RHBDF2. Dysregulation was also observed in the 
distribution of RHBDL2 and EphrinB3 in tylotic skin, consistent with disruption to pathways downstream of 
RHBDF2. In addition, HpV Immortalised tylosis keratinocytes exhibited increased migration compared with 
controls, particularly in the absence of EGF (p<0.005 in each case). These data demonstrate a key role for 
RHBDF2 in regulating EGF and EphrinB3 signalling in both cutaneous and oral keratinocytes. Importantly, 
this data also identifies RHBDF2 as having a major role in inherited oesophageal cancer and is therefore an 
important target for future research.
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Revertant mosaicism in patients with different subtypes of dystrophic epidermolysis bullosa
Dimitra Kiritsi1, Marta Garcia2, Renske Brander1,3, Cristina Has1, Jürgen Kohlhase4, Marcel 
Jonkman3, Marcela del Rio2, Leena Bruckner-Tuderman1,5, Marjon Pasmooij3 1University Medical 
Center, Department of Dermatology, Freiburg, Germany, 2Regenerative Medicine Unit and 
Cutaneous Disease Modelling Unit, Epithelial Biomedicine Division, CIEMAT, Madrid, Spain, 
3University Medical Center Groningen,Department of Dermatology, Groningen, The Netherlands, 
4Center for Human Genetics Freiburg, Freiburg, Germany, 5University of Freiburg,Freiburg 
Institute for Advanced Studies, Freiburg, Germany
Revertant mosaicism, also called ‘natural gene therapy’ has been reported in several inherited 
diseases, including blistering skin diseases of the epidermolysis bullosa (EB) group. EB is 
characterized by blister formation after minor trauma and is caused by mutations in components 
of the epidermal-dermal adhesion complexes. Dystrophic EB is caused by mutations in the 
collagen VII gene, COL7A1. Although revertant mosaicism is known to occur in several EB types, 
only two cases of mosaicism in dystrophic EB have been reported, both of them with the severe 
generalized form of the disease. Here we describe six new patients with revertant mosaicism 
and different subtypes of dystrophic EB. We report of the first patient with the generalized-other 
subtype of dystrophic EB due to slight reduction of collagen VII expression, who has multiple 
reverted skin patches. The reversion mechanisms include second-site mutations that affect 
splicing or result in substitution of the nonsense to missense mutation. In the six patients, the 
reverted areas were distributed all over the skin surface and they seemed to remain constant over 
life. Our study shows that this ‘natural gene therapy’ is more common than assumed in dystrophic 
EB and might have implications for therapeutic strategies, since it offers the opportunity to use 
reverted skin grafts on mutated skin.
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Identification of recessive IL1F5 mutations in Generalised Pustular Psoriasis (GPP)
Michael Simpson1, Alexandros Onoufriadis1, Andrew Pink1, Catherine Smith1, David Burden2, 
Francesca Capon1, Richard Trembath1, Jonathan Barker1 1King’s College London, London, UK, 
2Western Infirmary, Glasgow, UK
GPP is a rare, severe, life threatening form of psoriasis characterised by waves of sterile pustules 
and widespread skin inflammation associated with systemic illness. It can occur in the context 
of other forms of psoriasis or as a single entity. The pathomechanisms are poorly understood and 
the genetic architecture is unknown. To test the hypothesis that rare genetic variants contribute 
to GPP, we undertook an exome sequencing approach in five subjects with GPP. All cases were 
negative for HLA-Cw6, the main risk locus for psoriasis vulgaris. One affected case was the 
offspring of consanguineous parents. We therefore compared the exome variant profiles under 
a rare autosomal recessive model; highlighting genes harbouring homozygous or compound 
heterozygote combinations of rare variants. Only nonsynonymous, splice site and small indels 
with an estimated population frequency of <0.01 were considered as candidate pathogenic 
variants. Under this analysis model, a homozygous substitution in the IL1F5 gene (S113L) was 
identified in two of the five individuals and third subject was observed as compound heterozygote 
with the same S113L variant and a R48W substitution. S113 and R48 are evolutionary conserved 
residues within the protein. The three individuals with variants in IL1F5 had intermittent acute 
flares without evidence of other forms of psoriasis, whereas the two IL1F5 mutation negative cases 
also had acral disease. Taken together, these findings implicate recessive IL1F5 mutations in GPP 
without other features of psoriasis. The IL1F5 protein participates in IL-1 signalling highlighting 
this pathway as a target for therapeutic intervention in GPP distinct from psoriasis vulgaris.
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Late-onset erythropoietic protoporphyria caused by mosaicism after autologous blood stem cell 
transplantation and radiation therapy
Marko Siegesmund1,2, Theresa Strunk2, Richard Stefaniak3, Viola Kuerten2, Pamela Poblete-
Gutiérrez1, Norbert Neumann2, Michel van Geel1, Daniel Humme3, Jorge Frank1, Sandra 
Hanneken2 1Department of Dermatology and Euregional Porphyria Centre, Maastricht University 
Medical Center (MUMC), Maastricht, The Netherlands, 2Department of Dermatology and 
German Porphyria Specialist Centre, Heinrich Heine University Hospital, Duesseldorf, Germany, 
3Dept of Dermatology, Venereology and Allergology, Charité University Hospital, Berlin, Germany
Erythropoietic protoporphyria (EPP) is an autosomal semi-dominant disorder that is due to a marked 
deficiency of ferrochelatase (FECH), the eighth enzyme in heme biosynthesis. This enzymatic dysfunction 
results from inheritance of a germline FECH gene mutation on one parental allele in combination with 
a common hypomorphic intronic FECH variation, IVS3-48C, on the other parental allele. Usually, EPP 
manifests in early childhood with burning cutaneous photosensitivity. Here we present a 57-year-old 
Caucasian man who developed severe cutaneous photosensitivity six years after treatment of a large 
B-cell lymphoma with autologous blood stem cell transplantation and radiation therapy. Biochemical 
and enzymatic analyses confirmed the diagnosis of EPP. By leukocyte DNA sequencing we detected 
a nonsense mutation, p.R298X, in combination with the hypomorphic IVS3-48C variation in trans. 
Interestingly, the chromatographic intensity of the mutated T-allele at position 298 was reproducibly 
lower than that of the wild type C-allele, suggesting mosaicism. Most of the rare cases of late-onset EPP 
occurred in association with a myelodysplastic syndrome or myeloproliferative disorder due to a deletion 
on chromosome 18q, the region in which the FECH gene is located. Hence, we first excluded such a 
deletion by fluorescence in situ hybridization. Sequencing of DNA derived from cultured fibroblasts of the 
patient showed absence of p.R298X, confirming that this mutation arose as a result of mosaicism. This is 
the first report on late-onset EPP due to blood cell mosaicism caused by a spontaneous FECH mutation 
following autologous blood stem cell transplantation and radiation therapy of a large B-cell lymphoma.
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microRNA deep sequencing in Sézary Syndrome reveals upregulation of miR-199a2/miR-214 
cluster derived from the DNM3os transcript
Y. Qin1,3, H. P.J. Beurmans2, M. S. van Kester1, L. van der Fits1, J. J. Out-Luiting1, S. Osanto3, R. 
Willemze1, M. H. Vermeer1, C. P. Tensen1 1Department of Dermatology, Leiden University Medical 
Center, Leiden, The Netherlands, 2Department of Human genetics, Leiden University Medical 
Center, Leiden, The Netherlands, 3Department of Clinical oncology, Leiden University Medical 
Center, Leiden, The Netherlands
Sézary syndrome (SS) is an aggressive type of cutaneous T cell lymphoma. The hallmark of SS 
is presence of malignant CD4 Sezary cells in skin, lymph node and blood. MicroRNA is a class 
of small non-coding RNA often aberrantly expressed in human cancers, including lymphomas. 
To quantitatively and qualitatively analyze the microRNAs profile of Sezary cells, we performed 
microRNA deep sequencing of CD4+ T cells of 12 SS patients and controls, including 4 
patients with erythroderma secondary to atopic dermatitis (EAD) as well as 4 healthy donors. 
Sequencing results revealed that the SS miRNome is comprised of 571 known and 39 putative 
novel microRNAs. Compared to EAD patients, the miR-199a2/miR-214 cluster, miR-486 and 
let-7b showed significant overexpression in SS, whereas miR-126/126*, miR-99, miR-100, miR-
125b, miR326 and miR-193b were found to be downregulated. The major quantitative change 
in Sézary was the upregulation of miR-214/miR-199a2 cluster derived from a single non-coding 
transcript, DNM3os. Consistently, the upregulation of miR-199a2/miR-214 was also seen in SS 
when compared to normal CD4+ T cells of healthy donors. Since the miR-199a2/214 cluster 
represents the vast majority (>95%) of aberrantly overexpressed miRs and encompasses 10% of 
the miRNome of SS cells, a pivotal role in SS pathogenesis is anticipated. In addition, our data 
suggests that the miR-214/miR199a2 clusters as well as the precursor transcript (DNM3os) are 
novel diagnostic marker for SS.
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Cytokine mediated paracrine cell communication modulates the phenotype of Kindler 
Syndrome patients
Anja Heinemann1, Ute Wölfle1, Yinghong He1, Cristina Has1, Leena Bruckner-Tudermann1,2 
1Department of Dermatology, University Medical Center, Freiburg, Germany, 2Freiburg Institute 
for Advanced Studies, School of Life Sciences –LIFENET, Freiburg, Germany
Kindler syndrome (KS) is a recessive skin disorder caused by mutations in the FERMT1 gene 
encoding kindlin-1, a phosphoprotein involved in b1 integrin activation at focal adhesion 
sites. KS manifests first with skin blistering, followed by progressive poikiloderma, mild 
photosensitivity and fibrosis of the skin and mucosa. Here, we addressed the pathogenesis of 
fibrosis in KS by exploring cytokine profiles of KS keratinocytes, by characterizing KS fibroblasts 
in vitro and by validating the findings in vivo in the skin of nine KS patients. We show that 
the expression of important cytokines is upregulated in KS keratinocytes, including IL-20, IL-24, 
IL1F5, transforming growth factor-b2 (TGF-b2), platelet derived growth factor B (PDGFB) and 
connective tissue growth factor (CTGF). In the KS dermis, macrophage infiltration, the presence 
of a-smooth muscle actin-positive fibroblasts and expression of TGF-b1, IL-6 and CTGF were 
characteristic. An environmental stimulus in form of UVB irradiation caused an immediate 
inflammatory response in KS keratinocytes, leading to increased cell stress and release of 
proinflammatory cytokines IL-20 ,IL-24 and TNFα. These events were mediated by active p38, 
which directly influenced the expression of IL-20 and IL-24. These data uncovered cytokine-
mediated paracrine cell communication processes as phenotype modulators in KS and revealed 
high interconnectivity of pathways involved in pathogenesis of fibrosis and UVB response in this 
disease, thereby identifying new targets for therapeutic interventions.
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Natural history of ichthyosis with confetti in a patient with novel KRT10 mutation and 
confirmation of mitotic recombination
Bettina Burger1, Iris Spoerri1, Margit Schubert2, Cristina Has2, Peter Itin1 1University Hospital 
Basel, Basel, Switzerland, 2University Medical Center Freiburg, Freiburg, Germany
Ichthyosis with confetti (IWC) is an extremely rare sporadic skin disease with only 7 patients 
clinically reported up to now. IWC is characterized by erythroderma, prominent scale, and 
palmoplantar keratoderma. During childhood hundreds to thousands of pale confetti like spots 
appear which increase in number and size with time. In 2010 it was shown that IWC is caused 
by dominant mutations in the KRT10 gene (chromosome 17q21). All described mutations are 
frameshift mutations which result in an alternative reading frame leading to an arginine-rich 
protein and subsequently to a mislocation of keratin 10. The spots of normal-looking skin were 
shown to be caused by mitotic recombinations, leading to LOH and a reversion of the mutation. 
We report on clinical and molecular findings of a female patient, periodically investigated 
from birth to adulthood. We are able to document the appearance of normal skin within 
erythematous ichthyotic skin with a confetti-like pattern. Additionally, we describe new 
clinical details and novel KRT10 mutations concerning the ichthyotic skin of the patient. 
One mutation was a frameshift-deletion resulting in the arginine-rich protein, which was 
strongly reduced in keratinocytes originating from the normal appearing skin. Microsatellite 
analysis showed LOH of the region distal to KRT10 in the normal appearing spots and 
immunofluorescence staining confirmed the mislocation of K10 in the ichthyotic skin. 
We present here the first case of IWC who is clinically documented from birth until adulthood 
and genetically examined. We could confirm the underlying gene defect and revertant mosaicism 
mechanism for the first time.
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Skin Microbiome Analyses of Healthy Individuals and Atopic Dermatitis Patients
Julia Segre1, Heidi Kong2, Julia Oh1, Elizabeth Grice1, Sean Conlan1, Clay Deming1, Patrick 
Murray1, Maria Turner2 1NHGRI, NIH, Bethesda, MD, USA, 2NCI, NIH, Bethesda, MD, USA
Culture-based methods have been the primary techniques used to study microbes inhabiting 
humans; however, many species are not successfully grown in culture. We performed high 
throughput genomic sequencing surveys to investigate the topographical and temporal 
complexity of skin microbial communities from 20 skin sites in healthy adults. Significant 
differences were observed in the species predominating in particular microenvironments: 
sebaceous, moist, and dry. Interpersonal variation and temporal changes in the microbiome 
were site-specific. This comprehensive survey of the skin microbiome provided the foundation 
for analyzing changes in the microbial community associated with Atopic Dermatitis (AD). We 
studied 10 children with moderate to severe AD at baseline, flare, and post-flare, and healthy 
controls. Severity was quantified using SCORAD. Samples were obtained from characteristically 
affected areas (antecubital/popliteal fossa), a control site (volar forearm), and a common reservoir 
for S. aureus (nares). Microbial diversity was dramatically reduced during flare (69.1 ± 8.3%, 
mean ± SE) as compared to baseline (36.5 ± 7.4%; n=10, p<0.0043, Wilcoxon rank sum test) 
or post-flare (19.2 ± 4.0%; n=10, p<0.0001). Reduced microbial diversity (Shannon index) was 
correlated with higher SCORAD (r=-0.75, Pearson correlation, p<0.0001 corrected). These 
studies provide comprehensive characterization of skin microbes in AD and controls, confirm the 
frequent culture-based isolation of S. aureus in AD flares, demonstrate how microbial genomics 
complement culture methods in the study of microbes in skin diseases, and represent one of the 
earliest longitudinal investigations of the skin microbiome in a dermatologic disorder.
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The www.col7.info - online database for COL7A1 allelic variants
Cezary Kowalewski3, Katarzyna Wertheim-Tysarowska1, Agnieszka Sobczynska-Tomaszewska1,2, 
Michal Skronski4, Grzegorz Swieckowski1, Anna Kutkowska-Kazmierczak1, Katarzyna Wozniak3, 
Jerzy Bal1 1Institute of Mother and Child, Warsaw, Poland, 2Health Care Center GENOMED, 
Warsaw, Poland, 3Warsaw Medical University, Department of Dermatology, Warsaw, Poland, 
4Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and 
Lung Dieseases, Warsaw, Poland
COL7A1 gene spans 32 kb and comprises 118 exons and encodes collagen type VII, a major 
structural component of the anchoring fibrils (AF). Mutations in COL7A1 lead to epidermolysis 
bullosa dystrophica. We present the first online locus specific database dedicated to COL7A1. There 
are more than 730 variants deposited already in the database, however, we still add new ones. 
Among them, 532 (73%) accounts for mutation associated with disease, 69 (9%) are polymorphisms 
not causing disease and 129 (18%) are sequence variations of unknown clinical relevance. The 
core of the database is sequence view with each variant marked on it. This not only enables quick 
localization of each sequence variant, but also assure proper naming of newly identified ones. 
Detailed description of all, or selected variants can be easily downloaded in CSV format and further 
statistically analyzed in ordinary spreadsheet. We also created a module dedicated for adding 
more phenotypic description to particular mutations. All of them can also be transposed into CSV 
file. Thus the www.col7.info enables simple and rapid comparative analysis of various features. 
Beside global analysis, profound search tool in COL7A1 database is also developed, which can be 
used for the purpose of genetic counseling. In summary, the database presented here gathers the 
richest collection of pathogenic mutations and other allelic data and is the only tool, which enables 
profound correlation studies for Epidermolysis bullosa and COL7A1 gene.
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Junctional epidermolysis bullosa of late onset caused by COL17A1 mutations
Wing Yan Yuen1, Hendri H. Pas1, Richard J. Sinke2, Marcel F. Jonkman1 1Department of 
Dermatology, University Medical Center Groningen, Groningen, The Netherlands, 2Department 
of Genetics, University Medical Center Groningen, Groningen, The Netherlands
Junctional epidermolysis bullosa of late onset (JEB-lo) is a rare disease characterized by blistering 
of primarily the hands and feet starting at childhood. Our objective was to elucidate the genetic 
cause of this disease. Biopsies of lesional and non-lesional skin were taken of two JEB-lo patients, 
a brother and a sister, and examined using electron microscopy (EM) and immunofluorescence 
antigen mapping (IF). Genomic DNA was isolated from peripheral blood of both patients and 
of family members for molecular analysis. IF and EM showed subtle changes. The apical-
lateral staining of monoclonal antibodies (mAb) against type XVII collagen (Col17) was lost, 
and the mAb staining against the ectodomain of Col17, laminin-332, and type VII collagen was 
broadened. EM showed interruptions in the lamina densa and fuzzy electron dense material 
in the sublamina densa zone. Mutation analysis of COL17A1, encoding Col17, showed a 
compound heterozygosity for the novel maternal mutation c.1992_1995delGGGT and the 
known paternal mutation c.3908G>A in both patients. The deletion c.1992_1995delGGGT 
results in a premature termination codon and mRNA decay, leaving the patients functionally 
hemizygous for the missense mutation c.3908G>A (p.R1303Q) in the non-collagenous 4 domain 
of Col17. Both heterozygous parents were clinically unaffected. In conclusion our results show 
that JEB-lo is an autosomal recessive disorder caused by mutations in COL17A1 and that subtle 
aberrations in EM and IF are clues to diagnosis.
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Epidermolysis bullosa simplex in Spanish patients: first survey of novel and recurrent mutations
María José Escámez1,2, Marta García1, Ana Terrón3, Asunción Vicente4, Raúl De Lucas5, Ángela 
Hernández-Martín6, Daniele Castiglia7, Antonio Torrelo6, Giovanna Zambruno7, Marcela Del 
Río1,2 1CIEMAT-Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 
Madrid, Spain, 2Universidad Carlos III (UC3M), Madrid, Spain, 3Ninewells Hospital, Dundee, UK, 
4Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain, 5Hospital Universitario La 
Paz, Madrid, Spain, 6Hospital Niño Jesús, Madrid, Spain, 7Istituto Dermopatico dell’Immacolata 
(IDI)-IRCCS, Rome, Italy
Basal epidermolysis bullosa simplex (EBS) is a group of blistering genodermatoses mostly caused 
by mutations in KRT5 and KRT14 genes. Recessive mutations represent about 5% of all EBS 
mutations, being common and specific in consanguineous populations. In the present study, 21 
EBS families were analyzed. Immunofluorescence mapping at dermo-epidermal junction level 
was performed on patient skin biopsies. Mutation screening of the entire coding sequences of 
KRT5 and KRT14 in genomic DNA was assessed by direct sequencing. KRT5 or KRT14 causative 
mutations were identified in 18 of the 21 EBS families. 14 different mutations were disclosed, of 
which 12 were dominant missense mutations and two truncating recessive mutations. Five of the 
14 mutations were novel including three dominant in KRT5 (p.V186E, p.T321P and p.A428T) 
and two recessive in KRT14 (p.K116X and p.K250RfsX8). All 5 families with EBS Dowling-Meara 
subtype (EBS-DM), carried recurrent mutations affecting the highly conserved ends of the alpha-
helical rod domain of K5 and K14. The seven mutations associated to localized EBS subtype 
(EBS-loc) were distributed along KRT5 and KRT14 genes. Two families with mottled pigmentation 
(EBS-MP) carried the P25L mutation in KRT5, commonly associated with this subtype. This 
study further confirms the genotype-phenotype correlation established for EBS in other ethnic 
groups, being the first in a Mediterranean country (excluding Israel). This study adds two novel 
recessive mutations to the world record so far including a total of 14 mutations. As in previous 
reports, recessive mutations resulted in lack of keratin K14, giving rise to a generalized and 
severe presentation.
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In vivo assessment of low- and high-dose of UVB irradiation on xeroderma pigmentosum (XP-
C) and differentially pigmented human bioengineered skin
Marta García1,8, Sara Llames2,8, Eva García2,8, Álvaro Meana2,8, Susana Puig3,8, Eduardo Nagore4, 
Emilie Warrick7, Thierry Magnaldo5, Fernando Larcher1,8, Marcela Del Río6,8
1Regenerative Medicine Unit. CIEMAT, Madrid, Spain, 2Centro Comunitario de Sangre y Tejidos, 
Oviedo, Spain, 3Hospital Clinic-Centro de Investigación Biomédica en Red de Enfermedades 
Raras (CIBERER), Barcelona, Spain, 4Instituto Valenciano de Oncología, Valencia, Spain, 5CNRS 
UMR6267/INSERM U998, Nice, France, 6Department of Bioengineering. Universidad Carlos 
III (UC3M), Madrid, Spain, 7L’Oréal Recher, chevilly-Larue, France, 8Centro de Investigación 
Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Permanent human skin regeneration involving long-lasting epidermal stem cell engraftment and 
functional preservation is a requisite to generate reliable in vivo model systems. Our team has 
developed a skin-humanized mouse platform based on tissue bioengineering and optimized surgical 
procedures in immunodeficient hosts enabling human skin regeneration as well as skin disease 
modeling and therapeutic approaches. By using Caucasian or African-descent donor keratinocytes 
we were able to regenerate differentially pigmented skins without the need of adding exogenous 
melanocytes to the system as in other tissue engineered-based models. In addition, using XP-C 
patient-derived keratinocytes and fibroblasts we were also able to generate human XP-C skin 
bearing mice. Dose-dependent DNA damaging UVB responses and their modulation by the degree 
of skin pigmentation was evaluated. The model also proved satisfactory to test topic photoprotective 
agents and DNA damage repair kinetics after irradiation. The human XP-C regenerated skin on 
mice allowed assessing the persistence of UVB-induced DNA damage as well as unexpected skin 
histopathological changes occurring after acute low-dose UVB exposure.
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Psoriasis: a skin barrier disease?
Judith GM Bergboer1, Ivonne MJJ van Vlijmen-Willems1, Marijke Kamsteeg1, Masashi Narita2, 
Akemi Ishida-Yamamoto3, Patrick LJM Zeeuwen1, Joost Schalkwijk1 1Radboud University 
Nijmegen Medical Centre, Nijmegen, The Netherlands, 2Cambridge Research Institute, 
Cambridge, UK, 3Asahikawa Medical University, Asahikawa, Japan
Deletion of the late cornified envelope (LCE) genes LCE3B and LCE3C has recently been identified 
as a risk factor for psoriasis. We investigated the expression of 16 LCE genes of the LCE groups 1, 
2, 3, 5 and 6 in vivo and in vitro. Using qPCR, we found that moderate to high LCE expression 
is largely confined to skin and a few oropharyngeal tissues. Genes of the LCE3 group showed 
increased expression in lesional psoriatic epidermis, and were induced following superficial 
injury of normal skin. In contrast, expression of members of other LCE groups was downregulated 
under these conditions. Immunohistochemistry and immunoelectron microscopy showed 
that LCE2 protein expression was restricted to the uppermost granular layer and the stratum 
corneum. These data suggest that LCE proteins of groups 1, 2, 5 and 6 are involved in normal 
skin barrier function, whereas LCE3 genes encode proteins involved in barrier repair upon injury 
or inflammation. These findings may provide clues to the mechanistic role of LCE3B/C deletion 
in psoriasis.
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Cockayne syndrome revised: DNA-repair failure or ribosomopathy?
Robin Assfalg, Sylvia Koch, Omar Garcia Gonzalez, Adrian Schelling, Karin Scharffetter-
Kochanek Department of Dermatology, University of Ulm, Ulm, Germany
Cockayne syndrome(CS) is a devastating childhood disease characterized by premature aging 
traits as neurological degeneration, cataracts and cachexia followed by early infant death. 
It is a polygenic disease- the recessive mutation of five different genes can cause Cockayne 
syndrome. The gene products are all involved in nucleotide excision repair of UV-lesions so 
CS is commonly attributed as a DNA-repair disease. But a total failure of nucleotide excision 
repair is typical for XPA patients, followed by Xeroderma pigmentosum, a cancer-prone skin 
disease without childhood degeneration and infant death. Thus alternative redundant functions 
of the causal genes are investigated. Here we present evidence that all five genes involved in 
the pathogenesis of Cockayne syndrome are part of ribosomal biogenesis i.e. RNA polymerase I 
transcription. All gene products have been identified to bind to the rDNA promoter in vivo and 
gene internal regions. Three genes (CSB, XPB,XPD) are involved in transcription elongation of 
RNA polymerase I, the other two are currently under investigation. As disturbances in ribosomal 
biogenesis (“ribosomal stress”) are followed by p53 mediated cell cycle arrest and apoptosis, 
premature aging of CS patients might be due to a dysbalance between ribosomal biogenesis and 
p53 activation.
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Age Estimate of the c.6527insC Mutation Causing Recessive Epidermolisis Bullosa Dystrophic 
in Spanish Population
Carolina Sánchez-Jimeno1,2, Marta García1,2, María José Escamez1,3, Nuria Illera1,2, Jose María 
Millán4,5, Natividad Cuadrado-Corrales1,2, Marcela Del Rio3,1 1CIEMAT, Madrid, Spain, 2CIBERER 
U714, Madrid, Spain, 3Universidad Carlos III, Leganes, Madrid, Spain, 4Hospital Universitario de 
la Fe, Valencia, Spain, 5CIBERER u755, Valencia, Spain
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a genodermatosis caused by mutations 
in the COL7A1 gene and characterized by blistering of the skin following a minimal friction 
or mechanical trauma. Identification of COL7A1 mutations is a challenge since this gene 
comprises 118 exons and more than 500 mutations scattered over the gene with few prevalent 
mutations reported. The first COL7A1 mutation survey in a large Spanish RDEB cohort was 
recently carried out by our team and the c.6527insC mutation was disclosed as an unusually 
recurrent mutation. Its ancestral origin was previously suggested after the finding that all alleles 
carrying the c.6527insC mutation shared the same haplotype cosegregating with this mutation 
(CCGCTCAAA_6527insC). By extending the haplotype analysis over the 2 cM region of the 
COL7A1 gene with a total of 7 extragenic single nucleotide polymorphisms, we have been able 
to define five different haplotypes cosegregated with c.6527insC mutation that were used to 
estimate the allelic age. Two mathematical approaches were applied to date the mutation: 1) the 
program DMLE+ that uses a Bayesian inference with the Markov chain method and, 2) a Monte 
Carlo likelihood method implemented in the program BDMC21. They allowed identification of 
the likely origin of the c.6527insC mutation, in the Spanish population, between the IV and VI 
centuries BC. The present finding supports the hypothesis of the existence of a population cluster 
probably caused by high levels of inbreeding and genetic isolation rate that was seated 2400-
2600 years ago in the southwest of the Iberian Peninsula.
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Characterisation of rare variants in the RNF114 psoriasis susceptibility gene
Alexandros Onoufriadis1, David Burden2, Michael Simpson1, Richard Trembath1, Jonathan 
Barker1, Francesca Capon1 1Division of Genetics and Molecular Medicine, King’s College London, 
London, UK, 2Department of Dermatology, University of Glasgow, Glasgow, UK
Psoriasis is a chronic, inflammatory skin disorder with a multifactorial aetiology. Genetic studies 
have identified very significant disease associations for several common alleles localized within 
immune related genes. Our group has also uncovered a strong association for a cluster of 
common variants spanning the RNF114 and SPATA2 genes. As RNF114 is abundantly expressed 
in skin and immune cells, it is a more likely disease susceptibility gene at this locus. The aim of 
this study was to assess whether RNF114 was also contributing to the pathogenesis of psoriasis 
through rare variant(s) of strong effect. To achieve this purpose, we re-sequenced RNF114 in 171 
psoriatic patients with a positive family history for the disease. We found no changes in the gene 
coding sequence, but identified two novel variants mapping to the putative promoter (-33 C/A 
and -10 C/T). Neither substitution was found in a panel of 345 unrelated, healthy individuals. 
Functional experiments showed that both -33C/A and -10 C/T affect gene expression levels, due 
to a decrease in the binding affinity for the Sp1 transcription factor. Taken together, the results 
of these experiments suggest that regulatory rather than coding RNF114 alleles predispose to 
psoriasis susceptibility and that altered RNF114 expression is one of the mechanisms contributing 
to the pathogenesis of the disease.
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At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study
Emilie Sbidian1,2, Sylvie Bastuji-Garin1,3, Laurence Valeyrie-Allanore1,2, Salah Ferkal3,4, Jean-Pascal 
Lefaucheur5, Alain Drouet6, Pierre Brugière7, Cédric Vialette8, Patrick Combemale9, Sébastien 
Barbarot10, Pierre Wolkenstein1,2 1Université Paris Est, LIC EA4393, Créteil, France, 2Assistance 
Publique-Hôpital Paris, Hôpital Henri-Mondor, Service de Dermatologie, Créteil, France, 3Assistance 
Publique-Hôpital Paris, Hôpital Henri-Mondor, Pôle Recherche Clinique-Santé Publique, Créteil, 
France, 4INSERM, Centre d’Investigation Clinique 006, Créteil, France, 5Hôpital Henri-Mondor, 
Service de Physiologie-Explorations fonctionnelles, Créteil, France, 6Service de Neurologie, Hôpital 
d’Instruction des armées, Lyon, France, 7Assistance Publique-Hôpital Paris, Hôpital Henri-Mondor, 
Service de Neuroradiologie, Créteil, France, 8Assistance Publique – Hôpitaux de Paris, Hôpital Henri 
Mondor, Unité de Recherche Clinique, Créteil, France, 9Service de Dermatologie, Centre Léon 
Bérard, Lyon, France, 10Service de Dermatologie, CHU Hôtel Dieu, Nantes, France
We assessed associations between subcutaneous neurofibromas (SC-NFs) and internal neurofibromas in patients 
with NF-1 and to determine whether the association between SC-NFs and peripheral neuropathy was ascribable 
to internal neurofibromas. Prospective multicentre case-control study. Between 2005 and 2008, 110 NF-1 adults 
having two or more SC-NFs were individually matched for age, sex and hospital with 110 controls who had no 
SC-NF. Patients underwent standardized MRI of the spinal cord and an electrophysiological study. Analyses used 
adjusted multinomial logistic regression (ORa) to estimate the risk of the presence of internal neurofibromas or 
peripheral neuropathies associated with patients presented 2 to 9 SC-NFs, at least 10 SC-NFs as compared to patients 
without any (referential category). Cases had a mean age of 41 (±13) years; 85 (80%) had 2 to 9 SC-NFs and 21 
(19%) at ≥ 10. SC-NFs were more strongly associated with internal neurofibromas in patients ≥ 10 SC-NFs than in 
patients with 2 to 9 NF-SCs (aOR=29.1 [8.5 to 100] vs. 4.3 [2.1 to 9.0]). Axonal neuropathy with slowed conduction 
velocities (SCV) was more strongly associated with having ≥ 10 SC-NFs (aOR=29.9, 5.5 to 162.3) than with having 
fewer SC-NFs (aOR=4.4, 0.9 to 22.0). Bivariate analyses showed that the association between axonal neuropathy 
with SCV and internal neurofibromas was mediated by the association between SC-NFs and internal neurofibromas. 
We concluded that the at-risk phenotype of NF-1 patients (SC-NFs) is ascribable to associations linking SC-NFs to 
internal neurofibromas at risk for malignant transformation and to axonal neuropathies with SCV.
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Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 
in France
Tu Anh Duong1,2, Emilie Sbidian1,5, Laurence Valeyrie-Allanore1,4, Cedric Vialette6, Salah Ferkal4,6, Smail Hadj-Rabia7, 
Christophe Glorion8, Stanislas Lyonnet9, Michel Zerah10, Isabelle Kemlin11, Diana Rodriguez11, Sylvie Bastuji-Garin3,5, 
Pierre Wolkenstein1,4 1Dept of Dermatology Hop Henri Mondor, Creteil, France, 2Univ Paris Est, Creteil, France, 3Pôle 
Recherche Clinique-Santé Publique Hop Henri Mondor, Creteil, France, 4Centre de référence des Neurofibromatoses, 
Creteil, France, 5Univ Paris Est, LIC EA4393, Creteil, France, 6Univ Paris Est, INSERM, Centre d’Investigation Clinique 006, 
Creteil, France, 7Hôp Necker-Enfants Malades, Service de Dermatologie, Centre de référence des Maladies Génétiques 
à Expression Cutanée, Paris, France, 8Hôp Necker-Enfants Malades, Service d’Orthopédie, Paris, France, 9Hôp Necker-
Enfants Malades, Service de Génétique, Paris, France, 10Hôpital Necker-Enfants Malades, Service de Neurochirurgie, 
Paris, France, 11Hôp Trousseau, Service de Neuropédiatrie, Paris, France, 12Univ Pierre et Marie Curie, Paris, France
Neurofibromatosis 1 (NF1) is associated to a 15-year decrease in life expectancy. Our aim was to evaluate mortality in 
a large retrospective cohort of NF1 patients seen in France between 1980 and 2006. The standardized mortality ratio 
(SMR) with its 95% confidence interval (CI) was calculated as the ratio of observed over expected numbers of deaths. 
We studied factors associated with death and causes of death.1895 NF1 patients were seen. Median follow-up was 
6.8 years (range, 0.4-20.6). Vital status was available for 1226 (65%) patients, of whom 1159 (94.5%) survived and 67 
(5.5%) died. Overall mortality was significantly increased in the NF1 cohort (SMR, 2.02; CI, 1.6-2.6; P<10-4). The excess 
mortality occurred among patients aged 10 to 20 years (SMR, 5.2; CI, 2.6-9.3; P<10-4) and 20 to 40 years (SMR, 4.1; 
2.8-5.8; P<10-4). Significant excess mortality was found in both males and females. In the 10-20 year age group, females 
had a non significant increase in mortality compared to males (SMR, 12.6; CI, 5.7-23.9; and SMR, 1.8; CI, 0.2-6.4; 
respectively). The cause of death was available for 58 (86.6 %) patients; malignant nerve sheath tumor was the main 
cause of death (60%). We concluded that mortality was significantly increased in NF1 patients aged 10 to 40 years and 
tended to be higher in females than in males. The definitive diagnosis of NF1 in all patients is a strength of our study, 
and the high rate of death related to malignant transformation is consistent with previous work.
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Apoptosis of keratinocytes is a key mechanism in UVB-induced clearance of psoriasis
Sophie Weatherhead1,2, Peter Farr2, Daniel Swan1, David Jamieson1, Jennifer Hallinan1, James 
Lloyd2, Anil Wipat1, Nicholas Reynolds1,2 1Newcastle University, Newcastle-upon-Tyne, Tyne and 
Wear, UK, 2Royal Victoria Infirmary, Newcastle-upon-Tyne, Tyne and Wear, UK
The mechanisms underlying UVB-induced clearance of psoriasis are incompletely understood. 
We compared the cellular and molecular effects of a clinically effective wavelength of UVB 
(311nm) with a clinically ineffective wavelength (290nm) in vivo and in vitro to distinguish 
bystander effects and utilised a systems biology approach to understand functional significance. 
84 adult psoriatic patients were recruited. Biopsies were taken from lesional (plaque) skin before 
and 4-48h after irradiation with equi-erythemogenic doses of 311 and/or 290nm UVB (0.75-3.0 
MED). A significant increase in the numbers of apoptotic epidermal cells (active-caspase-3+ cells) 
was seen after a single irradiation with 2-3 MEDs 311 nm UVB compared to 2-3 MEDs 290 nm 
UVB or untreated psoriasis (median 12/1000, 0/1000 and 0/1000 epidermal cells respectively; 
p<0.001). Routine clinical doses of 311nm also induced apoptosis. Immunochemistry and 
electron microscopy showed that the vast majority of apoptotic cells were keratinocytes. Live cell 
imaging of irradiated cultured keratinocytes and mathematical modelling showed that the rate of 
keratinocyte apoptosis observed in vivo was sufficient to account for clearance of psoriasis. Gene 
array analysis was used to examine differential gene regulation at these early time-points, prior 
to clinical response. Apoptosis and control of cell cycle pathways were affected by 311nm but 
not 290nm UVB. CDKN1A (WAF1/p21) showed the greatest fold change (27 fold up-regulation) 
following irradiation with 311nm UVB but not 290nm. Together these data provide evidence 
that epidermal keratinocyte apoptosis is a key mechanism in psoriasis resolution and identifies 
keratinocyte apoptosis as a potential target for future drug development.
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Synthesis and characterization of non-viral liposomal carriers for the local application of siRNA 
molecules and anti-miRNAs in the therapeutic treatment of psoriasis
Stefanie Bracke1, Barbara Geusens1, Peter Dynoodt1, Mireille Van Gele1, Reinhart Speeckaert1, 
Sandra Tjabringa2, Joost Schalkwijk2, Jo Lambert1 1Department of Dermatology, Ghent University 
Hospital, Ghent, Belgium, 2Department of Dermatology, Radboud University Nijmegen Medical 
Centre, Nijmegen, The Netherlands
Psoriasis is a common inflammatory skin disease with a multifactorial genetic basis. A 
dysregulated interplay between keratinocytes and infiltrating immune cells underlies the 
cutaneous inflammation in psoriasis. Keratinocytes are important producers of antimicrobial 
peptides such as hBD-2 and LL37 and cytokines such as TNF-alpha, which are essential elements 
in this process of cell-cell communication. Recently miRNA-203, was identified as an important 
contributor to this dysfunctional cross talk. We have previously developed a new lipid-based 
nanosome (SECosome) that enables the effective delivery of siRNA into human skin. The aim 
of this project is to knockdown mRNA encoding hBD-2, LL37, TNF-alpha and miRNA-203 
by tranfection of keratinocytes with SECosomes for the delivery of siRNAs and anti-miRNAs. 
Ultimately, we want to create a new therapy for psoriasis by intervening at genetic level by means 
of a topical therapy. An optimized cytokine mix was used to induce a psoriatic phenotype starting 
from normal human keratinocytes. Complexes of siRNA or anti-miRNA and SECosomes were 
made and validated prior to transfection. 24h post-tranfection, qPCR analysis was performed to 
evaluate mRNA expression levels. Transfection experiments with the complexes showed a stable 
knockdown efficiency of more than 80% of hBD-2, LL37, TNF-alpha and miR-203 mRNA. In this 
in vitro work we prepared and characterized siRNA and anti-miRNA complexes with SECosomes 
against hBD-2, LL37, TNF-alpha and miR-203 respectively. These complexes efficiently knock-
down the targeted genes with concomitant downregulation of the associated proteins. Hereafter 
we will test the therapeutic applicability of our complexes in xenografted psoriatic skin by topical 
application.
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Mutations in TGM1 in Ecuadorians with autosomal recessive congenital ichthyosis
Hector Zambrano1, Martha Montalvan3, Anita Farhi2, Ying Lu2, Catherine Yang1, Jimmy Cabezas3, 
Richard Lifton2, Leonard Milstone1, Keith Choate1,2 1Yale University, Department of Dermatology, 
New Haven, CT, USA, 2Yale University, Department of Genetics, New Haven, CT, USA, 3Catholic 
University, School of Medical Technology, Guayaquil, Ecuador
There have been few genetic studies of ARCI in South America and none have been performed 
in Ecuador. We set out to determine the genetic basis of ARCI in a cohort of unrelated eleven 
Ecuadorian kindreds. We sequenced the exons and exon/intron boundaries of transglutaminase-
1(TGM1) in index cases. TGM1 mutations were identified in all kindreds. Nine cases showed 
homozygous mutation and two were compound heterozygous. Nine kindreds shared at least 
one mutant allele. In seven cases, a homozygous G to A nucleotide substitution was present in 
exon 7 (c.1187G>A) resulting in an arginine to histidine amino acid substitution (p.R396H). In 
one kindred, there was a homozygous G to A substitution in exon 2 (c.425G>A) which results 
in an arginine to histidine amino acid substitution (p.R142H). In two kindreds, compound 
heterozygous mutations were identified: both shared the exon 7 c.1187G>A substitution with 
one having an exon 14 C to T substitution (c.2278C>T) which results in premature termination 
(p.R760X) and the other demonstrating an exon 13 frameshift c.2149delC which results in a 
frameshift and premature termination (p.L716FfsX33); the latest is an unreported mutation. 
We also found this novel mutation in other kindred, as a homozygous deletion.Our findings 
demonstrate a high prevalence of TGM1 mutations in Ecuadorian ARCI and describe a mutation 
not reported in prior studies. The finding of a single mutation in multiple apparently unrelated 
kindreds strongly suggests the possibility of a founder effect which may account for a large 
proportion of ARCI cases in Ecuador.
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Global Analysis of Transcription Reveals BCSC-1 as a Melanoma Tumor Suppressor that 
Downregulates MITF
Silvia Anghel1, Rafael Correa-Rocha1,2, Eva Budinska3,4, Kayluz Frias Boligan1,5, Lionel 
Fontao1, Ghanem E Ghanem7, David E Fisher8, Frederic Lévy6,9, Mauro Delorenzi3,10, Vincent 
Piguet1,11 1Depts of Dermatology & Venereology, Microbiology & Molecular Medicine Univ 
Hosp & Med School of Geneva, Switzerland, 2Lab of Molec Immunobiology, Hosp General Univ 
Gregorio Marañon, Madrid, Spain, 3Swiss Inst Bioinformatics, Univ of Lausanne, Switzerland, 
4Inst of Biostatistics & Analyses, Masaryk Univ, Brno, Czech Republic, 5Nat Inst of Oncology & 
Radiobiology, Dept of Basic Research, Havana, Cuba, 6Ludwig Inst for Cancer Research, Univ of 
Lausanne, Epalinges, Switzerland, 7Lab d’Oncologie et Chirurgie Expérimentale, Inst J. Bordet, Univ 
Libre de Bruxelles, Belgium, 8Dept of Dermatology, Massachusetts General Hospital, Harvard Med 
School, Boston, USA, 9Debiopharm SA, Lausanne, Switzerland, 10Nat Center of Competence in 
Research Molecular Oncology, ISREC-SV-EPFL, Lausanne, Switzerland, 11Dept of Dermatology & 
Wound Healing, The Welsh Inst of Dermatology, Cardiff Univ & Univ Hosp of Wales, Cardiff, UK
Understanding the molecular aberrations involved in the development and progression of 
metastatic melanoma is essential for a better diagnosis and targeted therapy. Here we report the 
identification of BCSC-1 as a novel tumor suppressor in melanoma using a global analysis of 
alternative spliced variants. By using the in silico analysis of human publicly available microarray 
data, qRT-PCR and Western blot techniques on human biopsies we confirmed that BCSC-1 
expression is decreased in human metastatic melanoma and in melanoma cell lines. Moreover, 
its ectopic expression blocks tumor formation in vivo and melanoma cells proliferation in vitro. 
We demonstrate that BCSC-1 downregulates MITF at the transcriptional level via its interaction 
with Sox10, resulting in a switch of melanoma cells from a proliferative to a migratory phenotype. 
In conclusion, we identify BCSC-1 as a novel regulator of MITF, which could be used as a marker 
for melanoma progression and prognosis.
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Mutational analyses in Papillon-Lefèvre syndrome
Noriko Takiyoshi1, Daisuke Matsuura2, Ayano Umekoji4, Atsuko Kato4, Hajime Nakano1, Yuka 
Toyomaki1, Eijiro Akasaka1, Daiki Rokunohe1, Yoshihiko Mitsuhashi3, Daisuke Sawamura1, 
Toyoko Ochiai2 1Department of Dermatology,Hirosaki University Graduate School of Medicine, 
Hirosaki, Japan, 2Department of Dermatology,Nihon University Surugadai Hospital, Tokyo, 
Japan, 3Department of Dermatology,Tokyo Medical University, Tokyo, Japan, 4Department of 
Dermatology,Osaka Kaisei Hospital, Osaka, Japan
Papillon-Lefèvre syndrome (PLS) is a rare autosomal recessive disorder characterized by 
palmoplantar keratosis and early-onset periodontitis that leads to the loss of primary and 
secondary teeth. PLS is caused by mutations in the gene coding for cathepsin C (CTSC), which is 
located on chromosome 11q14-q21. CTSC is a lysosomal cysteine proteinase that activates many 
serine proteinases in immune/inflammatory cells. So far, there have been more than 60 different 
CTSC mutations reported. We performed mutational and functional analyses of CTSC in three 
Japanese families with PLS and identified three novel mutations. A nonsense mutation c.637C>T 
(p.Gln225X) was identified in two unrelated consanguineous families. In the third family, the 
proband was a compound heterozygote for c.969_972del4 (p.324QfsX9) and c.IVS3+5G>A. By 
cloning of the CTSC cDNA using total RNA prepared from the proband’s leukocytes, we found 
that at least two splicing variants transcribed from the allele harboring c.IVS3+5G>A. In addition, 
we confirmed that the CTSC mRNA expression level determined by quantitative RT-PCR was 
only about one-eighth of that in healthy controls. Furthermore, immunoblotting revealed that 
the heavy and light chains of CTSC, mature peptides having enzymatic activity, were hardly 
detectable. Our findings strongly suggest that not only DNA but also RNA and protein analyses 
are crucial for precise molecular diagnosis of PLS.
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The role of p63 in cochlea development and in sensorineural deafness in EEC syndrome
Alessandro Terrinoni1, Valeria Serra1, Hans van Bohkoven2, Andrea Codispoti1, Gerry Melino1,3 
1IDI-IRCCS Biochemistry Laboratory, c/o University of Tor Vergata, Dep. Experimental Medicine, 
Via Montpellier, 1, Rome, Italy, 2Radboud University Nijmegen Medical Centre, Nijmegen, The 
Netherlands, 3Medical Research Council, Toxicology Unit, Hodgkin Building, Leicester University, 
Leicester, UK
The ectodermal dysplasia (ED) syndromes are a group of inherited autosomal dominant human 
diseases. The prototype is the Ectrodactyly, Ectodermal dysplasia and Cleft lip/palate (EEC) 
syndrome. It is characterised clinically by ectodermal dysplasia affecting the skin, hair, nails and 
teeth, and by facial clefts. In addition, EEC patients show lachrymal duct abnormalities, urogenital 
problems, hearing loss and facial dimorphism. Heterozygous mutations in the p63 gene have 
been identified in EEC syndrome patients. p63 function is important in epithelial formation and 
it has been suggested that p63 is also important in the development and maintenance of other 
tissues/organs. Indeed, some patients affected by EEC syndrome show varying levels of deafness, 
from conductive to sensorineural. Using the mouse p63(-/-) model, (p63 knockout), and wt (wild 
type), we investigated the role of p63 in cochlea development to understand the mechanism of 
the sensorineural deafness phenotype in EEC patients. Transcriptional analysis of TAp63α and 
ΔNp63α isoforms shows that the genes of Notch pathway involved in cochlear neuroepithelial 
development are regulated by these proteins. Our studies show, that the transcription factor p63 is 
involved in the development of the organ of Corti in mice. In humans, the syndromes associated 
with p63 have been extensively studied over the years. The discovery that the sensorineural 
hearing loss is attributable to a loss of function of p63 emphasises the need to include this gene 
in the genetic analysis of hearing disorders.
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A newly identified missense mutation of the HR gene is possibly associated with a novel 
phenotype of Marie Unna Hereditary Hypotrichosis 1
Katalin Farkas1, Nikoletta Nagy1,2, Dóra Beke1, Ágnes Kinyó1, Lajos Kemény1,2, Márta Széll2 
1Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary, 
2Dermatological Research Group of the Hungarian Academy of Sciences, Szeged, Hungary
Marie Unna Hereditary Hypotrichosis 1 (MUHH1; OMIM 146550) is an autosomal dominant 
condition characterized by the development of sparse, twisted hair or complete hair loss affecting 
the scalp only (alopecia totalis) or other hair bearing areas (alopecia universalis). Besides 
hypotrichosis, other symptoms rarely occur. MUHH1 is the consequence of mutations located in 
the hairless (HR) gene. Recently we have identified a Hungarian family with one family member 
affected by alopecia universalis and limb deformities of all four extremities. The limb deformities 
were already present at birth, while the hair loss was developed shortly after birth. We aimed 
to identify the underlying genetic abnormality of this MUHH1 case. Direct sequencing of the 
coding regions and the flanking introns of the HR gene revealed a novel mutation in the third 
exon of the HR gene (c.974G/A, p.Gly325Asp). The affected family member carried the mutation 
in a heterozygous form, while the clinically unaffected family members and the unrelated 
controls carried only the wild type sequence. Further studies are needed to unreveal whether the 
newly identified mutation is responsible for both the hair and limb deformities.
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Association of vascular endothelial growth factor gene polymorphisms with psoriasis in Polish 
population
Monika Zablotna, Boguslaw Nedoszytko, Michal Sobjanek, Jolanta Glen, Jadwiga Roszkiewicz 
Department of Dermatology, Medical University of Gdansk, Gdansk, Poland
Neovascularization plays an important role in pathogenesis of psoriasis and vascular endothelial 
growth factor (VEGF) seems to be the main angiogenic factor involved in this disease. Published 
studies which analyzed the role of VEGF gene polymorphism in psoriasis were limited and the 
received controversial results. The aim of our study was to evaluate the association between 
-1154 G/A, -460 T/C and +405 G/C polymorphisms and the psoriasis susceptibility and to 
determine whether this genetic variation influence levels of VEGF protein expression. Two 
hundred and six patients with psoriasis and 215 ethnically matched controls were genotyped 
using ARMS-PCR and PCR-RFLP methods. VEGF serum levels were assessed in 47 patients and 
40 controls using ELISA test. We noted that an increased risk of type I psoriasis is associated 
with -1154 G allele (OR=1.9; p=0,04), +405 CC (OR=2.86; p=0,03) and -460 TT (OR=1.56; 
p=0,05) genotypes and demonstrated that a significantly increased risk of developing disease 
is related to presence of haplotype GTC among all patients (OR=1,97; p=0,001) and patients 
with type I psoriasis (OR=1,87;p=0,005). We have found significantly increased serum levels of 
VEGF in patients with psoriasis compared with healthy controls (p=0,008). Serum levels of VEGF 
significantly correlated with PASI: r=0.72, p<0,00001. Patients with elevated levels of VEGF in 
the serum showed more frequently : GC genotype (p=0,04), C allele (p=0,02) at the locus +405 
and TT genotype (p=0,03) at the locus -460. Our results strongly supports the role of VEGF gene 
polymorphism in the pathogenesis of psoriasis.
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Interleukin-13 promoter gene polymorphism -1112 C/T is associated with atopic dermatitis in 
Polish patients
Jolanta Glen, Boguslaw Nedoszytko, Magdalena Trzeciak, Malgorzata Sokolowska-Wojdylo, 
Aleksandra Wilkowska, Monika Zablotna, Jadwiga Roszkiewicz Department of Dermatology, 
Medical University of Gdansk, Gdansk, Poland
Interleukin 13 (IL-13) is one of the major cytokine involved in IgE synthesis in atopic dermatitis 
(AD). IL-13 gene has been mapped on chromosome 5q31-33 region associated with atopic 
conditions and several polymorphisms are described. The aims of study were to establish 
the frequency of the IL-13 gene polymorphism and its relation to serum IgE and IL-13 levels 
and SCORAD. In the 180 AD patients and 167 healthy persons the -1112 C/T IL-13 gene 
polymorphism were genotyped using allele-specific PCR method. Detection of serum total IgE 
level was measured by Uni-CAP 100 System. IL-13 level was measured using ELISA standard kit. 
The -1112T allele frequency was significantly higher in patients with AD compared to control 
(P=0.00001). TT and CT genotypes were correlated with increased serum tIgE concentration 
(P=0.0004). The TT genotype was associated with severe, CT genotype with moderate, whereas 
CC genotype with mild course of AD (P=0.0008). Both CT and TT genotypes dominated in cases 
of AD with concomitant asthma, CC genotype was not found in any case in this group (P=0.03). 
The average levels of serum IL-13 and tIgE were significantly higher in AD with concomitant 
asthma than in cases without (IL-13 P=0.03; tIgE P=0.0001 respectively). The positive correlation 
between concentration of serum IL-13 and severity of AD assessed by SCORAD index was found 
(P=0.0005). This correlation was also confirmed for tIgE and SCORAD (P=0.0000001). Our 
results confirm the significant role of -1112 C/T IL-13 gene polymorphism in the pathogenesis 
of AD.
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Modelling of Hailey-Hailey disease through silencing mRNA for the SPCA1
Laura Raiko1, Juha Peltonen1, My Mahoney2, Sirkku Peltonen1 1University of Turku, Turku, Finland, 
2Thomas Jefferson University, Philadelphia, PA, USA
Hailey-Hailey disease (HHD, OMIM 16960) is an autosomally inherited blistering skin disease 
with prevalence of about 1:40 000. HHD is caused by mutations in the ATP2C1 gene encoding 
a calcium-manganese pump SPCA1 which is located in the Golgi membranes. We modelled 
HHD using normal keratinocytes in which the mRNA for the SPCA1 was downregulated with 
the siRNA method. This resulted in a significant down-regulation of the SPCA1 mRNA as 
estimated by qPCR, and decrease of the SPCA1 protein beyond detectable level in keratinocytes 
as shown by western blotting. The expression of intercellular junction proteins (desmoplakin, 
desmoglein-3, betacatenin, e-cadherin, claudins 1 and 4, ZO-1, occludin) was then studied 
in the SPCA1-deficient and control keratinocytes cultured in high (1.2 mM) or low (0.06 mM) 
calcium concentration. As expected, the protein levels of the junction components were up-
regulated in non-treated control keratinocyte cultures upon the switch from low to high calcium 
concentration. In contrast, SPCA1-deficient keratinocytes displayed higher levels of most 
junction proteins studied (claudin-1 and 4, occludin and desmoplakin) already when maintained 
in low calcium concentration, and the switch from low to high calcium concentration did 
not significantly alter this expression level. The results suggest that the inhibition of ATP2C1-
gene may disturb the calcium homeostasis in Golgi apparatus which in turn may affect several 
different intercellular junction proteins representing desmosomal, adherens and tight junction 
components.
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Screening for high efficient double RNA trans-splicing molecules to exchange a single exon of 
the COL17A1 gene
Ulrich Koller1, Verena Wally1, Lloyd G Mitchell2, Alfred Klausegger1, Eva M Murauer1, Elisabeth 
Mayr1, Christina Gruber1, Stefan Hainzl1,3, Helmut Hintner1, Johann W Bauer1 1Division of 
Molecular Dermatology and EB House Austria, Dept of Dermatology, Paracelsus Medical 
University, Salzburg, Austria, 2RetroTherapy, Bethesda, USA, 3Lab for Immunological and 
Molecular Cancer Research, Third Medical Dept, Paracelsus Medical University, Salzburg, Austria
RNA trans-splicing is an approach to reprogram a target gene on pre-mRNA level. It may serve 
as an alternative repair strategy in genetic diseases, in which large genes preclude cDNA-based 
gene therapy strategies. So far, RNA trans-splicing has been applied to reprogram 5` or 3` 
portions of target genes. Internal exon replacement by the combination of 5’ and 3’ RNA trans-
splicing has not been investigated thoroughly. In this work we systematically demonstrated the 
ability to exchange exon 52 of the target gene COL17A1. We developed a novel fluorescence 
based screening system to compare the trans-splicing efficiency of various “RNA trans-splicing 
molecules” (RTMs) that bind to the 5`and 3` introns flanking the target exon to exchange. The 
reporter molecule GFP acts as marker for specific double trans-splicing events between the RTM 
and a COL17A1 mini gene in vitro. The RTM, capable of performing two targeted trans-splicing 
reactions, contains the middle part of GFP. The COL17A1 mini gene harbors the genomic target 
sequence of COL17A1 (intron 51 - exon 52 - intron 52) flanked by the 5’ and 3’ portion of GFP. 
Two RTMs of the RTM library induced double trans-splicing in up to 60% of all analyzed cells, 
manifested in high levels of GFP expression. Using this tool for designing optimal RTMs for 
internal exon replacement by RNA trans-splicing will reduce time and effort required to select 
optimal RTMs prior testing them in endogenous gene expression model systems.
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A 5´trans-splicing gene therapy approach for dystrophic epidermolysis bullosa
Elisabeth Mayr1, Ulrich Koller1, Eva M Murauer1, Christina Gruber1, Alfred Klausegger1, Manfred 
Kaiser1, Leena Bruckner-Tuderman2, Helmut Hintner1, Johann W Bauer1 1Division of Molecular 
Dermatology and EB House Austria, Department of Dermatology, Paracelsus Medical University 
Salzburg, Salzburg, Austria, 2Department of Dermatology, University Medical Center Freiburg, 
Freiburg, Germany
Mutations in COL7A1, the gene coding for type VII collagen, are the cause of dystrophic 
epidermolysis bullosa, a heritable mechanobullous skin disease. Because of its size COL7A1 
exceeds the packaging capacity of most viral vectors commonly used for delivery in gene 
therapy. Furthermore endogenous regulation of expression is crucial in tissue with a complex 
differentiation program. Therefore we chose a mRNA based gene therapy to repair defects in the 
COL7A1 gene by trans-splicing. We developed repair molecules for keratinocytes of collagen 
VII hypomorphic mice showing a phenotype comparable to dystrophic epidermolysis bullosa.To 
select the best molecules to correct mutations in the 5´part of COL7A1 we used a fluorescence-
based screening procedure to evaluate a library of randomly cloned pre-trans-splicing-
molecules. Thereby we identified molecules with a repair-rate of up to 94% in our test system in 
Hek293FT cells. The endogenous functionality in murine keratinocytes was proven by RT-PCR 
and sequencing. Transient transfection of two different PTMs, which have shown a high repair 
rate in the screen, into murine wildtype keratinocytes led to detection of GFP-COL7A1 fusion 
mRNAs as a result of specific and functional endogenous trans-splicing. Endogenously functional 
test molecules will be adapted to exchange the 5´ part of murine COL7A1 and therefore be 
able to correct mutations situated in the first 15 exons of murine COL7A1 and recover type VII 
collagen expression in keratinocytes of collagen VII hypomorphic mice.
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Whole Genome (Exome) Sequencing of Xeroderma pigmentosum patients reveals a finite and 
distinct pattern of mutations in pathophysiologically relevant genes
Peter Bauer, York Kamenisch, Claudia Bauer, Martin Röcken, Olaf Riess, Mark Berneburg 
University Tübingen, Tübingen, Germany
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease clinically characterized by 
photosensitivity, xerosis cutis, poikiloderma, telangiectasia and a 1000-fold increased risk to 
develop skin cancer. Patients with XP are defective in nucleotide excision repair a mechanism 
responsible for removal of bulky helix-distorting DNA damage mainly induced by ultraviolet 
(UV) radiation. When UV-induced DNA damage is not removed from the genome, the remaining 
photoproducts will give rise to UV-signature mutations such as C to T and CC to TT transitions. 
While in XP patients it has been shown that isolated genes such as p53 harbor such mutations, thus 
far it was technically impossible to comprehensively investigate the exome of the whole human 
genome. In this study, we identified somatic mutations in DNA from two patients suffering from XP 
complementation group C. Skin samples of sun-exposed and non-exposed skin were compared 
to the respective germline genomes derived from blood of the patient. Exome-Sequencing was 
performed using sequence capture (NimbleGen EZ1) followed by next-generation sequencing. 
Exome sequencing in PBCs enabled us to subtract the germline genome, leaving the 
somatic changes in XP. Although analysis are still under way, preliminary data demonstrate 
an over-representation of C>T and CC>TT transitions in skin cells (less than 500 in total). 
This study indicates that even in DNA repair deficient tissues with a presumed mutator 
phenotype, only a finite number of somatic mutations is present in skin samples exposed to the 
relevant genotoxic stress. These findings could shed new light on the relations of DNA mutations 
and cancer susceptibility.
405
Novel and recurrent TGM5 mutations in fourteen patients with acral peeling skin syndrome
Manuela Pigors1, Dimitra Kiritsi1, Jürgen Kohlhase2, Leena Bruckner-Tuderman1, Cristina Has1 
1Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany, 2Center for 
Human Genetics Freiburg, Freiburg, Germany
Acral peeling skin syndrome (APSS) is an autosomal recessive skin disorder characterized by 
acral blister formation and peeling of the outermost layers of the epidermis. So far, three different 
missense mutations in the transglutaminase 5 gene, TGM5, have been reported in patients with 
APSS. Interestingly, we identified the TGM5 mutation p.G113C in all patients in our APSS cohort 
of fourteen unrelated individuals and in a heterozygous state in three of 100 ethnically matching 
control individuals, suggesting that it is a recurrent mutation in the European population, possibly 
of ancestral inheritance. In addition, we extended the TGM5 mutation database by two novel 
mutations: p.L41P and c.640delC, whereby latter one is the first TGM5 mutation predicted to 
lead to a premature termination codon. Using quantitative real-time PCR, immunofluorescence, 
and immunoblot analysis we investigated the expression and distribution of transglutaminase 5, 
corneodesmosin as well as differentiation markers in the skin of four APSS patients, and showed 
that they are altered on both RNA and protein level. Furthermore, we demonstrated that the 
typical distribution of the symptoms on extensor areas of the extremities correlates with the 
preferential expression of transglutaminase 5 in skin of trunk and extremities. Our results give 
new insights into functional consequences of transglutaminase 5 mutations and also indicate that 
APSS might be more widespread than expected among the European population, but remains 
undiagnosed in most cases due to its mild phenotype.
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Absence of pathogenic γ-secretase mutations in familial and sporadic acne inversa in a 
European population
John R Ingram1, Michelle Wood2, Bethan John2, Rachel Butler2, Alex V Anstey1 1Aneurin Bevan 
Health Board, Newport, UK, 2University Hospital of Wales, Cardiff, UK
A recent study of severe acne inversa (AI, previously hidradenitis suppurativa) in Han Chinese 
families in Science identified pathogenic mutations in genes encoding subunits of γ-secretase, 
and this study was designed to check for reproducibility in a European AI population. Acne 
inversa patients conforming to a consensus disease definition were recruited from a secondary 
care outpatient setting. Following a detailed history and clinical examination, genomic DNA 
was extracted from venous blood-EDTA samples. Primers were designed to amplify the coding 
regions of the four γ-secretase genes NCSTN, PSENEN, PSEN1 and APH1A and these were Sanger 
sequenced. Twenty Caucasian AI patients were recruited, twelve with a family history of the 
condition and eight sporadic cases. The majority of patients were current smokers and obese, 
with a median BMI of 34. Analysis of the phenotype of familial and sporadic cases demonstrated 
no significant differences after correction for multiple comparisons. No pathogenic mutations 
were found in NCSTN, PSENEN, PSEN1 and APH1A. One variant with the potential to affect 
splicing, c.1180-5C>G (rs752638), was found in intron 11 of NCSTN in a familial AI patient 
but this single nucleotide polymorphism has a minor allele frequency of 12.4% in the European 
population (HapMap-CEU). The absence of pathogenic γ-secretase mutations in our patients may 
be due to downstream mutations in the γ-secretase-Notch pathway. This is supported by animal AI 
models resulting from a deficiency in Notch1. An alternative explanation is phenotypic disparity 
between our patients and the relatively severe atypical AI phenotype of the Han Chinese families.
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Investigation of ABCC6 in Japanese patients with Pseudoxanthoma elasticum
Akira Iwanaga1, Mariko Yozaki1, Tomoo Ogi2, Miki Tanioka3, Hiroshi Tamura7, Takashi Kitaoka4, 
Koji Maemura5, Yosuke Yamamoto6, Atsushi Utani1 1Department of Dermatology, Nagasaki 
University Graduate School of Biomedical Sciences, Nagasaki, , Japan, 2Department of Molecular 
Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical 
Sciences, Nagasaki, Japan, 3Department of Dermatology, Kyoto University Graduate School 
of Biomedical Sciences, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan, 4Department 
of Ophthalmology and Visual Sciences, Nagasaki University Graduate School of Biomedical 
Sciences, Nagasaki, Japan, 5Department of Cardiovascular Medicine, Nagasaki University 
Graduate School of Biomedical Sciences, Nagasaki, Japan, 6Department of Epidemiology and 
Healthcare Reserch, Kyoto University Graduate School of Biomedical Sciences, Shogoin, Sakyo-
ku, Kyoto, Japan, 7Department of Ophthalmology and Visual Sciences, Kyoto University Graduate 
School of Biomedical Sciences, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
Pseudoxanthoma elasticum (PXE) primarily affects organs that are abundant in elastic fibers, such 
as the skin, eye and blood vessels, and may eventually cause loss of vision or cardiovascular 
disease (CVD). PXE is caused by mutations in the ABCC6 (ATP binding cassette family C member 
6) gene, which encodes MRP6 (multidrug resistance-associated protein 6). The ABCC6 gene is 
encoded in 31 exons and translated into a 165 kDa protein of 1503 amino acids. Because vision 
loss and CVD are serious problems, its early detection is important for improving the quality of 
life of PXE patients. We investigated mutation in ABCC6 gene in Japanese patients with PXE. We 
are continuing the study and have already finished analysis of 4 patients at present. We detected 
a novel nonsense mutation in the ABCC6 gene. Furthermore, we report an epidemiology of more 
than a hundred Japanese PXE patients.
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Association of systemic mastocytosis with Toll- like receptor 2 gene polymorphism in Polish 
population
Boguslaw Nedoszytko1, Magdalena Lange1, Monika Zablotna1, Marek Niedoszytko2, Jolanta 
Glen1, Jadwiga Roszkiewicz1 1Department of Dermatology Medical University of Gdansk, 
Gdansk, Poland, 2Department of Allergy Medical University of Gdansk, Gdansk, Poland
Mastocytosis is a rare heterogenous disease characterized by aberrant proliferation and 
accumulation of mast cells in different tissues. Mastocytosis is considered a clonal disease of the 
bone marrow, usually associated with an activating point mutation of the c-KIT gene. However, 
numerous aspects of mastocytosis pathogenesis remains unclear. Several Toll- like receptors (TLR) 
are expressed on surface of MC and they play the role in microbial detection, anaphylactic 
reaction and immune system regulation. It has been published that gene polymorphism affects 
TLR function in several diseases, including sepsis, immunodeficiences, atherosclerosis and 
asthma. There is no data on that subject in mastocytosis. The aim of the study was to compare the 
frequency of TLR-2 Arg753Gln, TLR-4Asp299Glu and TLR-9/ -1237 C/T genes polymorphisms in 
patients with mastocytosis and in healthy controls. A total of 147 patients with mastocytosis (84 
with systemic and 96 with cutaneous form of the disease) diagnosed according to WHO criteria 
and 171 healthy controls were analyzed. Study group included 94 adults and 53 children. We 
found that mastocytosis patients had more frequently gene coding nonfuctional TLR-2 Gln753 
receptor (p=0,02) when compared with control group and it was associated with systemic form 
of disease (OR =3,4; CI:2,4-9,28; p=0,017). No differences in the frequency of TLR-4 and TLR-9 
polymorpisms between mastocytosis patients and control group were found, as well as between 
cutaneous and systemic mastocytosis cases. In conclusion, the results of our study suggest that 
TLR-2 gene variant coding nonfunctional receptor may play some role in the pathogenesis of 
mastocytosis.
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Filaggrin gene mutations in Mexican-mestizo patients: Correlation between Raman spectroscopy 
and genetic test (PCR and RFLP)
Rodrigo Valdes-Rodriguez1,2, Francisco Javier Gonzalez1,3, Claudio Castillo-Martinez1,2, 
Victor Saavedra-Alanis1, Ana Guevara-Velez1, Bertha Torrres-Alvarez1,2, Miguel Ramirez-
Elias1,3 1Universidad Autonoma de San Luis Potosi, San Luis Potosi, Mexico, 2Departamento de 
Dermatologia Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico, 3Instituto de 
Investigacion en Comunicacion Optica, San Luis Potosi, Mexico
Filaggrin (FLG) is a key protein required for the formation of the stratum corneum. In the European 
population carriers of filaggrin gene mutations have at least a 3-fold increased risk of developing 
atopic dermatitis (AD), being thus the strongest risk factor for AD known to date. Raman 
spectroscopy is a non-invasive and non-destructive technique that gives the molecular composition 
of a sample and can be used to detect the relative levels of a given molecule. In this study, we 
analyzed 30 patients with pruritus and dry skin. Raman spectroscopy was performed on the inner 
area of the forearm, while for the genetic analysis of the R501X and 2284del4 mutations DNA 
was extracted from buccal swabs and PCR and RFLP was performed. Our results show that 8 out 
of 30 (27%) patients presented the 2282del4 FLG mutation, 2 of which where homozygous and 6 
heterozygotes, whereas 1 (3.3%) was heterozygote for the R501X mutation and 1 was compound 
heterozygote for both. A numerical correlation was performed between the Raman spectra (RS) of 
the skin of the patients and the RS of pure filaggrin protein in order to determine the FLG content. RS 
were compared to the genetic analysis. The correlation showed that 7 out of the 8 patients with the 
2282del4 FLG mutation and the one patient with the R501X mutation presented low FLG content 
as measured with Raman spectroscopy. These results suggest that Raman spectroscopy might be a 
non-invasive tool that could predict the presence of truncating FLG gene mutations.
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In-vitro disadvantage of type XVII collagen revertant keratinocytes when cultured for revertant 
cell therapy
Antoni Gostynski1, Marta Garcia2, Sara Llames3, María José Escamez2, Lucia Martinez-
Santamaria2, Miranda Nijenhuis1, Marjon Pasmooij1, Alvaro Meana3, Fernando Larcher2, 
Marcel Jonkman1, Marcela Del Rio2 1Department of Dermatology, University Medical Center 
Groningen, Groningen, The Netherlands, 2Regenerative Medicine Unit, CIEMAT and Centro de 
Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER U714), Madrid, Spain, 
3Tissue Engineering Laboratory, CCST-PA and Centro de Investigaciones Biomédicas en Red de 
Enfermedades Raras (CIBERER U714), Oviedo, Spain
Revertant mosaicism, also referred to as “natural gene therapy”, has been described for a number of 
genetic diseases affecting blood, muscle, liver and skin. The first case of revertant mosaicism in the 
blistering disorder epidermolysis bullosa [EB] was described for the COL17A1 mutation c.1706delA in a 
junctional EB patient. In a healthy skin patch mutant and revertant keratinocytes co-existed. The revertant 
keratinocytes expressing normal levels of type XVII collagen due to a gene conversion could be used for 
autologous transplantation of “naturally corrected” cells. In this study we assessed the in vitro and in vivo 
capacity of COL17A1 revertant cells to attain long-term skin regeneration. Keratinocytes and fibroblasts 
were isolated, expanded and transplanted as bioengineered skin equivalents onto immunodeficient 
mice, which resulted in the engraftment of human skin. Samples of cultured cells, skin equivalents 
and engrafted human skin were analysed for type XVII collagen with immunofluorescence and flow 
cytometry. Surprisingly, results showed a decreasing percentage of revertant keratinocytes in vitro – 
from 40% after the first passage, 25% in the population used for graft production to 15% in the graft. 
Staining of the in vivo biopsies after 10 and 16 weeks corresponded with the in vitro results, showing 
a further decrease in the revertant area to 10% and 2%, respectively. Our data point to a possible 
growth disadvantage of type XVII collagen revertant cells compared to the mutant cell population when 
cultured in vitro and/or to an inefficient growth and regenerative performance of revertant stem cells.
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Severe Kindler Syndrome associated with two compound heterozygous novel FERMT1 
mutations
Elena Aguirregoicoa1, Paula C Luna3, Marta Garcia1, Maía José Escamez1,2, Marcela Del Rio 
Nechaevsky1,2, Margarita Larralde3 1Unidad de Medicina Regenerativa. CIEMAT-CIBERER U714, 
Madrid, Spain, 2Department of Bioengineering. Universidad Carlos III, Leganés, Spain, 3Servicio 
de Dermatoogía Hospital Alemán y sección dermatología pediatrica, Hospital Ramos Mejía., 
Buenos Aires, Argentina
Kindler syndrome (OMIM173650) is a rare autosomal recessive skin disorder. It is characterized 
by blistering and photosenstivity in infancy. Later in life, progressive poikiloderma with diffuse 
cutaneous atrophy, telangiectases, and reticulate pigmentation develops. Other features may 
include nail dystrophy, webbing of the fingers and toes, ectropion of the lower eyelids, chronic 
inflammation of the oral mucosa and poor dentition with early-onset periodontal disease. 
Mutations in the FERMT1 gene that encodes for the membrane-associated protein kindlin-1 have 
been identified. Kindlin-1 links the actin cytoskeleton to the extracellular matrix and is supposed 
to have cell-signaling functions owing to different functional domains. FERM proteins have been 
suggested to play a role in integrin-dependent processes such as cell growth, differentiation, 
and apoptosis. In this case, a combination of a two novel mutations (Q460X) and (1867delATC) 
in the FERMT1 gene lead to severe clinical features in a 22-years old patient including severe 
esophageal, anal, urethral, and vulvar stenosis in addition to gastrointestinal tract involvement.
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The pathoetiology of cutaneous neurofibromas: NF1 null genotype is intimately linked with the 
up-regulation of Class II HLA genes
Juha Peltonen1, Eeva-Mari Jouhilahti1, Ludwine Messiaen2, Sirkku Peltonen1 1University of Turku, 
Turku, Finland, 2University of Alabama at Birmingham, Birmingham, Alabama, USA
A germline mutation in the NF1 gene invariably manifests as a neurocutaneous-skeletal 
syndrome neurofibromatosis 1 (NF1). Cutaneous neurofibromas, the hallmark lesions of the 
syndrome contain a subpopulation of Schwann cells carrying an NF1 null (NF1-/-) genotype, 
which seems to be a prerequisite for the development of neurofibromas. The current study 
addresses the question how the second hit on the NF1-gene affects the reading of the whole 
genome in neurofibroma Schwann cells. Whole genome-wide expression profiling was carried 
out using Illumina Senrix Human HT-12, v.3 Expression BeadChips. Functional enrichment 
analysis towards Gene Ontology (GO), KEGG, and Biocarta databases was carried out using 
DAVID Bioinformatics Resources 6.7. The results highlighted inflammatory response, antigen 
presentation and processing, and myelination. More specifically, the NF1-/- genotype was 
intimately linked with the up-regulation of Class II HLA genes and down-regulation of 
myelination and Schwann cell differentiation -related genes e.g. MAG, MBP, PRX and PMP22. 
In further studies, immunocytochemistry and western blots revealed high levels of HLA-DR and 
HLA-DQ in NF1-/- Schwann cells, but not in NF1+/- Schwann cells. Immunohistochemistry of 
neurofibroma tissue detected a subpopulation of HLA Class II positive cells whose morphology 
was consistent with that of Schwann cells. We speculate that the pathoetiology of cutaneous 
neurofibromas includes emerging of inflammatory response with altered antigen presentation 
and processing as suggested by up-regulation of Class II HLA genes, and that altered NF1-/- 
Schwann cells may induce immunologic tolerance. In summary the results depict an unexpected 
novel way into the understanding the pathoetiology of cutaneous neurofibromas.
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Functional Pathways of the Psoriasis Candidate Gene Product CCHCR1
Mari Tervaniemi1,4, Kristiina Tammimies2, Annika Siitonen1,4, Sari Suomela3, Juha Kere2,1, Outi 
Elomaa1,4 1University of Helsinki, Helsinki, Finland, 2Karolinska Institutet, Stockholm, Sweden, 
3Helsinki University Central Hospital, Helsinki, Finland, 4Folkhälsan, Helsinki, Finland
Coiled-coil alpha-helical rod protein 1 (CCHCR1) is a plausible candidate gene in the 
PSORS1 locus and has a psoriasis associated allele CCHCR1*WWCC. We have found that 
CCHCR1 localizes at the centrosome and is suggested to play a role in cell proliferation and 
steroidogenesis. To evaluate functional pathways of CCHCR1 variant 1, the gene expression 
levels of stable HEK293 cells expressing either the Non-risk or the Risk (WWCC) haplotype were 
analyzed with the Affymetrix HuGene ST 1.0 micro arrays. Comparison of the Non-risk and Risk 
to the vector control cells identified 296 and 206 differentially regulated transcripts, respectively 
(1.5 fold, p<0.05). The expression profiles of the CCHCR1 Non-risk versus Risk cell lines shared 
only 50 genes and varied remarkably from each other by 656 transcripts. The most enriched 
gene ontology group in both cell lines was DNA-binding proteins, including several zinc finger 
protein genes. Transcripts encoding ribosomal and histone proteins, however, showed significant 
alteration only in the Risk cells, whereas in the Non-risk cells the most highlighted gene group 
associated with mitochondria. As enriched pathways, the analysis identified SLE (systemic lupus 
erythematosus) in the Risk cells and focal adhesion in the Non-risk cells, the former due to the 
altered expression of histone genes. Interestingly, histone acetylation in the epigenetic control 
of gene transcription is an important element of the innate immune responses of the skin. The 
results suggest that the CCHCR1 Non-risk and Risk haplotypes confer allele specific effects in the 
regulation of gene expression.
414
Mesenchymal Stromal Cells for the Treatment of Epidermolysis Bullosa
Markus Mezger1, Christian Hünefeld2, Eva Müller-Hermelink2, Ingo Müller3,1, Martin Röcken2, 
Alexander Nyström4, Johannes Kern4, Leena Bruckner-Tuderman4, Rupert Handgretinger1 
1University Children’s Hospital, Tübingen, Germany, 2Department of Dermatology, Tübingen, 
Germany, 3University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 4Department of 
Dermatology, Freiburg, Germany
Epidermolysis bullosa (EB) is an inherited disease characterized by the formation of blisters 
in the skin and mucosa. Over the past few years, several reports proposed different cell 
based therapies like haematopoietic stem cell transplantation (HSCT) and mesenchymal 
stromal cells (MSCs) as new therapeutic options for the management of EB. In this study, 
we analyzed in a well-described mouse model with a desmoglein-3 (Dsg-3) knockout, the 
therapeutic potential of MSC application for the treatment of intraepidermal skin defects. 
Murine transgenic EGFP or DsRed expressing MSCs were applied systemically or by local 
intradermal injections into the skin. Systemic application of MSCs was performed without 
irradiation or in a combined transplantation with haematopoietic stem cells (HSCs) including 
a myeloablative irradiation of the recipient mice. We found by Realtime PCR, Western 
Blot analysis and immuostainings that neither systemic application, nor local injection of 
MSCs into the dorsal skin of Dsg-3 knockout mice restored Dsg-3 expression. Furthermore, 
flow cytometry analysis of epidermal cell suspensions showed no EGFP or DsRed positive 
keratinocytes. Therefore, a transdifferentiation of MSCs into keratinocytes or a cell fusion of 
EGFP or DsRed positive donor cells with keratinocytes of the recipient seems to be unlikely. 
From this study, we concluded that MSCs possess a restricted transdifferentiation potential into 
epidermal cells albeit their importance for the treatment of dermal defects (like in the case of 
recessive dystrophic EB with mutations in the collagen 7 gene) seems to be promising since we 
found that MSCs express collagen 7 to similar amounts like fibroblasts.
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The role of keratinocyte activation in acne pathogenesis
Kornélia Szabó1, Gábor Tax2, Edit Urbán3, Lajos Kemény1,2 1Dermatological Research Group 
of the Hungarian Academy of Sciences, Szeged, Hungary, 2Department of Dermatology and 
Allergology, Faculty of Medicine, University of Szeged, Szeged, Hungary, 3Institute of Clinical 
Microbiology, University of Szeged, Szeged, Hungary
The activation of keratinocytes upon external stimuli plays an important role in various pathogenic 
conditions of the skin, including wound healing and psoriasis. Our aim was to investigate whether 
similar processes also play a role in the pathogenesis of acne. For that we followed the mRNA 
expression changes of activated keratinocyte markers in response to Propionibacterium acnes 
(P. acnes) treatment. A newly established human papilloma virus E6/16 protein immortalized 
human keratinocyte cell line (HPV-KER) was treated with a pathogenic P. acnes 889 clinical 
isolate, and mRNA expression changes of TNFα, IL-1α, TGFα, KRT6, KRT16, ICAM1 and VCAM1 
were measured. TNFα and IL-1α mRNA expressions exhibited a rapid and transient increase with 
the highest levels around 6h after the bacterial treatment, which disappeared by 24h. The TGFα 
and KRT6 mRNA expressions also increased but showed a delayed kinetics, which correlates 
with previous results suggesting that the expression of these genes is under the control of IL-
1α and TNFα. A low level but steady increase of ICAM1 mRNA expression was also noted. 
Our results suggest that P. acnes treatment alone initiates a cellular program marked by the 
increased expression of cytokines, growth factors, signaling molecules and extracellular matrix 
components in HPV-KER cells. The nature of these factors and the timing of the events propose 
that the bacterium is capable of the initiation of keratinocyte activation. The results suggest that 
atypical keratinocyte functions, hyperproliferation and abnormal differentiation observed in acne 
pathogenesis may be the result of P. acnes-induced keratinocyte activation.
416
A novel splice site mutation in NCSTN underlies familial acne inversa in a Japanese family
Yukiko Nomura1, Toshifumi Nomura1, Kaori Sakai1, Osamu Mizuno1, Hiroo Hata1, Satoru 
Aoyagi1, Riichiro Abe1, Yoshiyuki Itaya2, Masashi Akiyama3, Hiroshi Shimizu1 1Department of 
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan, 
2Department of Plastic Surgery, Shindo Hospital, Asahikawa, Hokkaido, Japan, 3Department of 
Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
Acne inversa (AI) is a chronic follicular occlusive disease whose characteristic features include 
recurrent draining sinuses, skin abscesses and disfiguring scars involving the intertriginous 
skin of the scalp, neck, axilla, groin, and inframammary, perianal and perineal regions. It has 
a profound impact on not only the quality of life of the patients, but also the prognosis since 
it is associated with an increased risk of developing squamous cell carcinoma. While most AI 
cases are non-familial, familial cases showing autosomal dominant inheritance pattern have 
been reported. Recently loss-of-function mutations in PSEN1, PSENEN or NCSTN, the genes 
encoding key components of the γ-secretase protein, were identified as a cause of familial AI in 
the Chinese and British populations. Here we conducted a mutation analysis of the γ-secretase 
genes in two Japanese patients with familial AI for the first time. DNA sequencing of exons and 
exon-intron boundaries of the genes encoding all the γ-secretase components, PSEN1, PSEN2, 
PSENEN, NCSTN, APH1A and APH1B, led to the identification of a novel NCSTN splice site 
mutation which was not carried by either unaffected individuals in the family or 50 unrelated 
healthy controls. Furthermore, we studied nine Japanese patients with non-familial AI. Notably, 
no pathogenic mutations were identified, although there is no difference in phenotype between 
familial and non-familial AI. In conclusion, a novel splice site mutation in NCSTN underlies 
familial AI in a Japanese family, but in non-familial AI.
417
Primary characterization of a novel HPV-E6 oncogene immortalized keratinocyte cell line
Hilda Polyánka1, Kornélia Szabó1, Gábor Tax2, Vilmos Tubak3, Erzsébet Kusz4, Zsuzsanna 
Újfaludi5,6, Imre Boros5,6, Zsuzsanna Bata-Csörgo1,2, Lajos Kemény1,2, Márta Széll1
1Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, 
Szeged, Hungary, 2Department of Dermatology and Allergology, University of Szeged, Szeged, 
Hungary, 3Institute of Genetics, Biological Research Centre, Hungarian Academy of Sciences, 
Szeged, Hungary, 4Institute of Biochemistry, Biological Research Centre, Hungarian Academy 
of Sciences, Szeged, Hungary, 5Chromatin Structure and Gene Expression Research Group of 
the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary, 6Department of 
Biochemistry and Molecular Biology, University of Szeged, Szeged, Hungary
Normal human keratinocytes (NHK) have a restricted availability and a short lifespan because of their 
limited proliferative capacity in culture. HaCaT, a spontaneously immortalized keratinocyte cell line has 
been widely used as a model of keratinocyte function, however these cells exhibit limitations for some 
applications. In this study we characterized a novel HPV-E6 oncogene immortalized human keratinocyte 
cell line (HPV-KER). The HPV-KER cells were synchronized than released from cell quiescence and the 
expression of proliferation- and differentiation-related genes were followed by real time RT-PCR. The 
differentiation-related K1, K2 and K10 genes showed the highest expression in the contact inhibited 
cells and their expression dropped right after the cells were released from cell quiescence. The K14, 
K17, Ki67 and α5 integrin genes showed a peak expression 12-24 hours after cells were released from 
cell quiescence, then their expression gradually decreased. Expressions of involucrin and loricrin genes 
could not be detected in this system. Next we investigated whether stress-induced processes of HPV-
KER cells resemble that of immortalized HaCaT cell line or NHKs. The expression of p53 was studied 
after UV-B irradiation and the TNFA gene expression was followed in Propionibacterium acnes-treated 
cells. Stress induced TNFA and p53 gene expressions in HPV-KER resembled and differed from what 
could be detected in HaCaT cells. These data suggest that the established novel human keratinocyte cell 
line has functional characteristics similar to NHKs therefore may serve as an in vitro model for studying 
keratinocyte functions.
418
Towards understanding molecular mechanisms in severe epidermolysis bullosa simplex
Thomas Lettner, Verena Wally, Helmut Hintner, Johann W. Bauer EB House Austria, Department 
of Dermatology, Paracelsus Medical University, General Hospital Salzburg, Salzburg, Austria
Epidermolysis bullosa simplex - type Dowling-Meara (EBS-DM) is caused by dominant 
mutations in the cytokeratins 5 and 14 and is the most severe subtype of EBS. In contrast 
to recessively inherited milder subtypes of EBS, keratin aggregates in the periphery of 
the cytoplasm are characteristic for patient keratinozytes, leading to a collapse of the 
cytokeratin filaments and the high cellular fragility in the basal layer of the epidermis. 
Here we investigate the possible pathomechanisms of EBS-DM using two patient cell lines 
(KEB-7, RM1) with dominant hotspot K14 mutations. Functionality assays showed an increased 
invasive and migratory potential of both cell lines compared to wildtype keratinocytes, and also 
a higher susceptibility to anoikis, as seen in anchorage independent survival assays. Microarray 
analysis of KEB-7 versus NEB-1 keratinocytes revealed a regulation of a number of potential 
disease relevant genes involved in cell migration and invasiveness, immunmodulation and 
cell structure. Besides already known genes we also identified a number of new candidates, 
potentially underlying the characteristic mechanisms of EBS-DM, among others matrix metallo 
proteinases (MMPs), kallikreins (KLKs) and chemokines. All candidates were verified by 
semi-quantitative real-time PCR, and most relevant candidates also by western blot analysis. 
From our studies, a clearer picture of pathomechanisms in EBS-DM is emerging, which will be of 
high relevance for the treatment and care of EBS-DM patients.
419
A novel mutation in CDSN causes peeling skin disease type B in a patient from Morocco
Juliette Mazereeuw-Hautier1,2, Emilie A Leclerc1, Michel Simon1, Guy Serre1, Nathalie Jonca1 
1UMR5165 / U1056 CNRS-INSERM-Université Toulouse III - CHU Purpan, Toulouse, France, 
2Centre de Référence des Maladies Rares de la Peau, Service de Dermatologie, Hôpital Larrey, 
Toulouse, France
Peeling skin diseases (PSD) refer to a group of rare monogenic disorders of cornification. The 
genetic basis of the type B inflammatory form of PSD has recently been demonstrated to be 
an autosomal recessive nonsense mutation in the gene of corneodesmosin (CDSN), namely 
p.K59X. Here, we report a novel CDSN mutation found to cause PSD type B. The proband was an 
8-year-old girl of consanguineous healthy parents, showing superficial peeling all over the body. 
She had extremely severe itching and elevated serum IgE level. Examination of a skin biopsy 
revealed a strong acanthosis and hypergranulosis. The hyperkeratotic stratum corneum showed 
large zones of detachment from the stratum granulosum. DNA sequencing revealed a novel 
nonsense mutation in CDSN, p.P252LfsX37. Interestingly, another monogenic disease associated 
with nonsense mutations in CDSN has been described, hypotrichosis simplex of the scalp (HSS), 
which results from amyloid deposits of truncated CDSN in the dermis of the patient. Here, by 
immunohistochemical experiments using two antibodies directed against different regions of 
CDSN, we demonstrate that truncated CDSN was totally absent from the skin of our patient. 
Hence, our results expand the mutation spectrum of CDSN in PSD type B and contribute to 
explain the completely different pathophysiology and disease expression in the two monogenic 
diseases caused by mutations in CDSN, HSS and PSD type B.
420
Pathway analysis: The new way from GWAS to disease genes
Pernilla Nikamo, Mona Ståhle Karolinska Institutet, Stockholm, Sweden
Psoriasis is a chronic inflammatory skin disease that is marked by a complex interplay of Dendritic 
Cells (DCs), T-cells, cytokines, and downstream transcription factors as part of a self-sustaining 
type 1 cytokine network. Genetic association studies aim to detect associations between disease 
phenotypes and genetic variants. A commonly used tool to establish association between a SNP 
and a disease is to perform statistical tests of association for each individual SNP marker. A 
multiple testing correction can then be applied to control the overall type I error. However, 
such an approach typically captures only a small proportion of the contributing genetic variants. 
One likely reason is that common and complex diseases result from the joint effects of multiple 
loci and environmental factors, each of which has a small individual contribution. A variety of 
tests have been proposed to establish the joint association of multiple SNPs with the phenotype. 
We have GWAS data from 529,651 SNPs, the information on gene ID, gene names, and their 
start and end positions on a chromosome will be downloaded from the National Center for 
Biotechnology Information (NCBI)’s Genome database http://www.ncbi.nlm.nih.gov/Genomes/. 
Genes rather than SNPs are considered the basic units in this pathway method, which is expected 
to reduce the degrees of freedom of the pathway test statistic. We have been able to show that 
markers that show no association separately are associated as a network. We have analyzed 
markers in cell signaling and molecular transportation.
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Gender medicine: Understanding the molecular mechanisms of skin aging in both genders
Evgenia Makrantonaki1,3, Thore Brink2, Vassiliki Zampeli1,3, Björn Hermes1, Amir Hossini3, James 
Adjaye2, Christos C. Zouboulis3 1Inst of Clinical Pharmacology & Toxicology, Lab for Biogerontology, 
Dermato-Pharmacology & Dermato-Endocrinology, Charité University Medicine, Berlin, Germany, 
2Dept of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany, 
3Depts of Dermatology, Venereology, Allergology & Immunology, Dessau Medical Center, Germany
In the current study, we investigated the gender-specific differences in the expression profiling 
of aged skin between young and elderly adults. Whole genome gene expression patterns were 
examined in sun-protected skin obtained from European Caucasian young and elderly males 
(mean age 20 ± 10 [n1=7] and 60 ± 10 [n2=7], respectively) and females (mean age 20 ± 10 
[n3=7] and 60 ± 10 [n4=4], respectively) using the Illumina array platform. Confirmation of gene 
regulation was performed by real-time RT-PCR. 870 genes were significantly regulated in female 
skin and 383 genes in male skin using the chosen criteria. Of these, 286 genes exhibited increased 
and 584 decreased expression with age in females and 213 genes showed increased and 170 
decreased expression in males. Differentially expressed genes were further filtered according to 
Gene Ontology (GO) terms or mapped to KEGG pathways using DAVID. The functional annotation 
of these genes identified several pathways related to mitochondrial function, oxidative stress, 
ubiquitin-mediated proteolysis, cell cycle, organization and adhesion, immune responses, steroid 
biosynthesis and phospholipid degradation. In total, 43 genes were common in the target lists of 
significantly regulated genes in males and females. 41 of these genes showed increased (16) or 
decreased (25) expression independently from gender. Only 2 genes showed different regulation 
with increased expression in male and decreased expression in female skin biopsies. In conclusion, 
our study provides biomarkers of endogenous skin aging in both females and males, which are not 
dependent on gender, and therefore, on the different hormone status.
422
PPARγ is a key regulator of sebaceous gland differentiation and proliferation in normal and 
pathological sebocytes
Anikó Dózsa1,2, Balázs Dezso1, Balázs István Tóth1, Attila Bácsi1, Gerhardt Liebisch4, Gerd 
Schmitz4, Christos Zouboulis3, Ralph Rühl1, Tamás Bíró1, Éva Remenyik1, László Nagy1 
1Universty of Debrecen, Debrecen, Hungary, 2Health Care Center in Miskolc, Miskolc, Hungary, 
3Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, 
Dessau, Germany, 4) University of Regensburg, Regensburg, Germany
Peroxisome proliferator-activated receptor-gamma (PPARγ) has been implicated in lipid 
metabolism and inflammation. PPARγ is expressed in lipid rich human sebocytes, and it appears 
to have roles in their functions. In our current study our aim is to show the role of PPARγ mediated 
signaling in human sebaceous gland (SG) biology. As model systems we used immortalyzed 
human sebocyte cell culture model SZ95 and laser microdissected human SG, to detect gene 
expression we used RT-qPCR. Nile red staining, Oil-red O staining and HPLC methods were 
used for determinating lipid accummulation and PUFA derivates. OImmunohystochemistry 
and ELIS were used to determinate PPARγ and IL6 proteins in SG. Demonstrating that mRNA 
of PPARγ and its lipid metabolism-associated target genes, ADRP and PGAR are expressed in 
sebocytes upon their differentiational stage, we show that the transcriptional factor is more 
active in well-differentiated SG. Moreover, although PPARγ is present in normal and hyperplastic 
SG, immortalized SZ95 cell line, we show that PPARγ is barely expressed in undifferentiated 
SG adenoma and carcinoma cells. Furthermore, selective inhibitor of PPARγ reduces sebocyte 
proliferation rate and suppresses citokine production. PPARγ has role in minor lipid classes 
synthesis and also in PUFA synthesis.These data indicate the major role of PPARγ signaling in 
sebocyte biology, and suggest that PPARγ is a promising target in the clinical management of 
proliferative/inflammatory SG disorders.
423
Interference of Lipid Metabolism Pathways by Morpholino Knockdown of abca12 and snap29 
Gene Expression Perturbs the Epidermal Morphogenesis - the Zebrafish Model of Ichthyosis
Qiaoli Li1, Michael Frank1, Masashi Akiyama2,3, Hiroshi Shimizu2, Eli Sprecher4, Jouni Uitto1 
1Jefferson Medical College, Philadelphia, PA, USA, 2Hokkaido University Graduate School of 
Medicine, Sapporo, Japan, 3Nagoya University Graduate School of Medicine, Nagoya, Japan, 4Tel 
Aviv Medical Center, Tel Aviv, Israel
Zebrafish (Danio rerio), a freshwater vertebrate with well characterized genome, can serve as 
a model for heritable skin diseases. The skin is rapidly developed during the first 5-6 days of 
embryonic growth, accompanied by expression of skin specific genes. Transmission electron 
microscopy (TEM) at day 5 reveals two-cell layer epidermis separated from the underlying 
collagenous stroma by a basement membrane with fully developed hemidesmosomes. Scanning 
electron microscopy reveals ordered surface contour of keratinocytes with discrete microridges. 
To gain insight into epidermal morphogenesis, we have employed morpholino-mediated 
knockdown of abca12 and snap29 genes, critical secretion and intracellular trafficking of lipids 
by lamellar granules. Morpholinos, when placed on exon-intron junctions, were >95% effective 
in preventing the corresponding gene expression when injected into 1-4 cell stage embryos. As 
early as day 3, TEM of abca12 morphants showed accumulation of lipid-containing electron-
dense lamellar granules while snap29 morphants showed presence of apparently empty vesicles 
in the epidermis. Evaluation of epidermal morphogenesis by SEM revealed perturbations 
in the microridge architecture and development of spicule-like protrusions on the surface of 
keratinocytes. These morphologic findings are akin to epidermal changes in harlequin ichthyosis 
and CEDNIK syndrome, autosomal recessive keratinization disorders due to mutations in the 
ABCA12 and SNAP29 genes, respectively. The results indicate that interference of independent 
pathways involving lipid metabolism and trafficking in the epidermis can result in phenotypically 
similar perturbations in epidermal morphogenesis, and that these fish mutants can serve as a 
model to study the pathomechanisms of these keratinization disorders.
424
Element Composition Status and Mineral Deposits in the Abcc6-/- Mice, a Model for 
Pseudoxanthoma Elasticum
Qiaoli Li1, Nadire Beril Kavukcuoglu2, Nancy Pleshko2, Jouni Uitto1 1Jefferson Medical College, 
Philadelphia, PA, USA, 2Temple University, Philadelphia, PA, USA
Pseudoxanthoma elasticum (PXE), a heritable multi-system disorder, is characterized by 
aberrant mineral deposits in peripheral connective tissues. The precise element content and the 
maturational status of the mineral deposits are unknown. We have utilized Energy Dispersive 
X-ray Analysis (EDAX) and Fourier Transform Infrared Spectroscopy (FTIR) to characterize the 
mineral deposits in Abcc6-/- knockout mice which recapitulate features of PXE, including 
mineralization of skin and the arterial blood vessels. EDAX analysis revealed that calcium and 
phosphate are the predominant elements in the mineralized tissues. The Ca/P ratio increased 
during the progression of the disease, and in 24-month old knockout mice, the level reached that 
in endochondral bone which has crystalline hydroxyapatite structure. FTIR revealed carbonated 
amorphous calcium phosphate in the mineralized skin of the 3-month old knockout mice, a 
mixture of brushite and hydroxyapatite in the 6-month old mice, and mostly hydroxyapatite 
at 24 months of age. The minerals identified in the blood vessels of the 24-month old mice 
are hydroxyapatite-like together with some undefined mineral. The results suggest that mineral 
deposits, consisting predominantly of calcium and phosphate, show progressive maturation from 
amorphous phase to hydroxyapatite in PXE. This information suggests that the mineralization 
process can be interfered at the early stages of crystallinization, e.g., by magnesium-enriched diet 
as recently demonstrated by us but once fully matured, the reversal of the mineralization may be 
difficult, impacting on the management of patients with PXE.
425
Development of a skin humanized mouse model for transglutaminase 1 deficient lamellar 
ichthyosis
Karin Aufenvenne1, Fernando Larcher3, Ingrid Hausser2, Robert H. Rice4, Heiko Traupe1 1University 
Hospital, Department of Dermatology, Muenster, Germany, 2University Hospital, Department 
of Dermatology, Heidelberg, Germany, 3CIEMAT-CIBERER, Cutaneous Disease Modelling Unit, 
Madrid, Spain, 4University of California, Department of Environmental Toxicology, Davis, USA
Lamellar ichthyosis (LI) is a severe autosomal recessive skin disease. In up to 45% of 
all cases it is caused by mutations in TGM1 coding for transglutaminase 1 (TG1), the 
key enzyme of cornified envelope (CE) formation. For molecular characterization and 
assessment of therapeutic approaches, a faithful pre-clinical model is needed. Although 
an animal model for TG1-deficient LI exists, this does not recapitulate the human disease. 
Present drawbacks of TGM1 knockout mice are early lethality, the lack of clinically visible 
hyperkeratosis and a marked impairment of the epidermal barrier with up to 100fold 
increased transepidermal water loss. Therefore, these mice die within 3-4 hours after birth. 
This prompted us to establish a skin-humanized mouse model of LI due to TG1-deficiency. Isolated 
primary keratinocytes and fibroblasts from patients with defined TGM1 mutations were used for 
generation of human skin equivalents which were grafted onto to the back of athymic nude mice. 
These grafts fully recapitulate the human skin phenotype. Histology shows a very thick and compact 
stratum corneum. Immunohistological staining of several epidermal differentiation markers show 
the same distribution in the grafts and skin of LI patients. In situ monitoring of TG1-activity on 
cryosections showed a complete absence of TG1-activity in the TG1-deficient grafts. Ultrastructural 
investigations revealed cholesterol clefts in the stratum corneum as typical ultrastructural markers. 
We conclude that the skin humanized mouse model faithfully recapitulates the human disease 
and should be an excellent tool for testing novel therapeutic approaches. Further studies such as 
proteome analyses are currently under work.
426
A Clinical and Genetic Survey of Hidradenitis Suppurativa (Acne Inversa)
Andrew Pink1, Michael Simpson1, Glen Brice3, Catherine Smith2, Nemesha Desai2, Peter 
Mortimer3, Jonathan Barker1, Richard Trembath1 1Department of Medical and Molecular 
Genetics, King’s College London, London, UK, 2St. John’s Institute of Dermatology, Guy’s and St. 
Thomas’ NHS Foundation Trust, London, UK, 3Division of Clinical Science, St. George’s University 
of London, London, UK
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that presents with painful 
nodules, cysts and abscesses in flexural areas. The condition may be familial and mutations have 
recently been reported in NCSTN, PSENEN and PSEN1 in autosomal dominant forms of the 
disease. We have undertaken a clinical and genetic study of HS. 78 individuals with HS meeting 
strict diagnostic criteria were recruited from our tertiary referral clinic. The patients were of mixed 
ethnicity (65% Caucasian, 29% Afro-Caribbean, 6% Asian). 61% were female and the average 
age of onset was 21.2 (5-48). 41% reported family histories (90% autosomal dominant, 10% 
familial occurrence). 31% of patients reported a history of acne vulgaris. 69% were current or 
ex-smokers and the average BMI was 31 (19-58). We evaluated the potential role of mutations in 
NCSTN, PSENEN and PSEN1 in our patient cohort. Coding regions and associated splice sites of 
these genes were Sanger sequenced in 55 individuals. We identified two mutations in individuals 
with a family history consistent with autosomal dominant inheritance (PSENEN (c.66_67insG), 
NCSTN (c.1101+1 G>A)). Interestingly, we also identified three novel variants in NCSTN in 
sporadic cases, though the functional impact of these alleles is unclear. These data further support 
the involvement of mutations in the gamma-secretase genes in the development of a minority of 
HS cases. Our results indicate that there is significant genetic heterogeneity underpinning HS and 
our studies are ongoing to identify further disease causing genes.
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Clinical and biological characteristics of 19 new xeroderma pigmentosum-variant patients
Kristina Opletalova1,2, Agnes Bourillon3, Caroline Pouvelle1, Jacques Amier1, Christina Mateus2, 
Caroline Robert2, Patricia Kannouche1, Nadem Soufir3, Alain Sarasin1,4 1Laboratory Genetic 
Stability and oncogenesis, UMR8200 CNRS, University Paris-sud and institute Gustave Roussy., 
Villejuif, France, 2Department of Dermatology, Institute Gustave Roussy, Villejuif, France, 
3Laboratory of Genetics, Hospital Bichat, University Paris 7, Paris, France, 4Department of 
Genetics, Institute Gustave Roussy, Villejuif, France
Xeroderma pigmentosum variant (XP-V) is a rare recessive disease characterized by sunlight 
hypersensitivity and high predisposition to cutaneous malignancies. In this study, we report the 
clinical and characteristics of 19 new XP-V, from 18 families, trying to find out a relationship 
between clinical and germinal mutations. All patients are living in France but originated from 
France, North Africa, Turkey and Congo, and their clinical features have been retrospectively 
reviewed. Level of nucleotide excision repair, sensitivity to UVC irradiation and hypersensitivity to 
UV in the presence of caffeine were realized on primary fibroblasts from all patients. POLH coding 
sequence was sequenced in all patients and the RNA from one patient was reviewed. Median 
age of onset was 28 years. Photosensitivity, basal cell carcinomas and epidermoid carcinomas 
were present in half of patients. Melanoma was also detected in 45% of patients. All realized 
cellular caffeine tests suggesting a XPV were confirmed by the presence of mutations in POLH 
or an abnormal transcript. Causative POLH mutations were found in 18 patients (95%): one 
homozygous in the promoter, 2 homozygous nonsense, 2 homozygous missense, 2 frameshift, 6 
homozygous deletions (2 in exon 6 and 4 in exon10) and 5 composite heterozygous mutations. 
For one patient, the POLH transcript was abnormal, demonstrating a splicing defect. In conclusion, 
clinical symptoms were in accordance of the literature, with a mention with the particular high rate 
of melanoma occurrence. In addition, the high rate of POLH deletion warrants further investigation.
428
Connective Tissue Mineralization in Abcc6 -/- Mice: Modification by Environmental Factors
Qiujie Jiang, Qiaoli Li, Alix E. Grand-Pierre, Jouni Uitto Jefferson Medical College, Philadelphia, 
PA, USA
Pseudoxanthoma elasticum (PXE) is characterized by progressive ectopic mineralization of 
connective tissues, potentially regulated by various environmental factors. This study examined 
the effects of an experimental diet, inflammation and surgical stress on ectopic mineralization 
process by utilizing a murine model (Abcc6-/-) for PXE. The Abcc6-/- mice at the age of 4 weeks 
were either fed with an experimental custom-designed mineral modification diet, injected 
with lipopolysaccharide (LPS) to induce peritoneal inflammation or performed a skin surgery. 
At 2 and 4 weeks, the mineralization of connective tissues was evaluated using quantitative 
morphometric image analysis and by chemical assays of calcium content of connective tissue 
capsule surrounding the vibrissae, a biomarker of the mineralization process. The results 
indicated increased mineralization in Abcc6-/- mice fed a diet low in magnesium and high in 
phosphate, as compared with those fed standard diet. Survey of mineralization in other organs by 
histopathology revealed significant mineral deposits also in the kidneys and heart of the Abcc6-
/- mice fed the experimental diet. Feeding Abcc6+/- or Abcc6+/+ mice with the experimental diet 
did not result in mineralization. The LPS-induced peritoneal inflammation and the surgical stress 
accelerated mineralization in the Abcc6-/- mice, when examined at 2 months after the treatment 
and compared with the age- and gender-matched untreated control mice. This study revealed 
that environmental factors, such diet and inflammatory or surgical stress, enhance mineralization 
in the murine PXE model in a time- and genotype-dependent patterns and may explain clinical 
variability in PXE patients even with the same mutation.
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Retinoid-receptor specific agonists inhibit keratin aggregate formation in immortalized 
keratinocytes from Epidermolytic Ichthyosis
Hao Li, Anders Vahlquist, Hans Törmä Uppsala University, Uppsala, Sweden
Epidermolytic Ichthyosis (EI) is an autosomal dominant skin fragility disorder caused by mutations 
in genes coding for keratin 1 and 10. Few treatments are available, none of which is disease 
specific. Some patients respond well to synthetic retinoids, yet the mechanism of action behind 
the treatment remains elusive. We have studied the effect of synthetic retinoids in an in vitro 
model, hoping to find the mechanism of action. Immortalized keratinocytes from an EI patient 
(K10_p.156Arg>Gly) were seeded on coverslips, differentiated by calcium exposure and treated 
with natural and synthetic retinoids including atRA (all-trans retinoic acid), CD336 (RARα 
agonist), CD2314 (RARβ agonist), CD347 (RARγ agonist), as well as a pan-RAR-inhibitor CD3106 
(pan-RAR antagonist) and CD2409 (which exhibits anti-AP-1 activity). The cells were subjected to 
heat-stress and stained using a K10 antibody. Keratin aggregates were monitored and quantified. 
Roughly 25% of the cells contained keratin aggregates after heat-stress. atRA (0.1-1 µM) reduced 
aggregate-containing cells to 10% and 7%, respectively. When combining 0.1µM atRA and 
1µM of the RAR-antagonist CD3106, cells showing keratin aggregates were 16%. Also, CD336 
(α) reduced keratin aggregate formation whereas CD2314 (β), CD437 (γ) and CD2409 (anti-AP-1) 
had no effect. In conclusion, retinoids decrease the formation of keratin aggregates in EI patient 
cells in a dose-dependent manner. RARα specific retinoids showed better effect than RARβ and 
RARγ agonists. Allele specific gene expression of wild type and mutant KRT10 transcripts will 
be studied in retinoid-exposed keratinocytes. Our findings may explain the beneficial effects of 
retinoid therapy in vivo.
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Association of TNFα and p40 polymorphisms with psoriasis in Spanish patients
Elena Gallo1, Teresa Cabaleiro2, Manuel Román2, Francisco Abad2, Esteban Daudén11Department 
of Dermatology. Hospital Universitario La Princesa, Madrid, Madrid, Spain, 2Department of 
Clinical Pharmacology. Hospital Universitario La Princesa, Madrid, Madrid, Spain
Psoriasis is a chronic autoimmune inflammatory disease in which tumour necrosis factor 
alpha (TNFα) and interleukine 12 (Il12) and interleukine 23 (Il23) play a major role. Several 
polymorphisms in the TNFα and p40 gene have been associated with psoriasis. We examined 
whether the TNFα-238, TNFα-308, TNFα-857, TNFα-1031, Il12 (rs3212227), Il12 (rs6687695), 
Il23 (rs7530511) and Il23 (rs11209026) are associated with psoriasis in Caucasian Spanish 
patients, by evaluating possible differences in genotype frequencies between patients and 
controls. Single nucleotide polymorphisms (SNPs) in TNFα-238 (G>A), TNFα-308 (G>A), TNFα-
857 (C>T), TNFα-1031 (T>C), Il12 (T>G and G>C), Il23 (C>T and G>A) were genotyped in 
psoriasis cases (n = 138) and healthy controls (n = 61). Differences in genotypic frequencies were 
determined using a corrected Pearson χ2 test. The study of the TNFα SNPs showed that patients 
more frequently than healthy volunteers had a wild-type TNFα-238 genotype and a wild-type 
TNFα-1031 genotype. In contrast, patients more frequently had a mutant genotype TNFα-857 
than controls. The study of the Il12-Il23 SNPs showed that patients had lower frequence of Il12 
(rs6687695) GG genotype than controls. In contrast, the wild-type Il23 (rs11209026) genotype 
was more frequent in patients than in healthy volunteers. This study establishes differences 
in the genotype frequency of TNFα-238, TNFα-857, TNFα-1031, Il12 (rs6687695) and Il23 
(rs11209026) between healthy volunteers and psoriasis patients, confirming that TNFα and Il12/
Il23 polymorphisms may be involved in susceptibility to psoriasis.
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ERAP1 association in childhood psoriasis
Josefin Lysell, Pernilla Nikamo, Mona Ståhle Institution of medicine, Stockholm, Sweden
Psoriasis is a highly heterogeneous disease with a strong genetic background. Stratification 
for subpopulations is crucial to understand this complexity. Evidence for an interaction 
between HLA-C and ERAP1 was found in a recent genome-wide association study, 
with the ERAP1 disease associated variant only affecting psoriasis susceptibility in 
individuals carrying the HLA-C risk allele. ERAP1 is an IFN-γ induced amino peptidase 
in the endoplasmic reticulum. ERAP1 plays an important role in MHC class I peptide 
processing and is also involved in cell surface shedding of TNFRI, IL-1RII and IL6R. 
To further investigate the association of ERAP1 in psoriasis we have genotyped our cohorts of 
childhood psoriasis (onset ≤ 15 years), adult onset psoriasis (onset >15 years) and healthy controls 
for 4 SNPs in the ERAP1 gene (rs27524(UTR3’), rs30187(Lys528Arg), rs27529(synonymous) 
and rs26653(Arg127Pro)). All patients have been genotyped for HLA-Cw06*. 
Children with psoriasis have a higher number of HLA-Cw06* alleles compared with adult 
cases irrespective of phenotype (67% vs. 36%) and show a significantly stronger association 
to ERAP1. In children, ERAP1 SNP rs27524 shows an OR of 2.12(95% CI 1.26-3.58) for the 
AA genotype and when combined with HLA-Cw06*, it gives an OR of 9.97(95% CI 4.42-
22.49). In adult cases, the same ERAP1 SNP shows an OR of 1.16(95% CI 0.85-1.57) for the 
AA genotype and when combined with HLA-Cw06* it gives an OR of 3.57(95% CI 1.13-11.28). 
We also analyzed ERAP1 immunoreactivity in lesional and non-lesional skin biopsies from 
patients with early onset, adult onset and controls. No difference was seen among groups.
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A systematic investigation of rheumatoid arthritis susceptibility loci in early-onset psoriasis 
supports association of REL and suggests 4 additional loci
Faisal Ali1, Anne Barton1, John Bowes1, Edward Flynn1, UK Rheumatoid Arthritis Genetics 
Consortium (UKRAG)2, Jane Worthington1, Christopher Griffiths1, Richard Warren1 1University 
of Manchester, Manchester, UK, 2UK Rheumatoid Arthritis Genetics Consortium, (UKRAG), UK
Phenotypically diverse autoimmune conditions share common genetic susceptibility loci and 
underlying molecular pathways. Exploring confirmed risk variants in other autoimmune disease 
has previously been successful in elucidating novel genetic associations with psoriasis. We 
systematically investigated 20 single nucleotide polymorphisms, previously confirmed as being 
associated with rheumatoid arthritis at genome-wide levels of significance, in a cohort of patients 
with early-onset psoriasis. 778 UK patients with early-onset psoriasis (presenting before age 40y) 
and over 5000 UK control subjects were genotyped. PLINK software was used to undertake 
statistical analysis and quality control. The power of our study to detect an association with 
alpha value 0.05 varied from 0.19-0.68. We confirmed the association of early onset psoriasis 
with REL (rs13031237, trend p= 7.49x10-6) and provide nominal evidence of association with 
AFF3 (rs10865031, trend p=0.009), IRF5 (rs1048863, trend p=0.02), C5orf30 (rs26232, trend 
p=0.04) and TAGAP (rs394581, trend p=0.04). As some cases (n=235) and all the control subjects 
were used in the original study reporting the association with REL, our work does not represent 
independent validation. However, subanalysis of REL in previously uninvestigated patients and 
independent controls produced an odds ratio of 0.86 whose confidence intervals (0.74-1.01) 
capture the odds ratio of our original analysis. The minor alleles of REL and TAGAP had opposing 
effects upon susceptibility to disease in psoriasis and rheumatoid arthritis patients. Although our 
findings require replication in a larger independent cohort of subjects, similar exploration of 
autoimmune loci and fine-mapping of such regions may provide further insight into the genetics 
of psoriasis.
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Insulin/IGF-1 signaling control epidermal morphogenesis by regulating asymmetric division
Christian Guenschmann1,2, Heike Stachelscheid1,2, Annika Schmitz1,3, Jens C. Brüning2,4, Carien 
M. Niessen1,4 1Dept of Dermatology, Univ of Cologne, Germany, 2Inst for Genetics, Univ of 
Cologne, Germany, 3Center for Molecular Medicine Cologne, Univ of Cologne, Germany, 
4Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD), 
Univ of Cologne, Germany
The skin epidermal barrier protects the organism from external challenges and dehydration. 
Recently, we identified insulin/IGF-1 signaling as key determinants of epidermal morphogenesis 
and proliferative potential. We observed a progressive decrease in the number of suprabasal layers 
in insulin receptor (IR), IGF-1 receptor (IGF-1R) or IR/IGF-1R (dko) knockout mice, first obvious at 
E16.5. Here we examined how IR/IGF-1R signalling regulates epidermal morphogenesis. Counting 
metaphase and anaphase spindles in vivo and in vitro we observed a mitotic arrest in the absence 
of IR/IGF-1R with a biased loss of asymmetric divisions. This was associated with disturbed spindle 
formation in IGF-1R-/- metaphase cells and reduced expression of AuroraB, a key regulator of mitosis, 
as well as other cell cycle regulators, such as p53 and stratifin (14-3-3s). We also observed reduced 
expression of p63, previously identified as a regulator of asymmetric divisions in the skin. Insulin/IGF 
signalling negatively regulate FoxO transcription factors. To examine if FoxOs are involved in insulin/
IGF dependent regulation of epidermal morphogenesis we expressed a constitutively nuclear FoxO 
mutant (FoxOADA) in the epidermis. These mice showed a single epidermal layer and die within 
several hours, a phenotype similar to p63-/- mice. Initial analysis suggests that FoxO can negatively 
regulate p63 transcriptional activity. The results indicate that epidermal Insulin/IGF1 signalling by 
negatively regulating FoxO promotes p63 function and couples cell cycle progression to asymmetric 
divisions, thereby regulating the number of suprabasal layers in the IFE during morphogenesis.
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Regulation of extracellular matrix component production in fibroblasts by mitogen-activated 
protein kinase pathways and zinc binding protein 89
Niina Hieta1, Risto Ala-aho1, Juanita Merchant2, Veli-Matti Kähäri1 1University of Turku, Turku, 
Finland, 2University of Michigan, Ann Arbor, MI, USA
Type I collagen is the major component of dermal extracellular matrix (ECM). Collagen and 
other ECM components are degraded by matrix metalloproteinases (MMPs). Tissue inhibitors 
of metalloproteinases (TIMPs) inhibit the active forms of MMPs, thus modulating the ECM. 
Transforming growth factor-β1 (TGF-β1) enhances TIMP-3 and type I collagen expression. ZBP-
89 is a widely expressed zinc finger transcription factor that functions as both a transcriptional 
activator and repressor. Interleukin-1β (IL-1β) has been shown to inhibit ZBP-89 expression 
in normal human fibroblasts, whereas tumor necrosis factor-α (TNF-α) or TGF-β1 have no 
effect. Here we show, that in normal dermal fibroblasts, the enhancement of TIMP-3 and type 
I collagen α1 chain mRNA expression by TGF-β1 is inhibited by adenoviral overexpression of 
wild-type ZBP-89. Also the enhancement of biglycan, but not PAI-1, expression by TGF-β1 is 
inhibited by overexpressing wild-type ZBP-89. Activation of ERK1,2 pathway enhances TIMP-3 
expression but down-regulates type I collagen α1 and α2 chain expression. ZBP-89 enhances 
the down-regulatory effect of ERK1,2 pathway on type I collagen α1 and α2 chain expression. 
Enhancement of TIMP-3 expression by the activation of ERK pathway is decreased by ZBP-89. 
These results show, that the expression of type I collagen and TIMP-3 is regulated by ZBP-89 
transcription factor in dermal fibroblasts, possibly through MAPK pathways. These results may 
have importance in the treatment of fibrotic skin diseases like scleroderma and chronic ulcers.
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Nuclear translocation of Bcl3 and p50 by IL-22 produces HB-EGF, IL-8, S100A7, and human 
β-defensin 2 in keratinocytes of psoriasis
Mikiko Tohyama, Yasushi Hanakawa, Yuji Shirakata, Xiuju Dai, Teruko Otani, Koji Hashimoto, 
Koji Sayama Ehime University Graduate School of Medicine, Toon-city, Ehime, Japan
IL-22 is a key cytokine in psoriasis, which induces STAT3 phosphorylation and the production of 
chemokines, S100 family proteins, β-defensins, and HB-EGF. However, the signaling mechanism 
from pSTAT3 to IL-22-inducible gene expression remains unclear. Here, we focused on Bcl3 and 
p50, since Bcl3 expression is increases by STAT3 activation and Bcl3 mediates gene expression 
with p50 (NFκB1). Firstly, immuno-staining revealed a strong staining of Bcl3 and p50 in the 
nuclei of the epidermal keratinocytes of psoriatic lesional skin, while those staining was absent 
in normal and atopic dermatitis lesional skin. The staining level was higher at the basal cell 
layer. Next we utilized cultured human keratinocytes expressing IL-22 receptor transfected 
with adenovirus vector. IL-22 increased Bcl3 mRNA expression, and Bcl3 was translocated to 
the nuclei together with p50. HB-EGF, IL-8, S100A7, and human β-defensin 2 (HBD2) mRNA 
expressions were also increased by IL-22 stimulation. siRNA for Bcl3 completely abolished the 
increase of HB-EGF mRNA expression, and markedly reduced the increase of IL-8, S100A7, 
and HBD2 mRNA expression. When Bcl3 was expressed by using adenovirus vector, Bcl3 
was translocated to the nuclei with p50 at 2 days after the infection. Expressions of HB-EGF, 
IL-8, S100A7, and HBD2 mRNA were also significantly increased as in IL-22 stimulation. In 
addition, these increases were abolished by siRNA for p50. These findings suggest that nuclear 
translocation of Bcl3 and p50 complex caused by IL-22 plays a central role in the continuous 
production of HB-EGF, IL-8, S100A7, and HBD2 in the keratinocytes of psoriasis.
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Function of constitutive IκB Kinase 2 activation in Epidermal Keratinocytes
Daniela Preukschat, Marion Bonnet, Manolis Pasparakis Institute for Genetics, Cologne, Germany
Inhibitor of κB kinase 2 (IKK2, IKKβ) is a subunit of the IκB kinase (IKK) complex and the main 
kinase inducing canonical nuclear factor κB (NF-κB) activation in response to various stress-
associated stimuli such as pathogen associated molecular patterns (PAMPs), inflammatory 
cytokines and UV-light. NF-κB regulates the expression of multiple genes involved in immunity 
and cell survival. In the epidermis, NF-κB has been proposed to have an important role for the 
regulation of keratinocyte proliferation but also for the maintenance of skin homeostasis. Here 
we used transgenic mice expressing constitutively active IKK2 (IKK2CA) specifically in epidermal 
keratinocyte to investigate the effect of constitutive NF-κB activation in the epidermis in vivo. 
Mice expressing IKK2CA in the epidermis showed skin blistering already during embryonic life 
and died within a few hours after birth. In contrast to the previously described role of NF-κB 
activation in mediating growth arrest of keratinocytes, IKK2CA expressing epidermis exhibited 
increased proliferation. Heterozygous genetic ablation of the NF-κB subunit p65 rescued the 
perinatal lethality of mice expressing IKK2CA in the epidermis, showing that reduction of p65 
expression levels by 50% was sufficient to neutralize in large part the deleterious effects of 
IKK2CA over-expression. Although heterozygous p65 ablation in the epidermis rescued perinatal 
lethality it did not fully prevent skin lesion development in IKK2CA-expressing epidermis, since 
these mice showed increasing hair loss and formation of epidermal cysts from 3 weeks on. These 
results underline that balanced activation of IKK2/NF-κB in epidermal keratinocytes is essential 
for the maintenance of skin homeostasis.
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Signalling of keratinocytes exposed to sensitizers in a reconstructed human epidermis induces 
transient expression of IL-8 and HB-EGF
Aurélie Frankart1, Alain Coquette2, Klaus-Rudolf Schroeder3, Yves Poumay1 1University of Namur 
(FUNDP), Namur, Belgium, 2SGS Life Science, Wavre, Belgium, 3Henkel AG & Co, Duesseldorf, 
Germany
Keratinocyte response to sensitizers is believed essential in the onset of allergic contact dermatitis. 
Embedding cultured keratinocytes in a reconstructed human epidermis (RHE) provides a complex 
but more realistic model than monolayers for epidermal exposure to chemicals through a barrier. 
When exposed to four different typical sensitizing chemicals, dinitrofluorobenzene, oxazolone, 
cinnamaldehyde, or isoeugenol, keratinocytes exhibit IL-8 release but no release of IL-1α. 
This release is linked to transient IL-8 mRNA induction around 4 hours following exposure, an 
event simultaneous to activation of EGF receptor (EGFR) signalling by the sensitizers. Inhibitors 
AG 1478 and PD 153035 of EGFR kinase activity demonstrate that EGFR signalling induces 
expression and release of IL-8. Using neutralizing LA1 antibody to block ligand-binding on EGFR, 
data illustrate that both ligand-dependent and independent activations of EGFR by sensitizers are 
involved. Concomitant induction of HB-EGF expression and release indicates a potential role 
for this growth factor in keratinocyte response and suggests, by analogy with previous studies, 
that keratinocyte activation may result from alteration of membrane lipid rafts by sensitizers. 
Exposure to an irritant or to non-sensitizing dichloronitrobenzene, the counterpart of sensitizing 
dinitrochlorobenzene, produces different keratinocyte responses. Thus, exposure of RHE to 
chemicals reveals potentially interesting targets to further analyze in order to better characterize 
keratinocyte response in such circumstances.
438
Valrubicin targets and activates protein kinase C α in keratinocytes
Ina Groenkjaer Laugesen1, Eva Hauge1, Stine Maria Andersen1, Karin Stenderup1, Elisabeth de 
Darkó2, Tomas Norman Dam3, Cecilia Rosada1 1Dermatology Dept., Aarhus University Hospital, 
Aarhus, Denmark, 2Valderm ApS, Lyngby, Denmark, 3Dermatology Dept., Roskilde Hospital, 
Roskilde, Denmark
Valrubicin is a semisynthetic anthracycline originally developed as an anti-cancer drug. The 
absence of skin toxicity and the lipophilic characteristics allow the use of valrubicin as topical 
treatment. Recently, we showed that valrubicin has a beneficial effect in treating psoriasis and 
non-melanoma skin cancer (NMSC) by local application in animal models. Valrubicin localizes 
predominantly in the cytoplasm, affects cell proliferation, and induces apoptosis. Protein kinase 
C (PKC) is a family of cytoplasmic serine/threonine protein kinases that take part in cellular 
processes by playing a crucial role in the initial events of signal transduction. PKCα, which 
is activated by calcium and the second messenger diacylglycerol (DAG), is observed in the 
suprabasal layers of normal skin and is associated to differentiation processes. Valrubicin 
possesses a valerate side chain resembling DAG in structure, thus, we hypothesized that the 
effect of topically applied valrubicin observed in skin inflammatory diseases is mediated through 
interaction with PKCα. The aim of the present study was to investigate valrubicin’s mode of 
action in keratinocytes by studying its effect on PKCα activation.The characteristic of PKCα to 
translocate from the cytoplasm to the cellular membrane when activated was observed both by 
confocal microscopy and by western blot of the soluble and membrane-bound cellular proteins. 
Downstream signaling was confirmed by phosphorylation of extracellular signal-regulated 
kinases (ERK1/2). Hence, valrubicin interacts with PKCα as observed by the increased PKCα 
activity. This increased activity may explain valrubicin’s effect observed in treating psoriasis and 
NMSC.
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The molecular analysis of IL-8 production by hapten-stimulated monocytes using a stable THP-
1-derived IL-8 reporter cell line
Yutaka Kimura1, Toshiya Takahashi1, Shigeaki Nishii2, Yoshihiro Ohmiya3, Setsuya Aiba1 1Tohoku 
University Graduate School of Medicine, Sendai, Japan, 2Tsuruga Institute of Biotechnology, 
TOYOBO, Tsuruga, Japan, 3Bioproduction Reserch Institute, AIST, Tsukuba, Japan
We have established a stable THP-1-derived IL-8 reporter cell line, THP-G8, in which SLO and 
SLR luciferase genes are regulated by IL-8 and G3PDH promoters, respectively. Using THP-G8, 
we developed a high throughput-screening test for haptens. To elucidate the mechanism 
of IL-8 induction by haptens, we stimulated THP-G8 cells with a representative allergen, 
4-nitrobenzylbromide (4-NBB), and a non-hapten, sodium lauryl sulfate (SLS), together with 
various signal transduction inhibitors. MRS2578, the P2Y6 receptor-selective antagonist, and the 
ERK inhibitors PD980059 and U0126, significantly suppressed SLO-LA induction by both 4-NBB 
and SLS, consistent with recent reports of UDP involvement in the production of IL-8 via ERK 
activation. To understand the mechanism by which UDP is released from THP-G8 stimulated with 
chemicals, we used 9 chemical inhibitors against reactive oxygen species (ROS) (NAC and DPI), 
mitochondria complex I (rotenone), calcium signaling (BAPTA-AM), phosphoinositide-3-kinase 
(LY-294002), Rho-dependent kinase (Y-27632), various Cl- channels (glybenclamide, arachidonic 
acid, and GdCl3). All these inhibitors except for GdCl3 significantly suppressed 4-NBB-induced 
SLO-LA, while only NAC and DPI but not the others suppressed UDP-induced SLO-LA. The results 
suggests that UDP release by 4-NBB-stimualted THP-G8 is at least partly mediated by 1) ROS 
production by mitochondria, 2) intracellular Ca2+ elevation, 3) PI3K, 4) Rho-dependent kinase, and 
5) some Cl- channel. Only DPI significantly suppressed SLS-induced SLO-LA, SLS releases UDP by 
a mechanism different from that of 4-NBB. These data suggest that THP-G8 could be a useful tool 
to investigate the molecular mechanism of IL-8 production as well as to identify skin sensitizers.
440
Allergic Contact Dermatitis and Small Vessel Vasculitis as a Manifestation of Occupational 
Exposure
Danny Guabiraba, Paloma Rebelo, Andrea Sampaio, Jorge Machado, Alex Bauk, Janine Pontes, 
Nathalia Farias, Maria Barbosa, Carolina Muga, Lorena Marques, Simon Salomao, Gabriela 
Santana, Carolina Gonçalves, Roney Mata, Yuri Mene, Janaina Leite, Tatiane Coelho, Olga Harris 
Ims-Gamboa, Rio De Janeiro, Brazil
We report a case of allergic contact dermatitis associated with small vessel vasculitis. 
A 44-year-old man who worked as doorman and janitor, initially presented with erythematous-
desquamative plaques in palms and soles and later erythroderma. Oral corticosteroids were 
initiated. After partial improvement, a biopsy revealed spongiotic dermatitis, suggestive of 
contact dermatitis. A patch test was performed. The patient then progressed with erythematous-
violaceous plaques on the lower limbs, with palpable purpura. A second and third biopsy were 
carried out. Symptoms improved as corticoids were reintroduced and the patient was kept away 
from his occupation. The test patch test was positive for Euxyl K-400, a substance present in 
cleaning products. The biopsies were compatible with spongiotic dermatitis in the erythematous-
violaceous lesion and lymphocytic vasculitis in the palpable purpura. These two dermatological 
conditions may be caused by chemical substances which the patient is exposed to in a daily 
occupation.
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Impaired IL-22-dependent activation of STAT3 and proliferative responses in human 
keratinocytes overexpressing suppressor of cytokine signaling (SOCS)1 and SOCS3
Rosanna Sestito1,2, Claudia Scarponi1, Stefania Madonna1, Giampiero Girolomoni2, Andrea 
Cavani1, Cristina Albanesi1 1IDI-IRCCS, Rome, Italy, 2University of Verona, Verona, Italy
IL-22 is highly released by Th22 and Th17 lymphocytes having a pathogenetic role in psoriasis. 
In this skin disorder, IL-22 is responsible for the altered proliferative and differentiative 
processes observed in the epidermis, and induces inflammatory molecules in keratinocytes. 
STAT3 is the main mediator of IL-22 signaling, and its activation requires Tyr705 and Ser727 
phosphorylations. Recently, we found that the negative regulation of STAT3 by molecules 
influencing STAT3 acetylation and, thus, Tyr705 phosphorylation (i.e. sirtuin1) efficiently inhibits 
IL-22 pathogeneticity in human keratinocytes. In this study, we determined whether IL-22 
signaling and biological effects on keratinocytes were inhibited by SOCS, a family of proteins 
suppressing inflammatory responses triggered by various cytokines in different cell types, 
including those elicited by IFN-γ in keratinocytes. We firstly analyzed SOCS mRNA expression 
in IL-22-activated keratinocytes, and found that IL-22 rapidly induced SOCS3, but not SOCS1 
or SOCS2. Interestingly, even though SOCS1 was not up-regulated by IL-22, its overexpression 
in stably transfected keratinocytes potently inhibited the IL-22-induced Tyr705 and Ser727 
phosphorylations of STAT3, likewise to what observed in SOCS3 clones. Consistently, transient 
transfection of keratinocytes with SOCS1 or SOCS3 plasmids markedly reduced the IL-22-
induced transactivation of a STAT3-responsive plasmid. In contrast, stable or transient SOCS2 
overexpression in keratinocytes had no effects on STAT3 activation by IL-22. As consequence of 
STAT3 inactivation, the IL-22-induced proliferation was impaired in SOCS3 and SOCS1 clones. 
Influencing SOCS1 and SOCS3 expression thus represents an approach for impairing IL-22 
action on keratinocytes, potentially useful in therapies aimed at reducing cytokine-dependent 
skin diseases.
442 [WITHDRAWN]
443
Large-scale protein analysis of primary human skin keratinocytes from skin punch biopsies by 
microsphere-based affinity proteomics
Daniel de la Rosa Carrillo1,2, Denis Khnykin3, Anders Holm1, Weiwei Wu1, Fridtjof Lund-
Johansen1 1Oslo University Hospital, Department of Immunology, Oslo, Norway, 2Oslo University 
Hospital, Department of Dermatology, Oslo, Norway, 3Oslo University Hospital , Department of 
Pathology, Oslo, Norway
Large-scale analysis of proteins in keratinocytes is typically performed using whole cell lysate of 
cultured keratinocytes obtained from human foreskin. Here, we present a new platform for large-
scale protein analysis based on skin punch biopsies. Five mm skin punch biopsies were treated 
with Dispase to release the epidermis from the dermis. Epidermis samples were treated sequentially 
with buffers optimized to extract proteins from the cytoplasm, organelles, membranes, and 
nucleus, respectively. Proteins from each compartment were biotinylated and further separated 
by size exclusion chromatography. The 96 fractions that were obtained were incubated with 
colour-coded microspheres carrying a total of 1,200 antibodies to cellular proteins. After overnight 
incubation, the microspheres were labelled with fluorescent streptavidin and measured by six-
colour flow cytometry. We also measured changes in protein levels in keratinocyte cultures under 
different conditions and at different time points. Samples obtained from human skin treated with 
UV-radiation were also analysed.The results provided size distribution profiles of the antibody 
targets. Proteins with known subcellular location were found in the expected fractions, such as 
Akt- and IkBa-protein (cytoplasm), Diablo (mitochondria), GOSR2 (Golgi apparatus), Fos (nucleus), 
and PARP (nucleus). Involucrin, and caspase 14, both keratinocyte differentiation markers, were 
found in the cytoplasmatic fraction. In conclusion, we have developed a new system that allows 
large scale analysis of proteins from small samples of human skin, while simultaneously providing 
information on protein context and subcellular distribution in primary human skin keratinocytes. 
The platform provides new opportunities to study mechanisms of skin diseases.
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Opposite effects of SIRT1 regulation on E-cadherin and epidermal growth factor receptor 
expression in HaCaT cells
Kozo Nakai, Kozo Yoneda, Yoichiro Hosokawa, Yasuo Kubota Kagawa University, Kagawa, Japan
SIRT1 is a nicotinamide adenine dinucleotide-dependent deacetylase. It has been found to 
function as a deacetylase for numerous protein targets involved in various cellular signaling 
pathways. In human keratinocytes, SIRT1 has been reported to inhibit proliferation and to 
promote differentiation. Although E-cadherin and epidermal growth factor receptor (EGFR) 
play important roles in proliferation or differentiation of keratinocytes, the effects of SIRT1 
regulation on E-cadherin and EGFR in epidermal keratinocytes still remains unclear. Therefore, 
we investigated whether SIRT1 influences the expression of E-cadherin and EGFR in HaCaT 
cells by western blot analysis. HaCaT cells were cultured with Dulbecco’s Modified Eagle 
Medium (DMEM) or phosphate buffer saline (PBS). Western blot analysis revealed that the 
expression levels of involucrin, keratin 1 and filaggrin were increased in PBS-cultured HaCaT 
cells compared with DMEM-cultured HaCaT cells, suggesting the proliferation of HaCaT cells 
in DMEM and the differentiation of HaCaT cells in PBS. SIRT1 activator, resveratrol, inhibited 
both E-cadherin and EGFR expression in DMEM-cultured HaCaT cells. However, resveratrol 
increased both E-cadherin and EGFR expression in PBS-cultured HaCaT cells. SIRT1 inhibitor, 
sirtinol, did not affect E-cadherin and EGFR expression in DMEM-cultured HaCaT cells, but 
it inhibited E-cadherin and EGFR expression in PBS-cultured HaCaT cells. AG1478, an EGFR 
inhibitor, inhibited both E-cadherin and EGFR expression in DMEM-cultured HaCaT cells, but it 
did not affect E-cadherin and EGFR expression in PBS-cultured HaCaT cells. These data suggest 
that SIRT1 regulate the E-cadherin and EGFR expression, but it may depend on the condition of 
keratinocytes: proliferation or differentiation.
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Interleukin-1β interferes with the balance between proliferation and differentiation through 
insulin resistance in human keratinocytes - implications for psoriasis pathogenesis
Claudia Buerger, Beatrice Richter, Kathrin Woth, Bartosz Malisiewicz, Sandra Diehl, Katja Hardt, 
Wolf-Henning Boehncke Goethe University, Frankfurt, Germany
Interleukin-1β (IL-1β) not only plays a crucial role in the pathogenesis of psoriasis, but also 
induces insulin resistance in metabolic tissues. Therefore we asked whether IL-1β can confer 
similar effects in the skin that might contribute to the manifestation on the disease. Using 
HaCaT or primary keratinocytes we found that IL-1β renders keratinocytes resistant to insulin 
dependant activation of the PI3-K/PKB cascade, which is mediated by p38MAPK. Insulin also 
induces expression of cytokeratin 10, a marker of terminal differentiation, suggesting that 
insulin drives differentiation of healthy keratinocytes. This effect is blunted under chronic IL-1β 
treatment, resembling the inflammatory situation in psoriasis, where keratinocytes differentiation 
is abnormal and shifted towards hyperproliferation. Surprisingly we found that in the psoriatic 
plaque PKB/Akt is hyperactivated. This effect seems to be mediated by IL-1β, which in vitro 
can transiently activate the PKB cascade. This effect is not only mediated via PI3-K but also via 
p38MAPK, IKK and JNK. This leads to IL-1β dependent proliferation of kerytinocytes. We provide 
evidence that under healthy conditions insulin regulates the equilibrium between differentiation 
and proliferation of keratinocytes which is the prerequisite for proper formation of the epidermal 
layers. Under conditions of systemic inflammation such as psoriasis, high levels of IL-1β in the 
skin lead to blockade of differentiation by means of insulin resistance. At the same time IL-1β 
promotes hyperproliferation of keratinocytes. Both mechanisms contribute to the formation of the 
psoriatic plaque. Thus, controlling correct insulin signaling in the skin might represent a novel 
anti-psoriatic strategy.
446
TNFα-Mediated Induction OF IL-17C In Human Keratinocytes Is Controlled By Nuclear Factor 
κB (NF-κB)
Claus Johansen, Jette Riis, Knud Kragballe, Lars Iversen Arhus University Hospital, Aarhus C, 
Denmark
IL-17C is a member of the IL-17 family of cytokines. The expression of IL-17C has been 
demonstrated to be strongly induced by TNFα in human keratinocytes, and recently the level of 
IL-17C was found to be increased in the inflammatory skin disease psoriasis. However, little is 
known about the molecular mechanisms involved in the regulation of IL-17C. Thus, the purpose 
of this study was to investigate IL-17C regulation. We demonstrated that pretreatment of cultured 
human keratinocytes with the inhibitor of κB kinase 2 (IKK) inhibitor, SC-514 resulted in a 
significant reduction in both IL-17C mRNA and protein expression, indicating the significance 
of this pathway in the regulation of IL-17C. NF-κB binding sites were identified upstream from 
the IL-17C gene, and by electrophoretic mobility shift assay (EMSA) NF-κB was shown to bind to 
all three identified binding sites. Moreover, NF-κB binding to these sites was inducible by TNFα. 
Supershift analysis revealed binding of the NF-κB subunits p65 and p50 to all three NF-κB binding 
sites. To determine the contribution of NF-κB in IL-17C expression, we conducted luciferase gene 
reporter experiments, and demonstrated that a 3204 bp promoter fragment of IL-17C containing 
three putative NF-κB binding sites was strongly activated by TNFα. Interestingly, mutations of the 
three NF-κB binding sites revealed that one specific NF-κB binding site was crucial for the TNFα-
mediated IL-17C induction. We conclude that the activation of NF-κB (p65/p50) is crucial for the 
TNFα-induced stimulation of IL-17C expression in cultured human keratinocytes.
447
The STAT1 expression is elevated in lesional psoriatic skin
Anne Hald, Maria Luise Salskov-Iversen, Rasmus Boye Kjellerup, Lars Iversen, Knud Kragballe, 
Claus Johansen Aarhus University Hospital, Aarhus, Denmark
Psoriasis is characterized by an accelerated proliferation of the keratinocytes and increased 
expression of proinflammatory cytokines. Studies have shown that changes in specific signal 
transduction pathways may explain part of the inflammatory condition seen in psoriasis. The 
purpose of this study was to investigate and characterize the role of the STAT1 signaling pathway 
in the pathogenesis of psoriasis. STAT1 was investigated in paired biopsies from lesional and 
nonlesional psoriatic skin by quantitative PCR and by Western blotting. Phosphorylated/activated 
STAT1(Tyr701) and STAT1(Ser727) proteins were examined by Western blotting and localized 
by immunofluorescence analysis in paraffin-embedded skin biopsies. We demonstrated a 
significant increase in both the mRNA and protein expression of STAT1 in lesional psoriatic 
skin compared with nonlesional psoriatic skin. In addition, we found that the phosphorylation 
level of STAT1(Tyr701) and STAT1(Ser727) was significantly increased in lesional psoriatic 
skin. Immunofluorescence analysis of phosphorylated STAT1(Tyr701) showed single positively 
stained cells localized in the epidermis of psoriatic skin, whereas, a nuclear staining scattered 
throughout the entire layers of the epidermis was seen for STAT1(Ser727) in lesional psoriatic 
skin.Taken together, our results demonstrate that the expression level of STAT1, as well as the 
phosphorylation level of STAT1(Tyr701) and STAT1(Ser727) are increased in lesional psoriatic 
skin, indicating that STAT1 plays an important role in the pathogenesis of psoriasis.
448
Epidermal growth factor receptor activation and inhibition in three-dimensional models of 
human cutaneous squamous cell carcinoma
Suzan Commandeur, Vincent van Drongelen, Frank R. de Gruijl, Abdoelwaheb El Ghalbzouri 
Leiden University Medical Center, Leiden, The Netherlands
The transmembrane tyrosine kinase epidermal growth factor receptor (EGFR) is considered a 
key player in development of cutaneous squamous cell carcinoma (SCC), which is the second 
most common malignancy in white populations. Inhibition of EGFR with the small molecule 
tyrosine kinase inhibitor erlotinib is currently under clinical investigation in cutaneous SCC 
patients. In this study, we investigated the effects of EGFR activation and inhibition on normal and 
malignant in vitro human skin equivalents (HSEs). In healthy HSEs, increasing EGF concentrations 
ranging from 5 ng ml-1 to 50 ng ml-1 resulted in a dramatic decrease in epidermal proliferation 
as immunohistochemically assessed by Ki67 and increased epidermal stress as assessed by K16 
and K17 after two weeks of air-exposed culture. Also, higher concentrations of EGF induced 
remarkable epidermal disorganization with loss of proper stratification. Similar effects were 
observed in HSEs generated with cutaneous SCC cell lines SCC-12B2 and SCC-13. Treatment of 
both healthy and SCC-HSEs with erlotinib resulted in efficient reduction of epidermal thickness 
from eight to three viable cell layers and counteracted EGF-induced epidermal stress. Remarkably, 
erlotinib treatment caused severe desquamation in healthy HSEs, reminiscent of xerosis as a 
known side effect in patients treated with erlotinib. The presented three-dimensional organotypic 
SCC models appear suitable for further unrestricted investigations on the morphological and 
functional impacts of modifying EGFR signaling in cutaneous SCC, without burdening patients 
or mice. The effective inhibition of epidermal growth by erlotinib in our HSEs confirms the 
therapeutic potential of this tyrosine kinase inhibitor for cutaneous SCC patients.
449
Alterations of cellular redox-sensitive pathways regulation in vitiligo melanocytes influences 
cell cycle regulation: is vitiligo a proliferative disorder?
Barbara Bellei1, Angela Pitisci1, Monica Ottaviani1, Matteo Ludovici1, Carlo Cota2, Maria Lucia 
Dell’Anna1, Mauro Picardo1 1Lab of Cutaneous Physiopatology, San Gallicano Dermatologic Institute, 
IRCCS, Rome, Italy, 2Dermatopathology Unit, San Gallicano Dermatological Institute, Rome, Italy
Vitiligo is an acquired disorder characterized by localized destruction of cutaneous melanocytes 
lacking of a satisfactory explanation. Here, we demonstrated a basal alteration of vitiligo 
melanocytes redox balance leading to a constitutive stimulation of antioxidant enzymes 
expression (Nrf2, HO-1, NQO1, SOD2, catalase). Vitiligo melanocytes cultivated in presence 
of a chemical inducer of cytotoxic stress were much more damaged than healthy cells, and 
the induction of Nrf2 and HO-1 in response to tert-Butyl hydroperoxide was lower than in 
normal human melanocytes. Regulation of antioxidant enzymes did not appear to be completely 
impaired in vitiligo cells since can be enhanced in response to α-Lipoic acid and α-tocopherol 
treatments. In order to study intracellular pathways crucially involved in stress-dependent vitiligo 
cells damage, we focused on cAMP/PKA/CREB and MAPK-dependent signal transduction. We 
found a full correlation between ROS production, activation of the stress activated protein kinase 
p38MAPK, p53 nuclear localization, hyperphosphorylation of CREB, and increased membrane 
cholesterol level. Notably, all these long-term effects of oxidative stress are also “biomarkers” 
premature senescence. Consistent with the hypothesis that vitiligo melanocytes are inclined to 
acquire senescent phenotype, we demonstrated that vitiligo cells presented a significant increase 
in p16 and p21. Moreover, despite the normal induction of cyclinD1 gene expression, cell 
proliferation remained largely inhibited for vitiligo melanocytes treated with α-MSH in minimal 
medium. We report for the first time evidence demonstrating that vitiligo melanocytes present 
alteration of redox homeostasis, transduction pathways, and of cell-cycle regulators expression 
that altogether argue for a proliferative disorder.
450
Involvement of N-acetylglucosaminyltransferase V (GnT-V) in homeostasis of epidermis through 
up-regulation of HB-EGF signaling
Akihiro Kimura1, Mika Terao1, Arisa Kato1, Hiroyuki Murota1, Eiji Miyoshi2, Ichiro Katayama1 
1Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, 
Japan, 2Department of Molecular Biochemistry&Clinical Investigation, Osaka University Graduate 
School of Medicine, Suita, Osaka, Japan
N-acetylgulcosaminyltransferase-V (GnT-V) is a glycosyltransferase that modulate sugar chains 
of various proteins by catalyzing the branching of β1-6GlcNAc on N-glycans. The expression 
of GnT-V is elevated during malignant transformation and metastasis in various type of cancer. 
Overexpression of GnT-V is reported to enhance the growth factor signaling such as EGF, FGF, and 
TGF-β through increased galectin-3 binding to polylactosamine structures on N-glycans of their 
receptors. We previously showed that EGF receptor signal is enhanced in mouse keratinocytes 
transfected with GnT-V gene. In this study, we investigated a role of GnT-V in homeostasis of 
epidermis by using normal human epidermal keratinocytes (NHEK) and murine model. First, 
we examined the effect of GnT-V on proliferation of keratinocytes. GnT-V knockdown by siRNA 
suppressed the proliferation of NHEK. In epidermal hyperproliferative conditions of murine 
model such as UVB irradiated skin (180mJ/cm2 daily for 2 weeks) and re-epithelization edge 
of skin ulcer, the expression of GnT-V was increased at mRNA and protein level. These data 
suggest that GnT-V may play a role in epidermal proliferation. One of the mechanisms for these 
hyperproliferative conditions is the induction heparin-binding EGF-like growth factor (HB-EGF), 
an important growth factor for wound healing. Moreover, addition of HB-EGF to keratinocytes 
in culture enhanced expression of GnT-V. These data suggest that GnT-V could enhance EGF 
receptor signaling through the inhibition of endcytosis of the receptor with oligosaccharide 
modification, and through its induction by HB-EGF. Our findings demonstrate a novel role of 
GnT-V in homeostasis of epidermis especially in hyperprolifertive conditions.
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Proinflammatory effector pathways of interleukin-1 and tumor necrosis factor in human 
sebocytes and the impact of a vitamin C derivative
Hiroshi Ikeno1, Mara Apel2, Christos Zouboulis3, Thomas A. Luger2, Markus Böhm2 1Ikeno Clinic 
of Dermatology and Dermatologic Surgery, Tokyo, Japan, 2Dept. of Dermatology, University 
of Münster, Münster, Germany, 3Departments of Dermatology, Venereology, Allergology and 
Immunology, Dessau Medical Center, Dessau, Germany
Acne is the most common inflammatory skin disease in which proinflammatory cytokines like 
interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) are considered key players. For 
example, targeting the IL-1 pathway in PAPA syndrome has dramatic effects on the course of acne. 
Moreover, anti-TNF-α strategies have been shown to have salutary effects on the most severe variant 
of acne, hidradenitis suppurativa. Importantly, both cytokines utilize intracellular oxidative stress to 
orchestrate subsequent proinflammatory cellular effects such as IL-6 and IL-8 induction. Since some 
vitamin C derivatives are antioxidants and L-ascorbyl-2-phosphate (APS) has anti-inflammatory 
effects in acne patients, we explored the effects of IL-1β and TNF-α on IL-6/IL-8 expression and 
NF-κB signalling as well as the role of APS. Both IL-1β and TNF-α evoked dose-dependent increases 
in IL-6 and IL-8 mRNA expression in SZ95 sebocytes. However, only IL-1β resulted in increased 
protein levels of both cytokines. APS attenuated the effect of both IL-1β and TNF-α on IL-6 and IL-8 
mRNA expression while having no detectable impact on protein secretion of the latter cytokines. 
Detailed studies of NF-κB activation including IκB degradation, phosphorylation and nuclear 
translocation of NF-κB p65 and p50 disclosed distinct differences in the activation patttern of the 
NF-κB pathway activated by IL-1β versus TNF-α. The fact that APS had modulatory effect on some 
intracellular signalling steps of the NF-κB cascade but did not affect protein secretion of IL-6 and 
IL-8 after IL-1β treatment further indicated a complex regulatory mechanism in the expression of the 
former gene products at transcriptional and posttranscriptional level in human sebocytes.
452
Regulation of STAT3 expression and activation in psoriasis
Rosa Maria Andres Ejarque1, Anne Hald2, Claus Johansen2, Knud Kragballe2, Lars Iversen2 1Dep. 
Pharmacology. University of Valencia and Center of Molecular Recognition and Technological 
Development (IDM), Valencia, Spain, 2Dep. Dermatology. Århus University Hospital, Århus, 
Denmark
The aim of this study has been to determine the involvement of STAT3 in psoriasis. For this purpose, 
keratome biopsies were taken from lesional and non-lesional psoriatic skin. Furthermore, normal 
human keratinocytes, obtained from skin samples from patients undergoing plastic surgery, were 
cultured in vitro. We found increased expression of total STAT3 protein as well as of increased 
STAT3 phosphorylation in lesional psoriatic skin compared to paired samples of non-lesional skin. 
This phenomenon was further studied by the incubation of primary human keratinocytes with 
different pro-inflammatory stimuli. STAT3 is activated trough phosphorylation at two different 
sites: Tyrosine 705 and Serine 727. We found that Il-6 (50ng/ml) and Il-20 (10nM) were able to 
induce the Tyr705 phosphorylation of STAT3 and TNFα (10ng/ml) and TPA (100 nM) were able to 
induce the phosphorylation of the Ser727 site. In order to further characterize this activation we 
tested a selective Jak2 inhibitor (1,2,3,4,5,6-hexabromocyclohexane) and p38 and ERK inhibitors 
(SB202190 and PD98059, respectively) to determine the specific signalling pathways involved. 
The Jak2 inhibitor was able to completely impair the Tyr705 phosphorylation induced by Il-6 and 
Il-20. TNFα phosphorylation of the Ser727 site was completely blocked by both the p38 and the 
ERK inhibitors while the TPA induced phosphorylation was only affected by the ERK inhibitor. 
Taken together, this study has demonstrated that STAT3 expression and activation are upregulated 
in lesional psoriatic skin and, furthermore, different signalling pathways have been identified to 
regulate STAT3 phosphorylation/activation.
453
Neuropilin 1 regulates UVB-induced apoptosis in keratinocytes through regulation of VEGF 
production and Rac1 activity
Anna Riese, Yvonne Eilert, Yvonne Meyer, Thomas Krieg, Peter Kurschat Uniklinik Köln, Institut 
für Dermatologie, Cologne, Germany
Neuropilin (NRP) 1 and 2 are important regulators of axonal outgrowth and vascularization during 
development, but they are also expressed by keratinocytes. To elucidate the role of epidermal 
Neuropilin 1 we generated epidermis-specific NRP1 deficient mice. We found that Neuropilin 
1 is a regulator of UVB-induced apoptosis. The NRP1-/- keratinocytes are more susceptible to 
apoptosis in vitro and in vivo. Consistent with this observation, the amount of anti-apoptotic 
Bcl-2 is reduced in the NRP1-/- keratinocytes after UVB irradiation. Since VEGF can directly 
bind Neuropilin 1 and has been demonstrated to inhibit apoptosis of neurons and cancer cells 
in a Neuropilin dependent manner, we measured VEGF production by NRP1-/- keratinocytes. 
We detected significantly reduced levels of VEGF, as compared to wild type keratinocytes. Next, 
we elucidated signal transduction events in Neuropilin 1 deficient keratinocytes after UVB 
irradiation. We found that in the absence of Neuropilin 1 the production of reactive oxygen 
species (ROS) was reduced after UVB treatment, whereas there were no differences in the 
phosphorylation of p38 and AKT. Furthermore, the activation of the small GTPase Rac1 and of 
ERK is decreased in NRP1-/- keratinocytes. Taken together, we demonstrate that NRP1 can protect 
keratinocytes from UVB-induced apoptosis. Within the cells, this effect is mediated by activation 
of Rac1 and ERK, leading to increased levels of anti-apoptotic Bcl-2.
454
The cyclosporin A binding protein cyclophilin B is expressed in the granular layer of epidermis 
and regulates human keratinocyte growth and differentiation
Aparna Sinha, Paula Fearon, Ann Lonsdale-Eccles, Alison Forrester, Carole Todd, Nick Reynolds 
Newcastle University, Newcastle upon Tyne, UK
Cyclosporin A (CsA), is an effective treatment for moderate-severe eczema and psoriasis but its 
use is limited due to longer-term side-effects. Cyclophilin B (CypB) was defined in T-cells as an ER 
resident protein that binds CsA with high affinity. We have recently shown that CypB is expressed 
and secreted by primary human keratinocytes. Immunohistochemical analysis revealed that CypB 
is expressed in suprabasal keratinocytes within the differentiating granular layer. We constructed 
retroviral vectors containing CypBWT-GFP and CypBW128A-GFP (a mutant reducing CsA binding to 
3%). By transducing human keratinocytes with CypBWT-GFP, CypBW128A-GFP and empty GFP-vector, 
we demonstrated high efficiency transfer, processing and secretion of CypBWT-GFP and CypBW128A-
GFP proteins. Transduction of CypBWT and CypBW128A significantly increased colony formation 
(1.5 fold, P<0.01, n=12, in 3 independent experiments). In addition, a significant increase in cell 
proliferation was seen in keratinoctyes transduced with CypBWT (1.9 fold) and to a greater extent, 
CypBW128A ( 2.7 fold) when compared to the empty vector control using a cell proliferation assay 
(p<0.05 and p<0.001, respectively, n=20, in 4 independent experiments). Furthermore, transduction 
of keratinocytes with shRNA CypBWT resulted in knockdown of CypBWT and resulted in reduced 
cell proliferation (P<0.05, n=36, in 4 independent experiments). Finally, transduction of CypBWT 
and to a greater extent CypBW128A positively regulated keratinocyte differentiation as assessed 
by transglutaminase promoter luciferase activity and cadaverine incorporation as a measure of 
transglutaminase activity. These studies provide increased understanding of the physiological role of 
CypB in keratinocytes and identify CypB as a potential novel therapeutic target in skin.
455
Genome organiser and special AT-rich binding protein Satb1 controls the establishing tissue-
specific chromatin organization during development of the epidermis
Michael Fessing1, Andrei Mardaryev1, Michal Gdula2, Andrei Sharov2, Tatyana Sharova2, Terumi 
Kohwi-Shigematsu3, Vladimir Botchkarev1 1University of Bradford, Bradford, UK, 2Boston 
University, Boston, MA, USA, 3Lawrence Berkeley National Laboratory, Berkeley, CA, USA
Special AT-rich binding protein 1 (Satb1) plays an important role in remodelling higher-order 
chromatin structure and regulates expression of a large number of genes in a cell type-specific 
manner. Here we show that during epidermal morphogenesis in mice, epidermal differentiation 
complex (EDC), located on mouse chromosome 3 shows marked remodelling of the higher-
order chromatin structure in its central domain that contains multiple genes activated during 
keratinocyte terminal differentiation. Satb1 binding to central EDC domain was confirmed 
by ChIP –on-chip. Satb1 ablation results in an alteration of three-dimensional EDC structure 
and a marked decrease in expression of the selected genes involved in the control of terminal 
keratinocyte differentiation and epidermal barrier formation including loricrin, involucrin and 
late cornified envelope genes. These alterations are accompanied by a significant decrease in 
the epidermal thickness and abnormal granular layer formation in Satb1-null mice compared 
to wild-type controls. Furthermore, ChIP and transient transfection analyses revealed that Satb1 
expression in keratinocytes is directly controlled by p63 transcription factor that serves as a 
master regulator of epidermal development. Thus, Satb1-dependent higher-order chromatin 
remodelling of the EDC locus is an important process in the differentiation program of epidermal 
progenitor cells controlled by p63. These data demonstrates that Satb1, as a target of p63, plays 
an important role in keratinocyte differentiation by establishing three-dimensional chromatin 
structure of the EDC locus.
456
In vitro pharmacological model of Hutchinson-Gilford Progeria Syndrome (HGPS) using human 
Induced Pluripotent Stem Cells
Sophie Blondel1, Xavier Nissan1, Annachiara De Sandre2, Odile Rigaud3, Michèle Martin3, Nicolas 
Levy2, Marc Peschanski1 1INSERM/UEVE U-861, I-STEM, AFM, Institute for Stem cell Therapy 
and Exploration of Monogenic Diseases, Evry, France, 2INSERM UMR S 910 Génétique médicale 
et génomique fonctionnelle, faculté de médecine Timone -Université de la Méditerranée, Evry, 
France, 3Laboratoire de Génomique et Radiobiologie de la Kératinopoïèse, Evry, France
Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare, fatal genetic 
disease characterized by an appearance of accelerated aging in children. This syndrome is 
typically caused by mutations in codon 608 (G608G) of the LMNA leading to the production of a 
mutated form of Lamin A precursor called Progerin. In order to set up an in vitro pharmacological 
model of HGPS suitable for drug discovery and pharmacological studies we used the unique 
potential of pluripotent stem cells (iPSC) to self renew and differentiate into any cell types of 
the organism. Thus iPSC were generated from patient dermal fibroblasts and then differentiated 
into several cell types, mesenchymal stem cells (MSC), neural stem cells (NSC), neurons, 
keratinocytes and melanocytes.We secondly demonstrated that among these HGPS iPSC 
progenies MSC and melanocytes displayedphenotypical defects characteristics of HGPS such 
as nuclear abnormalities, Progerin expression,altered DNA repair mechanism and premature 
senescence. Finally, based on this in vitro study we used MSC derived from HGPS IPSC to set 
up pharmacological assays compatible with Highthroughput screening (HTS) or High content 
screening (HCS) to investigate the potential of compounds libraries to attenuate or revert this 
different premature ageing phenotypes.
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The ERBB receptor family regulates sebocyte proliferation and differentiation
Maik Dahlhoff1, Christos C Zouboulis2, Marlon R Schneider1 1Institute of Molecular Animal 
Breeding and Biotechnology, Gene Center, LMU Munich, Munich, Germany, 2Departments of 
Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Germany
Previous studies from our laboratory suggested that epigen, a ligand of the epidermal growth 
factor receptor (EGFR), plays a role in sebaceous gland activity. Here, we generated a transgenic 
mouse line with doxycycline-inducible expression of epigen under the control of the keratin 14 
promoter to study the effects of this growth factor in the interfollicular epidermis, hair follicle, 
and sebaceous glands. Expression was induced by adding doxycycline to the drinking water 
and the effects were monitored by measuring epidermal sebum levels with a sebumeter and by 
histological analysis. In addition, we evaluated the expression of the EGFR/ERBB family in SZ95 
sebocytes during differentiation by qRT-PCR and Western blot. Induction of epigen expression 
before epidermal stratification and hair follicle morphogenesis (embryonic day 12.5) resulted in 
a thickened epidermis, enlarged sebaceous glands, and increased sebum levels from the third 
postnatal week. The sebaceous gland phenotype fully regressed within a few weeks following 
doxycycline removal but renewed administration of doxycycline resulted in its re-emergence. 
Surprisingly, induction of epigen expression in adult mice failed to evoke any phenotypical 
alteration. Both RT-PCR and Western blot analysis revealed that EGFR, ERBB2, and ERBB3 
are expressed by sebocytes, and the receptor levels are significantly reduced during sebocyte 
differentiation. Moreover, inhibition of ERBB2 phosphorylation reduced the proliferation of SZ95 
cells and enhanced their differentiation. Our results indicate that the EGFR/ERBB system is an 
important regulator of sebaceous gland homeostasis. Signaling via these receptors appears to 
support the proliferation of undifferentiated sebocytes and to avoid their premature differentiation.
458
Progenitor cell dynamics of sebaceous gland development in mammalian skin
Daniela Bobermien, Monika Petersson, Catherin Niemann Center for Molecular Medicine 
Colonge (CMMC), Cologne, Germany
Mammalian epidermis consists of the interfollicular epidermis (IFE) with associated hair follicles 
(HF) and sebaceous glands (SG). Functional SGs are important for barrier acquisition and 
protection against pathogens. Upon maturation, cells of the SG (sebocytes) disintegrate and release 
sebum. This requires constant replenishment of differentiated cells and implies stem or progenitor 
cells to be involved in SG-renewal. Previously, our lab has demonstrated that individual bulge 
stem cells (SC) and their descendants constantly regenerate the SG under homeostatic conditions. 
In contrast, little is known about the cellular origins and molecular mechanisms crucial for the 
development of this organ. Here, we investigate the cellular mechanisms of SG development in 
detail. We show that first differentiated sebocytes arise as one cluster of cells at the upper part of 
the developing HF of tail skin. These cells are characterised by Scd1-expression (Stearoyl-CoA-
Desaturase1). With further development, the single cluster of sebocytes is partitioned into two SG 
attached to one HF. Analysing the expression of a panel of known HF progenitor markers during 
skin morphogenesis, we demonstrate that HF SC niches are established prior SG formation and 
show that sebocytes emerge surrounded by progenitor cells. To investigate the cellular origin of 
SG formation, we have performed lineage tracing experiments during morphogenesis. First results 
suggest that cells originating in the IFE contribute to HF and SG formation. Further analysis will 
unravel essential cellular and molecular signals for SG development.
459
Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal 
regeneration after injury
Andrei Mardaryev1, Natalia Meier3, Krzysztof Poterlowicz1, Andrey Sharov2, Tanya Sharova2, 
Mohammed Ahmed1, Cristopher Lewis1, Mike Fessing1, Tomas Ruenger2, Sabina Werner4, Ralf 
Paus3,5, Vladimir Botchkarev1,2 1Centre for Skin Sciences, School of Life Sciences, University of 
Bradford, Bradford, UK, 2Department of Dermatology, Boston University School of Medicine, 
Boston, MA, USA, 3Department of Dermatology, University of Lübeck, Lübeck, Germany, 
4Department of Biology, Institute of Cell Biology, Swiss Federal Institute of Technology (ETH), 
Zürich, Switzerland, 5School of Translational Medicine, University of Manchester, Manchester, UK
The Lhx2 transcription factor plays essential roles in morphogenesis and patterning of ectodermal 
derivatives as well as in controlling stem cell activity. Here we show that Lhx2+ cells reside in the 
stem cell niche (bulge, secondary hair germ) and co-express selected stem cell markers (Sox9, 
Tcf4 and Lgr5) in telogen HFs. Remarkably, Lhx2+ cells represent the vast majority of cells in 
the bulge and secondary hair germ that proliferate in response to skin injury. This is functionally 
important, since the wound re-epithelialization is significantly retarded in Lhx2 heterozygous (+/-
) mice, while anagen onset in HFs located closely to the wound is accelerated compared to WT 
mice. This is associated with a decrease in number of Sox9+/Tcf4+ cells and increase expression of 
Lgr5 and cell proliferation in the HFs closely adjacent to the wound. Furthermore, acceleration of 
wound-induced anagen in Lhx2+/- mice is inhibited by administration of Lgr5 siRNA. In addition, 
Chip-on-chip/ChIP-qPCR and reporter assay analyses reveal Sox9, Tcf4 and Lgr5 as direct Lhx2 
targets. These data suggest that Lhx2 positively regulates Sox9 and Tcf4 in the bulge and promotes 
wound re-epithelization, while it simultaneously negatively regulates Lgr5 in the secondary hair 
germ and inhibits HF cycling. Thus, Lhx2 operates as a switchboard regulator of epithelial stem 
cell activity during skin response to injury.
460
A trial of in vitro reconstitution of human skin using transgene-free induced pluripotent stem cells
Ken Igawa1, Jun Harada1, Yukinobu Nakagawa1, Kyoji Horie2, Kosuke Yusa3, Hiroo Yokozeki4, Junji 
Takeda2, Ichiro Katayama1 1Dept of Dermatology, Graduate School of Medicine, Osaka Univ, 
Osaka, Japan, 2Dept of Social & Environmental Medicine, Graduate School of Medicine, Osaka 
Univ, Osaka, Japan, 3The Wellcome Trust Sanger Center, Cambridge, UK, 4Dept of Dermatology, 
Graduate School of Medicine, Tokyo Medical & Dental Univ, Tokyo, Japan
Some defined factors which are important for self-renewal of embryonic stem cells (ESCs) have been shown to 
reprogram both mouse and human somatic cells into ESCs-like pluripotent cells, named induced pluripotent 
stem cells (iPSCs). Induction of reprogramming by these defined factors had been mostly carried out by co-
infection with retroviral vectors. The main problems of this retrovirus-based method were oncogenicity and 
mutagenesis. Therefore, transgene integration-free iPSCs have been necessary for their future therapeutic 
application. In our present study, we tried to generate transgene integration-free human iPSCs (hiPSCs) and 
to differentiate these hiPSCs into keratinocytes and to reconstitute human skin equivalent in vitro. To achieve 
this, firstly, we used the piggyBac-transposon system to deliver the reprogramming factors. The piggyBac 
transposon is a moth-derived DNA transposon and has been used for gene delivery and mutagenesis. Among 
several DNA transposons, piggyBac transposon does not leave ‘footprint’ mutations upon excision. This 
means removal of piggyBac transposon from the host genome without changing any nucleotide sequences. 
Using the piggyBac-transposon system, we generated hiPSCs from human dermal fibroblasts (efficiency 
= ~0.1%). After the removal of piggyBac transposon, these hiPSCs can be transgene integration–free and 
mutation-free, which are invaluable for therapeutic applications. Next, we tried to differentiate these hiPSCs 
into keratinocytes and obtained a homogeneous population of cells that showed phenotypic characteristics 
of basal keratinocytes (K5/K14 positive). Finally, we performed three-dimensional culture of these induced-
keratinocytes and could observe a pluristratified epidermis. Our results indicated the great promise of hiPSCs 
in the dermatological regenerative medicine.
461
An efficient method to generate human iPS-derived epithelial progenitors / keratinocyte
Ophelia Veraitch1, Tetsuro Kobayashi1, Yoichi Imaizumi2, Wado Akamatsu2, Masayuki Amagai1, 
Hideyuki Okano2, Manabu Ohyama1 1Dept of Dermatology, Keio University School of Medicine, 
Tokyo, Japan, 2Dept of Physiology, Keio University School of Medicine, Tokyo, Japan
Recently, reports are beginning to emerge that murine and human induced pluripotent stem 
cells (iPS) lines are capable of differentiating into functional keratinocytes, providing an exciting 
potential source of patient specific keratinocytes for cell based therapies. The purpose of this study 
is to establish a robust protocol for generating functional epithelial progenitors / keratinocytes 
from human iPS. Three human iPS lines respectively generated with 4 or 3 Yamanaka factors 
were suspended in floating culture to form embryoid bodies and treated with retinoic acid and 
bone-morphogenetic protein-4 (BMP4) before being plated on collagen I in keratinocyte serum 
free medium (KSFM). As short as 3 days of incubation with retinoic acid and BMP4 was sufficient 
to form cystic embryoid bodies which significantly downregulated the stem cell marker OCT4. 
Cystic embryoid bodies attached and started to form epithelial cell-like colonies within 24 hours 
of being plated on collagen I. After 6 days in culture, the epithelial cell-like colonies had a 
significant relative gene expression for p63, keratin 18 and keratin 14. Approximately, up to 80% 
and 20% of the colonies demonstrated positive immunoreactivity for keratin 18 and keratin 14 
respectively. Passaged cells maintained a good viability and formed colonies for up to 50 days 
in KSFM. In addition, when passaged cells were incubated with 1.2mM calcium chloride, the 
cells demonstrated a significantly higher expression of keratin 14. The current protocol represents 
a timesaving and relatively cost-efficient method of generating sufficient number of human iPS-
derived keratinocytes for downstream analysis.
462
Effect of Radiofrequency radiation on human hair follicle cells in vitro
Sun Young Yoon1, Kyu Tae Kim2, Seong Jin Jo1, Soon Jin Choi1, A-Ri Cho1, Kyu Han Kim1, Woong-
Yang Park2, Oh Sang Kwon1 1Department of Dermatology, Seoul National University College of 
Medicine, Laboratory of Cutaneous Aging and Hair Research, Clinical Research Institute, Seoul 
National hospital, Institute of Dermatolog, Seoul, Republic of Korea, 2Department of Biomedical 
Science, Biochemistry and Molecular Biology, Seoul National University College of Medicine, 
Seoul, Republic of Korea
The biological effect of Radiofrequency (RF) exposure remains controversial and the different 
results may depend upon experimental conditions and model system. RF exposure does not 
transfer energy high enough to break the covalent bonds of macromolecules, but enough to induce 
molecular responses such as cell proliferation or death. Our purpose was to examine whether 
RF exposure has any effect on human HF and to investigate the mechanism of RF-dependent 
signaling on HF cells. 1763MHz RF exposure for an hour per day with 10W/kg SAR over 7 
days enhanced hair shaft elongation in ex vivo hair organ culture. Through immunoflurorescent 
staining of Ki-67 and TUNEL, we could confirm that RF exposure induced proliferation and 
suppressed apoptosis in matrix keratinocytes in hair bulb. Moreover, in cultured human dermal 
papilla cells (hDPCs), we monitored cellular and molecular changes after exposure to RF 
radiation at 10W/kg SAR. Real-time PCR showed that RF exposure significantly enhanced the 
mRNA expression of IGF-1. Western blotting revealed that RF exposure prevented cell death by 
increasing the ratio of Bcl-2/Bax and promoted the survival of hDPCs by upregulating cyclinD1 
and phosphorylated Erk. In addition, RF exposure did not provoke the oxidative stress even at 
the maximum power of 60w/kg SAR, 1.7GHz for 1h. In conclusion, these results suggest that RF 
exposure has favorable effects on hair growth and could be considered a potential candidate for 
the treatment of alopecia.
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The rs3185480 polymorphism of the adenomatosis polyposis coli down-regulated 1 (APCDD1) 
gene is associated with androgenic alopecia
Nikoletta Nagy1,2, Katalin Farkas1, Ágnes Kinyó1, Angéla Meszes1, Kinga Szentner1, Lajos 
Kemény1,2, Márta Széll2 1Department of Dermatology and Allergology, University of Szeged, 
Szeged, Hungary, 2Dermatological Research Group of the Hungarian Academy of Sciences, 
Szeged, Hungary
Adenomatosis polyposis coli down-regulated 1 (APCDD1) gene is an inhibitor of the Wnt 
signaling pathway therefore it may have a role in the development of the skin appendages, 
moreover a mutation of this gene has been shown to be associated with a rare hair condition, 
hereditary hypotrichosis simplex. In this study we aimed to investigate whether the single 
nucleotide polymorphisms (SNP) of APCDD1 gene contribute to the development of a common 
hair disease, androgenic alopecia. The genotypes of 9 SNPs in the coding region of the gene have 
been determined with direct sequencing. 210 patients with androgenic alopecia and 98 controls 
have been enrolled to the study. The severity of the androgenic alopecia was classified according 
to Hamilton-Norwood in the case of men and according to Ludwig in the case of women. We 
found a significant difference in the distribution of the genotypes of the c.1781C/T, p.L476L SNP 
(rs3185480) of the APCDD1 gene in exon 5, causing a 3.5 and a 2.8 times increased risk for the 
development of androgenic alopecia for the homozygote (CI 0.933 - 13.125; Nominal Regression 
p=0.063) and the heterozygote carriers (CI 1.086 - 7.217; Nominal Regression p=0.033) of the 
alleles respectively. Based on our results we conclude that carrying the c.1781C/T, p.L476L SNP 
(rs3185480) of the APCDD1 gene either in heterozygous or in homozygous form increases the 
risk for developing androgenic alopecia.
464
Two disulfide bridges in S100A3 crucial for the natural substrate recognition by PAD3
Masaki Unno1, Kenji Kizawa2, Claus W Heizmann3, Hidenari Takahara1,4 1FRC for Appl. Atom. 
Sci., Ibaraki University, Tokai, Ibaraki, Japan, 2Kanebo Cosmetics Inc., Odawara, Kanagawa, 
Japan, 3Dept of Pediatrics, University of Zürich, Zürich, Switzerland, 4Dept. of Appl. Biol. Res. 
Sci., Ibaraki University, Ami, Ibaraki, Japan
Within the cuticular cells of human hair follicle, S100A3, a cysteine-rich member of the S100 
Ca2+-binding protein family, is posttranslationally citrullinated by peptidylarginine deimiase type 
3 (PAD3). PAD3 specifically converts a symmetric pair of Arg51 residues locates on diametric 
S100A3, which causes the assembly of a Ca2+-bound homotetramer. Although the recombinant 
S100A3 produced in Escherichia coli may forms a few intramolecular disulfide bridges, the 
observed Cys residues of S100A3 are all in a reduced state in the previously reported crystal 
structure (PDB ID: 1KSO). In this study, we prepared properly folded S100A3 and its mutant 
protein (R51A: a pseudo-citrullinated form) in insect cells since the capacity of E. coli for protein 
folding and disulfide bond formation is insufficient. Determined structure of insect cell-derived 
S100A3 by crystal X-ray analyses (PDB ID: 1NSI) showed two previously undocumented disulfide 
bridges: one disulfide bridge is between Cys30 in the N-terminal pseudo-EF-hand and Cys68 in 
the C-terminal EF-hand (SS1), and another bridge attaches Cys99 in the C-terminal coil structure 
to Cys81 in helix IV (SS2). Mutational disruption of SS1 abolished the Ca2+ binding property and 
retarded the citrullination by PAD3, while SS2 disruption inversely increased both Ca2+ affinity 
and PAD3 reactivity in vitro. Comparative inspection of atomic coordinates shows that SS1 
renders the C-terminal Ca2+-binding loop flexible whereas SS2 shelters Arg51 in the metal-free 
form. Conformational change specifically enables Arg51 in S100A3 to protrude into the active-
site cleft of PAD3 might be induced in the presence of Ca2+.
465
Epidermal IGF-1 receptor is important in the maintenance of bulge stem cells, hair follicle cycle 
and response to skin wounds
Edwige Roy2, Fabien Linay1, Martin Holzenberger1, Michele Oster1, Selim Aractingi1, Kiarash 
Khosrotehrani2 1UPMC Univ Paris 6, fetal stem cell laboratory, INSERM U938 CDR Saint-Antoine, 
PARIS, France, 2University of Queensland centre for Clinical Research, Experimental Dermatology 
Group, Brisbane, Australia
IGF-1 signalling is essential in epidermal development and maintains the interfollicular epidermis 
(IFE). However its role in adult homeostasis of bulge stem cells and their contribution to skin 
wound is unclear. To address this question, we used Keratin 14 and Keratin 15 driven conditional 
deletion of the IGF1 receptor (IGF1R) to abrogate IGF-1 signalling in the epidermis and in the 
bulge stem cells in an inducible manner in adult mice. Despite similar appearance up to 6 
months of age, quantitative analyses of epidermal subpopulations by flow cytometry revealed 
a significant increase of IFE epidermal cells in K15 driven deletion and a reduction in the 
proportion of CD34 high bulge stem cells in both situations suggesting the importance of IGF1 
signalling in the maintenance of each compartment. In steady state, we observed an increased 
number of anagen-phase HFs from K15CreIGF-1Rko mice during the first hair cycle. Similarly, 
after synchronization of the HF cycle upon depilation, K15CreIGF-1Rko animals had a prolonged 
anagen phase compared to littermate controls. Besides skin wound re-epidermisation was 
significant delayed at any age in K14 driven IGF1R deletion and at older age in mice with IGF1R 
deficiency in bulge cells. In conclusion, IGF1 signalling significantly affected epidermal stem 
cell maintenance and activity both in the hair follicle bulge resulting in potentially prolonged 
activity. In addition, our results show the reduced capacity of bulge stem cells deficient in IGF1R 
to contribute to skin wound healing over time.
466
Changes in vesicle trafficking are required for barrier acquisition during epidermal development
Lisa Gerber1, Gehad Youssef1, Aishath Naeem1, Catherine O’Neill2, Masahiro Ono1, Ryan 
O’Shaughnessy1 1UCL Institute of Child Health, London, UK, 2University of Manchester, 
Manchester, UK
Acquisition of epidermal barrier function during late gestation in mammals is rapid, and can be 
visualised in late gestation mouse embryos by the inability of dye to penetrate the embryo. To 
date the mechanism that causes this phenomenon is unclear but we have previously shown that 
the process is mediated by a transient AKT-dependent PPP2R2A mediated dephosphorylation of 
cJun. Here we show that concomitant with this process was the redistribution of a number of 
tight junction and gap components from the cytoplasm to the cell surface, resulting in increase 
in paracellular barrier function. Inhibition of PPP2R2A mediated phosphatase activity in explant 
models and organotypic culture models prevented redistribution of these junction components. 
Defects in paracellular barrier function in PPP2R2A siRNA expressing rat epidermal keratinocytes 
were rescued by inhibition of cJun phosphorlyation by SP600125. In these cells there were 
increased amounts of various cell junction proteins localised at the cell surface. Cluster analysis 
of expression array data indicated a group of genes involved in endosomal trafficking and 
recycling whose expression levels were rescued by inhibitor treatment. Consistent with this, we 
there was a transient reduction in Rab5 positive vesicles during epidermal barrier acquisition in 
vivo. These data suggest that a principle driver of epidermal barrier acquisition is the AKT/PP2A 
dependent reduction of endocytosis of cell junction proteins.
467
Human Dermal Papilla Cells and Hair Follicle Stem Cells as cellular components for a bio-
engineered composite skin substitute
Gustavo José Leirós1, Hugo Drago2, Silvia Bossi2, Flavio Sturla2, Ana Gabriela Kusinsky1, Alejandra 
Inés Attorresi1, Inés Stella3, María Eugenia Balañá1 1Fundación Cassará-Instituto de Ciencia y 
Tecnología Dr. César Milstein (CONICET), Buenos Aires, Argentina, 2Banco de Tejidos-Hospital 
de Quemados de la Ciudad de Buenos Aires,, Buenos Aires, Argentina, 3Centro de Estudios 
Biomédicos, Ambientales y Diagnóstico-Universidad Maimónides, Buenos Aires, Argentina
The bio-engineered composite skin (dermo-epidemal) could be a useful tool to treat deep and 
extensive skin injuries. We studied the effect of human Dermal Papilla Cells (DPC) on tissue 
architecture and stem cell persistence of in vitro-generated composite skin and on its graft-take in 
nude mice. A porcine acellular dermis seeded with Hair Follicle Stem Cells (HFSC) alone, with 
DPC or with 3T3-Swiss cell line was cultured both in liquid or air-liquid interface. Composite 
constructions were also grafted into nude mice for graft-take evaluation. Histological analysis and 
immunohistochemistry for p63 and endothelial markers were performed. In liquid cultures no 
differences were observed among the different constructions. Among air-liquid interface cultures, 
DPC-containing constructions showed the most regular stratified epidermis with the highest 
number of cellular layers, basal p63-positive cells and invaginations. Graft-take in nude mice 
was favoured in DPC-containing composite skin supported by the fact of graft-epidermis survival. 
In these constructions, porcine acellular dermis showed fibroblast and angioblast invasion and 
a remodeling phenomenon mediated by macrophages and giant cells. Moreover, fibroblast and 
angioblast proliferation was observed from the wound border generating a granulation-tissue 
immediately below the graft-epidermis. Composite-skin containing 3T3-Swiss cells showed graft-
epidermis necrosis, reduced porcine dermis remodeling and absence of granulation-tissue below 
graft-epidermis. The results suggest that DPC and HFSC are promising cellular components for a 
permanent skin substitute.
468
Inhibition of Dermal papilla-induced Hair Follicle Stem Cells differentiation involves Glycogen 
synthase kinase-3β modulation in androgenetic alopecia
Alejandra Inés Attorresi, Gustavo José Leirós, María Eugenia Balañá Fundación Cassará-Instituto 
de Ciencia y Tecnología Dr. César Milstein (CONICET), Buenos Aires, Argentina
The hair follicle formation begins when signals from the mesenchyme-derived dermal papilla 
cells (DPC) reach multipotent epidermal stem cells (HFSC) in the bulge region. In androgenetic 
alopecia (AGA), circulating androgens act on sensitive DPC and alter regulatory paracrine 
factors probably involved in the differentiation and proliferation of the HFSC. While androgens 
have a regressive effect, Wnt/ß-catenin signaling is known to positively affect mammalian hair 
growth. The aim of this work is to determine the role of androgens in the DPC-induced HFSC 
differentiation. In a co-culture model with human DPC from patients suffering AGA and HFSC, 
androgens treatment abrogates hair differentiation downregulating the expression of the keratin 
K6hf, a hair differentiation marker, in HFSC. LiCl, which mimics the effects of Wnt signalling 
activation, restored the differentiation ability of androgen- treated DPC. In DPC, analysis of the 
cytoplasmic pool of β-catenin by Western blot showed that the ratio cytoplasmatic/total β-catenin 
is significantly lower in the presence of androgens indicating an inhibition of the canonical Wnt 
signalling. Glycogen synthase kinase-3β (GSK-3β) inhibits Wnt signalling by phosphorylation of 
β-catenin. In DPC, we found that androgens activate GSK-3β by upregulation of its expression 
and also by inhibition of its phosphorylation at Ser-9. These results suggest that the activation of 
GSK-3β in the presence of androgens may inhibit canonical Wnt signaling resulting in abrogation 
of DPC-induced HFSC differentiation.
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Innovative screening strategy to select adipogenesis-modulating substances in vitro
Sabine Pain1, Cécile Chagneau1, Christelle Gaillard1, Charlotte Lequeux2, Aurélie Boher1, Nicolas 
Bechetoille1, Odile Damour2, Valérie André-Frei1 1BASF Beauty Care Solutions France S.A.S, Lyon, 
France, 2Banque de tissues et cellules, Hôpital Edouard Herriot, Lyon, France
Adipose derived stem cells (ADSC) were used to develop an in vitro screening procedure in 
order to identify ingredients able to modulate the maturation of cultured adipocytes. Poorly 
differentiated adipocytes express Pref-1, which progressively decreases before disappearing in 
mature adipocytes. Inversely, EGFL9/Dlk2 expression increases along with adipocyte maturation. 
The commitment into adipocyte differentiation is also characterized by a clonal expansion step 
that precedes the proper differentiation step accompanied by the expression of proteins such as 
adiponectin. Human ADSC obtained from liposuction leftovers were isolated and brought in 
culture. The most adherent cells were shown to express the highest Pref-1 level and were used as 
reference cells. These cells were also shown to have a high proliferation rate. At confluence, the 
medium was replaced by a differentiation medium supplemented with IBMX which induced the 
disappearance of Pref-1 together with an increased expression of DLK-2. At day 4, the medium 
was replaced by a maturation medium devoid of IBMX. This maturation step was characterized by 
a decreased mRNA expression of C/EBPα and PPARγ. During the differentiation and maturation 
steps, the secretion of adiponectin was measured in the culture medium and was shown to 
continuously increase. Finally, Oil Red O staining was measured by image analysis of confocal 
microscopy pictures to evaluate the size of lipid droplets. Subsequently, different plant extracts 
were evaluated for their ability to first increase pre-adipocyte proliferation, decrease Pref-1 
expression and increase DLK-2 during the differentiation step, increase adiponectin secretion 
and finally increase the size of lipid droplets.
470
Impact of modulating circadian protein expression on stress-induced dermal papilla cell aging
Sandrine Ratz1, Armelle Perrin1, Frederique Portolan1, Jean Marie Botto1, Catherine Gondran1, 
Claude Dal Farra2, Nouha Domloge1 1SP Vincience, ISP Global Skin Research Center, Sophia-
Antipolis, France, 2ISP Corporate Research Center, Wayne, NJ, USA
In a previous study, we showed that modulation of circadian protein expression in human dermal 
papilla cells (HDPC) could be associated with maintaining the proliferation capacity of these 
cells. As previously demonstrated, the size of dermal papilla, taking into account the number of 
dermal papilla cells and their secretory activity, regulates thickness and length of the hair shaft. 
Moreover, HDPC senescence appears to be linked to reduction of their proliferation capacity. In 
the present study, we further investigated the effect of modulating circadian protein expression, 
in a model of accelerated, in vitro senescence induced by methylglyoxal (MGO). HPDC were 
treated with MGO (0.4 mM) for 24h, then the compound that previously exhibited an effect 
on circadian protein expression (IV09.019) was applied on these in vitro aged cells for 48 h. 
The effect of senescence induced by MGO on HDPC was studied on cell morphology (H&E), 
cell proliferation capacity (Ki67) and fibronectin synthesis. Cells stressed by MGO exhibited 
a granular and vacuolar aspect in their cytoplasm, a reduced number of Ki67-positive cells, as 
well as a disruption of fibronectin network. When the cells were treated by the circadian protein 
inducer, less irregular aspect of cytoplasm was observed, associated with partial recovery of the 
number of Ki67-positive cells and better organization of fibronectin network. Our results suggest 
that the induction of circadian protein expression in HDPC may help reduce the appearance of a 
senescent phenotype, in a model of accelerated stress-induced senescence.
471
Optimization of communication between keratinocytes and DPC via LN-511 signaling pathway
Armelle Perrin1, Celine Meyrignac1, Jean Marie Botto1, Catherine Gondran1, Claude Dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, Sophia-Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ, USA
Hair morphogenesis and anagen growth share common molecular effectors. Among them, 
laminin-511 (LN-511) was recently shown to facilitate epithelial-mesenchymal interactions 
during hair morphogenesis. Moreover, through its binding to β1-integrin receptor, LN-511 plays 
a crucial role in post natal hair growth and hair anagen maintenance. LN-511 signaling involves 
the protein Noggin, a BMP4 inhibitor that induces and maintains the anagen phase of hair cycle. 
These recent findings lead us to develop a new approach to promote hair growth by acting on 
LN-511 expression. For this purpose, normal human keratinocytes (NHK) and ex vivo scalp skin 
biopsies were treated for 24h and 48h with a biofunctional that targets LN-511 pathway. Alpha-5 
chain of LN-511, alpha-3 and beta-1 integrins, noggin, beta-catenin and Ki67 were characterized 
by immunostainings. We observed that application of the selective compound enhanced LN-511 
synthesis and alpha-3 and beta-1 integrins in NHK, as well as in hair follicles of scalp biopsies. 
This effect was accompanied by an increase in Noggin protein and alpha-3 integrin in human 
dermal papilla cells (HDPC) and a relocation of beta-catenin in the nucleus. Finally, conditioned 
medium of NHK treated with the compound increased nuclear beta-catenin expression in HDPC, 
suggesting an effect on cellular communication between these two cell types. In conclusion, 
our results report a positive modulation of LN-511 in NHK and basal membrane of the hair 
follicle. Our observations may suggest an optimal communication between epithelial cells and 
the dermal papilla, required to maintain hair growth conditions.
472
Modulation of transglutaminase isoform expression in the hair follicle
Celine Meyrignac1, Armelle Perrin1, Jean Marie Botto1, Catherine Gondran1, Claude Dal Farra2, 
Nouha Domloge1 1ISP Vincience, ISP Global Skin Research Center, Sophia-Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ, USA
Transglutaminases are calcium-dependent enzymes that catalyze the formation of ε-(γ-glutamyl) 
lysine bonds, conferring stability to cross-linked proteins. Transglutaminases are expressed in 
both epidermis and hair follicle, and contribute to the formation of the cornified envelope and 
to the physical stability of the cornified layer as well as to the strength of the hair shaft. We were 
interested in studying the effect of a biofunctional that could specifically target transglutaminase 
expression. Our studies were performed by immunostaining on normal human keratinocytes 
(NHK), human dermal papilla cells (HDPC) and hair follicles isolated by microdissection from 
scalp skin biopsies. Our results indicate that expressions of the transglutaminase isoforms 1, 3 
and 5 were boosted by a 24h application of the selected compound on NHK. The expression 
of transglutaminase 2, which is involved in matrix remodeling of the dermal papilla, was also 
increased in treated HDPC. In isolated hair follicle treated for 48h, we observed a more intense 
staining of transglutaminases 1 and 3, in IRS and hair shaft, respectively, compared to the control. 
This effect was accompanied by an increase in transglutaminase major substrates and structural 
proteins, involucrin and trichohyalin. We also analyzed the expression of desmocollin 1 as an 
indicator of terminal differentiation of hair follicle. In conclusion, these observations may be 
in favor of a reinforcement of hair follicle structure that could lead to an improvement of hair 
physical resistance.
473
Impacts of cultured dermal papilla microtissues on hair regeneration efficiency and hair quality
Chih-Chieh Chan1,2, Tse-Han Liu2, Wei-Ting Lin2, Sung-Jan Lin1,2 1National Taiwan University 
Hospital, Taipei, Taiwan, 2Institute of Biomedical Engineering, National Taiwan University, Taipei, 
Taiwan
Hair follicle (HF) regeneration with a desirable thickness (hair size) is essential to clinical 
outcome. However, how hair size is regulated and whether the size can be controlled during 
regeneration are yet to be explored. A reliable efficiency and the ability to control quality of 
regenerated hairs are crucial to future application of HF regeneration. Dermal papilla (DP) cells 
are able to induce HF neogenesis when transplanted as aggregates. However, the effect of DP 
quality on hair inductivity and hair quality is yet to be determined. Here we demonstrate a 
method enabling simple mass preparation of quality-controlled DP microtissues. We found DP 
cells do not attach on poly-vinyl alcohol (PVA)-coated commercially available PCR tubes and 
quickly aggregate into single spheroidal microtissues within the limited spaces. The microtissue 
volume shows dynamic change due to tissue compaction. Varying culture periods and seeded 
cell numbers enable us to generate DP microtissues of controllable sizes/cell numbers. In 
comparison with hanging-drop method, DP microtissues obtained here have higher viability and 
preserve DP signature gene expression. A proof of principle experiment demonstrated the quality 
of these microtissues on hair follicle regeneration. Both human and rat DP microtissues are able 
to induce HF neogenesis. Efficiency of HF regeneration is progressively enhanced by increasing 
size/cell number in each microtissue until an optimal size/cell number is reached. However, the 
quality/size of regenerated hairs doesn’t correlate well with size/cell number of DP microtissues. 
Our results demonstrate implication of DP aggregates on HF regeneration in terms of efficiency 
and hair quality.
474
In vivo Quantitative Monitoring of Hair Cycle Dynamics in Mice During Pregnancy and 
Lactation
Samantha Hodgson, Kiarash Khosrotehrani University of Queensland Centre for Clinical 
Research, Herston, Queensland, Australia
During pregnancy and lactation, hormonal influences appear to effect hair growth phase and 
it is believed that hair follicles enter telogen and are unable to re-enter anagen. We aimed to 
generate a model to quantitatively monitor beta-catenin activity to follow hair cycle dynamics 
during pregnancy. Mice harbouring a luciferase reporter gene under the control of beta-catenin 
binding sites were generated to track hair follicle cycles in live mice by in vivo bioluminescence 
imaging. Beta-catenin activity in the skin was seen to increase at a steady rate from birth peaking 
at P9 with >400 fold increase compared with newborns following the course of hair development 
and first hair cycle. In adults, hair plucking in telogen phase induced beta-catenin activity from 
day 6 that peaked at day 10. We have tracked hair follicle cycles in live mice during gestation 
and lactation. Mice were subjected to hair growth phase induction test on day 10 of gestation 
and following birth on day one of lactation. Pregnant and non-pregnant groups were both able 
to enter anagen during late pregnancy with a significant increase in beta catenin activity 8 days 
after hair plucking (day 18 of gestation). While non-pregnant mice were then able to enter the 
second natural anagen hair cycle, after giving birth, lactating mice remained in telogen phase. In 
conclusion, hair follicle cycle can be significantly affected by lactation during the post partum 
period.
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Treatment of Chemotherapy Induced Alopecia in Mice with a Novel Parathyroid Hormone 
Fusion Protein: Prophylaxis vs. Therapy
Robert Gensure1,2, Ranjitha Katikaneni1,2, Tulasi Ponnapakkam1,2 1Children’s Hospital at 
Montefiore, Bronx, NY, USA, 2Albert Einstein College of Medicine, Bronx, NY, USA
Alopecia is a psychologically devastating complication of chemotherapy, for which there is 
currently no effective therapy, although parathyroid hormone analogs have shown promise in 
this disorder. PTH-CBD is a parathyroid hormone analog containing a collagen binding domain 
that targets drug delivery to the skin. We compared the effects of prophylactic vs. therapeutic 
administration of PTH-CBD in a mouse model of chemotherapy-induced alopecia. C57/BL6 mice 
were treated with a single subcutaneous injection of PTH-CBD (320 mcg/kg) or vehicle control, 
followed by 3 courses of cyclophosphamide chemotherapy (150/mg/kg/week). After 1 year, mice 
pretreated with vehicle had evident hair changes (color change and hair loss), while those pre-
treated with PTH-CBD had a normal appearing coat. Vehicle mice were then divided into two 
groups, receiving either PTH-CBD (single subcutaneous injection, 320 mcg/kg) or vehicle control. 
After 4 months, mice receiving PTH-CBD showed partial recovery of the hair changes, while 
those receiving vehicle showed no recovery. After sacrifice, histological examination revealed 
small, mostly catagen hair follicles in mice receiving chemotherapy alone. Mice receiving PTH-
CBD prophylaxis prior to chemotherapy showed normal-appearing telogen hair follicles. Mice 
receiving PTH-CBD therapy after chemotherapy showed intermediate histological features, with 
hair follicles mostly in the anagen phase. Overall, it appears that PTH-CBD is effective in both 
prevention and treatment of chemotherapy-induced alopecia, but pre-treatment results in a better 
cosmetic outcome. PTH-CBD thus shows promise as an agent to prevent this complication of 
chemotherapy and improve the quality of life for cancer patients.
476
CD98hc Maintains Progenitor Function during Epidermal Homeostasis
Soline Estrach*, Etienne Boulter*, Aurelia Errante, Catherine Pons, Karim Ben Salah, Guerrino 
Meneguzzi, Chloe C Feral Inserm, equipe avenir, Nice, France
The T cell activation antigen CD98hc (SLC3A2) is highly expressed on a wide variety of proliferative 
cells. CD98hc physically interacts with integrins and regulates amino acid transport. Its absence 
in mice is embryonic lethal at E3.5-E9.5. Here, we report that disruption of CD98hc gene in 
epidermis of young adult mice drastically blocks hair growth by markedly impairing progenitor 
cell functions. Moreover, CD98hc efficient deletion in bulge stem cells aggravates the negative 
effects of its invalidation on skin homeostasis in young mice. This effect is not manifest in epidermis 
of elderly animals which present normal stem cell populations or skin morphology. Thus, we now 
show that skin progenitors are addicted to CD98hc during high epidermal renewal phase (young 
mice), but become CD98hc independent as epidermal proliferation decreases (aged mice). By 
using an in vivo wound healing model on young mice, we found that CD98hc absence limits 
both cell migration and proliferation. Importantly, we improved the RBD/PBD assays to directly 
assess in vivo activity of small GTPases. We show that CD98hc deletion impairs in vivo integrin-
dependent RhoA and Rac1 signals that support cell migration. Altogether, our data strongly indicate 
that CD98hc maintains progenitor function during epidermal homeostasis and wound healing. 
*These authors contributed equally
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Galanin is a novel inhibitor of human hair follicle growth
Barbara Holub1, Jennifer Klöpper2, Barbara Kofler1, Ralf Paus2,3 1Laura Bassi Centre of Expertise 
THERAPEP, Research Program for Receptorbiochemistry and Tumormetabolism, Department 
of Pediatrics, Paracelsus Medical University, Salzburg, Austria, 2Department of Dermatology, 
University Hospital Schleswig-Holstein, Lübeck, Germany, 3School of Translational Medicine, 
University of Manchester, Manchester, UK
Galanin, a trophic factor of the central and peripheral nervous system, is widely 
distributed throughout skin, including the epidermis and hair follicle (HF). However, 
the exact localization and the role of galanin in the HF has not been investigated. 
Here, we have determined the cellular localization of galanin in human HFs and have 
studied effects of galanin on human scalp HFs in organ culture. Immunohistochemistry 
was performed on cryosections of human female scalp skin. Anagen HFs were isolated 
and cultured up to 9 days and treated with 100 nM galanin. Staining for Ki-67, TUNEL 
and Masson-Fontana were used to analyze proliferation, apoptosis and hair cycle 
staging of the HFs. Quantitative real-time PCR (qRT-PCR) was performed with human 
RNA extracts to determine intrafollicular galanin and galanin receptor transcriptions. 
Here, we show that galanin-like immunoreactivity (galanin-LI) can be detected in the 
outer root sheath and inner root of the HFs, and galanin mRNA was found in HFs and 
outer root sheath keratinocytes. Galanin treated human scalp HFs showed reduced hair 
shaft elongation and inhibition of proliferation of hair matrix keratinocytes compared to 
vehicle controls. Galanin also reduced the duration of the hair growth phase (anagen). 
In summary, we present the first evidence that human HFs are a source and target of galanin, 
which, thus, enters the growing list of hair growth-modulatory neuropeptides and appears to 
primarily act as inhibitor of human hair growth. Therefore, GALR2 and/or GALR3 agonists 
deserve exploration as novel anti-hirsutism candidates, while antagonists may serve to counteract 
telogen effluvium.
478
Schwann cells in the subepidermal nerve plexus ensheath nerve fibers of different qualities 
simultaneously
Christina Maria Reinisch1, Dagmar Födinger1, Erwin Tschachler1,2 1Medical University of 
Vienna, Vienna, Austria, 2Centre de Recherches et d´Investigations Épidermiques et Sensorielles 
(CE.R.I.E.S.), Neuilly, France
The subepidermal nerve plexus encases our complete body surface like a delicate network. 
It consists of myelinated A-fibers and unmyelinated peptidergic and non-peptidergic C-fibers 
which are ensheathed by terminal Schwann cells. Thereby, it provides all necessary constituents 
to perceive stimuli from our environment like touch, temperature and pain. We made use of 
triple stainings of dermal sheet preparations to analyse the ratio of Schwann cells and nerve fibers 
in the plexus. As markers, antibodies for Nerve Growth Factor receptor, Protein Gene Product 
9.5, Calcitonin Gene Related Peptide and Neurofilament were applied. Analysis was done by 
laser scanning microscopy. In addition, we used immunostained dermal sheet preparations for 
electron microscopical analysis. We found that many Schwann cells contained multiple nerve 
fibers. Surprisingly, not only multiple PGP9.5 positive fibers were seen in single Schwann cells 
but also PGP9.5 positive fibers combined with NF or CGRP positive fibers. Detailed electron 
microscopical analysis confirmed our findings and revealed that most of the Schwann cells 
contained unmyelinated nerve fibers. In a few Schwann cells, we detected axons wrapped by two 
or three layers of the mesaxon and strikingly all of these Schwann cells additionally contained 
further axons wrapped by only one layer of mesaxon, qualifiying them as C-fibers. Potentially, 
this rudimental multi-layered sheath depicts the beginning of myelination in the periphery. So far, 
myelinated and unmyelinated axons have never been shown to occur in the same Schwann cell. 
This finding highlights the uniqueness of Schwann cells present in the subepidermal nerve plexus.
479
Analysis of androgen receptor gene polymorphism and skewed X chromosome inactivation in 
Russian premenopausal women with androgenetic alopecia
Sergey Rotanov1, Anastasia Mareeva1, Ilya Volkov1, Natalia Frigo1, Galina Chernukha2 1State 
Scientific Centre of Dermatovenereology and Cosmetology of Ministry of healthcare and social 
development, Moscow, Russia, 2Federal State Institution “Research Center for Obstetrics, 
Gynecology and Perinatology” Ministry of Healthcare and Social Development, Moscow, Russia
Androgenetic alopecia (AGA) is known to be affected by androgen levels, which act through the 
androgen receptor (AR). It has been demonstrated that androgenic action inversely correlates 
with a polymorphic AG repeat region in the AR gene. Since AR gene lies on the X-chromosome, 
it becomes pertinent to assess the X chromosome Inactivation (XCI) pattern as well. 
The purpose of this study was to investigate whether skewed X chromosome inactivation (XCI) 
and the AR gene CAG repeat polymorphism are associated with AGA in Russian premenopausal 
women. AR gene was evaluated by using a polymerase chain reaction-restriction fragment length 
polymorphism in 87 AGA patients (29,5±5,4 years old) and 64 age-matched controls (29,3 ± 5,7 
years). XCI analysis was also carried out to assess the inactivation percentages. The incidence 
of skewed XCI (> or=70%) was 50,7% in AGA group and 16,1% control group (p<0,05). The 
mean number of CAG repeats for the cases (20,76±2,08) and controls (21,42±2,26) was similar 
(p>0,05). The shorter (<22) CAG triplet repeat lengths in a combination of both alleles was 
more prevalent in AGA patients (p=0,0124; OR=0,25; 95%CI: 0,09-0,71). These data suggest 
that process of X chromosome inactivation and AR gene CAG repeat polymorphism can be 
determinant for the development of AGA among Russian premenopausal women.
480
Outer root sheath keratinocytes possess a functionally active endocannabinoid system
Judit Papp2,1, Gabriella Czifra1, Lídia Ambrus1, István Juhász2, Attila G. Szöllősi1, Attila Oláh1, 
Balázs I. Tóth1, Koji Sugawara3, Ralf Paus3, Tamás Bíró1 1University of Debrecen, Department 
of Physiology, Debrecen, Hungary, 2University of Debrecen, Department of Dermatology, 
Debrecen, Hungary, 3University of Lübeck, Department of Dermatology, Lübeck, Germany
In our previous experiments we verified that endocannabinoids anandamide (AEA) and 
2-arachidonoylglycerol (2-AG), along with the phytocannabinoid Δ9-tetrahydrocannabinol (THC) 
inhibit the growth of human organ cultured hair follicles (HF) and induce catagen transformation 
in a CB1 mediated manner. In our current experiments we continued the exploration of the 
endocannabinoid system on HF-derived outer root sheath keratinocytes (ORSKs) by examining 
the effect of an endo- (AEA) and a non-psychoactive phytocannabinoid (cannabidiol, CBD) on 
these cells. Using Q-PCR we identified the expression of “ionotropic cannabinoid receptors”, 
namely transient receptor potential vanilloid (TRPV) 1, 2 and 4, along with the previously 
described CB1. ORSKs also express enzymes involved in the synthesis (NAPE-PLD, DAG-lipase 
α and β) and degradation (MAG-lipase, FAAH) of endocannabinoids. These findings argue for 
the presence of a complex endocannabinoid system in ORSKs. To determine the functional 
role of the ECS we treated ORSKs with AEA and CBD. Both treatments significantly decreased 
the viability of the cells (MTT-assay). To elucidate the mechanisms involved in the decrease of 
viability we examined the apoptotic and necrotic processes of the cells, by tracking the decrease 
of mitochondrial membrane potential and the loss of membrane integrity (DilC1(5) and SYTOX 
Green staining respectively). We found that both cannabinoids cause dominantly apoptotic cell 
death. In our current experiments we are examining the effects of these cannabinoids on the 
differentiation and immunological function of ORSKs. Our preliminary findings highlight the 
possible application of cannabinoids in the treatment of disorders affecting the pilosebaceus unit.
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In situ labeling of DNA in human hair: potential application in forensics
Leopold Eckhart1, Sandra Szabo1, Heinz Fischer1, Karin Jäger1, Jennifer Scherz1, Walther Parson2, 
Erwin Tschachler1 1Medical University of Vienna, Department of Dermatology, Vienna, Austria, 
2Innsbruck Medical University, Institute of Legal Medicine, Innsbruck, Austria
Recently we established a novel method to detect DNA in hair by labeling with fluorescent 
dyes. The method was validated using hair from DNase1L2-deficient mice which fail to degrade 
nuclear DNA during hard cornification of keratinocytes. Here we modified this protocol and 
applied it to human hairs. Distal human hair samples were permeabilized with ammonia and 
incubated with the DNA-specific dye Hoechst 33258 to label DNA in situ. Residual nuclear DNA 
was visualized under a fluorescence microscope. Hair from some donors did not contain any 
stainable nuclei whereas hair from other donors contained a variable number of DNA-positive 
nuclear remnants. The number of DNA-containing nuclear remnants per millimeter of hair 
correlated with the amount of DNA that could be extracted and amplified by quantitative PCR. 
When individual hairs were investigated, only hairs, in which DNA could be labeled in situ, gave 
positive results in short tandem repeat (STR) genotyping, which is widely used in forensics. This 
study reveals that the completeness of DNA degradation during cornification of hair keratinocytes 
is a polymorphic trait. Furthermore, our results suggest that in situ labeling of DNA in hair may 
be used to predict the probability of success of forensic analysis of nuclear DNA in shed hair.
482
Do abnormal interactions between perifollicular mast cells and CD8+T-cells contribute to the 
pathogenesis of alopecia areata?
Marta Bertolini1, Patrick Kleditzsch1, Vladimir Emelianov1, Akiko Arakawa1,2, Koji Sugawara1, 
Katja Meyer1, Ralf Paus1,3 1Dept of Dermatology, University of Lübeck, Germany, 2Kyoto University, 
Kyoto, Japan, 3School of Translational Medicine, University of Manchester, UK
Mast cells (MC) activities are implicated in hair growth control, regulate CD8+T-cells in mice, 
and play a role in hair follicle (HF) immune privilege (IP) maintenance. Since MC number and 
degranulation are increased in alopecia areata (AA), an HF-restricted CD8+T-cell-dependent 
autoimmune disease that involves HF-IP collapse, we searched for evidence of abnormal MC/
CD8+T-cell interactions in AA. Therefore, we compared the number, degranulation and proliferation 
status of perifollicular MCs and MC/CD8+T-cell complexes in defined reference areas, in lesional 
AA and healthy human scalp skin by quantitative (immuno-)histomorphometry. In addition, we 
investigated the effects of endogenous (substance-P) and exogenous (compound 48/80) MC 
secretagogues on perifollicular MC/CD8+T-cell complexes in human skin organ culture. In lesional 
AA skin, not only MC degranulation was increased, but also the number and proliferation of mature 
and immature MCs was significantly higher than in healthy control skin, especially in the HF 
connective tissue sheath and in acute AA. Follicular expression of the HF-IP “guardian”, TGFbeta1, 
was notably down-regulated in AA patients. The latter also displayed significantly more peri- and 
intrafollicular- CD8+T-cell and “MC/CD8+T-cell complexes” compared to controls. In normal 
human skin organ-culture, MC/CD8+T-cell interactions significantly increased after addition of 
substance-P or compound 48/80. Taken together, these observations strongly encourage one to 
explore the new hypothesis that abnormal MC/CD8+T-cell interactions play an important role in AA 
pathogenesis. Considering that the stress-associated neuropeptide substance-P, which aggravates 
murine AA and cause HF-IP collapse of human HFs, and compound 48/80 both stimulate MC/
CD8+T-cell interactions, further supports this hypothesis.
483
Passaged Human Skin Dermal Fibroblasts: A Novel Source of Multi-potent Skin Derived 
Precursor Cells
Rebecca Hill1,2, Claire Higgins1,3, Heather Crawford1, Andrew Owens4, Clifford Lawrence5, 
Elizabeth James6, Bo Kara2, Colin Jahoda1 1Durham University, Durham, UK, 2Fujifilm, Billingham, 
UK, 3Columbia University, New York, USA, 4James Cook University Hospital, Middlesbrough, UK, 
5Royal Victoria Infirmary, Newcastle Upon Tyne, UK, 6University of Brighton, Brighton, UK
Human multi-potent skin derived precursor cells (SKPs) hold considerable promise for stem cell 
therapeutics, however their use depends on sourcing from dissociated skin dermal tissues. We 
demonstrate that adult human dermal fibroblast cells pre-cultured in conventional monolayers 
are capable of forming SKPs, even after extensive passaging and cryopreservation. Like SKPs 
generated from dissociated dermis, these monolayer SKPs (termed m-SKPs) expressed nestin, 
fibronectin, versican, p75 neurotrophin receptor (NTR), pax3, slug, Nanog, Oct 4, Sox2, Sox9 
and Dermo-1. Appropriate stimuli induced m-SKPs to accumulate lipid, form calcified deposits, 
label positively for S100β and form β-III tubulin positive cells with multiple processes. Others 
have shown that the number of SKPs obtained from skin samples varies according to patient 
age, body site and anatomical location, with the hair follicle dermal papilla in particular being 
a highly enriched source. m-SKP forming capacity was greater in fibroblast cultures with more 
alpha-smooth muscle actin(ASMA) expressing cells compared to cultures with less ASMA 
expression both at passage 3 (p3) and passage 12 (p12). In turn, elevated ASMA expression in 
the cultures correlated with them originating from specimens isolated from body sites containing 
more obvious terminal hair follicles. However, conversely and unexpectedly, cultured cells 
expressing high levels of ASMA derived specifically from the hair follicle dermal papilla, did not 
form m-SKPs. These findings reveal the potential for using expanded dermal fibroblast cultures 
to derive SKPs for cell based therapeutics, but also raise questions as to the progenitor status of 
hair follicle dermal papilla cells.
484
Cutaneous Squamous Cell Carcinoma exhibits significant tumour heterogeneity
Sonia Murray1, Nicola Foster2, Irene Leigh1, Norman Pratt2, Andrew South1 1University of Dundee, 
Dundee, UK, 2Ninewells Hospital, Dundee, UK
Tumour heterogeneity represents a major obstacle to therapy and is thought to contribute to 
cancer resistance and remission. Cutaneous squamous cell carcinoma (cSCC) is genetically 
complex as demonstrated by single nucleotide polymorphism mapping and comparative 
genomic hybridisation. We show here that early passage keratinocytes (p5-14) isolated from 8 
primary cSCC exhibit considerable heterogeneity. Cytogenetic analysis of 10-13 cells from each 
population demonstrated shared clonal markers but also revealed that in 6 of 8 cSCC cultures 
no two cells possessed identical karyotypes. The remaining 2 populations were composed of 
6 and 7 different karyotypes (identified from 10 and 13 cells respectively). To investigate this 
observation further we derived clonal populations from 2 of the cSCC cultures, SCCRDEB2 and 
SCCIC1. In each case we were able to derive multiple populations with distinct morphological 
appearance. This was most apparent for SCCIC1 where populations fell into three separate 
phenotypes reminiscent of para-, holo- and meroclone morphologies described for normal 
primary keratinocytes: A - little or no cell-cell adhesion, B - tight colonies of cells in close 
proximity and C - an intermediate phenotype with loosely packed colonies. Proliferation rates 
were similar among the clones but were greater in pooled and parental populations as measured 
using the MTS assay. Scratch wound assays identified clones A and C as being more migratory 
but surprisingly, organotypic cultures revealed these clones to be less invasive. Together our 
data identify that tumour keratinocytes derived from primary cSCC contain genetically and 
morphologically distinct populations which display varied migratory and invasive phenotypes.
485
Human hair follicle dermal cells and skin fibroblasts show differential activation of NF-kappa B 
in response to pro-inflammatory challenge
Rebecca Hill1, John Haycock2, Colin Jahoda1 1Durham University, Durham, UK, 2University of 
Sheffield, Sheffield, UK
Recent research highlights the need for greater understanding of immune biology relating to 
the follicle dermis, since it is a key site for the expression of an NKG2D ligand (ULBP3), whose 
upregulation may be a trigger for the autoimmune disease alopecia areata. We have previously 
described a role for hair follicle dermal sheath (DS) and papilla (DP) in wound healing and 
observed DS immune privilege in vivo in humans. However, the underlying mechanism of 
immune privilege in DS and DP populations is not well understood, and the responsiveness 
of hair follicle dermal cells to pro-inflammatory challenge is presently unknown. The NF-
kappaB/p65 transcription factor controls the expression of cytokines, cytokine receptors and cell 
adhesion molecules involved in inflammation. Here we investigated the response of cultured 
human DS and DP cells to pro-inflammatory challenge using analysis of TNF-alpha, IL1-beta or 
LPS stimulated NF-kappaB activation. We observed acute NF-kappaB activation in human DS, 
DP and dermal fibroblast (DF) cells challenged with TNF-alpha and IL1-beta. By contrast the DS 
and DP cells revealed an unexpected tolerance to bacterial LPS challenge relative to DF cells. 
The Toll-Like Receptor 4 (TLR4), recognizes LPS leading to activation of the NF-kappaB pathway, 
and as we observed TLR4 in DF, DS and DP cells, it is unlikely that the reduced responsiveness 
of DS and DP cells to LPS arises through the follicle dermal cells having lower levels of TLR4. 
Understanding follicle cell responses to typical pro-inflammatory stimuli could help provide 
insight into hair follicle immune privilege.
486
Interest of Glyceryl Laurate in Inhibition of 5 Alpha-Reductase Activity and Sebum Production 
in Human Sebocytes
Marguerite Leveque, Ophélie Lejeune, Marie-Florence Galliano, Cécile Viode, Daniel Redoules, 
Sandrine Bessou-Touya, Nathalie Castex-Rizzi Pierre Fabre Dermo-Cosmetique, Toulouse, France
Acne vulgaris is a chronic skin disease of pilosebaceous glands in which sebum production is 
excessive and androgens are known to strongly regulate this physiologic process. In order to 
develop new therapies against the development of acne lesions, we evaluated the effect of a 
new lauric acid derivative, namely the glyceryl laurate, on 5 alpha-reductase activity and sebum 
production during human sebocytes differentiation. For this purpose, normal human dermal 
fibroblasts were pre-incubated with increasing concentrations of glyceryl laurate (20 to 70µM) 
before the adding of [4-14C] testosterone. Finasteride (10µM) was used as reference molecule for 
its anti-5 alpha-reductase activity. Glyceryl laurate capacity to reduce sebum production was 
also investigated on the epithelial stem cell line TelE6E7 allowed to differentiate into mature 
sebocytes. Cells were incubated with differentiating agents including testosterone and increasing 
concentrations of glyceryl laurate (1 to 20µM). Intracellular neutral lipids were quantified by 
AdipoRed staining. Quantification of the different lipids classes extracted from sebocytes 
supernatants and lysates were processed by high performance thin layer chromatography 
(HPTLC). Glyceryl laurate treatment displayed a significant decrease of testosterone metabolites 
such as dihydrotestosterone (DHT) and androstane-3b, 5a, 17b-diol in fibroblasts supernatants. 
Moreover, glyceryl laurate significantly inhibited neutral lipids synthesis in sebocytes cell line, a 
result which was confirmed through HPTLC analysis.In conclusion, the new lauric acid derivative 
glyceryl laurate is able to inhibit 5 alpha-reductase activity and to reduce lipids production in 
human sebocytes, confirming its interest in the treatment of excessive sebum production in acne 
lesions.
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Prevention and Treatment of Alopecia Areata with Quercetin in the C3H/HeJ Mouse Model
Tongyu Wikramanayake, Lucia Mauro, Carmen Perez, Lawrence Schachner, Joaquin Jimenez 
University of Miami Miller School of Medicine, Miami, FL, USA
Alopecia areata (AA) is a non-scarring, inflammatory hair loss disorder. It often has a sudden 
onset, and can be acute, recurrent or chronic. Currently, therapeutic options for AA are limited, 
and there is no effective prevention for recurrent AA. We have previously established a mouse 
model for AA, using heat treatment to accelerate AA onset in the genetically susceptible C3H/
HeJ mouse strain. In this study, we tested the effects of quercetin, a flavonoid found in many fruits 
and vegetables, on preexisting AA and prevention of AA onset in our C3H/HeJ mouse model. 
We observed hair regrowth after administration of quercetin in the lesional areas of mice with 
spontaneous AA. While the level of HSP70 in lesional areas of mice (both spontaneous and heat-
induced) was greatly increased compared with control, it was of comparable level with control 
in quercetin-treated areas. In addition, quercetin administration at the time of heat treatment 
prevented hair loss, and Western blot analysis showed that administration of quercetin prevented 
HSP70 induction by heat treatment. Our results demonstrated that quercetin provided effective 
treatment to preexisting AA as well as prevention of AA onset in the C3H/H3J mouse model, 
suggesting that quercetin may provide both therapy to current AA and prevention of recurrent 
AA. As a dietary supplement, the ready availability of quercetin may lead to increased patient 
compliance and positive outcome for AA should it prove to have similar effects in clinical trials.
488
Activation of arylhydrocarbon receptor with nonylphenol suppresses the immune response via 
induction of regulatory T cells
Fatemeh Navid, Winfried Schuller, Thomas Schwarz, Agatha Schwarz University Kiel, Kiel, 
Schleswig-Holstein, Germany
Ultraviolet radiation (UVR) suppresses immune responses in an antigen-specific fashion via 
induction of regulatory T cells (Treg). The arylhydrocarbon receptor (AhR) has been identified as 
an intracellular molecular target for UVR. Since the AhR antagonists 3-methoxy-4-nitroflavone 
and resveratrol abrogated UVR-induced immunosuppression, we asked whether in turn activation 
of the AhR via the agonist nonylphenol (NP) causes immunosuppression. Thus, C57BL/6 mice 
were injected intraperitoneally with NP on 4 consecutive days followed by topical application of 
2,4-dinitrofluorobenzene on the shaved back. Five days later ear challenge was performed and 
the ear swelling measured. Upon injection of NP the contact hypersensitivity (CHS) response 
was significantly reduced. The suppression could be adoptively transferred in an antigen-specific 
fashion into naïve recipients, indicating induction of Treg in the donors. To prove whether the 
immunosuppressive effect of NP is mediated via the AhR, AhR knock-out (KO) mice were used. In 
contrast to wild type mice, injection of NP into AhR-KO mice did not suppress CHS. Furthermore, 
CHS was not reduced in wild type recipients upon adoptive transfer of lymphocytes obtained 
from NP-injected AhR-KO mice, indicating that NP did not induce Treg in the AhR-KO mice. 
Together, these data identify the AhR as a suitable target to induce immunosuppression. Since 
UVR suppresses the immune system not in a general but specific fashion, activation of the AhR 
might represent an alternative to modulate the immune system in a similar fashion like UVR but 
without causing the adverse effects of UVR including DNA damage.
489
Cutaneous exposure to TLR2 ligands is sufficient to induce systemic immune regulation 
mediated by myeloid-derived suppressor cells
Yuliya Skabytska, Martin Köberle, Ko-Ming Chen, Susanne Kaesler, Tilo Biedermann Department 
of Dermatology, Tuebingen, Germany
In order to investigate consequences of the cutaneous exposure to microbial PAMPs on atopic 
dermatitis skin, Th2 dominated contact hypersensitivity (CHS) to the hapten FITC with or without 
cutaneous exposure to TLR2 ligands Pam2Cys and Pam3Cys was investigated. 5 days following 
FITC+/- Pam exposure, FITC-CHS was elicited. Surprisingly, CHS inflammation was not changed 
in mice that were exposed to Pam3Cys. In sharp contrast, in mice previously exposed to Pam2Cys, 
ear swelling, FITC specific antibodies and T-cell proliferation were significantly reduced. 
Investigating underlying mechanisms, we identified a more than 10-fold upregulation of myeloid 
derived suppressor cells (MDSCs) exclusively following Pam2Cys exposure. Moreover, depleting 
MDSC by anti-Gr1 Abs ameliorated CHS suppression. Pam2Cys induced MDSCs were able to 
suppress T cell proliferation (NO and cell contact dependent) and induced IL-10++ semi-mature 
DCs, unable to effectively stimulate T cell proliferation. These effects were TLR2 dependent 
and experiments with chimeric mice revealed that signals through TLR2 on epidermal but not 
hematopoetic cells are required and sufficient for MDSCs expansion. Interestingly, TLR2 on 
MDSCs was not required for their induction, accumulation, activation, and suppressive function. 
In addition, we analyzed cutaneous sensitization to ovalbumin with or without exposure to 
Pam2Cys and consecutive immune responses to ovalbumin expressing B16 melanomas and 
found MDSC induction and ameliorated tumor defense as a consequence. Collectively, we show 
for the first time that the presence of certain lipoproteins on skin is sufficient to regulate systemic 
immune responses by TLR2 dependent induction of highly suppressive MDSC.
490
HLA-DQα2/β2: a new type of HLA class II molecules expressed in human epidermal Langerhans 
cells
Cédric Lenormand1, Florence Gross1, Huguette Bausinger1, Dominique Fricker1, Thomas Bieber2, 
Daniel Hanau1, Sylvie Tourne1, Henri de la Salle1 1INSERM U725 / EFS-Alsace, Strasbourg, 
France, 2Departments of Dermatology and Allergy, University of Bonn, Bonn, Germany
The precise role of human epidermal Langerhans cells (LCs) in the immune response is at present 
highly controversial. To refine our knowledge on the specificity of these cells at a molecular 
level, transcriptomes from (1) freshly purified human LCs and (2) in vitro differentiated LCs 
generated from CD34+ precursors were established, and compared with transcriptomes from 
other human dendritic cells (DCs). Among the genes preferentially expressed in LCs, the HLA-
DQB2 gene caught our attention. Despite a strong evolutionary conservation of their sequences, 
the coordinate expression of HLA-DQA2 / HLA-DQB2 genes, paralogs with HLA-DQA1 
/ HLA-DQB1 genes, has never been detected in any cell type. We first confirmed by RT-PCR 
that the HLA-DQA2 / -DQB2 genes were expressed in LCs, but not in DCs generated in vitro 
from monocytes. Using different transfected cell line models, we demonstrated that the DQα2 
and DQβ2 chains associate together to form heterodimers that egress from the endoplasmic 
reticulum. We further showed that DQα2/DQβ2 dimers associate with the invariant chain Ii to 
reach the late endosomes, interact with the chaperone molecule HLA-DM and are expressed 
on the cell surface. Finally, we obtained two monoclonal antibodies directed against the extra-
cellular domain of DQβ2 which allowed us to confirm its expression at the protein level in LCs. 
Altogether, our results strongly support the biological relevance of the expression of HLA-DQα2/
β2 molecules in LCs, and open the way for a functional characterization which should be useful 
to elucidate the specificity of this expression.
491
NOD2 triggers an IL-32 dependent dendritic cell program in leprosy
Robert L. Modlin1, Mirjam Schenk2 1Division of Dermatology, Department of Medicine and 
Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of 
Medicine at University of California, Los Angeles, California, USA, 2Division of Dermatology, 
Department of Medicine, David Geffen School of Medicine at University of California, Los 
Angeles, California, USA
Pattern recognition receptors (PRRs) of the innate immune system reside in defined subcellular 
compartments and recognize distinct microbial ligands. Here, we investigated whether activation 
of distinct PRRs differentially contributes to the innate immune response against an intracellular 
pathogen, regulating the differentiation of monocytes into dendritic cells (DCs) and macrophages. 
The gene expression profiles of human monocytes activated with defined mycobacterial ligands 
for TLR2/1 or NOD2, were compared to skin lesions from patients with the mycobacterial 
disease leprosy using an integrative bioinformatics approach. Only TLR2/1 induced macrophage 
differentiation, whereas NOD2 activation preferentially triggered a DC functional pathway. 
NOD2 activation uniquely induced CD1b+ DC differentiation via upregulation of IL-32, which 
by itself was sufficient to induce DC differentiation. DC derived by activation of monocytes via 
NOD2 or IL-32 were found to be more potent antigen presenting cells than those derived via 
TLR2/1 or GM-CSF. In leprosy, IL-32 and CD1b positive cells were more frequent in T-lep vs. 
L-lep skin lesions. Furthermore, NOD2 activation did not induce IL-32 or CD1b in monocytes 
from L-lep patients; however, the addition of exogenous IL-32 rescued DC differentiation. In 
conclusion, we provide evidence that NOD2 activation induces a novel IL-32-regulated DC 
program that contributes to both innate and acquired immune responses in human infectious 
disease, thereby providing a potential immune target for translational intervention.
492
IL-36α Is Overexpressed By The Keratinocytes Of Inflamed Skin And Orchestrates Myeloid Cell 
Infiltration via Chemokine Induction
Cynthia Chen1, Candace Loyd2, Sean Dawes2, Johann Gudjonsson1, Nicole Ward2, Andrew 
Johnston1 1Dermatology, University of Michigan, Ann Arbor, Michigan, USA, 2Dermatology, Case 
Western Reserve University, Cleveland, Ohio, USA
IL-36α (IL-1F6), IL-36β (F8), IL-36γ (F9) and their receptor antagonist IL-36Ra (F5) constitute a 
novel IL-1 signaling system. We have recently shown that these cytokines are over-expressed 
in lesions of patients with the inflammatory skin disease psoriasis and may contribute to tissue 
changes via their action on keratinocytes, inducing matrix metalloproteinases and antimicrobial 
peptides. In two murine models of psoriasis (KC-Tie2 and Imiquimod), IL-36α was the most 
strongly expressed IL-1 family member. To better understand the role of IL-36α in mediating 
psoriasisform skin inflammation, we intradermally injected either recombinant mouse IL-36α or 
BSA(5µg) into outbred CD1 mice every other day for 10 days. Skin was harvested and prepared 
for immunohistochemistry or snap-frozen and total RNA extracted for qRT-PCR analysis. 
Intradermal injection of rmIL-36α induced significant thickening of the epidermis and increased 
eosinophilic dermal collagen and leukocyte infiltration into skin. The infiltrate was strongly 
immuno-reactive for F4/80 and CD11b indicating a strong macrophage and myeloid character, 
moderate CD11c staining (dendritic cells), moderate CD4 immunoreactivity and little CD8 
immunostaining. qRT-PCR analysis revealed elevated levels of myeloid cell chemokine mRNAs: 
CCL3(3-fold, p<0.05), CCL4(2.7-fold) and CXCL12(4.9-fold, p=0.05) accompanied by decreased 
expression of T-cell chemokines: CCL1(3.3-fold, p=0.04), CCL5(13.6-fold, p=0.014), CCL8(4.9-
fold, p=0.025), CCL20(2.3-fold, p=0.05). Strikingly, although IL-36α-induced skin inflammation 
was accompanied by elevated expression of IL-1β and HB-EGF, the T-cell-derived cytokine 
IFN-γ was decreased and IL-17A and IL-22 were absent. These data support the view that IL-36α 
actively propagates skin inflammation by inducing keratinocyte chemokine expression which 
recruits inflammatory cells into skin contributing to cutaneous inflammation.
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Langerhans cells play an essential role in inducing protective humoral immune response 
subsequent to antigen uptake through tight junctions
Takeshi Ouchi1, Akiharu Kubo1, Takeya Adachi1, Tetsuro Kobayashi1, Daniela Y Kitashima1, 
Hideki Fujii2, Bjoern E Clausen3, Shigeo Koyasu2, Masayuki Amagai1, Keisuke Nagao1 1Dept 
of Dermatology, Keio Univ School of Medicine, Tokyo, Japan, 2Dept of Microbiology and 
Immunology , Keio Univ School of Medicine, Tokyo, Japan, 3Dept of Dermatology, Erasmus MC, 
Univ Medical Center, Rotterdam, Netherlands
Langerhans cells (LC) are extensively studied epidermal dendritc cells with in vivo functions that remain 
elusive. It was recently shown that LCs elicited IgG1 responses to gene gun-immunized bacterial antigens, 
and that they acquired foreign antigens by sending their dendrites through epidermal tight junction barriers. 
Herein, we utilized mice that were depleted of different skin dendritic cell subsets and showed that LCs 
were essential for the induction of IgG1 production against protein antigens that were captured across tight 
junction barriers. To demonstrate pathophysiological relevance of this percutaneous humoral response, we 
took advantage of a model for staphylococcal scaled skin syndrome (SSSS), a severe blistering disease caused 
by skin infection of exfoliative toxin (ET)-producing Staphylococcus aureus. Patch-immunization of ET did 
not affect epidermal integrity of immunization site, but led to ET-specific IgG1 production, indicating that 
antigen uptake by LCs via tight junctions had occurred. Patch-immunization-induced anti-ET IgG showed 
neutralizing activity in vitro. Strikingly, in contrast to control mice that developed SSSS upon intraperitoneal 
ET challenge, mice that were patch-immunized with ET were protected from disease. Mice that were 
depleted of LCs prior to immunization failed to elicit anti-ET IgG1 and developed SSSS upon challenge. 
Percutaneous humoral responses elicited by LCs highlight an efficient mechanism by which immunity 
to potentially pathogenic skin-surface microbes is provided without disrupting tight junction barriers, 
and demonstrate an important role for LCs in host defense in vivo. This Th2 response might also relate to 
percutaneous sensitization in allergic skin diseases such as atopic dermatitis.
494
Intra-venous administration of tumor-associated antigen (TAA) specific Th1 cells is much more 
efficient than intra-peritoneal administration despite a lack of migration to the tumor site
Christoph M. Griessinger1, Andreas Schmid1, Daniel Bukala1, Kerstin Fuchs1,2, Heidi Braumüller2, Susanne 
Kaesler2, Tilo Biedermann2, Martin Röcken2, Bernd J. Pichler1, Manfred Kneilling2 1Dept of Preclinical 
Imaging & Rediopharmacy, Univ of Tübingen, Germany, 2Dept of Dermatology, Tübingen, Germany
TAA-specific Th1 cell therapy of cancer requires suitable administration routes. Aims were to analyze 
differences of Tag2-/OVA-Th1 migration in RIP1-Tag2-pancreatic-cancers and OVA-B16-melanomas 
due to i.p. or i.v. administration and to proof treatment-efficacy in RIP1-Tag2 mice. We i.v.-/i.p.-
injected Cy5-fluorescence-labeled Tag2-Th1/OVA-Th1 into (i.v./i.p.) treated 17 weeks old RIP1-Tag2-
pancratic cancer- or OVA-B16/B16-melanoma bearing mice and sacrificed littermates 4-5 days later. 
We investigated Tag2-/OVA-specific Th1 bio-distribution in vivo and ex vivo by optical imaging (OI), 
FACS-analysis, and fluorescence microscopy (FM). To analyze treatment-efficacy we i.p.-/i.v.-injected 
Tag2-Th1 into RIP1-Tag2 mice once weekly and monitored mice in vivo by measurement of the tumor 
size by 7T small-animal magnetic resonance imaging (MRI) and detection of blood glucose levels 
(BGL). Cy5-labeled Tag2-Th1/OVA-Th1 migrated strongly to the tumor site after i.p.-administration 
but not after i.v.-administration. Interestingly we detected specific homing of OVA-Th1 into OVA-B16 
melanomas exclusively after i.p.-administration. TAA-Th1 resided primarily in the lung, liver, and 
spleen after i.v.-administration and in lymph nodes, peripancreatic-lymphatic-tissue, and spleen after 
i.p.-administration. FACS/FM analysis confirmed our OI results. In sham-treated 14 weeks old RIP1-
Tag2 mice medium tumor volume was 88±63mm³, in i.p.-Tag2-Th1-treated mice 7.4±5.5mm³ while 
no tumors were detectable in i.v.-treated mice (MRI). BGL in i.p.-treated mice were 69(±18)mg/dl, at 
normal values in i.v.-treated mice 129(±4)mg/dl, and < 30 mg/dl in sham-treated mice. H&E-staining 
confirmed large pancreatic tumors in i.p.-treated but only faint tumors in i.v.-treated 17 weeks old 
RIP1-Tag2 mice. Thus, i.v.-administration of Tag2-Th1 is a much more efficient in RIP1-Tag2 mice 
despite a lack of migration to the tumor site.
495
VitaminD3-exposed epidermal Langerhans cells and dermal dendritic cells induce different 
types of regulatory T cells
Angelic M.G. van der Aar1,2, Darya S. Sibiryak1, Ghaith Bakdash1, Toni M.M. van Capel1, Hanneke 
P.M. van der Kleij3, Dirk-Jan E. Opstelten3, Marcel B.M. Teunissen2, Martien L. Kapsenberg1, Esther 
C. de Jong1 1Cell Biology & Histology, Academic Medical Center, Amsterdam, The Netherlands, 
2Dermatology, Academic Medical Center, Amsterdam, The Netherlands, 3HAL Allergy, Leiden, The 
Netherlands
Because of their immunosuppressive potential vitamin D3 (VitD3) analogues are commonly used 
for topical treatment of mild to moderate plaque psoriasis. The exact mechanism how this drug 
exerts its immunosuppressive effect is unclear, but the appearance of regulatory T cells (Tregs) 
may play an important role. We investigated the effect of VitD3 metabolite 1,25(OH)2D3 on the 
phenotype and function of skin-derived and monocyte-derived Langerhans cells (LCs) and dermal 
dendritic cells (DDCs). In addition, we co-cultured VitD3-pretreated LCs or VitD3-pretreated 
DDCs with naive CD4+ T cells and analyzed the responding T cells. We found that VitD3-
exposed LCs and DDCs induced T cells with regulatory activity as demonstrated by their ability 
to suppress proliferation of activated bystander CD4+ T cells during co-culture. Remarkably, the 
Tregs generated by VitD3-exposed LCs were CD25hiCD127loFoxp3+ matching the features of 
classical inducible Tregs, whereas the T cells developing in response to VitD3-exposed DDCs 
were Foxp3- and expressing IL-10 corresponding to the Treg subtype Tr1. Inhibition experiments 
revealed that LC-derived TGF-β is a key factor in the induction of Foxp3+ Treg cells, whereas 
DDC-derived IL-10 is important for the induction of IL-10+ Tr1 cells. Although VitD3 induced a 
selective upregulation of ILT3 and ILT4 in LCs, these inhibitory molecules are likely not involved 
in the VitD3-induced differential Treg development, as ILT3 and ILT4 blocking did not affect the 
induction of Tregs. We demonstrate that VitD3 differentially modulate the function of LCs and 
DDCs resulting in the generation of either TGF-β-dependent Foxp3+ Tregs or IL-10-dependent 
IL-10+ Tregs, respectively.
496
Regulation of TSLP expression in the skin by the inflammasome and its impact on T cell fate
Sonia Schuepbach-Mallepell1, Virginie Philippe1, Stephanie Roques1, Olivier Gaide1,2 1Geneva 
University, Geneva, Switzerland, 2Harvard Medical School, Boston, USA
Contact and atopic dermatitis depend on similar yet opposing mechanisms linking innate and 
adaptive immune responses. The inflammasome is a key innate immune sensor that regulates 
adaptive immunity by controlling IL-1b activation. We have previously shown that it controls T 
cell fate in contact dermatitis, a Th1 model, while others have recently proposed that it induces 
the secretion of TSLP, a Th2 inducing cytokine that plays a key role in the development of atopic 
dermatitis and asthma. In order to clarify these seemingly contradictory findings, we have studied 
the activity of the inflamamsome on TSLP expression in vitro and in vivo in the context of a model 
of experimental atopy (aDBP-FITC). We provide clear evidence that, contrary to current models 
proposed in the literature, inflammasome and IL-1b activation antagonizes TSLP secretion in 
the skin, by showing that i) inflammasome activation is not required for DBP-FITC mediated 
Th2 response or TSLP induction in mice, ii) inflammasome activation blocks the induction of 
TSLP in murine and human primary keratinocytes as well as in human reconstituted epithelia, 
iii) inflammasome and IL-1b block TSLP secretion in mouse skin in an IL-1R dependent manner. 
We also show how these stimulations in turn influence T cell fate (Th1 vs Th2 vs Treg) to a given 
weak hapten (DNTB). Taken together, our data strongly suggest that Th1 vs Th2 cell fate decision 
is regulated at multiple levels and starts with innate immune events within peripheral epithelial 
tissues.
497
Co-factor dependent anaphylaxis triggered by innate immune signals is mediated by basophils
Florian Wölbing1, Wolfgang Kempf1, Balasaheb Siraskar2, Priscila Eckstein1, Martin Köberle1, 
Yuliya Skabytska1, Florian Lang2, Susanne Kaesler1, Tilo Biedermann1 1Department of 
Dermatology, Eberhard-Karls-University, Tübingen, Germany, 2Department of Physiology, 
Eberhard-Karls-University, Tübingen, Germany
Urticaria and anaphylaxis are mediated by mast cells (MC) and basophils. Exercise and infections 
play a role in both diseases as causative agent or co-factors. Consequently, patients receiving 
allergen-specific immunotherapies must not exercise or suffer from infections. To understand 
how infections trigger these diseases, mice were sensitized with Ovalbumine (OVA) and the 
lowest threshold OVA-dose eliciting early signs of anaphylaxis was determined. Anaphylaxis 
was detected by loss of core body temperature, reduced blood pressure, and by measuring 
serum histamine levels. Challenge with the OVA threshold-dose resulted in a weak temperature 
drop of -1,92±0,26°C. To mimic infection, mice were pretreated with different pathogen 
associated molecular pattern (PAMPs). Some PAMPs such as PGN elicited significantly increased 
temperature drop of -4°C in response to the threshold-dose, significantly reduced blood pressure 
(-25,3±8,8mmHg), and increased serum histamine levels (174±0,2ng/ml). Surprisingly, MC-
deficient Kitw-sash mice showed the same PAMP dependent anaphylaxis as wildtype mice. 
These in vivo data were confirmed in vitro: MCs generated from bone marrow, fetal skin, and 
peritoneum showed no augmented mediator release in response to allergen and PAMPs compared 
to allergen alone. In sharp contrast, co-factor dependent anaphylaxis was completely abrogated 
following basophil depletion and allergen mediated basophil activation was increased by PAMP 
pretreatment. Thus, in this new model of co-factor dependent anaphylaxis innate immune signals 
were able to trigger anaphylaxis and this effect was fully dependent on basophils. Our results 
help to better understand the role or infections in urticaria and co-factor dependent anaphylaxis 
and point to new therapeutic strategies.
498
Interferon-α inhibits suppressor activity of human CD4+CD25high regulatory T cells in vitro and 
in vivo
Nicole Bacher, Claudia Hofmann, Christian Becker, Edith Graulich, Kerstin Steinbrink Department 
of Dermatology, University Medical Center Mainz, University of Mainz, Mainz, Germany
Interferon-α (IFN-α) represents the only approved adjuvant therapeutic approach in stage III 
melanoma patients. Here, we investigated the effect of IFN-α on the function of human naturally 
occurring CD4+CD25high regulatory T cells (Tregs). Tregs and CD4+CD25low effector T cells 
(Teff) were cocultured in suppressor assays in the presence of irradiated PBMC as antigen 
presenting cells (APC) and soluble anti-CD3-mAb. As reported previously, Tregs inhibited 
the proliferation of Teff up to 90%. However, addition of IFN-α to Teff and Treg cocultures 
significantly abolished the suppressor activity of Tregs. Pre-incubation experiments of PBMC 
with IFN-α and an alternative activation of the suppressor assays by anti-CD3 and anti-CD28 
excluded APC as mediators of the IFN-α effect. Blockade of the IFN-α receptor-2 chain on Tregs 
prior to suppressor assays partly abolished the effect of IFN-α and restored suppressor function 
indicating that IFN-α directly abrogates Treg function. Notably, IFN-α treatment was followed 
by a pronounced reduction in cAMP levels of nTregs levels reported to be critically involved in 
suppressor activity of Tregs. Former studies showed that the intraperitoneal injection of human 
PBMC in newborn immunodeficient Rag2 γc-/- mice induces a lethal GvHD, which can be 
rescued by co-administration of human Tregs. Preincubation of co-administered Tregs with IFN-α 
was sufficient to abolish the beneficial effect of the Tregs and again resulted in a lethal GvHD 
demonstrating that IFN-α directly abolishes Treg function in vivo. Our study demonstrates that 
the inhibition of Treg-induced suppression by IFN-α may be relevant for modulation of tolerance 
processes in cancer patients.
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Characterisation and control of macrophage recruitment during skin wound healing by 
systemic CX3CR1 antagonism (F1)
Mathieu Rodero1, Karim Dorgham2, Samantha Hodgson1, Christophe Combadiere2, Kiarash 
Khosrotehrani1 1The University of Queensland Centre for Clinical Research, Brisbane QLD, 
Australia, 2Inserm UMR-S 945, Paris, France
Chronic skin wounds are associated with defective control of inflammation. We aimed to 
characterise and subsequently modulate monocyte-macrophage (MM) subpopulations during 
normal and pathological wound healing based on both functional and phenotypic markers to 
improve healing. Skin wound granulation tissue (gt), blood and bone marrow were isolated and 
analysed by flow cytometry and RTPCR in WT and Ob/Ob mice from D1 to D7. Finally, F1 was 
injected after wounding into WT mice in order to assess its effect on macrophage recruitment to 
wound site. We show that Ly6chi and low MM can be divided into subpopulations with distinct 
recruitment and transcriptomic profile based on MHCII expression. D1 infiltration consisted in 
inflammatory Ly6C-hi/MHCclassII-lo MMs that at later time points disappeared in favour of a “tissue 
repair” Ly6c-lo/MHC-lo population that peaked in number at D5. Ly6chi-MHCIIlo MM overexpress 
VEGFa and CX3CR1 compared to Ly6chi-MHCIIhi (p<0.01). As expected, Ob/Ob diabetic mice 
showed a significant increase in Ly6C-hi/MHCclassII-hi MMs in the gt and failed to switch to a 
remodelling phenotype at D2 compared to WT (respectively 62% and 40% of inflammatory MM, 
p=0.018). Finally, we showed that systemic F1 injections compared to PBS into WT mice induced 
a massive reduction of wound infiltration by CD11b or F4/80+ MMs (29 and 87 macrophages per 
hpf, p=0.015) with minor systemic effect. In conclusions, new MM populations important in wound 
repair with specific transcriptomic and recruitment profile were identified and support the potential 
of chemokine antagonism to control chronic wound associated inflammation.
500
Cytokine responses induced by S. aureus or S. epidermidis derived lipoteichoic acid differ 
significantly and are critically modulated by IL-4
Thomas Volz1, Susanne Kaesler1, Christian Draing2, Friedrich Götz3, Thomas Hartung2,4, Martin 
Röcken1, Tilo Biedermann1 1Department of Dermatology, Eberhard Karls University, Tübingen, 
Germany, 2Department of Biochemical Pharmacology, Konstanz, Germany, 3Microbial Genetics, 
Eberhard Karls University, Tübingen, Germany, 4Center for Alternatives to Animal Testing, Johns 
Hopkins University, Baltimore, MD, USA
Staphylococcus epidermidis is part of the skin microflora not leading to inflammation under 
physiological circumstances. In contrast, S. aureus colonization on atopic dermatitis (AD) skin induces 
inflammation and disease exacerbation. To investigate innate immune sensing of pathogenic and non-
pathogenic Staphylococci, lipoteichoic acid (LTA) from S. epidermidis and S. aureus was prepared and 
characterized. Both LTA preparations induced maturation of dendritic cells (DC) clearly depending 
on the TLR2-MyD88 pathway. Marked differences were seen in regard to cytokine production. While 
S. aureus LTA induced large amounts of IL-12p70 in DC, IL-12p70 levels remained low in response 
to S. epidermidis LTA. Interestingly, production of the anti-inflammatory cytokine IL-10 was similar 
in response to both LTA preparations. To mimic AD skin, DC were activated in the presence of IL-4 
resulting in enhanced IL-12p70 levels induced by S. aureus LTA. IL-4 further suppressed already low 
IL-12p70 levels induced by S. epidermidis LTA. This immune modulation was clearly dependent on 
STAT6 signaling as STAT6-deficient DC failed to regulate LTA induced IL-12p70 levels in response to 
IL-4.Our data demonstrate an undescribed functional difference between LTA from S. aureus and S. 
epidermidis. Although innate immune sensing of LTA is mediated by TLR2 and MyD88 in both cases, 
these pathways lead to marked differences in regard to the induction of pro-inflammatory cytokines. 
Furthermore, the typical AD cytokine environment dominated by IL-4 modulates LTA mediated 
cytokine production with opposing effects, thus providing an explanation how S. aureus leads to 
exacerbation of skin inflammation while S. epidermidis is well tolerated.
501
Dendritic cells are targets of IL-10 to limit parasite clearance and collateral tissue damage 
during Leishmania major infection
Mathilde J.H. Girard-Madoux1, Kordula Kautz-Neu2, Esther von Stebut2, Björn E. Clausen1 
1Erasmus MC, University Medical Center, Rotterdam, The Netherlands, 2Johannes-Gutenberg 
University, Mainz, Germany
Cutaneous leishmaniasis is a parasitic disease characterized by the formation of self-healing skin 
lesions in resistant humans and mice. The infection is resolved by a Th1/Tc1 response, which 
correlates with disappearance of the lesions. Persistence of small numbers of parasites in the 
skin and lymphoid tissues is crucial for resistance to re-infection. Thus, protective immunity 
requires a tight balance to contain, but not eradicate the parasites, which depends on IL-10. 
Mice lacking IL-10 eliminate the parasites and become susceptible to re-infection. Dendritic 
cells (DC) orchestrate immunity and tolerance, and Langerhans cells (LC) are negative regulators 
of the anti-Leishmania response. Whether DC and/or LC are targets of IL-10 during L. major 
infection remains unknown. To this aim, we deleted the IL-10 receptor specifically on DC (DC-
IL10R-/-). Following inoculation with a physiological low dose of L. major (1,000 parasites), DC-
IL10R-/- mice more efficiently cleared the parasites both locally (ears) and systemically (spleen) 
as compared to wild type controls. This was associated with enhanced skewing towards Th1 
demonstrated by higher levels of antigen-specific IFNγ and less IL-4. Intriguingly, despite faster 
parasite disappearance, infected DC-IL10R-/- mice developed larger ear lesions than controls. This 
correlated with augmented IL-12 and pro-inflammatory cytokine production by IL-10 receptor-
deficient, L. major-infected DC. In conclusion, our data establish that lack of IL-10 signaling 
in DC during leishmaniasis enables more effective clearance of the parasites, but promotes 
inflammation causing increased tissue damage.
502
Psoriasis and metabolic syndrome: Is Peroxisome Proliferator-Activated Receptor-γ a part of 
the missing link?
Rania Abdel Hay1, Rehab Hegazy1, Dalia Hafez1, Safinaz Sayed2 1Dermatology Department, 
Faculty of Medicine, Cairo University, Cairo, Egypt, 2Histology Department, Faculty of Medicine, 
Cairo university, Cairo, Egypt
Increased prevalence of Metabolic Syndrome (MS) in psoriasis was reported. Growing evidence 
points to a causative relationship between Peroxisome proliferator-activated receptors (PPARs) 
activity and the MS. The question is how can altered PPARγ levels (a metabolic sensor) translate 
the metabolic state among psoriatic patients? This observational analytical study was conducted 
on 30 psoriatic patients and 30 healthy volunteers. Patients were subgrouped according to the 
presence or absence of MS according to the guides of the International Diabetes Federation 
consensus worldwide definition. A skin biopsy was taken for histopathological examination and for 
immunohistochemical staining for PPARγ. Immunohistochemical examination of control specimens 
revealed strong positive PPARγ immunostaining in some nuclei and weak in others, with strong 
expression in the cytoplasm. In patients, with and without MS, weak nuclear immunostaining and 
strong cytoplasmic reaction were detected. Mean area % of positive PPARγ immunostaining in 
psoriasis sections (4.05±2.543) was compared to that in the controls (38.46±12.429). This decrease 
in PPARγ expression in psoriasis was of statistical significance (P <0.001). When comparing the 
mean area % of positive PPARγ immunostaining in between psoriatic patients with and without 
MS, and the controls with MS (1.41±0.483, 5.18±2.194 and 21.5±1.332 respectively), we found 
a statistically significant (P=0.006) difference with the lowest levels detected in psoriatic patients 
with MS. Reduced positive PPARγ immunostaning can translate the metabolic state among psoriatic 
patients and PPARγ agonists can present a therapeutic tool in the treatment of selected psoriatic 
patients with MS in order to ameliorate both conditions.
503
Expression of Fractalkine (CX3CL1) in Patients with Psoriasis and Atopic Dermatitis
Omar Azzam1, Tahra Leheta1, Rania Abdel Hay1, Marwa Fawzy1, Amira El Tawdy1, Laila Rashed2 
1Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, 2Clinical 
Biochemistry Department, Faculty of Medicine, Cairo University, Cairo, Egypt
Fractalkine (FKN) is a unique, membrane-bound chemokine, which exists into two forms; the 
soluble form is a potent chemotactic agent for T cells and the anchored form functions as an 
adhesion molecule. Psoriasis and atopic dermatitis (AD) lesions were examined to gain insight 
into the expression of FKN in pathologic lesions characterized by a prevalent Th1 (such as 
psoriasis) or Th2 response (such as AD). This study included 20 psoriatic patients (group 1), 20 
AD patients (group 2) and ten healthy individuals serving as controls (group 3). Skin biopsy was 
taken from both patients groups and volunteers for detection of FKN level by ELISA. Fractalkine 
was detected in all psoriatic patients with a mean of 204.385 µg/mg tissue, and in atopic patients 
with a mean of 229.225 µg/mg tissue. Regarding to the healthy individuals (group 3); FKN 
was detected with a mean of 219.150 µg/mg tissue. Statistical analysis revealed a significant 
difference (P value 0.047) between the three studied groups. When comparing each two groups; 
our results revealed that the mean value of FKN in atopic patients was statistically significant. 
We found higher (P value 0.042) than in psoriatic patients. We conclude that FKN can play a 
role in the recruitment of lymphocytes during the inflammatory reaction in atopic dermatitis and 
in psoriasis.
504
Epidermal Langerhans Cells Mediate Constitutive Stimulation of Skin Resident Regulatory T 
Cells (Treg) and Thereby Control the Inadvertent Activation of Skin Resident Effector Memory T 
Cells (TRM) in Normal Human Skin
Julien Seneschal1,3, Rachael A. Clark1, Jean François Moreau2, Alain Taieb3, Thomas S. Kupper1 
1Dermatology, Brigham and Women’s Hospital, Boston, USA, 2UMR 5164 CNRS Université 
Bordeaux 2, Bordeaux, France, 3INSERM U 1035 Université Bordeaux 2, Bordeaux, France
Normal adult human skin contains 20 billion resident memory T cells (TRM). These TRM are specific 
for antigens previously encountered through skin, and provide protection against future infectious 
challenge. Inappropriate activation of this population of TRM in normal skin must be tightly 
controlled, though the mechanisms are unknown. Langerhans cells (LC) reside in the epidermis, 
and their putative interactions with skin TRM have not been explored. To better understand the 
relation between LC and TRM in normal human skin, we carefully extracted both TRM and resident 
LC from the same normal donor. LC induced the proliferation of a small subset of TRM. These 
proliferating TRM uniformly reproducibly expressed the phenotype of Treg and could block the 
proliferation of non-TregTRM. Treg proliferation was blocked by antibodies to class II MHC, IL-2, and 
IL-15R. We next explored this phenomenon in intact normal human skin. By immunofluoresence 
microscopy, we showed that LC and FoxP3+ TregTRM co-localized in epidermis and follicular 
epithelium, and many of these TregTRM were positive for the proliferation marker Ki67. These data 
strongly suggest that LC constitutively stimulate Treg in normal skin. This stimulation of Treg could 
be reversed in the presence of foreign antigen in a dose-dependant fashion, as the addition of 
C.albicans to LC and TRM led to diminished Treg proliferation and increased TEM proliferation. These 
findings establish a novel immunological role for LC in human skin, allowing for the constitutive 
maintenance of tolerance, while also permitting the stimulation of resident immune memory in 
response to infectious challenge.
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Langerin+ Dermal DC, but not Langerhans cells, are required for effective CD8 mediated 
immune responses after skin scarification (S.S.) with Vaccinia virus (VACV)
Julien Seneschal1,3, Xiaodong Jiang1, Jean-François Moreau1, Alain Taieb3, Thomas S. Kupper1 
1Dermatology, Brigham and Women’s Hospital, Boston, USA, 2UMR CNRS 5164, Université 
Bordeaux 2, Bordeaux, France, 3INSERM U 1035, Université Bordeaux 2, Bordeaux, France
Dendritic Cells (DC) are professional antigen presenting cells that are required for naïve T cell 
priming. Three subsets of skin resident DC have been identified: Langerhans Cells (LC), Dermal 
Langerin+ DC (Ln+dDC) and Dermal Langerin- DC (Ln-dDC). The relative role of these DC in 
the induction of immune response after s.s. with VACV has not been studied. Transgenic mice 
expressing the diphtheria toxin (DT) receptor under the control of the murine langerin promoter 
allow for the conditional ablation of Ln+ expressing cells after injection of DT. Injection of DT 
ablates LC for several weeks, whereas Ln+dDC are replenished within few days. Taking advantage 
of this model we depleted either LC alone, or both LC and Ln+ DC. We used recombinant VACV 
that expressed the ovalbumin peptide OVA257-264 and adoptive transfer of OT-I TCR transgenic 
CD8+ T cells specifc for this peptide. We then analyzed activated OT-I cells in lymph nodes at 
various times after s.s. We demonstrated that Ln+dDC, but not LC, are required for the induction 
of a rapid and robust antigen-specific CD8+ T cells response after s.s. The absence of Ln+dDC, leds 
to a significant delay in the priming and proliferation of antigen-specific CD8+ T cells. Moreover 
CD8+ T cells generated after VACV s.s. in the absence of Ln+dDC lacked effector cytotoxic 
functions. Finally, the depletion of Ln+dDC leds to rapid lymphoma progression and mortality. 
These data indicate that only Ln+dDC are critical for the generation of robust CD8 T cell immunity 
after s.s. with VACV.
506
Examination of the effect of night sleep duration on patients diagnosed with alopecia areata 
compared with normal population.
Sepideh Asadbeigi1, Shiva Qods1, Setareh Karim Dizani1,2 1Tehran University Of Medical Science, 
Tehran, Iran, 2Shahid Benehshti University Of Medical Science, Tehran, Iran
Alopecia Areata (AA) is a common non-scarring alopecia directed against the anagenic hair 
follicle. AA is also known as one of the most frequent organ-restricted autoimmune diseases, yet 
its pathogenesis is still unclear. Previous studies have demonstrated an association between AA 
and psychological stress. Sleep is an important factor in relation to stress. Sleep duration is 
associated with most psychiatric disords. The disturbing effects of insomnia on psychological 
health may increase the risk of AA, although no studies have been carried out to support this 
theory. We sought to determine wether an association exists between the presence of AA and 
night sleep duration. This study was done in case-control method. After review literarture, case 
selection was done in census method. 37 patients with AA were enrolled as our exposed group 
and 37 patients with no history of alopecia were selected as our control subjects.the case and 
control groups were matched by gender and age.the information was gathered with checklists. 
Data analysis was carried out using SPSS(ver. 17) and the Chi-square test. P-value of 0.05 or 
less was considered significant. The mean of night sleep duration our cases with AA group 
was 6.9+_1.5 and the mean number of night sleep hours in normal population was 8.2
+_0.8.A 
significant association with alopecia areata and night sleep duration was found.Inadequate sleep 
time may be contributing to increase stress and psychological problem can increase the risk of 
AAamong these patients. This lack of enough sleep also can interupt the healing process and 
decrease the efficacy of the treatment. Study performed with more cases and control is suggested.
507
Biological characteristics and differentially expressed genes of bone marrow mesenchymal stem 
cells in patients with psoriasis
Guohua Yin, Ruifeng Liu, Junqin Li, Xinhua Li, Kaiming Zhang Shanxi Medical University, 
Taiyuan, China
To prove bone marrow mesenchymal stem cells (BMMSC) are abnormal in psoriatic patients, 
we isolated BMMSC from psoriatic patients and controls. At passage three, we examined their 
immunophenotypes and apoptotic rates, proliferative activities, and levels of cytokines secreted 
by BMMSC. We found that BMMSC from controls and all psoriatic patients except for the one 
whose parents had psoriasis had similar morphology. However, their proliferative activities, 
apoptotic rates and levels of cytokines secreted were significantly different (P<0.05). Interestingly, 
we found that BMMSC from the patient mentioned above spontaneously differentiated into 
vascular endothelial cells (VEC). We studied the differential expression of genes from the patient 
mentioned above, as well as psoriasis and controls using RNA sequencing. A total of 475 
genes were differentially expressed in BMMSC from this patient, both compared to psoriasis 
and controls. Among them, 370 genes were mapped to Gene Ontology database, 2 gene terms 
were significantly enriched (P<0.05). In addition, in the follow-up study, we also found that 
BMMSC from patients with psoriasis differentiated easily into vascular endothelial cells in the 
process of being induced to vascular endothelial cells. We concluded that psoriatic BMMSC can 
spontaneously differentiate into VEC and have abnormal biological activities, which not only 
contribute to the anomaly of patients’ bone marrow hematopoietic microenvironment, but may 
also relate to the abnormal microvascular proliferation of papillary layer in lesional dermis.
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Vitamin D induces regulatory T cells by modulating Langerhans cells
Agatha Schwarz, Fatemeh Navid, Thomas Schwarz Department of Dermatology, University of 
Kiel, Kiel, Germany
Painting of haptens onto ultraviolet radiation (UVR)-exposed skin does not result in sensitization 
but induces regulatory T cells (Treg). Emigration of UVR-damaged but still viable Langerhans 
cells (LC) from the epidermis into the regional lymph nodes is essential for the induction of Treg. 
Topical application of 1α,25-Dihydroxyvitamin D3 (VD3) was recently found to induce Treg as 
well. To study whether VD3 similarly to UVR induces the emigration of damaged LC from the 
epidermis into the lymph nodes, C57/B6 mice were painted with VD3 on the ears and backs for 
four days. On day 5 mice were sensitized with dinitrofluorobencene, 48 hours later ears and 
the regional lymph nodes were obtained. Immunofluorescence analysis of ear sheets using an 
anti-MHC class II antibody revealed upon VD3 treatment a dramatically reduced number of LC 
which were also altered in their morphology. FACS analysis of cells suspensions from the regional 
lymph nodes revealed an increased number of cells staining both for Langerin and annexin V, 
indicating that VD3 damages LC ultimately undergoing apoptosis in the lymph nodes. In vitro 
incubation of LC with VD3 resulted in downregulation of MHC class II and B7-2 expression. 
Together this suggests that VD3 damages LC which downregulate surface molecules relevant for 
antigen presentation and finally undergo apoptosis. This implies that VD3 might induce Treg in a 
similar fashion like UVR.
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Cytokines and subpopulations of lymphocytes at patients with psoriasis
Jolanta Maciejewska1, Waldemar Placek1, Lidia Gackowska2, Jacek Michalkiewicz2, Izabela 
Kubiszewska2 1Department of Dermatology,Nicolaus Copernicus University in Torun, Ludwik 
Rydygier Medical College, Bydgoszcz, Poland, 2Chair of Immunology,Nicolaus Copernicus 
University in Torun, Ludwik Rydygier Medical College, Bydgoszcz, Poland
Psoriasis is a chronic papulo-exfoliative illness connected with inflammable-proliferative 
processes in the skin.Purpose of the study is the assessment of the level of cytokines and 
distribution of the subpopulation of lymphocytes at persons with psoriasis before including the 
treatment as well as when PASI will take out 50%.Provided with the examination 40 persons with 
psoriasis and 20 persons from control group.Patients were divided into groups depending on the 
applied procedure: cured biologically, MTX, phototherapy and on the local treatment.Cells of the 
charged whole blood were prepared according to the standard protocol of colouring outside- and 
intra- cellular. Cells were subjected to colouring with applying monoclonal antibodies tagged for 
FITC, PE, PerCP and analysis with the use cytometru flow (FACScan of the BD company). 1.The 
evaluation of T CD4+ lymphocytes producing IL-17,IFN and TNF showed a double increase 
of percentage of positive cells in psoriasis patients with reference to the control for controlled 
cytokines.2.A slight decrease of percentage of cells producing IFN and a significant decrease of 
the percentage of cells producing TNF is observed in patients during the treatment.3.In patients 
treated with methrotrexat and phototherapy the level of intra-cellular IL-17 and IFN decreases. 
In patients treated with biological medication the level of intra-cellular IL-17 increases.4.Patients 
who at the beginning (before introducing the theraphy) have increased percentage of cells 
producing TNF, after methrotrexat or phototheraphy their level decreases, however, in patients 
who at the beginning have low level of cells producing TNF-α, their level does not change during 
the treatment.
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Patented avocado sugars modulate HBD-2 expression in human keratinocytes through toll-like-
receptor-2
Iole Paoletti1, Elisabetta Buommino1, Giovanna Donnarumma1, Adone Baroni2, Caroline 
Baudouin3, Philippe Msika3, Maria-Antonietta Tufano1 1University of Naples, Naples, Italy, 
2Faculty of Medicine and surgery, Naples, Italy, 3Laboratoires Expanscience, Epernon, France
Keratinocytes, major component of the epidermis participate in the defence against pathogens 
secreting a variety of cytokines, chemokines and growth factors, but also antimicrobial peptides 
such as beta-defensins (HBDs). HBD-2 is enhanced in cutaneous infection and inflammatory 
dermatitis like psoriasis vulgaris. In addition, HBD-2 accelerates wound repair by inducing 
migration and proliferation of keratinocytes and endothelial cell. Avocado sugars (AV) are natural 
patented sugars able to induce HBD-2 expression in human keratinocytes. The aim of this work 
was to analyse the receptor and the transductional pathway involved in AV-induced HBD-2 in 
human keratinocytes. Human keratinocytes were treated with 0.1% AV for 24h to analyse the 
possible toll like receptor induced. In order to investigate the role of TLR-2-mediated downstream 
signalling pathways involved in HBD-2 induction, p38 MAP kinase, c-Jun and ERK kinase 
inhibitors were used. Briefly, human keratinocytes were pre-treated for 1h with kinase inhibitors 
and, subsequently, stimulated with 0.1% AV for 24h. Our results demonstrated the up-regulation 
of TLR-2 by real time PCR. In addition, the use of a TLR-2 neutralizing antibody significantly 
inhibited the AV-induced HBD-2 expression in human keratinocytes. The results were confirmed 
by ELISA assay. Real time PCR results indicated that only in the presence of ERK kinase inhibitor, 
HBD-2 mRNA levels returned comparable to the control. Furthermore, western blot analysis 
confirmed that ERK was the kinase involved in AV-induced HBD-2 expression In summary, these 
experiments highlight a role for the TLR-2 receptor and ERK signalling pathway in the inducible 
HBD-2 gene regulation by avocado sugars.
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A Good Response to Hydroxychloroquine and Prednisolone treatment in a Patient With 
Melkersson-Rosenthal Syndrome and Crohn Disease
Pelin Ustuner1, Nursel Dilek2 1Rize 82. Yıl Government Hospital, Dermatology Department, Rize/
Turkey, Turkey, 2Rize University Mecical Faculty, Dermatology Department, Rize/Turkey, Turkey
Melkersson-Rosenthal Syndrome (MRS) which is characterized by recurrent, relapsing orofacial 
edema predominantly involving the lips, peripheral facial palsy (FP) and a fissured tongue. 
Granulomatous cheilitis (GC) presents as a diffuse painless local swelling of the lips and peri-
oral skin. The treatment of GC remains a challenge because of the unclear etiopathogenesis. 
A 30 year-old white woman presented with permanent lower lip sweeling, lingual fissures 
and furrows and episodic FP. Facial palsy first started about 15 years ago and relapsed once a 
year. Her edematous lip sweeling and the lingual burning complaints have occured for 5 years 
with unknown etiology. She also informed that she had some gastrointestinal complaints like 
dispepsia, colic and relapsing diarrhea for 2 years. After the intestinal biopsy examination, she 
was also diagnosed with Crohn disease (CD). In the dermatological examination; her lower lip 
was edematous with rubbery enlargement containing some crusting and a whitish jelatinous 
fluid on the lower lip mucosae. Longitidunal furrows and fissures were seen in the lateral edge 
of her tongue. With these clinical triad, she was diagnosed with MRS. The patient was given 
oral prednisolone treatment at 1 mg/kg for 2 week and oral hydroxychloroquine 200 mg/day. 
Two weeks later, the prednisolone dose was reduced gradualy and stopped in 2 weeks. The 
patient was almost completely improved after 1 month without anyrecurrence. Herein, we report 
a patient with MRS, well-responded to prednisolone and hydroxychloroquine combination. 
Hydroxychloroquine should also be kept in mind as a treatment choice in unresponsive patients 
with MRS.
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A three-dimensional full-thickness skin model fulfills all criteria to test the differentiation 
capacity of Langerhans cell precursor candidates
Christopher Schuster1, Michael Mildner4, Mario Mairhofer2, Wolfgang Bauer1, Wolfgang 
Eppel2, Christian Fiala3, Andrea Kolbus2, Erwin Tschachler4, Georg Stingl1, Adelheid Elbe-
Bürger1 1Department of Dermatology, DIAID, Vienna, Austria, 2Department of Gynaecology 
and Obstetrics, Vienna, Austria, 3Gynmed-Ambulatorium, Vienna, Austria, 4Department of 
Dermatology, Vienna, Austria
Previous work in mice and humans suggests that undifferentiated leukocytes colonize embryonic 
epidermis. These precursors eventually acquire the cell surface marker profile of Langerhans cells 
(LCs), depending either on the epidermal microenvironment or their lineage. Despite numerous 
studies, the exact phenotype of LC precursors is not known. In embryonic human epidermis, we 
occasionally observed CD45+ leukocytes which are negative for CD1a, CD1c, HLA-DR, CD36, 
CD14, and CD207. We have used a three-dimensional full-thickness skin model to compare 
the integration and differentiation potential of defined LC precursor candidates and, thus, to 
recapitulate the in vivo situation. Using immunohistochemistry and ELISA we found that our skin 
equivalents produce TGF-ß1 and GM-CSF, key cytokines required for the development of LCs. 
Subsequently, we tested the differentiation capacity of potential LC precursors phenotypically 
resembling those observed in vivo during ontogeny. CD34+ hematopoietic stem cells were 
differentiated using GM-CSF, Flt3L, SCF, and TNF-alpha for seven days. FACS-sorted, CD207- 
populations (CD14+CD1a-, CD14-CD1a+, CD14-CD1a- cells) were then co-cultured with primary 
keratinocytes to allow the integration of the precursor cells in the newly formed epidermis of the 
skin model. Dendritic, CD207+ cells were detectable in all epidermal fractions already after eight 
days with a frequency of 188.5 vs. 116 vs. 32.1 cells/mm2 (n=2) in the CD14-CD1a+, CD14-CD1a- 
and CD14+CD1a- fraction, respectively. Taken together, we found that CD14-CD1a+ progenitor 
cells possess a much higher differentiation potential than CD14+CD1a- progenitor cells.
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Predominant expression of β variable region of T cell receptor in peripheral blood T cells of 
patients with psoriasis
Xinhua Li, Hongzhou Cui, Guohua Yin, Kaiming Zhang Department of Dermatology, Taiyuan 
Central Hospital, Taiyuan City, China
Psoriasis is a skin disease featured with epithelial cell hyperproliferation and T cell infiltration. 
Immune abnormal T cells play an important role in psoriatic pathogenesis. To analyze 
predominant expression of β variable region of T cell receptor and discuss the role of T cells in 
pathogenesis of psoriasis, cDNA samples from 10 psoriatic patients and 10 healthy volunteers 
were amplified by RFQ-PCR. Each sample was amplified using 34 primer pairs, respectively, TCR 
α chain (TRAC) forward and reverse primer pair and TRBV2 toTRBV30 forward primers and TCR 
β constant region (TRBC) reverse primer pairs. The results show that TRBV2, TRBV5-7, TRBV6-
6/6-9, TRBV12, TRBV24 and TRBV29 were significantly up-regulated in psoriatic patients than 
healthy subjects, among which, TRBV6-6/6-9, TRBV12 and TRBV29 are predominantly expressed 
in psoriatic patients, which might play an important role in abnormal immune responses of T cells 
in psoriatic patients.
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Effects of epidermal barrier disruption on vitamin D3-induced atopic dermatitis-like 
inflammation in mice
Verena Martinz1, Caroline Baudouin2, Stéphanie Bredif2, Philippe Msika2, Matthias Schmuth1, 
Sandrine Dubrac1 1Department of Dermatology, Innsbruck Medical University, Innsbruck, 
Austria, 2Innovation R&D Direction, Laboratoires expanscience, Epernon, France
Topical vitamin D3 (VitD3) induces an atopic dermatitis (AD)-like inflammation by upregulating 
the expression of thymic stromal lymphopoietin (TSLP) in keratinocytes and requires the 
presence of epidermal Langerhans cells (LC). According to the hypothesis that TSLP-induced 
skin inflammation is aggravated by skin barrier impairment, Balb/c mice were topically treated 
with VitD3 after disruption of the epidermal skin barrier by tape stripping. Tape stripping prior 
to topical VitD3 worsened AD-like skin inflammation, including hyperkeratosis, epidermal 
hyperplasia and inflammatory infiltrates, when compared to controls treated with VitD3 only. 
In contrast, epidermal barrier disruption did not further enhance levels of plasma IgE and TSLP 
expression by keratinocytes, induced by topical VitD3. Furthermore, tape stripping combined 
with topical VitD3 induced greater cell numbers in skin draining lymph nodes, when compared 
to control mice treated with VitD3 alone. However, the VitD3-induced increase in numbers of 
activated CD4+ T cells, CD4+ CD25+ FOXP3+ regulatory T cells and emigrated dendritic cells 
(DC) in skin draining lymph nodes was not significantly further enhanced by epidermal barrier 
disruption. These results suggest that abnormal immune reactivity and impaired skin barrier 
function synergize in eliciting local AD-like symptoms.
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Cutaneous CD4+CD8αα+ T-Cells Expressing The CD160 Receptor Are Present In The Circulation 
As Effector Memory Cytotoxic T-Lymphocytes
Christian Schmitt1,2, Valérie Schiavon1,2, Jérôme Giustiniani1,2, Laurence Michel1,2, Martine 
Bagot1,2, Daniel Olive3,4, Armand Bensussan1,2 1Inserm U976, Paris, France, 2Univ Paris Diderot, 
Sorbonne Paris Cité, Paris, France, 3Inserm U891, Marseille, France, 4Univ de la Méditerranée, 
Marseille, France
CD160 is a GPI-anchored Ig-like receptor expressed by circulating CD56dim+ NK cells and 
TCRγδ lymphocytes, identified by the monoclonal antibody BY55. Whereas most intestinal T 
lymphocytes express it, only a minor circulating CD4+ or CD8+ T lymphocyte subset is CD160+, 
although it has been reported on most of these cells following their activation. Here we describe 
CD4+CD160+ T lymphocytes that can be isolated from the peripheral blood of normal individuals 
and correspond to less than 0.5% of the whole T cells. This unique T lymphocyte subset, which 
exhibits a limited TCR-Vβ repertoire, co-expresses CD8αα, CD244, perforin but lacks CD28 
expression, corresponding to an effector memory cytotoxic T-lymphocyte phenotype. Functional 
studies performed with purified CD4+CD160+ circulating cells confirmed their cytotoxic 
potential, limited proliferative capacity and lack of immunoregulatory functions. These cells are 
also distinct from circulating precursors of intra-epithelial intestinal lymphocytes as they lack 
CD103 expression associated with this population. Finally and importantly, CD4+CD160+ were 
found to represent 20 to 50% of the cutaneous CD3+ T lymphocytes present in the normal skin. 
These cells might represent specialized cutaneous lymphocytes devoted to immune surveillance 
of the skin barrier.
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Malassezia produced indoles induce aryl hydrocarbon receptor activation and inhibit Toll-like 
receptor maturation in monocyte derived dendritic cells
Christopher Vlachos1,2, Barbara Schulte1, Georgios Gaitanis2, Prokopios Magiatis3, Aristea 
Velegraki4, Gosse Adema1 1Dept of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, 
Radboud Univ, The Netherlands, 2Dept of Skin & Venereal Diseases, Univ of Ioannina Med School, 
Greece, 3Dept of Pharmacognosy & Natural Products Chemistry, Nat & Kapodistrian Univ of Athens, 
Greece, 4Mycology Lab, Microbiology Dept, Med School, Nat & Kapodistrian Univ of Athens, Greece
Malassezia yeasts are part of the normal skin microflora and can become opportunistic pathogens under 
currently insufficiently understood conditions. These yeasts can produce potent activators of the Aryl 
hydrocarbon Receptor (Ahr) as are indirubin, thrypanthrin, indole-[3,2b]-carbazole (ICZ) and malassezin, 
Our aim was to investigate the possible impact of these indoles in AhR activation and the maturation 
process of monocyte derived dendritic cells (moDCs) treated with Toll-like receptor (TLR) ligands. AhR 
activation and downstream Cyp1a1 and Cyp1b1 expression in moDCs was evaluated by qPCR and 
Western blotting. Inhibition of moDCs’ maturation and mediation of inflammatory signals was assessed 
by flow-cytometry, Elisa and Mixed Lymphocyte Reaction. After initial titration experiments indirubin 
and ICZ were shown to be the most active ligands (p<0.05) and were selected for the subsequent 
experiments. Concurrent exposure of moDCs to indirubin or ICZ with the TLR ligands significantly 
(p<0.05) augmented the induction of Cyp1a1 and Cyp1b1 genes. Indirubin and ICZ were also shown: 
i) to limit the TLR ligand-induced (LPS, R848 and PolyI:C) phenotypic maturation (CD80, CD83, CD86, 
MHC II) of moDCs (p<0.05); ii) to reduce the production of the inflammatory cytokines IL-6 and IL-12 
(p<0.05), and iii) to decrease the ability of stimulated moDCs to cause lymphocyte proliferation (p<0.05). 
These results demonstrated that AhR ligands of yeast or microbial origin have the ability to down-regulate 
moDC response to TLR-ligands and these immune cells can adapt through increased transcription of 
metabolizing enzymes like CYP1A1 and CYP1B1.
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Cutaneous trauma leads to a reduced expression of chemokine receptor D6 in human psoriatic 
skin
Kave Shams1, Mark Singh2, Susan Holmes1, David Burden1, Vicky King2, Clive McKimmie2, Gerard 
Graham2 1Alan Lyell Centre for Dermatology, Glasgow, UK, 2University of Glasgow, Glasgow, UK
Inflammatory skin responses involve the production of a range of inflammatory mediators, 
which include chemotactic cytokines known as chemokines. Chemokines recruit inflammatory 
leukocytes and thus initiate and perpetuate inflammation. The chemokine receptor D6 scavenges 
and internalises inflammatory CC-chemokines and thereby plays a role in the resolution of 
inflammation. In the absence of D6 inflammatory responses are exaggerated, which can lead 
to the development of a psoriasis-like pathology in mouse models of cutaneous inflammation. 
Psoriasis is a common human inflammatory skin condition, which is associated with considerable 
morbidity. The mechanism by which psoriatic plaques develop at specific sites, adjacent to 
apparently normal skin, has hitherto been poorly understood. We have explored the association 
between D6 gene transcripts in skin of patients with psoriasis and the development of psoriatic 
plaques. Our data from human patients with psoriasis shows that D6 expression is significantly 
elevated in unaffected skin (7.6-fold increase, p=0.02, n=9). However, D6 expression in lesional 
skin is significantly reduced in comparison (4.4-fold difference, p=0.03, n=10). Skin trauma can 
give rise to new psoriatic lesions. To determine how D6 expression is modulated in response to 
trauma, unaffected skin of patients with psoriasis was traumatised by means of tape stripping. 
Skin trauma induced a significant down-regulation of D6 levels, as compared to non-traumatised 
control skin (1.5-fold reduction, p=0.03, n=3). We propose that the localisation of psoriatic 
plaques is explained at least in part by a reduced expression of chemokine receptor D6, with 
trauma being one trigger for its reduced expression.
519
Does fetal microchimerism confer a protective role against melanoma in women?
Lucie Leveque, Mathieu Rodero, Nicholas Fisk, Kiarash Khosrotehrani The University of 
Queensland, UQ Centre for Clinical Research, Herston, QLD, Australia
Melanoma is reported to carry a better prognosis in women than men. During all pregnancies, 
fetal cells including T cells enter the maternal circulation and can persist for decades. It has been 
proposed that semi-allogenic fetal microchimeric (MC) cells protect against tumours by a graft 
versus tumour (GVT) effect. In women with a range of cancers, the level of circulating fetal MC 
cells has been found to be lower than in healthy controls. Despite this suggested protective role, 
no study has yet evaluated the GVT potential of naturally-acquired fetal MC cells. Our objective 
was to compare B16 melanoma innoculation in post-partum mothers of non-reactive versus 
fetuses alloreactive against melanoma cells. Thus, B6D2F1 female mice (H-2d/b) were mated 
to DBA/2 (H-2d/d) or B6 (H-2b/b) males. Only in the former would 50% of offspring harbour 
H-2d/d, allowing an allogeneic response against B16 melanoma cells with the H-2b/b haplotype. 
After serial pregnancies, parous females were injected with 50,000 luciferase-expressing B16 
cells intravenously, 14 in mothers who received allogeneic fetal MC cells and 16 control mothers. 
After 15 days, the number of lung nodules (5.4 vs 6.9, p=0.38) as well as luciferase signal (880.2 
vs 945.5 photon/cm2, p=0.70) were similar in both non-reactive (n=16) and allo-reactive (n=14) 
mothers despite the presence of fetal cells in blood, spleen and lung. We conclude that fetal 
MC do not protect against tumour initiation via a graft versus tumour type immune reaction in 
melanoma.
520
Zinc gluconate modulates the epidermic expression of Lipopolysaccharide-induced innate 
immunity markers
Carole Poiraud1,2, Anne-Chantal Knol1, Gaëlle Quereux1,2, Amir Khammari1,2, Brigitte Dréno1,2 
1INSERM U892, Nantes, France, 2Unit of Dermato-Cancerology, CIC-Biotherapies INSERM 0503, 
Nantes University Hospital, Nantes, France
Zinc salts are known to have good therapeutic effects in several inflammatory skin disorders, 
such as acne vulgaris or hidradenitis suppurativa, through the modulation of innate immunity. 
In this study, we investigated the modulation of the epidermic expression of Peroxisome 
Proliferator-associated Receptor α (PPARα), human β-defensins -2 and -4 (hBD-2 and -4), psoriasin 
and Interleukin (IL)-8 as a reference proinflammatory cytokine, in a model of inflammatory skin 
disorder. Skin explants were obtained from surgical samples of healthy abdominal skin and then 
stimulated with Lipopolysaccharide (LPS) during 3, 6 or 24h, with or without preincubation by zinc 
gluconate during 24h. The epidermic expression of PPARα, hBD-2 and -4, psoriasin and IL-8 at 
both molecular and protein levels were analyzed. In addition, the PPARα transcription factor DNA-
binding activity was analyzed. We demonstrated that the induction by LPS of the expression of the 
different epidermal innate immunity markers was inhibited by a preincubation by zinc gluconate. 
In conclusion, we describe several new targets of innate immunity, which are modulated by zinc 
gluconate and thus could explain the efficiency of zinc salts in inflammatory dermatosis, as acne 
and hidradenitis suppurativa. Zinc appears more and more to play a crucial role in the regulation 
of cutaneous innate immunity.
521
Foxp3+ cells are dispensable during the rapid recall response in experimental contact 
hypersensitivity
Sari Lehtimäki1, Katharina Lahl2, Tim Sparwasser3, Antti Lauerma4,1, Harri Alenius1, Nanna 
Fyhrquist1 1Finnish Institute of Occupational Health, Helsinki, Finland, 2Stanford University, 
Stanford, USA, 3Institute of Infection Immunology, Hannover, Germany, 4University of Tampere, 
Tampere, Finland
Contact hypersensitivity (CHS) response can be divided into three distinct phases: sensitization, 
elicitation and resolution. Regulatory T cells (Treg) are known to be involved in all three phases, 
but the relative importance of their activities during different phases as well as the contribution 
of different subtypes of Treg cells is still unknown. We studied the role of natural, Foxp3+, Treg 
(nTreg) cells during the three phases of the CHS response in conditional Foxp3 knock-out DEREG 
mice. The Foxp3+ cells can be transiently deleted in DEREG mice by a single diphtheria toxin 
treatment after which the Foxp3+ cell compartment is restored within few days. The mice were 
sensitized and challenged by oxazolone on day 0 and 5, respectively, and Foxp3+ cells were 
depleted one day prior to sensitization or one day prior to elicitation. Mice that were depleted 
prior to sensitization, developed significantly exacerbated CHS responses, including markedly 
increased ear swelling, cellular infiltration and production of inflammatory cytokines. In contrast, 
depleting Foxp3+ cells prior the elicitation had no effect on the inflammatory response during 
the first 24 hours post challenge, but significantly impaired the resolution of inflammation at later 
time points. These results demonstrate that nTreg cells are especially important in controlling 
the priming of naive T cells and downregulating the inflammation. However, during the rapid 
secondary response, nTreg cells are redundant, suggesting that nTreg dependent suppression is 
not a rapid event but rather a time-consuming process.
522
Number of T regulatory lymphocytes and expression of TLR 2 and 4 receptors in atopic 
dermatitis patients
Michal Rogowski-Tylman1, Aleksandra Lesiak1, Dorota Sobolewska1, Piotr Smolewski2, Anna 
Sysa- Jedrzejowska1, Joanna Narbutt1 1Medical University of Lodz, Department of Dermatology, 
Lodz, Poland, 2Medical University of Lodz, Department of Haematology, Lodz, Poland
Regulatory T cells (Tregs) have an immunoregulatory function and prevent T-cell reactivity. 
Although many studies showed their relevance in inflammatory diseases, the role of these cells 
in atopic dermatitis (AD) pathogenesis has not been fully elucidated. Toll-like receptors (TLRs) 
are a group of pathogen-associated molecular pattern (PAMP) receptors important for innate and 
adaptive immunity and their role in allergic inflammation in AD is postulated. To evaluate the 
number of circulating T regulatory cells and the number of peripheral blood mononuclear cells 
(PBMC) expressing TLR2 and TLR4 receptors in patients with atopic dermatitis and in healthy 
controls, PBMC and CD4+ CD25+ Treg lymphocytes were isolated from whole blood of 32 
patients with AD and 36 healthy volunteers. Expression of CD4+CD25+, TLR2 and TLR4 receptors 
and IL 17+ was assessed with the flow cytometry .In the peripheral blood samples of patients with 
AD the percentage of CD4+ CD25+ Treg lymphocytes was significantly higher when compared 
to the control group (p=0.0003). The number of PBMC with expression of TLR2 in AD patients 
was significantly higher then in the control (p=0.035), when the number of PBMC-TLR4+ was 
statistically lower ( p=0.001). Comparing the number of Tregs expressing TLR2 or TLR4 receptor 
we found no significant diffrences between two analysed groups (p>0,05 for all comparisons). 
Distinct number of Tregs and various distribution of TLR 2 and 4 expression on PBMC in atopic 
dermatitis patients suggest the contribution of these cells in the pathogenesis of AD.
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Immature B cell-like circulating lymphoid cells transiently express keratin 5 and present 
exogenous antigen comparable to plasmacytoid dendritic cell
Takaaki Hanafusa, Hiroaki Azukizawa, Ichiro Katayama Department of Dermatology, Osaka 
University Graduate School of Medicine, Suita, Osaka, Japan
Keratin 5 (K5) is a tissue-specific protein expressed in the epithelial cells of skin, esophagus and 
thymus. To study the role of ectopic epidermal self-protein expression, K5-Cre x CAG-CAT-loxp-
EGFP double transgenic (K5xGFP) mice that express enhanced green fluorescence protein (GFP) 
under the control of K5 promoter were employed for fate mapping of K5-expressing cells. GFP+ 
cells distinct from migratory DC were found not only in skin-draining lymph nodes (LNs), but also 
in mesenteric LNs, spleen, peripheral blood. They were B220+ IgM+ but IgD-, which was similar 
to immature B cells, but was negative for early B cell lineage marker CD93, indicating that none 
of the conventional B cell lineage cell was identical. Although Cre-mediated recombination in 
sorted GFP+ cells from LN and spleen was identified, GFP+ cells in the periphery did not express 
K5. Interestingly, GFP+ cells found in the CD93+ B cell progenitor cells expressed K5, indicating 
that GFP+ cells transiently express K5 in bone marrow (BM). Since GFP+ cells expressed MHC 
class II and B220 similar to plasmacytoid DC (pDC) and immature B cell, we clarified exogenous 
antigen-presenting capacity of those 3 subsets in vitro. GFP+ cells cross-presented ovalbumin 
(OVA) as well as immature B cells and pDC in vitro, whereas GFP+ cells and immature B cells, but 
not pDC, presented OVA to CD4 T cells. These results indicate that a novel immature B cell-like 
circulating lymphoid cell is a unique cell transiently expressing K5 in BM and is a potent antigen-
presenting cell of exogenous antigen.
524
Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with 
bexarotene
Anne Chantal Knol1, Gaëlle Quéreux2,1, Anabelle Brocard2,1, Fabienne Ballanger2, Jean Michel 
Nguyen3,1, Amir Khammari2,1, Brigitte Dréno2,1 1Inserm U892, CRCNA, NANTES, France, 2Unité 
d’onco-dermatologie CIC Biothérapie U0503, NANTES, France, 3Unité de biostatistiques, 
NANTES, France
Cutaneous T-cell lymphomas (CTCL) are characterized by the infiltration of the epidermis by 
activated malignant CD4+ T-lymphocytes. Bexarotene was the first synthetic RXR retinoid approved 
for the treatment of all stages of CTCL. Previously, six cases in which the initiation of bexarotene 
therapy for CTCL was associated with the progression of internal disease despite improvement of 
cutaneous signs and symptoms were reported. Moreover, it has been established that retinoids 
promote the generation of CD4+ Foxp3+ regulatory T cells (Tregs). The aim of this work was to 
determine if bexarotene induces an increase of functional Tregs which could play a role in the 
development of secondary extra-cutaneous lymphomas. Tregs were studied both in cutaneous 
biopsy specimens using an immunohistochemical analysis of CD4, CD25 and Foxp3 and in blood 
where proportion and functionality of circulating CD4+CD25high T-cells were determined. The 
study was performed in 10 patients stage IIb and III (TNM) (5 patients with SS and 5 MF), treated for 6 
months with bexarotene. Four healthy donors were used as controls. We found that the frequency of 
CD4+CD25high Tregs was not significantly different before starting bexarotene and after 6 months 
of treatment in CTCL patients. However, we observed that the frequency of CD4+CD25high Tregs 
before the beginning of the treatment was significantly increased compared to healthy donors. 
In addition, functional assays demonstrated that Foxp3 expressing CD4+CD25high T-cells were 
able to suppress autologous CD4+CD25- T-cell proliferation. In conclusion, the treatment with 
bexarotene does not seem to affect the regulatory T-cell compartment.
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In vitro assessment of the impact of Ipilimumab on Tumor infiltrating Lymphocyte (TIL) against 
autologous melanoma tumor cell-lines
Amir Khammari2,1, Anne Chantal Knol1, Marie Christine Pandolfino3,1, Hélène Aubert Wastiaux2,1, 
Gaëlle Quéreux2,1, Anabelle Brocard2,1, Soraya Saiagh3, Brigitte Dréno2,1 1Inserm U892, CRCNA, 
NANTES, France, 2Unité d’onco-dermatologie CIC Biothérapie U0503, NANTES, France, 3Unité 
de Thérapie Cellulaire et Génique, NANTES, France
At present, generating more reactive tumor infiltrating lymphocytes (TIL) would be highly 
convincing for using adoptive T-cell transfer in advanced stages of melanoma. Blocking the 
activity of CTLA-4 with neutralizing antibodies might greatly enhance immune responses 
and it was recently reported that treatment of advanced melanoma patients with Ipilimumab 
significantly improved overall survival. The aim of this work was to determine the reactivity of TIL 
against autologous melanoma tumor cell-lines in the presence of CTLA-4 neutralizing antibody 
Ipilimumab. The expression of CTLA-4 by expanded TIL from 7 stage III melanoma patients was 
first evaluated using flow cytometry. Four populations of expanded TIL were then stimulated 
by autologous melanoma cells in the presence of increasing concentrations of Ipilimumab. The 
response of tumor reactive TILs was finally evaluated by measuring the fraction of IFN-γ or IL-2 
secreting T cells among TIL stimulated by autologous melanoma cells. We observed that TIL 
did not express CTLA-4 or expressed very low levels. After 6 hour incubation with autologous 
melanoma cells together with anti-CTLA-4 antibody, we observed that the frequency of IFN-γ 
or IL-2 secreting T cells was not modulated by the presence of Ipilimumab at any of the 
concentrations tested. In conclusion, exposure of TIL in vitro to Ipilimumab in the presence of 
autologous tumor cells did not enhance their function in the conditions tested. The next step 
will thus be to start a pilot phase I/II in vivo trial by treating stage IV melanoma patients using 
therapeutic TIL combined with systemic administration of Ipilimumab.
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Slan-dendritic cells are a major population of human dermal dendritic cells in steady state and 
inflammation
Claudia Günther1, Josefine Starke3,1, Nick Zimmermann1, Michael Meurer1, Knut Schäkel2,1 
1Department of Dermatology, University Hospital Dresden, Dresden, Germany, 2Department of 
Dermatology, University Hospital Heidelberg, Heidelberg, Germany, 3Department of Pathology, 
Hospital am Steinenberg, Reutlingen, Germany
The skin immune system bares a network of resident dendritic cells (DCs) consisting of epidermal 
Langerhans cells and different subsets of dermal DCs, which are not well defined.. We recently 
reported on a new population of dermal DCs, called slan (6-sulfoLacNAc+) DCs, which have a 
potent capacity to stimulate Th17/Th1 T cell responses. Staining healthy skin for DCs revealed 
that slanDCs (CD1a-, CD1c-, CD11c-, CD14-, CD163-) can be found in healthy human dermis 
at a similar frequency compared to CD1c+, CD11c+, CD1a+, CD14-, CD163- DCs that were 
previously regarded as the major population of resident DCs. In the prototypic inflammatory 
disease psoriasis the frequency of slanDCs and CD1c+ DC doubled and slanDCs now expressed 
CD11c. The frequency of slanDCs correlated well with the clinical score of psoriatic skin lesions. 
In depth analysis of DCs in psoriatic dermis by four color immunofluorescence analysis revealed 
that in addition to slanDCs and CD1c+ DCs the pool of CD11c+ cells can be further subdivided 
into CD11c+ CD14+ CD163- DCs and CD11c+ CD163+ CD14+ macrophages.In conclusion, we 
provide evidence that slanDCs, initially described as large population of proinflammatory DCs 
in blood, are a novel major part of the resident dermal myeloid DC-network in healthy skin and 
inflammation.
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Characterization of stimulator of interferon genes (STING) expression in human epidermal 
keratinocytes
Yohei Nishikawa, Yasushi Matsuzaki, Hajime Nakano, Daisuke Sawamura Department of 
Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
The innate immune system is the first line of defense against microbial pathogens, and the 
production and secretion of type I IFN plays an important role of the innate response to RNA 
viruses. Recently stimulator of interferon genes (STING) has been identified as an intracellular 
adaptor, which activates both NF-κB and interferon regulatory factor 3 (IRF3) transcription 
pathways to induce type I IFN. We demonstrated that the STING expression is regulated by 
stimulation of various cytokines in human epidermal keratinocytes (HaCaT). Especially, IFN-γ 
induced the STING mRNA expression in a dose-dependent manner. On the other hand, 
polyinosinic-polycytidylic acid (poly I:C), which mimics viral infection, has no effect on the 
STING expression. STING promoter analysis showed that a gamma-activated sequence 
(GAS) located at -58 to -66 bp is essential for IFN-γ-regulated promoter activity. Moreover, 
electrophoretic mobility shift assay revealed that STAT1 binds to the GAS element on the STING 
promoter region, indicating that IFN-γ/JAK/STAT1 signaling is critical for the expression of STING 
in human epidermal keratinocytes.
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Enhanced innate immune response in newborn human skin
Nousheen Iram1, Michael Mildner2, Marion Prior1, Christian Fiala3, Gero Kramer4, Erwin 
Tschachler5, Adelheid Elbe-Bürger1 1Dept. of Dermatology, DIAID, Medical University of Vienna, 
Vienna, Austria, 2Dept. of Dermatology, Research Division of Biology and Pathobiology of the 
Skin, Medical University of Vienna, Vienna, Austria, 3Gynmed-Ambulatorium, Vienna, Austria, 
4Dept. of Urology, Medical University of Vienna, Vienna, Austria, 5CE.R.I.E.S, Neuilly, France
To examine when during ontogeny skin cells acquire the capacity to support adequate immune 
responses, we have evaluated the pattern recognition receptor (PRR) expression profiles in human 
skin specimens from selected age groups before (embryonic, fetal) and after birth (infant, child) 
and compared them to those of adult skin. Quantitative real-time PCR revealed significantly 
higher mRNA expression levels of TLRs 1-5, MD-2, NODs 1/2, NALPs 1/3, RIG1 and DECTIN-1 
in prenatal skin than in adult skin. TLR6 was equally expressed in all skin samples. TLRs 7-9 were 
weakly expressed in prenatal skin but absent in adult skin. When we analyzed TLR3 expression 
by immunohistochemistry, we found TLR3+ cells in the periderm, the epidermis and the dermis of 
prenatal skin already at 9 weeks estimated gestational age. Even though TLR3 mRNA expression 
remained significantly higher in the epidermis of infants and children compared to adults, no 
obvious differences in TLR3 protein expression were found in postnatal skin among all age groups 
investigated as determined by immunohistochemistry and Western blot analyses. Surprisingly, the 
activation of primary human keratinocytes with the synthetic TLR3 ligand poly (I:C), mimicking 
viral ds RNA, induced a significant enhanced secretion of proinflammatory cytokines such as 
IL-8 and TNF-a in newborn donors as compared to adult donors. Our data provide evidence 
for antiviral innate immunity already in prenatal skin that might contribute to the protection of 
developing human skin from viral infections in a scenario where the adaptive immune system is 
not yet fully functional.
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Correlation between serum level of IL-22 and disease severity in patients with active psoriasis
Sebastian Majewski1, Agnieszka Nawrocka1, Anna Wydrzynska1, Joanna Olkowska-
Truchanowicz2,3, Witold Owczarek1 1Dermatology Department, Military Institute of Medicine, 
Warsaw, Poland, 2Department of Transplantology and Central Tissue Bank, Medical University of 
Warsaw, Warsaw, Poland, 3Euroimplant S.A., Warsaw, Poland
Psoriasis is a chronic inflammatory disease which affects about 2% of the population worldwide. 
Regulation of local and systemic cytokines plays one of the key roles in its pathogenesis. The 
point of our interest was particular involvement of interleukin (IL)-22 in this process, with a 
direct projection on the clinical presentation of patients. IL-22, an IL-10 family member, is a 
proinflammatory cytokine. It is produced and secreted by the Th17 cells over the stimulation 
by IL-6, IL-23 or TGFβ. IL-22 is the strongest cytokine in the keratinocyte-proliferative ability. 
Moreover, IL-22, together with IL-17 can induce the critical events of psoriasis, including signal 
transducer and activator of transcription 3 (STAT3) activation or antimicrobial peptide elaboration. 
We evaluated the serum level of IL-22 in 16 healthy volunteers and 66 patients with psoriasis and 
determined its correlation with the disease severity. The serum levels of IL-22 was determined 
with the use of the ELISA method. The disease severity was assessed by PASI (psoriasis area and 
severity index) and BSA (body surface area) index, the most commonly used parameters in the 
evaluation of psoriasis severity. The serum level of IL-22 in psoriasis patients was higher (average 
59,74 pg/ml) than in healthy individuals (average 19,27 pg/ml). Moreover, the level of IL-22 
positively correlated with the disease severity measured in PASI (p<0.0001) and BSA (p<0.0001) 
indexes. Therefore, indicating serum level of IL-22 would be an useful tool in the measuring of 
the disease severity, progress of the treatment and would give additional data for further research.
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Anti- IL-6 receptor monoclonal antibody alleviates skin symptom, and increased plasamacytoid 
dendritic cells in the draining lymph nodes in mouse model of scleroderma
Shun Kitaba, Hiroyuki Murota, Takaaki Hanafusa, Mika Terao, Hiroaki Azukizawa, Ichiro 
Katayama Department of Dermatology Osaka University, Suita-shi Osaka, Japan
Scleroderma is an autoimmune disease characterized by sclerosis of the skin and internal organs. 
Although the pathogenesis of scleroderma remains uncertain, many reports have suggested that 
IL-6 is involved in pathogenesis of scleroderma. In this study, we investigated whether an anti-IL-6 
receptor monoclonal antibody (MR16-1) could inhibit dermal sclerosis in a bleomycin-induced 
murine model. To verify the above hypothesis, C57BL/6 and IL-6KO mice were administered 
BLM to induce dermal sclerosis, and bleomycine-treated and control PBS-treated mice were 
treated with MR16-1or isotype-matched control antibody (control Ab). Bleomycine-induced 
dermal sclerosis in IL-6KO mice was attenuated compared with that in C57BL/6 mice. Weekly 
administration of MR16-1, but not control Ab, prevented and improved dermal sclerosis. We 
also found that cutaneous draining LNs were visibly enlarged by bleomycine treatment in the 
scleroderma model mice, but not by PBS treatment, and the weight per lymph node (LN), and 
total LN cell count per LN in control antibody-treated BLM-injected mice were significantly 
increased compared with control Ab-treated PBS-injected mice. Detailed cell fractionation 
analysis of cells isolated from the draining LNs revealed that the ratio of PDCA1+CD11c+ double-
positive cells [plasmacytoid dendritic cells (pDCs)] was significantly increased in the draining LNs 
of prophylactically MR16-1-treated model mice. In vitro, MR16-1 suppressed α-SMA induction 
in IL-6–stimulated IL-6KO fibroblasts. Our results indicate that IL-6 contributes to bleomycin-
induced dermal sclerosis and that anti IL-6 receptor monoclonal antibody may improve the 
symptoms of scleroderma via suppression of fibroblast activation and an increased ratio of pDCs.
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Role of PU.1 in MHC class II expression via transcriptional regulation of class II transactivator 
pI in dendritic cells
Nao Kitamura1,2, Chiharu Nishiyama2, Nobuhiro Nakano2, Shunsuke Kanada2, Mutsuko Hara2, 
Tatsuo Fukai1,2, Hideoki Ogawa1,2, Ko Okumura2, Shigaku Ikeda1,2 1Department of Dermatology 
and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan, 2Atopy (Allergy) 
Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
Activation of T cell through the interaction of T cell receptor and MHC class II on antigen 
presenting cells is involved in several immune-related diseases including atopic dermatitis, and 
contact hypersensitivity. However, the expression mechanism of MHC class II on dendritic cells 
(DCs) is still obscure. We have previously found that siRNA treatment of a transcription factor 
PU.1 recovered contact hypersensitivity in mice. This observation prompted us to analyze the role 
of PU.1 in MHC class II expression in DCs. We performed a reporter assay, an electrophoretic 
mobility shift assay (EMSA), and a chromatin immuno-precipitation (ChIP) assay to evaluate the 
effect of PU.1 on the promoter function of CIITA, which is a master regulatory cofactor of MHC 
class II, in murine bone marrow-derived DC (BMDC). ChIP assay revealed that PU.1 constitutively 
bound to the CIITA first promoter (pI) independent from resting/stimulating conditions, whereas 
histone acetylation status of the CIITApI was dramatically down-regulated by LPS-stimulation, 
resulting in significant decrease of transcripts of MHC class II and CIITA. Reporter assay and 
EMSA showed that PU.1 trans-activated the CIITApI through direct binding via a PU.1-binding 
sequence located at just upstream of transcription initiation site. Knock down of PU.1 by siRNA 
resulted in downregulation of CIITA transcription, histone acetylation of the CIITApI and cell 
surface expression of MHC class II expression. From these results, we concluded that PU.1 plays 
critical roles in MHC class II expression as transcription factor and epigenetic regulator.
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Large-scale in vivo detection of inflammatory mediators in interstitial fluid of lesional and non-
lesional chronic atopic dermatitis skin
Krisztina Szegedi1, Pieter C. Res1, Rene Lutter2, Marcel B. M. Teunissen1, Jan D. Bos1, Rosalie 
M. Luiten1, Sanja Kezic3, Maritza A. Middelkamp-Hup1 1Department of Dermatology, Academic 
Medical Center, University of Amsterdam, Amsterdam, The Netherlands, 2Departments 
of Pulmonology and Experimental Immunology, Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands, 3Coronel Institute of Occupational Health, Academic 
Medical Center, University of Amsterdam, Amsterdam, The Netherlands
In vivo levels of inflammatory mediators in chronic atopic dermatitis (AD) skin are not well known, therefore 
we investigated the local cytokine milieu present in chronic AD. We obtained skin-derived interstitial fluid(ISF) 
using a novel minimally invasive technology that comprises the creation of micropores in skin by a laser, after 
which ISF is harvested through suction. After three hours, ISF was collected from lesional and non-lesional skin of 
AD patients or healthy volunteers. We determined the levels of 26 different pro-inflammatory, anti-inflammatory 
and immunoregulatory cytokines, chemokines and growth factors, including IL-31 and IL-22, cytokines recently 
implicated in AD pathogenesis by 24-plex Luminex and ELISA. In parallel, T cells were isolated from lesional 
AD skin or healthy donor skin and analysed for IL-13, IL-31, IL-17, IL-22 and IFN-γ cytokine production upon 
PMA/ionomycin stimulation. To determine the contribution of diminished skin barrier function, participants were 
genotyped for filaggrin null-mutations 2282del4, R501X, R2447X and S3247X. Out of 26 examined mediators 21 
could be detected in the ISF. The levels of several cytokines such as IL-5, IL-9, IL-10, IL-13, CXCL-9, CXCL-10, 
showed significant difference between lesional, non-lesional and/or healthy skin. Significantly more IL-31 and IL-
22 was found in ISF of lesional AD skin vs. non-lesional and healthy skin, corresponding to higher IL-31 and IL-22 
producing T cell levels in lesional AD skin. These elevated IL-31 and IL-22 levels/T cells were most predominant 
in filaggrin null-mutation 2282del4 carriers. This is the first time that a large-scale in vivo cytokine profile of AD 
skin is reported.
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Systems analysis of psoriasis reveals a dominant IL-22 signature and IL-22 as non redundant 
checkpoint in psoriatic inflammation
Gayathri Perera1, Chrysanthi Ainali3, Guillermo Barinaga1, Andrew Williams1, Muddassar Mirza4, 
Deepika Kassen1, Jonathan Barker1, Sophia Tsoka3, Wenjun Ouyang2, Frank Nestle1 1St. John’s 
Institute of Dermatology, King’s College London, Guy’s Hospital, London, UK, 2Department of 
Immunology, Genentech Inc., South San Francisco, USA, 3Centre for Bioinformatics, School 
of Physical Sciences and Engineering, King’s College London, Strand, London, UK, 4Genomics 
Centre, Biomedical Research Centre, King’s College London, Guy’s Hospital, London, UK
IL-22 is a cytokine of the IL-10 family and expressed by an array of immune cells such as CD4+Th17 cells, 
NK-like cells (NKp44, NKp46), LTi-like cells and a novel T helper subtype, Th22. The IL-22 receptor is 
located on non-immune, epithelial cells such as keratinocytes. Whilst IL-22 is able to induce keratinocyte 
proliferation, its role in psoriasis pathogenesis remains unclear. Using humanised mouse models and 
applying a systems biology approach, we demonstrate a novel cutaneous IL-22 transcriptomic signature 
and suggest a pivotal functional and therapeutic role for IL-22 in psoriasis. The IL-22 signature was created 
by the intradermal injection of rhIL-22 into normal human skin, xenografted onto immunocompromised 
mice, and demonstrated that IL-22 alone was capable of transforming normal human epidermis into a 
psoriasiform epidermis. The resultant cutaneous IL-22 signature was identified as a significant component 
of the human psoriasis transcriptome. Xenotransplantation of peri-lesional psoriasis skin determined the 
temporal expression of IL-22 and its signature during the induction of a psoriatic plaque whilst selective 
blocking of IL-22, in xenografted lesional skin, significantly reduced the psoriasiform phenotype and the 
IL-22 signature. These studies suggest that IL-22 is a critical mediator in psoriasis pathogenesis and its 
selective targeting is effective in ameliorating psoriasis. Network analysis of differentially expressed gene 
transcripts, from these models, identified a novel association between IL-22 and vascular development as 
a key pathogenic event. Together these studies demonstrate that IL-22 contributes to psoriasis pathogenesis 
and represents a potential therapeutic target in psoriasis.
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Understanding transcriptomes of cutaneous inflammatory diseases with “biological scales” 
generated by multidimensional analyses
Masahiro Ono Institute of Child Health, University College London, London, UK
During past decades, transcriptome analysis has been used increasingly to understand 
pathological processes of various diseases at molecular levels. The unique problem of skin is 
that it has many cellular components with complex anatomy. Indeed, we are often interested 
in more than two components (e.g. epidermis and immune cells) to understand pathological 
processes. However, it is practically impossible to obtain sufficient amounts of RNA from 
each cellular component for microarray analysis, and thus, most of transcriptomal data are 
from the whole skin, which complicates the understanding of these data. Currently, the most 
common approach for solving this problem is functional analysis based on annotation database. 
However, the influence of preknowledge from database is large and difficult to be controlled, 
and therefore, the analysis can be easily suffered from unfavourable biases in database. Here we 
propose an approach for dissecting transcriptomal data from skin samples into cellular/molecular 
components with least assumptions. To achieve this, we have learnt from psychometrics to define 
“biological scales” for measuring the degree of the activity of the pathological processes that 
underlie disease conditions. The key idea here is to quantify non-numeric, categorical data (e.g., 
the infiltration of immune cells, activities of signalling proteins) in an objective manner. First, the 
contribution of each gene to the biological process of interest was analysed by multidimensional 
analyses. Next, signature genes and their “weights” were determined, and thereby “biological 
scales” were defined. We show how transcriptomes from atopic dermatitis and psoriasis vulgaris 
can be understood by these scales.
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New Predictor for TNF-alpha Inhibitor Treatment Efficacy in Psoriasis: Cutaneous Lymphocyte 
Associated Antigen Expression on Circulating T Lymphocytes
Hajnalka Jókai1, Gábor Barna2, József Szakonyi1, Orsolya Kontár1, Sarolta Kárpáti1,3, Péter Holló1 
1Dept of Dermatovenerology & Oncodermatology, Semmelweis Univ, Budapest, Hungary, 21st 
Dept. of Pathology and Experimental Cancer Research, Semmelweis Univ, Budapest, Hungary, 
3Hungarian Academy of Sciences, Molecular Medicine Research Group, Budapest, Hungary
While TNF-alpha inhibitor treatment is effective in the majority of patients with severe psoriasis, a 
significant percentage has a relapse during long-term therapy. Currently there are no reliable prognostic 
markers of treatment outcome. Our aim was to extend our previous observations on cutaneous 
lymphocyte associated antigen (CLA) as an indicator of therapy effectiveness. Blood samples from 38 
chronic plaque psoriatic patients were collected before and after the 2. and the 6. week of therapy and 
from 5 healthy controls. CLA expression was determined by flow cytometry on circulating lymphocytes 
and CD3+CD4+ and CD3+CD8+ T-lymphocyte subsets. The number of CLA+ cells and the clinical 
severity by PASI were evaluated before and under treatment. 38/38 patients showed a mean 80% PASI 
improvement at the end of the 6. week, while at the 6 months treatment patients could be devided into a 
responder (32/38) and a relapsing (“non-responder”) (6/38) group. The non-responder patients presented 
a significantly higher CLA expression on circulating lymphocytes compared to the total cell number and 
the whole lymphocyte subset, than the responders (p=0,013617 and p=0,042639) before treatment. 
Similar difference was observed on the CD3+CD4+ and CD3+CD8+ T-lymphocyte subsets between the 
two groups. (p=0,033745 and p=0,042345). At the 6 weeks observation time a significant increasing 
tendency of CLA expression was detected among responders (p=0,000019) while CLA was measured 
in a significantly decreasing amount in the relapsing group (p=0,042607). These findings support our 
hypothesis that CLA could be used as a good and easy prognostic marker of biological therapy in psoriasis.
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Key cytokines in the pathogenesis of psoriasis induce insulin resistance at the endothelial cell 
level
Kathrin Woth, Claudia Prein, Katja Hardt, Sandra Diehl, Claudia Bürger, Wolf-Henning Boehncke 
Goethe University, Frankfurt am Main, Germany
Psoriasis is a common, chronic inflammatory skin disease which is characterized by red scaly 
plaques. Patients suffering from severe psoriasis have a higher incidence of diabetes and coronary 
atherosclerosis. The common denominator of these co-morbidities is insulin resistance. We have 
previously shown that the psoriatic cytokine milieu not only induces systemic insulin resistance, 
but epidermal insulin resistance represents a pathomechanism during the plaque development. 
Pathomechanisms in endothelial cells leading to the manifestation of the cutaneous phenotype on 
one hand and to the co-morbidities on the other hand are not sufficiently investigated. Due to the 
similarities between a psoriatic and an atherosclerotic plaque, we hypothesize that the underlying 
mechanism and pathways that are known to play a role in the development of atherosclerosis also 
contribute to the pathogenesis of psoriasis and its co-morbidities. Measuring insulin-dependent 
PKB phosphorylation, we could show that IL-17, IL-22, IL-23 and TNFα induce insulin resistance 
in primary endothelial cells (HUVEC and HDBEC [human dermal blood endothelial cells]) as well 
as in endothelial cell lines (HBMEC and HPEC-A2). Under normal conditions insulin counteracts 
the cytokine-dependent surface expression of ICAM-1, which is impaired under conditions of 
insulin resistance. Therefore insulin is not only cardio protective, but as well anti-inflammatory. 
We assume that these changes at the endothelial wall contribute to the pathogenesis of psoriasis 
and its co-morbidities. These novel insights can furthermore lead to novel therapeutic approaches 
that target the dermal and cardiovascular effects of the psoriatic inflammation.
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Pregnane X Receptor (PXR) links xenobiotic metabolism to the cutaneous immune response
Matthias Schmuth1, Andreas Elentner1, Frank J. Gonzalez2, Sandrine Dubrac1 1Innsbruck Medical 
School, Innsbruck, Austria, 2National Institutes of Health, Bethesda, Maryland, USA
The pregnane X receptor (PXR) is a member of the nuclear receptor superfamily that regulates 
the transcription of genes involved in all phases of endo- and xeno-biotic metabolism and thus 
prevents toxic accumulation of metabolites within cells. While skin is the largest metabolic organ 
of the body, the role of PXR in cutaneous immunity was never investigated. We here show that 
PXR activation ameliorates both irritant and allergic contact dermatitis. Moreover, rifampicin, 
a well-known activator of human PXR, when applied topically, improves allergic contact 
dermatitis in mice humanized for PXR (Tg-hPXR) and for PXR and CYP3A4 (Tg-CYP3A4/hPXR). 
Rifampicin down-regulates the expression of IL-1beta in a hPXR-mediated manner in PXR-
humanized epidermis sensitized and challenged with a contact allergen. Moreover, rifampicin 
down-regulates iNOS and IL-1beta in activated keratinocytes. Notably, Tg-CYP3A4/hPXR mice 
respond more readily to rifampicin than Tg-hPXR mice, suggesting a link between CYP3A4 and 
the rifampicin-mediated anti-inflammatory response. Conversely, PXR deficient mice exhibit 
exaggerated allergic contact dermatitis. Finally, PXR is expressed in lymphocyte-rich infiltrates 
of various human inflammatory skin disorders. In summary, PXR plays a regulatory role in the 
cutaneous immune system, and CYP3A4, the key enzyme of drug metabolism regulated by PXR, 
further modulates PXR-mediated anti-inflammatory activity.
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Modulation of Sphingosine-1-Receptors expression by LPS and contact allergen PPD
Susana Rosa1, Bruno Miguel Neves1, Margarida Gonçalo2, Maria Rosário Domingues3, Deolinda 
Santinha3, Bárbara Macedo4, Maria Celeste Lopes1, Maria Teresa Cruz1 1Metabolomics Core 
Service, Inst for Molecular & Cell Biology, Porto, Portugal, 2Dept of Dermatology, Univ Hospital 
of Coimbra, Portugal, 3Mass Spectrometry Centre, Chemistry Dept, University of Aveiro, Portugal, 
4Metabolomics Core Service, Institute for Molecular and Cell Biology, Porto, Portugal
Sphingosine-1-phosphate (S1P) is an important sphingolipid that regulates a variety of cell 
responses through the activation of G-protein coupled Sphingosine-1-Receptors (S1PRs). The 
S1P-S1PRs axis has an important role in the regulation of immune responses, such as allergic 
contact dermatitis (ACD), a common occupational disease. S1PRs ligands, namely S1P and its 
synthetic analog FTY720, have been shown to attenuate ACD through inhibition of dendritic 
cells migration. Since it is not known if contact allergens modulate S1PRs expression in dendritic 
cells, the aim of our work is to study the effect of Lipopolysaccharide (LPS), contact allergen 
Paraphenylenediamine (PPD) and irritant Benzalkonium chloride (BC) on the expression of 
S1PRs, in different models of dendritic cells, by qPCR analysis. Our results showed that the 
mouse skin derived dendritic cell line (FSDC) expressed S1PR2>-1>-4 >-3 in order of relative 
abundance. S1PR1>-2>-3>-4 and S1PR3>-1>-2>-4 was the expression pattern found in mouse 
bone marrow derived dendritic cells (BMDCs) and in dendritic-like THP1 cells, respectively. The 
maturational stimuli LPS and PPD induced a significant decrease in S1PR1 mRNA levels after 6 
hours of FSDC exposure, by two and three fold respectively, while BC had no effect, which was 
also observed in both BMDCs and THP1 cells. The pattern of S1PRs expression differs accordingly 
to the cell type, however S1PR1 downregulation in response to LPS and PPD, but not to BC, 
seems to be a common feature in the three cell models assessed. Further studies are necessary to 
better understand the implications of S1PR1 downmodulation in ACD physiopathology.
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Detoxification of snake venoms by human mast cells and human mast cell tryptase
Elizabeth Doyle1, Marcus Maurer1,2, Martin Metz1 1Allergie-Centrum-Charité, Department of 
Dermatology and Allergy, Charité –Universitätsmedizin Berlin, Berlin, Germany, 2Department of 
Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark
Snakebite is responsible for up to 100,000 deaths per year, primarily amongst poor, rural 
populations of Africa, Asia, Oceania, and Latin America (Kasturiratne, Anuradhani, et al, 2008). 
The World Health Organization lists it as one of 15 neglected tropical diseases that should be 
made a public health priority. Previously, we have shown that mast cells (MC) significantly reduce 
snake venom-induced pathology in mice, at least in part by protease-mediated degradation of 
venom components. To discover whether the same effect can be observed in primary human 
skin MC we have isolated MC from human skin and exposed them to the whole venoms of 
6 distinct, clinically relevant snake species. All were found to induce MC degranulation, as 
measured by beta-hexosaminidase and histamine release. To further assess whether the activation 
of MC leads to a detoxification of the venom, we next performed toxicity testing using zebrafish 
(Danio rerio) embryos 48 hours post fertilization. We found that human MC lysate significantly 
reduces mortality. Furthermore, the fatal effects of venom are completely neutralized by co-
incubation with purified human lung tryptase. To assess whether the observed loss of toxicity is 
due to a degradation of venom components, we analyzed the venom by mass spectrometry. This 
showed degradation of venom components in the mass range of major toxins by human MC and 
by human MC-derived tryptase. Our findings show that human skin MC are activated by and 
detoxify snake venoms, and indicate that human recombinant MC proteases may be a promising 
non-species-specific antidote to snake envenoming.
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Mast cells play a key role in host defense against lethal herpes simplex virus infection through 
TNF-α and IL-6 production
Rui Aoki1, Tatsuyoshi Kawamura1, Youichi Ogawa1, Fumi Goshima2, Yukihiro Nishiyama2, Shinji 
Shimada1 1University of Yamanashi, Yamanashi, Japan, 2Nagoya University Graduate School of 
Medicineof, Nagoya, Japan
Mast cells are not only effector cells in allergic responses, but are also initiator and regulator 
cells in both innate and adaptive immune responses. They are known as important players in 
host defense against bacteria, however, their role in viral infections is largely unknown. We have 
reported that intradermal injection with herpes simplex virus 2 (HSV-2) into mast cell deficient 
KitW/W-v mice lead to increased clinical severity and mortality with elevated levels of virus titers in 
HSV-infected skins. Moreover, the severe mortality in KitW/W-v mice was completely recovered by 
intradermal reconstitution with bone marrow-derived mast cells (BMMCs) which were derived 
from wild-type (WT), but not TNF-/- or IL-6-/-, mice. Here, we show that HSV did not directly 
induce these cytokine production, whereas supernatants from HSV-infected keratinocytes, Pam 
212, induced TNF-α and IL-6 production by BMMCs. We next examined which factor derived 
from HSV-infected keratinocytes induced TNF-α and IL-6 production by BMMCs using bloking 
antibody. IL-6 production by BMMCs was significantly blocked by neutralization of TNF-α, but 
not IL-1α, IFN-α or IFN-β, in the supernatants from HSV-infected keratinocytes. In addition, ex 
vivo HSV-specific tetramer staining assay revealed that there was no significant defference in the 
number of HSV-spesific CTLs in the draining lymph nodes between KitW/W-v and WT mice. Thus, 
our findings suggest that mast cells are involved in host defense at HSV-infected sites through 
TNF-α and IL-6 production, which may be induced by keratinocyte-derived TNF-α.
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An in vitro cell test for skin sensitizers prediction based on the analysis and integration of gene 
expression and signaling pathways activation
Bruno Neves1,2, Susana Rosa1,2, João Martins1,2, Margarida Gonçalo3, Maria Celeste Lopes1,2, 
Maria Teresa Cruz1,2 1Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal, 2Centre 
for Neuroscience and Cell Biology, Coimbra, Portugal, 3Dermatology Department, Coimbra 
University Hospital, Coimbra, Portugal
Allergic contact dermatitis, a clinical condition caused by skin exposure to a large subset of 
chemicals, is one of the commonest occupational diseases in developed countries. Nowadays, the 
sensitizing potential of chemicals is commonly assessed by using animals, however existing and 
forthcoming European legislation imposes the adoption of new alternative approaches. In this context, 
we developed an in-vitro predictive model based on the analysis and integration of changes in gene 
expression and signaling pathways activation, following dendritic cell exposure to chemicals. In a 
first step, cells were treated with a set of 4 known sensitizers and 2 non-sensitizers. The effects on 
the expression of 20 candidate genes and on the activation of MAPKs and NF-kB signaling pathways 
were analyzed by RT-PCR and Western Blot, respectively. In a second step, obtained data was used 
to construct a predictive classifier, based on linear discriminant analysis. From this analysis, the genes 
TRXR, HMOX1, NQO1 and IP-10 and the signaling pathways p38 MAPK and JNK were identified as 
good predictor variables. A classifier algorithm was developed and a large number of chemicals (an 
additional 9 sensitizers and 3 non sensitizers) were tested. From the total 18 chemicals tested, 16 were 
correctly classified representing a concordance of 88%, with a sensitivity of 86% and a specificity 
of 100%. These results indicate that the analysis of the proposed biomarkers in dendritic cell models 
could be a valuable approach for further use in an integrative test strategy towards the reduction/
substitution of animals use for skin sensitization prediction.
542
The Effect of green tea polyphenols on migration inhibitory factor-associated steroid resistance
Sun Up Noh, Chul Jong Park, Young Min Park Department Of Dermatology, Seoul St. Mary’s 
Hospital, College Of Medicine, The Catholic University Of Korea, Seoul, Republic Of Korea
Recently, evidence has been obtained to provoke inflammation through up-regulation of 
macrophage migration inhibitory factor (MIF) expression by steroids. However, little is known 
regarding the effect of steroids on MIF expression in human keratinocytes and the counter-effect 
of EGCG. We determined whether or not steroids cause the up-regulation of MIF in human 
keratinocytes, and if so, whether or not epigallocatechin-3-gallate (EGCG) suppresses MIF up-
regulation in keratinocytes by steroids. We then assessed the effects of EGCG on MIF-induced 
Th-related chemokine and cytokine expression in keratinocytes. HaCaT keratinocytes were 
first treated with dexamethasone in the presence or absence of EGCG in the culture medium. 
The keratinocytes were then treated with recombinant human (rh)-MIF in the presence or 
absence of EGCG in the culture medium. The expression of mRNA and protein in Th-related 
cytokines and chemokines, including MIF in the keratinocytes, was measured by real-time RT-
PCR, Western blotting, and ELISA. Dexamethasone significantly enhanced MIF expression in 
human keratinocytes, and EGCG significantly down-regulated the expression of dexamethasone-
induced MIF. EGCG also significantly down-regulated rh-MIF-induced expression of Th-related 
cytokines and chemokines, such as IL-6, IL-18, TGF-β, CCL17, CCL22, and CXCL10, in 
human keratinocytes.Taken together, these results demonstrated that EGCG may have a novel 
pharmacologic effect to prevent steroid-induced tachyphylaxis and inflammation by suppressing 
the expression of MIF in human keratinocytes.
543
Wnt5a inhibits maturation and interferon alpha production by human plasmacytoid dendritic 
cells
Katrin Hack1,2, Charlotte Proby1,2, Colin Fleming4,2, Irene Leigh1,2, Kathleen McLean1,2, Louise 
Reilly1,2, John Foerster3,4 1University of Dundee, College of Medicine, Dentistry, and Nursing, 
Medical Research Institute, Dundee, UK, 2Cancer Research UK Cancer Centre, Dundee, UK, 
3University of Dundee, College of Medicine, Dentistry, and Nursing, Education Division, Dundee, 
UK, 4NHS Tayside, Department of Dermatology, Dundee, UK
Malignant melanoma is a highly immunogenic tumor, many patients harbouring T cells capable 
of tumor-killing in vitro. Although many clinical vaccination trials of melanoma have shown 
impressive results in individual patients, immune evasion mechanisms by melanoma are a major 
limiting factor for immunotherapy. One immunosuppressive factor in melanoma are plasmacytoid 
dendritic cells (pDC) which are present in metastases and metastatic lymph nodes but exhibit 
anergic properties such as failure to secrete interferon alpha upon stimulation. Melanoma cells 
strongly express Wnt5a, one of the so-called non-canonical wingless-type ligands which do not 
act by beta-catenin activation. While the role of Wnt5a in melanoma motility and tissue invasion 
is well documented, its effect on pDC activation has not been studied. Here, we show that Wnt5a 
potently inhibits the upregulation of activation markers CD80 and CD86 on naïve human pDCs 
stimulated by the TLR9 agonist CpG ODN. It also inhibits the activation-independent cell size 
increase induced by CpG, consistent with its role as regulator of cytoskeleton rearrangements. 
Finally, Wnt5a blocks secretion of IFN alpha by pDC. Our results identify a novel role for 
Wnt5a in pDC regulation and suggest that it may contribute to suppression of pDC activation 
by melanoma.
544
Pathogenetic roles of Wnt ligand and Notch signaling in psoriasis
Jeong Eun Kim, Seung Hyun Bang, Sungeun Chang, Sik Haw, Chong Hyun Won, Mi Woo Lee, Jee 
Ho Choi, Kee Chan Moon Asan Medical Center, Seoul, Republic of Korea
Psoriasis is characterized by uncontrolled hyperproliferation, aberrant differentiation and dermal 
infiltration of immune cells, specifically, a Th17-subset of T cells. Recent studies have shown 
that Notch1, a determinant of keratinocyte terminal differentiation, is markedly decreased in 
psoriasis and Wnt5a signaling is increased. Our goal was to investigate the expression and 
interaction of Wnt5a and Notch signaling in psoriasis in relation to T-cell-mediated epidermal 
hyperproliferation. In this study, psoriatic skin biopsies, primary normal human keratinocytes 
(NHKs), and HaCaT cells were treated with recombinant Wnt5a (rWnt5a) or Wnt5a-conditioned 
media, and cell proliferation and the expression of Wnt5a/Notch1 signaling-related factors were 
assessed. In results, Wnt5a expression was increased and Notch1 expression was decreased 
in lesional samples compared to non-lesional samples of psoriatic and normal skin. Treatment 
with recombinant Wnt5a (rWnt5a) increased the proliferation of NHKs. Exposure of NHKs to a 
cytokine environment containing IL-1α, TNF-α, TGF-α, and IFN-γ downregulated Notch1 and 
HES1 and increased Wnt5a expression. Treatment of NHKs with rWnt5a increased the expression 
IL-23, IL-12 and TNF-α. Finally, overexpression of Wnt5a downregulated Notch1 and HES1. Our 
data strengthen the notion that Wnt5a and Notch signaling exert counteracting influences on each 
other and are involved in the central pathomechanism of psoriasis. Increased Wnt5a signaling 
and decreased Notch1 signaling may be associated with defects in terminal differentiation and 
enhanced proliferation of keratinocytes in the pathogenesis of psoriasis. Furthermore, increased 
Wnt5a may be a pathogenetic link between dermal infiltration of immune cells and abnormalities 
of keratinocytes in psoriasis.
545
An in vitro Test to Screen Skin Sensitizers Using a Stable THP-1-derived IL-8 Reporter Cell 
Line, THP-G8
Toshiya Takahashi1, Yutaka Kimura1, Rumiko Saito1, Yoshihiro Nakajima2, Yoshihiro Ohmiya2, 
Kenshi Yamasaki1, Setsuya Aiba1 1Department of Dermatology, Tohoku University Graduate 
School of Medicine, Sendai, Japan, 2Bioproduction Research Institute, National Institute of 
Advanced Industrial Science and Technology (AIST), Tsukuba, Japan
Several studies have suggested that IL-8 can serve as a biomarker to discriminate sensitizers 
from non-sensitizers. To develop a high throughput method to identify possible sensitizers, we 
established a stable THP-1-derived IL-8 reporter cell line, THP-G8, which translates SLO and 
SLR luciferase genes under the control of IL-8 and GAPDH promoters, respectively. After 6 h 
treatment with chemicals, the normalized SLO-LA (nSLO-LA) was calculated by dividing the 
SLO luciferase activity (SLO-LA) by SLR-LA, and fold induction of nSLO-LA (FInSLO-LA) was 
calculated by dividing nSLO-LA with chemical treatment by that without treatment. THP-G8 
increased nSLO-LA in response to LPS or several sensitizers. FInSLO-LA was positively correlated 
with IL-8 mRNA induction in THP-1 stimulated with LPS or sensitizers. When we examined 
the effects of 15 sensitizers and 7 non-sensitizers, THP-G8 significantly increased their nSLO-
LA (FInSLO-LA>=1.4) by 13 sensitizers as well as 5 non-sensitizers. Interestingly, pretreatment 
of N-acetylcysteine (NAC) suppressed the increase in FInSLO-LA induced by all sensitizers 
(suppression index (SI) <=0.8), while NAC did not suppress the increase in FInSLO-LA by most 
of the non-sensitizers. Then we evaluated the performance of this reporter assay with the criteria 
of sensitizers as FInSLO-LA>= 1.4 and SI<=0.8 in at least 2 of 3 independent experiments, which 
resulted in test accuracies of 82% for these 22 chemicals and 88 % for the chemicals proposed 
by Casati et al. This newly developed assay would be a candidate to replace animal tests for skin 
sensitization because of its accuracy, convenience, and high throughput performance.
546
A role for Adenosine triphosphate turnover in regulating immune responses during melanoma 
growth
Sabine Ring, Alexander Enk, Karsten Mahnke Ruprecht-Karls-University, Heidelberg, Germany
Adenosine triphosphat (ATP) is not only a universal energy carrier in cells, it has also potent 
immunostimulatory capacity. We have recently shown that regulatory T cells (Treg), which 
normally counteract immune reactions, become activated by micromolar concentrations of ATP. 
The ATP is then degraded by CD39/CD73 ectonucleotidases to immunosuppressive adenosine. 
Since tumors are metabolically active tissues and may sequester ATP, we hypothesize that 
enhanced ATP production by tumor cells may contribute to recruitment and stimulation of Treg, 
resulting in an immunosuppressive environment. When analyzing the ATP production of B16 
melanoma cells we measured significantly increased amounts of ATP as compared to fibroblasts. 
In addition, the frequency of Treg, relative to the total amount of tumor infiltrating lymphocytes, 
increased in the tumor site during tumor growth and when assessing the phenotype of the tumor 
derived Treg by FACS, we recorded upregulation of the activation marker CD69. To further disect 
the undelying mechanisms, we implanted B16 melanomas into CD73 deficient mice (CD73KO), 
which are impaired in adenosine production and showed that the growth of the tumors was 
significantly slowed down as compared to wild type mice. This effect was accompagnied by 
increased inflitration of the tumors by CD11c+ DC and CD4+ and CD8+ T cells, respectively. 
Our data suggests that the increased production of ATP by growing B16 melanoma cells may be 
responsible for recruitment and activation of Treg and adenosine production at the tumor site.
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ROS-mediated induction of the transcription factor ATF3 causes severe susceptibility to 
bacterial sepsis by suppressing IL-6
Wolfram Hoetzenecker1, Bernd Echtenacher2, Emmanuella Guenova1, Kim Kyu-Won3, Florian 
Woelbing1, Juergen Brueck1, Tilo Biedermann1, Kamran Ghoreschi1, Martin Roecken1 1University 
of Tuebingen, Tuebingen, Germany, 2University of Regensburg, Regensburg, Germany, 3Seoul 
National University, Seoul, Republic of Korea
A hallmark of sepsis is the generation of oxidative stress (ROS). Activation of the stress-sensitive negative 
transcription factor ATF3 protects against endotoxin-induced death. We found that ROS significantly 
enhances LPS-triggered ATF3 expression. In vivo, ROS stress enhanced glutathione depletion and, 
subsequently, increased LPS-induced ATF3 4-fold. Using luciferase constructs, Chip assays and Nrf2-
/- mice here we now demonstrate that the ROS-sensitive transcription factor Nrf2 binds to activating 
promoter regions of ATF3. In consequence, ROS significantly diminishes LPS-induced lethality in 
wild-type (wt). The ROS-scavenger N-acetyl-cysteine abrogated the ROS-mediated protection from 
LPS-induced death; ATF3-/- mice proved the key role of ATF3 in protecting from LPS-induced death. 
We speculated that this increased awareness of ATF3-/- mice to innate signals that sensitizes mice for 
LPS-induced death, should protect against systemic bacterial infections. To test this hypothesis we 
investigated systemic bacterial infection, using septic peritonitis (SP). At conditions where SP killed 
all wt mice within <7 days, 90% of ATF3-/- mice survived the SP. Depletion of glutathione increased 
ATF3 and further increased susceptibility of wt mice to SP. In sharp contrast, ATF3-/- resisted the 
bacterial peritonitis even after glutathione depletion. As ATF3 is a main transcriptional repressor of 
IL-6, we determine the role ATF3-mediated suppression of IL-6, analysing SP in ATF3-/- and ATF3-
/-xIL-6-/- double knock out mice. At conditions where all ATF3-/- mice survived SP, all ATF3-/-xIL-6-/- 
mice died. Being the first transcription factor that determines susceptibility to bacterial sepsis, ATF3 
thus provides a novel approach for the development of therapies against sepsis.
548
Drugs induced Herpesvirus reactivation in DRESS syndrome
Baptiste Janela1,2, Damien Picard1, Maud Vaillant1, Edmond Chua Wei Min2, Pascal Joly1, 
Sebastien Calbo1,2, Philippe Musette1 1Singapore immunology network, BMSI, A-STAR, Singapore, 
Singapore, 2INSERM U905, Rouen, France
Drug reaction with eosinophilia and systemic symptom (DRESS) is a severe drug-induced 
cutaneous reaction with visceral involvement and blood abnormalities associated with 
reactivations of herpes-virus family i.e., EBV, HHV-6, HHV-7 and CMV. Recently, we demonstrated 
that the immune response in DRESS, previously thought to be directed against drug components, 
is also mediated by herpes-virus specific cytotoxic CD8+ T lymphocytes which home to the skin 
and visceral organs We analyzed the effect of the culprit drug on EBV reactivation. An in vitro 
model based on EBV-transformed B lymphoblastoid cells lines from DRESS patients and healthy 
donors were used to study the specific effect of drugs on EBV titer. Because IL-10 modulates 
immune responses in order for herpes-virus to replicate and disseminate in the host, IL-10 was 
also quantified in serum by Elisa, intracellularly by Flow Cytometry and by Q-PCR in B-LCL and 
PBMC. Only in DRESS patients’ B-LCL, high increase of EBV production is induced by all DRESS 
inducer drugs. In addition, IL-10 is highly abundant in DRESS patients’ serum. Furthermore, IL-10 
gene transcripts are the most up-regulated cytokine transcript in patients’ PBMC. Moreover, IL-10 
is produced in vitro at high level by regulatory B cells and not by blood CD4+ T cells. Finally, 
DRESS inducer drugs up-regulate viral IL-10 gene transcripts specifically in DRESS B-LCL. Our 
results suggest a new role for drugs in the pathogenesis of DRESS and a possible key role for 
IL-10 in this disease.
549
Selective interaction between DC and Treg relies on the chemotactic activity of adenosine
Sabine Ring, Alexander Enk, Karsten Mahnke Ruprecht-Karls University, Heidelberg, Germany
Suppression of the sensitization phase of contact hypersensitivity reactions by CD4+CD25+Foxp3+ 
regulatory T-cells (Treg) is mediated by interaction between dendritic cells (DC) and Treg in the 
draining lymph nodes. To analyze why DC preferably interact with Treg but not with CD4 effector 
cells, we prepared in vitro cocultures of isolated murine Treg with bone marrow derived DC, 
or with ex vivo isolated MHC II+ DC respectively. We observed a rapid formation of aggregates 
between the cells within 2h, whereas conventional CD4+ T-cells and DC did hardly establish any 
stable contacts. Even in presence of CD4+ T-cells the formation of aggregates occurred selectively 
between Treg and DC. Analysis of the migratory behavior of the individual DC in cocultures 
with Treg or CD4+ T-cell, respectively, showed increased motility of the DC in presence of Treg 
as opposed to cocultures with CD4+ T-cells. Further analysis of the chemotactic activity of Treg 
using Boyden-chambers revealed a significantly higher migration rate of DC towards the Treg 
as compared to the migration towards conventional CD4+ T-cells or medium. Blocking the 
adenosine production of Treg via inhibition of the ectonucleotidase CD39 caused a complete 
inhibition of the chemotactic activity of Treg on DC, whereas application of adenosine to the 
Boyden-chambers reestablished the increased motility and a strong migration of DC towards 
adenosine. Our data indicate that adenosine produced by Treg acts as chemoattractant for DC 
and modulates the formation of Treg/DC aggregates, which is required for the immunosuppressive 
action exerted from Treg on DC.
550
Response of T cells from DNCB-sensitised individuals to dinitrophenylated proteins in HaCaT 
cells
Pete Boyd1, Chris Pickard1, Erika Parkinson2, Paul Skipp2, Maja Aleksic3, Peter Friedmann1, David 
O’Connor2, Eugene Healy1 1Dermatopharmacology, University of Southampton, UK, 2Centre 
for Proteomic Research, University of Southampton, UK, 3Safety and Environmental Assurance 
Centre, Unilever, Colworth, UK
Allergic contact dermatitis (ACD) arises as a result of aberrant immunological responses to small 
molecular weight chemical haptens following exposure of the skin to xenobiotics. The model hapten, 
2,4-dinitrochlorobenzene (DNCB), has been employed by various groups to investigate mechanisms 
underlying the development of ACD, but the exact antigenic peptides which DNCB generates are 
unknown. There is evidence that human serum albumin (HSA) becomes dinitrophenylated (DNP-
HSA) upon exposure to DNCB, but the primary importance of DNP-HSA in mediating ACD to 
DNCB is unclear. Although HSA is present in the extracellular fluid within the epidermis, it seems 
likely that keratinocyte related haptenated proteins might play a role in DNCB induced ACD. In 
this study, we identified that addition of 4 µM DNCB in vitro to HaCaT keratinocytes causes similar 
immunofluorescence positivity to DNP-proteins as seen when 50 µg cm-2 (equivalent to 700 µM) is 
applied epicutaneously to human skin. Immunoblotting of HaCaT cells and human skin lysates using 
anti-DNP antibodies showed similar protein banding profiles in both sets of samples. Furthermore, 
T cell proliferation assays and interferon gamma ELISpots demonstrated T cell immune responses 
by DNCB-sensitised individuals to haptenated proteins isolated from DNCB treated HaCaTs. UPLC 
and tandem mass spectrometry analysis of modified proteins isolated from HaCaTs has identified 
a number of potential hapten-associated proteins which may play a role in the immune response 
to DNCB. The data indicates that keratinocyte-related DNP-proteins are involved in immunological 
responses to DNCB in subjects who have been sensitised to this agent.
551
Non-CpG oligonucleotides trigger immune responses in keratinocytes and induce 
antiproliferative effects in hyperproliferative and malignant cell lines
Maja Natek, Monika Schäfer-Korting, Günther Weindl Institute of Pharmacy, Freie Universität 
Berlin, Berlin, Germany
CpG oligodeoxynucleotides (ODN) have been extensively studied for immunostimulatory effects 
and antitumour activity. It is widely accepted that CpG ODN trigger TLR9-mediated responses 
mainly by interacting with human B cells and plasmacytoid dendritic cells. To elucidate the role 
of epidermal TLR9 signaling in non-immune cells we stimulated normal human keratinocytes 
(NHK) as well as HaCaT and squamous cell carcinoma (SCC) cell lines with ODN2006, a 
prototype of class B ODN with a phosphorothioate (PS) backbone. CpG ODN2006 increased 
IL-8, IL-1α and TNF mRNA expression and release in NHK as analyzed by quantitative real-time 
RT-PCR and ELISA, respectively. Surprisingly, similar immune stimulatory effects were observed 
for non-CpG ODN (GpC ODN2006). ODN-induced IL-8 production was strongly reduced in 
the presence of chloroquine, an inhibitor of endosomal acidification, indicating TLR9-dependent 
cytokine responses in NHK. Furthermore, immunofluorescence and FACS analysis demonstrated 
that TLR9 was only weakly expressed in NHK but was upregulated by stimulation with PS-ODN. 
We hypothesized that PS-ODN may also have antiproliferative effects. Using MTT assay and 
BrdU labeling (ELISA), CpG and GpC ODN2006 showed only minor growth inhibitory effects 
against NHK but almost completely inhibited cell growth in HaCaT and SCC cell lines in a dose-
dependent manner. Interestingly, chloroquine did not abrogate PS-ODN-induced antiproliferative 
effects. Our data suggest that PS-ODN induce TLR9-dependent immune responses in normal 
keratinocytes whereas TLR9-independent pathways are involved in cell growth inhibition in 
hyperproliferative skin diseases.
552
Citalopram modulates allergic contact dermatitis and serotonin 2A receptor expression in mice
Husameldin El-Nour, Lars Lönnå Karolinska Institutet, Stockholm, Sweden
The aim of this study was to investigate the effect of citalopram, a selective serotonin reuptake 
inhibitor, administration on allergic contact dermatitis (ACD) in mice and its influence on 
serotonin 2A receptor (5-HT2AR) expression. Thirty two female balb/c mice were divided into 
4 groups, then 3 groups were induced with ACD, using oxazolone for sensitization (day 0) 
and challenge (days 6 and 16), while one control group was treated with the vehicle. Mice 
received morning and afternoon injections daily from day 6 to 16. Two groups were injected 
with citalopram at 1 or 2.5 mg/kg, whereas the remaining groups were administered saline. 
Pre- and post-challenge ear thickness was measured then ear samples were stained for 5-HT2AR 
expression using immunohistochemistry. Citalopram administration at 2.5 mg/kg significantly 
reduced (p<0.001) the ear thickness (mean±SD 0.34±0.01 mm) compared to 1 mg/kg (0.40±0.02) 
or saline (0.38±0.01), indicating a dose-dependent lowering of inflammation. The non-inflamed 
group had the lowest ear thickness at 0.22±0.00. 5-HT2AR expression was seen on nerve bundles 
and fibres. The numbers of positive bundles in the non-inflamed, saline, 1 mg/kg and 2.5 mg/kg 
groups were 4.3±0.9, 5.4±1.3, 4.8±1.0 and 4.6±1.3 respectively with a tendency to a decrease 
in 5-HT2AR bundle expression in citalopram-administered inflamed groups. The numbers of 
immunoreactive nerves were 2.1±0.7 nerves/section, 1.5±0.5, 1.4±0.2 and 1.1±0.1, respectively, 
indicating a diminished (p<0.01) 5-HT2AR neuronal expression at the highest concentration. Our 
findings demonstrate an anti-inflammatory effect of citalopram on murine ACD and suggest a 
down-regulating effect on 5-HT2AR peripheral expression on terminal nerves.
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TSLP-primed plasmacytoid dendritic cells induce a Th22-phenotype in Tcells
Anna Teske, Tilo Biedermann, Emmanuella Guenova Dermatology, Tuebingen, Germany
Increased numbers of the recently defined IL-22 producing Th22-cells have been identified in 
inflammatory skin lesions, including atopic dermatitis. Thymic stromal lymphopoietin (TSLP) is 
classically present in atopic inflammation; however the impact of a TSLP-dominated inflammatory 
milieu on Th22 differentiation hasn´t been analyzed till now. Since human plasmacytoid 
dendritic cells (pDC) proved to be superior to other DC subtypes in priming Th22, the phenotype 
of activated human pDC and their priming effect on naïve THcells was analyzed as a function of 
TSLP. Immature pDC were isolated from blood of healthy donors. CPG2006 activation of pDCs 
via TLR9 resulted in IL-6 and TNF production, as detected by intracytoplasmic-FACS-analysis. The 
presence of TSLP strongly and dose dependently enhanced TNF and especially IL-6 production 
in pDC. To determine functional consequences of TLSP conditioned pDCs, co-cultures of pDCs 
and Tcells were set up. TSLP treated pDCs not control DC orchestrated naïve Tcells to produce 
enhanced IL-22 and even reduced IFN-y levels upon Tcell restimulation. Th22 induction by 
pDCs could be further upregulated by adding exogenous IL-6 and/or TNF. This effect was not 
proliferation-biased, as all co-culture-conditions showed equal proliferation, as detected by H3-
thymidin incorporation. Our data provide further insight into the key role of IL-6 in the Th22-
priming and show that there is a regulatory impact of IL-6 in human pDC that is orchestrated by 
TSLP. This indirect Th22 polarizing capacity of TSLP is relevant in regard to function of TSLP in 
atopic diseases and may explain the presence of Th22 in atopic skin.
554
Toll-like receptor signalling modulates enzymes involved in sphingosine-1-phosphate 
metabolism in fibroblasts
Günther Weindl, Saghi Hamidi, Monika Schäfer-Korting Department of Pharmacology and 
Toxicology, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany
Recent evidence suggests that toll-like receptors (TLR) and sphingosine-1-phosphate (S1P) 
receptors are important regulators of inflammation, wound healing and fibrosis. S1P levels are 
tightly controlled by the action of enzymes responsible for S1P degradation (S1P phosphatases 
and S1P lyase) and synthesis (sphingosine kinases). The aim of this study was to investigate 
whether TLR signalling in normal human dermal fibroblasts affects S1P-metabolizing enzymes. 
First, cells were stimulated with TLR agonists and cytokine expression was determined 
by quantitative real-time RT-PCR and ELISA. Increased IL-6 and IL-8 levels were observed if 
fibroblasts were treated with the TLR ligands HKLM (TLR2), Pam3CSK4 (TLR2/1), poly(A:U) (TLR3), 
LPS (TLR4) or CpG ODN2006 (TLR9). TLR expression was confirmed at the mRNA and protein 
levels. Kinetic studies revealed that stimulation with TLR agonists induced S1P phosphatase 1 
(SPP1) gene expression over a period of 24h. In contrast, SPP2 mRNA was not detected and 
S1P lyase mRNA levels remained nearly constant. Interestingly, TLR signalling also slightly 
increased sphingosine kinase 1 (SphK1) mRNA levels while SphK2 expression was not altered. 
TLR9 activation resulted in increased SphK1 protein expression and secretion from fibroblasts 
as determined by immunofluorescence microscopy. Surprisingly, inhibition of SphK by N,N-
dimethylsphingosine or CAY10261, a selective inhibitor of SphK1, further increased IL-6 and IL-8 
levels after TLR9 ligation. Our results indicate that SphK1 activity serves to dampen inflammation 
in TLR-stimulated skin fibroblasts. These findings demonstrate an important novel role for 
enzymes involved in S1P metabolism in response to TLR activation.
555
IL-33 and IL-1F9 in allergic contact dermatitis: in vivo and ex vivo study
Martina Mattii, Anna Balato, Serena Lembo, Maria Schiattarella, Cataldo Patruno, Nicola Balato, 
Fabio Ayala Dermatology Dept University of Naples Federico II, Naples, Italy
IL-33 is the most recently identified IL-1 family member, detected in the nucleus of epithelial 
cells of tissues in contact with the environment. It primarily act through a Th2 pathway, but 
can also promote Th1-type responses. IL-1F9 is a pro-inflammatory IL-1 cytokine expressed in 
lymphocytes and, after Th1 cytokines stimulation, in keratinocytes. We aimed to assess the role 
of IL-33 and IL-1F9 in Allergic Contact Dermatitis (ACD). Ni2+ stimulated primary lymphocytes 
cultures, derived from Ni-allergic patients, were assessed for the production of IL-1F9 mRNA 
through qRT-PCR. Moreover, IL-33 and IL-1F9 mRNA were quantified in lesional and non 
lesional skin of 13 allergic patients and in matched healthy donors. Correlation with IL-13 and 
TNF-α levels, as positive control, was performed. To validate the “ex vivo skin organ culture” as a 
reliable model to study ACD, 3 mm punch biopsies from non lesional ACD patients skin and from 
healthy controls were cultured and stimulated by application of the positive allergen onto the 
epidermis. Our results showed that IL-1F9 was increased in allergic stimulated lymphocytes. IL-
1F9 and IL-33, were increased in allergic lesional vs non lesional skin and these increases were 
even higher when compared to healthy controls. Similarly, both interleukins were augmented in 
non lesional skin culture when compared to stimulated healthy skin culture. In conclusion ACD 
patients have basal higher expression of IL-33 and IL-1F9, which is augmented after hapten re-
exposure. Skin organ culture confirmed these results, representing a robust platform on which the 
immunological aspects of ACD can be investigated.
556
Effects of topical rapamycin versus tacrolimus in atopic dermatitis-like mouse model
Mostafa Abd El-latif, Mari Tanaka, Mari Wataya-Kaneda, Hiroyuki Murota, Ichiro Katayama 
Osaka University, Osaka, Japan
Sirolimus (Rapamycin), is a macrolide that has an immunosuppressive action similar to tacrolimus, 
and inhibited the response of T- and B-cells to IL-2. Thereby, it might be assumed that rapamycin 
has therapeutic potential in atopic dermatitis (AD) through inhibition of lymphocyte activation. 
NC/Nga mice were treated topically with 4% sodium dodecyl sulfate (SDS)/ dermatophagoides 
farinae (DF) extract ointment to induce AD like lesions, for 4 weeks, and with topical rapamycin 
(0.03%, 0.1%, and 0.2%), rapamycin vehicle or tacrolimus (TR) in the last 2 weeks. Dermatitis 
score (severity of skin inflammation) was evaluated weekly. Mice were sacrificed after 2 weeks 
of rapamycin treatment. As expected, the local rapamycin concentration was coinciding with 
concentration used with significant difference between both 0.1%, and 0.2% and 0.03% 
rapamycin. The difference in the dermatitis score before and after treatment was significant in 
0.03% treated group compared to vehicle treated group. This was associated with significant 
decrease in the mean epidermal thickness in the same group. Also there was a significant 
decrease in the dermal lymphocytic infiltrate in 0.03%, and 0.1% treated groups. However the 
differences in the serum IgE level, as well as the mast cell infiltration were not significant. The 
effects of 0.03% rapamycin treated group on the dermatitis score, and lymphocytic infiltrate 
were comparable to tacrolimus treated group and were significant with regard to the epidermal 
thickness. We conclude that topical rapamycin is effective in treatment of NC/NGA mice induced 
dermatitis. Topical rapamycin might be an effective therapeutic target for topical AD treatment.
557
The interleukin-1 family is taking more place in the pathogenesis of psoriasis: the position of 
IL-1F9
Maria Schiattarella, Anna Balato, Serena Lembo, Martina Mattii, Nicola Balato, Fabio Ayala 
Dermatology Dept University of Naples Federico II, Naples, Italy
IL-1F9 is a member of the interleukin (IL)-1 family, a growing group of proteins that plays an 
important role in immune regulation and inflammatory process. Keratinocytes have been 
reported as the predominant source of IL-1F9. A compact cluster of genes including IL-1F9 and 
some antimicrobial peptides (AMPs) have been found strongly expressed in psoriasis, induced 
by Th1 cytokines. Our aim was to clarify the role of IL-1F9 in the pathogenesis of psoriasis 
and to investigate its relationship with AMPs and vitamin D (VitD). The overall study population 
included 25 patients affected by moderate-to-severe psoriasis. Skin biopsy specimens were taken 
from uninvolved skin as well as psoriatic plaque and IL-1F9 gene expression was analyzed by 
qRT-PCR. HaCaT cells and primary keratinocytes were stimulated with VitD, TNF-α and IL-17; 
thereafter IL-1F9, defensin beta 4 (HBD2) and cathelicidin LL37 gene expression was quantified. 
IL-1F9 was significantly increased in psoriatic lesions of all 25 patients. From in vitro experiments 
we found that IL17 was able to induce HBD2 and LL-37, as well as IL-1F9. High synergism was 
detected between IL-17 and TNF-α in inducing IL-1F9; on the other hand, the addition of VitD 
was able to neutralize the effect of the single cytokines.Experimental results confirm that IL-1F9 is 
enhanced in psoriasis and in cell culture stimulated with typical psoriatic cytokines. VitD seems 
to inhibit this proinflammatory effect modulating also AMPs production. To clarify the role of 
these molecules, involved in inflammation and defence, could improve psoriasis pathogenesis 
understanding.
558
IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors
Terhi Savinko1, Sampsa Matikainen1, Ulpu Saarialho-Kere2, Maili Lehto1, Guoying Wang3, 
Lehtimäki Sari1, Henrik Wolff1, Antti Lauerma1,4, Harri Alenius1 1Finnish Institute of Occupational 
Health, Helsinki, Finland, 2University of Helsinki, Helsinki, Finland, 3Qingdao University Medical 
College, Qingdao, China, 4University of Tampere, Tampere, Finland
T helper type 2 cytokines are predominantly expressed in acute skin lesions of patients with 
atopic dermatitis. IL-33 is a novel tissue-derived cytokine which is mainly expressed by cells of 
barrier tissues and known to activate Th2 lymphocytes, mast cells and eosinophils. IL-33 signals 
through a receptor complex consisting of IL-33 specific receptor ST2 and a co-receptor IL-1RAcP. 
Since IL-33 is known to promote Th2-type immunity we examined expression profiles of IL-33 
and its receptor components in human AD skin, in the murine model of AD and in cell models 
relevant for atopic skin inflammation. We found increased expression of IL-33 and ST2 in AD skin 
after allergen or SEB-exposure. In addition, skin fibroblasts and keratinocytes efficiently produced 
IL-33 in response to the combined stimulation of TNFα and IFNγ, which was further enhanced 
by a mimetic of double-stranded RNA. Finally, the increased expression of IL-33 and ST2 caused 
by irritant, scratching, allergen or SEB-challenge was strongly suppressed by topical tacrolimus 
treatment. These results suggest an important role for IL-33-ST2 interaction in AD and emphasize 
that bacterial and viral infections may increase the production of IL-33.
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A possible new role for IL-33 in understanding the biology of psoriasis
Anna Balato1, Serena Lembo1, Martina Mattii1, Maria Schiattarella1, Amato De Paulis2, Nicola 
Balato1, Fabio Ayala1 1Dermatology Dept University of Naples Federico II, Naples, Italy, 2Clinical 
Immunology and Allergy Dept University of Naples Federico II, Naples, Italy
IL-33 is a pro-inflammatory cytokine recently identified as a ligand for the orphan receptor 
ST2. IL-33 constitutive nuclear expression has been found in cells of tissues exposed to the 
environment. Moreover endothelial cells have been shown to abundantly express IL-33. Many 
of the inflammatory effects of IL-33 define its ability to induce Th2-type mediated responses 
but recently IL-33 was found to have a pro-inflammatory role in arthritis, which is Th1 and/or 
Th17 mediated. It can be hypothesized that IL-33 has a pro-inflammatory role in psoriasis too. 
In the present study we aimed to assess the role of IL-33 in psoriasis, investigating its property to 
promote inflammation via MC and KC activation. Here we report that IL-33 is elevated in the skin 
of psoriasis patients. Furthermore, IL-33 upregulates IL-4 and IL-13 and is able to induce a higher 
increase of MCP-1 and VEGF respect to TNF-α in MCs. In presence of TNF-α, IL-33 induces 
MCP-1 and IL-6, whereas in association with IL-17, is able to induce IL-20 in KCs. In conclusion, 
our study provides evidence that IL-33 is involved in psoriasis biology. Furthermore, our results 
reinforce the IL-33 activity in driving Th1 response too, contributing to the maintenance of 
psoriasis pathogenesis.
560
Effects of Apremilast on Innate and Adaptive Immune Responses
Peter Schafer Celgene Corporation, Summit, NJ, USA
Apremilast (APR) is a novel, orally available small molecule that specifically inhibits 
phosphodiesterase 4. APR is known to inhibit innate immune responses, such as bacterial 
endotoxin-induced systemic TNF-α production, and natural killer cell-driven psoriasiform disease 
in murine models. The ability of APR to modulate adaptive immune responses was investigated 
using the ovalbumin (OVA)-specific transgenic T cell and hen egg lysozyme (HEL)-specific 
transgenic B cell transfer murine model. IgHb mice were injected with KJ+ T cells and MD4+ B 
cells, then immunized with OVA-HEL. APR (5 mg/kg/day p.o.) did not affect clonal expansion 
of either T or B cells. In transgenic T cells, APR did not significantly alter the upregulation of 
CD25 and CD69 but did inhibit the decrease in CD62L expression. APR also did not inhibit 
upregulation of CD40, CD86 and MHCII on transgenic B cells. Following restimulation of 
lymphocytes with OVA on Day 10, APR did not affect T cell proliferation or IFN-γ production. 
Production of OVA-specific IgG1, OVA-specific IgG2a, or HEL-specific IgMa was also not 
affected by APR. In conclusion, apremilast did not prevent adaptive T nor B cell clonal expansion 
or production of antibodies in vivo, but did prevent the decrease of CD62L decrease on T cells, a 
marker of effector memory transition. Overall, the effects of APR on adaptive immunity appear to 
be minor, especially in comparison to the suppression of innate immune responses.
561
Toll-like receptor-7 polymorphism and susceptibility to non melanoma skin cancer
Franco Bassetto1, Matteo Stocco1, Anna Belloni-Fortina2, Anna Michelotto2, Mauro Alaibac2 1Unit 
of Plastic Surgery, University of Padua, Padua, Italy, 2Unit of Dermatology, University of Padua, 
Padua, Italy
Toll-like receptors are a family of pattern recognition receptors that play a key role in the innate 
immune response. Toll-like receptor proteins can be implicated in immunological mechanisms 
involved in the anti-tumor response. Moreover, several toll-like receptor polymorphisms have 
been associated with an increase risk for developing neoplastic diseases. The aim of this study 
was to investigate a possible association of toll-like receptor-7 polymorphism and the occurrence 
of non-melanoma skin cancer. One hundred four patients with non-melanoma skin cancer were 
examined for Gln11Leu polymorphism on toll-like receptor 7 using a real-time TaqMan PCR 
system. These patients were compared to one hundred six healthy controls. No evidence of 
association was observed between Gln11Leu polymorphism on toll-like receptor 7 and the risk of 
non-melanoma skin cancer. Our results indicate that the above-mentioned polymorphism does 
not play a major role in non-melanoma skin cancer susceptibility. Future studies in other toll-like 
receptors polymorphisms will permit a more accurate assessment of the role of these receptors 
in non melanoma skin cancer.
562
Demodex mites induce TLR2 mRNA expression in keratinocytes in vitro
Noreen Lacey, Frank.C Powell University College Dublin/Regional Centre of Dermatology, Mater 
Misericordiae University Hospital, Dublin, Ireland
New insights to the pathophysiology of rosacea have emerged in recent years. Studies have shown 
a role for an aberrant innate immune response in the development of rosacea symptoms. The role 
for Demodex mites to induce such features remains unclear. The purpose of this study was to 
co-culture live Demodex mites with normal human keratinocytes to evaluate their potential as 
a cell stimulant. Live Demodex mites (n= 10) were extracted by gentle manipulation from skin 
surface biopsies by fine forceps under a stereomicroscope (X90). Mites were washed in sterile 
PBS before addition to normal human keratinocytes (NHEK) and co-cultured for 24 hr and 36 
hr. The response to live Demodex mite stimulation by NHEK was assessed on a gene and protein 
expression level. A high percentage of Demodex mites remained alive and active in culture at 
36hr. No significant change in mRNA levels for CAMP, KLK5, IL8 were found at either time point. 
However TLR2 mRNA expression was increased 10 fold in comparison to non treated control 
cells at 24hr and corresponded with Demodex viability. This indicates that live Demodex mites 
have the potential to induce TLR2 expression which may mediate the inflammatory response and 
symptoms associated with rosacea.
563
IL-17C is overexpressed in psoriasis lesions and contributes to cytokine-driven inflammation
Cynthia Chen1, Paul Al-Attar1, Wen Fu2, Candace Loyd2, Andrew Guzman1, Xianying Xing1, 
Marybeth Riblett1, Nicole Ward2, Johann Gudjonsson1, Andrew Johnston1 1Dermatology 
Department, University of Michigan, Ann Arbor, Michigan, USA, 2Dermatololgy, Case Western 
Reserve University, Cleveland, Ohio, USA
Interleukin (IL)-17C is a novel IL-17 family member: it shares 26% homology with IL-17A but 
utilizes a novel receptor (IL17RE) and is functionally distinct. Given the pro-inflammatory nature 
of IL-17A, we evaluated IL-17 family expression in psoriasis skin by QRT-PCR. IL-17C was the 
most strongly upregulated(30-fold, p<0.01) transcript in lesional psoriatic(PP) versus normal 
(NN) skin with IL-17C>17A>17F>17E>17B>17D, and IL-17C was increased 5-fold(p<0.04) 
in PP skin versus uninvolved(PN) skin by ELISA. IL-17C was one of the first transcripts to be 
significantly decreased during effective treatment of psoriasis with the anti-TNF-α agent 
etanercept(n=8,p=0.0181). Using normal human keratinocytes (NHK) we determined that IL-
17C is significantly induced by IL-1α, IL-17A or TNF-α (14-, 160-, and 14-fold respectively, all 
p<0.02). IL-17RE was expressed by human epidermis and dermal endothelial cells, and in the 
presence of sub-threshold TNF-α, IL-17C dose-dependently induced DEFB4, CCL20 and IL-1F9 
mRNA by NHK, and robust expression of TNF-α, IL-1β, IL-6 and IL-8 by cultured human dermal 
endothelial cells. As IL-17C was overexpressed in lesional psoriasis skin and is implicated in 
skin inflammation, we expressed murine IL-17C in basal mouse epidermal keratinocytes using 
an inducible K5-tTA/Tetos-Il17c system. By three months of age, bitransgenic mice showed 
dramatically elevated (10,000-fold) expression of Il17c mRNA, had erythema and scaling 
at sites of injury and histologically demonstrated acanthosis of non-injured skin and robustly 
increased dermal angiogenesis. Our results suggest that IL-17C may be part of a positive feedback 
loop involving TNF-α, keratinocytes and the vascular endothelium has an important role in 
maintaining inflammation in psoriatic lesions.
564
Human Toll-like receptor 4: A crucial receptor for the development of contact eczema to metal 
haptens
Marc Schmidt1, Badrinarayanan Raghavan1, Müller Verena1, Thomas Vogl2, György Fejer3, 
Sandrine Tchaptchet3, Simone Keck3, Christoph Kalis3, Peter Nielsen3, Chris Galanos3, Johannes 
Roth2, Arne Skerra4, Stefan F. Martin5, Marina A. Freudenberg3, Matthias Goebeler1 1University 
of Giessen, Department of Dermatology, Giessen, Germany, 2University of Münster, Institute 
of Immunology, Münster, Germany, 3Max-Planck-Institute of Immunobiology and Epigenetics, 
Freiburg, Germany, 4Technical University Munich, Munich Center of Integrated Protein Science 
and Chair for Biological Chemistry, Weihenstephan/Munich, Germany, 5University Medical 
Center Freiburg, Allergy Research Group, Department of Dermatology, Freiburg, Germany
Hypersensitivity reactions to nickel and cobalt are among the most frequent causes of contact 
hypersensitivity (CHS) in industrialized countries. Both a T-lymphocyte-specific as well as a 
proinflammatory signal are required for efficient development of CHS. Yet, the molecular mechanisms 
underlying the generation of this co-stimulatory signal are only partially understood. Moreover, it is 
unclear why - in contrast to humans - mice require co-administration of adjuvants to generate CHS to 
these metal haptens. We here demonstrate that both nickel and cobalt induce an inflammatory response 
via direct activation of human Toll-like receptor-4 (hTLR4), resulting in NF-kappa B-dependent gene 
expression. Remarkably, activation of TLR4 by nickel and cobalt is species-specific since mouse TLR4 
(mTLR4) is incapable to generate such a response. Studies with mutant hTLR4 proteins revealed a 
requirement of the non-conserved histidines 456 and 458 of hTLR4 for activation by nickel or cobalt but 
not by the natural TLR4 ligand LPS. Accordingly, transgenic hTLR4 expression in mTLR4-/- mice allowed 
efficient sensitization and elicitation of contact eczema. Altogether, our results reveal hTLR4 as crucial 
receptor for nickel and cobalt that is required for generating a proinflammatory signal. We furthermore 
provide a mouse model of contact allergy to these metal haptens that is not requiring additional adjuvants 
and thus is more closely resembling the human situation. Our data describe for the first time the molecular 
basis of co-stimulation for these important contact allergens and implicate site-specific hTLR4 inhibition 
as potential strategy for therapeutic intervention without affecting vital immune responses.
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Percutaneous transduction of heat shock protein70 attenuates contact hypersensitivity: Possible 
anti-oxidative effects of heat shock protein70
Do-Young Kim*1, Jeong Hwan Je*2, Dashlkhumbe Byamba1, Dong Hyun Kim3, Sang-Kyou Lee4, 
Tae-Gyun Kim1, Min-Geol Lee1 1Department of Dermatology and Cutaneous Biology Research 
Institute, Yonsei University College of Medicine, Seoul, Republic of Korea, 2National Academy of 
Agricultural Science, Rural Development Adminstration, Suwon, Republic of Korea, 3Department 
of Dermatology, CHA University College of Medicine, Seongnam, Republic of Korea, 4Department 
of Biotechnology, College of Engineering, Yonsei University, Seoul, Republic of Korea
Reactive oxygen species (ROS) are produced by dendritic cells (DCs) during antigen presentation in 
contact hypersensitivity (CHS). ROS cause a number of non-enzymatic protein modifications, such 
as carbonylation. Proteins that are carbonylated in DCs in response to hapten have not been fully 
indentified yet. To investigate the ROS-induced protein carbonylation, murine epidermis-derived 
dendritic cell line XS106 was challenged with a hapten, 2,4,6-trinitrobenzene sulfonic acid (TNBS). 
Among the carbonylated proteins induced by TNBS, heat shock protein70 (HSP70), an important 
subset of cell stress proteins, was identified by MALDI-TOF analysis. To verify the role of HSP70 in 
TNBS-treated XS106 cell, we fused protein transduction domain (PTD) to HSP70 to facilitate protein 
delivery into the cell. The fusion protein PTD-HSP70 successfully entered cells and caused transient 
increase of the cellular level of HSP70. Transient increase of HSP70 level in XS-106 DCs resulted in 
inhibition of ROS production, carbonylation of HSP70, p38 MAPK activation, and subsequently IL-12 
secretion. To check the effects of PTD-HSP70 in vivo, ear swelling experiments with 2,4,6-trinitro-1-
chlorobenzene (TNCB) were performed in BALB/c mice. Pretreatment of PTD-HSP70 reduced the CHS 
response to TNCB in vivo. In this work, we have found that carbonylation of HSP70 by ROS is related to 
the pathogenesis of CHS. These findings suggest that HSP70-targeting therapy may be effective in CHS. 
*The first two authors equally contributed to this work.
566
Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance 
to psoriasis treatment
Tae-Gyun Kim, Dashlkhumbe Byamba, Wen Hao Wu, Do-Young Kim, Min-Geol Lee Department 
of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, 
Seoul, Republic of Korea
Psoriasis is a chronic IL-23/Th17 pathway-associated skin disease. An increased expression of 
CCL20 in psoriatic plaques can recruit CCR6-expressing cells, such as Th17, into the lesions and 
lesional cytokine milieu persistently activates keratinocytes to produce CCL20. Lipid-lowering 
drugs, statins, possess various immune-modulating functions; however, there possible inhibitory 
effects on CCL20/CCR6 interaction are currently unknown. In this study, we explored whether 
specific types of statins could inhibit CCL20 production in HaCaT cells. We also investigated 
whether statins could attenuate the chemotactic migration of CD4+ T cells toward CCL20. We 
demonstrated that IL-1β, TNF-α, and IL-17A significantly increased CCL20 production from 
HaCaT cells in a dose-dependent manner. However, these increments were significantly inhibited 
by the addition of fluvastatin and simvastatin, but not by pravastatin. In the in vitro chemotaxis 
migration assay, pretreatment with fluvastatin and simvastatin, but not with pravastatin, inhibited 
the chemotactic migration of human CD4+ T cells toward CCL20. However, the level of surface 
expression of CCR6 on memory CD4+ T cells was not altered by statins. Our results suggest 
that not all, but specific types of statins may be of benefit in alleviating psoriasis partially via 
interrupting the chemotactic interaction between CCL20/CCR6, the mechanism which may 
eventually lessen the infiltration of Th17 cells.
567
Treatment of endotoxin-mediated shock and Pseudomonas aeruginosa sepsis with thrombin-
derived host defense peptides
Martina Kalle1, Praveen Papareddy1, Gopinath Kasetty1, Matthias Mörgelin2, Victoria Rydengård1, 
Martin Malmsten3, Barbara Albiger1, Artur Schmidtchen1 1Division of Dermatology and 
Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden, 
2Division of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical 
Center, Lund, Sweden, 3Department of Pharmacy, Uppsala University, Uppsala, Sweden
Systemic infections leading to sepsis and septic shock are a major cause of mortality in intensive 
health care units. Gram-negative sepsis is accompanied by an overactivated innate immune 
response as well as excessive coagulation mainly induced by endotoxins released from the 
bacteria. Due to rising antibiotic resistance and current lack of effective treatments there is an 
urgent need for new therapies. We have previously shown that thrombin-derived antimicrobial 
and anti-inflammatory peptides are found in human wounds. The aim of the present study 
was to explore the immunomodulatory effects and therapeutic potential of the thrombin-
derived C-terminal peptides GKY25 (GKYGFYTHVFRLKKWIQKVIDQFGE) and the related 
HVF18 (HVFRLKKWIQKVIDQFGE) in regard to endotoxin-mediated shock and Pseudomonas 
aeruginosa sepsis. Both peptides abrogate endotoxin effects in vitro and in vivo. In human blood 
they interfere with coagulation by modulating tissue factor-mediated clotting. Furthermore, in a 
mouse model of Pseudomonas aeruginosa sepsis, treatment with GKY25 leads to reduction of 
the inflammatory response, as well as decreased organ damage and reduced mortality. Taken 
together, the ability of these peptides to modulate both inflammation as well as coagulation 
makes them attractive therapeutic candidates in the development of novel treatments for sepsis.
568
The C-terminal sequence of several human serine proteases encodes host defense functions
Gopinath Kasetty1, Praveen Papareddy1, Martina Kalle1, Victoria Rydengård1, Björn Walse2, Bo 
Svensson2, Matthias Mörgelin3, Martin Malmsten4, Artur Schmidtchen1 1Division of Dermatology 
and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden, 2SARomics 
AB, Lund, Sweden, 3Division of Infection Medicine, Department of Clinical Sciences, Lund 
University, Lund, Sweden, 4Department of Pharmacy, Uppsala University, Uppsala, Sweden
Serine proteases of the S1 family have maintained a common structure over an evolutionary 
span of more than one billion years, and evolved a variety of substrate specificities and diverse 
biological roles, involving digestion and degradation, blood clotting, fibrinolysis, and epithelial 
homeostasis. We here show that a wide range of C-terminal peptide sequences of serine 
proteases, particularly from the coagulation and kallikrein systems, share characteristics common 
with classical antimicrobial peptides of innate immunity. Under physiological conditions, these 
peptides exert antimicrobial effects as well as immunomodulatory functions, by inhibiting 
macrophage responses to bacterial lipopolysaccharide. In mice, selected peptides are protective 
against lipopolysaccharide-induced shock. Moreover, these S1-derived host defense peptides 
exhibit helical structures upon binding to lipopolysaccharide, and also permeabilize liposomes. 
The results uncover new and fundamental aspects on host-defense functions of serine proteases 
present particularly in blood and epithelia, and provide tools for the identification of host defense 
molecules of therapeutic interest.
569
Modulation of innate tetherin antiviral activity in mature Dendritic Cells can restrict HIV 
replication and transfer
Fabien Blanchet1,2, Romaine Stalder2, Martin Lehmann2, Laura Rio2, Bastien Mangeat1,2, Vincent 
Piguet1,2 1Cardiff University School of Medicine and University Hospital of Wales, Cardiff, UK, 
2University Hospital and Medical School of Geneva, Geneva, Switzerland
Dendritic cells (DC) located at mucosal surfaces are among the first immune cells to encounter 
disseminating pathogens. The restriction factor Tetherin (also known as CD317, BST-2 or 
HM1.24) has been shown to potently restrict HIV-1 release by retaining viral particles at the 
cell surface. We report here that basal Tetherin expression in Myeloid (MyDC) and Monocyte-
Derived DC was upregulated by IFN-α treatment. In contrast to Hela or 293T cells, infectious 
viral release in DC was only modestly affected in the absence of Vpu compared to wild-type 
viruses. Strikingly, immunofluorescence analysis revealed that Tetherin was excluded from HIV-
containing Tetraspanin-Enriched Microdomain (TEM) even when cells were pre-treated with 
IFN-α. In contrast, in LPS-mediated mature DC, there was a dramatic tetherin relocalization 
to the TEM in mature DC. LPS-induced localization of Tetherin in TEM was correlated with an 
increase in restriction of DC-mediated HIV-DVpu transfer to CD4+ T cells. In conclusion, we 
unravel that HIV replication in DC and spread toward target T cells by-pass tetherin restriction 
due to viral trafficking via Tetherin-Excluded Microdomains. This lack of tetherin restriction could 
however be overcome with TLR4 agonists restoring an efficient Tetherin-mediated innate antiviral 
restriction.
570
Involvement of protease and proteinase-activated receptor 2 in dermatophyte-associated itch
Takako Yamakoshi1, Tsugunobu Andoh2, Yusuke Takayama2, Jung-Bum Lee3, Ayako Sano4, 
Tadamichi Shimizu1, Yasushi Kuraishi2 1Department of Dermatology,Graduate School of 
Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2Department of 
Applied Pharmacology,Graduate School of Medicine and Pharmaceutical Sciences, University 
of Toyama, Toyama, Japan, 3Department of Pharmacognosy, Graduate School of Medicine and 
Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 4Graduate School of Agriculture, 
University of the Ryukyus, Okinawa, Japan
Infection with dermatophytes causes severe pruritus that is resistant to H1 histamine receptor 
antagonists. In the present study, we investigated the involvement of protease and proteinase-
activated receptor 2 (PAR2) in dermatophyte-induced itch. Male ICR mice were used. An 
intradermal injection of an extract of Arthroderma vanbreuseghemii (E-ADVG), which had been 
isolated from the Norway rat and is genetically a member of Trichophyton mentagrophytes, 
induced scratching by the hind paw, an itch-related behavior, but heat-treated extract did not 
elicit scratching. E-ADVG-induced scratching was inhibited by the m-opioid receptor antagonist 
naltorexone, the serine proteinase inhibitor nafamostat mesilate, and the PAR2 antagonist Phe-
Ser-Leu-Leu-Arg-Tyr-NH2, but not by the H1 histamine receptor antagonist terfenadine. The 
analysis using zymography and specific substrate revealed serine proteinase activity in E-ADVG. 
The proteolytic cleavage within the extracellular N-terminus of PAR2 exposes receptor-activating 
N-terminal sequence that serves as a tethered ligand for the receptor. In line with this mechanism, 
E-ADVG cleaved a synthetic N-terminal peptide of PAR2. The present results raise the possibility 
that dermatophytosis-associated pruritus is mediated by dermatophyte-secreted proteinases, 
which activate PAR2 in keratinocytes and primary afferents.
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HTLV-1 oncogene tax regulates programmed cell death-1 expression in apoptosis via PI3K/Akt 
signaling pathway
Takatoshi Shimauchi1,2, Jun-ichi Sakabe1,2, Yu Sawada2, Motonobu Nakamura2, Yoshiki Tokura1 
1Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan, 
2Department of Dermatology, University of Occupational and Environmental Health, Japan, 
Kitakyusyu, Japan
Programmed cell death-1 (PD-1) and its ligands pathway contribute directly to T-cell dysfunction. 
On the other hand, PD-1 is an activation or apoptotic marker. We have previously found that 
PD-1 was highly expressed on CD4+ neoplastic cells in adult T-cell leukemia lymphoma (ATLL), 
which is caused by human T-lymphotropic virus type 1 (HTLV-1). However, the mechanisms 
of the regulation of PD-1 by HTLV-1 oncogene Tax remian unclear. We examined JPX-9 cells, 
expressing Tax under the control of Cd2+ inducible promotor, and three HTLV-1 infected cell 
lines (MT-1, MT-2, and HUT102). Flow cytometric analysis revealed that the Tax-expressing JPX-
9 cells showed higher expression levels of PD-1, apoptosis, and caspase-3 by UVB irradiation 
than the Tax-non-expressing cells. In contrast, Tax-expressing HTLV-1 infected cell lines, MT-2 
and HUT102, could not respond to UVB and expressed low levels of PD-1 compared to Tax-
non-expressing MT-1. By RT-PCR, MT-2 and HUT102 overexpressed cyclin-dependent kinase 
inhibitor 1A (CDKN1A/p21waf1/clip1) and had a defect in bcl-2. Tax promotes Akt phosphorylation by 
directly binding to PI3K, and activation of PI3K/Akt signaling contributes to the phosphorylation 
of CDKN1A, leading to the anti-apoptosis in HTLV-1 infected cell lines. To determine whether the 
blockade of Akt signaling induces apoptosis and PD-1 expression, we treated MT-2 and HUT102 
with a PI3K/Akt inhibitor, LY294002. In HUT102, LY294002 treatment augmented UVB-induced 
apoptosis and PD-1 expression. These findings suggest that PD-1 expression was regulated by Tax 
through the Akt/PI3K signaling pathway.
572
Synthetic lipopeptides as potential tool to fight biofilm related staphylococcal skin infections
Malgorzata Dawgul1, Wioletta Baranska-Rybak2, Dawid Ignatowicz3, Wojciech Kamysz1 1Faculty 
of Pharmacy Medical University of Gdansk, Gdansk, pomorskie, Poland, 2Faculty of Medicine 
Medical University of Gdansk, Gdansk, pomorskie, Poland, 3Polpharma SA, Starogard Gdanski, 
pomorskie, Poland
Staphylococcal skin infections constitute a significant problem of current dermatology. General 
overuse of broad spectrum antibiotics induces the development of resistant strains. Moreover 
complications of therapy are caused by growth of staphylococcal biofilm, characterized 
by strong resistance to antibiotics. It creates an urgent need to search for alternative to 
conventional therapy. Short synthetic lipopeptides seem to be interesting candidates as they 
exhibit antimicrobial activity against broad spectrum of bacteria and are designed basing on the 
structure of antimicrobial peptides (AMPs). AMPs are natural antimicrobial agents active found 
in all living organisms as essential part of their innate immune system. Mechanism of action is 
based on the lysis of microbial cell membrane. Lack of specific cell target allows expecting low 
risk of the resistance development. The purpose of this study was to synthesize a group of short 
cationic lipopeptides similar in structure to AMPs, but instead of amino acid hydrophobic region, 
containing fatty acid, and to evaluate their antistaphylococcal activity. We have investigated 
6 lipopeptides containing residues of arginine, glycine and lysine combined with palmitic 
fatty acid. 30 clinical strains were isolated from patients with diagnosed staphylococcal skin 
infections. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration 
(MBC) were measured for lipopeptides and conventional antimicrobials. Effectiveness against 
staphylococcal biofilm was determined on structures formed on polystyrene surfaces. Maturity 
of the structures has shown well-defined influence on the antimicrobial activity of conventional 
antimicrobials. Lipopeptides turned out to be very promising agents as the time of culture didn’t 
affect their activity so intensely.
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Mast cells mediate T cell responses in lymphocytic choriomeningitis virus skin infection in mice
Frank Siebenhaar1,2, Ulrich H. von Andrian2, Marcus Maurer1 1Department of Dermatologie and 
Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Department of Pathology, Harvard 
Medical School, Boston, MA, Germany
Mast cells (MCs) have been reported to contribute to the immune response elicited by viral 
infections, most likely though activation of Toll-like receptors (TLR) to produce proinflammatory 
cytokines and chemokines, and have also been shown to regulate CD8+ T-cell activities via TLR-3 
stimulation in vitro and in vivo. Here, we investigate the ability of MCs to mediate lymphocytic 
choriomeningitis virus (LCMV) skin infection by regulating CD8+ T-cell recruitment via LTB4 to 
the site of infection and promoting antigen-specific CD8+ T-cell responses against viral epitopes. 
MC-deficient KitW-sh/KitW-sh mice that have been intracutaneously infected with LCMV (5x104 pfu) 
exhibited decreased inflammatory response as compared to normal Kit+/+ or MC-reconstituted 
KitW-sh/KitW-sh mice assessed by measurement of ear thickness. Ear thickening after LCMV infection 
was accompanied by the recruitment of CD8+ T-cells, whereas the treatment of mice with the 
5-lipooxigenase inhibitor BW A4C, which inhibits the synthesis of LTB4, significantly reduced the 
number of infiltrating CD8+ T-cells at the site of infection as assessed by FACS analyses, which 
resulted in decreased ear thickness to the level of MC-deficient KitW-sh/KitW-sh mice. The expansion 
of antigen-specific CD8+ T-cells was diminished in the absence of MCs assessed by tetramer 
staining and re-stimulation of lymph node-derived cells by the LCMV epitope gp33 resulted 
in a dramatic reduction of IFNγ production by CD8+ T-cells in KitW-sh/KitW-sh mice as compared 
to normal Kit+/+ or MC-reconstituted KitW-sh/KitW-sh mice. These results demonstrate that MCs 
crucially contribute to host anti-viral immune response and provide further insights into MC-
driven modulation of adaptive immunity.
574
Development of a burn wound infection skin model for assessment of the effects of new 
experimental treatment options
Elisabeth Haisma, Marion Rietveld, Anna de Breij, Peter Nibbering, Abdoelwaheb El Ghalbzouri 
LUMC, Leiden, The Netherlands
Burn wound infections are often difficult to treat with antibiotics due to the presence of antibiotic 
resistant strains and biofilm formation. The aim of this study was to develop a three-dimensional 
burn wound infection skin model with methicillin resistant Staphylococcus aureus (MRSA) 
for analyzing the effects of experimental agents. For this purpose, full thickness wounds were 
introduced by a short application of liquid nitrogen onto the skin equivalents. In response to 
thermal wounding the hyperproliferation-associated keratin 16 and keratin 17 were up-regulated. 
Inoculation of wounded skin constructs with MRSA showed that the bacterial counts increased 
in time and maximum counts of 1 x 107 colony forming units were seen after 48 hours; equal 
counts for planktonic and biofilm associated bacteria. In response to infection, intact human skin 
equivalents enhance the expression of pro-inflammatory cytokines IL-6 and IL-8. In addition, the 
antimicrobial peptides hBD-2 and hBD-3 were also up-regulated in these models. Interestingly, in 
thermally injured skin equivalents MRSA enhanced the expression of the antimicrobial peptides, 
but not of IL-6 and IL-8. This may be explained by a decreased expression of toll-like receptor 
3 after thermal injury. Furthermore, treatment of human skin equivalents with a synthetic LL-37 
derived antimicrobial peptide leads a reduction in both planktonic and biofilm associated bacteria. 
In conclusion, this human burn wound infection model is useful for the assessment of the 
effects of experimental agents to combat bacterial infections. Such experimental agents may be 
instrumental in wound infection control in burn patients.
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Erythema Multiforme-like Secondary Syphilis in HIV-positive Patients: Report of Two Cases and 
Possible Pathogenic Mechanism
Chao-Kai Hsu1,2, Meng-Chi Wu1, Julia Yu-Yun Lee1, Sheau-Chiou Chao1, Wen-Chien Ko3, Hamm-
Min Sheu1 1Department of Dermatology, National Cheng Kung University College of Medicine 
and Hospital, Tainan, Taiwan, 2Institute of Clinical Medicine, National Cheng Kung University 
College of Medicine and Hospital, Tainan, Taiwan, 3Department of Internal Medicine, National 
Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan
Erythema multiforme (EM) often occurs in association with various drugs or infections, most 
commonly herpes simplex virus. Syphilis-associated EM, and in particular, secondary syphilis 
manifesting spirochete-positive EM skin lesions, appears very rare. We report two young men 
presenting a generalized erythematous papules or plaques with targetoid morphology on the 
trunk and proximal extremities. In both patients, skin biopsy of a targetoid lesion revealed changes 
consistent with EM. Spirochetes were demonstrated by immunohistochemistry in the EM specimens. 
Moreover, PCR study of EM-like skin tissue detected Treponema pallidum polA. Secondary syphilis 
and HIV infection were confirmed by positive syphilis serology and positive HIV antibody. Their 
CD4 counts were 209/mL and 370/mL, respectively. To understand the mechanism involved in 
the pathogenesis of secondary syphilis manifesting EM type lesion, we analyzed the CD4/CD8 
ratio by immunohistochemistry in biopsy specimens of secondary syphilis from 3 groups: EM type 
lesions in HIV(+) patients (n=2), and ordinary maculopapular lesions in HIV(+) patients (n=7) and in 
HIV(-) patients (n=4). CD4/CD8 ratio were 0.25±0.01, 1.11±0.29, and 1.73±0.18, respectively for 
groups 1, 2 and 3. Group 1 had the smallest ratio and the difference between groups 1 and 3 was 
statistically significant (Student’s t test, p=0.0054). The results suggested that certain change of T-cell 
subpopulations caused by HIV infection might lead to altered immune response to Treponema 
pallidum in secondary syphilis skin lesions, resulting in an EM type of tissue reaction.
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Evaluation of systemic immune responses against cutaneous wart-associated alpha-
Papillomaviruses in solid organ transplant recipients
Sonja Textor2, Maria R. Becker1,3, Tilo Senger4, Tim Waterboer4, Andreas Kaufmann5, Caner Süsal6, 
Alexander H. Enk1, Lutz Gissmann4, Anke S. Lonsdorf1 1Dept of Dermatology, Ruprecht-Karls-
University of Heidelberg, Germany, 2Innate Immunity, German Cancer Research Center (DKFZ), 
Heidelberg, 3Dermatology Branch, National Cancer Institutes (NCI), National Institutes of Health 
(NIH), Bethesda, USA, 4Infection & Cancer Program, German Cancer Research Center (DKFZ), 
Heidelberg, Germany, 5Clinic for Gynecology, Campus Mitte & Benjamin Franklin, Charité-
Universitaetsmedizin, Berlin, Germany, 6Department of Transplantation Immunology, Ruprecht-
Karls University of Heidelberg, Germany
Cutaneous Human Papillomaviruses (cHPVs), predominantly of genus alpha species 4 (HPV2, 27, 57) and 2 (HPV3, 
10, 77), are of major importance among viral skin infections. The increased prevalence of HPV infection and associated 
disease among immunosuppressed populations, including solid organ transplant recipients (OTR), documents the 
importance of the immunological control of HPV infection. To date, the natural course of immunological cHPV-
specific responses during systemic immunosuppression is poorly investigated. Thus, we analyzed natural systemic 
immune responses against the major capsid protein L1 of HPV types 2, 27, 57, 3, 10 and 77 in the blood of OTR 
before and after initiation of iatrogenic immunosuppression compared to immunocompetent individuals (IC). HPV-
L1-specific antibodies were detected by bead-based multiplex serology (Luminex) and L1-specific TH1, TH2 and 
cytotoxic T cell responses by flow cytometry. Among OTR, we observed a significant 42% decrease in humoral L1-
specific immune responses during the induction phase of iatrogenic immunosuppression, comparing median values 
30d before and 30d after initiation of immunosuppressive therapy. In contrast, direct comparison of L1-specific 
antibody responses in sera of individual OTR before and after long-term (> 1 year) immunosuppression showed 
no significant alterations. The predominant cellular L1-specific immune response was of type TH1 (CD4
+CD40L+IL-
2+IFN-γ+). Consistent with the detected L1-specific antibody titers, L1-specific TH1 responses were unchanged in 
long-term immunosuppressed OTRs compared to IC. We conclude that the systemic immune responses against 
cHPV reflect the degree of iatrogenic immunosuppression indicating a higher susceptibility for cHPV infection 
among OTR during the early phase after organ transplantation.
2011ESDR_8.25x10.875.indd   96 06/07/2011   18.24 
 www.jidonline.org S97
ABSTRACTS
577
Plantar ulcers of leprosy: a challenge in endemic countries
Felipe Ladeira de Oliveira, Bruna Obeica Vasconcelos, Karen E. Benício Lira, Mayara Brito do 
Nascimento, José Augusto da Costa Nery Instituto de Dermatologia Rubem David Azulay, Rio 
de Janeiro, Brazil
The aim of this scientific work is to describe the difficulties and ways of treating plantar ulcers 
caused by leprosy in endemic region (Rio de Janeiro - Brazil), and identify neural involvement of 
lower limbs. This study describes a small sample of patients who were diagnosed with hansen’s 
disease and had plantar ulcers as a sequel, we considered the response to our measures designed 
to prevent damage with the aim of healing existing ulcers and preventing development of new 
ulcers. A total of 20 patients were monitored during the study period, among these 14 (70%) had 
bacterial infections or recurrent ulcers and all had a history of signs and symptoms of hansen’s 
disease, including chronic involvement of the lower limbs. The lack of standardization of this foot 
injury and treatment, is associated with the lack of motivation of patients who own a majority, 
don’t worry or don’t follow the correct method of treatment, so the disharmony between bone 
structure, soft tissue, vascular and nervous exacerbates the plantar ulcers. Due to the increase in 
global travel and immigration, doctors in low endemic areas should consider hansen’s disease as 
a possible diagnosis of plantar ulcers not responding to treatment.
578
Delay in Diagnosis of Manifestations of Leprosy in Endemic Areas, Why It Happens?
Felipe Ladeira de Oliveira, Bruna Obeica Vasconcellos, Deborah Maria Brito Sírio, Mayara Brito 
do Nascimento, José Augusto da Costa Nery Instituto de Dermatologia Professor Rubem David 
Azulay, Rio de Janeiro, Brazil
The aim of this scientific work is to analyze classic manifestations of leprosy which come to 
our hospital with no diagnosis made and thereby discuss why these signs of leprosy are often 
missed by medical doctors even if they work in endemic area (Rio de Janeiro - Brazil). This 
study describes a case report of a patient who was diagnosed in our dermatology service with 
lepromatous leprosy and had not been diagnosed before. Through clinical investigation we found 
classical aspects of the systemic involvement of leprosy: diffuse infiltration and nodulation of 
the earlobe, diffuse infiltration and erythema of the skin and face, change in thermal sensitivity, 
impairment of olfaction and atrophic changes in the nasal mucose. We can conclude, that 
multibacillary patients, especially in lepromatous leprosy, may mimic other common diseases 
causing diagnostic mistakes, so becomes evident that leprosy should be included in the 
differential diagnosis in all patients with skin lesions not responding to treatment and in patients 
who live or have lived in a leprosy endemic area, preventing the delay in diagnosis.
579
Necrotic Ulcers in Erythema Nodosum Leprosum, A severe Presentation of Hansen’s Disease 
In Endemic Area
Felipe Ladeira de Oliveira, Bruna Obeica Vasconcellos, Karen E. Benicio Lira, Mayara Brito do 
Nascimento, José Augusto da Costa Nery Instituto de Dermatologia Professor Rubem David 
Azulay, Rio de Janeiro, Brazil
The aim of this scientific work is to describe and analyze erythema nodosum leprosum 
necrotizing lesions of a patient living in endemic area (Rio de Janeiro - Brazil), an uncommon 
presentation of hansen’s disease. This clinical study describes a patient who was in treatment of 
lepromatous leprosy and had an acute reaction onset of ulcerations and necrosis, followed by the 
infection of the lesions by Staphilococcus aureus and Pseudomonas aeruginosa. Through clinical 
and histologic investigation we found: extensive ulcerations and necrosis in lower and upper 
limbs (sometimes round lesions), signs and symptoms of an acute illness (fever, malaise and 
prostration), deposition of fibrin and neutrophilic infiltration within and around blood vessels. 
We can conclude, that in severe cases, erythema nodosum may present necrotizing lesions 
increasing the risk of neuromuscular sequele and when it is associated with secondary infections 
represents a clinical stage very difficult to control with a poor prognosis even with treatment.
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L.reuteri can inhibit S.aureus adhesion to keratinocytes in vitro
Tessa Prince, Andrew McBain, Catherine O’Neill University of Manchester, Manchester, UK
Probiotics are defined as “Live microorganisms which when administered in adequate amounts 
confer a health benefit on the host”. Studies in the gut have demonstrated the ability of probiotic 
bacteria to inhibit colonisation by pathogens through mechanisms including exclusion, 
competition and displacement of pathogen attachment to host tissues. Recent reports have 
indicated the potential of topical application of probiotic bacteria for the treatment or prevention 
of skin infections. We have investigated the protective effect of a Lactobacillus reuteri probiotic 
on the keratinocyte cytotoxicity of Staphylococcus aureus, a common cause of invasive 
infections. Normal human epidermal keratinocytes (NHEK) were pre-exposed to L.reuteri (108), 
simultaneously exposed or exposed 2 hours after S.aureus (106) addition and cell viability 
was assessed. Simultaneous and pre-exposure to L.reuteri for 1 hour resulted in a significantly 
lower decrease in NHEK viability compared to cells exposed to S.aureus alone (P=0.0016 and 
P=0.0003 respectively). Addition of L.reuteri 2 hours after exposure to S.aureus resulted in no 
significant change in cell viability (P=0.99). As adhesion of S.aureus to the cell is commonly 
the first step in infection, we examined whether L.reuteri was able to inhibit S.aureus adhesion. 
Pre-exposure to L.reuteri resulted in significantly less staphylococcal adhesion to keratinocytes 
(P=0.026), demonstrating that the probiotic excluded S.aureus from binding. Co-infection with 
L.reuteri also resulted in significantly lower staphylococcal adhesion (P=0.0078) suggesting that 
the probiotic competed with S.aureus for adhesion to the cell. In conclusion, we have shown 
that L.reuteri inhibits staphylococcal-induced cytotoxicity through bacterial exclusion and 
competition for adhesion.
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Recombinant lactoferrin-derived peptide inhibits KSHV infection of 293 cells
Philippe Grange1, Ludivine Gressier1, Ossie Dyson2, Shaw Akula2, Nicolas Dupin1 1Hôpital 
Cochin, UPRES EA 1833, Université René Descartes, Paris, France, 2The Brody school of Medicine, 
East Carolina University, Greenville, USA
Kaposi’s sarcoma-associated herpesvirus (KSHV) or HHV-8, is associated with several major 
acquired immunodeficiency syndromes (AIDS)-related malignancies like Kaposi’s sarcoma, 
B-cell lymphoma, primary effusion lymphoma and the multicentric Castleman disease. If the 
KSHV transmission route has not been characterized so far, a non-sexual route involving saliva 
could play an important role while KSHV is shed in the saliva of KSHV-infected patients. In our 
earlier study, we have shown the ability of KSHV to bind specifically to the 8-kDa-lactoferrin-
related peptide in the saliva. In this study we cloned and produced a recombinant 8-kDa peptide 
(LF8a/8b peptide) and analyzed its ability to alter KSHV infection of cells using the recombinant 
green fluorescent protein (GFP) encoding KSHV (rKSHV.152). Our results demonstrate that the 
incubation of KSHV with LF8a/8b prior to infecting 293 cells significantly lowered infection. A 
dose dependent inhibition of KSHV infection of cells was observed when the virus was incubated 
with LF8a/8b peptide compared to bovine serum albumin (BSA). These results confirm lactoferrin 
as a novel receptor to KSHV; especially considering saliva as the medium of transmission. 
Protein-derived saliva could be used for the emergence of a new strategy based on competing 
the adhesion of KSHV during the transmission routes and therefore contributing to lower the 
infection.
582
Leprosy reaction
Danny Guabiraba, Paloma Rebelo, Jorge Machado, Marcelo Lyra, Yuri Mene, Simon Salomao, 
Janaina Leite, Tatiane Coelho, Roney Mata, Gabriela Santana, Carolina Muga IMS- Gamboa, Rio 
De Janeiro, Brazil
We presented a case of reverse reaction in a young female patient with dimorphous leprosy , 
nine years after initial onset of the disease. The 27 years old, from Rio de Janeiro, referred from 
department of rheumatology with pain and patches of discoloration covering her entire body. She 
presented with patches of weil defined hypochromic macula,hipoesthesic in both superior and 
inferior limbs present for more than one years evolving with intense myalgia and arthralgia that 
show no improvement with one month of oral opioids. According, she had suffered with the same 
lesions since the age of 10, but diagnosed Leprosy at 16 and treated for one year. A bacilloscopy 
was performed with a negative result,while an incision biopsy showed an anatomical pathology 
presenting mononuclear inflammatory infiltrate,predominately lynphocytic,involving the 
neurovascular bundles and vessels of both the superficial and deep plexures. Occasionally it 
is possible to identify small group of epithelioid histiocytes. A Wade coloration does not reveal 
acid-alcohol resistant bacillus. Starting the patient on an oral corticoid treatment improves the 
symptoms and the lesions.
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Detection of HPyV9, a new human polyomavirus related to the African green monkey 
lymphotropic polyomavirus, at the skin surface of Merkel cell carcinoma patients and healthy 
individuals
Virginie Sauvage1, Vincent Foulongne2,5, Justine Cheval3, Meriem Ar Gouilh1, Kevin Pariente1, 
Olivier Dereure2,5, Jean Claude Manuguerra1, Jennifer Richardson4, Marc Lecuit1, Anna Burguiere1, 
Valérie Caro1, Marc Eloit1,4 1Institut Pasteur, Paris, France, 2INSERMU1058, Montpellier, France, 
3Pathoquest, Paris, France, 4Ecole nationale vétérinaire, Maisons Alfort, France, 5Centre Hospitalier 
Universitaire, Montpellier, France
The virome of the healthy-looking skin of a patient with a Merkel cell carcinoma (MCC) has been 
probed using unbiased high throughput sequencing.Among the million sequence reads obtained 
from DNA extracted from the material obtained by swabbing skin surface of the patient’s face, 
likely viral sequences were sorted out allowing a complete Merkel cell polyomavirus genome 
to be assembled. In addition, numerous human papillomaviruses contigs, together with contigs 
covering the genome of both recently-described human polyomaviruses 6 and 7 were detected. 
Moreover, we identified in the same sample a human polyomavirus nearly identical to HPyV9, 
a virus recently described in the blood and urine of renal transplant patients and closely related 
to the African green monkey lymphotropic polyomavirus. Specific PCR analysis further identified 
this virus in 2/8 MCC cases, but only in 1/111 non-MCC controls. We also found that it was 
shed for at least 20 months from the MCC index case, and that this virus was also present on the 
skin surface of the spouse of the index case. Detection of an additional human polyomavirus in 
cutaneous samples reinforces the perception of the skin as a complex micro-ecosystem colonized 
by many different viruses, with polyomaviruses representing part of this viral microbiota. This 
raises new questions regarding the pathomechanisms of virus-associated skin disorders.
584
Changes in the proteome of Propionibacterium acnes in response to growth in various 
atmospheric conditions as revealed by using SELDI-TOF Mass Spectrometry
Itaru Dekio1,2, Renata Culak2, Eishin Morita1, Saheer Gharbia2, Haroun Shah2 1Department of 
Dermatology, Faculty of Medicine, Shimane University, Izumo, Japan, 2Department for Bioanalysis 
and Horizon Technologies, Health Protection Agency, London, UK
Although isolated from a number of different sites in the body, the natural habitat of 
Propionibacterium acnes appears to be the skin of humans. Even though the surface of the skin 
is highly aerated, P. acnes is considered to be an anaerobe. In an on-going study 28 isolates 
have been isolated from 17 volunteers (healthy and diseased) and the growth of the strains 
were compared under anaerobic, micro-aerophilic and aerobic conditions to establish whether 
atmospheric conditions influence the capacity of particular strains to cause disease. Proteins 
were extracted from cells grown under 3 atmospheric conditions using Whitley A35 Anaerobic 
Workstation (strictly anaerobic), Oxoid CampyGen Kit (micro-aerophilic), and Heraeus Incubator 
(aerobic) for 5 days, and kept frozen prior to analysis. All were standardised to a protein 
concentration of 4 mg/mL and analysed using SELDI-TOF Mass Spectrometer with ProteinChip 
Arrays (H50, Q10, and CM10, Bio-Rad). The profile patterns were analysed by comparative Gel 
View Images and BioNumerics v6.1 for unique biomarkers among strains grown under these 
atmospheric conditions. As a result, all of 28 isolates grew in the anaerobic and micro-aerophilic 
conditions but 2 failed to grow in air. In some strains, the changes in the proteome were reflected 
by differences in growth conditions. Some mass ions were present in cells grown under anaerobic 
conditions but not in micro-aerophilic or aerobic atmospheres. Proteins comprising such peaks 
are related to changes in different atmospheric conditions and may have a bearing on their 
adaptation to the micro-environment of the hair follicle and the epidermis.
585
Effective Sterilization of Methicillin-Resistant Staphylococcus aureus (MRSA) with an Ultrasonic 
Levitation Washer Disinfector and Silver Electrolysis and Ozone Oxidation
Mariko Tamai1, Shigeto Matsushita1, Hiroaki Miyanohara2, Naoko Imuta3, Ryuji Ikeda4, Kazuhiro 
Kawai1, Junichiro Nishi3, Akihiro Sakamoto5, Takanori Shigihara6, Takuro Kanekura1
1Department of Dermatology,Kagoshima University Graduate School of Medical and Dental 
Sciences, Kagoshima, Japan, 2Clinical Laboratory of Kagoshima University Hospital, Kagoshima, 
Japan, 3Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental 
Sciences, Kagoshima, Japan, 4Department of Clinical Pharmacy and Pharmacology, Kagoshima 
University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 5Kagoshima 
Ultrasonic Technical Laboratory Co. Ltd., Kagoshima, Japan, 6Eroika Co. Ltd., Ashiya, Hyogo, 
Japan
Methicillin-resistant Staphylococcus aureus (MRSA) has rapidly emerged as a cause of severe 
and intractable infection in the skin and soft tissue. At present there are no effective topical 
treatments to reduce MRSA and infection or colonization on the skin and soft tissue raise serious 
medical problems. A newly developed ultrasonic levitation washer, which generates silver ions 
(Ag+) and ozone (O3), was designed to clean and sterilize various materials such as medical 
instruments. In this study, we examined the effect of ultrasonic levitation (levitation) with Ag+ and 
O3 on MRSA in vitro and in vivo using a mouse model. Levitation with Ag
+ and O3 dramatically 
decreased the survival of floating MRSA in a water tank. We also confirmed that levitation with 
Ag+ and O3 significantly decreased the viability of MRSA that had infiltrated or formed biofilm 
in the atelocollagen membranes regardless of the level of biofilm production. In vivo studies 
showed that the number of MRSA on murine skin ulcers was significantly decreased by the 
treatment of levitation with Ag+ and O3 for 15 min daily in 7 days. In addition, the ulcer size was 
significantly diminished after the 7th treatment of levitation with Ag+ and O3. Our study strongly 
suggests that levitation with Ag+ and O3 could be a valuable tool for treating MRSA infestation on 
the skin and accelerate wound healing.
586
Which cell hosts MCPyV in normal and pathological human skin?
Jean-Pierre Molès1, Vincent Foulongne1, Antoine Touzé2, Pierre Coursaget2, Olivier Dereure1 
1Inserm U1058, Montpellier, France, 2Inserm U618, Tours, France
The newly identified Merkel cell polyomavirus (MCPyV) was first associated with Merkel Cell 
Carcinoma, but rapidly viral sequences were detected in other cutaneous samples including normal 
Human skin. To date, the cellular tropism of this virus is not clearly established and the presence 
of viral sequences in cutaneous swabs not explained yet. Thirty three skin biopsies were screened 
by specific MCPyV PCR. Among nine PCR positive samples, 5 further yielded a concordant result 
by indirect immunofluorescence (IIF) the main capsid protein (VP1) and the large T antigen. 
MCPyV positive samples were detected within normal skin, basal cell carcinomas, squamous 
cell carcinomas, melanomas atopic dermatitis and psoriasis samples. The strongest signal was 
observed with a specific anti-VP1 antibody in ducts of sweat glands and in the associated pores. 
The signal was always cytoplasmic. No signal was observed in interfollicular epidermis. The 
large T antigen was rarely detected in this samples set. The localisation of the former stainings 
was next analysed by EM. No obvious viral particle was observed and immunoEM further 
confirmed that the antibody signal was not associated with a peculiar electron dense structure. 
Cells carrying MCPyV could localise in the ducts of sweat gland, however we cannot confirm 
the presence of viral particles and IIF signal was cytoplasmic when capsid protein is expected 
to be nuclear for this viral family. Indeed, the biology of MCPyV may be specific but the cellular 
tropism of this virus remains to be elucidated.
587
S. aureus derived TLR2 ligands and IL-4 initiate chronification of inflammation in a model of 
atopic dermatitis
Susanne Kaesler, Thomas Volz, Yuliya Skabytska, Ko-Ming Chen, Emmanuella Guenova, Tilo 
Biedermann University of Tuebingen, Tuebingen, Germany
Atopic dermatitis (AD) is a chronic inflammatory skin disease with Th2 cells preferentially 
found in acute flares and Th1 cells dominating chronic lesions. In general, inflamed AD skin is 
infected by Staphylococcus aureus providing potent TLR2 ligands, however, the direct impact 
of TLR2 ligands on AD inflammation is unclear. Therefore, we established a model for acute 
AD by adoptively transferring and activating OVA-specific Th2 cells in the ear skin of naive 
wt mice, where ear swelling correlates with antigen-specific inflammation. This cutaneous 
inflammation depends on IL-4 and on dendritic cells (DC) as demonstrated with IL-4R-deficient 
and DC-depleted mice. Importantly, addition of Staphylococcus aureus cell wall component 
and TLR2 ligand lipoteichoic acid or of synthetic TLR2 ligand Pam2Cys provoked prolonged and 
increased dermatitis similar to the transfer of OVA-specific Th1 cells. Cross-over experiments 
with TLR2-deficient mice and Th cells revealed that TLR2 on accessory cells but not on T cells 
is responsible for TLR2 mediated exacerbation of cutaneous inflammation. In vitro activation of 
DC with TLR2 ligands induced Th1 cytokine IL-12 as well as IL-10. However, IL-10 is completely 
downregulated by IL-4-costimulation. This shift was also observed in vivo and applying our AD 
model to IL10ko mice resulted in prolonged cutaneous inflammation compared to wildtype.
These data indicate that S. aureus derived TLR2 ligands shift transient Th2 dominated cutaneous 
inflammation towards chronic and persistent dermatitis through a concerted activation of TLR2 
and IL-4R and suppression of IL-10 seems to be crucial for the initiation of this chronification.
588
Interferon gamma enhances TLR3 expression and function in keratinocytes surrounding 
herpetic vesicles
Shin Morizane1, Ai Kajita1, Kenshi Yamasaki2, Yumi Aoyama1, Keiji Iwatsuki1 1Department of 
Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical 
Sciences, Okayama, Japan, 2Department of Dermatology, Tohoku University Graduate School of 
Medicine, Sendai, Miyagi, Japan
Among Toll-like receptors (TLR), which recognize specific microbial products, TLR3 recognizes 
double-stranded RNA and is considered to play roles in viral skin infection. However, the 
regulation of TLR3 expression and the function in keratinocytes are not fully understood. We 
first confirmed high TLR3 expression in keratinocytes surrounding vesicles of herpes zoster by 
immunohistochemistry (n=3). To understand regulation of TLR3 in keratinocytes, we investigated 
factors that affect TLR3 expression in normal human epidermal keratinocytes (NHEKs) in vitro. 
Among a panel of cytokines, a Th1 cytokine interferon gamma (IFN-γ, 2 ng/ml) increased TLR3 
mRNA expression (76.7-fold, p=0.0108) in NHEKs, while Th2 cytokines IL-4 and IL-13, or Th17 
cytokines including IL-17A, IL-22 and IL-23 did not. IFN-g increased TLR3 mRNA expression in 
a dose-dependent manner and a corresponding increase of TLR3 protein was also confirmed by 
immunocytofluorescence. A functional significance of TLR3 increase by IFN-γ was confirmed 
as co-stimulation with IFN-γ (2 ng/ml) and TLR3 ligand poly(I:C) (0.1 mg/ml) tremendously 
increased mRNA expression of beta-defensin-2 (884.4-fold, p<0.0001), IL-6 (6,763-fold, 
p<0.0001), IL-8 (91.3-fold, p<0.0001) and IFN-β (42.6-fold, p<0.0007) in NHEKs, compared 
to stimulation with poly(I:C) alone. Corresponding increases of protein were also confirmed 
by ELISA. Chloroquine (50 mg/ml), an endosomal acidification inhibitor that suppresses TLR3 
functional activity, inhibited the cytokine inductions by co-stimulation with IFN-γ and poly(I:C). 
Immunohistochemistry also showed that IFN-γ expression was increased in infiltrating cells 
and keratinocytes surrounding herpetic vesicles. These results suggest that a Th1 cytokine IFN-γ 
induces TLR3 in keratinocytes and amplifies responsiveness to viral ds-RNA.
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The upregulation of mouse beta defensin 3 and 14 expression after Staphylococcus aureus 
infection is mediated by IL-1 beta, but not by IL-1 alpha
Kerstin Ahrens1, John S Cho2, Jürgen Harder1, Lloyd S Miller2, Ehrhardt Proksch1 1Department of 
Dermatology, University of Kiel, Kiel, Germany, 2Division of Dermatology, David Geffen School of 
Medicine at UCLA, Los Angeles, California, USA
Skin infections such as impetigo, cellulitis, folliculitis/furunculosis, and abscesses are common 
and often caused by Staphylococcus aureus. Induction of antimicrobial peptides (AMPs) is a 
major cutaneous defense mechanism against S. aureus infection. We examined whether skin 
infection by S. aureus in vivo promoted expression of AMPs and whether the expression of AMPs 
is regulated by IL-1alpha or beta. Scalpel cuts of the back skin of wildtype or IL-1alpha, IL-1beta 
or IL-1R-deficient mice deficient, were inoculated with S. aureus or PBS (control) and mRNA 
and protein expression of mBD-1, mBD-3, mBD-14 and CRAMP was determined by QPCR and 
by immuno-histochemistry after infection. mRNA expression of mBD-3 and CRAMP, but not 
mBD-1 and mBD-14, was increased after S. aureus infection in wildtype mice at 6 and 24 hours 
after infection. Immunohistology revealed a slight increase in mBD-1 and a moderate to strong 
increase in mBD-3, mBD-14 and CRAMP protein expression at 24 hours after infection. In IL-
1R-deficient mice the increased mRNA expression of CRAMP was slightly reduced compared 
to wild type mice. In IL-1R-deficient mice the protein expression of mBD-3 and mBD-14 was 
reduced whereas the expression of mBD-1 and CRAMP expression was similar to wild type mice. 
The increased protein expression of mBD-3 and mBD-14 after infection was reduced in IL-1beta, 
but not in IL-1alpha deficient mice. In summary, these data demonstrate a mechanism by which 
S. aureus skin infection induces mBD-3, mBD-14 and CRAMP expression and the expression of 
mBD-3 and mBD-14 is regulated by IL-1beta.
590
High Detection Of Hepatitis C Infection RNA In Psoriatic Sera
Samar Samoud, Neila Hannachi, Jalel Boukadida, Rafia Nouira Farhat Hached Hospital, Sousse, 
Tunisia
Psoriasis is considered as a multifactorial chronic disorder. The pathogenic role of viral agents 
was not fully investigated in psoriasis. An association between psoriasis and Hepatitis C virus 
(HCV) infection was described in the literature however these data were not confirmed. To study 
the relationship between Hepatitis C infection and psoriasis, we aimed to analyze serum’s HCV 
RNA and determine the seroprevalence of anti-HCV antibodies (abs) from psoriatic patients in 
comparison with healthy controls (HC) and their association with disease activity. Sera samples 
from 41 psoriatic patients (Ps) a were analysed for the presence of anti-HCV abs with enzyme-
linked immunosorbent assays. As controls, we used sera samples from 64 volunteers, age and sex 
matched. RNA was extracted from sera using Qiagen kit. PVB19 DNA was detected by nested 
PCR. The activity of the disease was based on PASI score. The prevalence of HCV infection 
in Ps patients was 9.75% (4/41). All HC sera were negative for anti-HCV abs. The difference 
was statistically significant (p=0.03). HCV prevalence in Ps patients was higher than that found 
in Tunisian population (0.04%). In addition, the presence of HCV RNA in psoriatic sera was 
significantly higher than in controls (26.83% vs. 6.25%, p =0.003). However, no correlation was 
found between HCV RNA presence nor anti-HCV abs and patients’ age, sex, type of psoriasis, or 
PASI. Our findings support the hypothesis that HCV infection may play a role in the pathogenesis 
of psoriasis.
591
Lepromatous Leprosy In Type 2 Lepra Reaction
Clara Emilia Márquez Palencia, Fermín Jurado Santa Cruz, Obdulia Rodríguez Rodríguez, Gisela 
Navarrete Franco, Myrna Rodríguez Acar Centro Dermatológico Pascua, Mexico, City, Mexico
A 54 year old male with lepromatous leprosy since 2002. He had been on treatment with 
multibacillary multi drug therapy (MBMDT) for the previous 7 months, because of he didn´t 
notice improvement of the lesions he decided to discontinue the treatment. In April 2005 he 
presented an acute episode of multiple erythematous tender nodules, myalgia, arthralgia and 
fever. On examination, the patient had multiple painless, nodular and necrotic ENL lesions over 
the trunk, gluteal region and extremities. Blood investigations revealed hemoglobin 8.8, the 
erythrocyte sedimentation rate was elevated ( 65 mm/hr ). Earlobe infiltration is present . Cubital 
nerves are thickened uniformly but nontender. A slit-skin smear from the earlobe and nasal 
mucosa were read as 2 + on the bacteriological/bacterial index (BI) scale. Skin histopathological 
examination from the trunk showed dense inflammatory infiltrate extending from papillary 
dermis to deeper dermis with thinning and necrosis of epidermis. There is also mild perivascular 
mixed inflammatory infiltrate. Fite stain for acid-fast organisms is positive. The integral diagnosis 
was: Nodular Lepromatous Leprosy, in type 2 Lepra reaction with erythema nodosum leprosum 
(ENL). The patient was start on standard WHO multibacillary multi drug (MB MDT) therapy for 
leprosy and started thalidomide 300 mg / day. His ENL lesions started to abate by the fourth day. 
After a lesion free period of 2 weeks, thalidomide was tapered to 200 mg/day then 100 mg/day. 
After two more weeks he was maintained on 50 mg/day. After regular treatment, his skin lesions 
show improvement.
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Inhibition of aryl hydrocarbon receptor (AhR) signaling enhances nucleotide excision repair (NER)
Thomas Haarmann-Stemmann1, Katrin Frauenstein1, Thierry Douki2, Marc Majora1, Julia Tigges1, 
Susanne Grether-Beck1, Charlotte Esser1, Josef Abel1, Ellen Fritsche1,3, Jean Krutmann1 1Leibniz 
Research Institute for Environmental Medicine, Düsseldorf, Germany, 2Laboratoire Lésions des 
Acides Nucléiques, Service de Chimie Inorganique et Biologique, CEA/DSM/INAC, Grenoble, 
France, 3Department of Dermatology, University Hospital RWTH, Aachen, Germany
Efficient removal of UVB-induced DNA damage in skin critically depends on NER. Although 
cytokines like IL-12 were shown to enhance NER activity, its complex regulation is still poorly 
understood. We now report that keratinocytes are also equipped with a negative regulator of NER: 
the AhR, a cytosolic transcription factor that is rapidly activated upon ligand-binding to stimulate 
gene expression. We have previously shown that 6-formylindolo[3,2b]carbazole, a tryptophan 
photoproduct that is intracellularly formed upon UVB-absorption by free tryptophan, is a strong 
AhR ligand, which triggers the DNA damage-independent part of the UVB-response. Now, we 
have investigated if AhR activation also impacts on the DNA damage-dependent UVB-response. 
We have found that chemical AhR inhibition in human keratinocyte cell lines leads to a faster 
repair of UVB-induced cyclobutan pyrimidine dimers (CPD). This was confirmed by using AhR-
/- keratinocytes, which exhibited significantly lower amounts of CPDs, 6h and 24h after UVB-
irradiation, as the control cells. In order to assess the in vivo relevance of these observations, we 
irradiated AhR+/+ and AhR-/- SKH-1 mice with 180J/m2 UVB. The CPD amount in skin samples was 
measured by HPLC-MS/MS immediately, 24h and 48h after UVB-exposure. Strikingly, 48h after 
irradiation, the skin of AhR-/- mice contained only 50% of the CPDs measured in skin samples from 
AhR+/+ mice. Mechanistic in vitro studies indicate that the AhR represses the expression of NER-
stimulating cytokines and influences cell-cycle regulation. Thus, the AhR is a negative regulator 
of NER that may represent a novel target for chemoprevention against UVB-induced skin damage.
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Oral nicotinamide for skin cancer prevention
Diona Damian1, Devita Surjana1, Andrew Martin2, Gary Halliday1 1Dermatology, University of 
Sydney, NSW, Australia, 2NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia
Daily sunscreen use can reduce both premalignant actinic keratoses (AKs) and cutaneous 
squamous cell carcinomas within relatively short timeframes. Compliance with sunscreen 
application and reapplication is however surprisingly poor, even in those at highest risk of 
skin cancer. Nicotinamide (vitamin B3) prevents photocarcinogenesis in mice and is highly 
protective against UVA and UVB-induced immunosuppression in humans. Nicotinamide is the 
precursor of NAD, which is central to energy metabolism. Repair of photodamaged DNA is 
highly energy-intensive, and UV depletes keratinocytes of energy when their requirements are 
greatest. Nicotinamide prevents this UV-induced energy loss and enhances repair of direct and 
oxidative DNA damage in human keratinocytes and ex vivo skin. We assessed the effectiveness of 
nicotinamide, 500mg twice daily, in reducing AKs in 35 heavily sun damaged participants who 
were encouraged to continue their usual sun protection measures. Patients were randomised to 
placebo or nicotinamide with AKs counted at baseline, 2 and 4 months by a blinded observer. 
Nicotinamide reduced AKs by 35% relative to placebo at 2 and 4 months (p<0.001). Similar 
results were found with nicotinamide 500mg daily in a second study. We also found significant 
reduction in skin cancers with nicotinamide in these two trials; 32% of the placebo group 
developed at least one new cancer during the 4-month study period (21 cancers in total), 
compared to 8% of those taking nicotinamide (4 cancers in total; p<0.01, Fishers Exact test). 
Nicotinamide is non-toxic, inexpensive and widely available, and holds great promise for skin 
cancer prevention.
594
HDAC inhibition can normalize UVA-induced transcriptional dysregulation in CSB-deficient 
fibroblasts
Marc Majora, Christine Goetz, Christine Glon, Maren Schneider, Jean Krutmann IUF - Leibniz 
Research Institute for Environmental Medicine, Duesseldorf, Germany
Cockayne syndrome is a fatal progeroid disease caused by mutations in either the Cockayne 
syndrome B (CSB) or CSA gene. Cells lacking a functional CSB protein are characterized by 
defective transcription-coupled repair and the inability to mount normal transcriptional 
responses towards stress conditions like hypoxia or UV radiation. We have previously shown that 
CSB-deficient hairless mice are resistant against wrinkle formation upon chronic UVA irradiation. 
This finding correlated well with decreased expression of the major murine collagenase MMP-
13 and increased expression of the endogenous MMP inhibitor TIMP-1 in the skin of the mice. 
On the other hand increased expression of MMP-3 was detected in the skin of UVA-irradiated 
CSB-deficient mice when compared to wildtype mice. According to that, a single dose UVA 
irradiation of CSB-deficient and wildtype MEFs resulted in a similar phenotype with regard to 
the differential expression of MMP-13 and MMP-3 while no consistent regulation was noted 
for TIMP-1. However, treatment with the histone deacetylase (HDAC) inhibitors SAHA or TSA 
could restore the abnormal expression levels of MMP-13 and MMP-3 in CSB-deficient cells to 
wildtype levels upon UVA irradiation. Moreover, HDAC inhibitors could also render both CSB-
deficient and wildtype MEFs sensitive to UVA-induced upregulation of TIMP-1 expression. These 
data indicate that the defective transcriptional response towards UVA radiation in CSB-deficient 
cells can be normalized by HDAC inhibitors at least for some genes. Moreover, they suggest that 
aberrant protein acetylation may be a novel molecular mechanism contributing to the pathology 
of Cockayne syndrome.
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cis-urocanic acid up-regulates interleukin-1β production and UDP-glucose receptor P2RY14 
expression: possible danger sensor of UVB irradiation
Motonobu Nakamura1, Yoshiki Tokura2 1University of Occupational and Environmental Health, 
Kitakyushu, Japan, 2Hamamatsu University School of Medicine, Hamamatsu, Japan
Exposure of human skin to solar ultraviolet (UV) irradiation induces the production of a number 
of cytokines, such as interleukin-1α (IL-1α) and IL-1β, that stimulate innate immune responses. 
Urocanic acid (UCA) is an epidermal chromophore that undergoes trans to cis isomerization after 
UVB irradiation. cis-UCA is an potent modulator of cutaneous acquired immunity, as has been 
studied in contact hypersensitivity induced through UVB-preirradiated skin. However, its role in 
innate immunity still remains unclear. Here, we explored the modulatory effects of cis-UCA on 
innate immunity in normal human epidermal keratinocytes (NHEK) and monocytic leukemia 
cell line, THP-1 cells. cis-UCA increased secretion of IL-1β by NHEK and THP-1 cells, while 
trans-UCA had no effect. The promoted IL-1β production by cis-UCA was inhibited by addition 
of caspase-1 inhibitor or by siRNA-mediated knockdown of NLR family, pyrin domain containing 
3 (NLRP3) gene. DNA microarray analysis revealed that cis-UCA increased the expression of 
a G-protein coupled receptor, P2RY14. Quantitative real-time RT-PCR analysis showed that 
the expression of P2RY14 was enhanced only by cis-UCA, but not by trans-UCA. Uridine 
diphosphoglucose (UDP-glucose), an agonist for P2RY14, induced the IL-1β secretion by THP-
1 cells dose-dependently. Immunohistochemical study demonstrated that P2RY14 was highly 
expressed in the basal cell layer of the epidermis in the patients with actinic keratrosis. Taken 
together, these data suggested that P2RY14 and its agonist, UDP-glucose, trigger innate immune 
responses and may play important roles as danger signals of UVB irradiation.
596
Modulation of the contact hypersensitivity in mice by psoralen photooxidation products: 
alteration in the cytokine balance and generation of cells with specific suppressive functions
Alla Kyagova, Diana Albegova, Svetlana Pavlova, Ilya Pyatnitskiy, Ivan Kozlov, Lyudmila Kozir, 
Alexander Potapenko Russian State Medical University, Moscow, Russia
Psoralens (PS) plus UVA-light photochemotherapy is used for treatment of skin and autoimmune 
diseases. PS-photochemotherapy exerts its beneficial effects via suppression of the T-cell immune 
response. Photolysis of PS with formation of the PS photooxidation products (POP) occurs 
during PS-photochemotherapy. We have previously shown that POP may contribute to the 
immunosuppression. However, the immune mechanism behind the POP-induced suppression 
has yet to be explained. We assessed effect of POP on contact hypersensitivity (CSH) to 
2,4-dinitrofluorobenzene (DNFB) in mice. It was found that orally administered or intravenously 
injected POP induced suppression of both sensitization and elicitation phases of the CHS. 
Application of POP to mice 24 hours after DNFB sensitization led to decrease in the number 
of draining lymph node (LN) cells and to reduction of their proliferative activity ex-vivo. These 
POP effects were accompanied by a decrease in IL-2, IL-4 and IFNγ production and an increase 
in IL-17 production by LN cells. This indicates that the Th1 and Th2 immune responses were 
switched to process of Th17-cells formation during sensitization phase of the CHS. No influence 
of the POP in vivo treatment on production of IL-10 and IL-6 by LN cells from DNFB-sensitized 
mice was found. POP-induced ssuppression of the CHS was found to be adoptively transferable 
and antigen-specific suggesting the generation of cells with specific suppressive functions. 
Adoptive cell transfer of cell subsets separated by negative immunomagnetic selection revealed 
that suppressive cells generated by POP in vivo treatment were partially related to the CD4+ 
lymphocytes.
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A co-ordinated change in skin chemokines and cytokines mediates mast cell recruitment and 
activation
Scott Byrne, Clare Beaugie, Sarah Leighton, Gary Halliday University of Sydney, NSW, Australia
The ultraviolet (UV) part of sunlight has powerful and wide-ranging immunosuppressive 
capabilities. While mast cells are known to play a role in this process, the factors that recruit 
and activate mast cells is unknown. We have discovered that the inflammatory chemokine 
and mast cell chemoattractant CCL5 is significantly upregulated following UV exposure. Mast 
cells expressed CCL5 receptors and were attracted into the skin following CCL5 injection. 
Simultaneously, the CCL5 antagonists CCL17 and CCL22, were significantly downregulated. 
These results show that a major shift in the chemokine axis occurs in UV-exposed skin that 
facilitates mast cell recruitment. Shortly thereafter, mast cells are exposed to a range of other 
UV-induced factors. We have discovered that one such factor is interleukin-33 (IL-33), a new 
cytokine belonging to the IL-1 family that was significantly up-regulated following UV exposure. 
IL-33 acted on mast cells to induce their release of anti-inflammatory and immunosuppressive 
mediators like IL-10 and IL-13. Our studies have identified two new UV-induced factors that 
coordinate the recruitment and activation of mast cells. While these events lead to systemic 
immunosuppression and the promotion of skin tumour growth in the long term, they may also be 
an important homeostatic mechanism designed to curb excess UV-inflammation.
598
Two Dendritic Cell Subsets Migrate into Epidermis after UV Exposure in humans and Mediate 
the Recovey of Immune System Homeostasis
Amine Achachi1, Marc Vocanson1, Vincent Gaillard1, Gaëlle Poyet1, Josette Peguet-Navarro2, 
Isabelle Castiel-Higounenc3, Jean-François Nicolas1, Audrey Gueniche3 1INSERM, U851, Lyon, 
France, 2Université Lyon 1, Lyon, France, 3L’Oreal recherche innovation, Clichy, France
UV injury profoundly affects the skin immune homeostasis by promoting both inflammation and 
immunosuppression. Here, we characterized the hematopoietic cells that colonize human epidermis in 
the days following UV exposure, in 27 healthy volunteers exposed twice to 1.5 minimal erythema doses. 
Suction blister fluids and roofs were collected 1, 4 and 10 days after UV exposure from non-irradiated 
and irradiated skin areas and used for ELISA and identification of epidermal cells using 6 to 8-color 
flow cytometry analysis. As expected, UV exposure induced a marked upregulation of proinflammatory 
cytokines including TNFα, IL-6, IL-8 and the anti-inflammatory cytokine IL-10 in suction blister fluids 
raised one day post-irradiation. The UV-induced inflammatory environment promotes a rapid activation 
and migration of Langerhans cells (LCs) out of the epidermis, that correlates with the tissue infiltration of 
CD45+CD1a-CD14+CD36+CD163+CD206+ monocytic/macrophagic cells and lymphocytes, one day post-
irradiation. More importantly, whereas classical CD45+CD1ahiCD1c+CD207+CD14-CD36-CD206- LCs 
were the unique dendritic cell (DC) subset in un-irradiated epidermis, we detected two new subsets of 
CD1alowCD1c+CD207-CD14-CD36+/-CD206+ and CD1alowCD1c+CD207+CD14-CD36+/-CD206+ DCs that 
sequentially repopulated epidermis 1 and 4 days post irradiation and exhibit efficient allostimulatory 
function. These DC subsets differed from classical epidermal LCs by the expression of the CD206 mannose 
receptor that has been earlier described on inflammatory dendritic epidermal cells (IDECs) found in 
several inflammatory skin diseases. Finally, LCs almost represent the only haematopoietic cell population 
in the epidermis on day 10 post-irradiation. In conclusion, the newly described DC subsets may actively 
participate to the recovery of the epidermal immune function following UV exposure.
599
Extracorporeal Photopheresis in the Treatment of Bronchiolitis Obliterans Syndrome after Lung 
Transplantation: the Vienna Experience
Robert Knobler, Ulrike Just, Walter Klepetko, Peter Jaksch Medical University of Vienna, Austria
Since 1998 Extracorporeal photopheresis (ECP) is used to treat acute and chronic rejection in 
lung transplant recipients. Data supporting its use for bronchiolitis obliterans syndrome (BOS) 
after lung transplantation are limited. We evaluated efficacy and safety of ECP for progressive 
BOS in a prospective manner. Between 10/ 2000, and 6/2010, 47 lung allograft recipients were 
treated for progressive BOS. Only patients with a minimum follow up of 6 months were included 
( n=45). Time from lung transplantation to BOS grade 1 was 1216±898 days (mean±SD)(range 
161-4306 days). The interval between initiation of BOS 1 and start of ECP was 255±332 days. 
Mean number of ECP cycles was 16. During the 6-month period before the initiation of ECP, the 
average rate of decline in forced expiratory volume in 1 second (FEV1) was -123.0 ml/month, but 
the slope decreased to -13 ml/month during the 3-month period after the initiation of ECP and 
-16ml/month during the 12month period . The mean difference in the rate of decline between 
this 12-month period and the period before ECP was 42/ month (95% CI, 71-130 ml/month; 
p =0,006). The FEV1 improved in 17% of patients over 1 year after the initiation of ECP, 11% 
showed an improvement for only 3-6 months, FEV1 stabilized in 36% and showed a progressive 
decline in 36%. ECP reduces the rate of decline in lung function associated with progressive 
BOS. Subgroups of patients responded with an improvement or stabilization of FEV1 for over 1 
year. Future studies are warranted.
600
Alkinnin regulates HSP70 expression in human keratinocytes exposed to UVB
Yoko Yoshihisa, Mariame Ali Hassan, Yukihiro Furusawa, Takasi Kondo, Tadamichi Shimizu 
University of Toyama, Toyama, Japan
Alkannin is an active constituent from the root extract of Alkanna tinctoria of the Boraginaceae 
family and it may have utility as heat shock protein 70 (HSP70) inducer in living organisms. 
Here, the effects of alkannin-induced HSP70 on UVB (40 mJ/cm2)-induced apoptosis were 
investigated in human keratinocyte HaCaT cells. Pretreatment of the cells with alkannin (1 µM) 
caused significant inhibition of UVB-induced apoptosis in HaCaT cells. Moreover, pretreatment 
with alkannin decreased UVB-induced cleavage of caspase-3. On the other hand, the stimulation 
of HSP70 inhibitor (KNK437) increased UVB-induced apoptosis in a dose-dependent manner. 
In addition, differences in gene expression were investigated using a genechip, associated with 
the suppression of UVB-induced apoptosis in presence of alkannin. The results indicate that 
alkannin suppress UVB-induced apoptosis via the induction of HSP70 in human keratinocytes, 
and therefore, this result suggests the usefulness of the compound as antiaging agent.
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Numerical simulation of the interaction of radiation ultraviolet with human skin
John Jairo Sandoval llanos Universidad Antonio Nariño, Bogota, Colombia
Geant4 is a toolkit for the simulation of the passage of particles through matter. Its areas of 
application include high energy, nuclear and accelerator physics, as well as studies in medical 
and space science. [1] The validate of Geant4 in medical physics applications was performed 
some time ago in this paper the results obtained with Geant4 are compared with codes widely 
used in medical physics: MCNP, EGS4, and EGSnrc, when possible, the simulation results are 
also compared to experimental data, finally they conclude that Geant4 is a promising Monte 
Carlo simulation toolkit for low-energy medical applications. We developed a computational 
program based on Geant4 for simulate the interaction of ultraviolet radiation with human 
skin. Whit this new tool we can study the physical behavior of each photon in human skin. 
We take in to account some physical procces as Rayleigh scattering, photon absortion and 
boundary procces. Skin is modeled as a water block with different percentages of eumelian. 
We still do not have a complete picture of the macromolecular structure of the eumelian 
pigment nevertheless some physical and chemical properties are known. This propierties also 
take account in the software. The first result in our work is the band UV absorption spectrum. 
[1] http://www.geant4.org/geant4/
602
Suppression of UV-induced Wrinkle Formation by Expression of HSP70
Minoru Matsuda1,2, Tohru Mizushima3 1Graduate School of Medical and Pharmaceutical Sciences, 
Kumamoto University, Kumamoto, Japan, 2Saishunkan Pharmaceutical Co., Ltd., Kumamoto, 
Japan, 3Faculty of Pharmacy, Keio University, Tokyo, Japan
The skin is damaged by ultraviolet (UV) irradiation (photo-aging). UV-induced skin both 
hyperpigmentation disorders due to abnormal melanin production and wrinkle formation due 
to degradation and degeneration of extracellular matrix (such as collagen and elastic fibers) are 
major clinical and cosmetic problems associated with photo-aging. Inflammation-mediated 
abnormal activation of matrix metalloproteinases (MMPs) and elastase is believed to play an 
important role in UV-induced wrinkle formation. Expression of heat shock proteins (HSPs), 
especially HSP70, is induced by various stressors, including UV irradiation. We recently found 
that expression of HSP70 at the skin inhibits UV-induced not only inflammatory damage but 
also melanin production. In this study, we examined the effect of expression of HSP70 on UV-
induced pathological and mechanical alterations related to wrinkle formation by using transgenic 
mice expressing HSP70. UV-induced epidermal hyperplasia and degradation and degeneration 
of collagen and elastic fibers were significantly suppressed in transgenic mice expressing 
HSP70. The skin elasticity decreased after UV-irradiation and this decrease was suppressed 
in the transgenic mice. UV-induced activation of MMPs and elastase were also suppressed in 
the transgenic mice. The suppression of UV-induced epidermal hyperplasia, degradation and 
degeneration of collagen and elastic fibers and decrease in skin elasticity was also observed 
in the heat-treated skin of hairless mice. Furthermore, UV-induced wrinkle formation was also 
suppressed by this heat treatment. This study provides the first evidence of an inhibitory effect 
of HSP70 on UV-induced wrinkle formation. We propose that HSP70 inducers are beneficial for 
UV-induced wrinkle formation.
603
Prevention of UVB Radiation-induced Epidermal Damage by Expression of Heat Shock Protein 70
Tohru Mizushima1, Minoru Matsuda2,3, Ryutaro Shinya3 1Faculty of Pharmacy, Keio University, 
Tokyo, Japan, 2Saishunkan Pharmaceutical Co., Ltd., Kumamoto, Japan, 3Graduate School of 
Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Irradiation with UV light, especially UVB, causes epidermal damage via the induction of 
apoptosis, inflammatory responses, and DNA damage. Various stressors, including UV light, 
induce heat shock proteins (HSPs) and the induction, particularly that of HSP70, provides cellular 
resistance to such stressors. The anti-inflammatory activity of HSP70, such as its inhibition of 
nuclear factor kappa B (NF-κB), was recently revealed. These in vitro results suggest that 
HSP70 protects against UVB-induced epidermal damage. Here we tested this idea by using 
transgenic mice expressing HSP70 and cultured keratinocytes. Irradiation of wild-type mice 
with UVB caused epidermal damage such as induction of apoptosis, which was suppressed 
in transgenic mice expressing HSP70. UVB-induced apoptosis in cultured keratinocytes was 
suppressed by overexpression of HSP70. Irradiation of wild-type mice with UVB decreased 
the cutaneous level of IκB- α (an inhibitor of NF-κB) and levels of pro-inflammatory cytokines 
and chemokines in the epidermis. These inflammatory responses were suppressed in transgenic 
mice expressing HSP70. In vitro, the overexpression of HSP70 suppressed the UVB-induced 
expression of pro-inflammatory cytokines and chemokines and increased the level of IκB-α. 
UVB induced an increase in cutaneous levels of cyclobutane pyrimidine dimers and 8-hydroxy-
2’-deoxyguanosine, both of which were suppressed in transgenic mice expressing HSP70. We 
also suggested that the repair of damaged DNA is stimulated by HSP70. This study provides 
genetic evidence that HSP70 protects the epidermis from UVB-induced radiation damage. The 
findings here also suggest that the protective action of HSP70 is mediated by anti-apoptotic, anti-
inflammatory, and anti-DNA damage effects.
604
Integrated Testing In Vitro Strategy For Assessment Of Chemical-Induced Phototoxicity
Laurent Marrot, Jean Phillipe Belaïdi, Damien Lelièvre, Philippe Perez, Stéphanie Ringeissen, 
Gladys Ouedraogo, Jean Roch Meunier L’Oreal Advanced Research, Aulnay sous Bois, France
Sunlight absorbing chemicals used in drugs, cosmetics or food sometimes produce adverse 
photobiological effects when present in skin upon UVA exposure. There is thus a need for 
methodologies providing relevant data at the molecular and cellular levels for detecting 
photoreactivity of such compounds. For ethical and practical reasons, in a context where 
photo(geno)toxicity assessment on animals is banned by the seventh amendment of the European 
Cosmetic Directive, in vitro models have got an increasing importance in safety screening. Here, 
we propose a strategy using complementary tools aiming at anticipating the phototoxic potential 
of chemicals. First, a silico model was defined in order to predict the photo-pro-oxidant potential 
of a drug. Then, complementary methods with increasing complexity are implemented in order to 
get a rational evaluation of the phototoxic risk in exposure conditions mimicking daily sunlight: 
(i) supercoiled circular DNA for in tubo assessment of photoreactivity, (ii) in addition to the 
validated 3T3 NRU test, use of normal cultured human skin cells where photogenotoxicity can 
be detected using the comet assay (iiii) and finally reconstructed skin where cell death as well 
as DNA damage can be measured after either systemic or topical application of the studied 
chemical. Such a strategy allows the evaluation of compounds with various physico-chemical 
properties, and it is thus particularly well adapted to rigorously ensure the safety of products 
likely to be exposed to sunlight.
605
Neonatal mice do not have increased photocarcinogenic sensitivity
Catharina Lerche1, Thomas Poulsen1,2, Hans Christian Wulf1 1Bispebjerg University Hospital, 
Copenhagen NV, Denmark, 2Soenderborg Hospital, Soenderborg, Denmark
Squamous cell carcinoma (SCC) is linked with the lifelong cumulative effect of ultraviolet 
radiation (UVR). In contrast, epidemiological data have shown that sunburn in childhood is 
a stronger risk factor for cutaneous malignant melanoma than continuous UVR, indicating a 
higher carcinogenic sensitivity early in life. We investigated how high neonatal doses of UV 
affect the development of SCC in mice irradiated later in life with two different kinds of radiation. 
We used simulated solar radiation (SSR), which is similar to natural sun, and solarium radiation 
(SR), as found in many sunbeds. We used 99 C3.Cg/TifBomTac-immunocompetent hairless mice 
divided into 6 groups. The groups received 0. 25 or 35 standard erythema doses (SED) UVB 
radiation when they were 4 days old followed by 4-SED-SSR or 4-SED-SR 3 times/weekly from 
9- to 52-weeks of age.Tumours developed faster in mice treated with 35-SED-UV+4 SED-SSR 
compared with 4-SED-SSR, but no change was observed in the cumulative dose required for 
tumour development. Tumours also developed faster in mice treated with 35-SED-UV+4-SED-SR 
compared with 4-SED-SR, and a difference was also observed in the cumulative dose required 
for tumour development. If we used the SCUP-m spectrum instead of the CIE-erythema action 
spectrum, tumours developed after the same accumulated dose. In conclusion, it did not matter 
when the neonatal UV dose was given since the cumulative UV dose was the only important 
factor. Furthermore, this study does not indicate higher photocarcinogenic sensitivity early in life.
606
Vitamin D deficiency in Central Poland Farmer families
Joanna Narbutt, Michal Rogowski-Tylman, Anna Sysa-Jedrzejowska, Aleksandra Lesiak 
Department of Dermatology, Medical University of Lodz, Lodz, Poland
Environmental factors, mainly ultraviolet radiation and nutrition are considered as major 
determinants of vitamin D level in human beings. Over 90% of daily vitamin D demand is 
produced in the skin under sunlight. Most human photobiological research has been performed 
with acute doses of UVR in healthy adult volunteers, however there is an little evidence on vitamin 
D synthesis due to natural solar exposure. Thus, the aim of study, within the EC-funded ICEPURE 
project, was to assess the fluctuation of 25-hydroxyvitamin D (25OH)D serum concentrations 
between January and September 2010 in Polish farmer families. The study group consist of 109 
healthy volunteers from Central Poland (49 adults, 60 children; mean age of adults 38 y.o., mean 
age of children 13 y.o; phototypes I-IV). The serum level of vitamin D was measured 4 times: in 
January, April, July and September. They were advised to use sunscreens according to their usual 
habits. The mean serum concentration of 25 (OHD) was 22.5 ng/ml, 27.4ng/ml, 25.3 ng/ml and 
20.5 ng/ml, respectively and these changes were statistically significant (p<0.0001). Although we 
observed the significant increase in serum 25(OH)D level during summer months, it should be 
underlined that vitamin D values in each period were below optimal serum concentration. The 
obtained results showed deficiency of vitamin D level in Polish farmers and indicate the necessity 
of its supplementation in this particular population.
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The relation between sunscreen layer thickness and the vitamin D blood level in humans - a 
randomised clinical trial
Annesofie Faurschou, Ditte M Beyer, Morten Bogh, Peter A Philipsen, Hans Christian Wulf 
Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark
Vitamin D is produced in the skin upon exposure to the short-wave ultraviolet radiation (UVB) 
of sunlight. It has been described that vitamin D deficiency may increase the risk of certain 
cancers, cardiovascular disease, and autoimmune disease. One of the major concerns has been 
that sunscreen use may lead to vitamin D deficiency. However, the vast majority of people put 
on sunscreen in layers that are way too thin to achieve the intended protection. The purpose 
of the present study was to investigate the relation between the amount of sunscreen applied 
and the vitamin D blood level in humans. Thirty-seven healthy volunteers with light skin types 
were randomised into five groups that were treated on the torso with an organic sunscreen SPF8 
in different amounts: 0 mg/cm2, 0.5 mg/cm2, 1 mg/cm2, 1.5 mg/cm2, and 2 mg/cm2. Twenty 
minutes after sunscreen application, the participants were irradiated with UVB. This procedure 
was repeated four times with three days apart. Blood samples were drawn three days after the 
last irradiation to determine the serum vitamin D level expressed as 25-hydroxyvitamin D(3) 
(25(OH)D). In contrast to theoretical estimations, the results of the this study showed that 
applying a sunscreen SPF8 in the recommended amount of 2 mg/cm2 only reduces the increase 
in vitamin D production 4-fold upon exposure to UVB compared with no use of sunscreen. Our 
study moreover revealed that the vitamin D blood level increases in an exponential manner with 
decreasing thickness of sunscreen layer. This may add importantly to the debate on sunscreen use 
and vitamin D production.
608
Effects of the Interplay between UVA and UVB Radiation on Apoptosis, Proliferation, and DNA 
Damage in Normal Human Melanocytes
Christian Jantschitsch1, Agatha Schwarz2, Hubert Pehamberger1, Dagmar Födinger1 1Division 
of General Dermatology, Department of Dermatology, Medical University of Vienna, Vienna, 
Austria, 2Department of Dermatology, Kiel University, Kiel, Germany
In contrast to non-melanoma skin cancer, the exact correlation between melanoma and sun 
light is not clear. Although sun light contains both UVA and UVB in varying proportions, so far 
mostly the effects of particular spectra were studied. Hence, we investigated the impact of the 
interplay between UVA and UVB on normal human melanocytes. Cells were exposed to 20 J/cm² 
of UVA-1 (340-400 nm) and 0.4 J/cm² of UVB (290-320 nm) simultaneously and 24 hours later 
apoptosis was determined. In comparison to exposure to UVB only, simultaneous irradiation with 
UVA-1 and UVB significantly reduced the apoptotic rate. In addition, the proliferative capacity 
of melanocytes was determined using colony formation assays. Compared to treatment with UVB 
alone, simultaneous exposure to UVA-1 and UVB resulted in a remarkably increased proliferative 
capacity. To assess the influence of UVA-1 on UVB-induced DNA damage, the amounts of 
cyclobutane pyrimidine dimers (CPD) were evaluated 6 hours after exposure to 0.08 J/cm² of 
UVB using South-Western dot-blot analysis. Simultaneous irradiation of melanocytes with UVA-1 
and UVB induced comparable amounts of CPD as UVB alone, indicating that UVA-1 does not 
influence DNA-repair. In summary, UVA-1 might contribute to melanomagenesis via supporting 
survival and proliferation of melanocytes carrying UVB-induced DNA damage.
609
Skin compartments of different body areas harbour different amounts of mitochondrial 
deletions in aged wildtype mice
Jennifer Knoch1, York Kamenisch1, Hartmut Geiger2, Martin Röcken1, Karin Scharffetter-
Kochanek2, Mark Berneburg1 1University Tübingen, Germany, 2University Ulm, Germany
Mutations of mitochondrial DNA play a causative role in aging of the skin including subcutaneous 
fat. We could previously show that the so called mitochondrial common deletion, a long-term 
marker for oxidative stress, is increasing in an age-associated manner in subcutaneous fat from 
the facial area of mice deficient in the repair of oxidative stress. Here, we investigated whether 
these mutations are also present in aged wildtype mice and whether reduction of subcutaneous 
fat is also associated with increased mutations of mitochondrial DNA at other body sites than 
the face. To address this question, skin samples of wildtype mice of different ages (3-4months 
and 18-24 months) and different body areas (forehead, cheek, neck, shoulder, lower and medial 
back, breast and pads of the fore limbs and hind limbs) were taken, dissected in epidermal, 
dermal and subcutaneous fat compartments and subsequently screened for mitochondrial DNA 
deletions. Dermal and epidermal compartments showed low levels of mitochondrial deletions 
and no significant age dependent increase of mitochondrial deletions in any investigated 
body areas. While epidermal and dermal compartments of all investigated body areas display 
only mild accumulation of mitochondrial deletions, there is an age dependant increase of the 
mitochondrial deletion in subcutaneous fat. This is particularly increased in the pads of the fore 
limbs compared to all other body sites. These results indicate that mitochondrial DNA deletions 
are increased in those areas of the body where prominent reduction of subcutaneous loss is 
observed in humans during the normal aging process.
610
Cis-urocanic acid modulates claudin-1 expression and tight junction function in human 
keratinocytes
Cath O’Neill, Neil Gibbs University of Manchester, Manchester, UK
Exposure of human skin to solar simulated ultraviolet radiation (UVR) transiently impairs skin 
barrier function (SBF) which recovers over a period of 2-14 days. Recent evidence suggests that 
epidermal tight junctions (TJ) in the granular layer are critically involved in maintaining SBF with 
mice lacking the TJ protein, claudin-1 (Cld-1) dying of dehydration within 24h of birth. Trans-
urocanic acid (trans-UCA) is a major epidermal chromophore located in the stratum corneum and 
exposure of human skin to UVR photoisomerises trans-UCA to cis-UCA. In a previous Affymetrix 
study, the Cld-1 encoding gene, CLDN1, was listed as one of several markers induced by cis- 
but not trans-UCA, in normal human epidermal keratinocytes (NHEK) We therefore examined 
UCA isomer-dependent changes in Cld-1 protein expression (assessed by immunoblotting) and TJ 
function (assessed as transepithelial electrical resistance; TEER) in differentiating NHEK in vitro. 
Cis-UCA produced a time and concentration dependent increase in Cld-1 protein which was 
maximal 48h post-treatment with 25µg/ml (increased ~ 3 fold; n=4, p=0.02). In cis-UCA treated 
cells, TEER was ~150 ohms/cm2 higher than in untreated cells (n=6, p=0.004). Similar effects 
were observed after treatment of NHEK with UVR-irradiated trans-UCA (comprising ~50% cis-
UCA). In contrast, trans-UCA had no effect on Cld-1 expression or TEER. This study demonstrates 
that cis-UCA upregulates Cld-1 protein levels and TJ function in NHEK in an isomer-specific 
manner. Our data suggest that production of cis-UCA from endogenous trans-UCA may have an 
important role in the recovery of human SBF following exposure to UVR.
611
Innovative Treatment Option for Moderate-to-Severe Generalized Plaque Psoriasis Using 
308nm-UVB Excimer Laser, Clobetasol Spray, and Calcitriol Ointment
Misha M. Heller1, Eric S. Lee2, Faranak Kamangar3, Kelly Park4, Tina Bhutani4, John Y.M. Koo4 
1University of Southern California, Keck School of Medicine, Los Angeles, California, USA, 
2University of Nebraska Medical Center, College of Medicine, Omaha, Nebraska, USA, 3University 
of California Davis, School of Medicine, Sacramento, CA, USA, 4University of California San 
Francisco, Department of Dermatology, San Francisco, CA, USA
Our objective was to determine the safety and efficacy of a combination therapy for the treatment 
of generalized psoriasis, using 308nm-UVB excimer laser, clobetasol spray, and calcitriol 
ointment.This is a 12-week on-going open-label, pilot study. All patients receive excimer laser 
treatments twice weekly for the first 6 weeks. For the remaining 6 weeks, only patients who 
achieve less than PASI 75 response or are concerned of falling below PASI 75 will continue twice 
weekly excimer laser treatments. In regards to topical therapies, the study is conducted in three 
distinct periods (A, B, and C). During Period A (weeks 1-4), patients use clobetasol spray twice 
daily. During Period B (weeks 5-8), patients use calcitriol ointment twice daily. During Period 
C (weeks 9-12), patients use clobetasol spray twice daily and calcitriol ointment twice daily. 
Ten patients have been recruited. 7/9 (78%) patients who completed the first 6 weeks achieved 
PASI 75. 4/5 (80%) patients who completed all 12 weeks achieved PASI 75. Preliminary data 
is promising. This treatment regimen for generalized psoriasis has thus far demonstrated both 
outstanding efficacy and fast onset of action. Clobetasol spray may be an ideal partner to the 
excimer laser, enhancing the efficacy of treatment and minimizing the risk of phototoxic reaction 
from aggressive UVB irradiation. Calcitriol ointment provides the required steroid holiday to 
prevent adrenal suppression. Thus, this approach may be effective and feasible for a significant 
proportion of patients with generalized psoriasis with <20% body surface area involvement and 
reasonably confluent plaque configuration.
612
NADPH depletion in human normal dermal fibroblasts transiently enhances tolerance against 
ROS
Hitoshi Masaki, Yuri Okano Tokyo University of Technology, Hachioji/Tokyo, Japan
It had been established that the intracellular oxidative stress is one of important triggers and 
promoters in aging process. The intracellular redox potential is regulated by the concentrations of 
oxidants and reductants. Among the intracellular reductants, NADPH is a ubiquitous reductant 
and produced by glucose-6-phosphate dehydrogenase (G6PDH) in the pentose phosphate 
pathway. The purpose of the study is to address the influence of NADPH depletion in human 
normal dermal fibroblasts (HNDF) focusing on tolerance against ROS. NADPH depletion 
was achieved by treatment with an inhibitor of G6PDH, 6-aminonicotinamide (6-AN). 6-AN 
suppressed NHDF proliferation without cytotoxicity. In addition, NHDFs treated with 6-AN for 
24 h prospectively showed an elevation of intracellular ROS level detected by ROS-sensitive 
fluorescence probes. However, tolerances of 6-AN treated cells against UVB and H2O2 gave 
paradoxical augmentation. To address reasons of the high torelance, we measured intracellular 
SH level and catalase-like H2O2 scavenging activity in cells. NHDFs treated with 6-AN exhibited 
an elevation of SH level and H2O2 scavenging activity according to up-regulations of antioxidant-
relating mRNA expression such as catalase and γ-glutamylcystenyl synthase. On the other 
hand, HNDFs treated with 6-AN for 6 days showed a reduction of a tolerance against H2O2 
and an elevation of intracellular protein carbonylation. The successive depletion of NADPH 
prospectively increased susceptibility against ROS. However, the transient augmentation by 
a short-term NADPH depletion might be realized by switching on a SOS system like sirtuin 
activation. In the study, we presented the paradoxical behavior of NADPH depletion.
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Photoprotective properties of endogenous urocanic acid in human skin
Joanne Tye1, Zenas Yui1, John Walter2, Christopher E.M. Griffiths1, Neil K. Gibbs1 1Dermatological 
Sciences, School of Translational Medicine, University of Manchester, Manchester, UK, 2Willink 
Biochemical Genetics Unit, University of Manchester, Manchester, UK
We examined the ‘natural sunscreening’ properties of endogenous urocanic acid (UCA) we 
quantified UVB-induced skin photodamage in normal subjects and subjects with histidinaemia, 
a rare (1 in 11 000) genetic condition who lack epidermal UCA. Histidinaemic (n = 6) and 
healthy age, sex and skin phototype matched control (n = 6) subjects were recruited. HPLC 
confirmed that control subjects had normal levels of skin UCA which was not detectable in 
histidinaemic subjects. 24h after skin exposure to a range (20-200 mJ/cm2) of broadband UVB 
(TL-12; 280-315 nm) doses, erythema was quantified using a Diastron reflectometer. Epidermal 
thickness, thymine dimers (T^T), p53 protein, active caspase-3 and TUNEL were quantified 
by immunohistochemistry in biopsies taken from the 200 mJ/cm2 site. The mean (± SE) UVB 
dose causing minimal erythema (D0.025) in histidinaemics was significantly lower than in control 
subjects (P < 0.05; 31 ± 3 and 64 ± 11 mJ/cm2 respectively) suggesting a UVB protection factor 
of approximately 2. UCA photoprotection was evident across a UVB dose range of 40-117 
mJ/cm2 (P < 0.04) above which erythema was not significantly different in histidinaemics and 
normals. At a dose of 200 mJ/cm2 the presence of UCA did not influence UVB-induced epidermal 
thickening, T^T and P53 levels (P > 0.05). However, there was a significantly lower levels of 
TUNEL (p<0.05) and reduced active caspase-3 in normal skin suggesting protection against UVB-
induced apoptosis.This study is the first to demonstrate a photoprotective role for endogenous 
UCA in human skin in vivo.
614
The study of apoptosis induced by ultraviolet B radiation in HaCat cells
Na Wang, Hongguang Lu Dept. of Dermatology,Affiliated Hospital of Guiyang Medical University, 
Guiyang, China
We investigated the effect of apoptosis of HaCat cells irradiated by UVB in different doses 
and its mechanism. MTT assay was used to test the viability of HaCat cells, flow cytometry to 
measure apoptosis rate, a specific ELISA to detect the concentration of tumor neurosis factor-
α,and light and transmission electron microscope to observe the ultrastructure of HaCaT cells 
. It was found that 10-30 mJ/cm2 UVB irradiation can induce apoptosis of cultured HaCat 
cells, which was observed by transmission electron microscope and also examined by flow 
cytometry. There were negative linear correlation between HaCaT cell apoptotic rate and its 
proliferation. The increasing secrete content of TNF-α in cultured medium of HaCat cells was 
checked after irradiation, and the apoptosis rate and concentration of TNF-α got to be a positive 
linear correlation. We conclude that UVB can induce apoptosis in HaCat cells, and TNF-α may 
contribute to the induction of apoptosis.
615
MC1R Expression in HaCaT Keratinocytes Inhibits UVA-Induced ROS Production via EGFR and 
cAMP-Dependent Mechanisms
Pauline Henri1, Sylvain Beaumel4, Anne Guezennec2, Carine Poumes2, Pierre-Emmanuel 
Stoebner1,3, Marie-José Stasia4, Joëlle Guesnet2, Jean Martinez1, Laurent Meunier1,3 1Institut 
of Biomolecules Max Mousseron (IBMM), University Montpellier I and II, UMR CNRS 5247, 
Montpellier, France, 2Yves Saint Laurent Researche and Developpement, Neuilly sur Seine, 
France, 3Department of Dermatology, University Hospital Caremeau, Nîmes, France, 4Chronic 
Granulomatous Disease Diagnosis and Research Center (CDiReC), University Hospital Grenoble, 
Therex-TIMC/Imag UMR CNRS 5525, University Joseph Fourier, Grenoble, France
Melanocortin-1 Receptors (MC1R) are G protein-coupled receptors that may be induced in keratinocytes after 
ultraviolet (UV) exposure. UVA stimulate reactive oxygen species (ROS) production in keratinocytes via a Nox1-
based NADPH oxidase mechanism and recent findings suggest that PKA-dependent phosphorylation of the 
regulatory NoxA1 subunit is a new pathway for inhibition of ROS production. To investigate the effect of MC1R 
signaling on UVA-induced ROS (UVA-ROS) production, we generated HaCaT cells that stably express human 
MC1R (HaCaT-MC1R) or the Arg151Cys (R151C) non-functional variant (HaCaT-R151C). We assessed ROS production 
immediately after UVA exposure and found that UVA-ROS production was strongly reduced in HaCaT-MC1R but 
not in HaCaT-R151C cells compared to parental HaCaT cells. This inhibitory effect was further amplified by alpha-
melanocyte stimulating hormone (α-MSH) treatment of HaCaT-MC1R cells before UVA exposure. NADPH oxidase 
inhibitors such as apocynin and gp91 ds-tat inhibited UVA-ROS production in parental HaCaT and HaCaT-R151C 
cells but had minor effects on HaCaT-MC1R cells. After UVA irradiation, NoxA1 phosphorylation was increased 
in HaCaT-MC1R compared to HaCaT and HaCaT-R151C cells. Inhibition of PKA in HaCaT-MC1R cells resulted in 
a marked increase of UVA-ROS production. Inhibition of epidermal growth factor receptor (EGFR) or extracellular 
signal-regulated kinases (ERK) resulted in a reduction of α-MSH-induced cAMP production and stimulated PKA-
induced phosphorylation of NoxA1 in HaCaT-MC1R cells. The ability of HaCaT-MC1R cells to produce UVA-ROS 
was restored by inhibiting EGFR or ERK activity before UVA exposure. Our findings suggest that constitutive activity 
of MC1R in keratinocytes may reduce UVA-induced oxidative stress via EGFR and cAMP-dependent mechanisms.
616
UVA1 induces key gene changes associated with inflammation, response to hypoxia, 
immunosuppression and extracellular remodelling in vivo in humans
Angela Tewari1,2, Dimitra Dafou2, Robert Sarkany1,2, Antony Young1,2 1St John’s Institute of 
Dermatology, Guy’s Hospital, London, UK, 2Division of Genetics and Molecular Medicine, King’s 
College, London, UK
UVA1(340-400nm) makes up 75% of solar ultraviolet radiation(UVR), and UVA1 carcinogenicity 
is under scrutiny. UVA1 phototherapy is increasingly being used, and it also plays an important 
role in induction of several photodermatoses. Despite this, little is known of its mode of action 
in vivo. 5 healthy skin type I/II volunteers (mean 22.9 years) were exposed to 50J/cm2 UVA1 (~1 
MED) on sun-protected skin, and biopsies taken 6 and 24h post-irradiation. Gene expression 
profiles with Agilent microarray platforms, Rosetta Resolver software, GeneGo and DAVID were 
used. In total, 1620 genes were upregulated and 952 genes were down regulated at 6h, and 
1265 genes were upregulated and 1015 genes down regulated at 24h(p = <0.01, FDR<0.2). 193 
and 87 were upregulated at 6 and 24h respectively (threshold ³2 fold increase(p£0.01), with 21 
upregulated at both 6 and 24h. Key pathways included genes involved in inflammation(p=3e-3), 
apoptosis (p=3.82e-15), response to hypoxia(p=1.988e-11) at 6h, and extracellular matrix 
remodelling(p=4e-3) at 24h. Genes of interest include MMP1,MMP3,MMP9,MMP12,IL6,IL8,I
L1B,TNF,IL20,HMOX, PTGS2 and were confirmed by RTqPCR. Interestingly IL20: key in tissue 
remodelling and wound healing is markedly overexpressed and this UVR increase has not been 
demonstrated before. There is an average 50 fold increase at 6h and 100 fold at 24h with MMP12 
and this is also a new finding. CD83, a positive regulator of IL10, was highly expressed at 6h 
and 24h. Our data suggests that UVA1 has profound effects on human skin, which is unique and 
different to the current in vivo literature on UVB gene expression.
617
Cytoprotection and improved DNA repair in UVB-exposed keratinocytes upon treatment with 
the cell-penetrating antioxidant OTZ
Lionel Valenti1, Frédéric Maccario1, Mathilde Frechet2 1Sedifa-Laboratoire, Monaco, Monaco, 
2Exsymol, Monaco, Monaco
Ultraviolet (UV) is the most important environmental factor involved in skin aging and skin 
photocarcinogenesis. Actually, UV wavelengths constitute a major genotoxic stress by inducing 
direct and indirect [reactive oxygen species (ROS)-dependent] DNA damages. Eukaryotic cells 
have evolved two strategies: inducing repair mechanisms in order to counteract the deleterious 
effects of DNA lesions or inducing apoptosis in order to escape from genomic instability. We have 
investigated the effect of 2-oxo-1,3-thiazolidine (OTZ), a cell-penetrating antioxidant, on UVB-
induced DNA damage and repair in a human skin keratinocyte cell line, HaCaT. OTZ, added 
immediately after UVB exposure was able to interfere with DNA damage formation. In addition, 
cell cycle arrest and apoptosis were assessed by flow cytometry, demonstrating the cytoprotective 
efficiency of OTZ. Repair kinetics of Cyclobutane pyrimidine dimers (CPDs), one of the 
predominant UVB-induced photoproduct, showed that keratinocytes pre-treatment with OTZ 
improves the repair efficiency of these lesions. These results correlate with increased expression 
of Nucleotide Excision Repair (NER) proteins. γH2Ax, the phosphorylated form of the histone 
H2Ax, described as a key factor in the repair process of Double Strand Breaks (DSBs), is recruited 
to damage site and in turn recruits other DNA repair machinery. We show that UVB-induced 
γH2Ax is decreased in OTZ pre-treated cells. In conclusion, OTZ exerts a protection against 
UVB-induced DNA damages by limiting their formation and by enhancing repair processes.
618
A broad spectrum sunscreen effectively prevents gene modulation induced by daily ultraviolet 
light
Claire Marionnet1, Cécile Pierrard1, François Lejeune1, Philippe Bastien1, Thierry Cotton1,2, 
Béatrice Renault1,2, Françoise Bernerd1 1L’Oréal Research and Innovation, Clichy, France, 2L’Oréal 
Research and Innovation, Chevilly-Larue, France
Realistic non-zenithal solar ultraviolet exposure, obtained using standard ultraviolet daylight 
spectrum (DUVR), has deleterious impact on epidermal and dermal compartments of human 
skin from clinical to molecular alterations. Here was tested the protective effect of a broad 
spectrum sunscreen on human reconstructed skin exposed to DUVR at gene expression level. 
Reconstructed skins were exposed to 12 J/cm² DUVR (physiological dose) with or without 
prior use of the sunscreen (SPF 13, IP-PPD 10.5). Six hours post exposure, gene expression was 
investigated in fibroblasts (224 genes) and keratinocytes (242 genes) separately using quantitative 
PCR arrays. Genes showing modulation ratio above 2 and adjusted p value < 0.05 (Student’s t 
test) were considered as significantly modulated. Hierarchical clustering allowed us to gather 
conditions showing similar gene expression profiles. DUVR exposure led to gene expression 
alterations in the dermal fibroblasts and the epidermal keratinocytes, with 35 and 66 significantly 
modulated genes, respectively. The modulated genes were involved in extracellular matrix 
homeostasis, oxidative stress, cell growth, inflammation and epidermal differentiation. DUVR 
effect on gene modulation was significantly reduced by sunscreen use. Hierarchical clustering 
showed that gene expression profiles in DUVR-exposed but protected samples were very close 
to those of unexposed samples. Sunscreen application led to a strong decrease in the number 
of modulated genes following DUVR exposure since only zero and 4 genes were significantly 
modulated in fibroblasts and keratinocytes, respectively. We showed that a broad-spectrum 
sunscreen product is highly effective in protecting human skin against daily UV radiation- 
induced alteration of gene expression.
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Influence of oral long chain omega-3 polyunsaturated fatty acids on cutaneous prostaglandin 
E2: E3 ratio and photoimmunosuppression in humans
Suzanne Pilkington1, Karen Massey2, Susan Bennett1, Khaled Roshdy1, Naser Al-Aasswad2, Anna 
Nicolaou2, Lesley Rhodes1 1The University of Manchester, UK, 2The University of Bradford, UK
Omega (n)-3 PUFA eicosapentaenoic acid (EPA) reduces local and systemic photoimmunosuppression 
in mice. We hypothesise the same phenomenon occurs in humans and is mediated by increased 
skin levels of PGE3, partial agonist of immune-suppressive PGE2. We assessed the impact of oral 
EPA on photoimmunosuppression using a nickel contact hypersensitivity (NiCHS) model, and 
examined for changes in skin EPA and PG. In a double-blind randomised controlled trial, 72 
females (23-59y, phototype II, nickel-sensitive) took 4g capsules of n-3 PUFA (70%EPA/10%DHA) 
or placebo (medium-chain triglyceride(GTCC)) daily for 3months. Blood samples were collected 
at 0 and 3m, along with biopsies and suction blister fluid from unirradiated and UV-irradiated 
skin. Red blood cell (rbc) and dermal EPA were measured using gas chromatography, and blister 
fluid PG by mass spectrometry. Post-supplementation, nickel was applied to 3 skin sites prior-
irradiated with SSR (1.9, 3.8, 7.6 J/cm2) for 3 consecutive days. NiCHS responses were measured 
using a reflectance instrument. Post-supplement EPA levels were higher in the active group, in rbc 
(mean3.61±SD1.25%wt vs 0.90±0.35%wt vs placebo, p<0.001) and dermis (0.12±0.03%wt vs 
0.06±0.03% wt, p<0.001). A trend for reduced %photoimmunosuppression was observed after 
n-3 PUFA, reaching statistical significance at 3.8J/cm2 vs placebo (p<0.05). Post-supplementation 
PGE2:PGE3 was lower in the n-3 PUFA vs placebo group, in both unirradiated (9:1 vs 19:1, (p<0.05) 
and UV-irradiated skin (10:1 vs 29:1, p<0.01). Thus, EPA accumulates in blood and skin, associated 
with a trend for abrogation of photoimmunosuppression. This may be mediated by the decreased 
cutaneous PGE2:PGE3 ratio, causing dampened UVR-PGE2 signalling.
620
Photooxidation of polyunsaturated membrane lipids in dermal fibroblasts generates stress 
signals and senescence- promoting oxidation products
Florian Gruber1, Valery N Bochkov1, Susanne Karner1, Veronika Mlitz1, Wolfgang Bicker3, Erwin 
Tschachler1,2 1Medical University of Vienna, Vienna, Austria, 2CE.R.I.E.S, Neuilly, France, 3FTC, 
Vienna, Austria
Uptake of polyunsaturated fatty acids, especially of the omega-3 conformation, is widely regarded 
to yield health benefits for mammals. In sun exposed skin, however, polyunsaturated fatty acids 
and membrane lipids are exposed to high oxidative stress, which may lead to their oxidation 
and formation of reactive degradation compounds. To investigate the spectrum of oxidation 
products formed in sun exposed dermal fibroblasts (FB), we did a targeted lipidomic analysis of 
PUFA supplemented and UVA-exposed FB using HPLC-MS/MS. We further investigated whether 
PUFA supplementation would promote cellular senescence in UVA-exposed FB or FB subjected 
to an H2O2 senescence protocol. We investigated senescence parameters on mRNA, protein 
and functional levels. The lipidomic analysis showed that a)Dermal fibroblasts incorporate 
supplemented free docosahexaenoic acid (DHA) into their membrane phospholipids; b) that 
DHA- supplemented FB have a higher content of oxidized PUFA lipids after UVA exposure and c) 
that PUFA supplementation enhances lipid peroxidation after UVA stress. When FB were grown 
in presence of lipid peroxidation products or on collagen matrix modified by lipid peroxidation 
products, transcriptional and cellular markers of senescence were enhanced. Furthermore, 
we could identify the lipid scavenging receptor “oxidized low density lipoprotein receptor 1” 
(OLR1) as a novel marker that shows specificity lipid-stress enhanced FB senescence. PUFA 
supplementation and subsequent exposure to oxidizing stress elicits an increased antioxidant 
response, but also increased lipid peroxidation and senescence in FB. Upon lipoxidative stress FB 
synthesize a scavenger receptor which may not only be a senescence marker also have functional 
relevance for oxidized lipid turnover.
621
Enhanced repair of UVB-induced DNA lesions in photolyase mRNA-transfected keratinocytes
Gábor Boros1, Dávid Rózsa1, Eszter Emri1, Georgina Nagy1, Edit Miko1, Attila Juhász1, István 
Juhász1, Gijsbertus van der Horst2, Hiromi Muramatsu3, Drew Weissman3, Katalin Karikó3, 
Gabriella Emri1, Éva Remenyik1, Irén Horkay1 1University of Debrecen, Debrecen, Hungary, 
2Erasmus University Medical Center, Rotterdam, The Netherlands, 3University of Pennsylvania, 
Philadelphia, USA
Cyclobutane pyrimidine dimers (CPDs) are the most frequent and deleterious photolesions 
induced by UVB irradiation. CPD photolyase repairs these photoproducts in a light-dependent 
manner but the enzyme is absent in humans. Here, we present a novel mRNA-based gene-
therapy method that directs functional photolyase synthesis in cultured human cells. Messenger 
RNA encoding photolyase of Potorous tridactylus was generated by in vitro transcription. 
Superior translation was achieved by codon-optimization and by incorporating pseudouridines, 
long polyA-tail and cap1 structure into the mRNA. The mRNA complexed with lipofectamine 
LTX was delivered into HaCaT cells and normal human epidermal keratinocytes where the 
encoded photolyase was detectable by western blot and immunocytochemistry (ICC) at least 72 
h posttransfection. To determine whether the photolyase is functional the mRNA-transfected cells 
were subjected to 20 mJ/cm2 UVB, followed by exposure to one hour visible light or darkness. 
Using ELISA and ICC, we detected 50% less CPD lesions in cells exposed to photoreactivating 
light, as compared to those deprived from this energy source required for photolyase activity. 
Photoreactivation also significantly reduced the antiproliferative effect induced by 60 mJ/cm2 
UVB. Thus, photolyase mRNA is a powerful tool to remove UVB-induced CPDs from cultured 
human keratinocytes, and has the potential for a therapeutic use in prevention of skin cancer.
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Assessment of solar radiation-induced tissue damage in pig ear skin organ culture and 
reconstructed human skin model
Daniel Bacqueville, Chloé Belles, Laure Duprat, Sandrine Bessou-Touya, Hélène Duplan Centre 
R&D Pierre-Fabre Laboratoire de Pharmacologie tissulaire et Pharmacocinétique cutanée, 
Toulouse, France
Reconstructed human epidermis models constitute an innovative alternative for phototoxicity 
and photoprotection studies in the cosmetic industry. However, little information is currently 
available concerning the harmful effects of solar-simulated radiation (SSR) in these in vitro skin 
models. In this study, the phototoxic effects of a single acute SSR dose of 165 kJ m-2 were evaluated 
in a newly engineered skin equivalent, and were compared to those obtained from an ex vivo 
skin organ culture recently developed from domestic pig ears. The SSR-induced cytotoxicity was 
associated to a significant release of the lactate dehydrogenase in the culture medium 24h after 
irradiation in both tissue models. Loss of skin viability was confirmed by using the tetrazolium 
salt reduction (MTT) assay. The tissue damage were correlated to the formation of sunburn cells, 
but also to the generation of DNA damage (thymine dimers and DNA fragmentation in situ), as 
respectively assayed by immunostaining and TUNEL technique. Interestingly, the DNA alterations 
coincided with the activation of the caspase-3 protease in both porcine and human basal 
epidermis. None of the above cellular responses was observed in non-irradiated skin, and the 
topical application of a broad-spectrum UVB + A sunscreen at a 2 mg/cm2 concentration afforded 
an efficient photoprotection. Thus, the organotypic human skin model responded in a similar 
fashion to pig skin following solar irradiation, suggesting that these two alternative skin models 
are complementary tools to assess SSR-induced phototoxicity and to evaluate sunscreen efficacy.
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A common pathway for age-related protein oxidation and photoageing
Sarah Thurstan1,2, Rachel Watson1,2, Christopher Griffiths1,2, Neil Gibbs1,2, Michael Sherratt1,3 
1Manchester Academic Health Sciences Centre, Manchester, UK, 2School of Translational 
Medicine, Manchester, UK, 3School of Regenerative Biomedicine, Manchester, UK
Remodelling of extracellular matrix (ECM) proteins as a result of solar ultraviolet radiation 
(UVR) exposure plays a key role in skin photoageing. We have recently demonstrated that UVR 
chromophore-rich fibrillin microfibrils undergo photodegradation following UV irradiation 
in a cell-free environment. In this study, we test the hypotheses that fibrillin microfibril 
degradation following UVR exposure: i) occurs via the photodynamic production of reactive 
oxygen species (ROS) and; ii) alters the susceptibility of resultant microfibril photoproducts 
to protease-mediated degradation. Fibrillin microfibrils were isolated from cultured human 
dermal fibroblasts. Microfibril structure after UVB irradiation (Phillips TL-12 source; 500mJ/
cm2) in ambient and O2-depleted conditions or after treatment with H2O2 (40mM; up to 2hrs) 
was quantified by atomic force microscopy (AFM). The effect of UVB irradiation (50mJ/cm2) on 
the susceptibility of microfibrils to MMP-3 proteolysis was also quantified by AFM.In ambient 
oxygen, UVB irradiation caused a dose-dependent decrease in median fibrillin microfibril flexion 
angle. However, in an O2-depleted environment the UVB mediated effects were significantly 
abrogated. Structural changes were mimicked by exposure to H2O2. Individually, UVB or MMP-3 
significantly decreased the median microfibril flexion angle. However, addition of MMP-3 to 
UVB irradiated microfibrils appeared to selectively degrade low flexion angle fibrillin microfibrils 
leaving a population with a median flexion angle that was not significantly different to the 
controls. These observations suggest that UVB degradation involves the photodynamic formation 
of ROS and that exposure to H2O2 can mimic the effects of UVB degradation. Furthermore, MMP-
3 appears to selectively degrade UVB-damaged fibrillin microfibrils in vitro.
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Alpha-MSH attenuates TNF-alpha-mediated NF-κB signaling and suppression of melanogenesis 
key enzymes in human melanocytes possibly by suppressors of cytokine signaling 1/3
Agatha Kokot, Markus Böhm Dept. of Dermatology, University of Münster, Münster, Germany
Suppressors of cytokine signaling (SOCS) are a family of proteins which negatively regulate 
cytokine signaling. SOCS are induced by several cytokines including interleukin (IL)-1, IL-6, 
tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta. These cytokines are 
produced by UVB irradiation of epidermal cells and suppress melanogenesis and proliferation. 
Since UVB also induces alpha-melanocyte-stimulating hormone (alpha-MSH), which increases 
proliferation and melanogenesis we hypothesized that this peptide may orchestrate the UVB-
response of melanocytes to the above cytokines. Our results show that α-MSH time- and dose-
dependently increased SOCS1/3 mRNA expression in normal human melanocytes (NHM) as 
well as SOCS1 in murine B16 melanoma cells. This inductive effect of alpha-MSH on SOCS1 
expression in NHM was confirmed by Western immunoblotting. Pretreatment with actinomycin 
D and pathway inhibition studies with several kinase inhibitors revealed that the inductive effect 
of alpha-MSH on SOCS1/3 expression is mediated transcriptionally and appears to be cAMP-
PKA and MAPK-MEK-dependent. According with this, in silico promoter analysis disclosed 
several putative CREB binding sites within the promoters of SOCS1 and SOCS3. Interestingly, 
preincubation of NHM with alpha-MSH attenuated TNF-alpha-induced nuclear translocation 
of NF-κB/p65 and as well TNF-alpha-induced IL-6 and IL-8 mRNA expression in line with 
known molecular interference of SOCS1/3 with p65. Moreover, preincubation with alpha-MSH 
antagonized the TNF-alpha-mediated suppression of melanogenesis key enzymes in NHM. Our 
findings show for the first time that alpha-MSH induces SOCS1/3 in melanocytes. Via induction of 
SOCS1/3, alpha-MSH may direct the behaviour of melanocytes exposed to cytokines after UVB 
exposure into a coordinated, unidirectional but protective response.
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Human KSS-derived 3-D equivalents as a model for aged skin
Bianca Schuermann1, Christine Goetz1, Marc Majora1, Susanne Franke1, Maren Schneider1, Jens 
Fischer2, Katharina Roeck2, Hossein Hajimiragha1, Ekkehard Wilichowski3, Françoise Bernerd4, 
Peter Schroeder1, Jean Krutmann1 1IUF Leibniz Institute, Duesseldorf, Germany, 2Institute for 
Pharmacology, Duisburg-Essen, Germany, 3Department of Paediatrics and Neuropaediatrics, 
Goettingen, Germany, 4L’Oreal Recherche, Paris, France
Kearns-Sayre syndrome (KSS) is a rare disease affecting multiple organs caused by large-scale 
deletions of mtDNA. Mutations of mtDNA are not only found in mitochondriopathies like KSS 
but are also frequently detected in aged tissues. It has therefore been suggested that mtDNA 
mutations are causally related to the aging process. We have proposed that mtDNA mutagenesis 
causes photoaging of human skin. To verify our hypothesis, human dermal equivalents (DEs) 
were generated using KSS fibroblasts and compared to those derived from normal human 
volunteers (NHF). Apart from producing more reactive oxygen species (ROS), KSS DEs showed 
increased expression as well as proteolytic activity of matrix metalloproteinase-1 (MMP-1). 
This was associated with progressive loss of intact collagen fibers and a concomitant increase 
in collagen fragments in KSS DEs. Increased MMP-1 expression was reduced if KSS DEs were 
treated with the antioxidants N-acetyl-L-cysteine and ascorbic acid or with retinyl acetate. Aging 
effects were not only restricted to the dermal compartment. Full skin equivalents using normal 
human keratinocytes were generated to evaluate the impact of mtDNA mutations on epidermal 
integrity. It was demonstrated that epidermis grown in the presence of KSS DEs exhibited atrophic 
degeneration in comparison to NHF based equivalents. In aggregate, the changes observed in 
KSS DEs strongly resembled those observed in photoaged human tissue. Skin equivalents derived 
from these cells may thus serve as an adequate model for aged human skin.
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Phototherapeutic hardening modulates systemic baseline cytokine levels in PLE patients
Alexandra Gruber-Wackernagel1, Beate Rinner2, Antonia Griesbacher2, Andrea Groselj-Strele2, 
Angelika Hofer1, Franz J. Legat1, Rudolf Stauber3, Scott N. Byrne4, Peter Wolf1 1Research Unit for 
Photodermatology, Dept of Dermatology, Med University of Graz, Austria, 2Center for Medical 
Research, Med Univ of Graz, Austria, 3Div of Gastroenterology and Hepatology, Dept of Internal 
Medicine, Med Univ of Graz, Austria, 4Dept of Infectious Diseases and Immunology, Sydney 
Medical School, The Univ of Sydney, Australia
The etiopathogenesis of polymorphic light eruption (PLE) has been linked to impaired UV- 
immunosuppression, Langerhans cell (LC) retention and an absence of neutrophil infiltration into UV-
exposed PLE skin. We have previously shown that photohardening restores the impaired neutrophil 
responsiveness to the chemoattractants leucotriene B4 and formyl-methionyl-leucyl-phenylalanin in PLE 
patients. The aim of this study was to investigate whether photohardening modulates baseline chemokine 
and cytokine levels which would alter chemoresponsiveness and hence immune function in PLE patients. 
17 PLE patients received photohardening therapy for 6-9 weeks from either 311nm UVB or PUVA. Plasma 
samples were taken both before and within 48h of the penultimate therapeutic exposure. Plasma from 
these 17 patients, 8 non-irradiated PLE patients, and 14 control subjects was analyzed for IL-1beta, IL-8 
(CXCL8), IL-10, IL-17, TNF-alpha, MCP-1 (chemokine ligand 2, CCL2), RANTES (CCL5), eotaxin (CCL11), 
and MDC (CCL22). These cytokines and chemokines were measured in early spring and in late spring. 
PLE patients had a significantly higher baseline level of eotaxin (p=0.002) and IL-1beta (p=0.001) in early 
spring before phototherapy. In late spring, after phototherapy, PLE patients had significantly elevated MCP-
1 (p=0.012) and TNF-alpha (p=0.004) but lowered plasma levels of IL-8 (p=0.006). When comparing 
the cytokine shifts from early to late spring, while healthy controls showed an increase, PLE patients 
undergoing photohardening had a significant decrease in IL-1beta (p=0.0056). Taken together, our results 
indicate that photohardening may alter the complex baseline cytokine milieu helping to normalize the 
response to subsequent UV exposure in PLE patients.
627
Narrow-band ultraviolet B exposures and oral vitamin D substitution in the treatment of 
vitamin D insufficiency
Meri Johanna Ala-Houhala1, Katja Vähävihu1, Hannu Kautiainen2,3, Taina Hasan1, Erna Snellman4, 
Timo Reunala1,5 1Department of Dermatology, Tampere University Hospital, Tampere, Finland, 
2Unit of Family Practice, Central Finland Central Hospital, Jyväskylä, Finland, 3Unit of Primary 
Health Care, Kuopio University Hospital, Kuopio, Finland, 4Department of Dermatology, Päijät-
Häme Central Hospital, Lahti, Finland, 5Medical School, University of Tampere, Tampere, Finland
Previously we have shown that a short course of narrow-band ultraviolet B (NB-UVB) exposures 
efficiently increases serum vitamin D concentration in winter. In this study we compared the 
effects of NB-UVB to oral vitamin D substitution. Healthy adult hospital employees and medical 
students were screened for vitamin D insufficiency in winter 2010 - 2011. Those with serum 
25-hydroxyvitamin D [25(OH)D] concentration below 75 nmol/l were randomly given either 
12 NB-UVB exposures or 20 ug of oral cholecalciferol daily for one month. The NB-UVB 
exposures were given with a Waldmann UV 7001 cabin equipped with twenty TL01 tubes. The 
total dose was 45.7 standard erythema doses. Serum 25(OH)D was measured before and after 
the treatments by radioimmunoassay. The mean increase in serum 25(OH)D in the 32 NB-UVB 
treated subjects was 41.7 nmol/l (78.7 %, from 53.0 ± 10.6 to 94.8 ± 22.6 nmol/l). The oral 
vitamin D substitution given for 25 subjects increased their mean serum 25(OH)D by 19.8 nmol/l 
(37.8 %, from 55.1 ± 11.8 to 75.0 ± 17.8 nmol/l). One month after the treatments the 25(OH)
D concentrations had continued to increase in both groups and were 97.2 ± 26.2 nmol/l and 
84.9 ± 17.2 nmol/l, respectively. The present study shows that a NB-UVB course increases serum 
25(OH)D concentration even more than daily oral vitamin D supplementation. A short course of 
NB-UVB is an effective way to improve vitamin D insufficiency in winter.
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Distant cutaneous UV-immunosuppression in melanoma patients
Leena Koulu1, Seppo Pyrhönen2, Tero Vahlberg3, Christer Jansen1 1Department of Dermatology, 
Turku University Hospital, Turku, Finland, 2Department of Oncology, Turku University Hospital, 
Turku, Finland, 3Department of Biostatistics, University of Turku, Turku, Finland
Local UV-immunosuppression refers to the ability of ultraviolet radiation (UV) to suppress the 
induction of cell-mediated immunity at irradiated skin sites. Human studies on distant cutaneous 
UV-immunosuppression, in which UV-irradiation of a skin area suppresses the induction of contact 
hypersensitivity (CHS) through a distant, nonirradiated skin, have yielded discordant results. We 
compared the effects of two types of UV-exposures, low dose on large skin areas vs. large dose on 
a limited area, in the distant UV-immunosuppression model in cutaneous malignant melanoma 
(CMM) patients and healthy controls, using a standardized CHS-induction test. A single exposure 
to a sunburn dose (6 SED, standard erythemal dose) on 5 x 5 cm skin area completely inhibited 
the induction of CHS to diphenylcyclopropenone at a non-irradiated skin site in 2 of 9 CMM-
patients and in 2 of 9 controls. In addition to the totally UV-immunosuppressible individuals, 
there was a general attenuation in the elicitation responses in both groups as compared to the 
unirradiated subjects. When UVB-irradiation with one individual MPED (minimal perceptible 
erythemal dose) was repeated on four consecutive days on large body areas in only 2 of 22 
controls and none of 11 CMM-patients contact sensitization at a non-irradiated skin site was 
completely prevented. The results indicate that distant cutaneous UV-immunosuppression can be 
demonstrated in a subpopulation of humans, that this trait is no more frequent in CMM-patients, 
and that a local sunburn is more injurious to the cell-mediated immunity of the whole skin than 
a moderate UV-exposure of large skin areas.
629
3-aminobenzamide protects human keratinocytes from UV-induced cell death by a PARP 
independent mechanism
Petra Lakatos1, Peter Bai1, Csaba Hegedus1, Pal Gergely1, Eva Szabo2, Laszlo Virag1 1Department 
of Medical Chemistry, Medical and Health Science Center, University of Debrecen, Debrecen, 
Hungary, 2Department of Dermatology, Medical and Health Science Center, University of 
Debrecen, Debrecen, Hungary
Poly(ADP-ribosyl)ation (PARylation) is a NAD-dependent protein modification carried out by 
members of the PARP [poly(ADP-ribose) polymerase] enzyme family. As PARP1 and PARP2 are 
activated by DNA damage, and UV light is known to alter cellular functions via DNA damage, 
therefore we set out to investigate the role of PARylation in UVB-induced cell death of normal 
human epidermal keratinocytes. UVB radiation (0,05-4J/cm2) caused a concentration-dependent 
cell death as measured/assessed with MTT assay, caspase activation, DNA fragmentation and cell 
morphology (May-Grünwald-Giemsa staining). Only high doses (2-4J/cm2) of UVB induced PARP 
activation as measured by PARP activity assay and PAR immunostaining, whereas toxicity could 
be observed even at lower doses. In line with data from the literature, the weak PARP inhibitor 
3-AB provided significant protection from UVB-induced cell death. However, the more potent 
and specific PARP inhibitor PJ34 (and several other potent and specific inhibitors) failed to protect 
cells from UVB, while effectively blocking PAR synthesis in UVB-irradiated cells. UVB also 
induced a suppression of cellular oxygen consumption as measured with a Seahorse metabolic 
analyzer. 3-AB but not PJ-34 prevented the inhibition of cellular respiration. These data indicate 
that 3-AB protects keratinocytes from UVB-induced death by a PARP-independent mechanism 
and the protection may be due to maintenance of cellular energy metabolism.
630
Lipid homeostasis and modulation of antioxidant defence: two possible determinants of anti-
ageing mechanisms of 17β-estradiol and genistein
Stefania Briganti, Enrica Flori, Giorgia Cardinali, Daniela Kovacs, Monica Ottaviani, Matteo 
Ludovici, Emanuela Camera, Mauro Picardo Laboratory of Cutaneous Physiopathology and 
Integrated Center of Metabolomics Research, San Gallicano Dermatologic Institute, IRCCS, 
Rome, Italy
Skin mirrors the first signs of human ageing accompanying hormone decline. Although the role 
of estrogens in ageing processes remains unclear, hormone replacement therapy is effective 
in reducing hallmarks of skin ageing in post-menopausal women. Moreover, phytoestrogens 
have proven to be photoprotective and effective against photoimmunosuppression. To better 
understand the influence of gender on photoageing, we investigated the ability of 17β-estradiol 
or genistein to counteract photoinduced cell senescence. For this purpose we adopted a 
stress-induced premature cell senescence model based on single exposure of human dermal 
fibroblasts to PUVA. Photoactivated fibroblasts grown in the presence of 17β-estradiol or 
genistein were partly, but significantly, rescued from the features of senescence phenotype, 
such as cytoplasmic enlargement, expression of senescence-associated-βgalactosidase and 
of matrix-metalloproteinase-1. The mechanisms by which 17β-estradiol and genistein exerted 
their protective effects involved the up-modulation of different components of cell antioxidant 
network and the preservation of cell membrane lipid constituents. In particular, PUVA-treated 
cells showed an immediate decrease of free cholesterol. Four weeks after PUVA, when all 
fibroblasts manifested the senescent phenotype, cholesterol content increased 3-folds above the 
basal level. Consistently, we observed a progressive accumulation of oxysterols, which are the 
oxidation products of cholesterol. Short-term effects of 17β-estradiol or genistein added after 
PUVA were the abrogation of cholesterol depletion and oxysterol generation, whereas long-term 
effects resulted in the inhibition of cholesterol accumulation. Our data suggest that the estrogen-
induced activation of biological pathways involved in the lipid homeostasis can play a key role 
in protecting skin from aging.
2011ESDR_8.25x10.875.indd   105 06/07/2011   18.24 
S106 Journal of Investigative Dermatology (2011), Volume 131 
ABSTRACTS
631
Ellagic and rosmarinic acid: modulatory effect on cytokines/chemokines released by 
keratinocytes after ultraviolet B radiation
Serena Lembo1, Anna Balato1, Francesca Gaudiello1, Franco Gasparri2, Giuseppe Monfrecola1 
1Dermatology Dept University of Naples Federico II, Naples, Italy, 2Rottapharm Madaus Dermo-
Cosmetic R&D Division, Monza, Italy
Ultraviolet radiation (UV) induces cutaneous inflammatory responses characterized by the 
increase of multiple cytokines such as IL-1β, IL-6, IL-8, IL-10, MCP-1, TNF-α. Rosmarinic acid 
(RA) and ellagic acid (EA) are naturally compounds found in many medicinal species of plants 
(basil, sage, rosemary, mint) or fruits and nuts (raspberries, strawberries, walnuts, grapes) known 
to have anti-inflammatory and immunomodulatory activities. We have investigated, by qRT-PCR 
analyses, the ability of EA and RA to modulate the production of the above mentioned cytokines 
from HaCaT cells, after UVB irradiation. Both, UVB dose (100 mJ/cm²), and study substances 
concentrations, have been determined after multiple cell viability experiments. The expression of 
cytokines/chemokines from HaCaT UVB-irradiated vs control cells, has been quantified at 6, 12 
and 24 hours, in order to identify, for each cytokine, the time of release peak, after stimulation. 
We found that IL-1β, IL-6 and IL-8 were mainly expressed 6 hours post UVB, whereas IL-10, 
MCP-1 and TNF-α were mainly expressed 24 hours post UVB stimulation. Incubation with 
EA (5µM 0,1% DMSO) or RA (2,75µM 0,5% DMSO) immediately after UVB irradiation lead 
to a modulation of cytokines expression. In particular, RA was able to reduce IL-6 and IL-8 
expression measured 6 hours post UVB, MCP-1 and TNF-α expression measured 24 hours post 
UVB stimulation. EA was able to reduce IL-8 and MCP-1 expression. Conversely, both substances 
were able to increase IL-10 gene expression measured 24 hours post UVB irradiation.
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Green tea catechins reduce UVR-upregulation of the pro-inflammatory lipoxygenase metabolite 
12-HETE in human skin
Gemma Darby1, Tristan Dew2, Karen Massey3, Kayleigh Clarke2, Susan Bennett1, Rachel Watson1, 
Anna Nicolaou3, Gary Williamson2, Lesley Rhodes1 1University of Manchester, Manchester, UK, 
2University of Leeds, Leeds, UK, 3University of Bradford, Bradford, UK
Acute exposure of human skin to ultraviolet radiation (UVR) results in an inflammatory response. 
Green tea catechins (GTC) are anti-inflammatory agents, reported to inhibit cyclooxygenase 
(COX) and lipoxygenase (LOX), which may offer systemic photoprotection. We aimed to identify 
whether GTC are bioavailable in skin and to assess their impact on UVR-induced inflammation 
and pro-inflammatory eicosanoid expression. Healthy females (n=11, 27-56y, phototype I/II) took 
encapsulated GTC (550 mg/day) and vitamin C (50 mg/day) for 3m. Pre- and post-supplementation, 
the volunteers minimal erythemal dose (MED) to solar simulated radiation (SSR) was assessed 
and UVR-erythemal dose response quantified. Buttock skin was then irradiated with 3MED of 
SSR. Skin punch biopsies and suction blister fluid were taken from un-irradiated and irradiated 
skin and 24h urine samples collected. Samples were analysed using mass spectrometry (LC-MS/
MS). Following supplementation, mean MED was unchanged, but a reduction in skin erythema 
was seen at higher UVR doses (p<0.05). Levels of the COX metabolite prostaglandin (PG)E2 and 
LOX metabolite 12-hydroxy eicosatetraenoic acid (12-HETE) were up-regulated post-UVR. Post-
supplementation, a reduction in UVR-induced 12-HETE expression occurred (p=0.003) while 
PGE2 was not significantly altered. Increase in native catechins and their metabolites was seen in 
blister fluid and skin post-supplementation. Compliance was confirmed in 10/11 subjects, with 
all major GTC observed in urine. Thus oral GTC are bioavailable in human skin, where evidence 
of protection is found against skin inflammation elicited by higher UVR doses. Attenuation of 
UVR-induced 12-HETE expression is consistent with LOX inhibition by GTC.
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Narrow ultraviolet B light induces apoptosis in cultured keratinocytes
Adam Reich1, Michael Meurer2 1Department of Dermatology, Venereology and Allergology, 
Wroclaw Medical University, Wroclaw, Poland, 2Department of Dermatology, Carl Gustav Carus 
Medical Faculty, University of Technology, Dresden, Germany
Narrow band ultraviolet B 311 nm (NB-UVB) produced significant structural alterations in 
irradiated keratinocytes. The aim of this study was to analyse, whether structural alteration 
induced by NB-UVB might be related to apoptosis. Immortalised human keratinocytes (HaCaT 
cell line) were cultured under standard conditions for 48h, then irradiated with NB-UVB 
ranging from 50 to 800 mJ/cm2 or left unirradiated for control and analysed 2, 24 and 48 h 
post irradiation. Apoptotic cell death was detected by fluorescence microscopy. To visualize 
nuclear morphology and to assess changes typical for apoptotic condensation of chromatin 
cells were incubated in Hoechst 33258. The externalization of phosphatidylserine in apoptotic 
cells was detected by staining with FITC-conjugated annexin V/propidium iodide according to 
manufacturer instruction. The stained cells were visualized under a fluorescent microscope with 
appropriate filter combination. NB-UVB doses between 50 and 200 mJ/cm2 did not significantly 
change the mitotic and apoptotic indexes of irradiated cells. At 400 mJ/cm2 a significant increase 
of apoptosis was noted 24 h after irradiation. However, the apoptotic index of cells surviving the 
first 24 h after NB-UVB exposure and seeing 48 h post UVB irradiation did not differ from that 
measured for control cells. Apoptosis was very common for the HaCaT cells characterized 24 
and 48 h post NB-UVB exposure with 800 mJ/cm2. We concluded that irradiation with NB-UVB 
is able to induce apoptosis in cultured keratinocytes.
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Characterisation of tight junction proteins in photoaged human skin
Suha Althubaiti, Christopher Griffiths, Neil Gibbs, Catherine O’Neil, Rachel Watson University 
of Manchester, Manchester, UK
Tight junction (TJ) plays an important role as a barrier which protects the skin against dehydration 
and infection. Skin is subject to a variety of environmental insults, in particular ultraviolet 
radiation (UVR), termed photoageing. Exposure to UVR is known to modify skin barrier 
function but the role of TJs in this process is unknown. Therefore, we examined whether TJ 
proteins expression is altered in photoaged compared to photoprotected human skin. Caucasian 
volunteers (65-75 yrs; n=8) were recruited. Punch biopsies (6mm diameter) were taken from 
photoprotected (upper inner arm [UIA]) and photoaged (forearm) sites. Cryosections (10µm) 
were prepared, stained with polyclonal antibodies to claudins-1, -4, -5, -7, -8 & -12, occludin 
and ZO-1 and visualised using appropriate FITC-conjugated secondary antibodies. Staining 
intensity was quantified using ImageJ software (NIH). Immunofluorescence confirmed the 
epidermal protein expression of claudin-1, -4, -5, -7, -8 & -12, occludin and zo-1. Image analysis 
revealed a significant reduction in claudin-1 signal in photoaged forearm (mean ± SE; UIA, 31.2 
± 4.4; forearm, 20.7 ± 1.7; Student’s t-test, p=0.005). Conversely, claudin-7 and -12 showed 
significantly increased expression in photoaged skin (claudin-7: UIA, 1510.7 ± 194.2; forearm, 
2213.1 ± 83. 2, p=0.006; claudin-12: UIA, 31.0 ± 4.9; forearm, 49.9 ± 2.8, p=0.004). Other 
TJ proteins showed no significant changes in their protein expression. This study demonstrates 
altered tissue expression of claudins-1, -7 and -12 in chronically photoaged human skin. Further 
work is required to clarify the mechanisms underlying these observations and their functional 
consequences on the epidermal barrier.
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Safety assessment of the use of two-photon laser microscopy in dermatology
Dora Haluszka1, Nora Gyongyosi1, Andras Banvolgyi1, Attila Kolonics2, Robert Szipocs2, Sarolta 
Karpati1, Norbert Wikonkal1 1Department of Dermatology, Venereology and Dermatooncology, 
Semmelweis University, Budapest, Hungary, 2Research Institute for Solid State Physics and Optics 
of the Hungarian Academy of Sciences, Budapest, Hungary
Imaging of deeper layers of the skin is a challenging task for several reasons, yet it’s clinical value 
is beyond any doubt. The use of two-photon lasers is a novel approach of optical imaging without 
ionizing radiation or magnetic resonance, though it provides a superior degree of penetration, 
and high resolution when compared to confocal microscopy. Combined with CARS (Coherent 
anti-Stokes Raman Spectroscopy), FLIM (Fluorescence Lifetime Imaging Microscopy) or SHG 
(Second Harmonic Generation) methods it is suitable for assesing level of redox status and aging 
of the skin, or diagnosing malignant skin tumors, as melanoma. The ideal laser source for this type 
of imaging bears with energy low enough (wavelenght range: 650-1300 nm) not to permanently 
damage the subject of imaging so in vivo use may also become available in the future. 
We set out to investigate safety profile of a newly developed laser source on human and 
murine skin. Tissue specimen were collected from human volunteers and mice, then exposed 
various doses of laser beam irradiation.To assess tissue damage we stained for the presence 
of cyclobutane pyrimidine dimers (CPD) as signs of specific DNA changes caused by laser or 
UV irradiation. As a positive control UVB irradiation were also used on parallel specimen.Our 
data show that not only no visible damage was observed, but CPD formation was inferior to 
that of seen after moderate dose of UV irradiation.These findings indicate that two-photon laser 
microscopy can be used safely in future for in vivo experiments and diagnostics.
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Potential anti-aging properties of a hydroglycolic preparation from Epilobium angustifolium 
aerial parts
José Cheel1, Ema Ruszová1,2, Stanislav Pávek1, Martina Hašová1, Martina Hermannová1, Ilona 
Matejková1, Vladimír Velebný1, Lukáš Kubala3 1Dept of Research and Development, CPN 
Ltd., Dolní Dobrouc, Czech Republic, 2Institute of Experimental Biology, Dept of Physiology & 
Immunology of Animals, Faculty of Science, Masaryk University, Brno, Czech Republic, 3Institute 
of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
The potential anti-aging properties of a hydroglycolic preparation (HP) from Epilobium angustifolium were assessed 
by determining its ability to reduce the stress induced senescence of dermal fibroblasts (NHDF) in vitro and to 
protect skin against harmful UV in vivo. The chemical profile of HP was determined by using LC-DAD-MS. Treatment 
of NHDF by HP at 10 µg/ml increased the cell viability of senescent (serum-free cultivated cells) NHDF. This 
preparation diminished the connective tissue growth factor and fibronectin gene expression in senescent NHDF. 
It also elevated collagen release in repeatedly UV-irradiated NHDF and down-regulated the induced release of 
both matrix metalloproteinases (MMPs) -1 and -3, and tissue inhibitor of MMP -1 and -2. In addition, a down-
regulating effect of HP on gene expression of hyaluronidase 2 in repeatedly UV-irradiated NHDF was observed. 
The in vivo experiments showed that the application of HP before single UV-exposure protected skin against UV-
induced erythema formation. Major constituents of HP were preliminarily identified as gallic acid, oenothein B, 
chlorogenic acid, myricetin-3-O-hexoside, myricetin-3-O-rhamnoside, quercetin-7-O-glucuronide and kaempferol-
3-O-hexoside. The observed reduction in connective tissue growth factor, fibronectin and tissue inhibitor of MMPs 
indicates the antifibrotic and anti-scarring potential of HP. It is suggested that this phytopreparation protects dermal 
cells and extracellular matrix components against cutaneous aging and exhibits a significant photoprotective effect. 
Polyphenols, the major constituents of HP, may account for the observed benefits. HP from Epilobium angustifolium 
could be a potential candidate to be used as an active ingredient in dermatological and cosmetic formulations.
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Hepatocyte growth factor induces resistance to ERK inhibitors in BRAF mutant melanoma cells 
through Twist1
Dinoop Ravindran Menon, Christian Wels, Shripad Joshi, Helmut Schaider Medical University 
of Graz, Austria
Melanomas harbour BRAF mutations which constitutively activate the MAPK pathway in 70-80% 
of cases. Recently there have been reports of acquired resistance to molecular-targeted therapy 
of BRAF which could be related to the induction of survival proteins or alternative pathways. 
Potentially, epithelial-mesenchymal transition regulators (EMTRs) and growth factors may be 
involved in acquiring such a resistance. Therefore we investigated on the possible targets that 
compromise the acquired resistance in melanoma cell lines. We found that TGF beta1 enhances 
the apoptotic effect of ERK and BRAF inhibitors in BRAF mutant cells. This effect was reversible 
in the presence of HGF which invoked resistance to enhanced apoptosis induction of TGF beta1 
possibly due to the activation of AKT signalling. Based on our previous study in which we showed 
that Twist1, an EMTR, is regulated by both MAPK and AKT signalling we investigated whether 
Twist1 over expression in melanoma cells can induce a similar effect. As we expected, Twist1 
induced a survival advantage in these cancer cells against these inhibitors and also against the 
combined exposure of inhibitors and TGF beta1. Our findings suggest that TGF beta1 along with 
BRAF or ERK signalling inhibitors might be a better strategy for treatment of melanoma cells with 
BRAF mutantions, however there is a possible threat of acquired resistance by stabilisation of 
Twist1 through the PI3K-AKT signalling.
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Epigenetic Control of Gene Expression Programs in the Skin: Distinct Nuclear Architecture 
and Higher Order Chromatin Organization of Cell-Type Specific Genes In Melanocytes and 
Keratinocytes
Michal Gdula1,2, Tatyana Sharova1, Michael Fessing2, Andrey Sharov1 1Boston University School of 
Medicine, Boston, USA, 2Centre for Skin Sciences, School of Life Sciences, University of Bradford, 
Bradford, UK
The mammalian nucleus is a complex and highly organized organelle that allows cells 
differentiate and effectively fulfill their functions. Higher-order chromatin structure and nuclear 
compartmentalization of transcriptionally active and inactive domains and transcription 
machinery play an important role in regulation of gene expression and can be altered in diseases. 
Melanocytes and keratinocytes are highly specialized cells playing distinct functions in the skin 
controlled by the cell-type specific gene expression programs. By three-dimensional fluorescence 
in situ hybridization (3D-FISH) and confocal microscopy, we show that intra-nuclear positioning 
of the DNA loci containing melanocyte specific genes tyrosinase (TYR), tyrosinase-related protein 
1 (TYRP1) and the melanoma antigen 1 recognized by T cells (MART1) in the primary human 
melanocytes differ very substantially, compared to the primary keratinocytes. Analysis of the radial 
distributions of the genetic loci showed that TYR locus, TYRP1 and MART1 loci were occupied 
much more nuclear interior position in the melanocytes, while in primary keratinocytes these 
loci were located significantly more peripherally in the nucleus (p<0.01) closer to the nuclear 
membrane. Furthermore, primary melanocytes also showed the distinct spatial organization of 
the transcriptionally active and inactive nuclear domains depicted by phospho-serine-2 RNA 
Polymerase II and tri-methylated H3K4 and H3K27 staining, as compared to keratinocytes. These 
data demonstrate for the first time a distinct intra-nuclear organization of the pigment-specific 
genes, transcriptionally active nuclear domains and nuclear bodies in melanocytes versus 
keratinocytes and suggest an involvement of the distinct epigenetic mechanisms in the control of 
gene expression in pigment and epithelial cells.
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Cyclin dependent kinases 2 and 4 are downstream targets of the mitogen activated protein 
kinase pathway in human melanoma and are of potential therapeutic application
Ahmad Jalili1, Christine Wagner1, Kirsten D. Mertz1, Mikhail Pashenkov1, Sridhar Ramaswamy2, 
Georg Stingl1, Stephan N. Wagner1 1DIAID, Department of Dermatology, Medical University of 
Vienna, Vienna, Austria, 2Massachusetts General Hospital Cancer Center, Boston, USA
MAPK signaling pathway contains frequent mutations in human melanoma. More than 50% of melanomas 
are positive for BRAFV600E. PLX 4032 is a very specific inhibitor of BRAFV600E. Current clinical trials with 
PLX 4032 in melanoma patients resulted in a rapid, significant but short lasting clinical response. 
Among acquired resistant mechanisms are de novo mutations in NRAS, MEK and over-expression of 
receptor-tyrosine-kinases IGF-1R/PDGFRβ; all being upstream members of the MAPK pathway. We 
therefore hypothesized that downstream effectors of MAPK pathway (largely undefined in melanoma) 
would be better suited for therapeutic intervention. Here, we show that BRAFV600E can induce the AP-1 
transcription factor. Interference with AP-1 activity by overexpressing dominant negative AP-1 resulted 
in G1 cell cycle arrest, reduced cell proliferation and induced apoptotic cell death both in vitro and 
in vivo. Induction of G1 cell cycle arrest upon AP-1 deactivation was mediated through combined 
induction of p18INK4c and p21Waf1/Cip1 cyclin-dependent kinase (CDK) inhibitors. AP-1 repressed p18INK4c 
expression through direct binding to its promoter and the p21Waf1/Cip1 indirectly through its upstream 
negative regulator Tbx2 but not p53 or c-Myc. Combined silencing of p18INK4c and p21Waf1/Cip1 was able to 
completely rescue the human melanoma cell death upon AP-1 deactivation. Interestingly, simultaneous 
pharmacological inhibition of p18INK4c and p21Waf1/Cip1 targets CDK2 and CDK4, in combination with 
or without MAPK inhibitors resulted in decreased human melanoma cell viability in vitro and in vivo. 
Our results demonstrate how MAPK activity can be linked to cell cycle control in human melanoma and 
identify novel therapeutic strategies.
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Monobenzone increases the immunogenicity of melanoma cells, and is effective as melanoma 
immunotherapy
Jasper van den Boorn1, Esther Tjin1, Daisy Picavet1, Henk van Veen2, Debby Konijnenberg1, Paul van 
Swieten3, Peter van Veelen4, Nico Meeuwenoord3, Dmitri Filippov3, Wietze van der Veen1, Toni van 
Capel2, Esther de Jong2, Jan Wouter Drijfhout4, Eric Reits2, Jan Bos1, Cornelis Melief4, Rosalie Luiten1 1Dept 
of Dermatology & the Netherlands Inst for Pigment Disorders, AMC, Univ of Amsterdam, The Netherlands, 2Dept 
of Cell Biology & Histology, AMC, Univ of Amsterdam, The Netherlands, 3Leiden Inst of Chemistry, Univ of Leiden, 
The Netherlands, 4Dept of Immunohematology & Bloodtransfusion, Leiden Univ Med Center, The Netherlands
Skin depigmentation during immunotherapy of melanoma is a favourable prognostic sign. We aimed at inducing 
vitiligo to achieve effective anti-melanoma immunity. The phenolic compound monobenzone induces progressive 
skin depigmentation, clinically and histologically indistinguishable from vitiligo vulgaris. We investigated how 
monobenzone increases the immunogenicity of melanoma cells, leading to anti-melanoma immunity and melanoma 
growth inhibition. Monobenzone inactivated tyrosinase enzyme in melanoma cells, leading to decreased cellular 
melanin synthesis, and the formation of quinone metabolites that bind as haptens to melanosomal proteins. Moreover, 
monobenzone-tyrosinase interaction induced increased levels of reactive oxygen species, and the release of tyrosinase- 
and MART-1-containing CD63+ exosomes. We also found that monobenzone induces ubiquitination of tyrosinase as 
well as melanosome autophagy; a lysosomal degradation process leading to the targeting of tyrosinase to MHC class-
II compartments. Monobenzone-exposed melanoma cells activated human dendritic cells, leading to the activation 
of melanoma-reactive human CD8+ T cells. Together, these data show that monobenzone, by its specific effects on 
the enzyme tyrosinase, induces potent CD8+ T cell immunity against auto-antigens expressed by melanocytes and 
melanoma cells. Monobenzone induced melanoma antigen-specific cellular and humoral immunity in vivo, which 
eradicated subcutaneous B16.F10 melanoma in up to 85% of C57BL/6 mice, when combined with immune-stimulatory 
imiquimod cream and CpG oligodeoxynucleotide injections (MIC therapy). Importantly, this regimen induced over 
100 days of tumor-free survival in up to 60% of the mice, and suppressed tumor growth upon re-challenge after MIC 
treatment cessation. Based on these results, we have started a clinical trial in melanoma patients.
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miR-125b induces cellular senescence in melanocytes and malignant melanoma
Anne-Marie Nyholm1, Line Marie Broksø Holst1, Catharina Lerche1, Valentina Manfé1, Edyta 
Biskup1, Martin Glud1, Nina Hastrup2, Birthe Mørk Thomsen3, Vibeke Pless1, Anne Rosbjerg1, 
Hans Christian Wulf1, Robert Gniadecki1 1Dermatology, Copenhagen NV, Denmark, 2Pathology, 
Copenhagen Ø, Denmark, 3Pathology, Copenhagne NV, Denmark
Small, regulatory RNAs (microRNAs) are involved in oncogenesis, either by acting as oncogenes 
or as tumor suppressors. By comparing miRNA expression in metastasizing with non-
metastasizing cutaneous malignant melanoma we have previously detected decreased miR-125b 
expression in metastasizing tumors and proposed that miR-125b is a tumor suppressor. Here, 
we analyzed the miR-125b by in situ hybridisation in primary human malignant melanoma and 
in melanoma lymph node metastases and found increased expression on single, large tumor 
cells with abundant cytoplasm, which could represent melanoma cells undergoing senescence. 
Overexpression of miR-125b in human melanoma cell line Mel-Juso resulted in a G0/G1 cell 
cycle block and emergence of large cells expressing senescence markers senescence-associated 
beta-galactosidase, p21, p27 and p53. Mel-Juso cells overexpressing miR-125b were tumorigenic 
in mice, but the tumors exhibited higher level of cell senescence and decreased expression of 
proliferation markers, cyclin D1 and Ki67 that the control tumors. Expression of miR-125b was 
increased in melanocytes undergoing replicative senescence and BRAFV600E oncogene- induced 
senescence. Similar to the Mel-Juso cells, overexpression of miR-125b in melanocytes induced 
senescence. We conclude that cellular senescence, which is one of the central mechanisms 
protecting against the development and progression of MM is regulated by miR-125b.
2011ESDR_8.25x10.875.indd   107 06/07/2011   18.24 
S108 Journal of Investigative Dermatology (2011), Volume 131 
ABSTRACTS
643
Epidermal growth factor affects development of lymph node metastasis in a mouse melanoma 
xenotransplantation model
Andreas Bracher, Stefanie Tauber, Robert Loewe Department of Dermatology, Medical University 
of Vienna, Vienna, Austria
Sentinel lymph node (SLN) metastasis reflects a major event of progression in cutaneous 
melanoma and is an important diagnostic procedure in patients with high risk primary melanomas. 
Using our previously described xenotransplantation model, in which human melanoma cells 
injected into the skin of CB17-SCID mice metastasize to SLN, we aimed to identify events 
leading to SLN metastasis. Gene expression analysis using a mouse microarray revealed 
epidermal growth factor (EGF) - EGF receptor dependent genes to be differently regulated in 
tumor negative SLNs of tumor bearing SCID mice when compared to SLNs of control animals. 
To analyze, if EGF secreted by primary tumors is influencing melanoma SLN metastasis, we 
employed EGF knockdown (EGFkd) in EGF-high M24met as well as in EGF-low A375 melanoma 
cell lines. In vitro, EGF knockdown in M24met cells lead to decreased migration and sprouting. 
Conversely, knockdown of EGF in A375 cells had no effect on the migratory and sprouting 
behavior. In our xenotransplantation model, mice inoculated with M24met EGFkd cells had a 
significantly reduced degree of SLN metastasis, compared to M24met as well as A375 and A375 
EGFkd tumors. Additionally, M24met EGFkd tumors showed a significantly reduced amount 
of lymph vessels as examined by immunohistochemistry. By using RNA isolated from human 
melanoma samples, we correlated mRNA expression levels of EGF with factors characterizing 
lymphangiogenesis.  In conclusion, our data point to an important role of EGF in the mediation 
of lymph node metastasis.
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PACE4, a member of the prohormone convertase family, mediates increased proliferation, 
migration and invasiveness of melanoma cells in vitro and enhanced subcutaneous tumor 
growth in vivo
Markus Böhm1, Arianna Mastrofrancesco2, Nina Weiss1, Björn Kemper3, Gerd von Bally3, Mauro Picardo2, 
Thomas A. Luger1, Carsten Weishaupt1 1Dept of Dermatology, Univ of Münster, Germany, 2Istituto San 
Gallicano, Rome, Italy, 3Center for Biomedical Optics & Photonics, Univ of Münster, Germany
Prohormone convertases (PCs) are mostly known in cutaneous biology for their role in processing 
of pro-opiomelanocortin, the precursor for melanocortin peptides and endogenous opioids. We 
investigated impact of selective overexpression of Paired basic Amino-acid-Cleaving Enzyme 4 
(PACE4), a family member of PCs, in melanoma cells in vitro and in vivo. SK-Mel30 melanoma 
cells were stably transfected with rPACE4. In vitro, PACE4 transfectants secreted high amounts of 
rPACE4, showed elevated expression of matrix metalloproteinase 1 and 2, displayed increased 
cell motility as shown by digital holographic microscopy in collagen as well as enhanced 
invasiveness demonstrated in Matrigel migration assays. Interestingly, PACE4 transfectants but 
not vector-alone transfected melanoma cells exhibited also increased metabolic activity and cell 
proliferation but did not show any change in melanin content. In vivo, subcutaneous injection 
of PACE4 transfectants into immunodeficient SCID Hairless Outbred mice resulted in increased 
local tumor growth compared with injected control cells. However, ectopic PACE4 expression did 
not enable transfectants to metastasize. To assess the relevance of these findings we examined the 
endogenous expression of PACE4 in human melanoma cell lines as well as in human melanoma 
specimens. In 6 out of 9 melanoma cell lines, mRNA expression levels were significantly elevated 
compared with normal human melanocytes. Immunohistochemical analysis revealed that PACE4 
expression is detectable within melanoma cells in 89 % of 47 tumor samples with the highest 
immunoreactivity in primary melanomas. Our findings highlight PACE4 as a novel player in 
melanoma biology and point towards novel future strategies for treatment of melanoma.
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Restoring the cAMP pathway through inhibition of PDE4 reduces invasion and cell proliferation 
of melanoma cell lines
Amandine Servy1,3, Armand Bensussan1,2, Martine Bagot1,3, Nicolas Dumaz1,2 1INSERM U976, 
Paris, France, 2Univ Paris Diderot, Sorbonne Paris Cité, Paris, France, 3Service de dermatologie, 
hôpital Saint Louis, Paris, France
Studying the role of altered cAMP activity during melanocyte transformation, we have recently 
shown that cAMP signalling is impaired in the presence of mutant RAS in melanoma cell lines. 
To understand the molecular mechanism of this inhibition, we examined members of the 
phosphodiesterase (PDE) superfamily, enzymes which physiologically degrade cAMP. Using PDE 
inhibitors and siRNA silencing in melanoma cells harbouring mutant RAS, we identified PDE4B 
and PDE4D as predominant suppressors of cAMP signalling in these cells. We showed that 
PDE4 is necessary for malignant transformation and that reactivating the cAMP pathway inhibits 
proliferation and induces apoptosis of RAS mutated melanoma cells but not melanocytes. We 
now show that BRAF induced melanocyte transformation also caused altered cAMP signalling 
due to increased PDE4 activity. Inhibitors of PDE4 combined with α-MSH stimulation resulted in 
reactivation of the CREB protein, indicating that activated cAMP and PKA signalling in response 
to α-MSH were restored. Interestingly and contrary to RAS mutated melanoma, reactivating the 
cAMP pathway in BRAF mutated melanoma did not induced apoptosis but inhibited invasion 
and colony formation. The discovery that melanocyte transformation by oncogenic RAS or BRAF 
attenuates cAMP signalling has important implications for our understanding of melanoma 
biology and therapy. Because PDE orchestrate the delicate balance of feedback loops in cyclic 
nucleotide signalling cascades, targeted inhibition of PDE, as an anti-tumour approach, is a 
topic of active exploration. Targeted inhibition of specific PDE isoforms may eventually serve 
as a complementary therapeutic process in the treatment of melanoma harbouring RAS or BRAF 
mutants.
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Involvement of TGF-β signaling and the GLI2 transcription factor in M-MITF regulation and 
pigmentation in melanoma cells.
Marie-Jeanne Pierrat1, Veronique Marsaud1, Corine Bertolotto2, Alain Mauviel1, Delphine 
Javelaud1 1Institut Curie, INSERM U1021-CNRS UMR3347, ORSAY, France, 2INSERM U895, 
Nice, France
The melanocyte-specific transcription factor M-MITF is involved in numerous aspects of 
melanoblast lineage biology including pigmentation, survival, migration, as well as melanoma 
progression and metastasis. We have previously shown that expression of M-MITF in human 
melanoma cell lines is highly variable and inversely correlated with that of GLI2, a Hedgehog 
mediator identified as a TGF-β gene target. In this study, we demonstrated that GLI2 overexpression 
in highly pigmented melanoma cells reduced the expression of M-MITF and that of its gene 
targets TYR, TRP-1, DCT/TRP-2, accompanied with a decrease of melanin synthesis. Transient cell 
transfection experiments with 5’-end M-MITF promoter deletion constructs identified the -317/-
280 region as critical for GLI2-driven transcriptional repression. Chromatin immunoprecipitation 
(ChIP), identified GLI2 bound to the -395/-228 region of the M-MITF promoter. TGF-β induced 
a strong inhibition of M-MITF promoter activity. ChIP experiments indicated that TGF-β induces 
GLI2 binding to the -395/-228 region of the M-MITF promoter in melanoma cells. Yet, TGF-β still 
repressed M-MITF promoter activity after GLI2 knockdown, suggesting that other mechanisms are 
involved to drive TGF-β effect. Remarkably, TGF-β inhibited both CREB phosphorylation and PKA 
activity in melanoma cells and mutation of the cAMP Responsive Element (CRE) located at position 
-147/-140 of the M-MITF promoter abolished the inhibitory effect exerted by TGF-β. Taken together, 
these results suggest that TGF-β represses M-MITF expression and transcription by two distinct and 
concomitant means implicating GLI2 induction and inhibition of the cAMP/PKA pathway.
647
A new tumor marker of malignant melanoma, the circulating microRNA-221
Satoshi Fukushima, Hisashi Kanemaru, Junji Yamashita, Yuji Inoue, Jun Aoi, Masatoshi Jinnin, 
Hironobu Ihn Kumamoto University, Kumamoto, Japan
Malignant melanoma (MM) is an aggressive neoplasm that can be fatal, especially at the 
metastatic stage, necessitating early diagnosis and better diagnostic tools. MicroRNA-221 
(miR-221) is known to be abnormally expressed in MM cells, and it favors the induction of the 
malignant phenotype through down-modulation of p27Kip1/CDKN1B and the c-KIT receptor. 
This suggests that the serum levels of miR-221 might increase in patients with MM and thus 
could be used as a new tumor marker. Serum samples were obtained from 94 MM patients and 
20 healthy controls. MicroRNAs were purified from the sera, and miR-221 levels were measured 
by quantitative real-time polymerase chain reaction. Circulating miR-221 was detectable and 
could be quantified in serum samples. MM patients had significantly higher serum miR-221 
levels than healthy controls. Among the MM patients, the miR-221 levels were significantly 
increased in patients with stage I–IV MM compared to those with MM in situ, and the levels 
were correlated with tumor thickness. Moreover, a longitudinal study revealed a tendency for the 
miR-221 levels to decrease after surgical removal of the primary tumor, and to increase again at 
recurrence. Serum levels of miR-221 may be useful not only for the diagnosis of MM, but also 
for the differentiating MM in situ from stage I–IV MM, and for evaluating tumor progression and 
monitoring patients during the follow-up period. In addition, considering that the serum levels 
of miR-221 were correlated with tumor thickness, miR-221 might also be useful as a prognostic 
marker for patients with MM.
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Suppression of Melanin Production by Expression of HSP70
Tatsuya Hoshino1, Daisuke Maji2, Tohru Mizushima3 1Faculty of Life Sciences, Kumamoto 
University, Kumamoto, Japan, 2Saishunkan Pharmaceutical Co., Ltd., Kumamoto, Japan, 3Faculty 
of Pharmacy, Keio University, Tokyo, Japan
Skin hyperpigmentation disorders due to abnormal melanin production induced by ultraviolet 
(UV) irradiation are both a clinical and cosmetic problem. UV irradiation stimulates melanin 
production in melanocytes by increasing intracellular cAMP. Expression of heat shock proteins 
(HSPs), especially HSP70, is induced by various stressors, including UV irradiation, to provide 
cellular resistance to such stressors. In this study, we examined the effect of expression of HSP70 
on melanin production both in vitro and in vivo. IBMX (a cAMP-elevating agent) stimulated 
melanin production and transcription of the tyrosinase gene in cultured melanoma cells and 
this stimulation was suppressed in cells overexpressing HSP70. Expression of MITF, which 
positively regulates transcription of the tyrosinase gene was up-regulated by IBMX; however, 
this up-regulation was not suppressed in HSP70-overexpressing cells. On the other hand, 
immunoprecipitation analysis revealed a physical interaction between MITF and HSP70. 
Furthermore, the transcription of tyrosinase gene in nuclear extract was inhibited by purified 
HSP70. In vivo, UV irradiation of wild-type mice increased the amount of melanin in the basal 
layer of the epidermis and this increase was suppressed in transgenic mice expressing HSP70. 
This study provides the first evidence of an inhibitory effect of HSP70 on melanin production both 
in vitro and in vivo. This effect seems to be mediated by modulation of MITF activity through a 
direct interaction between HSP70 and MITF. We propose that HSP70 induces are beneficial for 
skin hyperpigmentation disorders, because they could not only suppress melanin production but 
also protect against UV-induced skin damage.
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Topical diphencyprone immunotherapy for extensive cutaneous metastatic melanoma
Diona Damian1,2, John Thompson1,2 1Dermatology, University of Sydney, NSW, Australia, 
2Melanoma Institute Australia, NSW, Australia
Melanoma metastatic to skin or locally recurrent is often resistant to or unsuitable for surgery, 
radiotherapy or regional or systemic chemotherapy. Diphencyprone (DPCP) is a potent contact 
sensitizer which is used in the treatment of alopecia areata and cutaneous warts. We use DPCP, 
applied topically once per week, to treat patients with extensive cutaneous metastatic melanoma 
who are unsuitable for other therapies. For each patient, a concentration of DPCP is chosen 
which causes a definite but not excessive contact hypersensitivity response at treated sites. So far, 
30 patients have received at least one month of DPCP treatment. Fourteen (47%) have achieved 
complete clearance of their cutaneous disease, 12 (40%) have demonstrated partial response 
and 4 patients (13%) had disease which failed to respond to DPCP. Topical immunotherapy 
with DPCP is an inexpensive and well-tolerated treatment for extensive cutaneous metastases 
unsuitable for or resistant to other therapies.
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HSP70 inducers from herbs and their effect on melanin production and cell damage
Yasuhiro Yamashita1, Daisuke Maji2, Tohru Mizushima3 1Graduate School of Medical and 
Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan, 2Saishunkan Pharmaceutical 
Co., Ltd., Kumamoto, Japan, 3Faculty of Pharmacy, Keio University, Tokyo, Japan
Skin hyperpigmentation disorders due to abnormal melanin production induced by ultraviolet 
(UV) irradiation are both a clinical and a cosmetic problem. On the other hand, UV-induced 
modest melanin production plays an important role in protection against UV-dependent skin 
damage. Therefore, it is important to suppress melanin production without aggravation of UV-
induced skin damage. Expression of heat shock proteins (HSPs), particularly HSP70, is induced 
by various stressors, including UV irradiation to provide cellular resistance against such stressors. 
We recently found that expression of HSP70 not only protects skin against UV-induced damage 
but also inhibits melanin production and proposed that HSP70 inducers could be beneficial as 
hypopigmenting cosmetics and medicines. In this study, we searched for HSP70 inducers from 
herbs and selected Eupatorium lindleyanum and Arnica montana, both of which have been used 
to reduce inflammation and pains in China and Europe, respectively. Extracts from each herb 
induced expression of HSP70 and activation of HSF1 (a transcription factor for hsp genes) at 
concentrations that did not significantly affect cell viability. Not only melanin production but also 
UV-induced cell death was suppressed by pre-incubation of cells with extracts from each herb 
and this protection was partially suppressed by transfection of siRNA for HSP70. These results 
suggest that extracts from each herb suppress UV-induced melanin production and cell death 
partly through induction of expression of HSP70. We propose that extracts from each herb could 
be beneficial as a hypopigmenting cosmetic and medicine.
652
The miRNA expression pattern of oncogene-induced-senescence in human melanocytes
Line Marie Broksø Holst1, Valentina Manfe1, Bogumil Kaczkowski2, Anne Rosberg1,2, Britt 
Lauenborg2, Martin Glud1, Robert Gniadecki1 1Bispebjerg Hospital, Copenhagen NV, Denmark, 
2Copenhagen University, Copenhagen Ø, Denmark
Mutated, monogenic BRAFV600E can paradoxically block proliferation in melanocytes inducing 
oncogene-induced senescence (OIS), the process that is now considered to prevent the 
evolution of malignant melanoma. There is accumulating evidence that microRNAs are involved 
in the pathogenesis of malignant melanoma, but whether they regulate OIS has not yet been 
investigated. We have therefore preformed a miRNA screen by microarray technology to 
identify the miRNA species which are differentially expressed in human epidermal melanocytes 
induced to OIS by BRAF V600E transfection versus normal, sham-transfected melanocytes and the 
melanocytes subjected to replicative senescence. We found 27 upregulated miRNAs in OIS and 
39 upregulated miRNAs in replicative senescent melanocytes (False Discovery Rate <0.05). Six 
miRNAs; miR-10a, miR-31, miR-125b, miR-204, miR-320c and miR-378 were upregulated 
during both OIS and in replicative senescence, indicating that these miRNAs contribute to the 
cellular senescence in melanocytes. We confirmed the changes in the expression by q-RT-PCR. 
Interestingly, it is known that miR-10a, miR-31 and miR-125b are expressed in different cancers, 
including malignant melanoma and it is known that miR-125b is downregulated in both atypical 
nevi and malignant melanoma. It has been proposed that induction of senescence is a major 
mechanism responsible for the therapeutic effect of cytostatics. Our findings may provide a 
promising approach to future therapy of malignant melanoma.
653
Role of voltage-gated calcium channels in the viability of melanoma
Arindam Das1, Anabel Sorolla1, Judit Herreros1, Ramón Vilella4, Xavier Matías-Guiu2, Rosa Maria 
Martí3, Carles Cantí1 1Laboratori d’Investigació, IRBLleida. Universitat de Lleida, Lleida, Spain, 
2Department of Pathology and Molecular Genetics. Hospital Universitari Arnau de Vilanova. 
Universitat de Lleida. IRBLleida, Lleida, Spain, 3Department of Dermatology. Hospital Universitari 
Arnau de Vilanova. Universitat de Lleida. IRBLleida, Lleida, Spain, 4Servei d’Immunologia, 
Hospital Clínic de Barcelona, Barcelona, Spain
Oscillations in the cytoplasmic levels of ionic calcium, a universal second messenger, are 
indispensable for cell proliferation. The ultimate source of cell Ca2+ is extracellular, which flows 
into the cells through specific channels present in the plasma membrane. Up to 10 genes have 
been described to encode the pore-forming subunits of voltage-gated calcium channels (VGCCs), 
being the most highly selective channels for calcium ions. VGCCs activate and inactivate by 
depolarization of the plasma membrane and are classified in 3 different families based on 
sequence homology analysis and functional properties: 1) Cav1 family members encode mainly 
high-voltage activated L-type channels. 2) Cav2 family members encode high-voltage activated 
P/Q-type, N-type and R-type channels. 3) Cav3 family members encode low-voltage activated 
T-type channels. Ca2+-signalling is frequently deregulated in cancer cells, often involving the 
selective up or down-regulation of VGCCs. However, the contribution of VGCCs to melanoma 
calcium homeostasis or signalling has not been investigated. In the present study we have tested 
the hypothesis that VGCCs are functionally expressed in melanoma and play a critical role in 
the viability of these cells. We have performed a comprehensive analysis of melanoma cell lines 
and primary tumours. The results attained by combining expression analysis, Ca2+-imaging and 
viability assays, indicate a widespread expression of all VGCC families in melanoma cells, and a 
principal role for T-type channels in melanoma homeostasis.
654
Macrophages influence melanocyte proliferation after ultraviolet radiation exposure
Mathieu Rodero1, Herlina Handoko2, Graeme Walker2, Kiarash Khosrotehrani1 1University of 
Queensland UQ Centre for Clinical Research, Brisbane QLD, Australia, 2Queensland Institute of 
Medical Research, Brisbane QLD, Australia
Sunburns result in an inflammatory response in the skin that is accompanied by melanocyte 
(MC) proliferation. However, the nature of this response is not well understood, nor is the 
potential source and homing path of critical immune cells involved in this process. Neonatal 
mice were exposed to a single burning dose of UVB radiation (UVR). Animals were sacrificed 
at multiple time points after UVR and the skin was stained by immunofluorescence, or digested 
for flow cytometry analysis using a panel of antibodies that differentiate the various myeloid 
lineages. After neonatal UVR, MCs increased in number in the interfollicular epidermis, the 
infundibulum, and the bulge regions of hair follicles. UVR induced an inflammatory infiltrate 
mostly comprised of macrophage subpopulations that dynamically changed over time. Initial 
infiltration was dominated at day 1 by Ly6C-hi/MHCclassII-lo cells that at later time points 
disappeared in favour of a Ly6c-lo/MHC-hi population that peaked in number at day 4 after 
UVR and virtually disappeared by day 7. Most importantly, systemic and topical treatment 
with clodronate-filled liposomes resulted in a significant decrease of MC numbers after 
UVR. This correlated with reduced infiltration of the skin by macrophages and particularly 
the Ly6C-lo/MHCII-hi population. This subpopulation therefore seems responsible for MC 
activation. Of interest, MC responses to UVR in IFNg null pups were comparable to WT. 
Our results indicate a prominent role for the Ly6C-lo/MHCIIhi macrophages in inducing a 
melanocyte response after neonatal UVR. Further dissection of the inflammatory response to 
UVR might offer clues for new paradigms of melanomagenesis.
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MMP-9 supplied by bone marrow-derived cells does not contribute to melanoma lung metastasis
Markus Meissner, Gabi Reichenbach, Igor Hrgovic, Andreas Pinter, Monika Doll, Jens Gille, 
Roland Kaufmann University of Frankfurt, Dept. of Dermatology, Frankfurt, Germany
Melanoma has a high probability of metastasizing to the lung. The matrix metalloproteinases 
(MMPs) are a family of proteolytic enzymes including more than24 human MMPs, that contain a 
zinc ion in the active site. MMPs function in physiological and pathological processes including 
migration, angiogenesis, and tissue repair, as well as metastasis and tumor progression. Up to now 
it is unclear whether MMP-9 secreted from infiltrating bone-marrow derived cells or resident cells 
in the lung contribute to pulmonal melanoma metastasis. Using a tail vein injection experimental 
lung metastasis model, MMP-9 knockout mice demonstrated a more than two-fold decrease 
in melanoma lung metastasis compared to wild type mice following injection with B16F10 
syngeneic melanoma cells. There constitution of the bone marrow of MMP-9 knockout mice 
with bone marrow competent to produce MMP-9 did not recapitulate the WT phenotype 
of overwhelming burden of pulmonal metastasis. In contrast, wilde type mice reconstituted with 
the bone marrow of MMP-9 knockout mice displayed the same burden of pulmonal metastatic 
disease as the WT phenotype. Hence, these results demonstrate that rather stromal derived MMP-
9 from resident cells contribute to melanoma lung metastasis instead of MMP-9 secreted from 
infiltrating bone-marrow derived cells. These results provide new insights into the influence of 
MMP-9 in melanoma lung metastasis and demonstrates that bone-marrow derived MMP-9 is not 
essential for the growth and establishment of pulmonal melanoma metastasis.
656
Quantitative assessment of 3D melanin distribution inside human skin by in vivo multiphoton 
microscopy
Hassan Ait El Madani1,2, Ana-Maria Pena1, Alain Dupuy3, Armand Bensussan2, Martine Bagot2,3, 
Emmanuelle Tancrède-Bohin1,3 1L’Oréal Recherche & Innovation, Aulnay Sous Bois, France, 
2INSERM UMR-S-976, Université Paris 7, Denis Diderot, Centre de Recherche sur la Peau, Paris, 
France, 3Service de Dermatologie -Hôpital St. Louis, Paris, France
Melanin is one of the main pigments determining the human skin color. Its amount and 
distribution inside the skin can be modified due to pigmentation disorders or application of 
whitening products. In both cases, the in vivo characterization of the melanin 3D distribution 
inside the human skin would offer a mean to study the pigmentation modifications. In this work, 
we characterize the application of multiphoton microscopy to melanin imaging. We show 
that the highly concentrated melanin regions at the basal layers of the epidermis create a high 
intensity fluorescence signal stronger that the one created by the other cellular fluorophores. We 
use this information to develop a melanin quantification procedure that allows us to estimate a 
melanin volume density as the ratio of the number of voxels occupied by melanin and the total 
number of voxels in the investigated area. We then apply this method to the study of melanin 
distribution between different skin phototypes and to the assessment of topical corticosteroid 
cutaneous side effects. This study illustrates the potential of multiphoton microscopy for non 
invasive in vivo kinetic studies of skin integrity and pigmentation.
657
Fibroblasts regulate both physiological and pathological pigmentation of skin in vitro and in vivo
Muriel Cario-Andre1,2, Khaled Ezzedine2, Catherine Pain1, Alain Taieb1,2 1University V Segalen, 
Inserm 1035, Bordeaux, France, 2National reference center for rare skin disease, Dermatology 
Unit, Bordeaux University Hospital, Bordeaux, France
We have previously described that white human skin or white human epidermal reconstructs 
xenografted onto nude mice could become black or totally white. These modifications of 
pigmentary pattern were associated with changes in densities of dermal fibroblasts. In vitro, we 
have compared reconstructs made on DDD colonized or not with various concentrations of 
fibroblasts or treated with fresh or frozen media conditioned by various densities of fibroblasts 
and we have reproduced this phenomenon of increase or decrease of pigmentation. We have 
noticed that FGF2 and K5 were overexpressed in epidermis of hyperpigmented samples. In vitro 
treatment of reconstructed epidermis without fibroblasts with FGF2 increased cytokeratin 5 
expression. Using our model of reconstructed epidermis with fibroblasts of systemic scleroderma 
(SSc) patients, we were able to demonstrate that SSc fibroblasts can either stimulate or inhibit 
pigmentation according to patients. To better understand the dermal influence on pigmentation 
we compared lesional and perilesional skin of a patient with a pronounced depigmentation 
following erythema multiforme. We found that the number of melanocytes was decreased in 
lesional skin and that the remaining melanocytes were non functional. Interestingly, FGF2 
was overexpressed in lesional area whereas densities of fibroblasts and K5 expression were 
similar in both areas. Since all these data point out the key role of FGF2 we are using our 
model of reconstructs with FGF2 overexpressing fibroblasts to detect changes in pigmentation. 
In conclusion, our data associated with clinical observations of pigmentary disorders support the 
hypothesis that fibroblasts modulate pigmentation by paracrine factors especially FGF2.
658
Partial failure of lymphatic function around melanoma
Victoria Akhras1, Anthony Stanton1, Rodney Levick1, Martin Cook2, Peter Mortimer1 1St George’s 
University of London, London, UK, 2Royal Surrey County Hospital and Division of Clinical 
Medicine, University of Surrey, Guildford, UK
Melanomas release lymphangiogenic growth factors resulting in an increased histological 
perilesion lymphatic vessel density. This is thought to increase the chance of tumour cell entry 
into lymphatics and metastasis (the lymphangiogenesis-metastasis link) but lymphatic vessels 
must be functional for metastasis to occur. The aim of the study was to quantify functional and 
histological lymphatic vessel density near melanomas and naevi to test the following hypotheses: 
1) Functional and histological lymphatic vessel density is increased near melanomas (but 
unchanged near naevi) relative to normal skin. 2) Changes in lymphatic vessel density near 
metastatic melanomas are greater than those near non-metastatic melanomas. Fluorescence 
microlymphangiography (FML) was used to quantify functional lymphatic vessel density in 
perilesion and matched normal skin. Histological lymphatic vessel density was quantified in 
standard biopsies using lymphatic markers. FML: Contrary to hypothesis 1 lymphatic length 
densities at 281 µm and 563 µm from the edge of melanomas were 53% (P = 0.002, Wilcoxon 
signed rank test) and 43% (P = 0.03) lower than control. By contrast, around naevi total lymphatic 
length density was increased by 64% relative to control (P = 0.008). Immunohistology: Lymphatic 
densities were 68% (P = 0.0003, paired t test) and 17% (P = 0.03) higher around melanomas and 
naevi respectively than in control. Although histological lymphatic vessel density is increased 
near pigmented lesions, functional lymphatic vessel density is decreased near melanomas and 
increased near naevi. The results indicate that there is a partial failure of lymphatic function 
around melanoma.
659
Real time electrochemical measurement of oxidative stress in human melanoma skin cells and 
its relationship with mitochondrial DNA damage and pigmentation
Helen Swalwell, SarahJayne Boulton, Philip Manning, Calum McNeil, Mark Birch-Machin 
Newcastle University, Newcastle upon Tyne, UK
UVA irradiation initiates oxidative stress in human skin; however its exact role in skin cancer 
remains unclear, although there is evidence for a melanin-dependent mechanism in melanoma. 
We have investigated UVA-induced production of reactive oxygen species (ROS) in human 
pigmented and non-pigmented, normal and melanoma skin cells. A cytochrome c functionalised 
amperometric sensor has been developed and used to monitor, in real time, the generation of 
superoxide (O2
ˉ). As the mitochondrial electron transport chain (mETC) is the major cellular 
generator of ROS, it is desirable to monitor ROS generation from the mitochondria exclusively. 
We report a novel application of the amperometric sensor to monitor O2
ˉ generation in 
isolated mitochondrial fractions, directly and in real-time. This is the first time that this type of 
measurement has been demonstrated and we show the dynamics of mitochondrial O2
ˉ release 
following inhibition of complexes I (rotenone) and III (antimycin) of the mETC in a human 
melanoma cell line. We have also used mitochondrial DNA (mtDNA) as a damage marker to 
relate the real time measurement of oxidative stress in cells to downstream DNA damage, using 
UVA and H2O2 as stressors. We used a novel long template (i.e. 11kb) qPCR assay developed 
in our laboratory to measure mtDNA strand breaks in pigmented (e.g. moderately pigmented 
(SKmel 23 and FM55) and heavily pigmented (FM94)) and non-pigmented melanoma cells (e.g. 
A375) and show that the degree of damage is significantly associated with levels of pigmentation 
(ANOVA with post-hoc Tukey’s analysis).
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A large French case-control study assessing the association of MC1R with melanoma: clarifying 
the role of non-RHC and rare MC1R variants
Hui-Han Hu1, Vincent Descamps1,2, Agnes Bourillon3, Nicole Basset-Seguin1,4, Khaled Ezzedine5,6, 
Celeste Lebbe1,4, Martine Bagot1,4, Armand Bensussan1,4, Philippe Saiag7,8, Bernard Grandchamp3, 
Nadem Soufir1,3 1INSERM U976, Centre de Recherche sur la Peau, Hôpital Saint-Louis, Université 
Paris7, Paris, France, 2Service de Dermatologie, Hôpital Bichat Claude Bernard, APHP, Paris, 
France, 3Lab de Biochimie Hormonale et Génétique, Hôpital Bichat Claude Bernard, APHP, 
Paris, France, 4Service de Dermatologie, Hôpital Saint Louis, APHP, Paris, France, 5INSERM U876, 
Université V Segalen Bordeaux, France, 6Service de Dermatologie, CHU Bordeaux, Bordeaux, 
France, 7Service de Dermatologie, Hôpital Ambroise Paré, APHP, Boulogne Billancourt, France, 
8Université Saint Quentin en Yvelines, France
As the contribution of MC1R non-RHC variants (r variants) on melanoma risk is still debated, we assessed the 
role of various classes of MC1R variants on melanoma predisposition. The coding region of MC1R was sequenced 
in 1131 melanoma patients and 869 skin-cancer-free Caucasian controls. MC1R variants were classified in two 
categories: R (RHC), and r (non-RHC). Rare r variants (allelic frequency <1%) were thereafter classified in functional 
(F) or non-functional (nF) according to the type of mutation and/or in silico predicted functional effect. Association 
with melanoma risk was assessed with Fisher’s exact test and Odds Ratio.In addition to known R and r variants, we 
detected 70 rare variants of which 63% were functional (F). Both R and r variants, interestingly, were associated with 
melanoma (OR=3.29 [2.7-4.02] and OR=1.84 [1.55-2.14]), especially V60L and V92M (ORs=1.82 and 2.17). In 
addition, rare F variants, present in 3% of patients, were associated strongly with melanoma (OR=2.93 [1.74-4.93]). 
At the opposite, rare nF variants had no effect on melanoma risk (P=0.82). Furthermore, the contribution of both 
R and r variants to melanoma risk remained after multivariate analysis. R variants also associated with familial and 
multiple melanoma risks (P=0.019 and P=0.0018).In conclusion, we showed a clear association of frequent MC1R r 
variants with melanoma risk and defined a novel strong melanoma risk factor: MC1R F variants. These findings may 
have consequences in defining melanoma high-risk patients and/or may help in the future to the genetic council.
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Periorbital hyperchromia in a Caucasian population is associated with local melanin 
accumulation in a pro-inflammatory environment
Caroline Pollefliet1, Katrin Van Rillaer1, Ann Neven1, Hugo Corstjens1, Lieve Declercq1, Dan 
Yarosh2 1Estée Lauder Companies, Oevel, Belgium, 2Estée Lauder Companies, Melville, NY, USA
A large proportion of the population shows signs of periorbital hyperchromia or dark under eye 
circles, but its etiology is poorly defined. We non-invasively characterised the under-eye area 
of 140 Caucasian volunteers with skin type II or III, with or without periorbital hyperchromia. 
Chromameter measurements revealed that in the study population of people that suffered from 
periorbital hyperchromia, the under-eye area had a darker skin tone compared to the cheek 
(p<10-5). This difference was not observed in the group of non-sufferers (p=0.79). The melanin 
content as measured with the Siascope was higher on the under eye area compared to the cheek 
(p<10-5). Next, people were classified in three groups according to the clinical manifestation 
of periorbital hyperchromia. There was no dependence between the clinical severity and the 
age of the panelist. As expected, skin tone and colour contrast (Visia-CR) between under eye 
area and cheek gradually increased at increasing clinical severity. Melanin but not hemoglobin 
gradually increased in the under eye area of people with no, moderate and severe periorbital 
hyperchromia, indicating that melanin levels partially accounted for the degree of periorbital 
hyperchromia in this panel. Lastly, D-squame tape strippings were analysed for PLA2 activity. 
PLA2 activity was significantly increased in the under-eye area compared to the cheek (p<10-3) 
and this difference was detected in all groups with different severities. Since PLA2 is implicated 
in skin inflammation, these data suggest a pro-inflammatory state of the under eye area in this 
Caucasian test panel, with a possible effect on periorbital hyperchromia.
662
Site dependent significance of sun induced damage as risk factor of melanoma in a central 
European population
Judith Wendt, Oliver Schanab, Michael Binder, Hubert Pehamberger, Ichiro Okamoto Medical 
University of Vienna, Dept of Dermatology, Division of General Dermatology, Vienna, Austria
Most studies that address the role of phenotypical risk factors and melanoma were conducted 
in northern European populations. Therefore, we aimed to study clinically detectable risk factors 
of melanoma in a large cohort of central European origin, including comprehensive information 
regarding pigmentation phenotype and clinical signs of sun damage. Cases (n=1146) and controls 
(n= 1053) were recruited between March 2008 and July 2010 in a hospital based case-control 
study in Vienna. Skin phototype, fair eye- and hair color, presence of signs of sun damage and 
number of nevi were significantly associated with melanoma risk. Additionally, a site dependent 
extent of odds ratio (OR) for signs of sun damage was calculated: The highest OR was consistently 
observed on the back compared to other sites. After adjustment for sex and age at recruitment, 
lentigines, freckling and Favre-Racouchot on the back or neck had an OR of 2.80, 2.84 and 3.06 
(all p<0.001), respectively. OR for analogous alterations on the face were 2.24 for lentigines and 
1.77 for Favre Racouchot, respectively (all p<0.001). Our data confirm the importance of sun 
related factors in a central European population. Moreover, signs of sun damage on the back 
seem to be more relevant as risk factors of melanoma than such alterations on other chronically 
sun exposed sites. This finding should be considered in future risk assessment processes.
663
Protective role of host-derived ADAM-9 in the progression of malignant melanoma
Anna Abety1, Jay W. Fox3, Alexander Schoenefuss1, Jan Zamek1, Jennifer Landsberg2, Thomas 
Krieg1, Carl Blobel4, Cornelia Mauch1, Paola Zigrino1 1University of Cologne, Cologne, Germany, 
2University of Bonn, Bonn, Germany, 3University of Virginia, Charlottesville, Virginia, USA, 
4Hospital for Special Surgery New York, New York, USA
ADAMs are members of the zinc protease superfamily characterized by the presence of 
disintegrin and metalloprotease domains. ADAM-9 is increased in a variety of cancer types 
including prostate, breast, intestinal cancer and melanoma. In human melanoma, ADAM-9 is 
expressed at the tumor-stroma border in both, melanoma and stromal cells. Using animals with 
complete depletion of ADAM-9, we investigated the role of host-derived ADAM-9 in melanoma 
progression. Tumors developed in ADAM-9 knockout mice were significantly larger compared 
to wild type and displayed a significant increase in tumor cell proliferation accompanied by 
decrease in apoptosis. Using co-culture systems of isolated primary fibroblasts and B16F1 
melanoma cells, we could detect increased melanoma cell proliferation when cells were cultured 
with supernatants collected from ADAM-9 knockout but not wild type fibroblasts. Among the 
secreted proteins differentially expressed in the conditioned media from knockout as compared 
to wild type fibroblasts, we have identified the tissue inhibitor of metalloproteinases-1 (TIMP-1). 
Neutralization of TIMP-1 using specific antibodies abolished the induced B16F1 proliferation 
to a similar level as observed when using conditioned medium of control fibroblasts. However, 
TIMP-1 neutralization did not influence cellular apoptosis. Increased levels of soluble TNFR1 in 
ADAM-9-/- fibroblasts supernatants are likely responsible for the reduced cellular apoptosis by 
neutralization of soluble TNF. Taken together, our results indicate a protective role for stromal 
ADAM-9 expression during development of melanoma mediating the regulation of stromal 
expression of TIMP-1 and sTNFR1.
664
Phenotypic analysis of PBMCs from IFN-α-treated melanoma patients: mechanisms of 
melanoma tumor containment
Madeleine L. Kalb1, Bärbel Reininger1, Frieder Koszik1, Markus Neumann2, Klemens 
Rappersberger2, Georg Stingl1 1Department of Dermatology, DIAID, Medical University of Vienna, 
Vienna, Austria, 2Department of Dermatology, Rudolfstiftung, Vienna, Austria
Recombinant IFN-α is used as adjuvant treatment for stage II/III melanoma patients. It is thought to 
increase patient survival by directly inhibiting tumor growth via its antiproliferative and cytotoxic 
properties and, indirectly, through immune-activation. To gain a better understanding of how IFN-α 
contributes to melanoma tumor containment we analyzed, by flow cytometry, PBMCs of melanoma 
patients (n=8) before and during IFN-α therapy and compared them to healthy controls (HC). Results 
obtained showed a significant reduction in myeloid but not plasmacytoid dendritic cell (DC) numbers 
during IFN-α therapy. Detailed phenotypic analyses revealed that plasmacytoid DCs of melanoma 
patients expressed higher levels of CD40 and CD86 compared to HC. Myeloid DCs, in contrast, 
exhibited elevated levels of CD62L, CCR6 and CXCR4, and a down-regulation of CCR7. These 
changes were even more pronounced during IFN-α therapy and were consistent with phenotypic 
properties found on DCs endowed with the ability to migrate into (tumor) tissue and. We and others 
have previously shown that IFN-α induces the cytotoxic molecule TNF-related apoptosis-inducing 
ligand (TRAIL), which both in its membrane-bound and soluble form lyses tumor targets in vitro. 
In patients undergoing IFN-α therapy we now observed an upregulation of membrane TRAIL on 
monocytes, NK cells and in one case also on plasmacytoid DCs and these changes were paralleled 
by an increase of soluble TRAIL in the serum (ELISA). Taken together our findings suggest that IFN-
α-mediated antitumor immunity involves multiple and diverse immunological mechanisms. Better 
understanding these mechanisms will enable us to develop novel therapeutic strategies.
665
IMQ- or IFN-α-stimulated pDCs kill melanoma cells in a TRAIL-dependent manner
Astrid Glaser, Madeleine L. Kalb, Frieder Koszik, Georg Stingl Department of Dermatology, 
DIAID, Medical University of Vienna, Vienna, Austria
We and others have previously shown that the TLR7/8 agonist Imiquimod (IMQ) effectively 
induces tumor regression of skin cancers (BCC, melanoma). Both in man and mice, tumor 
regression was associated with an infiltrate of plasmacytoid dendritic cells (pDCs) expressing the 
cytotoxic molecule TNF-related apoptosis-inducing ligand (TRAIL). Since IMQ-induced TRAIL 
expression was shown to be dependent on IFN-α in vitro, we asked whether TRAIL+ pDCs could 
play a role in melanoma patients treated with IFN-α. To test this hypothesis, we first analyzed the 
susceptibility of established melanoma cell lines and such generated from stage IV melanoma 
patient metastases to soluble TRAIL by flow cytometric annexin V/PI staining. While neither IFN-α 
nor IMQ themselves induced apoptosis at significant levels, overnight treatment with soluble TRAIL 
induced apoptosis in melanoma cell lines, particularly when they had been pretreated with IFN-α. 
We next assessed the expression of TRAIL on pDCs after overnight stimulation with IMQ and/
or IFN-α. Interestingly, low doses of IMQ, that were not sufficient to activate pDCs, enhanced 
IFN-α-induced expression of TRAIL. To assess the relevance of cytotoxic pDCs in melanoma 
cell killing we performed 2h and 4h cytotoxicity assays. We found that both, IMQ- and IFN-α-
activated pDCs killed melanoma cells with 20-40% effectivity, whereas killing was reduced to 
baseline levels in the presence of a neutralizing antibody against TRAIL. These results strongly 
suggest a role for cytotoxic pDCs in IFN-α and IMQ-mediated tumor containment and may 
provide the basis for novel therapeutic strategies.
666
The viral chemokine receptor US28 mediates its anti-tumorigenic effect in melanoma via 
GNA13
Shripad Joshi1, Christian Wels1, Mizuho Fukunaga-Kalabis2, Meenhard Herlyn2, Helmut Schaider1 
1Medical University of Graz, Graz, Austria, 2The Wistar Institute, Philadelphia, USA
Reports investigating on the biology of the human cytomegalovirus encoded G-protein coupled 
receptor US28 in different cell types led to the understanding that it has potential to impart 
differential effects like apoptosis, tumorigenesis, migration etc. on target cells, most probably 
depending on the host and cellular microenvironment. Here we report that US28 expression 
in melanoma cell lines results in reduced proliferation and caspase mediated apoptosis. The 
observation that the signaling mutant R129A shows reduced effects compared to wild type 
US28 while the C-tail truncated mutant has an enhanced effect due to its higher surface level 
retention indicated that modulation of intracellular signaling by US28 is responsible for the 
observed effects. As US28 is known for activation of different signaling pathways via multiple 
G-protein interactions, the involvement of different G-proteins was determined. We found that 
GNA13 is selectively executing the apoptosis inducing effects of US28. Interestingly, endogenous 
expression levels of GNA13 vary drastically in the analyzed panel of melanoma cell lines with 
a gradual loss at advanced stage of disease. In vivo reduced tumor growth for US28 compared 
to GFP control expressing melanoma cells was observed. Currently the influence of GNA13 
on other important features in cancer biology like migration and metastases are investigated 
suggesting a much broader role for this G-protein. Based on these findings we are keen to follow 
up the role of GNA13 and developing US28 towards a potential candidate for gene therapeutic 
approaches.
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Immunohistochemical characterization of metallothionein-expression in primary cutaneous 
malignant melanoma
Eszter Emri1, Gabriella Emri1, Kristof Egervari2, Livia Beke2, Tunde Varvolgyi1, Gabor Mehes2, 
Iren Horkay1, Eva Remenyik1 1Department of Dermatology, Debrecen, Hungary, 2Department of 
Pathology, Debrecen, Hungary
Formation of metastases and efficacy of systemic therapies in malignant melanoma depend on 
the characteristics of the tumor cells e.g. mitotic activity, apoptosis resistance, change in cell 
adhesion properties as well as on the host immune response. Several studies could identify 
altered gene expression patterns in melanoma cells, however, only a few reports can be found 
about analysis of protein markers of tumor invasiveness and local immune response in the 
same tumor tissue sample. Our pilot immunohistochemical study was performed on archived 
tissue blocks of primary cutaneous melanomas (n=21). We investigated metallothionein (MT) 
expression in comparison with the presence of infiltrating macrophages and dendritic cells (DC). 
MT-expression has previously been reported to be promising marker of the risk of haematogenous 
metastasis. Our results suggest that MT-expression of the tumor cells might be more reliable 
prognostic factor in thin (<1.5 mm) melanomas, we found less difference between metastatic and 
non-metastatic primaries regarding their MT-expression in thick tumors. Macrophages (CD68+) 
and immature DC (DC-SIGN+) were present in the intratumoral as well as in the peritumoral 
areas. CD1a+ DC could be observed in the epidermis only. An interesting new finding is that 
MT-positivity was also detectable in cells with dendritic morphology and peritumoral presence of 
these cells seemed to be associated with better prognosis.
668
Importance of BRN2 phosphorylation for melanocyte migration
Irina Berlin1, Laurence Denat1, Anne-Lise Steunou2, Isabel Puig1, Delphine Champeval1, Sophie 
Colombo1, Karen Roberts3, Elise Bonvin1,3, Yveline Bourgeois1, Irwin Davidson4, Véronique 
Delmas1, Laurence Nieto2, Colin Goding3, Lionel Larue1 1Institut Curie, Orsay, France, 2IPBS, 
Toulouse, France, 3Ludwig Institute for Cancer Research, Oxford, UK, 4IGBMC, Illkirch, France
BRN2 is a POU domain transcription factor overproduced in human melanoma cell lines and 
involved in melanocyte proliferation and invasion, and known to control the transcription of 
MITF-M and PAX3. The T361 and S362 residues of BRN2 were mutated by two alanine residues 
generating BRN2AA. As PKA cannot phosphorylate BRN2AA, this kinase mainly targets the TS 
residues in vitro. In vivo and in vitro BRN2TS induced proliferation and repressed migration 
whereas BRN2AA repressed both proliferation and migration. We thus investigated the binding 
and transactivation of BRN2TS and BRN2AA on PAX3 and MITF-M at the molecular and genetic 
levels. MITF-M transcription is repressed similarly by both BRN2TS and BRN2AA whereas PAX3 
transcription is induced by BRN2TS but repressed by BRN2AA. Melanoblast migration and 
proliferation are controlled by amount of non-phosphorylated BRN2 through PAX3 and by the 
total BRN2 level through MITF-M.
669
RASSF1A, a melanoma suppressor gene, is also methylated in melanocytic nevi
Maiko Maeda1,2, Masayuki Sakiyama1,2, Junichi Furuta1, Shingo Tajima2, Fujio Otsuka1 1University 
of Tsukuba, Tsukuba, Ibaraki, Japan, 2National Defense Medical College, Tokorozawa, Saitama, 
Japan
The RAS-BRAF-MAPK pathway is the most important signalling pathway involved in the 
pathogenesis of melanoma. BRAF and NRAS mutations and Ras association domain family 
member 1 (RASSF1A) methylation are frequently seen in this condition. Recently, BRAF and 
NRAS mutations have also been observed in melanocytic nevi. Therefore, the abovementioned 
pathway is assumed to be involved in the pathogenesis of all melanocytic tumours. However, the 
methylation of RASSF1A has not been analysed in melanocytic nevi. The aim of this study was 
to evaluate the methylation status of RASSF1A in melanocytic nevi. Promoter hypermethylation 
status of RASSF1A was detected after isolating genomic DNA from the tissue samples of 13 
individuals with melanocytic nevi using methylation-specific PCR (MSP) technique. The primer 
set used for MSP confirmed the correlation between gene promoter methylation statuses and 
mRNA expression of RASSF1A by RT-PCR method in melanoma cell lines. As a result, RASSF1A 
methylation was detected in 3 of 13 (23%) melanocytic nevi; it was detected in 36% of 
melanomas as previously reported. Thus, this result suggests that the inactivation of RASSF1A 
by promoter methylation may play an important role not only in the pathogenesis of malignant 
melanoma but also in that of melanocytic tumours. This study was a small-sized preliminary 
examination, and further large-sized studies using MSP and immunohistochemical techniques 
are needed.
670
Combination therapy accelerates repigmentaion in the treatment of vitiligo
Sik Haw1, Jungran Choi2, Ounjae Park1, Gyeunghun Park1, Hyejung Jung1, Heesung Chung2, 
Eoksoo Oh2, Jeongeun Kim1, Sungeun Chang1, Miwoo Lee1 1Dept of Dermatology, Asan Medical 
Center, Univ of Ulsan College of Medicine, Seoul, Republic of Korea, 2Dept of Life Sciences, Div 
of Life & Pharmaceutical Sciences, Center for Cell Signaling & Drug Discovery Research, Ewha 
Womans Univy, Seoul, Republic of Korea
Vitiligo is an acquired depigmentaion disorder resulting from destruction of cutaneous melanocytes. 
Phototherapy and topical corticosteroids or tacrolimus are mainstay of treatment strategy and sometimes, 
combination of these treatment options can be chosen for treatment. We compared the effect of combining 
topical tacrolimus and 308-nm excimer laser therapy vs. 0.1% tacrolimus ointment monotherapy or 
excimer laser monotherapy in the treatment of vitiligo. This retrospective study was performed on 276 
patients with 372 non-generalized, non-segmental vitiligo lesions distributed on the face/neck, trunk or 
extremities. The patients were divided into three groups: group A: 308-nm excimer laser twice per week; 
group B: tacrolimus ointment twice daily; group C: the combined excimer laser and tacrolimus of above 
regimen. Also, for in vitro study, we measured the melanin contents and tyrosinase acitivity using human 
melanocyte cells. Our results showed the combination treatment of tacrolimus ointment and 308-nm 
excimer laser are more effective than each monotherapy for the treatment of vitiligo (P = 0.012). Also, 
there was statistical significance between repigmentation and the duration of combination treatment 
whereas lesion’s location was not associated. Early initiation of treatment for the lesions of less than 
6 months’ duration responded better to combination treatment. In vitro study demonstrated combined 
excimer laser and tacrolimus treatment led to higher level of melanogeneis than that of the single treated 
cells. We concluded that the combination treatment of tacrolimus and excimer laser is an effective therapy 
for vitiligo and accelerates repigmentation compared to monotherapy.
671
Targeting The Proteasome In Melanoma
Anabel Sorolla1,2, Andree Yeramian1,2, Ana Velasco2, Maria Santacana2, Xavier Dolcet1,2, Joan 
Valls5, David Llobet1,2, Ramon Egido2, Josep M Casanova3, Ramon Vilella6, Antonio Llombart-
Cussac4, Xavier Matias-Guiu2, Rosa M Marti3 1Lab of Research, Hospital Univ Arnau de Vilanova, 
Univ of Lleida, IRBLLEIDA, Spain, 2Dept of Pathology & Molecular Genetics, Hospital Univ Arnau 
de Vilanova. Univ of Lleida, IRBLLEIDA, Spain, 3Dept of Dermatology, Hospital Univ Arnau de 
Vilanova, Univ of Lleida, IRBLLEIDA, Spain, 4Dept of Oncology, Hospital Univ Arnau de Vilanova, 
Univ of Lleida, IRBLLEIDA, Spain, 5Biostatistics Unit, Hospital Univ Arnau de Vilanova, University 
of Lleida, IRBLLEIDA, Spain, 6Dept of Immunology, Hospital Clinic, Barcelona, Spain
We and others have demonstrated that melanoma cells are sensitive to Bortezomib and other proteasome 
inhibitors in in vitro and in vivo melanoma models. However, first clinical trials employing Bortezomib 
indicated that it is quite effective in some hematologic malignancies but not in malignant melanoma 
and other solid tumors, nor as single agent, nor in combination with conventional chemotherapy. 
Nevertheless, multiple preclinical studies supported that proteasome inhibitors could synergize with 
several targeted therapies. Additional studies of our group and others also demonstrated that different 
antioxidants are able to block different proteasome inhibitors in a specific way. Recently, our group 
showed that a combined exposure to the multikinase inhibitor Sunitinib and Bortezomib resulted in a 
synergistic decrease of cell viability and an increase in apoptosis in two Sunitinib sensitive melanoma 
cell lines (M16 and M17). Sunitinib inhibited constitutive activated PDGFRα or VEGFR2, respectively, Akt 
phosphorylation and downregulated cyclin D1. In addition, Sunitinib partially inactivated ERK in M17 
but not in M16 cell line that harbored the BRAF/V600E mutation. Downregulation of phospho-Akt by 
Sunitinib seemed to mediate the synergy. Altogether, our results suggest that melanoma cells harboring an 
activated tyrosin-kinase receptor (RTK) may be responsive to a strategy combining proteasome inhibitors 
and RTK inhibitors and that the presence of antioxidant compounds should be considered in the design of 
drug mixtures containing proteasome inhibitors.
672
Expression of MIA (melanoma inhibitory activity) in vitiliginous melanocytes: a novel 
pathogenetic pathway?
Matteo Bordignon1, Chiara Castellani2, Marni Fedrigo2, Mauro Alaibac2, Annalisa Angelini2 
1Venetian Oncology Istitute, Padova, Italy, 2University of Padua, Padova, Italy
The aim of our study was to investigate the presence of MIA (melanoma inhibitory activity) in 
vitiliginous melanocyte and its relationship with alpha5beta1 integrins in order to established if 
these molecules could be involved in vitiligo pathogenesis. We analysed ten biopsy from patients 
suffering for vitiligo. We tested antibodies against human alpha5beta1 integrin and MIA in two 
different sequential sections of patients and controls and visualized the results with peroxidase 
diaminobenzidine. Double immunostaining to illustrate co-localization of MIA protein with 
alpha5beta1 integrin slides was done simultaneously on the same section with a sequential 
immunostaining technique. The outcome was visualized with anti-mouse or anti-rabbit 
fluorescein isothiocyanate- or rhodamine-conjugated secondary antibodies. Microphotographs 
were taken using a TCS-SL laser scanner confocal microscope. All the biopsies of vitiliginous 
skin tested except one were positive for MIA. We found that the only MIA-negative specimen 
was derived from a patient suffering from segmental vitiligo, whereas all the other MIA-positive 
samples were derived form patients suffering from non-segmental vitiligo.We also found 
that anti-alpha5beta1 antibody co-localized with anti-MIA antibody. The presence of MIA in 
non-malignant melanocytes was completely unexpected. On the basis of our data, a novel 
pathogenetic mechanism can be proposed in non-segmental vitiligo. It is plausible that formation 
of the vitiliginous patches is consequent to a melanocytorrhagy determined by the interaction of 
MIA and alpha5beta1 integrins.
2011ESDR_8.25x10.875.indd   112 06/07/2011   18.24 
 www.jidonline.org S113
ABSTRACTS
673
The expression of CCR5 is associated with TGF-beta production by melanoma cells
Ryosuke Hino, Haruna Fueki, Ryutaro Yoshiki, Motonobu Nakamura University of Occupatiolan 
and environmental Health, Kitakyusyu, Japan
Tumor-induced immune escape is often seen in patients with malignant melanoma and this 
phenomenon is caused by complicated mechanism. Many chemokines show antitumor activity by 
stimulating immune cells or by inhibiting tumor neovascularization, however, other chemokines 
promote tumor growth and metastasis by direct growth stimulation, enhancing cell motility, or 
angiogenesis. We found that some isolated tumor cells from advanced melanoma patient strongly 
express CCR5. We checked some immunosuppresssive reactions by adding CCR5 ligands CCL3 
or CCL5 to melanoma cell line WM-115 cells. WM-115 cells showed significant chemotactic 
activity by CCL3 and CCL5 in a dose dependent manner. TGF-beta production from WM-115 
cells was significantly enhanced by CCL3 or CCL5, and CCR5 blocking peptide attenutated the 
enhancement in 3 days culture supernatants or intracytoplasmic cytokine staining. On the other 
hands, IL-10 prodiction by WM-115 cells was not changed by CCL3 or CCL5. These chemoines 
did not affect the proliferation of WM-115 cells. These findings suggest that CCR5 on melanoma 
cell may play a crucial role for immune escape in patients with malignant melanoma.
674
Inhibition of laser-induced post-inflammatory hyperpigmentation by tranexamic acid : in vitro 
study and clinical implication
Myoungshin Kim, Sik Haw, Sungeun Chang Department of Dermatology, Asan Medical Center, 
University of Ulsan College of Medicine, Seoul, Republic of Korea
Although various treatments, such as hydroquinone, vitamin C, glycolic acid, Kojic acid, 
and low fluence Q-switched 1,064 nm Nd:YAG laser, have been used for hyperpigmentation 
disorders, they are still challenging to dermatologists. In recent years, tranexamic acid has been 
reported to be effective in melasma and postinflammatory hyperpigmentation (PIH) in Asian 
countries. Tranexamic acid is a well-known drug inhibiting plasmin/plasminogen system, which 
has been used for preventing blood loss during surgery. In addition to its hemostatic effects, 
several studies showed that tranexamic acid had inhibitory effect on UV-induced melanogensis. 
Although the mechanism of the inhibitory effect of tranexamic acid on melanogenesis is not fully 
understood, it has been postulated that such effect comes from suppressing free arachidonic 
acid and its metabolites, and interfering with the interaction of melanocytes and keratinocytes 
through inhibition of the plasmin/plasminogen system, which ultimately leads to a decrease 
melanocyte tyrosinase activity. To clarify this mechanism, we studied the effects of tranexamic 
acid on melanogenesis in mouse melanocytes (Melan A cell) and moderately pigmented human 
melanocytes. In the cells which are cultured with laser-treated keratinocytes, and treated with 
tranexamic acid, we evaluated cell viability, melanin content, tyrosinase activity and protein 
level of tyrosinase, tyrosinase related protein (TRP)-1 and, TRP-2.
675
Inhibition of the subtilisin-kexin isozyme-1 – an emerging avenue for the future treatment of 
human melanoma?
Nina Weiß, Agatha Kokot, Thomas A. Luger, Carsten Weishaupt, Markus Böhm Dept.of 
Dermatology, University of Münster, Münster, Germany
Prohormone convertases (PCs) are mostly known as regulators of prohormone processing but 
their role in human pigment cells is poorly investigated. Here, we focused on subtilisin-kexin 
isozyme-1 (SKI-1), one of the most recently identified PCs. SKI-1 was constitutively expressed 
at mRNA and protein level in normal human melanocytes (NHM) and 9 human melanoma cell 
lines as determined by quantitative real-time RT-PCR and Western immunoblotting. Via in silico 
promoter analysis we found several putative transcription factor binding sites for transcription 
factors that are typically activated by melanocytes mitogens as well as by extracellular and 
intracellular stressors. However, among various factors, only phorbol-12-myristate-13-acetate 
and tunicamycin affected SKI-1 expression in NHM. Decanoyl (dec)-RRLL-chloromethylketone 
(CMK), a cell-permeable pharmacological SKI-1 inhibitor, led to a dose-dependent inhibition 
of the metabolic activity and proliferation of normal and transformed melanoma cells in vitro 
as assessed by XTT and crystal violet assay. Interestingly, melanoma cells were more sensitive 
towards dec-RRLL-CMK. Mechanistically, dec-RRLL-CMK dose-dependently induced apoptosis 
of melanoma cells as shown by cell death detection assay, Annexin-V staining and processing 
of poly-adenosine diphosphate-ribose polymerase 1/2. This effect was associated with reduced 
expression of two prototypical SKI-1 target genes, caveolin-1 and glucose-regulated-protein 78, 
which are implicated in melanoma growth and progression. Our findings provide first evidence 
for expression and regulation of SKI-1 in pigment cells. Moreover, induction of apoptosis by SKI-1 
inhibition may be envisioned as a novel approach in the future treatment of human melanoma.
676
Association of differentially expressed chemokines with melanoma progression
Ana Soler, Andreas Bracher, Robert Loewe Department of Dermatology, Medical University of 
Vienna, Austria
Development of distant metastases is the most important step in the progression of cutaneous 
melanoma; formation of metastases reduces outcome prognosis of affected patients significantly. 
Nevertheless, only little is known about mechanisms regulating tumor cell migration and the 
initial steps leading to the development of metastasis. Chemokines seem to play an important 
role in facilitating and guiding tumor cell motility as well as in targeting tumor cells to distinct 
metastatic sites. By using microarray technology, we have analyzed chemokine expression 
patterns in the stroma of primary tumors in a SCID mouse human melanoma xenotransplantation 
system. We were able to identify differentially expressed chemokines in the tumor stroma when 
compared to normal skin. In a next step, expression of corresponding human chemokines was 
analyzed by using real-time PCR on samples from human primary melanomas, stage T1 to T4. 
We found chemokines whose expression levels correlated significantly with tumor thickness 
(and tumor stage). Interestingly, the identified chemokines have not yet been reported to be of 
prognostic importance in human melanoma. Therefore, these differentially expressed chemokines 
might serve as new prognostic markers for cutaneous melanoma.
677
A method introducing a soluble recombinant protein specifically localized in the plasma 
membrane of melanocyte using the protein transduction
Kentaro Ohko1,2, Michitoshi Watanabe1,3, Michihiro Igarashi1,3, Masaaki Ito2 1Div. Mol. Cell. Biol. 
Grad. Sch. Med. Dent. Sci., Niigata Univ., Niigata, Japan, 2Dept. Dermatol. Grad. Sch. Med. 
Dent. Sci., Niigata Univ., Niigata, Japan, 3ransdisciplinary Res., Niigata Univ., Niigata, Japan
The mechanism of the melanin transfer in detail remains still unclear, however, one possible mechanism 
for this process is the transport and the exocytosis of melanosomes, and the subsequent phagocytosis 
of melanin. Some of the molecules involved in these steps have been identified. Many approaches 
have been tried to establish assays for this process, however, we must develop the novel techniques for 
the functions of the proteins involved in it, for complete understanding of the mechanism. We show a 
new method introducing a soluble recombinant protein specifically localized in the plasma membrane 
of melanocyte using the protein transduction. Protein transduction is a method for introducing 
exogenous recombinant proteins into cells using a virus-derived tag. These tags are usually composed 
of a cluster of basic amino acids, which interacts with the negative charge of the plasma membrane 
surface. R11, composed of eleven arginine(R) residues, is a highly potent mediator of plasma 
membrane permeation, and it has been used in many protein transduction studies to characterize 
the cellular functions of proteins. This method has several advantages over overexpression. For 
example, protein transduction can be used to introduce a protein into cells within less than an hour. 
In this study, we produced proteins with the membrane-targeting tag H3S, derived from the membrane 
protein syntaxin-3 [192-241], to maintain proteins in the plasma membrane. We confirmed that the 
H3S fragment targeted two fusion proteins into the area near the plasma membrane. Application of 
this method may give us the novel progress for assaying melanosome transfer.
678
Transcriptome variation in human keratinocytes and melanocytes regarding the genomic status 
of CDKN2A and MC1R genes
Joan Anton Puig-Butille1, Mª José Escamez2, Francisco Garcia-Garcia3, Celia Badenas1, Paula 
Aguilera1, Lucia Martinez Santamaria2, Joaquin Dopazo3, Marcela del Río2, Susana Puig1 
1Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d’Investigacions Biomèdiques Agustí 
Pi i Sunyer), Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), 
Barcelona, Spain, 2Department of Bioengineering, UC3M. Regenerative Medicine Unit, CIEMAT. 
Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain, 
3Bioinformatics Department, Centro de Investigación Príncipe Felipe (CIPF), Centro Investigación 
Biomédica en Red en Enfermedades Raras (CIBERER), Valencia, Spain
To analyze the effect of germinal CDKN2A mutations or MC1R red hair colour variants in the transcriptome of 
human skin cell types. Keratinocytes and melanocytes were obtained from four familial melanoma patients: two were 
CDKN2A mutation carriers and two were MC1R variants carriers. RNA from keratinocyte cultures (containing also 
melanocytes) derived from each patient was extracted and analyzed with the Whole Human Genome Microarray 
4x44K (Agilent). Differential gene expression analysis was carried out using the limma package from Bioconductor. 
Gene set analysis was carried out for the Gene Ontology terms and for the KEGG Pathways using FatiScan. Multiple 
testing adjustments of p-values were done according to False Discovery Rate method. Overall, 1535 transcripts were 
differentially expressed in CDKN2A mutated cells versus wild-type. Most of them were overexpressed (60.8%) in 
mutant cells. No pathway or molecular function was overrepresented in this subset of transcripts. In contrast, the 
downregulated genes group (39.2%) an overrepresentation of transcripts implicated in five molecular functions and 
Notch signanling pathway was observed. Comparison of MC1R variants carriers and non carriers found differences 
in 3570 transcripts. Upregulated group of transcripts (1954/3570; 54%) showed overrepresentation of 12 molecular 
functions and 16 pathways. Analysis of downregulated group of transcripts (1616/3570; 46%) identified three 
associated pathways. No molecular function was statistically significant in this group. In conclusion, both MC1R 
and CDKN2A genes modify the transcriptome of human skin cell types. The effect of MC1R variants in transcriptome 
variation is higher than a CDKN2A mutation.
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5,6-dihydroxyindole-2-carboxylic acid (DHICA) acts as a paracrine protecting messenger 
between melanocytes and keratinocytes
Daniela Kovacs1, Flori Enrica1, Vittoria Maresca1, Monica Ottaviani1, Nicaela Aspite1, Maria 
Lucia Dell’Anna1, Lucia Panzella2, Alessandra Napolitano2, Marco d’Ischia2, Mauro Picardo1 1Lab 
of Cutaneous Physiopathology & Integrated Center of Metabolomics Research, San Gallicano 
Dermatologic Institute, Rome, Italy, 2Dept of Organic Chemistry & Biochemistry, Univ of Naples 
Federico II, Naples, Italy
Skin photoprotection is generally associated to the synthesis of black eumelanin end products but 
increasing evidence suggests an active role of all the intermediates of the melanin biochemical 
pathway. The aim of the present study was to analyze the possibile role of the eumelanin 
intermediate DHICA in contributing to the skin defence mechanisms not only as a source 
forming melanin pigments in melanocytes but also as a messenger acting on the neighborhood 
keratinocytes. We treated primary cultures of human keratinocytes with increasing concentrations 
of DHICA and evaluated its possibile protective role in response to UVA irradiation. The results 
demonstrated that DHICA significantly preserved the overall cell survival and counteracted the 
peroxidation of the cell membrane polyunsatured fatty acids (PUFA), a parameter known to be 
associated with the loss of membrane integrity. Finally, cell death after UVA irradiation was 
significantly reduced in the presence of DHICA. Since the epidermis possesses enzymatic and 
non-enzymatic antioxidant systems to neutralize all the environmental oxidative stressors, we 
also evaluated the effects of DHICA on the keratinocytes antioxidant defences and we found that 
this compound was able to enhance the activity and the protein expression of the antioxidant 
enzymes catalase and superoxide dismutase. Taken together, our results demonstrate an important 
additional biological role of DHICA in skin photoprotection through its action as a paracrine 
messenger among epidermal cells and not only in the producing melanocytes themselves.
680
Epigenetic Dysregulation of Novel Genes in Melanoma
Hexiao Wang1, Angela McHugh1, Rubeta Matin2, Colin Fleming1, Irene Leigh1, Catherine 
Harwood2, Timothy Crook3, Gareth Inman1, Charlotte Proby1 1Welcome Trust Centre for 
Molecular Medicine and Biomedical Research Institute, College of Medicine, Dentistry and 
Nursing, Ninewells Hospital, University of Dundee, Dundee, UK, 2Barts & the London NHS Trust, 
London, UK, 3Department of Oncology, Southend University NHS Trust, Westcliff on Sea, UK
Cutaneous malignant melanoma (CMM) is an aggressive malignancy with a poor prognosis once 
metastatic. Epigenetic silencing of critical genes by promoter hypermethylation is thought to be 
crucial in melanoma progression and identification of melanoma-specific hypermethylation may 
reveal important molecular mechanisms of clinical relevance. We hypothesize that circulating 
methylated DNA from patients’ sera could be a robust biomarker for metastasis and patient 
outcome. Methylation reversal studies identified a number of candidate genes including TFPI2, 
EGR2 and DKK1. We investigated promoter methylation from melanoma cell lines (n=17), tissue 
samples (n = 122), benign naevi (n=10) and serum samples (n=32). Additionally, we investigated 
the TGF-β signaling components, Dab2 and Smad3. There was a high frequency of promoter 
methylation for EGR2 (70.6%), DKK1 (76.5%), Smad3 (82.4%) and TFPI2 (64.7%) in melanoma 
cell lines. In melanoma tissue samples we found significantly increased Dab2 methylation with 
low and intermediate methylation levels for Smad3 and TPFI2, respectively. Comparatively, 10 
benign naevi had no methylation of these 3 candidate genes. Hypermethylation of Dab2 and 
TFPI2 was detected in 12/20 (60%) of sera from patients with poor prognosis melanoma with only 
1/12 (10%) positive serum in good prognosis disease (Breslow <1 mm). These data support a role 
for epigenetic silencing of TGF-β pathway components, Smad3 and Dab2, as well as TFPI2, EGR2 
and DKK1 in melanoma. Detection of promoter hypermethylated Dab2 and TFPI2 in patient 
serum samples suggests ‘serum epigenetics’ could provide novel biomarkers with clinical utility 
for early detection of metastasis.
681
Defective autophagy in melanoma development and progression: role of oncogenic B-RAF 
signalling
Jane Armstrong1, Hannah Polson2, Rob Ellis1, Nigel Kirkham3, Stuart Horswell2, Sharon Tooze2, 
Penny Lovat1 1Newcastle University, Newcastle Upon Tyne, UK, 2London Research Institute, 
Cancer Research UK, London, UK, 3Royal Victoria Infirmary, Newcastle Upon Tyne, UK
Cutaneous melanoma is a major public health problem and novel treatment strategies remain 
in acute demand. Autophagy is an essential lysosome-mediated process for the degradation 
and recycling of surplus proteins and damaged organelles, and suppression of autophagy has 
recently been associated with tumourigenesis. We have previously demonstrated that oncogenic 
B-RAF signalling results in deregulated autophagy in melanoma cells, and the purpose of the 
present study is to decipher the molecular regulation of autophagy inhibition in this context. Data 
demonstrate that over-expression of the autophagy regulatory protein WIPI-1 in B-RAF wild-type 
melanoma cells resulted in blockade of autophagy activation in response to nutrient deprivation, 
identifying WIPI-1 as a novel autophagy inhibitory protein in melanoma. Furthermore, melanoma 
cells with oncogenic mutations (B-RAF, PTEN) resulting in activated MEK/ERK signalling express 
increased levels of WIPI-1 compared to cells with basal MEK/ERK signalling. In addition, WIPI-
1 expression was increased by over-expression of mutant B-RAF in B-RAF wild-type cells, 
whereas inhibition of MEK signalling resulted in down-regulation of WIPI-1 expression in B-RAF 
mutated melanoma cells. Data also show that primary early stage tumours derived from B-RAF 
mutated melanoma exhibit significantly increased WIPI-1 expression compared to B-RAF wild-
type tumours (P < 0.001). As B-RAF signalling is activated in the majority of melanomas, these 
data suggest that increased WIPI-1 expression and deregulated autophagy may play a role in 
the development/progression of melanoma. The identification of novel proteins coupled with 
defective autophagy may therefore facilitate the discovery of novel therapeutic targets and 
biomarkers of melanoma progression.
682
Correlation of the biopolymer poly(ADP-ribose) with clinical parameters of malignant 
melanomas
Zsuzsanna Gehl2, Peter Bai1, Edina Bodnar4, Gabriella Emri4, Eva Remenyik4, Janos Nemeth4, Pal 
Gergely1,3, Laszlo Virag1,3, Eva Szabo4 1Department of Medical Chemistry, Medical and Health 
Science Center, University of Debrecen, Debrecen, Hungary, 2Department of Ophthalmology, 
Semmelweis University, Budapest, Hungary, 3Cell Biology and Signaling Research Group of the 
Hungarian Academy of Sciences, Debrecen, Hungary, 4Department of Dermatology, Medical and 
Health Science Center, University of Debrecen, Debrecen, Hungary
Poly(ADP-ribose) (PAR) is a NAD-derived biopolymer synthesized by poly(ADP-ribose) 
polymerase (PARP) enzymes and degraded by poly(ADP-ribose) glycohydrolase (PARG). 
Information on its role in the skin is scarce although it has been implicated in inflammatory 
dermatoses and burns. Here we set out to detect the presence of PAR in normal human skin 
and it histological samples of melanoma patients. Cutaneous malignant melanoma (CMM) and 
uveal melanoma (UM) represent the most aggressive pigment cell tumor types. We have found 
the presence of PAR in keratinocytes, sebocytes, in hair follicles, in endothelial cells and in 
subcutaneous adipocytes in the normal skin. CMM cells were PAR positive and tumor invasion 
level/thickness of CMM was correlated with the PAR content of the cells’ nuclei with higher 
Clark and Breslow indices associating with higher PAR content. Of note, this correlation was 
especially strong in the samples of female patients. In UM tumors (n=12) a slight overall and 
strong perivascular PAR staining was observed with marked individual variations. In the view 
of successful recent clinical trials with PARP inhibitors used as adjuvant chemotherapeutic 
agents, our results suggest that melanomas may display differential sensitivity towards this novel 
therapeutic modality which should be considered for the selection of patients.
683
Determination of epidermal melanin density is an independent predictor of risk of cutaneous 
melanoma
Oliver Schanab1, Judith Wendt1, Andreas Gleiss2, Hubert Pehamberger1, Ichiro Okamoto1 
1Department of Dermatology, Division of General Dermatology, Medical University Vienna, 
Vienna, Austria, 2Center for Medical Statistics, Informatics and Intelligent Systems, Medical 
University Vienna, Vienna, Austria
The estimation of the density of epidermal melanin by spectrophotometry has been suggested 
to be an objective method to measure constitutive skin color and consequently an appropriate 
approach to identify individuals at high risk of cutaneous melanoma. To validate the relevance 
of this objective measure of skin phenotype as a predictor of risk of melanoma, a case-control 
study was conducted for the first time, in a Caucasian population of middle European ancestry 
in Austria. Incident melanoma cases (n = 358), diagnosed between 1998 and 2009 and controls 
(n = 434) were frequency-matched by age and sex. In addition to detailed interviews and 
dermatologic examinations, melanin measurement from skin reflectance of light of 400 and 420 
nm wavelengths in the UV-shielded sites at the medial upper quadrant of the buttock and at the 
upper inner arm, respectively, were performed. For melanoma the odds ratios comparing the least 
with the highest of four melanin categories were 5.9 (95% confidence interval (CI): 3.2, 10.6) 
at the buttock and 5.4 (95% CI: 2.1, 14.1) at the upper inner arm, respectively. There were no 
gender related differences in the risk estimates. Furthermore, inclusion of additional covariates 
such as sun exposure pattern, sunburn history and skin reaction to sun exposure in a multi-
variable statistical model did not change considerably risk estimates for any of the four melanin 
categories. This study emphasizes that the objective determination of constitutive skin color is a 
largely independent and strong predictor of risk of melanoma.
684
Combined treatment with cobetasol and cognitive behavioral therapy in adult patients with 
vitiligo
Ana Caballero, Fermín Jurado, Ma Luisa Peralta, Gisella Solano Centro Dermatológico Dr. 
Ladislao de la Pascua, Distrito Federal, Mexico
Compare the effectiveness of topical treatment with clobetasol and cognitive behavioral 
therapy to topical treatment with clobetasol in adult patients with vitiligo of recent onset. 
Randomized controlled trial. Patients with vitiligo of less 2 years of evolution, facial 
involvement and or hands, 18 to 40 years without systemic diseases and levels of anxiety or 
depression mild to moderate (assessed by psychology); the control group received topical 
clobetasol and the experimental group also received psychotherapy. Patients in both groups 
were evaluated every 2 weeks by dermatology, the treatment was applied 1 once a day for 
2 months. The experimental group received 8 weekly psychological sessions. Patients in 
both groups were followed up 2 months after therapeutic intervention to assess its stability. 
The improvement was evaluated through an iconographic analysis and statistical using SPSS. 
It initially work with 38 patients of whom 20 were eliminated for several reasons. 18 patients who 
were 10 in the control and 8 experimental, at 2 months of treatment the control group showed an 
average improvement of 23.5% against 31.4% in the experimental group, the fourth month the 
control group had an average improvement of 37.1% against 42.3% in the experimental group. 
Studen t = -0.99 which corresponds to p = .334. While noting improvements in the experimental 
group was not supported statistically generalize this type of intervention, however it is important 
to consider this factor, since as noted if it influences the therapeutic response, we agree with other 
authors as to the combination of treatments for best results in our patients.
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Desmoglein 2 depletion leads to increased migration and upregulation of secretogranin II in 
melanoma cells
Wiebke K. Peitsch, Yvette Doerflinger, Alexander Bauer, Stefan W. Schneider, Sergij Goerdt 
Department of Dermatology, University Medical Centre Mannheim, Heidelberg University, 
Mannheim, Germany
During development and progression of melanomas, an important role has been attributed to 
alterations of cell-cell adhesions, specifically, to a “cadherin switch” from E- to N-cadherin. 
We have recently shown that a subtype of melanoma cells contains, in addition to classical 
cadherins, the desmosomal cadherin desmoglein 2 (Dsg2) as non-junction-bound cell surface 
protein. To study the impact of Dsg2 on melanoma cell migration, invasion, adhesion and 
proliferation, two melanoma lines containing high endogenous amounts of Dsg2, i. e. C32 cells 
derived from a primary amelanotic melanoma and MeWo cells originating from a lymph node 
metastasis, were depleted of the protein by siRNA treatment. In Transwell migration, scratch 
wounding and Matrigel invasion assays, cells depleted of Dsg2 showed significantly – 2.9 to 6.1-
fold – increased migration as well as 3.8 to 7.3-fold enhanced invasion, whereas cell-substratum 
adhesion and proliferation were largely unaltered. In gene expression profiling comparing Dsg2-
depleted to non-targeting siRNA-treated MeWo and C32 cells as well as in subsequent real time 
PCR analyses, significant upregulation of the secretory protein secretogranin II, which has not 
been described in melanoma cells before, was noted upon Dsg2 knockdown. As the bioactive 
peptide derived from secretogranin II, secretoneurin, is known to exert pro-migratory and 
chemoattractive functions, increased secretogranin II production might be a novel mechanism 
triggering melanoma cell migration, possibly contributing to development and progression of 
melanomas.
686
Identification of new genetic biomarkers involved in genetic predisposition to cutaneous 
melanoma
Nadem Soufir1,3, Mickael Guedj4, Hui-Han Hu1, Maider Ibarrola5, Philippe Aegerter6, Vincent 
Descamps7,2, Nicole Basset-Seguin8,2, Armand Bensussan3, Martine Bagot8,3, Eduardo Nagore9, 
Gloria Ribas5, Philippe Saiag10, Bernard Grandchamp1,2 1Laboratoire de Génétique, Hopital 
Bichat, APHP,, Paris, France, 2Université Paris 7, Paris, France, 3Inserm U976, Centre de Recherche 
Sur la Peau, Hopital Saint Louis, Paris, France, 4Laboratoire Statistiques et genomes, Evry, France, 
5Department of Haenatology and Medical Oncology, Fundacion Investigacion Hospital Clinico-
INCLIVA,, Valencia, Spain, 6URC, Hopital Ambroise Paré, APHP,, Boulogne Billancourt, France, 
7Service de Dermatologie, Hopital Bichat, APHP,, Paris, France, 8Service de Dermatologie, Hopital 
Saint Louis, APHP,, Paris, France, 9Instituto Valenciano de Oncología, Valencia, Spain, 10Service de 
Dermatologie, Hopital Ambroise Paré, Boulogne Billancourt, France
In this study, we investigated the involvement of 338 candidate SNPs in genetic predisposition to 
melanoma by using a dedicated chip (Illumina technology) as part of a case-control study (1069 
melanoma patients, 925 controls). These SNPs belong to 110 genes involved in pigmentation and 
most of these were predicted to be functional using bioinformatic algorithms. The genotyping 
was performed on a beadexpress station using Goldengate technology. Statistical association 
between melanoma risk and each marker was tested in genotypic, additive, dominant, recessive 
models by calculating the P value and the odds ratio (OR). Twenty genetic markers in 19 different 
genes were significantly associated with melanoma risk: WNT3 (OR: 0.80 [0.69-0.94]), VPS41 
(OR: 0.83 [0.72-0.95]), SLC24A4 (OR : 1; 16 [1.10-1.34]), EGFR (OR: 0.82 [0.72-0.94]), POLH 
(OR: 0.66 [0.45-0.98], OR: 0.62 [0.43-0.90] ), AP3B1 (OR: 0.72 [0.65-0.94]), MUTED (OR: 0.86 
[0.74-0.99]), PAX3 (OR: 1.17 [1.01-1.35]) MITF (OR: 0.80 [0.70-0.92]), TP53 (OR: 0.80 [0.67-
0.96]), SLC31A2 (OR: 1.33 [1.12-1.57]), HERC2 (OR : 0.78 [0.69-0.89]), MYO5A (OR: 0.87 
[0.77-0.99]), HPS1 (OR: 0.79 [0.63-0.98]), TYRP1 (OR: 0.87 [0.76-0.98] ) HPS4 (OR: 1.24 [1.01-
1.53]), ASIP (OR: 0.75 [0.61-0.92]), DCT (OR: 0.85 [0.73-0.99]), and GNA11 (OR: 1.21 [1.06-
1.38]). Most of these markers remain significant after adjustment on pigmentation characteristics, 
and several markers have been replicated in two spanish cohorts of 1017 melanomas and 822 
controls. These results may useful in the future in identifying individuals highly predisposed to 
melanoma.
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